PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Long, MY; Thornton, K				Long, MY; Thornton, K			Gene duplication and evolution	SCIENCE			English	Editorial Material							PRESERVATION; DROSOPHILA		Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Vision, Todd J/B-4867-2010	Vision, Todd J/0000-0002-6133-2581; Thornton, Kevin/0000-0003-0743-4445				Force A, 1999, GENETICS, V151, P1531; Li W. H, 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Weichenhan D, 1998, CYTOGENET CELL GENET, V80, P226, DOI 10.1159/000014985; Zeng LW, 1998, GENETICA, V102-3, P369, DOI 10.1023/A:1017035109224	9	62	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1551	1551						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533445				2022-12-28	WOS:000170802900001
J	Samuelson, P				Samuelson, P			Anticircumvention rules: Threat to science	SCIENCE			English	Editorial Material								Scientists who study encryption or computer security or otherwise reverse engineer technical measures, who make tools enabling them to do this work, and who report the results of their research face new risks of legal liability because of recently adopted rules prohibiting the circumvention of technical measures and manufacture or distribution of circumvention tools. Because all data in digital form can be technically protected, the impact of these rules goes far beyond encryption and computer security research. The scientific community must recognize the harms these rules pose and provide guidance about how to improve the anticircumvention rules.	Univ Calif Berkeley, Sch Informat Management & Law, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Samuelson, P (corresponding author), Univ Calif Berkeley, Sch Informat Management & Law, Berkeley, CA 94720 USA.							Appel AW, 2000, COMMUN ACM, V43, P21, DOI 10.1145/348941.348968; COHEN JE, 2000, NEW REPUBLIC    0523; DAWSON K, 2001, IND STANDARD    0507; Lemley MA, 1998, DUKE LAW J, V48, P147, DOI 10.2307/1373106; MANN CC, 2001, INSIDE MAGAZINE 0422; National Research Council, 1997, BITS POW ISS GLOB AC; REICHMAN JH, 1999, BERKELEY TECHNOLOGY, V14, P793; REICHMAN JH, 1997, VANDERBILT LAW REV, V50, P51; Samuelson P, 1999, BERKELEY TECHNOLOGY, V14, P519; Samuelson P., 1997, VA J INT L, V37, P369; Zittrain J, 2000, STANFORD LAW REV, V52, P1201, DOI 10.2307/1229513	11	25	25	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2028	2031		10.1126/science.1063764	http://dx.doi.org/10.1126/science.1063764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	473FB	11557876				2022-12-28	WOS:000171028700057
J	Groom, AV; Wolsey, DH; Naimi, TS; Smith, K; Johnson, S; Boxrud, D; Moore, KA; Cheek, JE				Groom, AV; Wolsey, DH; Naimi, TS; Smith, K; Johnson, S; Boxrud, D; Moore, KA; Cheek, JE			Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIELD GEL-ELECTROPHORESIS; CHILDREN; OUTBREAK; CLONE; RISK; EPIDEMIOLOGY; STRAINS; MRSA; MEC	Context Until recently, methicillin-resistant Staphylococcus aureus (MRSA) infections have been acquired primarily in nosocomial settings. Four recent deaths due to MRSA infection in previously healthy children in the Midwest suggest that serious MRSA infections can be acquired in the community in rural as well as urban locations. Objectives To document the occurrence of community-acquired MRSA infections and evaluate risk factors for community-acquired MRSA infection compared with methicillin-susceptible S aureus (MSSA) infection. Design Retrospective cohort study with medical record review. Setting Indian Health Service facility in a rural midwestern American Indian community. Patients Patients whose medical records indicated laboratory-confirmed S aureus infection diagnosed during 1997. Main Outcome Measures Proportion of MRSA infections classified as community acquired based on standardized criteria; risk factors for community-acquired MRSA infection compared with those for community-acquired MSSA infection; and relatedness of MRSA strains, determined by pulsed-field gel electrophoresis (PFGE). Results Of 112 S aureus isolates, 62 (55%) were MRSA and 50 (45%) were MSSA. Forty-six (74%) of the 62 MRSA infections were classified as community acquired. Risk factors for community-acquired MRSA infections were not significantly different from those for community-acquired MSSA. Pulsed-field gel electrophoresis subtyping indicated that 34 (89%) of 38 community-acquired MRSA isolates were clonally related and distinct from nosocomial MRSA isolates found in the region. Conclusions Community-acquired MRSA may have replaced community-acquired MSSA as the dominant strain in this community. Antimicrobial susceptibility patterns and PFGE subtyping support the finding that MRSA is circulating beyond nosocomial settings in this and possibly other rural US communities.	Indian Hlth Serv, Natl Epidemiol Program, Albuquerque, NM 87110 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA USA; Minnesota Dept Hlth, Acute Dis Epidemiol Sect, Minneapolis, MN USA; Minnesota Dept Hlth, Div Publ Hlth Labs, Minneapolis, MN USA; ICAN Inc, Eden Prairie, MN USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Minnesota Department of Health (MHD)	Cheek, JE (corresponding author), Indian Hlth Serv, Natl Epidemiol Program, 5300 Homestead Rd NE,Headquarters, Albuquerque, NM 87110 USA.			Naimi, Timothy/0000-0001-9849-4413	PHS HHS [U50/CCU511190] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abi-Hanna P, 2000, CLIN INFECT DIS, V30, P630, DOI 10.1086/313706; ANTHONY BF, 1967, PEDIATRICS, V39, P263; Ayliffe GAJ, 1997, CLIN INFECT DIS, V24, pS74, DOI 10.1093/clinids/24.Supplement_1.S74; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; *CDCP, 1998, NAT NOS INF SURV SYS; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; *CDCP, 1997, EP INF VERS 6 04C; Cockerill FR, 1997, JAMA-J AM MED ASSOC, V277, P38, DOI 10.1001/jama.277.1.38; Cookson BD, 2000, INFECT CONT HOSP EP, V21, P398, DOI 10.1086/501781; *CYT SOFTW CORP, 1997, STATX 3; DAJANI AS, 1973, ARCH DERMATOL, V108, P517, DOI 10.1001/archderm.108.4.517; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; Frank AL, 1999, PEDIATR INFECT DIS J, V18, P993, DOI 10.1097/00006454-199911000-00012; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Joe J R, 1996, J Am Med Womens Assoc (1972), V51, P141; JORGENSEN JH, 1986, EUR J CLIN MICROBIOL, V5, P693, DOI 10.1007/BF02013307; Kallen AJ, 2000, INFECT CONT HOSP EP, V21, P223, DOI 10.1086/501750; KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647; Macfarlane L, 1999, J HOSP INFECT, V41, P29, DOI 10.1016/S0195-6701(99)90034-8; Maguire GP, 1996, MED J AUSTRALIA, V164, P721, DOI 10.5694/j.1326-5377.1996.tb122270.x; Monnet DL, 1998, INFECT CONT HOSP EP, V19, P552; MORENO F, 1995, CLIN INFECT DIS, V21, P1308, DOI 10.1093/clinids/21.5.1308; MUSSER JM, 1992, J CLIN MICROBIOL, V30, P2058, DOI 10.1128/JCM.30.8.2058-2063.1992; National Committee for Clinical Laboratory Standards, 1997, M2A6 NCCLS CLIN LAB, V6th; National Committee for Clinical Laboratory Standars, 1999, M100S9 NAT COMM CLIN; NISHI JI, 1995, J LAB CLIN MED, V126, P29; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; RHOADES ER, 1987, PUBLIC HEALTH REP, V102, P361; Roberts RB, 1998, MICROB DRUG RESIST, V4, P175, DOI 10.1089/mdr.1998.4.175; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Tenover F, 1998, BACTERIAL INFECT HUM, P83; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Warshawsky B, 2000, INFECT CONT HOSP EP, V21, P724, DOI 10.1086/501718; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435	40	282	296	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1201	1205		10.1001/jama.286.10.1201	http://dx.doi.org/10.1001/jama.286.10.1201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559265	Bronze			2022-12-28	WOS:000170910400030
J	Bedford, H; de Louvois, J; Halket, S; Peckham, C; Hurley, R; Harvey, D				Bedford, H; de Louvois, J; Halket, S; Peckham, C; Hurley, R; Harvey, D			Meningitis in infancy in England and Wales: follow up at age 5 years	BRITISH MEDICAL JOURNAL			English	Article							BACTERIAL-MENINGITIS; INFLUENZAE MENINGITIS; HEARING-LOSS; CHILDREN; OUTCOMES; SEQUELA	Objective To describe important sequelae occurring among a cohort of children aged 5 years who had had meningitis during the first year of life and who had been identified by a prospective national study of meningitis in infancy in England and Wales between 1985 and 1987. Design Follow up questionnaires asking about the children's health and development were sent to general practitioners and parents of the children and to parents of matched controls. The organism that caused the infection and age at infection were also recorded. Setting England and Wales. Participants General practitioners and parents of children who had had meningitis before the age of 1 year and of matched controls. Main outcome measures The prevalence of health and developmental problems and overall disability among children who had had meningitis compared with controls. Results Altogether, 1584 of 1717 (92.2%) children who had had meningitis mid 1391 of 1485 (93.6'%) controls were successfully followed up, Among children who survived to age 5 years 247 of 1584 (15.6%) had a disability; there was a 10-fold increase in the risk of severe or moderate disability at 5 years of age among children who had had meningitis (relative risk 10.3, 95% confidence interval 6.7 to 16.0, P<0.001). There was considerable variation in the rates of severe or moderate disability in children infected with different organisms. Conclusion The long term consequences of having meningitis during the first year of life are significant: 32 of 1717 (1.8%) children died within five years. Not only did almost a fifth of children with meningitis have a permanent, severe or moderately severe disability, but subtle deficits were also more prevalent.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Publ Hlth Lab Serv, Environm Surveillance Unit, London NW9 5EQ, England; Queen Charlottes & Chelsea Hosp, Dept Paediat & Neonatal Med, Imperial Coll Sch Med, Karim Ctr Meningitis Res, London W6 0XG, England	University of London; University College London; Public Health England; Imperial College London	Bedford, H (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		peckham, catherine s/I-6300-2013					BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BERLOW SJ, 1980, LARYNGOSCOPE, V90, P1445, DOI 10.1288/00005537-198009000-00004; CRIMWOOD K, 1995, PEDIATRICS, V95, P646; DAVIES PA, 1994, NEONATAL MENINGITIS, P140; DELOUVOIS J, 1991, ARCH DIS CHILD, V66, P603, DOI 10.1136/adc.66.5.603; DODGE PR, 1984, NEW ENGL J MED, V311, P869, DOI 10.1056/NEJM198410043111401; FELDMAN HM, 1988, PEDIATRICS, V81, P339; FORTNUM HM, 1992, ARCH DIS CHILD, V67, P1111, DOI 10.1136/adc.67.9.1111; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; KAPLAN SL, 1981, PEDIATRICS, V68, P8; MCINTYRE P, 1993, MED J AUSTRALIA, V159, P766, DOI 10.5694/j.1326-5377.1993.tb141344.x; NADOL JB, 1978, LARYNGOSCOPE, V88, P739; RIORDAN A, 1993, BRIT J AUDIOL, V27, P375, DOI 10.3109/03005369309076713; Shields M D, 1995, Qual Health Care, V4, P269, DOI 10.1136/qshc.4.4.269; UNHANAND M, 1993, J PEDIATR-US, V122, P15, DOI 10.1016/S0022-3476(05)83480-8	16	178	186	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					533	536		10.1136/bmj.323.7312.533	http://dx.doi.org/10.1136/bmj.323.7312.533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546697	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000170934600017
J	Puthalakath, H; Villunger, A; O'Reilly, LA; Beaumont, JG; Coultas, L; Cheney, RE; Huang, DCS; Strasser, A				Puthalakath, H; Villunger, A; O'Reilly, LA; Beaumont, JG; Coultas, L; Cheney, RE; Huang, DCS; Strasser, A			Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis	SCIENCE			English	Article							BCL-2 FAMILY; LIGHT-CHAIN; CELL-DEATH; APOPTOSIS; DYNEIN; MEMBER; BIM; PURIFICATION; INTEGRINS	Bcl-2 family members bearing only the BH3 domain are essential inducers of apoptosis. We identified a BH3-only protein, Bmf, and show that its BH3 domain is required both for binding to prosurvival Bcl-2 proteins and for triggering apoptosis. In healthy cells, Bmf is sequestered to myosin V motors by association with dynein light chain 2. Certain damage signals, such as loss of cell attachment (anoikis), unleash Bmf, allowing it to translocate and bind prosurvival. Bcl-2 proteins. Thus, at least two mammalian BH3-only proteins, Bmf and Bim, function to sense intracellular damage by their localization to distinct cytoskeletal structures.	Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; Univ N Carolina, Chapel Hill, NC 27599 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of North Carolina; University of North Carolina Chapel Hill	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Huang, David C. S./C-7586-2013; Puthalakath, Hamsa/B-8541-2011; Strasser, Andreas/C-7581-2013	Huang, David C. S./0000-0002-3101-4873; Strasser, Andreas/0000-0002-5020-4891; Cheney, Richard/0000-0001-6565-7888	NATIONAL CANCER INSTITUTE [R01CA080188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003299] Funding Source: NIH RePORTER; NCI NIH HHS [CA 80188] Funding Source: Medline; NIDCD NIH HHS [R29 DC003299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; PUTHALAKATH H, UNPUB; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Wick W, 1996, ONCOGENE, V12, P973; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; [No title captured]	23	470	503	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1829	1832		10.1126/science.1062257	http://dx.doi.org/10.1126/science.1062257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546872				2022-12-28	WOS:000170894400047
J	Brotherton, SE; Simon, FA; Etzel, SI				Brotherton, SE; Simon, FA; Etzel, SI			US graduate medical education, 2000-2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH	For the last three quarters of a century, the American Medical Association's national collection of graduate medical education (GME) data has evolved in its scope and methods. This year's GME survey involved new technology. The National GME Census for 2000-2001, jointly administered by the American Medical Association and the Association of American Medical Colleges, was part of an Internet-based product called GME Track. Because of technical problems, data collection was less complete than in previous years. Similar to the 1999-2000 survey, we observed an increase in the number of subspecialty programs, with 79 more than last year (2.1% increase), and a decrease in the number of specialty programs, with 40 (0.9%) fewer. Parallel to this continuing trend was a decrease in the number of graduates of US medical schools who were matched into primary care residencies, particularly family practice programs (20% decrease compared with 1996-1997). The number of graduates of osteopathic medical schools training in allopathic programs continued to rise, increasing 7.9% from last year. Numbers of Hispanic and Asian graduates from US allopathic medical schools (USMDs) in graduate year 1 (GY1) positions increased numerically to 887 and 2356, respectively, and proportionally by 7.2% and 17.3%, respectively. Although the number of white USMDs in GY1 positions increased, their proportion decreased slightly among those with known race or ethnicity from 72.2% to 71.7%, and the number of black USMD GY1 residents, numbering 859, declined from the previous year. Although we observed an overall decline in the average number of on-duty hours expected of residents in their first year in a program (from 55 in 1996-1997 to 54 in 2000-2001; P<.001), the average number of hours reported by the majority of programs that typically report the most on-duty hours did not decrease. The issues of resident work hours and the diversity and specialty distribution of the physician workforce continue to foster debate.	Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, Chicago, IL 60610 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, 515 N State St, Chicago, IL 60610 USA.							*AM COLL SURG, 1994, B AM COLL SURG, V79, P89; Association of American Medical Colleges, 2001, AAMC DAT BOOK STAT I; *COUNC GRAD MED ED, 1999, COGME PHYS WORKF POL; *COUNC GRAD MED ED, 1992, IMPR ACC HLTH CAR PH; *COUNC GRAD MED ED, 1994, REC IMPR ACC HLTH CA; Defoe DM, 2001, OBSTET GYNECOL, V97, P1015, DOI 10.1016/S0029-7844(01)01363-1; Gabel J, 2000, HEALTH AFFAIR, V19, P144, DOI 10.1377/hlthaff.19.5.144; MARTIN S, 2001, DROWSY DOCTORS YOUNG; Politzer RM, 1999, J RURAL HEALTH, V15, P11, DOI 10.1111/j.1748-0361.1999.tb00594.x	9	30	30	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1056	+		10.1001/jama.286.9.1056	http://dx.doi.org/10.1001/jama.286.9.1056			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469EW	11559290				2022-12-28	WOS:000170802500019
J	Astagneau, P; Desplaces, N; Vincent, V; Chicheportiche, V; Botherel, AH; Maugat, S; Lebascle, K; Leonard, P; Desenclos, JC; Grosset, J; Ziza, JM; Brucker, G				Astagneau, P; Desplaces, N; Vincent, V; Chicheportiche, V; Botherel, AH; Maugat, S; Lebascle, K; Leonard, P; Desenclos, JC; Grosset, J; Ziza, JM; Brucker, G			Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak	LANCET			English	Article							IMMUNOCOMPETENT PATIENT; DISEASE; PREVENTION; ARTHRITIS; GUIDELINE; FRANCE	Background Mycobacterium xenopi spinal infections were diagnosed in 1993 in patients who had undergone surgical microdiscectomy for disc hernia, by nucleotomy or microsurgery, in a private hospital. Contaminated tap water, used for rinsing surgical devices after disinfection, was identified as the source of the outbreak. Several cases were recorded in the 4 years after implementation of effective control measures because of the long time between discectomy and case detection. The national health authorities decided to launch a retrospective investigation in patients who were exposed to M xenopi contamination in that hospital. Methods Mailing and media campaigns were undertaken concurrently to trace exposed patients for spinal infections. Patients we re screened by magnetic resonance imaging (MRI), and the scans were reviewed by a radiologist who was unaware of the diagnosis. Suspected cases had discovertebral biopsy for histopathological and bacteriological examination. Findings Of 3244 exposed patients, 2971 (92%) were informed about the risk of infection and 2454 (76%) had MRI, Overall, 58 cases of M xenopi spinal infection were identified (overall cumulative frequency 1.8%), including 26 by the campaign (mean delay in detection 5.2 years, SD 2.4, range 1-10 years). Multivariate analysis showed that the risk of M xenopi spinal infection was related to nucleotomy and high number of patients per operating session. Interpretation Failures in hygiene practices could result in an uncontrolled outbreak of nosocomial infection. Patients who have been exposed to an iatrogenic infectious hazard should be screened promptly and receive effective information.	CCLIN Paris Nord, Inst Cordeliers, F-75006 Paris, France; Hop Croix St Simon, Paris, France; Inst Pasteur, Paris, France; Hop Lariboisiere, F-75475 Paris, France; Hop La Pitie Salpetriere, Paris, France; Inst Veille Sanitaire, St Maurice, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris 13; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institute of Public Health Surveillance	Astagneau, P (corresponding author), CCLIN Paris Nord, Inst Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.		Astagneau, Pascal/AAF-3473-2020					Astagneau P, 2001, J HOSP INFECT, V47, P84, DOI 10.1053/jhin.2000.0874; BANKS J, 1984, THORAX, V39, P376, DOI 10.1136/thx.39.5.376; BENNETT SN, 1994, AM J RESP CRIT CARE, V150, P245, DOI 10.1164/ajrccm.150.1.8025757; BULLIN CH, 1970, J HYG-CAMB, V68, P97, DOI 10.1017/S0022172400028540; Coombes GM, 1996, BRIT J RHEUMATOL, V35, P1008; Danesh-Clough R, 2000, SPINE, V25, P626, DOI 10.1097/00007632-200003010-00015; DECLUDT B, 2000, B EPIDEMIOL HEBD, V17, P71; ElHelou P, 1997, CLIN INFECT DIS, V25, P206, DOI 10.1086/514525; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; FEYEN J, 1983, CLIN ORTHOP RELAT R, P189; Froideveaux D, 1996, CLIN INFECT DIS, V22, P723, DOI 10.1093/clinids/22.4.723; GHOSEZ JP, 1994, RACHIS, V6, P147; GOUJARD J, 1988, INT J EPIDEMIOL, V17, P423, DOI 10.1093/ije/17.2.423; GROSS W M, 1976, Bulletin of the International Union Against Tuberculosis, V51, P267; Jiva TM, 1997, CLIN INFECT DIS, V24, P226, DOI 10.1093/clinids/24.2.226; JONES PG, 1995, CLIN INFECT DIS, V21, P1352, DOI 10.1093/clinids/21.5.1352-a; Kelly M, 1999, CLIN INFECT DIS, V29, P1342, DOI 10.1086/313447; Lot F, 1999, ANN INTERN MED, V130, P1, DOI 10.7326/0003-4819-130-1-199901050-00002; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; MARKS J, 1975, TUBERCLE, V56, P157, DOI 10.1016/0041-3879(75)90026-4; MILLER WC, 1994, CLIN INFECT DIS, V19, P1024, DOI 10.1093/clinids/19.6.1024; PICARDEAU M, 1995, RES MICROBIOL, V146, P237, DOI 10.1016/0923-2508(96)80279-8; PROSSER AJ, 1986, TUBERCLE, V67, P229, DOI 10.1016/S0041-3879(86)80030-7; RAHMAN MAA, 1992, TUBERCLE LUNG DIS, V73, P392, DOI 10.1016/0962-8479(92)90047-N; Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8; SCHWABACHER HERTA, 1959, JOUR HYG, V57, P57; SMITH MJ, 1983, THORAX, V38, P373, DOI 10.1136/thx.38.5.373; SNIADACK DH, 1993, INFECT CONT HOSP EP, V14, P636; Telgt DSC, 1997, BRIT J RHEUMATOL, V36, P1025; VESTAL ASM, 1975, PROCEDURES ISOLATION	30	72	75	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					747	751		10.1016/S0140-6736(01)05843-3	http://dx.doi.org/10.1016/S0140-6736(01)05843-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551599				2022-12-28	WOS:000170729500031
J	Fish, RM; Geddes, LA				Fish, RM; Geddes, LA			Effects of stun guns and tasers	LANCET			English	Editorial Material									Univ Illinois, Dept Bioengn Elect & Comp Engn, Urbana, IL 61801 USA; Univ Illinois, Coll Med, Urbana, IL 61801 USA; Purdue Univ, Sch Biomed Engn, W Lafayette, IN 47907 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Fish, RM (corresponding author), Univ Illinois, Dept Bioengn Elect & Comp Engn, Urbana, IL 61801 USA.							ALLEN TB, 1992, J FORENSIC SCI, V37, P956; *AMN INT, 1996, AMR514596; DAVIS WM, 1991, GEN PHARMACOL-VASC S, V22, P723, DOI 10.1016/0306-3623(91)90086-L; JONSSON S, 1983, AM J MED, V75, P1061, DOI 10.1016/0002-9343(83)90889-6; KORNBLUM RN, 1991, J FORENSIC SCI, V36, P434; MEHL LE, 1992, ACTA OBSTET GYN SCAN, V71, P118, DOI 10.3109/00016349209007967; Murray J, 1997, GUIDE TASER TECHNOLO; ORDOG GJ, 1987, ANN EMERG MED, V16, P73, DOI 10.1016/S0196-0644(87)80292-5; ROBINSON MN, 1990, MED SCI LAW, V30, P285, DOI 10.1177/106002809003000403; ROY OZ, 1989, MED BIOL ENG COMPUT, V27, P445, DOI 10.1007/BF02441441	10	19	19	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					687	688		10.1016/S0140-6736(01)05950-5	http://dx.doi.org/10.1016/S0140-6736(01)05950-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551573				2022-12-28	WOS:000170729500006
J	He, FJ; MacGregor, GA				He, FJ; MacGregor, GA			Fortnightly review - Beneficial effects of potassium	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLOOD-PRESSURE; DIETARY POTASSIUM; URINARY CALCIUM; STROKE; RISK; EXCRETION; MAGNESIUM; FRUIT; METABOLISM; DIURETICS		Univ London St Georges Hosp, Sch Med, Blood Pressure Unit, London SW17 0RE, England	St Georges University London	MacGregor, GA (corresponding author), Univ London St Georges Hosp, Sch Med, Blood Pressure Unit, London SW17 0RE, England.	g.macgregor@sghms.ac.uk						ANDERSSON OK, 1991, J INTERN MED, V229, P89; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; COHEN JD, 1987, AM J CARDIOL, V60, P548, DOI 10.1016/0002-9149(87)90303-1; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; CONN JW, 1965, NEW ENGL J MED, V273, P1135, DOI 10.1056/NEJM196511182732106; DYER AR, 1994, AM J EPIDEMIOL, V139, P940, DOI 10.1093/oxfordjournals.aje.a117100; FALCK JM, 1996, AM J MED S3A, V101, pS53; GILLMAN MW, 1995, JAMA-J AM MED ASSOC, V273, P1113, DOI 10.1001/jama.273.14.1113; Gurhan G.C., 1993, NEW ENGL J MED, V328, P833; He FJ, 1999, AM J HYPERTENS, V12, P849; Iso H, 1999, STROKE, V30, P1772, DOI 10.1161/01.STR.30.9.1772; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; LEIER CV, 1994, AM HEART J, V128, P564, DOI 10.1016/0002-8703(94)90633-5; LEMANN J, 1991, KIDNEY INT, V39, P973, DOI 10.1038/ki.1991.123; MACGREGOR GA, 1982, LANCET, V2, P567; MIALL WE, 1983, BMJ-BRIT MED J, V287, P1249; New SA, 1997, AM J CLIN NUTR, V65, P1831, DOI 10.1093/ajcn/65.6.1831; New SA, 2000, AM J CLIN NUTR, V71, P142; Osorio AV, 1997, PEDIATRICS, V100, P675, DOI 10.1542/peds.100.4.675; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; ROSENSTOCK J, 1982, DIABETOLOGIA, V22, P184, DOI 10.1007/BF00283750; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SAGILD U, 1961, ACTA MED SCAND, V169, P243; SEBASTIAN A, 1994, NEW ENGL J MED, V330, P1776, DOI 10.1056/NEJM199406233302502; SIANI A, 1991, ANN INTERN MED, V115, P753, DOI 10.7326/0003-4819-115-10-753; TOBIAN L, 1986, J HYPERTENS, V4, pS67; TOBIAN L, 1984, HYPERTENSION, V6, pI170, DOI 10.1161/01.HYP.6.2_Pt_2.I170; Tucker KL, 1999, AM J CLIN NUTR, V69, P727; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; YOUNG DB, 2000, HDB PHYSL 7, P306	35	127	134	3	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					497	501		10.1136/bmj.323.7311.497	http://dx.doi.org/10.1136/bmj.323.7311.497			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532846	Green Published			2022-12-28	WOS:000170838500023
J	DEPATER, I; HEILES, C; WONG, M; MADDALENA, RJ; BIRD, MK; FUNKE, O; NEIDHOEFER, J; PRICE, RM; KESTEVEN, M; CALABRETTA, M; KLEIN, MJ; GULKIS, S; BOLTON, SJ; FOSTER, RS; SUKUMAR, S; STROM, RG; LEPOOLE, RS; SPOELSTRA, T; ROBISON, M; HUNSTEAD, RW; CAMPBELLWILSON, D; YE, T; DULK, G; LEBLANC, Y; GALOPEAU, P; GERARD, E; LECACHEUX, A				DEPATER, I; HEILES, C; WONG, M; MADDALENA, RJ; BIRD, MK; FUNKE, O; NEIDHOEFER, J; PRICE, RM; KESTEVEN, M; CALABRETTA, M; KLEIN, MJ; GULKIS, S; BOLTON, SJ; FOSTER, RS; SUKUMAR, S; STROM, RG; LEPOOLE, RS; SPOELSTRA, T; ROBISON, M; HUNSTEAD, RW; CAMPBELLWILSON, D; YE, T; DULK, G; LEBLANC, Y; GALOPEAU, P; GERARD, E; LECACHEUX, A			OUTBURST OF JUPITER SYNCHROTRON-RADIATION AFTER THE IMPACT OF COMET SHOEMAKER-LEVY-9	SCIENCE			English	Article							RADIO IMAGES	Jupiter's nonthermal microwave emission, as measured by a global network of 11 radio telescopes, increased dramatically during the Shoemaker-Levy 9 impacts. The increase was wavelength-dependent, varying from similar to 10 percent at 70 to 90 centimeters to similar to 45 percent at 6 and 36 centimeters. The radio spectrum hardened (flattened toward shorter wavelengths) considerably during the week of impacts and continued to harden afterward. After the week of cometary impacts, the flux density began to subside at all wavelengths and was still declining 3 months later. Very Large Array and Australia Telescope images of the brightness distribution showed the enhancement to be localized in longitude and concentrated near the magnetic equator. The evidence therefore suggests that the increase in flux density was caused by a change in the resident particle population, for example, through an energization or spatial redistribution of the emitting particles.	NATL RADIO ASTRON OBSERV,GREEN BANK,WV 24944; UNIV BONN,D-53121 BONN,GERMANY; MAX PLANCK INST RADIOASTRON,D-53121 BONN,GERMANY; CSIRO,EPPING,NSW 2121,AUSTRALIA; CALTECH,JET PROP LAB,PASADENA,CA 91109; USN,RES LAB,WASHINGTON,DC 20375; NATL RES COUNCIL CANADA,DOMIN RADIO ASTROPHYS OBSERV,PENTICTON,BC V2A 6K3,CANADA; NETHERLANDS FDN RES ASTRON,7990 AA DWINGELOO,NETHERLANDS; LEIDEN UNIV,2300 RA LEIDEN,NETHERLANDS; NEW MEXICO INST MIN & TECHNOL,SOCORRO,NM 87801; UNIV SYDNEY,SCH PHYS,SYDNEY,NSW 2006,AUSTRALIA; DEPT ASTROPHYS PLANETARY & ATMOSPHER SCI,BOULDER,CO 80309; OBSERV PARIS,F-92195 MEUDON,FRANCE	National Radio Astronomy Observatory (NRAO); University of Bonn; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Navy; Naval Research Laboratory; National Research Council Canada; Leiden University; Leiden University - Excl LUMC; New Mexico Institute of Mining Technology; University of Sydney; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	DEPATER, I (corresponding author), UNIV CALIF BERKELEY,DEPT ASTRON,BERKELEY,CA 94720, USA.		Bolton, Scott/M-4392-2019	bolton, scott/0000-0002-9115-0789				BAARS JWM, 1977, ASTRON ASTROPHYS, V61, P99; BIRD MK, 1994, 6069 INT ASTR UN CIR; BOLTON SJ, 1991, THESIS U CALIFORNIA; BOLTON SJ, 1994, EOS                S, V75, P405; BRECHT SH, IN PRESS GEOPHYS RES; BRICE N, 1973, ICARUS, V18, P206, DOI 10.1016/0019-1035(73)90204-2; CLARKE JT, 1995, SCIENCE, V267, P1302, DOI 10.1126/science.7871427; DEPATER I, 1991, ASTRON J, V102, P795, DOI 10.1086/115911; DEPATER I, 1990, J GEOPHYS RES-SPACE, V95, P39, DOI 10.1029/JA095iA01p00039; DEPATER I, 1990, ANNU REV ASTRON ASTR, V28, P347, DOI 10.1146/annurev.astro.28.1.347; DEPATER I, 1994, J GEOPHYS RES-SPACE, V99, P2271, DOI 10.1029/93JA02097; DEPATER I, 1994, GEOPHYS RES LETT, V21, P1071, DOI 10.1029/94GL01058; DEPATER I, UNPUB; DEPATER I, 1994, 6074 INT ASTR UN CIR; DEPATER I, NASA P, V494, P139; DESSLER AJ, 1994, GEOPHYS RES LETT, V21, P1043, DOI 10.1029/94GL01294; DESSLER AJ, 1994, B AM ASTRON SOC, V26, P1593; DULK GA, IN PRESS GEOPHYS RES; GROSSMAN AW, 1994, B AM ASTRON SOC, V26, P1587; HILL T, 1994, EOS                S, V75, P402; HORANYI M, 1994, GEOPHYS RES LETT, V21, P1039, DOI 10.1029/94GL01326; IP WH, 1994, PLANET SPACE SCI, V42, P527, DOI 10.1016/0032-0633(94)90073-6; IP WH, 1994, EOS                S, V75, P404; IP WH, IN PRESS PLANET SPAC; KLEIN MJ, NASA P, V494, P151; LEBLANC Y, IN PRESS GEOPHYS RES; OTT M, 1994, ASTRON ASTROPHYS, V284, P331; ULICH BL, 1976, ASTROPHYS J SUPPL S, V30, P247, DOI 10.1086/190361; WAITE JH, IN PRESS SCIENCE; Willis A. G., 1977, IAU S, V74, P39; Wong M, UNPUB	31	40	40	0	2	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 30	1995	268	5219					1879	1883		10.1126/science.11536723	http://dx.doi.org/10.1126/science.11536723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF990	11536723				2022-12-28	WOS:A1995RF99000032
J	DAMSTE, JSS; WAKEHAM, SG; KOHNEN, MEL; HAYES, JM; DELEEUW, JW				DAMSTE, JSS; WAKEHAM, SG; KOHNEN, MEL; HAYES, JM; DELEEUW, JW			A 6,000-YEAR SEDIMENTARY MOLECULAR RECORD OF CHEMOCLINE EXCURSIONS IN THE BLACK-SEA	NATURE			English	Article							PHOTOSYNTHESIS; DIAGENESIS	THE Black Sea is the world's largest anoxic basin; it is also a contemporary analogue of the environment in which carbonaceous shales and petroleum source beds formed1. Recently, Repeta et al.2,3 reported that anoxygenic photosynthesis may be an important component of carbon cycling in the present Black Sea, owing to a shoaling of the chemocline and consequent penetration of the photic zone by anaerobic waters in the past few decades4,5. It has been suggested4 that this was due to an anthropogenic decrease in freshwater input to the Black Sea, although natural causes were not ruled out. Here we report the distributions of sequestered photosynthetic pigments in eight core samples of sediments from the Black Sea ranging in age from zero to 6,200 years before the present. Our results show that photosynthetic green sulphur bacteria (Clorobiaceae) have been active in the Black Sea for substantial periods of time in the past. This finding indicates that the penetration of the photic zone by anaerobic waters is not a recent phenomenon, and suggests that natural causes for shoaling of the chemocline are more likely than anthropogenic ones4.	DELFT UNIV TECHNOL,ORGAN GEOCHEM UNIT,2628 RZ DELFT,NETHERLANDS; SKIDAWAY INST OCEANOG,SAVANNAH,GA 31416; INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Delft University of Technology; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	DAMSTE, JSS (corresponding author), NETHERLANDS INST SEA RES,DIV MARINE BIOGEOCHEM,POB 59,1790 AB DEN BURG,NETHERLANDS.		Damste, Jaap S Sinninghe/F-6128-2011; de Leeuw, Jan W/F-6471-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; 				BRASSELL SC, 1986, NATURE, V320, P160, DOI 10.1038/320160a0; BRYANTSEV VA, 1988, OCEANOLOGY, V28, P180; BUKRY D, 1974, MEM AM ASS PETROL GE, V20, P253; DEMAISON GJ, 1980, AAPG BULL, V64, P1179; DEUSER WG, 1974, AAPG BULL, V20, P133; HAY BJ, 1991, DEEP-SEA RES, V38, pS1211; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; KEMPE S, 1990, NATURE, V346, P419, DOI 10.1038/346419a0; KOHNEN MEL, 1990, GEOCHIM COSMOCHIM AC, V54, P3053, DOI 10.1016/0016-7037(90)90121-Z; KOHNEN MEL, 1992, SCIENCE, V256, P358, DOI 10.1126/science.256.5055.358; KOHNEN MEL, 1991, NATURE, V349, P775, DOI 10.1038/349775a0; MURRAY JW, 1989, NATURE, V338, P411, DOI 10.1038/338411a0; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; REPETA DJ, 1991, DEEP-SEA RES, V38, pS969, DOI 10.1016/S0198-0149(10)80019-6; REPETA DJ, 1989, NATURE, V342, P69, DOI 10.1038/342069a0; Ross D., 1974, BLACK SEA GEOLOGY CH, P183; ROSS DA, 1970, SCIENCE, V170, P163, DOI 10.1126/science.170.3954.163; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; TUGRUL S, 1992, NATURE, V359, P137, DOI 10.1038/359137a0	21	199	203	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 29	1993	362	6423					827	829		10.1038/362827a0	http://dx.doi.org/10.1038/362827a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ563	11536532				2022-12-28	WOS:A1993KZ56300051
J	ALLAMANDOLA, LJ; SANDFORD, SA; TIELENS, AGGM; HERBST, TM				ALLAMANDOLA, LJ; SANDFORD, SA; TIELENS, AGGM; HERBST, TM			DIAMONDS IN DENSE MOLECULAR CLOUDS - A CHALLENGE TO THE STANDARD INTERSTELLAR-MEDIUM PARADIGM	SCIENCE			English	Article							METEORITES; EVOLUTION; ORIGIN; DUST	Observations of a newly discovered infrared C-H stretching band indicate that interstellar diamond-like material appears to be characteristic of dense clouds. In sharp contrast. the spectral signature of dust in the diffuse interstellar medium is dominated by -CH2- and -CH3 groups. This dichotomy in the aliphatic organic component between the dense and diffuse media challenges standard assumptions about the processes occurring in, and interactions between, these two media. The ubiquity of this interstellar diamond-like material rules out models for meteoritic diamond formation in unusual circumstellar environments and implies that the formation of the diamond-like material is associated with common interstellar processes or stellar types.	UNIV HAWAII,INST ASTRON,HONOLULU,HI 96822	University of Hawaii System	ALLAMANDOLA, LJ (corresponding author), NASA,AMES RES CTR,MAIL STOP 245-6,MT VIEW,CA 94035, USA.							ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROPHYS J, V399, P134, DOI 10.1086/171909; Bellamy L.J, 1958, INFRA RED SPECTRA CO; BERNATOWICZ TJ, 1990, ASTROPHYS J, V359, P246, DOI 10.1086/169056; BLAKE DF, 1988, NATURE, V332, P611, DOI 10.1038/332611a0; Clayton D. D., 1981, P LUNAR PLANET SCI, V12B, P1781; DULEY WW, 1989, MON NOT R ASTRON SOC, V236, P709, DOI 10.1093/mnras/236.4.709; EHRENFREUND P, 1992, ASTRON ASTROPHYS, V252, P612; Greenberg J. M., 1982, Submillimetre Wave Astronomy, P261; JONES AP, 1990, Q J ROY ASTRON SOC, V31, P567; JORGENSON UG, 1989, NATURE, V322, P702; KOBASHI K, 1988, SPIE, V969, P159; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LEWIS RS, 1989, NATURE, V339, P117, DOI 10.1038/339117a0; MCKEE CF, 1989, INTERSTELLAR DUST, P431; MING T, 1988, GEOCHIM COSMOCHIM AC, V52, P1235, DOI 10.1016/0016-7037(88)90277-3; MORRISON RT, 1966, ORGANIC CHEM; NUTH JA, 1987, NATURE, V329, P589, DOI 10.1038/329589b0; NUTH JA, 1985, NATURE, V318, P166, DOI 10.1038/318166a0; PENDLETON Y, UNPUB; SANDHU GS, 1988, SPIE DIAMOND OPTICS, V969, P37; SILVERSTEIN RM, 1967, SPECTROMETRIC IDENTI, pCH3; Tielens A. G., 1987, PHYSICAL PROCESSES I, V333; TIELENS AGG, 1989, INTERSTELLAR DUST, P239; TIELENS AGG, 1990, NASA CP3061, P59; TIELENS AGGM, 1987, ASTROPHYS J, V319, pL109, DOI 10.1086/184964; Wexler AS, 1967, APPL SPECTROSC REV, V1, P29, DOI DOI 10.1080/05704926708547581; WILLNER SP, 1982, ASTROPHYS J, V253, P174, DOI 10.1086/159622	29	89	89	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 2	1993	260	5104					64	66		10.1126/science.11538059	http://dx.doi.org/10.1126/science.11538059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV423	11538059				2022-12-28	WOS:A1993KV42300025
J	BARON, R; JOSEPH, RD; OWEN, T; TENNYSON, J; MILLER, S; BALLESTER, GE				BARON, R; JOSEPH, RD; OWEN, T; TENNYSON, J; MILLER, S; BALLESTER, GE			IMAGING JUPITER AURORAE FROM H-3+ EMISSIONS IN THE 3-4 MU-M BAND	NATURE			English	Article							SOUTH POLAR AURORAE; FUNDAMENTAL-BAND; IUE DATA; NORTH; SPECTROMETRY; VOYAGER	SINCE H-3+ was first spectroscopically detected on Jupiter 1,2, there has been considerable interest in using this simple molecular ion to probe conditions existing in the planet's auroral regions. Here we present a series of images of Jupiter recorded at wavelengths sensitive to emission by H-3+, which reveal the spatial distribution of excited H-3+ molecular ions in the jovian ionosphere, as seen from Earth. We believe that they provide high-spatial-resolution images of polar aurorae on Jupiter. They suggest that the intensity of the auroral emission can vary on a timescale of an hour, a shorter period than had previously been noted. We also find that the spatial distribution of H-3+ emissions correlates only partially with the loci of auroral activity inferred from ultraviolet and longer-wavelength infrared observations. The H-3+ emission may therefore be controlled by auroral processes that are different from those responsible for the ultraviolet and infrared emissions.	UNIV LONDON UNIV COLL,DEPT PHYS & ASTRON,LONDON WC1E 6BT,ENGLAND; UNIV OXFORD,DEPT EARTH SCI,OXFORD OX1 3PR,ENGLAND	University of London; University College London; University of Oxford	BARON, R (corresponding author), UNIV HAWAII,INST ASTRON,2680 WOODLAWN DR,HONOLULU,HI 96822, USA.		Tennyson, Jonathan/I-2222-2012	Tennyson, Jonathan/0000-0002-4994-5238; Miller, Steven/0000-0002-7159-6871				BARON R, 1991, IAU5132 CIRC; BARON R, 1991, IAU5211 CIRC; BROADFOOT AL, 1981, J GEOPHYS RES-SPACE, V86, P8259, DOI 10.1029/JA086iA10p08259; CALDWELL J, 1980, ICARUS, V44, P667, DOI 10.1016/0019-1035(80)90135-9; CALDWELL J, 1988, ICARUS, V74, P331, DOI 10.1016/0019-1035(88)90045-0; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P8370, DOI 10.1029/JA086iA10p08370; DROSSART P, 1986, ICARUS, V66, P610, DOI 10.1016/0019-1035(86)90094-1; DROSSART P, 1989, NATURE, V340, P539, DOI 10.1038/340539a0; HERBERT F, 1987, J GEOPHYS RES, V92, P3141, DOI 10.1029/JA092iA04p03141; KIM SJ, 1985, ICARUS, V64, P233, DOI 10.1016/0019-1035(85)90088-0; KOSTIUK T, 1987, ICARUS, V72, P394, DOI 10.1016/0019-1035(87)90182-5; LIVENGOOD TA, 1990, GEOPHYS RES LETT, V17, P2265, DOI 10.1029/GL017i012p02265; LIVENGOOD TA, 1991, EOS, V72, P186; LIVENGOOD TA, 1990, J GEOPHYS RES, V95, P10365; MAILLARD JP, 1990, ASTROPHYS J, V363, pL37, DOI 10.1086/185859; MAJEWSKI WA, 1989, ASTROPHYS J, V347, pL51, DOI 10.1086/185605; MILLER S, 1990, ASTROPHYS J, V360, pL55, DOI 10.1086/185811; OKA T, 1990, ASTROPHYS J, V351, pL53, DOI 10.1086/185678; PRANGE R, IN PRESS ADV SPACE R; SKINNER TE, 1984, THESIS J HOPKINS U; Strobel D.F., 1983, INT REV PHYS CHEM, V3, P145, DOI [10.1080/01442358309353342, DOI 10.1080/01442358309353342]; TRAFTON L, 1989, ASTROPHYS J, V343, pL73, DOI 10.1086/185514	22	92	92	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 10	1991	353	6344					539	542		10.1038/353539a0	http://dx.doi.org/10.1038/353539a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ643	11538254				2022-12-28	WOS:A1991GJ64300059
J	FREEMAN, KH; HAYES, JM; TRENDEL, JM; ALBRECHT, P				FREEMAN, KH; HAYES, JM; TRENDEL, JM; ALBRECHT, P			EVIDENCE FROM CARBON ISOTOPE MEASUREMENTS FOR DIVERSE ORIGINS OF SEDIMENTARY HYDROCARBONS	NATURE			English	Article									INDIANA UNIV,DEPT GEOL,BLOOMINGTON,IN 47405; UNIV STRASBOURG 1,DEPT CHIM,CHIM ORGAN SUBST NAT LAB,F-67008 STRASBOURG,FRANCE	Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	FREEMAN, KH (corresponding author), INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LABS,GEOL BLDG,BLOOMINGTON,IN 47405, USA.		Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				COLEMAN DD, 1981, GEOCHIM COSMOCHIM AC, V45, P1033, DOI 10.1016/0016-7037(81)90129-0; COLLISTER JW, IN PRESS B US GEOL S; CORBET B, 1980, J AM CHEM SOC, V192, P1171; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DIDYK BM, 1978, NATURE, V272, P216, DOI 10.1038/272216a0; Ensminger A., 1973, ADV ORG GEOCHEM, P245; FRY B, 1986, LIMNOL OCEANOGR, V31, P79, DOI 10.4319/lo.1986.31.1.0079; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; HAYES JM, 1987, NATURE, V329, P48, DOI 10.1038/329048a0; KEPKAY PE, 1979, SCIENCE, V204, P68, DOI 10.1126/science.204.4388.68; KIMBLE BJ, 1974, GEOCHIM COSMOCHIM AC, V38, P1165, DOI 10.1016/0016-7037(74)90011-8; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; MICHAELIS W, 1989, SCI TOTAL ENVIRON, V81-2, P41, DOI 10.1016/0048-9697(89)90109-5; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; OURISSON G, 1987, ANNU REV MICROBIOL, V41, P301, DOI 10.1146/annurev.mi.41.100187.001505; OURISSON G, 1979, PURE APPL CHEM, V51, P709, DOI 10.1351/pac197951040709; OURISSON G, 1982, TRENDS BIOCHEM SCI, V7, P236, DOI 10.1016/0968-0004(82)90028-7; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; QUIRK MM, 1984, CHEM GEOL, V42, P25, DOI 10.1016/0009-2541(84)90003-2; RIESKAUTT M, 1989, CHEM GEOL, V76, P143, DOI 10.1016/0009-2541(89)90133-2; Risatti J.B., 1984, ORG GEOCHEM, V6, P93, DOI DOI 10.1016/0146-6380(84)90030-5; ROBINSON N, 1989, CHEM GEOL, V76, P153, DOI 10.1016/0009-2541(89)90134-4; SEIFERT WK, 1980, ADV ORG GEOCHEM, P229; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; TENHAVEN HL, 1987, NATURE, V330, P641, DOI 10.1038/330641a0; TRENDEL JM, 1989, TETRAHEDRON, V45, P4457, DOI 10.1016/S0040-4020(01)89081-5; VANDORSSELAER A, 1977, B SOC CHIM FR II-CH, P165; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; ZUNDEL M, 1985, FEMS MICROBIOL LETT, V28, P61, DOI 10.1111/j.1574-6968.1985.tb00764.x	31	448	489	1	78	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 18	1990	343	6255					254	256		10.1038/343254a0	http://dx.doi.org/10.1038/343254a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	11536462				2022-12-28	WOS:A1990CJ68200068
J	MAHER, KA; STEVENSON, DJ				MAHER, KA; STEVENSON, DJ			IMPACT FRUSTRATION OF THE ORIGIN OF LIFE	NATURE			English	Article											MAHER, KA (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.							ABBOTT DH, 1984, TECTONICS, V3, P429, DOI 10.1029/TC003i004p00429; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; AWRAMIK SM, 1982, MINERAL DEPOSITS EVO, P309; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; CAIRNSMITH AG, 1985, SCI AM, V256, P90; CARR MH, 1984, NASA SP469; CHANG S, 1982, PHYS EARTH PLANET IN, V29, P261, DOI 10.1016/0031-9201(82)90017-6; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; Gault D.E., 1982, GEOL SOC AM SPEC PAP, V190, P69; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1979, ICARUS, V38, P230, DOI 10.1016/0019-1035(79)90180-5; GRIEVE RAF, 1984, 27TH INT GEOL C MOSC, V19, P99; HARTMAN WK, 1977, COMETS ASTEROIDS MET, P277; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; KASTING JF, 1984, ORIGINS LIFE EVOL B, V14, P75, DOI 10.1007/BF00933642; LAZCANO A, 1983, PRECAMBRIAN RES, V20, P259, DOI 10.1016/0301-9268(83)90076-1; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI [10.1016/0012-821X(73)90162-3, 10.1016/0012-821X(74)90115-0]; Melosh H. J., 1982, GEOL SOC AM SPEC PAP, V190, P121; MILLER SL, 1982, MINERAL DEPOSITS EVO, P155; MOORBATH S, 1984, ORIGINS LIFE, V15, P251; OKEEFE JD, 1982, NATURE, V298, P123, DOI 10.1038/298123a0; PRINN RG, 1985, EOS, V46, P813; SCHMIDT RM, 1982, GEOL SOC AM SPEC PAP, V190, P93, DOI DOI 10.1130/SPE190-P93; SEEBAUGH WR, 1977, IMPACT EXPLOSION CRA, P1043; Shoemaker E. M., 1979, ASTEROIDS, P253; SHOEMAKER EM, 1970, ICARUS, V12, P188, DOI 10.1016/0019-1035(70)90072-2; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, 1982, NEW SOLAR SYSTEM, P33; Toon OB., 1982, GEOL SOC AM SPEC PAP, V190, P187	31	269	275	1	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	FEB 18	1988	331	6157					612	614		10.1038/331612a0	http://dx.doi.org/10.1038/331612a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M1180	11536595				2022-12-28	WOS:A1988M118000053
J	Boogaerts, M; Winston, DJ; Bow, EJ; Garber, G; Reboli, AC; Schwarer, AP; Novitzky, N; Boehme, A; Chwetzoff, E; De Beule, K				Boogaerts, M; Winston, DJ; Bow, EJ; Garber, G; Reboli, AC; Schwarer, AP; Novitzky, N; Boehme, A; Chwetzoff, E; De Beule, K		Itraconazole Neutropenia Study Grp	Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; BLOOD-STREAM INFECTION; CANDIDA-ALBICANS; NATIONAL SURVEILLANCE; FUNGAL-INFECTIONS; UNEXPLAINED FEVER; CLINICAL-TRIAL; SCOPE PROGRAM; FLUCONAZOLE; SUSCEPTIBILITY	Background: Amphotericin B deoxycholate is currently the standard empirical antifungal therapy in neutropenic patients with cancer who have persistent fever that does not respond to antibiotic therapy. However, this treatment often causes infusion-related and metabolic toxicities, which may be dose limiting, Objective: To compare the efficacy and safety of itraconazole with those of amphotericin B as empirical antifungal therapy. Design: An open randomized, controlled, multicenter trial, powered for equivalence. Setting: 60 oncology centers in 10 countries. Patients: 384 neutropenic patients with cancer who had persistent fever that did not respond to antibiotic therapy. Intervention: Intravenous amphotericin B or intravenous itraconazole followed by oral itraconazole solution. Measurements: Defervescence, breakthrough fungal infection, drug-related adverse events, and death. Results: For itraconazole and amphotericin B, the median duration of therapy was 8.5 and 7 days and the median time to defervescence was 7 and 6 days, respectively. The intention-to-treat efficacy analysis of data from 360 patients showed response rates of 47% and 38% for itraconazole and amphotericin B, respectively (difference, 9.0 percentage points [95% Cl, -0.8 to 19.5 percentage points]). Fewer drug-related adverse events occurred in the itraconazole group than the amphotericin B group (5% vs. 54% of patients; P = 0.001), and the rate of withdrawal because of toxicity was significantly lower with itraconazole (19% vs. 38%; P = 0.001). Significantly more amphotericin B recipients had nephrotoxicity (P < 0.001). Breakthrough fungal infections (S patients in each group) and mortality rates (19 deaths in the itraconazole group and 25 deaths in the amphotericin B group) were similar. Sixty-five patients switched to oral itraconazole solution after receiving the intravenous formulation for a median of 9 days. Conclusions: Itraconazole and amphotericin B have at least equivalent efficacy as empirical antifungal therapy in neutropenic patients with cancer. However, itraconazole Is associated with significantly less toxicity.	Univ Hosp Gasthuisberg, Dept Hematol, B-3000 Louvain, Belgium; Univ Calif Los Angeles, Ctr Med, Los Angeles, CA 90024 USA; Univ Manitoba, Winnipeg, MB, Canada; Univ Ottawa, Ottawa Gen Hosp, Ottawa, ON, Canada; Cooper Univ Hosp, Robert Wood Johnson Med Sch, Camden, NJ USA; Alfred Hosp, Melbourne, Vic, Australia; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; Univ Hosp, Frankfurt, Germany; Janssen Res Fdn, Issy Les Moulineaux, France; Janssen Res Fdn, B-2340 Beerse, Belgium	KU Leuven; University Hospital Leuven; University of California System; University of California Los Angeles; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; Cooper University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Florey Institute of Neuroscience & Mental Health; University of Cape Town; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Johnson & Johnson; Johnson & Johnson	Boogaerts, M (corresponding author), Univ Hosp Gasthuisberg, Dept Hematol, Herestr 49, B-3000 Louvain, Belgium.	marc.boogaerts@uz.kuleuven.ac.be	McGeer, Allison/AAB-6885-2020; Herbrecht, Raoul/AAT-1763-2021; Burzykowski, Tomasz/T-2222-2018; pagliuca, antonio/F-8886-2013	McGeer, Allison/0000-0001-5647-6137; Herbrecht, Raoul/0000-0002-9381-4876; Burzykowski, Tomasz/0000-0003-3378-975X; pagliuca, antonio/0000-0003-2519-0333				Anaissie EJ, 1996, CLIN INFECT DIS, V23, P964, DOI 10.1093/clinids/23.5.964; Anaissie EJ, 1996, AM J MED, V101, P170, DOI 10.1016/S0002-9343(96)80072-6; BARCHIESI F, 1994, ANTIMICROB AGENTS CH, V38, P1530, DOI 10.1128/AAC.38.7.1530; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; BOOGAERTS MA, 1989, MYCOSES, V32, P103, DOI 10.1111/j.1439-0507.1989.tb02299.x; Boogaerts MA, 2001, ANTIMICROB AGENTS CH, V45, P981, DOI 10.1128/AAC.45.3.981-985.2001; Bow EJ, 1998, BRIT J HAEMATOL, V101, P1; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; GOODWIN SD, 1995, CLIN INFECT DIS, V20, P755, DOI 10.1093/clinids/20.4.755; Hughes WT, 1997, CLIN INFECT DIS, V25, P551, DOI 10.1086/513764; KARP JE, 1991, REV INFECT DIS, V13, P592; Manavathu EK, 1998, ANTIMICROB AGENTS CH, V42, P3018, DOI 10.1128/AAC.42.11.3018; MARIE JP, 1993, CAH ONCOL, V2, P171; MEUNIER F, 1989, AM J MED, V86, P668; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P121, DOI 10.1016/S0732-8893(97)00192-2; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V31, P327, DOI 10.1016/S0732-8893(97)00240-X; PIZZO PA, 1982, AM J MED, V72, P101, DOI 10.1016/0002-9343(82)90594-0; Prentice A. G., 1997, Blood, V90, p545A; PRENTICE AG, 1994, J ANTIMICROB CHEMOTH, V34, P247, DOI 10.1093/jac/34.2.247; Prentice HG, 1997, BRIT J HAEMATOL, V98, P711, DOI 10.1046/j.1365-2141.1997.2473063.x; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235; STEIN RS, 1986, SOUTHERN MED J, V79, P863, DOI 10.1097/00007611-198607000-00020; STEIN RS, 1982, CANCER, V50, P2247, DOI 10.1002/1097-0142(19821201)50:11&lt;2247::AID-CNCR2820501102&gt;3.0.CO;2-7; Viscoli C, 1996, EUR J CANCER, V32A, P814, DOI 10.1016/0959-8049(95)00619-2; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; White MH, 1998, CLIN INFECT DIS, V27, P296, DOI 10.1086/514672	27	237	264	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					412	422		10.7326/0003-4819-135-6-200109180-00010	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560454				2022-12-28	WOS:000170972500003
J	Sniderman, AD; Scantlebury, T; Cianflone, K				Sniderman, AD; Scantlebury, T; Cianflone, K			Hypertriglyceridemic hyperapoB: The unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CHEMISTRY STANDARDIZATION PROJECT; APOLIPOPROTEIN-A-I; VERY-LOW-DENSITY; SCANDINAVIAN-SIMVASTATIN-SURVIVAL; FAMILIAL COMBINED HYPERLIPIDEMIA; INCREASED HEPATIC SECRETION; CHOLESTERYL ESTER TRANSFER; NONESTERIFIED FATTY-ACIDS	Abnormalities in insulin and glucose metabolism do not seem to entirely account for the high frequency of cardiovascular disease in patients with type 2 diabetes mellitus. An important additional factor may be hypertriglyceridemic hyperapoB, an atherogenic dysilpoproteinemia that is common in these patients. The major features of hypertriglyceridemic hyperapoB are hypertriglyceridemia; low levels of high-density lipoprotein cholesterol; and increased numbers of small, dense low-density lipoprotein (LDL) particles. This article reviews the pathophysiology of this disorder, focusing on the changes in lipoprotein particle number and composition rather than lipoprotein lipid levels. The in vitro and in vivo evidence that small, dense LDL are more atherogenic than normal larger, buoyant LDL is summarized, and the particularly high-risk state conferred by increased numbers of small, dense LDL is delineated. This review demonstrates how abnormalities in the plasma lipoproteins may relate to the effectiveness with which adipose tissue traps and retains fatty acid. The effects of increased fatty acid flux on the hepatic metabolism of lipids and apoB secretion are detailed, and the mechanisms by which fibrates and statins may improve these are described. An understanding of these principles should provide the physician with a more physiologic basis on which to choose appropriate therapy.	McGill Univ, Ctr Hlth, Montreal, PQ, Canada; Concordia Univ, Montreal, PQ, Canada	McGill University; Concordia University - Canada	Sniderman, AD (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	allan.sniderman@muhc.mcgill.ca	Adiels, Martin/C-9278-2011					Aguilar-Salinas CA, 1998, ATHEROSCLEROSIS, V141, P203, DOI 10.1016/S0021-9150(98)00198-1; Alaupovic P, 1999, ATHEROSCLEROSIS, V146, P369, DOI 10.1016/S0021-9150(99)00151-3; ALBERS JJ, 1992, CLIN CHEM, V38, P658; Anber V, 1996, ATHEROSCLEROSIS, V124, P261, DOI 10.1016/0021-9150(96)05842-X; Austin MA, 1999, AM J CARDIOL, V83, p13F; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; BARBIR M, 1988, BRIT HEART J, V60, P397; Bjornheden T, 1996, ATHEROSCLEROSIS, V123, P43, DOI 10.1016/0021-9150(95)05770-6; BOWIE A, 1993, ATHEROSCLEROSIS, V102, P63, DOI 10.1016/0021-9150(93)90084-8; Bredie SJH, 1997, ARTERIOSCL THROM VAS, V17, P1465; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWNLEE M, 1985, DIABETES, V34, P938, DOI 10.2337/diabetes.34.9.938; BRUNZELL JD, 1976, METABOLISM, V25, P313, DOI 10.1016/0026-0495(76)90089-5; Calabresi L, 1997, CURR OPIN LIPIDOL, V8, P219, DOI 10.1097/00041433-199708000-00005; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P187, DOI 10.1161/01.ATV.12.2.187; Connelly PW, 1999, CAN J CARDIOL, V15, P409; Contois JH, 1996, CLIN CHEM, V42, P515; CORESH J, 1993, J LIPID RES, V34, P1687; CROUSE JR, 1985, J LIPID RES, V26, P566; CUMMINGS MH, 1995, DIABETOLOGIA, V38, P959, DOI 10.1007/s001250050378; CUMMINGS MH, 1995, CLIN SCI, V88, P225, DOI 10.1042/cs0880225; DACHET C, 1995, ATHEROSCLEROSIS, V113, P1, DOI 10.1016/0021-9150(94)05411-B; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; DEJAGER S, 1993, J LIPID RES, V34, P295; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; DURRINGTON PN, 1986, BRIT HEART J, V56, P206, DOI 10.1136/hrt.56.3.206; DURRINGTON PN, 1978, CLIN CHIM ACTA, V82, P151, DOI 10.1016/0009-8981(78)90038-4; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; ELOVSON J, 1988, J LIPID RES, V29, P1461; Evans M, 2000, CIRCULATION, V101, P1773, DOI 10.1161/01.CIR.101.15.1773; Feher MD, 1999, DIABETES-METAB RES, V15, P395, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<395::AID-DMRR65>3.3.CO;2-E; FEINGOLD KR, 1992, ARTERIOSCLER THROMB, V12, P1496, DOI 10.1161/01.ATV.12.12.1496; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Festa A, 1999, DIABETES CARE, V22, P1688, DOI 10.2337/diacare.22.10.1688; Festa A, 1999, ARTERIOSCL THROM VAS, V19, P605, DOI 10.1161/01.ATV.19.3.605; Fuller JH, 1996, ANN MED, V28, P319, DOI 10.3109/07853899608999088; FUNGWE TV, 1994, J LIPID RES, V35, P311; GALEANO NF, 1994, J BIOL CHEM, V269, P511; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002; Glomset J A, 1980, Adv Intern Med, V25, P91; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Gotto AM, 1998, CIRCULATION, V97, P1027, DOI 10.1161/01.CIR.97.11.1027; GRIFFIN BA, 1994, ATHEROSCLEROSIS, V106, P241, DOI 10.1016/0021-9150(94)90129-5; Griffin BA, 1999, CLIN SCI, V97, P269, DOI 10.1042/CS19990056; Guerin M, 1996, ARTERIOSCL THROM VAS, V16, P763, DOI 10.1161/01.ATV.16.6.763; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; HAFFNER SM, 1989, ARTERIOSCLEROSIS, V9, P928, DOI 10.1161/01.ATV.9.6.928; Haffner SM, 1999, ARCH INTERN MED, V159, P2661, DOI 10.1001/archinte.159.22.2661; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hegele RA, 1999, CLIN BIOCHEM, V32, P143, DOI 10.1016/S0009-9120(98)00101-5; HOWARD BV, 1983, CIRCULATION, V68, P714, DOI 10.1161/01.CIR.68.4.714; HOWARD BV, 1995, AM J EPIDEMIOL, V142, P254, DOI 10.1093/oxfordjournals.aje.a117632; HOWARD BV, 1987, METABOLISM, V36, P870, DOI 10.1016/0026-0495(87)90096-5; HOWARD BV, 1980, J LIPID RES, V21, P1032; HOWARD BV, 1987, J LIPID RES, V28, P613; HOWARD BV, 1984, J CLIN ENDOCR METAB, V58, P544, DOI 10.1210/jcem-58-3-544; HUNT SC, 1989, ARTERIOSCLEROSIS, V9, P335, DOI 10.1161/01.ATV.9.3.335; HURTCAMEJO E, 1990, J LIPID RES, V31, P1387; JAMES RW, 1991, DIABETOLOGIA, V34, P246, DOI 10.1007/BF00405083; Jungner I, 1998, CLIN CHEM, V44, P1641; Koyama K, 1997, AM J PHYSIOL-ENDOC M, V273, pE708, DOI 10.1152/ajpendo.1997.273.4.E708; KRAUSS RM, 1982, J LIPID RES, V23, P97; KRAUSS RM, 1987, LANCET, V2, P62; KUKITA H, 1985, ATHEROSCLEROSIS, V55, P143, DOI 10.1016/0021-9150(85)90093-0; KWITEROVICH PO, 1993, AM J CARDIOL, V71, P631, DOI 10.1016/0002-9149(93)91002-Y; LAGROST L, 1991, BIOCHIM BIOPHYS ACTA, V1085, P209, DOI 10.1016/0005-2760(91)90096-Z; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LAMARCHE B, 1995, AM J CARDIOL, V75, P1189, DOI 10.1016/S0002-9149(99)80760-7; Laws A, 1997, ARTERIOSCL THROM VAS, V17, P64, DOI 10.1161/01.ATV.17.1.64; Mack WJ, 1996, ARTERIOSCL THROM VAS, V16, P697, DOI 10.1161/01.ATV.16.5.697; Mackness MI, 1998, CURR OPIN LIPIDOL, V9, P319, DOI 10.1097/00041433-199808000-00006; Malmstrom R, 1997, DIABETOLOGIA, V40, P454, DOI 10.1007/s001250050700; MARCEL YL, 1980, ATHEROSCLEROSIS, V35, P127, DOI 10.1016/0021-9150(80)90078-7; MARCOVINA SM, 1991, CLIN CHEM, V37, P1676; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; McGuire DK, 1999, AM HEART J, V138, pS366; MCKEIGUE PM, 1993, ARTERIOSCLER THROMB, V13, P1187, DOI 10.1161/01.ATV.13.8.1187; Miller BD, 1996, CIRCULATION, V94, P2146, DOI 10.1161/01.CIR.94.9.2146; MORTON RE, 1982, J LIPID RES, V23, P1058; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Murthy V, 1996, PHARMACOL THERAPEUT, V70, P101, DOI 10.1016/0163-7258(96)00005-8; Mykkanen L, 1999, ARTERIOSCL THROM VAS, V19, P2742, DOI 10.1161/01.ATV.19.11.2742; Naoumova RP, 1996, EUR J CLIN INVEST, V26, P332, DOI 10.1046/j.1365-2362.1996.138285.x; NELSON RG, 1990, CIRCULATION, V81, P987, DOI 10.1161/01.CIR.81.3.987; NORDESTGAARD BG, 1989, ARTERIOSCLEROSIS, V9, P176, DOI 10.1161/01.ATV.9.2.176; OBrien SF, 1997, DIABETIC MED, V14, P974, DOI 10.1002/(SICI)1096-9136(199711)14:11<974::AID-DIA495>3.0.CO;2-I; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; RANDLE PJ, 1963, LANCET, V1, P785; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; REAVEN GM, 1987, AM J MED, V83, P31, DOI 10.1016/0002-9343(87)90801-1; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sattar N, 1998, ATHEROSCLEROSIS, V138, P229, DOI 10.1016/S0021-9150(98)00037-9; Sattar N, 1997, J CLIN ENDOCR METAB, V82, P2483, DOI 10.1210/jc.82.8.2483; SCHUMACHER MC, 1992, DIABETES CARE, V15, P1285, DOI 10.2337/diacare.15.10.1285; SCOPPOLA A, 1995, DIABETES CARE, V18, P1362, DOI 10.2337/diacare.18.10.1362; SELBY JV, 1993, CIRCULATION, V88, P381, DOI 10.1161/01.CIR.88.2.381; Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SINGH ATK, 1995, ARTERIOSCL THROM VAS, V15, P1805, DOI 10.1161/01.ATV.15.11.1805; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; SNIDERMAN A, 1991, ATHEROSCLEROSIS, V89, P109, DOI 10.1016/0021-9150(91)90050-D; SNIDERMAN A, 1978, J CLIN INVEST, V61, P867, DOI 10.1172/JCI109012; SNIDERMAN AD, 1993, ARTERIOSCLER THROMB, V13, P629, DOI 10.1161/01.ATV.13.5.629; SNIDERMAN AD, 1982, ANN INTERN MED, V97, P833, DOI 10.7326/0003-4819-97-6-833; Sniderman AD, 1998, ARTERIOSCL THROM VAS, V18, P147, DOI 10.1161/01.ATV.18.2.147; Sniderman AD, 1999, CLIN CHIM ACTA, V286, P7, DOI 10.1016/S0009-8981(99)00090-X; Sniderman AD, 2000, ATHEROSCLEROSIS, V148, P215, DOI 10.1016/S0021-9150(99)00282-8; Sorell L, 2000, CLIN CHIM ACTA, V294, P199, DOI 10.1016/S0009-8981(99)00262-4; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Steiner G, 2001, LANCET, V357, P905; STEWART BF, 1994, J AM COLL CARDIOL, V23, P899, DOI 10.1016/0735-1097(94)90635-1; Stewart MW, 1998, ATHEROSCLEROSIS, V139, P115, DOI 10.1016/S0021-9150(98)00065-3; SVEDBERG J, 1991, J CLIN INVEST, V88, P2054, DOI 10.1172/JCI115534; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; TASKINEN MR, 1992, DIABETES, V41, P12, DOI 10.2337/diab.41.2.S12; TASKINEN MR, 1983, DIABETES CARE, V6, P224, DOI 10.2337/diacare.6.3.224; TENG B, 1983, P NATL ACAD SCI-BIOL, V80, P6662, DOI 10.1073/pnas.80.21.6662; TENG B, 1986, J CLIN INVEST, V77, P663, DOI 10.1172/JCI112360; TENG B, 1985, J BIOL CHEM, V260, P5067; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vaisanen S, 1997, THROMB HAEMOSTASIS, V78, P1495; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Vega GL, 1996, CURR OPIN LIPIDOL, V7, P209, DOI 10.1097/00041433-199608000-00007; Wagner AM, 1999, DIABETES CARE, V22, P812, DOI 10.2337/diacare.22.5.812; Watts GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE462, DOI 10.1152/ajpendo.1997.273.3.E462; WATTS GF, 1993, METABOLISM, V42, P1461, DOI 10.1016/0026-0495(93)90199-X; WATTS GF, 1995, METABOLISM, V44, P1052, DOI 10.1016/0026-0495(95)90104-3; Webster MWI, 1997, LANCET, V350, pSI23; WEISSER B, 1993, CIRC RES, V73, P118, DOI 10.1161/01.RES.73.1.118; WEISSER B, 1993, BIOCHEM BIOPH RES CO, V192, P1245, DOI 10.1006/bbrc.1993.1550; Weyer C, 1999, OBES RES, V7, P444, DOI 10.1002/j.1550-8528.1999.tb00432.x; WITZTUM JL, 1982, DIABETES, V31, P283, DOI 10.2337/diabetes.31.4.283; YUAN JN, 1994, ATHEROSCLEROSIS, V110, P1, DOI 10.1016/0021-9150(94)90062-0; Zambon A, 1999, CIRCULATION, V99, P1959, DOI 10.1161/01.CIR.99.15.1959; Zhang ZJ, 1999, ARTERIOSCL THROM VAS, V19, P743, DOI 10.1161/01.ATV.19.3.743; 2000, CIRCULATION, V1020, P21	144	218	225	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					447	459		10.7326/0003-4819-135-6-200109180-00014	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00014			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560458				2022-12-28	WOS:000170972500006
J	Boulay, F; Berthier, F; Schoukroun, G; Raybaut, C; Gendreike, Y; Blaive, B				Boulay, F; Berthier, F; Schoukroun, G; Raybaut, C; Gendreike, Y; Blaive, B			Seasonal variations in hospital admission for deep vein thrombosis and pulmonary embolism: analysis of discharge data	BRITISH MEDICAL JOURNAL			English	Article									Nice Teaching Hosp, Dept Resp Med, F-06003 Nice 1, France; Nice Teaching Hosp, Dept Publ Hlth & Med Informat, F-06003 Nice, France	CHU Nice; CHU Nice	Boulay, F (corresponding author), Nice Teaching Hosp, Dept Publ Hlth & Med Informat, BP 1179, F-06003 Nice 1, France.							Allan TM, 1996, BRIT MED J, V312, P1227; Bounameaux H, 1996, BMJ-BRIT MED J, V312, P284; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; ROGER JH, 1977, BIOMETRIKA, V64, P152, DOI 10.2307/2335789; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1	5	77	79	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					601	602		10.1136/bmj.323.7313.601	http://dx.doi.org/10.1136/bmj.323.7313.601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557707	Bronze, Green Published			2022-12-28	WOS:000171087300018
J	Plsek, PE; Greenhalgh, T				Plsek, PE; Greenhalgh, T			Complexity science - The challenge of complexity in health care	BRITISH MEDICAL JOURNAL			English	Article									Paul E Plsek & Associates Inc, Roswell, GA 30075 USA; UCL, London N19 3UA, England	University of London; University College London	Plsek, PE (corresponding author), Paul E Plsek & Associates Inc, 1005 Allenbrook Lane, Roswell, GA 30075 USA.	paulplsek@directedcreativity.com	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				[Anonymous], 1971, INSECT SOC; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Briggs J., 1992, FRACTALS PATTERNS CH; FRASER S, IN PRESS BMJ; Gell-Mann M., 1995, QUARK JAGUAR ADVENTU; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Hansen BC, 1999, ANN NY ACAD SCI, V892, P1, DOI 10.1111/j.1749-6632.1999.tb07782.x; Holland J. H., 1995, HIDDEN ORDER ADAPTAT; Hurst DK, 1994, J MANAGE INQUIRY, V3, P339, DOI [10.1177/105649269434008, DOI 10.1177/105649269434008]; Kolb D.A, 1984, EXPERIENTIAL LEARNIN; LANGTON CG, 1989, STUDIES SCI COMPLEXI, V6; Mandelbrot BB, 1999, SCI AM, V280, P70, DOI 10.1038/scientificamerican0299-70; Morgan G, 1997, IMAGES ORG; PISEK P, IN PRESS BMJ; PLSEK PE, IN PRESS BMJ; Schafer R., 1976, NEW LANGUAGE PSYCHOA; Schon D.A, 2017, REFLECTIVE PRACTITIO; Sharp L F, 1995, Qual Manag Health Care, V3, P71; STACEY RD, 1996, STRATEGIC MANAGEMENT; STICH SP, 1990, INVITATION COGNITIVE, V3; VARELA FJ, 1991, IMMUNOL TODAY, V12, P159, DOI 10.1016/0167-5699(91)90081-4; Waldrop M.M., 1992, COMPLEXITY EMERGING; WILSON T, IN PRESS BMJ; Zimmerman B. J., 1998, EDGEWARE COMPLEXITY	25	1087	1103	7	82	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					625	628		10.1136/bmj.323.7313.625	http://dx.doi.org/10.1136/bmj.323.7313.625			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557716	Green Published			2022-12-28	WOS:000171087300026
J	Cowan, CA; Henkemeyer, M				Cowan, CA; Henkemeyer, M			The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals	NATURE			English	Article							ABL TRANSFORMING ACTIVITY; CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; TRANSMEMBRANE LIGANDS; BINDING PROTEINS; SH3 DOMAIN; NCK; RECEPTORS; CATENIN; PATHWAY	Bidirectional signals mediated by membrane-anchored ephrins and Eph receptor tyrosine kinases have important functions in cell-cell recognition events, including those that occur during axon pathfinding(1,2) and hindbrain segmentation(3,4). The reverse signal that is transduced into B-ephrin-expressing cells is thought to involve tyrosine phosphorylation of the signal's short, conserved carboxy-terminal cytoplasmic domain(5,6). The Src-homology-2 (SH2) domain proteins that associate with activated tyrosine-phosphorylated B-subclass ephrins have not been identified, nor has a defined cellular response to reverse signals been described. Here we show that the SH2/SH3 domain adaptor protein Grb4 binds to the cytoplasmic domain of B ephrins in a phosphotyrosine-dependent manner. In response to B-ephrin reverse signalling, cells increase FAK catalytic activity, redistribute paxillin, lose focal adhesions, round up, and disassemble F-actin-containing stress fibres. These cellular responses can be blocked in a dominant-negative fashion by expression of the isolated Grb4 SH2 domain. The Grb4 SH3 domains bind a unique set of other proteins that are implicated in cytoskeletal regulation, including the Cbl-associated protein (CAP/ponsin), the Abl-interacting protein-1 (Abi-1), dynamin, PAK1, hnRNPK and axin. These data provide a biochemical pathway whereby cytoskeletal regulators are recruited to Eph-ephrin bidirectional signalling complexes.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Henkemeyer, M (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.			Henkemeyer, Mark/0000-0002-7525-1061				Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Keegan K, 1996, ONCOGENE, V12, P1537; Kurakin A, 1998, J PEPT RES, V52, P331; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Wunderlich L, 1999, CELL SIGNAL, V11, P25, DOI 10.1016/S0898-6568(98)00027-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	31	278	284	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					174	179		10.1038/35093123	http://dx.doi.org/10.1038/35093123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557983				2022-12-28	WOS:000170918800049
J	Firestein, S				Firestein, S			How the olfactory system makes sense of scents	NATURE			English	Review							PUTATIVE PHEROMONE RECEPTORS; GATED CATION CHANNEL; MULTIGENE FAMILY; 7-TRANSMEMBRANE PROTEINS; FUNCTIONAL EXPRESSION; VOMERONASAL NEURONS; ODORANT RECEPTORS; CELLS; MAMMALS; MAP	The human nose is often considered something of a luxury, but in the rest of the animal world, from bacteria to mammals, detecting chemicals in the environment has been critical to the successful organism. An indication of the importance of olfactory systems is the significant proportion-as much as 4%-of the genomes of many higher eukaryotes that is devoted to encoding the proteins of smell. Growing interest in the detection of diverse compounds at single-molecule levels has made the olfactory system an important system for biological modelling.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, 923 Fairchild,MC 2438, New York, NY 10027 USA.							ACHE BW, 1995, CURR OPIN NEUROBIOL, V5, P461, DOI 10.1016/0959-4388(95)80006-9; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Dudai Y, 1999, NEURON, V23, P633, DOI 10.1016/S0896-6273(01)80020-9; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; GIMELBRANT AA, 2000, J BIOL CHEM, V1, P1; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Krieger Juergen, 1997, Invertebrate Neuroscience, V3, P137, DOI 10.1007/BF02480368; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Meister M, 2001, J NEUROSCI, V21, P1351; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Meredith M, 2001, CHEM SENSES, V26, P433, DOI 10.1093/chemse/26.4.433; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Reisert J, 2000, CHEM SENSES, V25, P483, DOI 10.1093/chemse/25.4.483; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	64	777	807	18	299	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					211	218		10.1038/35093026	http://dx.doi.org/10.1038/35093026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557990				2022-12-28	WOS:000170918800056
J	Lapostolle, F; Surget, V; Borron, SW; Desmaizieres, M; Sordelet, D; Lapandry, C; Cupa, M; Adnet, F				Lapostolle, F; Surget, V; Borron, SW; Desmaizieres, M; Sordelet, D; Lapandry, C; Cupa, M; Adnet, F			Severe pulmonary embolism associated with air travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ECONOMY-CLASS SYNDROME; THROMBOEMBOLIC DISEASE; VENOUS THROMBOEMBOLISM; RISK-FACTORS; THROMBOSIS; FLIGHTS	Background Air travel is believed to be a risk factor for pulmonary embolism, but the relation between pulmonary embolism and distance flown has not been documented. The aim of this study was to investigate whether the duration of air travel is related to the risk of pulmonary embolism. Methods From November 1993 to December 2000, we systematically reviewed all cases of pulmonary embolism requiring medical care on arrival at France's busiest international airport. Data on the geographic origins of all flights and the numbers of passengers were collected in order to evaluate the incidence of pulmonary embolism per million passenger arrivals as a function of the distance traveled. Results A total of 135.29 million passengers from 145 countries or other areas arrived at Charles de Gaulle Airport during the period of the study, of whom 56 had confirmed pulmonary embolism. The incidence of pulmonary embolism was much higher among passengers traveling more than 5000 km (3100 mi) (1.5 cases per million, as compared with 0.01 case per million among those traveling less than 5000 km). The incidence of pulmonary embolism was 4.8 cases per million for those traveling more than 10,000 km (6200 mi). Conclusions A greater distance traveled is a significant contributing risk factor for pulmonary embolism associated with air travel. (N Engl J Med 2001; 345: 779-83.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Paris 13, SAMU 93, Hop Avicenne, F-93009 Bobigny, France; George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; George Washington Univ, Sch Med, Div Occupat & Environm Hlth, Washington, DC USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; George Washington University; George Washington University	Lapostolle, F (corresponding author), Univ Paris 13, SAMU 93, Hop Avicenne, 125 Rue Stalingrad, F-93009 Bobigny, France.	frederic.lapostolle@avc.ap-hop-paris.fr						BEIGHTON PH, 1968, BRIT HEART J, V30, P367; BENOIT R, 1992, J MAL VASCUL, V17, P84; CRUICKSHANK JM, 1988, LANCET, V2, P497, DOI 10.1016/S0140-6736(88)90134-1; DRUILHE L, 1994, J MED LEG DROIT MED, V37, P429; Eklof B, 1996, DERMATOL SURG, V22, P637, DOI 10.1111/j.1524-4725.1996.tb00610.x; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Ferriman A, 2000, BRIT MED J, V321, P1310, DOI 10.1136/bmj.321.7272.1310; FINCH PJ, 1988, LANCET, V2, P1025; Geroulakos G, 2001, BRIT MED J, V322, P188, DOI 10.1136/bmj.322.7280.188; GOBIN JP, 1994, ARTERES VEINES, V13, P5; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; KIEFFER B, 1989, MED AERONAUTIQUE SPA, V28, P300; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; LEDERMANN JA, 1983, POSTGRAD MED J, V59, P104, DOI 10.1136/pgmj.59.688.104; LEVY Y, 1995, ISRAEL J MED SCI, V31, P621; MARSEPOIL T, 1991, PRESSE MED, V20, P383; Mercer A, 1998, AVIAT SPACE ENVIR MD, V69, P154; MILLER GAH, 1971, BRIT MED J, V2, P681, DOI 10.1136/bmj.2.5763.681; MILLS FJ, 1983, BMJ-BRIT MED J, V286, P1131, DOI 10.1136/bmj.286.6371.1131; MOYSES C, 1987, INT J MICROCIRC, V5, P311; Nissen P, 1997, VASA-J VASCULAR DIS, V26, P239; NODDELAND H, 1988, EUR J APPL PHYSIOL O, V57, P409, DOI 10.1007/BF00417985; Paganin F, 1996, LANCET, V347, P1195, DOI 10.1016/S0140-6736(96)90659-5; Ribeiro A, 1997, AM HEART J, V134, P479, DOI 10.1016/S0002-8703(97)70085-1; Ribier G, 1997, REV MED INTERNE, V18, P601, DOI 10.1016/S0248-8663(97)82460-5; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; SARVESVARAN R, 1986, MED SCI LAW, V26, P35, DOI 10.1177/002580248602600108; Satoh A, 1998, Nihon Kokyuki Gakkai Zasshi, V36, P524; Simon R, 1999, WIEN KLIN WOCHENSCHR, V111, P596; Sinzinger H, 1999, VASA-J VASCULAR DIS, V28, P199, DOI 10.1024/0301-1526.28.3.199; SYMINGTON IS, 1977, BRIT J DIS CHEST, V71, P138, DOI 10.1016/0007-0971(77)90097-3; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; 1985, LANCET, V1, P353; 1988, LANCET, V2, P797	36	261	275	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					779	783		10.1056/NEJMoa010378	http://dx.doi.org/10.1056/NEJMoa010378			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556296				2022-12-28	WOS:000170906800001
J	Ernst, E; Pittler, MH				Ernst, E; Pittler, MH			Assessment of therapeutic safety in systematic reviews: literature review	BRITISH MEDICAL JOURNAL			English	Review									Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England	University of Exeter	Ernst, E (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England.							Ernst E., 1998, COMPLEMENT THER MED, V6, P115, DOI [10.1016/S0965-2299(98)80002-2, DOI 10.1016/S0965-2299(98)80002-2]; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; RAWLINS MD, 1995, J ROY COLL PHYS LOND, V29, P41; Stevinson C, 1999, CNS DRUGS, V11, P125, DOI 10.2165/00023210-199911020-00004	4	67	68	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					546	546		10.1136/bmj.323.7312.546	http://dx.doi.org/10.1136/bmj.323.7312.546			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546700	Green Published, Bronze			2022-12-28	WOS:000170934600021
J	Fortnum, HM; Summerfield, AQ; Marshall, DH; Davis, AC; Bamford, JM				Fortnum, HM; Summerfield, AQ; Marshall, DH; Davis, AC; Bamford, JM			Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study	BRITISH MEDICAL JOURNAL			English	Article							EARLY IDENTIFICATION; EPIDEMIOLOGY; CHILDREN; INTERVENTION	Objective To estimate the prevalence of confirmed permanent childhood hearing impairment and its profile across age and degree of impairment in the United Kingdom. Design Retrospective total ascertainment through sources in the health and education sectors by postal questionnaire. Setting Hospital based otology and audiology departments, community health clinics, education services for hearing impaired children. Participants Children born from 1980 to 1995, resident in United Kingdom in 1998, with permanent childhood hearing impairment (hearing level in the better ear >40 dB averaged over 0.5,1, 2, and 4 kHz). Main outcome measures Numbers of cases with date of birth and severity of impairment converted to prevalences for each annual birth cohort (cases/1000 live births) and adjusted for underascertainment. Results 26000 notifications ascertained 17160 individual children. Prevalence rose from 0.91 (95% confidence interval 0.85 to 0.98) for 3 year olds to 1.65 (1.62 to 1.68) for children aged 9-16 years. Adjustment for underascertainment increased estimates to 1.07 (1.03 to 1.12) and 2.05 (2.02 to 2.08). Comparison With previous studies showed that prevalence increases with age, rather than declining With year of birth. Conclusions Prevalence of confirmed permanent childhood hearing impairment increases until the age of 9 years to a level higher than previously estimated. Relative to current yields of universal neonatal hearing screening mi the United Kingdom, which are close to 1/1000 live births, 50-90% more children are diagnosed with permanent childhood hearing impairment by the age of 9 years. Paediatric audiology services must have the capacity to achieve early identification and confirmation of these additional cases.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Univ Manchester, Human Commun & Deafness Grp, Manchester M13 9PL, Lancs, England	University of Manchester	Fortnum, HM (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.		Davis, Adrian C/E-6022-2015	Davis, Adrian C/0000-0001-7134-7528				Bloor M, 2000, J Health Serv Res Policy, V5, P89; British Society of Audiology, 1988, BRIT J AUDIOL, V22, P123, DOI DOI 10.3109/03005368809077807; Cheng AK, 2000, JAMA-J AM MED ASSOC, V284, P850, DOI 10.1001/jama.284.7.850; Conrad R., 1979, DEAF SCHOOLCHILD LAN; Cormack RM, 1999, J CLIN EPIDEMIOL, V52, P909, DOI 10.1016/S0895-4356(99)00058-X; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; Davis A, 1997, HEALTH TECHNOL ASSES, V1, P1; Davis A., 1993, J AUDIOL MED, V3, P35; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P10; *DEP HLTH, 2001, PIL INTR UN NEON HEA; Downs MP, 1999, PEDIATR CLIN N AM, V46, P79, DOI 10.1016/S0031-3955(05)70082-1; Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037; Gregory S, 1995, DEAF CHILDREN THEIR; Kennedy CR, 1999, ACTA PAEDIATR, V88, P73, DOI 10.1080/080352599750029448; LAPORTE RE, 1992, LANCET, V339, P494, DOI 10.1016/0140-6736(92)91103-F; Maki-Torkko EM, 1998, SCAND AUDIOL, V27, P95, DOI 10.1080/010503998420333; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; *NHS EX, 2001, LAUNCH PIL PROJ PROV; *NIH, 1993, AM FAM PHYSICIAN, V48, P521; *OFF NAT STAT, 1999, POP TRENDS SUMM 1992; *OFF NAT STAT, 1999, POP TRENDS SUMM 1999; Steel KP, 2000, BRIT MED J, V320, P622, DOI 10.1136/bmj.320.7235.622; Uus K, 2000, AUDIOLOGY, V39, P192; Van Naarden K, 1999, PEDIATRICS, V103, P570, DOI 10.1542/peds.103.3.570; VANCAMP G, 2001, HEREDITARY HEARING L; Watkin PM, 1999, ARCH DIS CHILD, V81, P380, DOI 10.1136/adc.81.5.380; WOOD D, 1986, TEACHING TALKING DEA; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	28	278	300	1	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					536	539		10.1136/bmj.323.7312.536	http://dx.doi.org/10.1136/bmj.323.7312.536			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546698	Bronze, Green Published			2022-12-28	WOS:000170934600018
J	Gibbs, MJ; Armstrong, JS; Gibbs, AJ				Gibbs, MJ; Armstrong, JS; Gibbs, AJ			Recombination in the hemagglutinin gene of the 1918 "Spanish flu"	SCIENCE			English	Article							INFLUENZA-VIRUS; EVOLUTION; SEQUENCE; ORIGIN	When gene sequences from the influenza virus that caused the 1918 pandemic were first compared with those of related viruses, they yielded few clues about its origins and virulence. Our reanalysis indicates that the hemagglutinin gene, a key virulence determinant, originated by recombination. The "globular domain" of the 1918 hemagglutinin protein was encoded by a part of a gene derived from a swine-lineage influenza, whereas the "stalk" was encoded by parts derived from a human-lineage influenza. Phylogenetic analyses showed that this recombination, which probably changed the virulence of the virus, occurred at the start of, or immediately before, the pandemic and thus may have triggered it.	Australian Natl Univ, Fac Sci, Div Bot & Zool, Canberra, ACT 2601, Australia	Australian National University	Gibbs, AJ (corresponding author), Australian Natl Univ, Fac Sci, Div Bot & Zool, Canberra, ACT 2601, Australia.	mark.gibbs@anu.edu.au						Anderson JP, 2000, J VIROL, V74, P10752, DOI 10.1128/JVI.74.22.10752-10765.2000; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; BEKLEMISHEV AB, 1993, MOL GEN MIKROBIOL VI, V1, P24; BERGMANN M, 1992, J VIROL, V66, P7576, DOI 10.1128/JVI.66.12.7576-7580.1992; BIKOUR MH, 1995, J GEN VIROL, V76, P2539, DOI 10.1099/0022-1317-76-10-2539; CROSBY AW, 1989, AM FORGOTTEN PLAGUE; FIELDS S, 1982, CELL, V28, P303, DOI 10.1016/0092-8674(82)90348-8; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; KILBOURNE ED, 1977, JAMA-J AM MED ASSOC, V237, P1225, DOI 10.1001/jama.237.12.1225; Lederberg J, 2001, P NATL ACAD SCI USA, V98, P2115, DOI 10.1073/pnas.051000798; Pita JS, 2001, J GEN VIROL, V82, P655, DOI 10.1099/0022-1317-82-3-655; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCHOLTISSEK C, 1993, ARCH VIROL, V131, P237, DOI 10.1007/BF01378629; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Taubenberger JK, 2000, VIROLOGY, V274, P241, DOI 10.1006/viro.2000.0495; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352	31	97	116	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1842	1845		10.1126/science.1061662	http://dx.doi.org/10.1126/science.1061662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546876				2022-12-28	WOS:000170894400051
J	Nimis, PL				Nimis, PL			A tale from bioutopia	NATURE			English	Editorial Material									Univ Trieste, Dept Biol, I-34127 Trieste, Italy	University of Trieste	Nimis, PL (corresponding author), Univ Trieste, Dept Biol, Via L Giorgieri 10, I-34127 Trieste, Italy.								0	12	12	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					21	21		10.1038/35092637	http://dx.doi.org/10.1038/35092637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544504				2022-12-28	WOS:000170801200019
J	Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT				Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT			Effect of coinfection with GB virus C on survival among patients with HIV infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-G VIRUS; INTERFERON-ALPHA THERAPY; TYPE-1 REPLICATION; HIGH PREVALENCE; T-CELLS; PROGRESSION; DISEASE; RNA; ASSOCIATION; INHIBITION	Background: Previous studies have suggested that people with human immunodeficiency virus (HIV) infection who are coinfected with GB virus C (GBV-C, or hepatitis G virus) have delayed progression of HIV disease. GBV-C is related to hepatitis C virus but does not appear to cause liver disease. Methods: We examined the effect of coinfection with GBV-C on the survival of patients with HIV infection. We also evaluated cultures of peripheral-blood mononuclear cells infected with both viruses to determine whether GBV-C infection alters replication in vitro. Results: Of 362 HIV-infected patients, 144 (39.8 percent) had GBV-C viremia in two tests. Forty-one of the patients with GBV-C viremia (28.5 percent) died during the follow-up period, as compared with 123 of the 218 patients who tested negative for GBV-C RNA (56.4 percent; P<0.001). The mean duration of follow-up for the entire cohort was 4.1 years. In a Cox regression analysis adjusted for HIV treatment, base-line CD4+ T-cell count, age, sex, race, and mode of transmission of HIV, the mortality rate among the 218 HIV-infected patients without GBV-C coinfection was significantly higher than that among the 144 patients with GBV-C coinfection (relative risk, 3.7; 95 percent confidence interval, 2.5 to 5.4). HIV replication, as measured by the detection of p24 antigen in culture supernatants, was reproducibly inhibited in cultures of peripheral-blood mononuclear cells by GBV-C coinfection. Coinfection did not alter the surface expression of HIV cellular receptors on peripheral-blood mononuclear cells, as determined by flow cytometry. Conclusions: GBV-C infection is common in people with HIV infection and is associated with significantly improved survival.	Univ Iowa, Coll Med, Dept Internal Med, SW 54,GH UIHC, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Dept Res, Iowa City, IA 52242 USA; Helen C Levitt Ctr Viral Pathogenesis & Dis, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Stapleton, JT (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, SW 54,GH UIHC, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Diekema, Daniel/0000-0003-1273-0724; Stapleton, Jack/0000-0002-2302-9055; George, Sarah/0000-0002-9699-1042	NIAAA NIH HHS [R01 AA12671] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012671] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; Cook RT, 1997, J INVEST MED, V45, P265; COX DR, 1972, J R STAT SOC B, V34, P187; Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;97::AID-JMV16&gt;3.0.CO;2-V; Elvander M, 1998, ACTA VET SCAND, V39, P251; Fisher LD., 1997, BIOMETRICS, V53, P1182; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lau DTY, 1999, J INFECT DIS, V180, P1334, DOI 10.1086/315031; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Nerurkar VR, 1998, J MED VIROL, V56, P123, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;123::AID-JMV4&gt;3.0.CO;2-A; Pessoa MG, 1998, HEPATOLOGY, V27, P877, DOI 10.1002/hep.510270335; Pinto LA, 2000, J VIROL, V74, P4505, DOI 10.1128/JVI.74.10.4505-4511.2000; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; RINALDO CR, 1976, INFECT IMMUN, V14, P660, DOI 10.1128/IAI.14.3.660-666.1976; Rowland-Jones S, 1999, J INFECTION, V38, P67, DOI 10.1016/S0163-4453(99)90070-1; SHIRAZI Y, 1993, VIROLOGY, V193, P303, DOI 10.1006/viro.1993.1126; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Theodore D, 1997, HEPATOLOGY, V25, P1285, DOI 10.1002/hep.510250541; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; XIANG J, 1999, J VIRAL HEPAT S1, V6, P6; Xiang JH, 1998, J VIROL, V72, P2738, DOI 10.1128/JVI.72.4.2738-2744.1998; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; 1989, MMWR MORB MORTAL S5, V38, P1	34	289	305	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					707	714		10.1056/NEJMoa003364	http://dx.doi.org/10.1056/NEJMoa003364			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547739				2022-12-28	WOS:000170772900001
J	Bauer, KA				Bauer, KA			The thrombophilias: Well-defined risk factors with uncertain therapeutic implications	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FACTOR-V-LEIDEN; RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; COAGULATION-FACTOR-V; POOR ANTICOAGULANT RESPONSE; FACTOR-VIII; PROTHROMBIN-GENE; FETAL LOSS; MUTATION	Discovery of the factor V Leiden and prothrombin G20210A mutations has greatly increased the percentage of patients in whom venous thrombosis can be attributed to hereditary thrombophilia. The first step in the diagnostic approach to all patients with venous thrombosis consists of a careful history and physical examination combined with routine laboratory testing to characterize the severity of the thrombotic condition and determine the presence of any of the acquired causes of hypercoagulability. The second step is to consider screening for the causes of hereditary and acquired thrombophilia in selected subsets of patients. The selection of patients for testing, the choice of tests to perform, and the timing of the testing are important and challenging issues to consider. Routine testing would be warranted if the identification of abnormalities led to an alteration in the type or duration of initial anticoagulant therapy or the use of long-term prophylactic anticoagulation. The available data, however, do not yet indicate that most patients with defined thrombophilic states should be managed any differently than patients without identifiable abnormalities. On the basis of relative prevalences of the various thrombophilias, patients can be classified as "strongly" or "weakly" thrombophilic depending on their thrombotic histories. Management considerations and guidelines are offered for patients who are found to have one or more defined abnormalities, hereditary or otherwise. The future identification of additional laboratory abnormalities predisposing patients to thrombosis, coupled with prospective clinical trials, should enable us to better identify patients at high risk for recurrence who will benefit from prolonged anticoagulant prophylaxis.	Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bauer, KA (corresponding author), Vet Affairs Boston Healthcare Syst, 1400 VFW Pkwy, W Roxbury, MA 02132 USA.	kbauer@caregroup.harvard.edu						BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; De Groot CJM, 1999, AM J OBSTET GYNECOL, V181, P975, DOI 10.1016/S0002-9378(99)70335-2; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; de Visser MCH, 1999, BLOOD, V93, P1271, DOI 10.1182/blood.V93.4.1271.404k22_1271_1276; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Friederich PW, 1996, ANN INTERN MED, V125, P955, DOI 10.7326/0003-4819-125-12-199612150-00003; Gerhardt A, 2000, NEW ENGL J MED, V342, P374, DOI 10.1056/NEJM200002103420602; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202; Hyers TM, 1998, CHEST, V114, p561S, DOI 10.1378/chest.114.5_Supplement.561S; Jick H, 1996, LANCET, V348, P981, DOI 10.1016/S0140-6736(96)07114-0; Kamphuisen PW, 1999, THROMB HAEMOSTASIS, V81, P680, DOI 10.1055/s-0037-1614553; Kamphuisen PW, 2000, BRIT J HAEMATOL, V109, P519, DOI 10.1046/j.1365-2141.2000.02091.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kluijtmans LAJ, 1998, THROMB HAEMOSTASIS, V79, P254, DOI 10.1055/s-0037-1614974; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Kutteh WH, 1996, AM J OBSTET GYNECOL, V174, P1584, DOI 10.1016/S0002-9378(96)70610-5; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; Lensing AWA, 1999, THROMB HAEMOSTASIS, V82, P1564; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Lindqvist PG, 1999, THROMB HAEMOSTASIS, V81, P532; Margaglione M, 1999, THROMB HAEMOSTASIS, V82, P1583; Martinelli I, 2000, NEW ENGL J MED, V343, P1015, DOI 10.1056/NEJM200010053431405; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Meinardi JR, 1999, ANN INTERN MED, V130, P736, DOI 10.7326/0003-4819-130-9-199905040-00013; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; ODonnell J, 1997, THROMB HAEMOSTASIS, V77, P825; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Ridker P M, 1998, Vasc Med, V3, P67; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; RIDKER PM, 1995, CIRCULATION, V92, P2800, DOI 10.1161/01.CIR.92.10.2800; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; van Tilburg NH, 2000, BLOOD, V95, P2855, DOI 10.1182/blood.V95.9.2855.009k02_2855_2859; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Vlieg AV, 2000, BLOOD, V95, P3678	52	148	151	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					367	373		10.7326/0003-4819-135-5-200109040-00013	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00013			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529700				2022-12-28	WOS:000170780600007
J	Smith, GCS; Pell, JP				Smith, GCS; Pell, JP			Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL AGE; INFANT-MORTALITY; PRETERM BIRTH; WEIGHT; DETERMINANTS; ADOLESCENTS; DELIVERY; SMOKING; MOTHERS; PARITY	Objective To determine whether first and second births among teenagers are associated With increased risk of adverse perinatal outcomes after confounding variables have been taken into account. Design Population based retrospective cohort study using routine discharge data for 1992-8. Setting Scotland. Main outcome measures Stillbirth, preterm. delivery, emergency caesarean section, and small for gestational age baby among non-smoking mothers aged 15-19 and 20-29. Results The 110 233 eligible deliveries Were stratified into first and second births. Among first births, the only significant difference in adverse outcomes by age group was for emergency caesarean section, which was less likely among younger mothers (odds ratio 0.5, 95% confidence interval 0.5 to 0.6). Second births in women aged 15-19 Were associated with an increased risk of moderate (1.6, 1.2 to 2.1) and extreme prematurity (2.5, 1.5 to 4.3) and stillbirth (2.6, 1.3 to 5.3) but a reduced risk of emergency caesarean section (0.7, 0.5 to 1.0). Conclusions First teenage births are not independently associated with ari increased risk of adverse pregnancy outcome and are at decreased risk of delivery by emergency caesarean section. However, second teenage births are associated with an almost threefold risk of preterm delivery and stillbirth.	Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Univ Glasgow, Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G3 8SH, Lanark, Scotland	University of Glasgow	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997				Astolfi P, 1999, HUM REPROD, V14, P2891, DOI 10.1093/humrep/14.11.2891; Berenson AB, 1997, J REPROD MED, V42, P559; BLANKSON ML, 1993, JAMA-J AM MED ASSOC, V269, P1401, DOI 10.1001/jama.269.11.1401; COLE SK, 1980, PERINATAL AUDIT SURV, P39; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; ELSTER AB, 1984, AM J OBSTET GYNECOL, V149, P845, DOI 10.1016/0002-9378(84)90602-1; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; HELLERSTEDT WL, 1995, AM J PUBLIC HEALTH, V85, P1139, DOI 10.2105/AJPH.85.8_Pt_1.1139; HOSMER DW, 1989, APPL LOGISTIC REGRES; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Lao TT, 1998, HUM REPROD, V13, P3228, DOI 10.1093/humrep/13.11.3228; Lao TT, 1997, HUM REPROD, V12, P2303, DOI 10.1093/humrep/12.10.2303; LEE KS, 1988, AM J OBSTET GYNECOL, V158, P84, DOI 10.1016/0002-9378(88)90783-1; LUMLEY J, 1993, BAILLIERE CLIN OB GY, V7, P477, DOI 10.1016/S0950-3552(05)80445-6; MCCORMICK MC, 1984, AM J PUBLIC HEALTH, V74, P18, DOI 10.2105/AJPH.74.1.18; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Olausson PMO, 1997, OBSTET GYNECOL, V89, P451, DOI 10.1097/00006250-199703000-00027; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; STROBINO DM, 1995, AM J EPIDEMIOL, V142, P504, DOI 10.1093/oxfordjournals.aje.a117668; SWEENEY PJ, 1989, AM J OBSTET GYNECOL, V160, P1361, DOI 10.1016/0002-9378(89)90856-9; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	24	139	142	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					476	479		10.1136/bmj.323.7311.476	http://dx.doi.org/10.1136/bmj.323.7311.476			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532837	Bronze, Green Published			2022-12-28	WOS:000170838500014
J	Love, SG; Ahrens, TJ				Love, SG; Ahrens, TJ			Origin of asteroid rotation rates in catastrophic impacts	NATURE			English	Article							COLLISIONAL EVOLUTION; DESPINNING ASTEROIDS	The rotation rates of asteroids, which are deduced from periodic fluctuations in their brightnesses(1), are controlled by mutual collisions(2-8). The link between asteroid spin and collision history is usually made with reference to impact experiments on centimetre-scale targets, where material strength governs the impact response(2,3,9-11). Recent work, however, indicates that for objects of the size of most observed asteroids (greater than or equal to 1 km in diameter), gravity rather than intrinsic strength controls the dynamic response to collisions(12-14). Here we explore this idea by modelling the effect of impacts on large gravitating bodies. We find that the fraction of a projectile's angular momentum that is retained by a target asteroid is both lower and more variable than expected from laboratory experiments, with spin evolution being dominated by 'catastrophic' collisions that eject similar to 50 per cent of the target's mass. The remnant of an initially non-rotating silicate asteroid that suffers such a collision rotates at a rate of similar to 2.9 per day, which is close to the observed mean asteroid rotation rate of similar to 2.5 d(-1) Moreover, our calculations suggest that the observed trend in the mean spin frequency for different classes of asteroids(4) (2.2 d(-1) for C-type asteroids, 2.5 d(-1) for S-type, and 4.0 d(-1) for M-type) is due to increasing mean density, rather than increasing material strength.			Love, SG (corresponding author), CALTECH,SEISMOL LAB 25221,PASADENA,CA 91125, USA.							BELTON MJS, 1995, NATURE, V374, P785, DOI 10.1038/374785a0; Binzel R.P., 1989, ASTEROIDS, P416; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; Bottke WF, 1996, NATURE, V381, P51, DOI 10.1038/381051a0; BURNS JA, 1973, MON NOT R ASTRON SOC, V165, P403, DOI 10.1093/mnras/165.4.403; CELLINO A, 1990, ICARUS, V87, P391, DOI 10.1016/0019-1035(90)90142-V; DAVIS DR, 1989, ASTEROIDS, V2, P805; DOBROVOLSKIS AR, 1984, ICARUS, V57, P464, DOI 10.1016/0019-1035(84)90130-1; DONES L, 1993, SCIENCE, V259, P350, DOI 10.1126/science.259.5093.350; FARINELLA P, 1992, ASTRON ASTROPHYS, V253, P604; FUJIWARA A, 1981, ICARUS, V48, P329, DOI 10.1016/0019-1035(81)90113-5; Fujiwara A., 1989, ASTEROIDS, VII, P240; Harris A.W., 1989, ASTEROIDS, VII, P39; Harris A.W., 1996, LUNAR PLANET SCI, V27, P493; HARRIS AW, 1979, ICARUS, V40, P142; HOLSAPPLE KA, 1994, PLANET SPACE SCI, V42, P1067, DOI 10.1016/0032-0633(94)90007-8; Love SG, 1996, ICARUS, V124, P141, DOI 10.1006/icar.1996.0195; Melosh H.J, 1989, OXFORD MONOGRAPHS GE; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; RYAN EV, 1995, EOS, V76, pF336; TILLOTSON JH, 1962, GA3216 GEN DYN CORP; YANAGISAWA M, 1991, ICARUS, V94, P272, DOI 10.1016/0019-1035(91)90227-K	22	19	19	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAR 13	1997	386	6621					154	156		10.1038/386154a0	http://dx.doi.org/10.1038/386154a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WM973	11536797				2022-12-28	WOS:A1997WM97300055
J	Volkmann, N; Amann, KJ; Stoilova-McPhie, S; Egile, C; Winter, DC; Hazelwood, L; Heuser, JE; Li, R; Pollard, TD; Hanein, D				Volkmann, N; Amann, KJ; Stoilova-McPhie, S; Egile, C; Winter, DC; Hazelwood, L; Heuser, JE; Li, R; Pollard, TD; Hanein, D			Structure of Arp2/3 complex in its activated state and in actin filament branch junctions	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP/SCAR PROTEINS; N-WASP; ACANTHAMOEBA; NUCLEATION; MOTILITY; CYTOSKELETON; DISSECTION; NETWORKS; PROFILIN	The seven-subunit Arp2/3 complex choreographs the formation of branched actin networks at the leading edge of migrating cells. When activated by Wiskott-Aldrich Syndrome protein (WASp), the Arp2/3 complex initiates actin filament branches from the sides of existing filaments. Electron cryomicroscopy and three-dimensional reconstruction of Acanthamoeba castellanil and Saccharomyces cerevisiae Arp2/3 complexes bound to the WASp carboxy-terminal domain reveal asymmetric, oblate ellipsoids. Image analysis of actin branches indicates that the complex binds the side of the mother filament, and Arp2 and Arp3 (for actin-related protein) are the first two subunits of the daughter filament. Comparison to the actin-free, WASp-activated complexes suggests that branch initiation involves large-scale structural rearrangements within Arp2/3.	Burnham Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; Harvard University; Harvard Medical School; Washington University (WUSTL)	Hanein, D (corresponding author), Burnham Inst, La Jolla, CA 92037 USA.		Heuser, John/H-5940-2012					Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1998, MOL BIOL CELL, V9, P841, DOI 10.1091/mbc.9.4.841; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	28	196	203	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2456	2459		10.1126/science.1063025	http://dx.doi.org/10.1126/science.1063025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11533442				2022-12-28	WOS:000171237200048
J	Duffy, PE; Fried, M				Duffy, PE; Fried, M			Biomedicine - Turncoat antibodies	SCIENCE			English	Editorial Material							CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; HUMAN PLACENTA; RECEPTOR; ADHESION; DOMAINS		Seattle Biomed Res Inst, Seattle, WA 98109 USA; Walter Reed Army Inst Res, Silver Spring, MD 20910 USA	Center for Infectious Disease Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Duffy, PE (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.							Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Degen R, 2000, EXP PARASITOL, V95, P113, DOI 10.1006/expr.2000.4512; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Kristoffersen EK, 1996, EUR J IMMUNOL, V26, P1668, DOI 10.1002/eji.1830260741; Loukas A, 2001, INFECT IMMUN, V69, P3646, DOI 10.1128/IAI.69.6.3646-3651.2001; Lyden TW, 2001, J IMMUNOL, V166, P3882, DOI 10.4049/jimmunol.166.6.3882; Maubert B, 2000, PARASITE IMMUNOL, V22, P191, DOI 10.1046/j.1365-3024.2000.00292.x; Reeder JC, 2000, INFECT IMMUN, V68, P3923, DOI 10.1128/IAI.68.7.3923-3926.2000; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878	15	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2009	2010		10.1126/science.1065302	http://dx.doi.org/10.1126/science.1065302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557864				2022-12-28	WOS:000171028700045
J	Boule, NG; Haddad, E; Kenny, GP; Wells, GA; Sigal, RJ				Boule, NG; Haddad, E; Kenny, GP; Wells, GA; Sigal, RJ			Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus - A meta-analysis of controlled clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TERM PHYSICAL-EXERCISE; RANDOMIZED CONTROLLED-TRIALS; INCREASES INSULIN ACTION; GLUCOSE-TOLERANCE; METABOLIC-CONTROL; ENDURANCE EXERCISE; RESISTANCE EXERCISE; AEROBIC EXERCISE; ADIPOSE-TISSUE; OBESE PATIENTS	Context Exercise is widely perceived to be beneficial for glycemic control and weight loss in patients with type 2 diabetes. However, clinical trials on the effects of exercise in patients with type 2 diabetes have had small sample sizes and conflicting results. Objective To systematically review and quantify the effect of exercise on glycosylated hemoglobin (HbA(1c)) and body mass in patients with type 2 diabetes. Data Sources Database searches of MEDLINE, EMBASE, Sport Discuss, Health Star, Dissertation Abstracts, and the Cochrane Controlled Trials Register for the period up to and including December 2000. Additional data sources included bibliographies of textbooks and articles identified by the database searches. Study Selection We selected studies that evaluated the effects of exercise interventions (duration greater than or equal to8 weeks) in adults with type 2 diabetes. Fourteen (11 randomized and 3 nonrandomized) controlled trials were included. Studies that included drug cointerventions were excluded. Data Extraction Two reviewers independently extracted baseline and postintervention means and SDs for the intervention and control groups. The characteristics of the exercise interventions and the methodological quality of the trials were also extracted. Data Synthesis Twelve aerobic training studies (mean [SD], 3.4 [0.9] times/week for 18 [15] weeks) and 2 resistance training studies (mean [SD], 10 [0.7] exercises, 2.5 [0.7] sets, 13 [0.7] repetitions, 2.5 [0.4] times/week for 15 [10] weeks) were included in the analyses. The weighted mean postintervention HbA(1c) was lower in the exercise groups compared with the control groups (7.65% vs 8.31%; weighted mean difference, -0.66%; P<.001). The difference in postintervention body mass between exercise groups and control groups was not significant (83.02 kg vs 82.48 kg; weighted mean difference, 0.54; P = .76). Conclusion Exercise training reduces HbA(1c) by an amount that should decrease the risk of diabetic complications, but no significantly greater change in body mass was found when exercise groups were compared with control groups.	Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Sch Human Kinet, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Sch Human Kinet, Dept Epidemiol & Community Med, Ottawa, ON, Canada; Univ Ottawa, Fac Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Sigal, RJ (corresponding author), Ottawa Hlth Res Inst, Clin Epidemiol Unit, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	rsigal@ohri.ca	Sigal, Ronald/AAU-6081-2020; Sigal, Ron/AAK-7627-2020					AgursCollins TD, 1997, DIABETES CARE, V20, P1503, DOI 10.2337/diacare.20.10.1503; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; BLONK MC, 1994, DIABETIC MED, V11, P449, DOI 10.1111/j.1464-5491.1994.tb00305.x; BOGARDUS C, 1984, DIABETES, V33, P311, DOI 10.2337/diabetes.33.4.311; BOUCHARD C, 1994, PHYS ACT FITN HLTH 2; Brooks GA, 1995, EXERCISE PHYSL HUMAN; COGGAN AR, 1993, AM J PHYSIOL, V264, pE215, DOI 10.1152/ajpendo.1993.264.2.E215; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; CRAIG BW, 1989, MECH AGEING DEV, V49, P147, DOI 10.1016/0047-6374(89)90098-5; DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862; DELA F, 1993, J PHYSIOL-LONDON, V469, P615, DOI 10.1113/jphysiol.1993.sp019833; Despres J P, 1997, Exerc Sport Sci Rev, V25, P271; DESPRES JP, 1994, J INTERN MED, V236, P7, DOI 10.1111/j.1365-2796.1994.tb01114.x; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dunstan DW, 1999, THROMB HAEMOSTASIS, V81, P367; Dunstan DW, 1997, DIABETES CARE, V20, P913, DOI 10.2337/diacare.20.6.913; Dunstan DW, 1998, DIABETES RES CLIN PR, V40, P53, DOI 10.1016/S0168-8227(98)00027-8; DUNSTAN DW, 1997, THESIS U W AUSTR; Earle CC, 2000, MED DECIS MAKING, V20, P104, DOI 10.1177/0272989X0002000113; EBELING P, 1993, J CLIN INVEST, V92, P1623, DOI 10.1172/JCI116747; Eriksson J, 1998, HORM METAB RES, V30, P37, DOI 10.1055/s-2007-978828; Eriksson J, 1997, DIABETOLOGIA, V40, P125; Eriksson J, 1997, INT J SPORTS MED, V18, P242, DOI 10.1055/s-2007-972627; FLUCKEY JD, 1994, J APPL PHYSIOL, V77, P1087, DOI 10.1152/jappl.1994.77.3.1087; Foss M. L, 1998, FOXS PHYSL BASIS EXE; Fujii S, 1992, Rinsho Byori, V40, P1129; FUJII S, 1982, Osaka City Medical Journal, V28, P1; Fujitani J, 1998, METABOLISM, V47, P874, DOI 10.1016/S0026-0495(98)90129-9; Grundy SM, 1998, AM J CLIN NUTR, V67, p563S, DOI 10.1093/ajcn/67.3.563S; Halbert JA, 1997, J HUM HYPERTENS, V11, P641, DOI 10.1038/sj.jhh.1000509; HAUSER E, 1994, EFFECTS PHYSICAL ACT; Honkola A, 1997, ACTA DIABETOL, V34, P245, DOI 10.1007/s005920050082; Ivy J L, 1999, Exerc Sport Sci Rev, V27, P1; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joslin EP, 1959, TREATMENT DIABETES M; KAPLAN RM, 1987, J GEN INTERN MED, V2, P220, DOI 10.1007/BF02596443; KAPLAN RM, 1985, DIABETES CARE, V8, P343, DOI 10.2337/diacare.8.4.343; KELLEY G, 1994, AM J HYPERTENS, V7, P115, DOI 10.1093/ajh/7.2.115; KROTKIEWSKI M, 1986, INT J OBESITY, V10, P331; Lamarche B, 1998, JAMA-J AM MED ASSOC, V279, P1955, DOI 10.1001/jama.279.24.1955; LEHMANN R, 1995, DIABETOLOGIA, V38, P1313; MANDROUKAS K, 1984, EUR J APPL PHYSIOL O, V52, P355, DOI 10.1007/BF00943363; MILLER JP, 1994, J APPL PHYSIOL, V77, P1122, DOI 10.1152/jappl.1994.77.3.1122; MILLER WJ, 1984, MED SCI SPORT EXER, V16, P539; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mori TA, 1999, METABOLISM, V48, P1402, DOI 10.1016/S0026-0495(99)90150-6; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; MULROW CD, 1997, COCHRANE COLLABORATI; Orwin R.G., 1994, HDB RES SYNTHESIS; PONJEE GAE, 1993, BLOOD COAGUL FIBRIN, V4, P21, DOI 10.1097/00001721-199304010-00004; RAZ I, 1994, ISRAEL J MED SCI, V30, P766; REAVEN GM, 1994, DIABETOLOGIA, V37, P948, DOI 10.1007/s001250050202; RONNEMAA T, 1984, DIABETOLOGIA, V27, pA326; RONNEMAA T, 1988, DIABETES RES CLIN EX, V7, P79; RONNEMAA T, 1986, ACTA MED SCAND, V220, P219; Ryan AS, 1996, J GERONTOL A-BIOL, V51, pM199, DOI 10.1093/gerona/51A.5.M199; Saltin B, 1977, Ann N Y Acad Sci, V301, P3, DOI 10.1111/j.1749-6632.1977.tb38182.x; Samaras K, 1997, DIABETES RES CLIN PR, V37, P121, DOI 10.1016/S0168-8227(97)00061-2; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SKARFORS ET, 1987, DIABETOLOGIA, V30, P930, DOI 10.1007/BF00295876; SMUTOK MA, 1994, INT J SPORTS MED, V15, P283, DOI 10.1055/s-2007-1021061; Tessier D, 2000, ARCH GERONTOL GERIAT, V31, P121, DOI 10.1016/S0167-4943(00)00076-5; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UK PROSP DIAB STU, 1999, ACP J CLUB, V130, P28; Uusitupa MIJ, 1996, ANN MED, V28, P445, DOI 10.3109/07853899608999106; VANNINEN E, 1992, DIABETOLOGIA, V35, P340, DOI 10.1007/BF00401201; VANNINEN E, 1993, DIABETIC MED, V10, P66, DOI 10.1111/j.1464-5491.1993.tb01999.x; Wallace MB, 1997, MED SCI SPORT EXER, V29, P1170, DOI 10.1097/00005768-199709000-00008; WING RR, 1988, DIABETOLOGIA, V31, P902; Yeater R A, 1990, W V Med J, V86, P287; YKIYARVINEN H, 1998, DIABETES-METAB RES, V14, P45; Zachwieja JJ, 1996, METABOLISM, V45, P254, DOI 10.1016/S0026-0495(96)90063-3; Zinman B, 1997, DIABETES CARE, V20, P1908	75	1133	1176	2	236	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1218	1227		10.1001/jama.286.10.1218	http://dx.doi.org/10.1001/jama.286.10.1218			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559268				2022-12-28	WOS:000170910400033
J	Dockray, GJ				Dockray, GJ			Gastrin-releasing peptide: an Identity crisis at 30?	LANCET			English	Editorial Material							BOMBESIN; SECRETION		Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dockray, GJ (corresponding author), Univ Liverpool, Physiol Lab, POB 147, Liverpool L69 3BX, Merseyside, England.							ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Degen LP, 2001, GASTROENTEROLOGY, V120, P361, DOI 10.1053/gast.2001.21174; DOCKRAY GJ, 1979, NEUROSCIENCE, V4, P561; ELOMAR E, 1995, GUT, V36, P534, DOI 10.1136/gut.36.4.534; Gibbons AH, 1997, GASTROENTEROLOGY, V112, P1940, DOI 10.1053/gast.1997.v112.pm9178686; Hildebrand P, 2001, GUT, V49, P23, DOI 10.1136/gut.49.1.23; HOLST JJ, 1990, SCAND J GASTROENTERO, V25, P89, DOI 10.3109/00365529008999214; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; Moore EDW, 1999, J BIOL CHEM, V274, P22493, DOI 10.1074/jbc.274.32.22493; Rozengurt E, 1998, AM J PHYSIOL-GASTR L, V275, pG177, DOI 10.1152/ajpgi.1998.275.2.G177; SCHUBERT ML, 1992, AM J PHYSIOL, V262, pG685, DOI 10.1152/ajpgi.1992.262.4.G685; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418; WALSH JH, 1979, FED PROC, V38, P2315	13	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					778	779		10.1016/S0140-6736(01)06008-1	http://dx.doi.org/10.1016/S0140-6736(01)06008-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564479				2022-12-28	WOS:000170989300005
J	Martinez, E; Mocroft, A; Garcia-Viejo, MA; Perez-Cuevas, JB; Blanco, JL; Mallolas, J; Bianchi, L; Conget, I; Blanch, J; Phillips, A; Gatell, JM				Martinez, E; Mocroft, A; Garcia-Viejo, MA; Perez-Cuevas, JB; Blanco, JL; Mallolas, J; Bianchi, L; Conget, I; Blanch, J; Phillips, A; Gatell, JM			Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; NUCLEOSIDE ANALOG THERAPY; ANTIRETROVIRAL-THERAPY; BODY-COMPOSITION; METABOLIC ABNORMALITIES; FAT DISTRIBUTION; HIV-INFECTION; PERIPHERAL LIPODYSTROPHY; INSULIN-RESISTANCE; HYPERLIPIDEMIA	Background Risk factors for lipodystrophy in patients infected with HIV-1 treated with highly active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly understood. We aimed to identify the risk factors for lipodystrophy in antiretroviral-naive HIV-1-infected adults on HAART. Methods Moderate or severe body-fat changes were clinically assessed and categorised as subcutaneous lipoatrophy, central obesity, or both, in all consecutive antiretroviral-naive HIV-1-infected adults who began HAART with two nucleoside reverse transcriptase inhibitors plus at least one protease inhibitor from October, 1996, to September, 1999. A person-years analysis was used to calculate the incidence of types of lipodystrophy, and Cox proportional hazards models were used to describe the univariate and multivariate factors associated with progression to any lipodystrophy. Findings After a median follow-up of 18 months, 85 (17%) of the 494 patients developed some type of lipodystrophy. The incidences of any lipodystrophy, lipodystrophy with subcutaneous lipoatrophy, and lipodystrophy with central obesity were 11.7 (95% CI 9.2-14.2), 9.2 (7.0-11.4), and 7.7 (5.7-9.7) per 100 patient-years. An increased risk for any lipodystrophy was found among women as compared with men (relative hazard 1.87 [1.07-3.28]), heterosexuals (2.86 [1.50-5.48]), and homosexuals (2.17 [1.07-4.42]) as compared with intravenous drug users, with increasing age (1.33 per 10 years older [1.08-1.62]), and with the duration of exposure to antiretroviral therapy (1.57 per 6 months extra [1.30-1.88]) but not with any individual antiretroviral agent. The factors associated with an increased risk for lipodystrophy with subcutaneous lipoatrophy or lipodystrophy with central obesity were very similar to those associated with any lipodystrophy. The duration of indinavir use may represent an additional contribution for the development of lipodystrophy with central obesity (1.26 per 6 months extra [0.99-1.60]); p=0.064). Interpretation Risk factors associated with development of any lipodystrophy, lipodystrophy with subcutaneous lipoatrophy, and tipodystrophy with central obesity in patients infected with HIV-1 who were receiving HAART containing protease inhibitors are multifactorial and overlapping, and cannot be exclusively ascribed to the duration of exposure to an particular antiretroviral agent.	August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Infect Dis, Barcelona 08036, Spain; August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Radiol, Barcelona 08036, Spain; August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Endocrinol, Barcelona 08036, Spain; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; UCL, Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of London; University College London; University of London; University College London	Martinez, E (corresponding author), Hosp Clin Barcelona, Infect Dis Unit, C Villarroel 170, E-08036 Barcelona, Spain.	esteban@intercom.es	Blanch, Jordi/I-9022-2012; Phillips, Andrew N/B-4427-2008; Mocroft, Amanda/G-8748-2011; Mocroft, Amanda/C-1527-2008; Gatell, Jose M/ABC-3607-2020	Blanch, Jordi/0000-0003-2597-8454; Phillips, Andrew N/0000-0003-2384-4807; Mocroft, Amanda/0000-0001-8316-1122; Mallolas Masferrer, Josep/0000-0002-8365-141X				Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Carbonnel F, 1998, AIDS, V12, P1777, DOI 10.1097/00002030-199814000-00009; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CARR A, 1997, 9 ANN C AUSTR SOC HI; DAUCOURT V, 1999, 1 INT WORKSH ADV DRU; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; FALUTZ J, 1999, 1 INT WORKSH ADV DRU; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; GALLI M, 1990, 1 INT WORKSH ADV DRU; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; Hadigan C, 1999, J CLIN ENDOCR METAB, V84, P1932, DOI 10.1210/jc.84.6.1932; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Kotler DP, 1999, J ACQ IMMUN DEF SYND, V20, P228, DOI 10.1097/00042560-199903010-00003; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Martinez E, 2000, CLIN INFECT DIS, V31, P1266, DOI 10.1086/317426; Martinez E, 2000, LANCET, V356, P1412, DOI 10.1016/S0140-6736(00)02850-6; Martinez E, 1999, AIDS, V13, P805, DOI 10.1097/00002030-199905070-00009; Martinez E, 1999, CURR OPIN INFECT DIS, V12, P13, DOI 10.1097/00001432-199902000-00003; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; MUURAHAINEN N, 1999, 1 INT WORKSH ADV DRU; Pernerstorfer-Schoen H, 1999, AIDS, V13, P2389, DOI 10.1097/00002030-199912030-00010; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; SCHWARTZ RS, 1990, J GERONTOL, V45, P181; SHIMOKATA H, 1989, J GERONTOL, V44, P66; Silva M, 1998, AIDS, V12, P1645, DOI 10.1097/00002030-199813000-00012; VIARD JP, 1999, 1 INT WORKSH ADV DRU; WARD DJ, 1999, 1 INT WORKSH ADV DRU	33	329	337	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					592	598		10.1016/S0140-6736(00)04056-3	http://dx.doi.org/10.1016/S0140-6736(00)04056-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558485				2022-12-28	WOS:000167119100011
J	Kasting, JF				Kasting, JF			Planetary atmospheres - Warming early Earth and Mars	SCIENCE			English	Editorial Material							SURFACE TEMPERATURES; OXIDATION-STATE; METHANE; CO2; PHOTOCHEMISTRY; GREENHOUSE; EVOLUTION; CLIMATE; AMMONIA; CARBON				Kasting, JF (corresponding author), PENN STATE UNIV,DEPT GEOSCI,UNIVERSITY PK,PA 16802, USA.		Kasting, James/AAF-6851-2020					BADA JL, 1994, P NATL ACAD SCI USA, V91, P1248, DOI 10.1073/pnas.91.4.1248; BROWN L, THESIS PENNSYLVANIA; CARR MH, 1995, J GEOPHYS RES-PLANET, V100, P7479, DOI 10.1029/95JE00260; FINK U, 1977, J QUANT SPECTROSC RA, V18, P447, DOI 10.1016/0022-4073(77)90077-2; GIVER LP, 1978, J QUANT SPECTROSC RA, V19, P311, DOI 10.1016/0022-4073(78)90064-X; Holland HD., 1984, CHEM EVOLUTION ATMOS; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1983, PRECAMBRIAN RES, V20, P121, DOI 10.1016/0301-9268(83)90069-4; KHARE BN, 1981, ICARUS, V48, P290, DOI 10.1016/0019-1035(81)90110-X; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PIERREHUMBERT RT, UNPUB; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1986, ICARUS, V65, P442, DOI 10.1016/0019-1035(86)90147-8; Righter K, 1997, EARTH PLANET SC LETT, V146, P541, DOI 10.1016/S0012-821X(96)00243-9; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; Schopf JW, 1983, EARTHS EARLIEST BIOS; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALTER MJ, 1995, SCIENCE, V270, P1166; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zahnle Kevin, COMMUNICATION	31	73	74	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 23	1997	276	5316					1213	1215		10.1126/science.276.5316.1213	http://dx.doi.org/10.1126/science.276.5316.1213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XA497	11536804				2022-12-28	WOS:A1997XA49700030
J	BOWYER, S				BOWYER, S			ASTRONOMY AND THE EXTREME-ULTRAVIOLET EXPLORER SATELLITE	SCIENCE			English	Article							INTERSTELLAR	The extreme ultraviolet wave band (100 to 912 angstroms) was thought until recently to be useless to astronomy, primarily because the opacity of the interstellar medium would prevent observations at these wavelengths. However, the interstellar medium has been found to be markedly inhomogeneous in both density and ionization state and the sun is fortunately located in a region of low extreme ultraviolet opacity. The Extreme Ultraviolet Explorer, launched in June 1992, has surveyed the sky in this wave band and has detected a wide variety of astronomical sources at considerable distances, including some extragalactic objects. Studies in the extreme ultraviolet band have already begun to increase our understanding of the contents of the universe.			BOWYER, S (corresponding author), UNIV CALIF BERKELEY,CTR EUV ASTROPHYS,2150 KITTREDGE ST,BERKELEY,CA 94720, USA.							ALLER LH, 1959, PUBL ASTRON SOC PAC, V71, P324, DOI 10.1086/127390; BOWYER S, 1988, APPL OPTICS, V27, P1414, DOI 10.1364/AO.27.001414; Bowyer S., 1991, EXTREME ULTRAVIOLET, P397; BOWYER S, UNPUB; CASH W, 1978, ASTROPHYS J, V221, pL87, DOI 10.1086/182670; CASSINELLI JP, UNPUB; CULLY SL, 1993, ASTROPHYS J, V414, pL49, DOI 10.1086/186993; DUPREE AK, IN PRESS ASTROPHYS J; DUPUIS J, UNPUB; DUPUIS J, IN PRESS BR ASS ADV; FLEMING TA, 1986, ASTROPHYS J, V308, P176, DOI 10.1086/164488; FRUSCIONE A, IN PRESS ASTROPHYS J; GLADSTONE GR, UNPUB; GLADSTONE GR, IN PRESS GEOPHYS RES; GREEN J, 1990, ASTROPHYS J, V359, P499, DOI 10.1086/169081; GURSKY H, 1963, PHYS REV LETT, V11, P530, DOI 10.1103/PhysRevLett.11.530; HEILES C, 1991, EUV ASTRONOMY, P313; HENRY P, 1975, ASTROPHYS J, V195, P107, DOI 10.1086/153309; HETTRICK MC, 1983, APPL OPTICS, V22, P3921, DOI 10.1364/AO.22.003921; KIMBLE RA, 1993, ASTROPHYS J, V404, P663, DOI 10.1086/172319; KRASNOPOLSKY VA, UNPUB; LAMPTON M, 1976, ASTROPHYS J, V203, pL71, DOI 10.1086/182022; LIVINGSTON PM, 1968, J GEOPHYS RES, V73, P1107; MARTIN C, 1981, REV SCI INSTRUM, V52, P1967; PARESCE F, 1974, ASTROPHYS J, V187, P633, DOI 10.1086/152673; POUNDS K, 1993, MON NOT R ASTRON SOC, V206, P77; SIEGMUND OHW, 1986, J OPT SOC AM A, V3, P2139, DOI 10.1364/JOSAA.3.002139; SNOWDEN SL, 1993, ASTROPHYS J, V409, pL21, DOI 10.1086/186850; SPITZER L, 1990, ANNU REV ASTRON ASTR, V28, P71; VALLERGA JV, 1993, ASTROPHYS J, V414, pL65, DOI 10.1086/186997; VEDDER PW, 1993, IN PRESS ASTROPHYS J, V414, pL61; VENNES S, 1993, ASTROPHYS J, V410, pL119, DOI 10.1086/186894; [No title captured]	33	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 7	1994	263	5143					55	59		10.1126/science.11536659	http://dx.doi.org/10.1126/science.11536659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MQ301	11536659				2022-12-28	WOS:A1994MQ30100025
J	OWEN, T; BARNUN, A; KLEINFELD, I				OWEN, T; BARNUN, A; KLEINFELD, I			POSSIBLE COMETARY ORIGIN OF HEAVY NOBLE-GASES IN THE ATMOSPHERES OF VENUS, EARTH AND MARS	NATURE			English	Article							AMORPHOUS WATER ICE; TERRESTRIAL PLANETS; METEORITES; SHERGOTTITES; BASALTS; IMPACT; GLASS	MODELS that trace the origin of noble gases in the atmospheres of the terrestrial planets (Venus, Earth and Mars) to the 'planetary component' in chondritic meteorites confront several problems. The 'missing' xenon in the atmospheres of Mars and Earth (Fig. 1) is one of the most obvious; this gas is not hidden or trapped in surface materials 1. On Venus, the absolute abundances of neon and argon per gram of rock are higher even than those in carbonaceous chondrites, whereas the relative abundances of argon and krypton are closer to solar than to chondritic values (there is only an upper limit on xenon) 2 (Fig. 1). Pepin 3 has developed a model that emphasizes hydrodynamic escape of early, massive hydrogen atmospheres to explain the abundances and isotope ratios of noble gases on all three planets. We have previously suggested that the unusual abundances of heavy noble gases on Venus might be explained by the impact of a low-temperature comet 4-6. Further consideration of the probable history of the martian atmosphere 7, the noble-gas data from the (Mars-derived) SNC meteorites 8-10 and laboratory experiments on the trapping of noble gases in ice 6,11,12 lead us to propose here that the noble gases in the atmospheres of all of the terrestrial planets are dominated by a mixture of an internal component and a contribution from impacting icy planetesimals (comets). If true, this hypothesis illustrates the importance of impacts in determining the volatile inventories of these planets.	TEL AVIV UNIV, DEPT GEOPHYS & PLANETARY SCI, IL-69978 TEL AVIV, ISRAEL	Tel Aviv University	OWEN, T (corresponding author), UNIV HAWAII, INST ASTRON, 2680 WOODLAWN DR, HONOLULU, HI 96822 USA.							BARNUN A, 1989, ICARUS, V80, P243, DOI 10.1016/0019-1035(89)90136-X; BARNUN A, 1988, PHYS REV B, V38, P7749, DOI 10.1103/PhysRevB.38.7749; BIEMANN K, 1976, SCIENCE, V194, P76, DOI 10.1126/science.194.4260.76; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOSS AP, 1989, ORIGIN EVOLUTION PLA, P35; BUS SJ, 1991, SCIENCE, V251, P774, DOI 10.1126/science.251.4995.774; CAMERON AGW, 1983, ICARUS, V56, P195, DOI 10.1016/0019-1035(83)90032-5; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; HART R, 1983, NATURE, V305, P403, DOI 10.1038/305403a0; Hoffman JH, 1980, J GEOPHYS RES-SPACE, V85, P7871, DOI 10.1029/JA085iA13p07871; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; HUNTEN DM, 1988, METEORITES EARLY SOL, P565; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; KANEOKA I, 1983, EARTH PLANET SC LETT, V66, P427, DOI 10.1016/0012-821X(83)90156-5; LAUFER D, 1987, PHYS REV B, V36, P9219, DOI 10.1103/PhysRevB.36.9219; LUNINE JI, 1991, ICARUS, V94, P333, DOI 10.1016/0019-1035(91)90232-I; LUU JX, 1990, ASTRON J, V100, P913, DOI 10.1086/115571; MCELROY MB, 1972, SCIENCE, V175, P443, DOI 10.1126/science.175.4020.443; MEECH KJ, 1989, IAU4470 CIRC; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MUSSELWHITE DS, 1991, NATURE, V352, P697, DOI 10.1038/352697a0; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; OTT U, 1988, GEOCHIM COSMOCHIM AC, V52, P1937, DOI 10.1016/0016-7037(88)90017-8; OTT U, 1988, METEORITICS, V23, P295; OTT U, 1985, NATURE, V317, P509, DOI 10.1038/317509a0; OWEN T, 1991, ASTROPHYS SPACE SC L, V167, P429; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; OWEN T, 1986, WORKSHOP EVOLUTION M, P31; OWEN T, IN PRESS MARS; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; SILL GT, 1978, ICARUS, V33, P13, DOI 10.1016/0019-1035(78)90020-9; STERN SA, 1992, ICARUS, V95, P157, DOI 10.1016/0019-1035(92)90198-G; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; STOLPER EM, 1978, GEOCHIM COSMOCHIM AC, V42, P589; STUDACHER T, 1986, CHEM GEOL, V56, P193; WACKER JF, 1984, GEOCHIM COSMOCHIM AC, V48, P2373, DOI 10.1016/0016-7037(84)90232-1; WATSON LL, IN PRESS P LUNAR PLA; WETHERILL GW, 1990, ANNU REV EARTH PL SC, V18, P205, DOI 10.1146/annurev.ea.18.050190.001225; WETHERILL GW, 1981, ICARUS, V46, P70, DOI 10.1016/0019-1035(81)90076-2; WIENS RC, 1986, EARTH PLANET SC LETT, V77, P149, DOI 10.1016/0012-821X(86)90156-1; ZAHNLE K, 1990, ICARUS, V84, P502, DOI 10.1016/0019-1035(90)90050-J; [No title captured]	44	111	111	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					43	46		10.1038/358043a0	http://dx.doi.org/10.1038/358043a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB341	11536499				2022-12-28	WOS:A1992JB34100046
J	ENGEL, MH; MACKO, SA; SILFER, JA				ENGEL, MH; MACKO, SA; SILFER, JA			CARBON ISOTOPE COMPOSITION OF INDIVIDUAL AMINO-ACIDS IN THE MURCHISON METEORITE	NATURE			English	Article									UNIV VIRGINIA,DEPT ENVIRONM SCI,CHARLOTTESVILLE,VA 22903	University of Virginia	ENGEL, MH (corresponding author), UNIV OKLAHOMA,SCH GEOL & GEOPHYS,100 E BOYD ST,NORMAN,OK 73019, USA.		Macko, Stephen/K-4588-2015					CHANG S, 1978, LUNAR PLANET SCI, V9, P157; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; Cronin J. R., 1988, METEORITES EARLY SOL; CRONIN JR, 1971, SCIENCE, V172, P1327, DOI 10.1126/science.172.3990.1327; CRONIN JR, 1976, ORIGINS LIFE EVOL B, V7, P337, DOI 10.1007/BF00927928; Engel M.H., 1985, CHEM BIOCHEM AMINO, P462; ENGEL MH, 1982, NATURE, V296, P837, DOI 10.1038/296837a0; ENGEL MH, 1984, ANAL CHEM, V56, P2598, DOI 10.1021/ac00277a075; ENGEL MH, 1986, NATURE, V323, P531, DOI 10.1038/323531a0; ENGEL MH, 1983, NATURE, V301, P496, DOI 10.1038/301496a0; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FREEDMAN PA, 1988, J AM LAB, P114; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; GRADY MM, 1988, GEOCHIM COSMOCHIM AC, V52, P2855, DOI 10.1016/0016-7037(88)90152-4; HARE PE, 1985, CHEM BIOCH AMINO ACI, P415; JULL AJT, 1989, GEOCHIM COSMOCHIM AC, V53, P2095, DOI 10.1016/0016-7037(89)90327-X; KENNICUTT MC, 1990, ORG GEOCHEM, V15, P193, DOI 10.1016/0146-6380(90)90083-C; KHARE BN, 1986, ICARUS, V68, P176, DOI 10.1016/0019-1035(86)90080-1; MACKO SA, 1981, THESIS U TEXAS AUSTI; NOYES HP, 1977, ORIGINS LIFE EVOL B, V8, P21, DOI 10.1007/BF00930935; PILLINGER CT, 1982, NATURE, V296, P802, DOI 10.1038/296802a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SERBAN A, 1988, ORG GEOCHEM, V13, P1123, DOI 10.1016/0146-6380(88)90298-7; SHOCK EL, IN PRESS GEOCHIM COS; SILFER JA, UNPUB ANAL CHEM; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; 1990, SEARCH LIFES ORIGINS	28	219	222	1	40	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 1	1990	348	6296					47	49		10.1038/348047a0	http://dx.doi.org/10.1038/348047a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF994	11536470				2022-12-28	WOS:A1990EF99400056
J	ANDERS, E				ANDERS, E			PRE-BIOTIC ORGANIC-MATTER FROM COMETS AND ASTEROIDS	NATURE			English	Article									UNIV CHICAGO, DEPT CHEM, CHICAGO, IL 60637 USA	University of Chicago	ANDERS, E (corresponding author), UNIV CHICAGO, ENRICO FERMI INST, CHICAGO, IL 60637 USA.		Anders, Edward/B-7980-2009					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1968, ACCOUNTS CHEM RES, V1, P289, DOI 10.1021/ar50010a001; ANDERS E, 1973, SCIENCE, V182, P781, DOI 10.1126/science.182.4114.781; Anders E., 1973, Moon, V8, P3, DOI 10.1007/BF00562747; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARKER JL, 1968, GEOCHIM COSMOCHIM AC, V32, P627, DOI 10.1016/0016-7037(68)90053-7; BROWNLEE DE, 1985, REV EARTH PLANET SCI, V13, P189; CHAPMAN CR, 1975, SCIENCE, V190, P553, DOI 10.1126/science.190.4214.553; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; Cronin JR., 1988, ORGANIC MATTER CARBO, P819; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; DEAMER DW, IN PRESS ORIGINS LIF; DELSEMME AH, 1984, ORIGINS LIFE EVOL B, V14, P51, DOI 10.1007/BF00933639; DOHNANYI JS, 1971, SCIENCE, V173, P558, DOI 10.1126/science.173.3996.558; EMILIANI C, 1981, EARTH PLANET SC LETT, V55, P317, DOI 10.1016/0012-821X(81)90161-8; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; GROS J, 1976, P LUNAR PLANET SCI C, V7, P2403; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; Hertogen J., 1977, PROC LUNAR SCI C, P17; HUDSON B, 1981, SCIENCE, V211, P383, DOI 10.1126/science.211.4480.383; Hughes D. W., 1978, Cosmic dust, P123; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LEWIS RS, 1986, METEORITICS, V21, P434; Mason B., 1966, PRINCIPLES GEOCHEMIS, DOI DOI 10.1016/j.iswcr.2018.09.001; MATSUI T, 1986, NATURE, V322, P526, DOI 10.1038/322526a0; MORGAN JW, 1981, TECTONOPHYSICS, V75, P47, DOI 10.1016/0040-1951(81)90209-2; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; MULLIE F, 1987, TOP CURR CHEM, V139, P83; OPIK EJ, 1961, P GEOPHYS LAB LAWREN, P1; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PALME H, 1981, GEOCHIM COSMOCHIM AC, V45, P2417, DOI 10.1016/0016-7037(81)90095-8; REVELLE DO, 1979, J ATMOS TERR PHYS, V41, P453, DOI 10.1016/0021-9169(79)90071-0; SCHRAMM LS, 1989, METEORITICS, V24, P99, DOI 10.1111/j.1945-5100.1989.tb00950.x; Sears D. W., 1975, Modern Geology, V5, P155; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; THOMAS PJ, 1989, LUNAR PLANET SCI, V20, P1117; TURCO RP, 1982, ICARUS, V50, P1, DOI 10.1016/0019-1035(82)90096-3; TUREKIAN KK, 1969, EARTH PLANET SC LETT, V6, P346, DOI 10.1016/0012-821X(69)90183-6; Weissman P. R., 1982, GEOL SOC AM SPEC PAP, V190, P15; WETHERILL GW, 1981, ICARUS, V48, P308, DOI 10.1016/0019-1035(81)90112-3; WETHERILL GW, 1987, PHILOS T R SOC A, V323, P323, DOI 10.1098/rsta.1987.0089; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; ZAHNLE KJ, 1988, ICARUS, V74, P62, DOI 10.1016/0019-1035(88)90031-0; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; [No title captured]	49	293	295	12	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	1989	342	6247					255	257		10.1038/342255a0	http://dx.doi.org/10.1038/342255a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ874	11536617				2022-12-28	WOS:A1989AZ87400046
J	Schon, JH; Kloc, C; Batlogg, B				Schon, JH; Kloc, C; Batlogg, B			RETRACTED: High-temperature superconductivity in lattice-expanded C-60 (Retracted Article. See vol 298, pg 961, 2002)	SCIENCE			English	Article; Retracted Publication							CRYSTALS	C-60 single crystals have been intercalated with CHCl3 and CHBr3 in order to expand the lattice. High densities of electrons and holes have been induced by gate doping in a field-effect transistor geometry. At low temperatures, the material turns superconducting with a maximum transition temperature of 117 K in hole-doped C-60/CHBr3. The increasing spacing between the C-60 molecules follows the general trend of alkali metal-doped C-60 and suggests routes to even higher transition temperatures.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Konstanz, Dept Phys, D-78457 Constance, Germany; Swiss Fed Inst Technol, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Alcatel-Lucent; Lucent Technologies; AT&T; University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schon, JH (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	hendrik@lucent.com	Kloc, Christian/A-2255-2011					Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Cappelluti E, 2000, PHYS REV LETT, V85, P4771, DOI 10.1103/PhysRevLett.85.4771; GLOVER RE, 1960, PHYS REV LETT, V5, P248, DOI 10.1103/PhysRevLett.5.248; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; HADDON RC, 1993, PHILOS T ROY SOC A, V343, P53, DOI 10.1098/rsta.1993.0040; JANSEN L, 2001, PHYSICA A; JANSEN M, 1995, Z ANORG ALLG CHEM, V621, P14, DOI 10.1002/zaac.19956210105; KLAPWIJK TM, 1989, SUPERCONDUCTING ELEC, P385; Kloc C, 1997, J CRYST GROWTH, V182, P416, DOI 10.1016/S0022-0248(97)00370-9; Mannhart J, 1996, SUPERCOND SCI TECH, V9, P49, DOI 10.1088/0953-2048/9/2/001; Marsiglio F, 1998, PHYS LETT A, V245, P172, DOI 10.1016/S0375-9601(98)00373-9; MAZIN II, 1992, PHYS REV B, V45, P5114, DOI 10.1103/PhysRevB.45.5114; Ramirez A. P., 1994, Superconductivity Review, V1, P1; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2000, SCIENCE, V288, P656, DOI 10.1126/science.288.5466.656; Schon JH, 2001, SCIENCE, V292, P252, DOI 10.1126/science.1058812; Schon JH, 2001, NATURE, V410, P189, DOI 10.1038/35065565	18	168	180	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2432	2434		10.1126/science.1064773	http://dx.doi.org/10.1126/science.1064773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11533443				2022-12-28	WOS:000171237200040
J	Klarreich, E				Klarreich, E			Top researchers plan to snub fertility conference	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					241	241		10.1038/35095185	http://dx.doi.org/10.1038/35095185			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11564998	Bronze			2022-12-28	WOS:000171040500007
J	Thewissen, JGM; Williams, EM; Roe, LJ; Hussain, ST				Thewissen, JGM; Williams, EM; Roe, LJ; Hussain, ST			Skeletons of terrestrial cetaceans and the relationship of whales to artiodactyls	NATURE			English	Article							LOCOMOTOR EVOLUTION; EARLIEST CETACEANS; MIDDLE EOCENE; ORIGIN; MAMMALIA; PAKISTAN; INDIA; MODEL; TIME	Modern members of the mammalian order Cetacea (whales, dolphins and porpoises) are obligate aquatic swimmers that are highly distinctive in morphology, lacking hair and hind limbs, and having flippers, flukes, and a streamlined body. Eocene fossils document much of cetaceans' land-to-water transition, but, until now, the most primitive representative for which a skeleton was known was clearly amphibious and lived in coastal environments. Here we report on the skeletons of two early Eocene pakicetid cetaceans, the fox-sized Ichthyolestes pinfoldi, and the wolf-sized Pakicetus attocki. Their skeletons also elucidate the relationships of cetaceans to other mammals. Morphological cladistic analyses have shown cetaceans to be most closely related to one or more mesonychians, a group of extinct, archaic ungulates, but molecular analyses have indicated that they are the sister group to hippopotamids. Our cladistic analysis indicates that cetaceans are more closely related to artiodactyls than to any mesonychian. Cetaceans are not the sister group to (any) mesonychians, nor to hippopotamids. Our analysis stops short of identifying any particular artiodactyl family as the cetacean sister group and supports monophyly of artiodactyls.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA	Northeast Ohio Medical University (NEOMED); University of Arizona; Howard University	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu		Thewissen, J. G. M./0000-0002-0973-4137				Bajpai S, 2000, CURR SCI INDIA, V79, P1478; Bajpai S, 1998, ADV VERT PALEOBIOL, P213; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Gatesy J, 1998, ADV VERT PALEOBIOL, P63; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Gentry AW, 1988, PHYLOGENY CLASSIFICA, V35B, P235; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; GINGERICH PD, IN PRESS SCIENCE; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; Howell A.B., 1930, AQUATIC MAMMALS THEI; Howell AB, 1944, SPEED ANIMALS THEIR; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Kellogg R, 1936, REV ARCHAEOCETI; King J. E., 1991, SEALS WORLD; LENHARDT M L, 1982, Journal of Auditory Research, V22, P153; Luckett W. Patrick, 1998, Journal of Mammalian Evolution, V5, P127, DOI 10.1023/A:1020501622015; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 2000, NATURE, V404, P235, DOI 10.1038/35005194; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; MADAR SI, IN PRESS J VERTEBR P; Milinkovitch MC, 1998, ADV VERT PALEOBIOL, P113; Milinkovitch MC, 1997, NATURE, V388, P622, DOI 10.1038/41650; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; RADO R, 1989, HEARING RES, V41, P23, DOI 10.1016/0378-5955(89)90175-5; SHAEFFER B, 1947, AM MUS NOVIT, P1; Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759; SWOFFORD DL, 1998, PAUP 40B8 PHYLOGENET; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J.G.M., 1998, Bulletin of Carnegie Museum of Natural History, V34, P220; Thewissen J. G. M., 1994, Journal of Mammalian Evolution, V2, P157, DOI 10.1007/BF01473527; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; THEWISSEN JGM, 1990, ANAT HISTOL EMBRYOL, V19, P37, DOI 10.1111/j.1439-0264.1990.tb00876.x; Thewissen JGM, 1998, NATURE, V395, P452, DOI 10.1038/26656; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Uhen MD, 1999, J PALEONTOL, V73, P512, DOI 10.1017/S002233600002802X; Vaughan TA, 1986, MAMMALOGY; Weber M, 1928, SAUGETIERE; Zhou Xiaoyuan, 1992, Contributions from the Museum of Paleontology University of Michigan, V28, P289	48	208	218	6	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					277	281		10.1038/35095005	http://dx.doi.org/10.1038/35095005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565023				2022-12-28	WOS:000171040500030
J	Aitman, TJ				Aitman, TJ			Science, medicine, and the future - DNA microarrays in medical practice	BRITISH MEDICAL JOURNAL			English	Review							INSULIN-RESISTANCE; HYPERTENSIVE-RATS; HUMAN-GENOME; MOLECULAR CLASSIFICATION; FATTY-ACID; IDENTIFICATION; ARRAYS; POLYMORPHISMS; METABOLISM; DISEASE		Hammersmith Hosp, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England; Hammersmith Hosp, Res Inst, Imperial Coll Genet & Genom, London W12 0NN, England	Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Hammersmith Hosp, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England.	taitman@csc.mrc.ac.uk		Aitman, Timothy/0000-0002-7875-4502				Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Gingeras TR, 1998, GENOME RES, V8, P435, DOI 10.1101/gr.8.5.435; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; St Croix B, 2000, SCIENCE, V289, P1197; Todd JA, 2001, NATURE, V411, P537, DOI 10.1038/35079223; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; 1996, NATURE GENET, V14, P367	23	62	69	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					611	615		10.1136/bmj.323.7313.611	http://dx.doi.org/10.1136/bmj.323.7313.611			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557712	Green Submitted, Green Published			2022-12-28	WOS:000171087300022
J	Fleitlich, B; Goodman, R				Fleitlich, B; Goodman, R			Social factors associated with child mental health problems in Brazil: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; Univ Sao Paulo, Dept Psychiat, BR-05403010 Sao Paulo, Brazil	University of London; King's College London; Universidade de Sao Paulo	Goodman, R (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England.	r.goodman@iop.kcl.ac.uk		Goodman, Robert/0000-0001-5596-1667	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Hackett R, 1999, INT REV PSYCHIATR, V11, P225, DOI 10.1080/09540269974410; MARI JD, 1985, PSYCHOL MED, V15, P651	5	87	99	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					599	600		10.1136/bmj.323.7313.599	http://dx.doi.org/10.1136/bmj.323.7313.599			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474CT	11557705	Bronze, Green Published			2022-12-28	WOS:000171087300016
J	Crim, FF				Crim, FF			Chemistry - Close encounters	SCIENCE			English	Editorial Material							DIFFERENTIAL CROSS-SECTIONS; INELASTIC-SCATTERING; REACTION DYNAMICS		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Crim, FF (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.							Alexander MH, 1999, J CHEM PHYS, V111, P7435, DOI 10.1063/1.480067; ALEXANDER MH, 1993, J CHEM PHYS, V99, P7725, DOI 10.1063/1.465702; BONTUYAN LS, 1993, J PHYS CHEM-US, V97, P6342, DOI 10.1021/j100126a006; CHANDLER DW, 1987, J CHEM PHYS, V87, P144; HECK AJR, 1995, ANNU REV PHYS CHEM, V46, P335, DOI 10.1146/annurev.pc.46.100195.002003; HOUSTON PL, 1995, ACCOUNTS CHEM RES, V28, P453, DOI 10.1021/ar00059a003; Lorenz KT, 2001, SCIENCE, V293, P2063, DOI 10.1126/science.1062754; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; SUITS AG, 1992, J CHEM PHYS, V96, P8618, DOI 10.1063/1.462265	9	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2014	2015		10.1126/science.1064979	http://dx.doi.org/10.1126/science.1064979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557868				2022-12-28	WOS:000171028700049
J	Uemura, N; Okamoto, S; Yamamoto, S; Matsumura, N; Yamaguchi, S; Yamakido, M; Taniyama, K; Sasaki, N; Schlemper, RJ				Uemura, N; Okamoto, S; Yamamoto, S; Matsumura, N; Yamaguchi, S; Yamakido, M; Taniyama, K; Sasaki, N; Schlemper, RJ			Helicobacter pylori infection and the development of gastric cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	101st Annual Meeting of the American-Gastroenterological-Association	MAY 21-24, 2000	SAN DIEGO, CA	Amer Gastroenterol Assoc			DUODENAL-ULCER DISEASE; CARCINOMA; STOMACH; RISK; CLASSIFICATION; INFLAMMATION; EPIDEMIOLOGY; PREVALENCE; ANTIBODY; ATROPHY	Background: Although many studies have found an association between Helicobacter pylori infection and the development of gastric cancer, many aspects of this relation remain uncertain. Methods: We prospectively studied 1526 Japanese patients who had duodenal ulcers, gastric ulcers, gastric hyperplasia, or nonulcer dyspepsia at the time of enrollment; 1246 had H. pylori infection and 280 did not. The mean follow-up was 7.8 years (range, 1.0 to 10.6). Patients underwent endoscopy with biopsy at enrollment and then between one and three years after enrollment. H. pylori infection was assessed by histologic examination, serologic testing, and rapid urease tests and was defined by a positive result on any of these tests. Results: Gastric cancers developed in 36 (2.9 percent) of the infected and none of the uninfected patients. There were 23 intestinal-type and 13 diffuse-type cancers. Among the patients with H. pylori infection, those with severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia were at significantly higher risk for gastric cancer. We detected gastric cancers in 21 (4.7 percent) of the 445 patients with nonulcer dyspepsia, 10 (3.4 percent) of the 297 with gastric ulcers, 5 (2.2 percent) of the 229 with gastric hyperplastic polyps, and none of the 275 with duodenal ulcers. Conclusions: Gastric cancer develops in persons infected with H. pylori but not in uninfected persons. Those with histologic findings of severe gastric atrophy, corpus-predominant gastritis, or intestinal metaplasia are at increased risk. Persons with H. pylori infection and nonulcer dyspepsia, gastric ulcers, or gastric hyperplastic polyps are also at risk, but those with duodenal ulcers are not. (N Engl J Med 2001;345:784-9.) Copyright (C) 2001 Massachusetts Medical Society.	Kure Kyosai Hosp, Dept Gastroenterol, Kure, Japan; Kure Kyosai Hosp, Dept Clin Pathol, Kure, Japan; Fukuoka Univ, Sch Med, Dept Internal Med, Fukuoka 81401, Japan	Fukuoka University	Uemura, N (corresponding author), Kure Kyosai Hosp, Dept Gastroenterol, 2-3-28 Nishi Chuo, Kure, Japan.	n-uemura@mua.biglobe.ne.jp						[Anonymous], 1983, LANCET, V1, P1273; ASAKA M, 1999, GASTRIC CANC HELICOB, P116; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO;2-I; CORREA P, 1992, CANCER RES, V52, P6735; Danesh J, 1999, ALIMENT PHARM THERAP, V13, P851; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Enomoto H, 1998, EUR J GASTROEN HEPAT, V10, P473, DOI 10.1097/00042737-199806000-00007; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Kimura K, 1969, ENDOSCOPY, V1, P1; Kokkola A, 1996, SCAND J GASTROENTERO, V31, P643, DOI 10.3109/00365529609009143; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Meining A, 1997, VIRCHOWS ARCH, V431, P11, DOI 10.1007/s004280050063; Miwa H, 2000, DIAGN MICR INFEC DIS, V36, P95, DOI 10.1016/S0732-8893(99)00143-1; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Ohara S, 1998, J GASTROENTEROL, V33, P6, DOI 10.1007/PL00009968; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; SAS Institute, 1996, SAS STAT SOFTW CHANG; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; SIPPONEN P, 1992, J CLIN PATHOL, V45, P319, DOI 10.1136/jcp.45.4.319; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Solcia E, 1996, AM J SURG PATHOL, V20, pS8; STOLTE M, 1990, Z GASTROENTEROL, V28, P229; Tabata H, 1999, DIGEST DIS SCI, V44, P2027, DOI 10.1023/A:1026622418625; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639	33	3233	3391	6	345	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					784	789		10.1056/NEJMoa001999	http://dx.doi.org/10.1056/NEJMoa001999			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	471BK	11556297				2022-12-28	WOS:000170906800002
J	Bloch, S				Bloch, S			Moses Maimonides' contribution to the biopsychosocial approach in clinical medicine	LANCET			English	Review							MODEL		Univ Melbourne, St Vincents Hosp, Ctr Study Hlth & Soc, Melbourne, Vic 3065, Australia; Univ Melbourne, St Vincents Hosp, Dept Psychiat, Melbourne, Vic 3065, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Bloch, S (corresponding author), Univ Melbourne, St Vincents Hosp, Ctr Study Hlth & Soc, Melbourne, Vic 3065, Australia.							Beck A.T., 1967, DEPRESSION CLIN EXPT; EISENMAN DJ, 1993, M MAIMONIDES PHYSICI, P145; Engel G.L., 1997, FAMILIES SYSTEMS HLT, V14, P425, DOI [10.1037/h0089973, DOI 10.1037/H0089973]; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Engel PA, 2001, PSYCHOSOMATICS, V42, P94, DOI 10.1176/appi.psy.42.2.94; Hartman David, 1976, MAIMONIDES TORAH PHI; HESCHEL A, 1982, MAIMONIDES LIFE TIME; Husik Isaac, 1958, HIST MEDIEVAL JEWISH; MAIMONIDES M, 1970, MED APHORISMS M MAIM; MAIMONIDES M, 1974, M MAIMONIDES CAUSES; MAIMONIDES M, 1963, MED WRITINGS M MAIMO, P1; MIAMONIDES M, 1958, REGIMEN SANITATIS PR; Rosner F, 2000, ARCH INTERN MED, V160, P242, DOI 10.1001/archinte.160.2.242; Seligman M. E. P., 1998, LEARNED OPTIMISM; Simon SR, 1999, ARCH INTERN MED, V159, P1841, DOI 10.1001/archinte.159.16.1841; Thompson J. A. K., 1955, NICOMACHEAN ETHICS	17	3	3	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					829	832		10.1016/S0140-6736(01)05974-8	http://dx.doi.org/10.1016/S0140-6736(01)05974-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564509				2022-12-28	WOS:000170989300035
J	Abrams, NE; Primack, JR				Abrams, NE; Primack, JR			Essays on science and society - Cosmology and 21st-century culture	SCIENCE			English	Editorial Material									Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Abrams, NE (corresponding author), Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA.	nancy@physics.ucsc.edu; joel@physics.ucsc.edu						ABRAMS N, ALIEN WISDOM CD HER; Abrams N. E., 2001, PHILOS SCI, V9, P75; Guth Alan, 1997, INFLATIONARY UNIVERS; KUHN TS, 1959, COPERNICAN REVOLUTIO, P222; MILLER JB, 2001, ANN NY ACAD SCI  DEC; PRIMACK JR, 2001, TIKKUN, V16, P59; Rees Martin, 1997, BEFORE BEGINNING OUR	7	6	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1769	1770		10.1126/science.1063090	http://dx.doi.org/10.1126/science.1063090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	470WN	11546855				2022-12-28	WOS:000170894400026
J	Rose, NF; Marx, PA; Luckay, A; Nixon, DF; Moretto, WJ; Donahoe, SM; Montefiori, D; Roberts, A; Buonocore, L; Rose, JK				Rose, NF; Marx, PA; Luckay, A; Nixon, DF; Moretto, WJ; Donahoe, SM; Montefiori, D; Roberts, A; Buonocore, L; Rose, JK			An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; RHESUS-MONKEYS; PRIMARY ISOLATE; NEUTRALIZING ANTIBODIES; LYMPHOCYTE DEPLETION; TYPE-1; ENVELOPE; GLYCOPROTEINS; INFECTION	We developed an AIDS vaccine based on attenuated VSV vectors expressing env and gag genes and tested it in rhesus monkeys. Boosting was accomplished using vectors with glycoproteins from different VSV serotypes. Animals were challenged with a pathogenic AIDS virus (SHIV89.6P). Control monkeys showed a severe loss of CD4(+) T cells and high viral loads, and 7/8 progressed to AIDS with an average time of 148 days. All seven vaccinees were initially infected with SHIV89.6P but have remained healthy for up to 14 months after challenge with low or undetectable viral loads. Protection from AIDS was highly significant (p=0.001). VSV vectors are promising candidates for human AIDS vaccine trials because they propagate to high titers and can be delivered without injection.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70043 USA; Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Yale University; Yale University; Tulane University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University	Rose, JK (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	john.rose@yale.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045510, R37AI040357, R01AI040357, R01AI045510, N01AI085343] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45510, AI-40357, AI-85343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; CHEN ZW, 1995, J EXP MED, V182, P21, DOI 10.1084/jem.182.1.21; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Donahoe SM, 2000, VIROLOGY, V272, P347, DOI 10.1006/viro.2000.0404; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; Haglund K, 2000, VIROLOGY, V268, P112, DOI 10.1006/viro.1999.0120; Hinman A, 1999, ANNU REV PUBL HEALTH, V20, P211, DOI 10.1146/annurev.publhealth.20.1.211; Johnson JE, 1997, J VIROL, V71, P5060, DOI 10.1128/JVI.71.7.5060-5068.1997; JOHNSON KM, 1966, AM J TROP MED HYG, V15, P244, DOI 10.4269/ajtmh.1966.15.244; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kretzschmar E, 1997, J VIROL, V71, P5982, DOI 10.1128/JVI.71.8.5982-5989.1997; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998; Moretto WJ, 2000, AIDS, V14, P2625, DOI 10.1097/00002030-200011100-00034; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Richardson TM, 1996, J VIROL, V70, P753, DOI 10.1128/JVI.70.2.753-762.1996; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Rose NF, 2000, J VIROL, V74, P10903, DOI 10.1128/JVI.74.23.10903-10910.2000; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schlereth B, 2000, J VIROL, V74, P4652, DOI 10.1128/JVI.74.10.4652-4657.2000; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Schnell MJ, 1998, EMBO J, V17, P1289, DOI 10.1093/emboj/17.5.1289; TESH RB, 1969, AM J EPIDEMIOL, V90, P255, DOI 10.1093/oxfordjournals.aje.a121068; *UNAIDS, 2000, AIDS EP UPD; Wagner R.R., 1996, RHABDOVIRIDAE VIRUSE, P1121; ZINKERNAGEL RM, 1978, EXP CELL BIOL, V46, P53	45	380	404	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					539	549		10.1016/S0092-8674(01)00482-2	http://dx.doi.org/10.1016/S0092-8674(01)00482-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551502	Bronze			2022-12-28	WOS:000170973200005
J	Rabinowitz, HK; Diamond, JJ; Markham, FW; Paynter, NP				Rabinowitz, HK; Diamond, JJ; Markham, FW; Paynter, NP			Critical factors for designing programs to increase the supply and retention of rural primary care physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-SCHOOL ADMISSIONS; FAMILY PHYSICIANS; GENERALIST PHYSICIANS; FOLLOW-UP; EDUCATION; STUDENTS; NUMBER; IMPROVE; CHOICES; IMPACT	Context The Physician Shortage Area Program (PSAP) of Jefferson Medical College (Philadelphia, Pa) is one of a small number of medical school programs that addresses the shortage of rural primary care physicians. However, little is known regarding why these programs work. Objectives To identify factors independently predictive of rural primary care supply and retention and to determine which components of the PSAP lead to its outcomes. Design Retrospective cohort study. Setting and Participants A total of 3414 Jefferson Medical College graduates from the classes of 1978-1993, including 220 PSAP graduates. Main Outcome Measures Rural primary care practice and retention in 1999 as predicted by 19 previously collected variables. Twelve variables were available for all classes, 7 variables were collected only for 1978-1982 graduates. Results Freshman-year plan for family practice, being in the PSAP, having a National Health Service Corps scholarship, male sex, and taking an elective senior family practice rural preceptorship (the only factor not available at entrance to medical school) were independently predictive of physicians practicing rural primary care. For 1978-1982 graduates, growing up in a rural area was the only additionally collected independent predictor of rural primary care (odds ratio [OR], 4.0; 95% Cl, 2.1-7.6; P<.001). Participation in the PSAP was the only independent predictive factor of retention for all classes (OR, 4.7; 95% Cl, 2.0-11.2; P<.001). Among PSAP graduates, taking a senior rural preceptorship was independently predictive of rural primary care (OR, 2.5; 95% Cl, 1.3-4.7; P=.004). However, non-PSAP graduates with 2 key selection characteristics of PSAP students (having grown up in a rural area and freshman-year plans for family practice) were 78% as likely as PSAP graduates to be rural primary care physicians, and 75% as likely to remain, suggesting that the admissions component of the PSAP is the most important reason for its success. In fact, few graduates without either of these factors were rural primary care physicians (1.8%). Conclusions Medical educators and policy makers can have the greatest impact on the supply and retention of rural primary care physicians by developing programs to increase the number of medical school matriculants with background and career plans that make them most likely to pursue these career goals. Curricular experiences and other factors can further increase these outcomes, especially by supporting those already likely to become rural primary care physicians.	Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Jefferson University	Rabinowitz, HK (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Suite 401,1015 Walnut St, Philadelphia, PA 19107 USA.	howard.rabinowitz@mail.tju.edu						Ackermann R J, 1996, Fam Med, V28, P395; ADKINS RJ, 1987, J MED EDUC, V62, P810; *AM AC FAM PHYS, 2000, FACTS FAM PRACT 2000, P158; *AM AC FAM PHYS, 1990, FACTS FAM PRACT 1990, P114; Boulger J G, 1991, J Rural Health, V7, P105, DOI 10.1111/j.1748-0361.1991.tb00713.x; Brazeau N K, 1990, Fam Med, V22, P350; *BUR PRIM HLTH CAR, 1999, APPL INF B 2000 2001; COHEN JJ, 1999, ACAD MED, V73, P1277; Council on Graduate Medical Education, 1998, PHYS DISTR HLTH CAR; CULLISON S, 1976, JAMA-J AM MED ASSOC, V235, P502, DOI 10.1001/jama.235.5.502; Donaldson M, 1996, PRIMARY CARE AM HLTH; Ernst R. L., 1985, PHYSICIAN LOCATION S; Geyman JP, 2000, J RURAL HEALTH, V16, P56, DOI 10.1111/j.1748-0361.2000.tb00436.x; GONNELLA JS, 1993, ACAD MED S, V68, P3; Hojat M, 1996, ED HLTH, V9, P99; JOLLY P, 1998, ASS AM MED COLL DATA; KASSEBAUM DG, 1993, ACAD MED, V68, P232, DOI 10.1097/00001888-199303000-00019; Ludmerer K., 1999, TIME HEAL AM MED ED; MAYERS L, 1924, DISTRIBUTION PHYSICI; PATHMAN DE, 1992, JAMA-J AM MED ASSOC, V268, P1552; Pathman DE, 1996, ACAD MED, V71, P963, DOI 10.1097/00001888-199609000-00010; PHILLIPS DM, 1998, PHYSICIAN RECRUITMEN; PROCTOR J, 2000, AAMC REPORTER, V9, P10; Pusey WA, 1925, J AMER MED ASSOC, V84, P281, DOI 10.1001/jama.1925.26620300002013; RABINOWITZ HK, 1988, NEW ENGL J MED, V319, P480, DOI 10.1056/NEJM198808253190805; Rabinowitz HK, 1999, JAMA-J AM MED ASSOC, V281, P255, DOI 10.1001/jama.281.3.255; RABINOWITZ HK, 1993, NEW ENGL J MED, V328, P934, DOI 10.1056/NEJM199304013281307; Rabinowitz HK, 2000, J RURAL HEALTH, V16, P249, DOI 10.1111/j.1748-0361.2000.tb00468.x; Rabinowitz HK, 1999, J RURAL HEALTH, V15, P212, DOI 10.1111/j.1748-0361.1999.tb00742.x; Rabinowitz HK, 2000, AM J PUBLIC HEALTH, V90, P1225, DOI 10.2105/AJPH.90.8.1225; ROSENBLATT RA, 1992, JAMA-J AM MED ASSOC, V268, P1559, DOI 10.1001/jama.268.12.1559; Rosenthal MP, 1996, ACAD MED, V71, P675, DOI 10.1097/00001888-199606000-00024; ROSENTHAL MP, 1992, ACAD MED, V67, P328, DOI 10.1097/00001888-199205000-00012; Rosenthal T C, 1998, Fam Med, V30, P90; Stearns JA, 2000, FAM MED, V32, P17; VERBY JE, 1991, JAMA-J AM MED ASSOC, V266, P110, DOI 10.1001/jama.266.1.110; WHITCOMB ME, 1991, IMPACT FEDERAL FUNDI; Xu G, 1997, ACAD MED, V72, P1026, DOI 10.1097/00001888-199712000-00004	38	247	248	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1041	1048		10.1001/jama.286.9.1041	http://dx.doi.org/10.1001/jama.286.9.1041			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469EW	11559288	Bronze			2022-12-28	WOS:000170802500017
J	Kressin, NR; Petersen, LA				Kressin, NR; Petersen, LA			Racial differences in the use of invasive cardiovascular procedures: Review of the literature and prescription for future research	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; OF-VETERANS-AFFAIRS; CORONARY-REVASCULARIZATION PROCEDURES; ARTERY-BYPASS-SURGERY; HEALTH-CARE-SYSTEM; PATIENT-PHYSICIAN RELATIONSHIP; ISCHEMIC-HEART-DISEASE; CARDIAC PROCEDURES; ETHNIC-DIFFERENCES; DECISION-MAKING	Purpose: The cause of racial disparities in the use of invasive cardiac procedures remains unclear. To summarize, evaluate, and clarify gaps in the literature, studies examining racial differences in cardiac catheterization, percutaneous transluminal coronary angioplasty (PTCA), and coronary artery bypass grafting (CABG) were reviewed. Data Sources: MEDLINE search for English-language articles published from 1966 to May 2000. Study Selection: Empirical studies of adults. Data Extraction: The odds ratios for procedure use by race were examined for each study; cohorts and covariates were also documented. Data Synthesis: Literature was classified as one of three groups on the basis of study design. For the first group, which used administrative data, odds ratios (ORs) for African-American patients compared with white patients ranged from 0.41 to 0.94 for cardiac catheterization, from 0.32 to 0.80 for PTCA, and from 0.23 to 0.68 for CABG. Procedure rates were also lower for Hispanic and Asian patients. In the second group, which used detailed clinical data, African-American patients remained disproportionately less likely to receive cardiac catheterization (OR, 0.03 to 0.85), PTCA (OR, 0.20 to 0.87), and CABG (OR, 0.22 to 0.68). A few studies noted that Hispanic and Asian patients were also disproportionately less likely to receive such procedures. The third group used survey methods but found conflicting results regarding patient refusals as a source of racial variation. Less-educated patients and patients who were not as experienced with the procedure were more likely to decline PTCA. Physician bias was also associated with racial variation in recommendations for treatment. Conclusions: Racial differences in invasive cardiac procedure use were found even after adjustment for disease severity. Future studies should comprehensively and simultaneously examine the full range of patient, physician, and health care system variables related to racial differences in the provision of invasive cardiac procedures.	Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Houston Vet Affairs Med Ctr, Houston, TX USA; Baylor Coll Med, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine	Kressin, NR (corresponding author), Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, 200 Springs Rd,Bldg 70 152, Bedford, MA 01730 USA.	nkressin@bu.edu		Kressin, Nancy/0000-0003-2767-4286				ALDERMAN EL, 1990, CIRCULATION, V82, P1629, DOI 10.1161/01.CIR.82.5.1629; [Anonymous], CORONARY ANGIOGRAPHY; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; Barnhart JM, 1997, NEW ENGL J MED, V337, P131; Barnhart JM, 2000, CLIN CARDIOL, V23, P580, DOI 10.1002/clc.4960230807; BEARDEN D, 1994, J AM GERIATR SOC, V42, P1143, DOI 10.1111/j.1532-5415.1994.tb06979.x; Betson DM, 1997, FUTURE CHILD, V7, P25, DOI 10.2307/1602385; BLENDON RJ, 1989, JAMA-J AM MED ASSOC, V261, P278, DOI 10.1001/jama.261.2.278; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; BLUSTEIN J, 1995, MED CARE, V33, P864, DOI 10.1097/00005650-199508000-00010; BROOK RH, 1990, NEW ENGL J MED, V323, P1173, DOI 10.1056/NEJM199010253231705; Canto JG, 1998, AM J CARDIOL, V82, P1013, DOI 10.1016/S0002-9149(98)00590-6; Carlisle DM, 1997, AM J PUBLIC HEALTH, V87, P263, DOI 10.2105/AJPH.87.2.263; Carlisle DM, 1999, AM J MED, V106, P391, DOI 10.1016/S0002-9343(99)00051-0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins TC, 2000, J GEN INTERN MED, V15, P160; Conigliaro J, 2000, ARCH INTERN MED, V160, P1329, DOI 10.1001/archinte.160.9.1329; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Corcoran ME, 1997, FUTURE CHILD, V7, P40, DOI 10.2307/1602386; Daumit GL, 1999, ANN INTERN MED, V130, P173, DOI 10.7326/0003-4819-130-3-199902020-00002; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; ESCARCE JJ, 1993, AM J PUBLIC HEALTH, V83, P948, DOI 10.2105/AJPH.83.7.948; Ferguson JA, 1998, AM J MED SCI, V315, P302, DOI 10.1097/00000441-199805000-00003; Ferguson JA, 1998, ARCH INTERN MED, V158, P1450, DOI 10.1001/archinte.158.13.1450; Ferguson JA, 1997, J AM COLL CARDIOL, V30, P1707, DOI 10.1016/S0735-1097(97)00365-3; FINUCANE TE, 1990, J GEN INTERN MED, V5, P120, DOI 10.1007/BF02600511; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Flores G, 2000, J PEDIATR-US, V136, P14, DOI 10.1016/S0022-3476(00)90043-X; FORD E, 1989, AM J PUBLIC HEALTH, V79, P437, DOI 10.2105/AJPH.79.4.437; FORD ES, 1995, HEALTH SERV RES, V30, P237; Franks Adele L., 1993, Ethnicity and Disease, V3, P213; GATSONIS CA, 1995, MED CARE, V33, P625, DOI 10.1097/00005650-199506000-00005; Giacomini MK, 1996, ARCH INTERN MED, V156, P1217, DOI 10.1001/archinte.156.11.1217; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; GILLUM RF, 1987, AM HEART J, V113, P1255, DOI 10.1016/0002-8703(87)90952-5; GILLUM RF, 1982, AM HEART J, V104, P839, DOI 10.1016/0002-8703(82)90021-7; Gillum RF, 1997, J AM COLL CARDIOL, V29, P1557, DOI 10.1016/S0735-1097(97)00089-2; GILLUM RF, 1984, AM HEART J, V108, P728, DOI 10.1016/0002-8703(84)90665-3; GITTELSOHN AM, 1991, AM J PUBLIC HEALTH, V81, P1435, DOI 10.2105/AJPH.81.11.1435; GOLDBERG KC, 1992, JAMA-J AM MED ASSOC, V267, P1473, DOI 10.1001/jama.267.11.1473; GONZALEZKLAYMAN N, 1998, CVD PREVENTION, V1, P114; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Gregory PM, 1999, AM HEART J, V138, P507, DOI 10.1016/S0002-8703(99)70154-7; HANNAN EL, 1991, MED CARE, V29, P430, DOI 10.1097/00005650-199105000-00004; Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010; Hughes D, 1996, SOCIOL HEALTH ILL, V18, P172, DOI 10.1111/1467-9566.ep10934703; JOHNSON PA, 1993, ANN INTERN MED, V118, P593, DOI 10.7326/0003-4819-118-8-199304150-00004; JONES JS, 1981, NATURE, V293, P188, DOI 10.1038/293188a0; Kressin Nancy R., 2000, Journal of the National Medical Association, V92, P62; Laouri M, 1997, J AM COLL CARDIOL, V29, P891, DOI 10.1016/S0735-1097(96)00434-2; Laouri M, 1997, INT J QUAL HEALTH C, V9, P15, DOI 10.1093/intqhc/9.1.15; LAVEIST TA, 1994, HEALTH SERV RES, V29, P1; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; MAYNARD C, 1986, AM J PUBLIC HEALTH, V76, P1446, DOI 10.2105/AJPH.76.12.1446; MAYNARD C, 1991, AM J CARDIOL, V67, P18, DOI 10.1016/0002-9149(91)90092-Y; Maynard C, 1997, AM HEART J, V133, P656, DOI 10.1016/S0002-8703(97)70167-4; MCBEAN AM, 1994, AM HEART J, V127, P287, DOI 10.1016/0002-8703(94)90115-5; Mickelson JK, 1997, J AM COLL CARDIOL, V29, P915, DOI 10.1016/S0735-1097(97)00034-X; Mirvis DM, 1998, AM J CARDIOL, V81, P982, DOI 10.1016/S0002-9149(98)00076-9; Mirvis DM, 1999, AM HEART J, V137, P706, DOI 10.1016/S0002-8703(99)70227-9; MIRVIS DM, 1994, J AM COLL CARDIOL, V24, P1297, DOI 10.1016/0735-1097(94)90112-0; Nakamura Y, 1999, AM HEART J, V138, P500, DOI 10.1016/S0002-8703(99)70153-5; Ness J, 1999, AM J CARDIOL, V84, P932, DOI 10.1016/S0002-9149(99)00470-1; NWASOKWA ON, 1991, ANN INTERN MED, V114, P1035, DOI 10.7326/0003-4819-114-12-1035; OBERMAN A, 1984, AM HEART J, V108, P688, DOI 10.1016/0002-8703(84)90656-2; Oka RK, 1996, AM J CARDIOL, V78, P861, DOI 10.1016/S0002-9149(96)00457-2; PETERSEN LA, 1998, 16 ANN VET AFF HLTH; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Ramsey DJ, 1997, J CLIN EPIDEMIOL, V50, P603, DOI 10.1016/S0895-4356(97)80002-9; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Sanderson BK, 1998, AM J EPIDEMIOL, V148, P741; Schoenbaum M, 1997, J GERONTOL B-PSYCHOL, V52, P61, DOI 10.1093/geronb/52B.Special_Issue.61; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; Scirica BM, 1999, AM HEART J, V138, P1065, DOI 10.1016/S0002-8703(99)70071-2; Sedlis SP, 1997, J CLIN EPIDEMIOL, V50, P899, DOI 10.1016/S0895-4356(97)00089-9; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Taylor AJ, 1997, J AM COLL CARDIOL, V30, P901, DOI 10.1016/S0735-1097(97)00271-4; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; *US DEP HHS, 1980, INT CLASS DIS; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Weitzman S, 1997, AM J CARDIOL, V79, P722, DOI 10.1016/S0002-9149(96)00857-0; WENNEKER MB, 1989, JAMA-J AM MED ASSOC, V261, P253, DOI 10.1001/jama.261.2.253; Whittle J, 1997, J GEN INTERN MED, V12, P267, DOI 10.1046/j.1525-1497.1997.012005267.x; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008; WOLINSKY FD, 1985, MED CARE, V23, P1358, DOI 10.1097/00005650-198512000-00005; YEDIDIA MJ, 1992, ARCH INTERN MED, V152, P595, DOI 10.1001/archinte.152.3.595	93	323	323	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					352	366		10.7326/0003-4819-135-5-200109040-00012	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00012			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529699				2022-12-28	WOS:000170780600006
J	Adhiyaman, V; Vaishnavi, A; Freese, S				Adhiyaman, V; Vaishnavi, A; Freese, S			Drug points - Hypersensitivity reaction to balsalazide	BRITISH MEDICAL JOURNAL			English	Article							LUPUS-LIKE SYNDROME; ULCERATIVE-COLITIS; PATIENT		Withybush Gen Hosp, Haverfordwest SA61 2PZ, Pembrokeshire, Wales		Adhiyaman, V (corresponding author), Withybush Gen Hosp, Haverfordwest SA61 2PZ, Pembrokeshire, Wales.							DEBOEVER G, 1989, AM J GASTROENTEROL, V84, P85; DENT MT, 1992, BRIT MED J, V305, P159, DOI 10.1136/bmj.305.6846.159-b; GRIFFITHS ID, 1977, BMJ-BRIT MED J, V2, P1188, DOI 10.1136/bmj.2.6096.1188; HABAL FM, 1988, AM J GASTROENTEROL, V83, P15; JENSS H, 1990, AM J GASTROENTEROL, V85, P332	5	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					489	489		10.1136/bmj.323.7311.489	http://dx.doi.org/10.1136/bmj.323.7311.489			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532843	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000170838500020
J	Bond, L; Carlin, JB; Thomas, L; Rubin, K; Patton, G				Bond, L; Carlin, JB; Thomas, L; Rubin, K; Patton, G			Does bullying cause emotional problems? A prospective study of young teenagers	BRITISH MEDICAL JOURNAL			English	Article							PEER VICTIMIZATION; SCHOOL-CHILDREN; PSYCHIATRIC-DISORDER; DEPRESSION; ANXIETY; MALADJUSTMENT; HEALTH	Objectives To establish the relation between recurrent peer victimisation and onset of self reported symptoms of anxiety or depression in the early teen years. Design Cohort study over two years. Setting Secondary schools in Victoria, Australia. Participants 2680 students surveyed twice in year 8 (aged 13 years) and once in year 9. Main outcome measures Self reported symptoms of anxiety or depression were assessed by using the computerised version of the revised clinical interview schedule. Incident cases were students scoring greater than or equal to 12 in year 9 but not previously. Prior victimisation was defined as having been bullied at either or both survey times in year 8. Results Prevalence of victimisation at the second survey point in year 8 was 51% (95% confidence interval 49% to 54%), and prevalence of self reported symptoms of anxiety or depression was 18% (16% to 20%). The incidence of self reported symptoms of anxiety or depression in year 9 (7%) was significantly associated with victimisation reported either once (odds ratio 1.94, 1.1 to 3.3) or twice (2.30,1.2 to 4.3) in year 8. After adjustment for availability of social relations and for so cio demographic factors, recurrent victimisation remained predictive of self reported symptoms of anxiety or depression for girls (2.60, 1.2 to 5.5) but not for boys (1.36, 0.6 to 3.0). Newly reported victimisation in year 9 was not significantly associated with prior self report of symptoms of anxiety or depression (1.48, 0.4 to 6.0). Conclusion A history of victimisation and poor social relationships predicts the onset of emotional problems in adolescents. Previous recurrent emotional problems are not significantly related to future victimisation. These findings have implications for how seriously the occurrence of victimisation is treated and for the focus of interventions aimed at addressing mental health issues in adolescents.	Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Murdoch, WA, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Bond, L (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Flemington Rd, Parkville, Vic 3052, Australia.		Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020; Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013	Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463; Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326; BOND, LYNDAL/0000-0003-1693-5508				BOIVIN M, 1995, DEV PSYCHOPATHOL, V7, P765, DOI 10.1017/S0954579400006830; BOULTON MJ, 1992, BRIT J EDUC PSYCHOL, V62, P73, DOI 10.1111/j.2044-8279.1992.tb01000.x; Cicchetti D, 1998, AM PSYCHOL, V53, P221, DOI 10.1037/0003-066X.53.2.221; Craig WM, 1998, PERS INDIV DIFFER, V24, P123, DOI 10.1016/S0191-8869(97)00145-1; Dawkins J. L., 1995, RECENT ADV PEDIAT, V13, P103; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; Hodges EVE, 1999, J PERS SOC PSYCHOL, V76, P677, DOI 10.1037/0022-3514.76.4.677; Kochenderfer BJ, 1996, CHILD DEV, V67, P1305, DOI 10.1111/j.1467-8624.1996.tb01797.x; Kumpulainen K, 1999, CHILD ABUSE NEGLECT, V23, P1253, DOI 10.1016/S0145-2134(99)00098-8; LEWIS G, 1988, PSYCHOL MED, V18, P737, DOI 10.1017/S0033291700008448; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; MONCK E, 1994, BRIT J PSYCHIAT, V165, P770, DOI 10.1192/bjp.165.6.770; NEARY A, 1994, PERS INDIV DIFFER, V16, P183, DOI 10.1016/0191-8869(94)90122-8; Olweus D., 1993, AGGRESSIVE BEHAV CUR; Patton GC, 2000, AUST NZ J PSYCHIAT, V34, P586, DOI 10.1046/j.1440-1614.2000.00718.x; Patton GC, 1996, J EPIDEMIOL COMMUN H, V50, P661, DOI 10.1136/jech.50.6.661; Rigby K, 1998, J Health Psychol, V3, P465, DOI 10.1177/135910539800300402; Rigby K, 1999, BRIT J EDUC PSYCHOL, V69, P95, DOI 10.1348/000709999157590; Rothman K., 1998, MODERN EPIDEMIOLOGY; Salmon G, 1998, BRIT MED J, V317, P924; SLEE PT, 1993, CHILD PSYCHIAT HUM D, V23, P273, DOI 10.1007/BF00707680	23	526	547	4	201	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					480	484		10.1136/bmj.323.7311.480	http://dx.doi.org/10.1136/bmj.323.7311.480			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469WF	11532838	Bronze, Green Published			2022-12-28	WOS:000170838500015
J	Sherwood, T				Sherwood, T			100 years' observation of risks from radiation for British (male) radiologists	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Sherwood, T (corresponding author), Lancet, London WC1X 8RR, England.							Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507; COURT BROWN W M, 1958, Br Med J, V2, P181; SMITH PG, 1981, BRIT J RADIOL, V54, P187, DOI 10.1259/0007-1285-54-639-187; SOUTHWOOD TRE, 1994, CLIN RADIOL, V49, P1, DOI 10.1016/S0009-9260(05)82905-8	4	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					604	604		10.1016/S0140-6736(01)05818-4	http://dx.doi.org/10.1016/S0140-6736(01)05818-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530145				2022-12-28	WOS:000170615500006
J	Ascher, NL				Ascher, NL			Immunosuppressant substitutes in liver transplantation	LANCET			English	Editorial Material							ACUTE REJECTION; MYCOPHENOLATE MOFETIL; WITHDRAWAL; IMPACT		Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ascher, NL (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.							ALLISON AC, 1993, TRANSPLANT REV, V7, P129, DOI DOI 10.1016/S0955-470X(05)80012-6; Beik AI, 1997, NEPHROL DIAL TRANSPL, V12, P1949, DOI 10.1093/ndt/12.9.1949; FASOLA CG, 2000, TRANSPLANT CHICAGO; Gregoor PJHS, 2000, TRANSPLANTATION, V70, P143; Groth CG, 1996, TRANSPL P, V28, P30; Halloran PF, 2000, TRANSPLANTATION, V70, P3; Keown P, 1996, TRANSPLANTATION, V61, P1029; LINDHOLM A, 1993, TRANSPLANTATION, V56, P307, DOI 10.1097/00007890-199308000-00010; MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P1098, DOI 10.1097/00007890-200010150-00018; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; Stegall MD, 1997, HEPATOLOGY, V25, P173, DOI 10.1002/hep.510250132; van Besouw NM, 2000, TRANSPLANTATION, V70, P136; Wu John C., 1994, Perspectives in Drug Discovery and Design, V2, P185, DOI 10.1007/BF02171743	14	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					571	572		10.1016/S0140-6736(00)04073-3	http://dx.doi.org/10.1016/S0140-6736(00)04073-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558477				2022-12-28	WOS:000167119100003
J	Martin, W; Stoebe, B; Goremykin, V; Hansmann, S; Hasegawa, M; Kowallik, KV				Martin, W; Stoebe, B; Goremykin, V; Hansmann, S; Hasegawa, M; Kowallik, KV			Gene transfer to the nucleus and the evolution of chloroplasts	NATURE			English	Article							COMPLETE SEQUENCE; EUGLENA; PROCHLOROPHYTES; CHLOROPHYLL; ORIGINS; GENOME; ALGAE; TREES; MODEL; DNA	Photosynthetic eukaryotes, particularly unicellular forms, possess a fossil record that is either wrought with gaps or difficult to interpret, or both. Attempts to reconstruct their evolution have focused on plastid phylogeny, but were limited by the amount and type of phylogenetic information contained within single genes(1-5). Among the 210 different protein-coding genes contained in the completely sequenced chloroplast genomes from a glaucocystophyte, a rhodophyte, a diatom, a euglenophyte and five land plants, we have now identified the set of 45 common to each and to a cyanobacterial outgroup genome. Phylogenetic inference with an alignment of 11,039 amino-acid positions per genome indicates that this information is sufficient - but just barely so - to identify the rooted nine-taxon topology. We mapped the process of gene loss from chloroplast genomes across the inferred tree and found that, surprisingly, independent parallel gene losses in multiple lineages outnumber phylogenetically unique losses by more than 4:1. We identified homologues of 44 different plastid-encoded proteins as functional nuclear genes of chloroplast origin, providing evidence for endosymbiotic gene transfer to the nucleus in plants.	Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, D-38023 Braunschweig, Germany; Univ Dusseldorf, Inst Bot, D-40225 Dusseldorf, Germany; Inst Stat Math, Minato Ku, Tokyo 106, Japan	Braunschweig University of Technology; Heinrich Heine University Dusseldorf; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Martin, W (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Spielmannstr 7, D-38023 Braunschweig, Germany.	w.martin@tu-bs.de	Martin, William F./O-5446-2015; Martin, William/C-5680-2008	Martin, William F./0000-0003-1478-6449; 				ACACHI J, 1996, COMPUT SCI MONOGRAPH, V28; Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; CavalierSmith T, 1996, EUR J PHYCOL, V31, P315, DOI 10.1080/09670269600651541; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GIBBS SP, 1978, CAN J BOT, V56, P2883, DOI 10.1139/b78-345; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; HELMCHEN TA, 1995, J MOL EVOL, V41, P203; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Herrmann RG, 1997, EUKARYOTISM SYMBIOSI, P73, DOI [10.1007/978-3-642-60885-8_7, DOI 10.1007/978-3-642-60885-8_7]; Kaneko T, 1996, DNA Res, V3, P109; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; LOFFELHARDT W, 1994, MOL BIOL CYANOBACTER, P56; Lynch M, 1996, MOL BIOL EVOL, V13, P209, DOI 10.1093/oxfordjournals.molbev.a025557; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Melkonian Michael, 1996, Progress in Botany, V57, P281; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Naylor GJP, 1997, NATURE, V388, P527, DOI 10.1038/41460; PALENIK B, 1992, NATURE, V355, P265, DOI 10.1038/355265a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URBACH E, 1992, NATURE, V355, P267, DOI 10.1038/355267a0; VanDePeer Y, 1996, P NATL ACAD SCI USA, V93, P7732, DOI 10.1073/pnas.93.15.7732; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794	30	572	604	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	1998	393	6681					162	165		10.1038/30234	http://dx.doi.org/10.1038/30234			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	11560168				2022-12-28	WOS:000073619900046
J	SCHLEMMER, S; COOK, DJ; HARRISON, JA; WURFEL, B; CHAPMAN, W; SAYKALLY, RJ				SCHLEMMER, S; COOK, DJ; HARRISON, JA; WURFEL, B; CHAPMAN, W; SAYKALLY, RJ			THE UNIDENTIFIED INTERSTELLAR INFRARED BANDS - PAHS AS CARRIERS	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; INTERPLANETARY DUST PARTICLES; MICRON EMISSION FEATURES; LABORATORY EVIDENCE; MOLECULES; SPECTRUM; BENZENE; IDENTIFICATION; SPECTROSCOPY; NAPHTHALENE	Infrared emission spectra of gas-phase naphthalene and pyrene have been measured in the range of 3 to 7.5 micrometers with ultraviolet laser desorption-excitation and a spectroscopic technique featuring single-photon counting in the infrared. The spectra were compared with the unidentified infrared emission bands that are observed in many astronomical objects. Marked discrepancies between those observations and the laboratory emission spectra in the wavelengths and relative intensities of principal spectral features led to the conclusion that small neutral unsubstituted polycyclic aromatic hydrocarbons cannot be the carriers of the unidentified infrared emission bands.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley			Harrison, John A/A-6449-2016; Schlemmer, Stephan/E-2903-2015	Harrison, John A/0000-0001-6163-6799; Schlemmer, Stephan/0000-0002-1421-7281; SAYKALLY, RICHARD/0000-0001-8942-3656				AITKEN DK, 1981, MNRAS, V196, P39; ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; ALLAMANDOLA LJ, 1989, ASTROPHYS J, V345, pL59, DOI 10.1086/185552; BARKER JR, 1992, J PHYS CHEM-US, V96, P7361, DOI 10.1021/j100197a042; BREGMAN JD, 1989, ASTROPHYS J, V344, P791, DOI 10.1086/167844; BRENNER JD, 1992, ASTROPHYS J, V388, pL39, DOI 10.1086/186325; BUCK M, 1989, APPL SURF SCI, V43, P358, DOI 10.1016/0169-4332(89)90239-0; CHERCHNEFF I, 1989, ASTROPHYS J, V341, pL21, DOI 10.1086/185448; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; COHEN M, 1986, ASTROPHYS J, V302, P737, DOI 10.1086/164035; FULARA J, 1993, NATURE, V366, P439, DOI 10.1038/366439a0; GEBALLE TR, 1985, ASTROPHYS J, V292, P500, DOI 10.1086/163182; GEBALLE TR, 1989, ASTROPHYS J, V340, pL29, DOI 10.1086/185431; GEBALLE TR, 1983, JUL P WORKSH LAB OBS; GILLETT FC, 1975, ASTROPHYS J, V198, pL65, DOI 10.1086/181813; HARRISON JA, UNPUB; HUDGINS DM, 1994, J PHYS CHEM-US, V98, P4243, DOI 10.1021/j100067a008; JOBLIN C, 1990, NATURE, V346, P729, DOI 10.1038/346729a0; LEGER A, 1989, ANN PHYS-PARIS, V14, P181, DOI 10.1051/anphys:01989001402018100; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; PAUZAT F, 1992, J PHYS CHEM-US, V96, P7882, DOI 10.1021/j100199a011; PETROFF MD, 1987, APPL PHYS LETT, V51, P406, DOI 10.1063/1.98404; RUSSELL RW, 1978, ASTROPHYS J, V220, P568, DOI 10.1086/155937; RUSSELL RW, 1977, ASTROPHYS J, V217, pL149, DOI 10.1086/182559; SCHLEMMER S, UNPUB; SCHUTTE WA, 1990, ASTROPHYS J, V360, P577, DOI 10.1086/169146; SCHUTTE WA, 1993, ASTROPHYS J, V415, P397, DOI 10.1086/173173; SHAN J, 1991, ASTROPHYS J, V383, P459, DOI 10.1086/170803; SHAN J, 1992, J PHOTOCH PHOTOBIO A, V63, P139, DOI 10.1016/1010-6030(92)85129-I; SZCZEPANSKI J, 1993, NATURE, V363, P699, DOI 10.1038/363699a0; SZCZEPANSKI J, 1993, ASTROPHYS J, V413, P646; WHITTET DCB, 1988, MON NOT R ASTRON SOC, V233, P321, DOI 10.1093/mnras/233.2.321; WHITTET DCB, 1984, ASTRON SOC MON NOT, V21, P29; WILLIAMS RK, UNPUB ASTROPHYS J; WILLNER SP, 1977, ASTROPHYS J, V217, pL121, DOI 10.1086/182553; WOLSTENCROFT RD, 1984, OBS OCCAS REP, V12, P93	38	95	96	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 16	1994	265	5179					1686	1689		10.1126/science.11539830	http://dx.doi.org/10.1126/science.11539830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG284	11539830				2022-12-28	WOS:A1994PG28400023
J	Flick, K; Scholander, C; Chen, QJ; Fernandez, V; Pouvelle, B; Gysin, J; Wahlgren, M				Flick, K; Scholander, C; Chen, QJ; Fernandez, V; Pouvelle, B; Gysin, J; Wahlgren, M			Rote of nonimmune IgG bound to PfEMP1 in placental malaria	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; PREGNANCY	Infections with Plasmodium falciparum during pregnancy lead to the accumulation of parasitized red blood cells (infected erythrocytes, IEs) in the placenta. IEs of A falciparum isolates that infect the human placenta were found to bind immunoglobulin G (IgG). A strain of P. falciparum cloned for IgG binding adhered massively to placental syncytiotrophoblasts in a pattern similar to that of natural infections. Adherence was inhibited by IgG-binding proteins, but not by glycosaminoglycans or enzymatic digestion of chondroitin sulfate A or hyaluronic acid. Normal, nonimmune IgG that is bound to a duffy binding-like domain beta of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) might at the IE surface act as a bridge to neonatal Fc receptors of the placenta.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, S-17177 Stockholm, Sweden; Univ Aix Marseille 2, Fac Med, Unite Parasitol Expt, F-13385 Marseille 5, France	Karolinska Institutet; Swedish Institute for Infectious Disease Control; UDICE-French Research Universities; Aix-Marseille Universite	Wahlgren, M (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Box 280, S-17177 Stockholm, Sweden.	Mats.wahlgren@smi.ki.se	Pouvelle, Bruno/AAA-3968-2022					BEESON JG, 2000, NAT MED, V6, P1; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; BULMER JN, 1993, HISTOPATHOLOGY, V22, P3; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109; Gysin J, 1999, INFECT IMMUN, V67, P6596; McGregor I A, 1987, Parassitologia, V29, P153; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robert C, 1995, RES IMMUNOL, V146, P383, DOI 10.1016/0923-2494(96)81042-X; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SCHOLANDER C, 1996, NAT MED, V2, P2	17	121	121	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2098	2100		10.1126/science.1062891	http://dx.doi.org/10.1126/science.1062891			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557894				2022-12-28	WOS:000171028700076
J	Meindl, JD; Chen, Q; Davis, JA				Meindl, JD; Chen, Q; Davis, JA			Limits on silicon nanoelectronics for terascale integration	SCIENCE			English	Editorial Material							RLC INTERCONNECT MODELS; LINE TRANSIENT; PART II	Throughout the past four decades, silicon semiconductor technology has advanced at exponential rates in both performance and productivity. Concerns have been raised, however, that the limits of silicon technology may soon be reached. Analysis of fundamental, material, device, circuit, and system limits reveals that silicon technology has an enormous remaining potential to achieve terascale integration (TSI) of more than I trillion transistors per chip. Such massive-scale integration is feasible assuming the development and economical mass production of double-gate metal-oxide-semiconductor field effect transistors with gate oxide thickness of about 1 nanometer, silicon channel thickness of about 3 nanometers, and channel length of about 10 nanometers. The development of interconnecting wires for these transistors presents a major challenge to the achievement of nanoelectronics for TSI.	Georgia Inst Technol, Microelect Res Ctr, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Meindl, JD (corresponding author), Georgia Inst Technol, Microelect Res Ctr, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	james.meindl@mirc.gatech.edu						Bhavnagarwala AJ, 2000, IEEE T VLSI SYST, V8, P235, DOI 10.1109/92.845891; BOWMAN KA, 1998, IEEE T ELECTRON DEV, V45, P580; Chen Q. B., COMMUNICATION; Davis JA, 2000, IEEE T ELECTRON DEV, V47, P2068, DOI 10.1109/16.877168; Davis JA, 2000, IEEE T ELECTRON DEV, V47, P2078, DOI 10.1109/16.877169; Davis JA, 1998, IEEE T ELECTRON DEV, V45, P590, DOI 10.1109/16.661220; Frank DJ, 2001, P IEEE, V89, P259, DOI 10.1109/5.915374; HAKEN H, 1984, ATOMIC QUANTUM PHYSI, pCH7; Keyes RW, 2001, P IEEE, V89, P227, DOI 10.1109/5.915372; KEYES RW, 1961, P IBM J RES DEV, V5, P183; Meindl J, 2001, P IEEE, V89, P223, DOI 10.1109/JPROC.2001.915371; Meindl JD, 2000, IEEE J SOLID-ST CIRC, V35, P1515, DOI 10.1109/4.871332; MEINDL JD, 1995, P IEEE, V83, P619, DOI 10.1109/5.371970; Plummer JD, 2001, P IEEE, V89, P240, DOI 10.1109/5.915373; Roldan JB, 1997, SEMICOND SCI TECH, V12, P321, DOI 10.1088/0268-1242/12/3/014; Semiconductor Industry Association, 1999, INT TECHN ROADM SEM; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SWANSON RM, 1972, IEEE J SOLID-ST CIRC, VSC 7, P146, DOI 10.1109/JSSC.1972.1050260; TANG X, 1999, P IEEE INT SOI C, P42; von Neumann J., 1966, THEORY SELF REPRODUC, P66	20	269	281	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2044	2049		10.1126/science.293.5537.2044	http://dx.doi.org/10.1126/science.293.5537.2044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557881				2022-12-28	WOS:000171028700062
J	Herzig, S; Long, FX; Jhala, US; Hedrick, S; Quinn, R; Bauer, A; Rudolph, D; Schutz, G; Yoon, C; Puigserver, P; Spiegelman, B; Montminy, M				Herzig, S; Long, FX; Jhala, US; Hedrick, S; Quinn, R; Bauer, A; Rudolph, D; Schutz, G; Yoon, C; Puigserver, P; Spiegelman, B; Montminy, M			CREB regulates hepatic gluconeogenesis through the coactivator PGC-1	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; CAMP RESPONSE ELEMENT; GTP GENE; LEPTIN RECEPTOR; BINDING PROTEIN; TRANSCRIPTION; GLUCOCORTICOIDS; PROMOTER; MICE; IDENTIFICATION	When mammals fast, glucose homeostasis is achieved by triggering expression of gluconeogenic genes in response to glucagon and glucocorticoids. The pathways act synergistically to induce gluconeogenesis (glucose synthesis), although the underlying mechanism has not been determined(1-4). Here we show that mice carrying a targeted disruption of the cyclic AMP (cAMP) response element binding (CREB) protein gene, or overexpressing a dominant-negative CREB inhibitor, exhibit fasting hyperglycaemia and reduced expression of gluconeogenic enzymes. CREB was found to induce expression of the gluconeogenic programme through the nuclear receptor coactivator PGC-1, which is shown here to be a direct target for CREB regulation in vivo. Overexpression of PGC-1 in CREB-dercient mice restored glucose homeostasis and rescued expression of gluconeogenic genes. In transient assays, PGC-1 potentiated glucocorticoid induction of the gene for phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme in gluconeogenesis. PGC-1 promotes cooperativity between cyclic AMP and glucocorticoid signalling pathways during hepatic gluconeogenesis. Fasting hyperglycaemia is strongly correlated with type II diabetes, so our results suggest that the activation of PGC-1 by CREB in liver contributes importantly to the pathogenesis of this disease.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA	Salk Institute; Harvard University; Joslin Diabetes Center, Inc.; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Herzig, Stephan/0000-0003-3950-3652				Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ANGRAND PO, 1994, CELL GROWTH DIFFER, V5, P957; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Jitrapakdee S, 1997, J BIOL CHEM, V272, P20522, DOI 10.1074/jbc.272.33.20522; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; LIU JK, 1988, GENE DEV, V2, P528, DOI 10.1101/gad.2.5.528; LIU JS, 1991, J BIOL CHEM, V266, P19095; Long FX, 2001, DEVELOPMENT, V128, P541; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Wexler ID, 1998, PEDIATR RES, V43, P579, DOI 10.1203/00006450-199805000-00004; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	29	1098	1138	6	103	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					179	183		10.1038/35093131	http://dx.doi.org/10.1038/35093131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557984				2022-12-28	WOS:000170918800050
J	Chang, G; Roth, CB				Chang, G; Roth, CB			RETRACTED: Structure of MsbA from E-coli: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters (Retracted Article. See vol 314, pg 1875, 2006)	SCIENCE			English	Article; Retracted Publication							REFINEMENT; MOLSCRIPT; PROGRAM	Multidrug resistance (MDR) is a serious medical problem and presents a major challenge to the treatment of disease and the development of novel therapeutics. ABC transporters that are associated with multidrug resistance (MDR-ABC transporters) translocate hydrophobic drugs and lipids from the inner to the outer leaflet of the cell membrane. To better elucidate the structural basis for the "flip-flop" mechanism of substrate movement across the lipid bilayer, we have determined the structure of the lipid flippase MsbA from Escherichia coli by x-ray crystallography to a resolution of 4.5 angstroms. MsbA is organized as a homodimer with each subunit containing six transmembrane alpha -helices and a nucleotide-binding domain. The asymmetric distribution of charged residues lining a central chamber suggests a general mechanism for the translocation of substrate by MsbA and other MDR-ABC transporters. The structure of MsbA can serve as a model for the MDR-ABC transporters that confer multidrug resistance to cancer cells and infectious microorganisms.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-9, La Jolla, CA 92037 USA.	gchang@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061905] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61905-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CANOGAUCI DF, 1995, BIOCHEM BIOPH RES CO, V209, P2; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; DOERRIER WT, 2001, J BIOL CHEM, V276, P15; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GROS P, 1987, SCIENCE, V235, P458; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; HUGHES AL, 1994, MOL BIOL EVOL, V11, P6; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; MARGOLLES A, 1999, BIOCHEMISTRY-US, V38, P49; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; McDonald MK, 1997, J BACTERIOL, V179, P7638, DOI 10.1128/jb.179.24.7638-7643.1997; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Pellegrini M, 1997, PROTEINS, V29, P426, DOI 10.1002/(SICI)1097-0134(199712)29:4<426::AID-PROT3>3.3.CO;2-J; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SARKADI B, 1992, J BIOL CHEM, V267, P7; SENIOR A, 1998, BIOCHEMISTRY-US, V37, P3; SMIT JJ, 1993, CELL, V75, P3; SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4; Thompson JD, 1994, NUCLEIC ACIDS RES, V22, P22; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; *WHO, 2000, DRUG RES THREAT REV; Zhou Y, 1999, ARCH BIOCHEM BIOPHYS, V367, P74, DOI 10.1006/abbi.1999.1221	46	579	588	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1793	1800		10.1126/science.293.5536.1793	http://dx.doi.org/10.1126/science.293.5536.1793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546864				2022-12-28	WOS:000170894400037
J	Dong, XZ; Han, SK; Zylka, MJ; Simon, MI; Anderson, DJ				Dong, XZ; Han, SK; Zylka, MJ; Simon, MI; Anderson, DJ			A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; PUTATIVE PHEROMONE RECEPTORS; NEUROPEPTIDE FF RECEPTORS; LECTIN-BINDING ANALYSIS; DORSAL-ROOT; SPINAL-CORD; CAPSAICIN RECEPTOR; ODORANT RECEPTORS; TASTE RECEPTORS; COMPREHENSIVE IMMUNOFLUORESCENCE	In vertebrates, peripheral chemosensory neurons express large families of G protein-coupled receptors (GPCRs), reflecting the diversity and specificity of stimuli they detect. However, somatosensory neurons, which respond to chemical, thermal, or mechanical stimuli, are more broadly tuned. Here we describe a family of approximately 50 GPCRs related to Mas1, called mrgs, a subset of which is expressed in specific subpopulations of sensory neurons that detect painful stimuli. The expression patterns of mrgs thus reveal an unexpected degree of molecular diversity among nociceptive neurons. Some of these receptors can be specifically activated in heterologous cells by RFamide neuropeptides such as NPFF and NPAF, which are analgesic in vivo. Thus, mrgs may regulate nociceptor function and/or development, including the sensation or modulation of pain.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NIGMS NIH HHS [GM-34236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034236, R01GM034236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akopian AN, 1996, TRENDS NEUROSCI, V19, P240, DOI 10.1016/0166-2236(96)10030-8; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON L, 1995, BIOCHEM J, V311, P385, DOI 10.1042/bj3110385; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DADO RJ, 1993, NEUROREPORT, V5, P341, DOI 10.1097/00001756-199312000-00041; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Friedel RH, 2001, MOL CELL NEUROSCI, V17, P31, DOI 10.1006/mcne.2000.0912; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Gouarderes C, 2000, SYNAPSE, V35, P45, DOI 10.1002/(SICI)1098-2396(200001)35:1<45::AID-SYN6>3.0.CO;2-0; Gouarderes C, 1996, NEUROSCIENCE, V74, P21, DOI 10.1016/0306-4522(96)00122-4; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jackman A, 2000, J COMP NEUROL, V418, P281; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Michael GJ, 1999, J NEUROSCI, V19, P1844; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Perez SE, 1999, DEVELOPMENT, V126, P1715; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Rice FL, 1997, J COMP NEUROL, V385, P149; ROSS PC, 1990, P NATL ACAD SCI USA, V87, P3052, DOI 10.1073/pnas.87.8.3052; Scott SA, 1992, SENSORY NEURONS DIVE; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	72	476	542	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					619	632		10.1016/S0092-8674(01)00483-4	http://dx.doi.org/10.1016/S0092-8674(01)00483-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551509	Bronze			2022-12-28	WOS:000170973200012
J	Hicke, L				Hicke, L			A new ticket for entry into budding vesicles - Ubiquitin	CELL			English	Review							DEUBIQUITINATING ENZYME; PROTEIN; MOTIF; INTERNALIZATION; DEGRADATION; COMPONENTS; COMPLEX; DOMAIN		Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Hicke, L (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	l-hicke@northwestern.edu						Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; REGGIORI F, 2001, IN PRESS EMBO J; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198	19	269	281	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					527	530		10.1016/S0092-8674(01)00485-8	http://dx.doi.org/10.1016/S0092-8674(01)00485-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551499	Bronze			2022-12-28	WOS:000170973200002
J	Stevens, DP; Holland, GJ; Kizer, KW				Stevens, DP; Holland, GJ; Kizer, KW			Results of a nationwide Veterans Affairs initiative to align graduate medical education and patient care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN WORKFORCE; VA; GENERALIST; SYSTEM; REFORM	Context Planning for the US physician workforce is imprecise. Prevailing policy generally advocates more training in primary care specialties. Objective To describe a program to increase primary care graduate medical education (GME) in a large academic health system-the Veterans Health Administration of the Department of Veterans Affairs (VA). Design In 1995, a VA advisory panel recommended a 3-year plan to eliminate 1000 specialist training positions and add 750 primary care positions. After assessing the impact of the first year of these changes on patient care, the VA implemented modifications aimed at introducing primary care curricula for training of internal medicine subspecialists, neurologists, and psychiatrists. The change in strategy was in response to the call for better alignment of GME with local patient care and training needs to provide coordinated, continuous care for seriously and chronically ill patients. Setting The VA health system, including 172 hospitals, 773 ambulatory and community-based clinics, 206 counseling centers, and 132 nursing homes. Participants A total of 8900 VA residency training positions affiliated with 107 medical schools. Main Outcome Measure Proportion of residents in primary care training during the 3-year alignment. Results Over 3 years, primary care training in the VA increased from 38% to 48% of funded positions. Of this total, 39% of the increase was in internal medicine subspecialties, neurology, and psychiatry. Conclusion In this case study of GME realignment, national policy was driven more by local patient care issues than by a perceived national need for primary care or specialty positions.	Dept Vet Affairs, Vet Hlth Adm, Off Acad Affiliat, Washington, DC USA; Dept Vet Affairs, Vet Hlth Adm, Off Under Secretary, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Stevens, DP (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	dstevens@aamc.org						[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; *COMM FUT PRIM CAR, 1996, PRIM CAR AM HLTH NEW; COOPER RA, 1994, JAMA-J AM MED ASSOC, V272, P680, DOI 10.1001/jama.272.9.680; *DEP VET AFF, 1996, REP RES REAL REV COM; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Hart IG, 1997, HEALTH AFFAIR, V16, P55, DOI 10.1377/hlthaff.16.1.55; KINDIG DA, 1993, JAMA-J AM MED ASSOC, V270, P1069; Kizer KW, 1999, AM J MED QUAL, V14, P3, DOI 10.1177/106286069901400103; Kizer KW, 1996, JAMA-J AM MED ASSOC, V275, P1069, DOI 10.1001/jama.275.14.1069; Rivo ML, 1996, NEW ENGL J MED, V334, P892, DOI 10.1056/NEJM199604043341405; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; St Peter RF, 1999, NEW ENGL J MED, V341, P1980, DOI 10.1056/NEJM199912233412606; Stevens DP, 1997, ACAD MED, V72, P986, DOI 10.1097/00001888-199711000-00017; Stevens DP, 1997, AM J MED, V103, P458, DOI 10.1016/S0002-9343(97)90100-5; *US DEP HHS, 1994, 4 US DEP HLTH HUM SE; *VET HLTH ADM, 1997, VET EQ RES ALL EQ FU; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WEINER JP, 1994, JAMA-J AM MED ASSOC, V272, P222; Wilson NJ, 1997, HEALTH AFFAIR, V16, P200, DOI 10.1377/hlthaff.16.4.200; [No title captured]	20	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1061	1066		10.1001/jama.286.9.1061	http://dx.doi.org/10.1001/jama.286.9.1061			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559291				2022-12-28	WOS:000170802500020
J	Carrol, ED; Latif, AH; Misbah, SA; Flood, TJ; Abinun, M; Clark, JE; Pugh, RE; Cant, AJ				Carrol, ED; Latif, AH; Misbah, SA; Flood, TJ; Abinun, M; Clark, JE; Pugh, RE; Cant, AJ			Lesson of the week - Recurrent bacterial meningitis: the need for sensitive imaging	BRITISH MEDICAL JOURNAL			English	Review									Leighton Hosp, Dept Paediat, Crewe CW1 4QJ, Cheshire, England; Leeds Gen Infirm, Dept Clin Biochem & Immunol, Leeds LS1 3EX, W Yorkshire, England; Newcastle Gen Hosp, Dept Paediat & Infect Dis & Immunol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Leeds General Infirmary; University of Leeds; Newcastle General Hospital	Carrol, ED (corresponding author), Royal Liverpool Childrens Hosp, Inst Child Hlth, Liverpool L12 2AP, Merseyside, England.		Clark, Julia/A-8214-2012	Clark, Julia/0000-0001-7746-0599; Carrol, Enitan/0000-0001-8357-7726				CastanoDuque CH, 1997, REV NEUROLOGIA, V25, P230; CHOUDHURY AR, 1982, J NEUROSURG, V57, P552, DOI 10.3171/jns.1982.57.4.0552; Ohga Shouichi, 1995, Acta Paediatrica Japonica, V37, P196; SPONSEL C, 1994, POSTGRAD MED, V95, P109, DOI 10.1080/00325481.1994.11945784; STEELE RW, 1985, PEDIATRICS, V76, P950; Tang YW, 2000, CLIN INFECT DIS, V30, P176, DOI 10.1086/313616	6	17	17	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					501	503		10.1136/bmj.323.7311.501	http://dx.doi.org/10.1136/bmj.323.7311.501			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532847	Green Published			2022-12-28	WOS:000170838500024
J	Owens, DR; Zinman, B; Bolli, GB				Owens, DR; Zinman, B; Bolli, GB			Insulins today and beyond	LANCET			English	Review							LONG-ACTING INSULIN; TYPE-1 DIABETES-MELLITUS; BLOOD-GLUCOSE CONTROL; DOUBLE-BLIND CROSSOVER; TIME-ACTION PROFILE; NPH INSULIN; ANALOG LISPRO; GLARGINE HOE-901; CONTROLLED TRIAL; GLYCEMIC CONTROL	The advent of insulin almost 80 years ago revolutionised treatment of diabetes and must be one of the most outstanding achievements of twentieth century medicine. Since then, there has been an ever-increasing awareness and acceptance of the need to achieve and sustain near-normoglycaemia to delay onset and retard progression of diabetic angiopathy. Physiological insulin replacement is therefore central to management of patients with diabetes who are unable to take insulin. Insulin formulations, treatment strategies, and methods, and routes of delivery have changed much, with more and more options for monitoring the effect on blood glucose concentrations. Patients with type 1 and type 2 diabetes need insulin much more aggressively than previously. Parallel developments in glucose-sensing technologies are welcomed as an integral part of safe and optimum implementation of insulin replacement therapy.	Llandough Hosp, Diabet Res Unit, Penarth CF64 2XX, S Glam, Wales; Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada; Univ Perugia, Di M 1, I-06100 Perugia, Italy	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Perugia	Owens, DR (corresponding author), Llandough Hosp, Diabet Res Unit, Penlan Rd, Penarth CF64 2XX, S Glam, Wales.		Zinman, Bernard/E-7266-2013					Ahmed ABE, 1998, DIABETES CARE, V21, P1707, DOI 10.2337/diacare.21.10.1707; Ahmed ABE, 1998, DIABETES CARE, V21, P1162, DOI 10.2337/diacare.21.7.1162; Anderson JH, 1997, DIABETES, V46, P265, DOI 10.2337/diabetes.46.2.265; Bahr M, 1997, EUR J PHARMACOL, V320, P259, DOI 10.1016/S0014-2999(96)00903-X; Barnett AH, 1997, LANCET, V349, P47, DOI 10.1016/S0140-6736(96)06032-1; Berti L, 1998, HORM METAB RES, V30, P123, DOI 10.1055/s-2007-978849; BEULKESAM J, 1994, J AM COLL TOXICOL, V13, P247; BINDER C, 1984, DIABETES CARE, V7, P188, DOI 10.2337/diacare.7.2.188; Bolli GB, 1999, DIABETOLOGIA, V42, P1151, DOI 10.1007/s001250051286; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; Brunelle RL, 1998, DIABETES CARE, V21, P1726, DOI 10.2337/diacare.21.10.1726; Bruttomesso D, 1999, DIABETES, V48, P99, DOI 10.2337/diabetes.48.1.99; Calle-Pascual AL, 2000, DIABETES NUTR METAB, V13, P173; Ciofetta M, 1999, DIABETES CARE, V22, P795, DOI 10.2337/diacare.22.5.795; Colombel A, 1999, DIABETIC MED, V16, P319, DOI 10.1046/j.1464-5491.1999.00077.x; COSCELLI C, 1992, DIABETES CARE, V15, P1628, DOI 10.2337/diacare.15.11.1628; Del Sindaco P, 1998, DIABETIC MED, V15, P592; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Francis A J, 1985, Diabet Med, V2, P177; Gale EAM, 2000, DIABETIC MED, V17, P209; Gammeltoft S, 1999, Expert Opin Investig Drugs, V8, P1431, DOI 10.1517/13543784.8.9.1431; Garg SK, 1996, DIABETIC MED, V13, P47, DOI 10.1002/(SICI)1096-9136(199601)13:1<47::AID-DIA999>3.0.CO;2-M; Gershonov E, 1999, DIABETES, V48, P1437, DOI 10.2337/diabetes.48.7.1437; Hansen BF, 1996, BIOCHEM J, V315, P271; Heinemann L, 1999, J DIABETES COMPLICAT, V13, P105, DOI 10.1016/S1056-8727(99)00031-8; Heinemann L, 1999, DIABETIC MED, V16, P332, DOI 10.1046/j.1464-5491.1999.00081.x; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Heise T, 1998, DIABETES CARE, V21, P800, DOI 10.2337/diacare.21.5.800; Heller SR, 1999, DIABETES CARE, V22, P1607, DOI 10.2337/diacare.22.10.1607; Hermansen K, 2001, DIABETES CARE, V24, P296, DOI 10.2337/diacare.24.2.296; Holcombe J., 1997, Diabetologia, V40, pA343; Holleman F, 1997, NEW ENGL J MED, V337, P176, DOI 10.1056/NEJM199707173370307; Home PD, 2000, DIABETIC MED, V17, P762, DOI 10.1046/j.1464-5491.2000.00380.x; Home PD, 1999, EUR J CLIN PHARMACOL, V55, P199, DOI 10.1007/s002280050618; Home PD, 1998, DIABETES CARE, V21, P1904, DOI 10.2337/diacare.21.11.1904; HOWEY DC, 1994, DIABETES, V43, P396, DOI 10.2337/diabetes.43.3.396; Jacobsen LV, 2000, EUR J CLIN PHARMACOL, V56, P399, DOI 10.1007/s002280000159; Janssen MMJ, 2000, DIABETES CARE, V23, P629, DOI 10.2337/diacare.23.5.629; Jehle PM, 1999, LANCET, V354, P1604, DOI 10.1016/S0140-6736(98)12459-5; JORGENSEN S, 1989, BRIT MED J, V299, P415, DOI 10.1136/bmj.299.6696.415; Jovanovic L, 1999, DIABETES CARE, V22, P1422, DOI 10.2337/diacare.22.9.1422; Jovanovic L, 1999, DIABETES CARE, V22, P846, DOI 10.2337/diacare.22.5.846; Koivisto VA, 1999, DIABETES CARE, V22, P459, DOI 10.2337/diacare.22.3.459; Kurtzhals P, 1997, J PHARM SCI, V86, P1365, DOI 10.1021/js9701768; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lalli C, 1999, DIABETES CARE, V22, P468, DOI 10.2337/diacare.22.3.468; LAURITZEN T, 1979, DIABETOLOGIA, V17, P291, DOI 10.1007/BF01235885; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Malone JK, 2000, CLIN THER, V22, P222, DOI 10.1016/S0149-2918(00)88480-5; MALONE JK, 1998, DIABETIC MED S2, V15, pS34; Markussen J, 1996, DIABETOLOGIA, V39, P281; MARKUSSEN J, 1990, PROTEIN DESIGN DEV N, V19, P397; Melki V, 1998, DIABETES CARE, V21, P977, DOI 10.2337/diacare.21.6.977; Mohn A, 1999, DIABETES CARE, V22, P27, DOI 10.2337/diacare.22.1.27; Mohn A, 2000, DIABETES CARE, V23, P557, DOI 10.2337/diacare.23.4.557a; Mortensen HB, 2000, EUR J PEDIATR, V159, P483, DOI 10.1007/s004310051315; Mortensen HB, 1998, DIABETIC MED, V15, P752, DOI 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W; NOLTE MS, 1983, DIABETES, V32, P1177, DOI 10.2337/diabetes.32.12.1177; OKHUBO Y, 1995, DIABETES RES CLIN PR, V28, P103; OWENS DR, 1988, DIABETES RES CLIN EX, V7, P35; OWENS DR, 1984, DIABETOLOGIA, V26, P261; Owens DR, 2000, DIABETES CARE, V23, P813, DOI 10.2337/diacare.23.6.813; Owens DR., 1986, HUMAN INSULIN CLIN P, DOI [DOI 10.1007/978-94-009-4161-8, 10.1007/978-94-009-4161-8]; Pieber TR, 2000, DIABETES CARE, V23, P157, DOI 10.2337/diacare.23.2.157; Raskin P, 2000, DIABETES CARE, V23, P1666, DOI 10.2337/diacare.23.11.1666; Raskin P, 2000, DIABETES CARE, V23, P583, DOI 10.2337/diacare.23.5.583; Rassam AG, 1999, DIABETES CARE, V22, P133, DOI 10.2337/diacare.22.1.133; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Renner R, 1999, DIABETES CARE, V22, P784, DOI 10.2337/diacare.22.5.784; Rosenstock J, 2001, DIABETES CARE, V24, P631, DOI 10.2337/diacare.24.4.631; Rosenstock J, 2000, DIABETES CARE, V23, P1137, DOI 10.2337/diacare.23.8.1137; Scholtz HE, 1999, DIABETOLOGIA, V42, pA235; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shojaee-Moradie F, 1998, DIABETIC MED, V15, P928, DOI 10.1002/(SICI)1096-9136(1998110)15:11<928::AID-DIA702>3.0.CO;2-W; SHOJAEEMORADIE F, 1995, DIABETOLOGIA, V38, P1007; SLEIKER LJ, 1997, DIABETOLOGIA SI, V40, pS54; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Torlone E, 1996, DIABETES CARE, V19, P945, DOI 10.2337/diacare.19.9.945; Torlone E, 1998, BIODRUGS, V9, P363, DOI 10.2165/00063030-199809050-00002; TUOMINEN JA, 1995, DIABETOLOGIA, V38, P106, DOI 10.1007/BF02369359; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yki-Jarvinen H, 1999, ANN INTERN MED, V130, P389, DOI 10.7326/0003-4819-130-5-199903020-00002; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130; ZINMAN B, 1989, NEW ENGL J MED, V321, P363; Zinman B, 1999, DIABETES CARE, V22, P603, DOI 10.2337/diacare.22.4.603; Zinman B, 1997, DIABETES, V46, P440, DOI 10.2337/diabetes.46.3.440	87	271	293	1	43	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					739	746		10.1016/S0140-6736(01)05842-1	http://dx.doi.org/10.1016/S0140-6736(01)05842-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551598				2022-12-28	WOS:000170729500030
J	Kirkwood, TBL				Kirkwood, TBL			Where will it all end?	LANCET			English	Editorial Material									Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Inst Hlth Elderly, Dept Gerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle General Hospital; Newcastle University - UK	Kirkwood, TBL (corresponding author), Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Inst Hlth Elderly, Dept Gerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.							Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366	4	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					576	576		10.1016/S0140-6736(00)04077-0	http://dx.doi.org/10.1016/S0140-6736(00)04077-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558481				2022-12-28	WOS:000167119100007
J	Nieman, K; Oudkerk, M; Rensing, BJ; van Ooijen, P; Munne, A; van Geuns, RJ; de Feyter, PJ				Nieman, K; Oudkerk, M; Rensing, BJ; van Ooijen, P; Munne, A; van Geuns, RJ; de Feyter, PJ			Coronary angiography with multi-slice computed tomography	LANCET			English	Article							ARTERY STENOSES	Background A new generation of subsecond multi-slice computed tomography (MSCT) scanners, which allow complete coronary coverage, are becoming widely available. We investigated the potential value of MSCT angiography in a range of coronary disorders. Methods We studied 35 patients, including 11 who had undergone percutaneous transluminal coronary angioplasty and four who had had coronary-artery bypass grafts, by both MSCT and conventional coronary angiography. After intravenous injection of a non-ionic contrast medium with high iodine content, the entire heart was scanned within a single breath-hold. The total examination time was no more than 20 min. The retrospective electrocardiographically gated reconstruction source images and three-dimensional reconstructed volumes were analysed by two investigators, unaware of the results of conventional angiography. Findings In the 31 patients without previous coronary surgery, 173 (73%) of the 237 proximal and middle coronary segments were assessable. In the assessable segments, 17 of 21 significant stenoses (>50% reduction of vessel diameter) were correctly diagnosed. The non-assessable segments included four lesions. Misinterpretations were mainly the result of severe calcification of the vessel wall. Segments with implanted stents were poorly visualised, but stent patency could be assessed in all cases. Of the 17 segments of bypass grafts, 15 were assessable and four of five graft lesions were detected. Two cases of anomalous coronary anatomy could be visualised well. Interpretation These preliminary data suggest that MSCT allows non-invasive imaging of coronary-artery stenoses and has potential to develop into a reliable clinical technique.	Univ Rotterdam Hosp, Thoraxctr BD 406, Dept Cardiol, Catheterizat Lab, NL-3000 CA Rotterdam, Netherlands; Univ Rotterdam Hosp, Daniel Den Hoed Klin, Dept Radiol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	de Feyter, PJ (corresponding author), Univ Rotterdam Hosp, Thoraxctr BD 406, Dept Cardiol, Catheterizat Lab, POB 2040, NL-3000 CA Rotterdam, Netherlands.		van Geuns, Robert-Jan M/N-7976-2017; van Geuns, Robert/AAR-6386-2021; van Ooijen, Peter/B-9150-2008	van Geuns, Robert-Jan M/0000-0003-2943-5932; van Ooijen, Peter/0000-0002-8995-1210; Oudkerk, Matthijs/0000-0003-2800-4110				Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; Austen W G, 1975, Circulation, V51, P5; Becker CR, 2000, RADIOLOGE, V40, P118, DOI 10.1007/s001170050019; Bielak LF, 2000, CIRCULATION, V102, P380; de Feyter PJ, 2000, HEART, V84, P442, DOI 10.1136/heart.84.4.442; Hu H, 2000, RADIOLOGY, V215, P55, DOI 10.1148/radiology.215.1.r00ap3755; Huber A, 1999, AM J ROENTGENOL, V173, P95, DOI 10.2214/ajr.173.1.10397107; Kachelriess M, 1998, MED PHYS, V25, P2417, DOI 10.1118/1.598453; Kessler W, 1997, AM J CARDIOL, V80, P989, DOI 10.1016/S0002-9149(97)00590-0; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Leclerc X, 2000, AM J ROENTGENOL, V174, P820, DOI 10.2214/ajr.174.3.1740820; Ohnesorge B, 2000, RADIOLOGY, V217, P564, DOI 10.1148/radiology.217.2.r00nv30564; PATTYNAMA PMT, 1994, AM HEART J, V128, P595, DOI 10.1016/0002-8703(94)90636-X; Pennell DJ, 1996, HEART, V75, P127, DOI 10.1136/hrt.75.2.127; Post JC, 1996, AM J ROENTGENOL, V166, P1399, DOI 10.2214/ajr.166.6.8633453; Rensing BJ, 1998, CIRCULATION, V98, P2509, DOI 10.1161/01.CIR.98.23.2509; Sandstede JJW, 1999, AM J ROENTGENOL, V172, P135, DOI 10.2214/ajr.172.1.9888755; van Geuns RJM, 1999, HEART, V82, P515, DOI 10.1136/hrt.82.4.515; van Geuns RJM, 2000, RADIOLOGY, V217, P270, DOI 10.1148/radiology.217.1.r00oc01270; Wielopolski PA, 2000, EUR RADIOL, V10, P12, DOI 10.1007/s003300050004	20	522	576	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					599	603		10.1016/S0140-6736(00)04058-7	http://dx.doi.org/10.1016/S0140-6736(00)04058-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558487				2022-12-28	WOS:000167119100013
J	Schlitt, HJ; Barkmann, A; Boker, KHW; Schmidt, HHJ; Emmanouilidis, N; Rosenau, J; Bahr, MJ; Tusch, G; Manns, MP; Nashan, B; Klempnauer, J				Schlitt, HJ; Barkmann, A; Boker, KHW; Schmidt, HHJ; Emmanouilidis, N; Rosenau, J; Bahr, MJ; Tusch, G; Manns, MP; Nashan, B; Klempnauer, J			Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study	LANCET			English	Article							ALLOGRAFT RECIPIENTS; CYCLOSPORINE; CONVERSION; NEPHROTOXICITY; AZATHIOPRINE; IMPAIRMENT; REJECTION	Background Renal dysfunction is a major complication of long-term immunosuppressive therapy with calcineurin inhibitors (CNI) in liver-transplant recipients. We undertook a randomised study to assess the safety and efficacy of CNI withdrawal and replacement by mycophenolate mofetil. Methods 28 people who had had renal dysfunction attributable to suspected CNI toxicity after liver transplantation participated in the study. We replaced CNI with mycophenolate mofetil in a stepwise pattern in half the group (study patients); the other half (controls) stayed on CNI immunosuppression. Renal function, blood pressure, uric acid, and blood lipids were measured before and 6 months after study entry. Side-effects of medication and graft function were recorded throughout the study. Findings At the end of the study, mean (SD) serum creatinine had fallen by 44.4 (48.7) mu mol/L in study patients compared with 3.1 (14.3) mu mol/L in controls; a mean difference of 41.3 mu mol/L (95% CI 12.4-70.2). Moreover, systolic and diastolic blood pressure, and serum uric acid decreased significantly in the study group but not in the control group (mean [95% CI] between group differences 10.8 mm Hg [3.0-18.6], 5.0 mm Hg [0.9-9.2], and 83.1 mu mol/L [12.7-153.6], respectively). There were no changes in cholesterol or triglyceride concentrations in either group. Side-effects were reported by eight of the study patients. Three reversible episodes of acute graft rejection occurred in study patients during mycophenolate mofetil monotherapy, whereas none occurred in the control group. Interpretation Substitution of CNI by mycophenolate mofetil can improve renal function, blood pressure, and uric acid concentration of liver-transplant patients, but there is an increased rejection risk with mycophenolate mofetil monotherapy.	Med Hsch Hannover, Viszeral & Transplantat Chirurg Klin, D-30623 Hannover, Germany; Med Hsch Hannover, Gastroenterol & Hepatol Abt, D-30623 Hannover, Germany; Med Hsch Hannover, Biometrie Abt, D-30623 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Schlitt, HJ (corresponding author), Med Hsch Hannover, Viszeral & Transplantat Chirurg Klin, D-30623 Hannover, Germany.		Schlitt, Hans J./ABG-4368-2020; Baehr, Mathias/K-2188-2014; Nashan, Björn/H-9087-2019	Nashan, Björn/0000-0001-7587-9935; Bahr, Matthias J./0000-0001-6242-5299				Barkmann A, 2000, TRANSPLANTATION, V69, P1886, DOI 10.1097/00007890-200005150-00025; DISCHE FE, 1988, LAB INVEST, V58, P395; Falkenhain ME, 1996, TRANSPLANTATION, V62, P364, DOI 10.1097/00007890-199608150-00011; Fisher NC, 1998, TRANSPLANTATION, V66, P59, DOI 10.1097/00007890-199807150-00010; GRAHAM RM, 1994, CLEV CLIN J MED, V61, P308; HALL BM, 1988, NEW ENGL J MED, V318, P1499, DOI 10.1056/NEJM198806093182304; Herrero JI, 1999, LIVER TRANSPLANT SUR, V5, P414, DOI 10.1002/lt.500050513; HOLLANDER AAMJ, 1995, LANCET, V345, P610, DOI 10.1016/S0140-6736(95)90520-0; MCKENZIE N, 1985, HEART TRANSPLANT, V4, P400; Meiser BM, 1999, TRANSPLANTATION, V67, pS111, DOI 10.1097/00007890-199904150-00445; MORRIS PJ, 1987, LANCET, V1, P586; Papatheodoridis GV, 1999, TRANSPLANTATION, V68, P155, DOI 10.1097/00007890-199907150-00029; PERSSON H, 1994, TRANSPLANT INT, V7, P172, DOI 10.1007/BF00327083; PLATZ KP, 1994, TRANSPLANTATION, V58, P170, DOI 10.1097/00007890-199405820-00007; Romero F, 1999, KIDNEY INT, V55, P945, DOI 10.1046/j.1523-1755.1999.055003945.x; SANDBORN WJ, 1994, HEPATOLOGY, V19, P925; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; Wu John C., 1994, Perspectives in Drug Discovery and Design, V2, P185, DOI 10.1007/BF02171743	18	206	210	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					587	591		10.1016/S0140-6736(00)04055-1	http://dx.doi.org/10.1016/S0140-6736(00)04055-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558484				2022-12-28	WOS:000167119100010
J	LOGAN, GA; HAYES, JM; HIESHIMA, GB; SUMMONS, RE				LOGAN, GA; HAYES, JM; HIESHIMA, GB; SUMMONS, RE			TERMINAL PROTEROZOIC REORGANIZATION OF BIOGEOCHEMICAL CYCLES	NATURE			English	Article							CARBON ISOTOPE RATIOS; FOSSIL RECORD; ORGANIC-COMPOUNDS; WATER COLUMN	THE Proterozoic aeon (2,500-540 million years ago) saw episodic increases in atmospheric oxygen content(1), the evolution of multicellular life(2,3) and, at its close, an enormous radiation of animal diversity(3). These profound biological and environmental changes must have been linked, but the underlying mechanisms have been obscure, Here we show that hydrocarbons extracted from Proterozoic sediments in several locations worldwide are derived mainly from bacteria or other heterotrophs rather than from photosynthetic organisms, Biodegradation of algal products in sedimenting matter was therefore unusually complete, indicating that organic material was extensively reworked as it sank slowly through the water column, We propose that a significant proportion of this reworking will have been mediated by sulphate-reducing bacteria, forming sulphide, The production of sulphide and consumption of oxygen near the ocean surface will have inhibited transport of O-2 to the deep ocean, We find that preservation of algal-lipid skeletons improves at the beginning of the Cambrian, reflecting the increase in transport by rapidly sinking faecal pellets, We suggest that this rapid removal of organic matter will have increased oxygenation of surface waters, leading to a descent of the O-2-sulphide interface to the sea Boor and to marked changes in the marine environment, ultimately contributing to the Cambrian radiation.	INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA; GEOL SURVEY AUSTRALIA ORG, CANBERRA, ACT 2601, AUSTRALIA	Indiana University System; Indiana University Bloomington	LOGAN, GA (corresponding author), INDIANA UNIV, DEPT GEOL SCI, BIOGEOCHEM LABS, BLOOMINGTON, IN 47405 USA.		Summons, Roger Everett/AAL-3789-2020					ALT JC, 1993, EARTH PLANET SC LETT, V119, P477, DOI 10.1016/0012-821X(93)90057-G; [Anonymous], [No title captured]; BENDER ML, 1990, J GEOPHYS RES-OCEANS, V95, P22243, DOI 10.1029/JC095iC12p22243; Beukes N.J., 1992, PROTEROZOIC BIOSPHER, P147; BJOROY M, 1992, ORG GEOCHEM, V19, P89, DOI 10.1016/0146-6380(92)90029-W; BRASIER MD, 1992, J GEOL SOC LONDON, V149, P621, DOI 10.1144/gsjgs.149.4.0621; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; COLLISTER JW, 1992, THESIS INDIANA U; CRIMES TP, 1992, ANNU REV ECOL SYST, V23, P339, DOI 10.1146/annurev.es.23.110192.002011; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; GUTHRIE JM, 1994, THESIS INDIANA U; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; HAYES JM, 1993, MAR GEOL, V113, P111, DOI 10.1016/0025-3227(93)90153-M; HIESHIMA GB, 1992, THESIS INDIANA U; HOERING TC, 1965, YB CARNEGIE I WASH, V64, P215; HOERING TC, 1966, YB CARNEGIE I WASH, V65, P365; HOLLANDER DJ, 1993, ORG GEOCHEM, V20, P1253, DOI 10.1016/0146-6380(93)90013-2; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1993, PALAIOS, V8, P512, DOI 10.2307/3515029; KNOLL AH, 1992, NATURE, V356, P673, DOI 10.1038/356673a0; LAMBERT IB, 1990, STABLE ISOTOPE COMPO, P260; LIEN AY, 1983, GLOBAL BIOGEOCHEMICA, P95; LIPPS TH, 1992, ORIGIN EARLY EVOLUTI; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MOORE TB, 1992, PROTEROZOIC BIOSPHER, P605; MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0; NOTHOLT AJG, 1990, SPEC PUBL GEOL SOC L, V52; RAFF RA, 1970, NATURE, V228, P1003, DOI 10.1038/2281003a0; ROSS GM, IN PRESS PRECAMBR RE; Runnegar B, 1991, PALAEOGEOGR PALAEOCL, V97, P97, DOI 10.1016/0031-0182(91)90186-U; SCHOELL M, 1994, ORG GEOCHEM, V21, P713, DOI 10.1016/0146-6380(94)90014-0; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9	38	347	370	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	1995	376	6535					53	56		10.1038/376053a0	http://dx.doi.org/10.1038/376053a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH111	11536694				2022-12-28	WOS:A1995RH11100059
J	JENNISKENS, P; BLAKE, DF				JENNISKENS, P; BLAKE, DF			STRUCTURAL TRANSITIONS IN AMORPHOUS WATER ICE AND ASTROPHYSICAL IMPLICATIONS	SCIENCE			English	Article							SOLID WATER; INTERSTELLAR GRAINS; LIQUID WATER; VAPOR; PRESSURE; AMORPHIZATION; DIFFRACTION; BEHAVIOR; REGION; IH	Selected area electron diffraction is used to monitor structural changes of vapor-deposited water ice in vacuum during warm-up from 15 to 188 K. A progression of three amorphous forms of water ice is found with well-defined transitions. The formation of a high-density amorphous form (I(a)h) at 15 K is confirmed, and the transition to the more familiar low-density form (I(a)l) occurs gradually over the range 38 to 68 K. At 131 K, the ice transforms into a third amorphous form (I(a)r), which precedes the crystallization of cubic ice (I-c) and coexists metastably with I-c from 148 K until at least 188 K. These structural transformations of amorphous water ice can be used to explain hitherto anomalous properties of astrophysical ices. The structural transition from I(a)h to I(a)l is responsible for the diffusion and recombination of radicals in ultraviolet-photolyzed interstellar ices at low temperatures. The occurrence and persistence of I(a)r explains anomalous gas retention and gas release from water-rich ices at temperatures above 150 K.			JENNISKENS, P (corresponding author), NASA,AMES RES CTR,SPACE SCI MICROSCOPY LAB,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.							ALLEN LC, 1974, PHYSICS CHEM ICE, P13; BARATTA GA, 1990, ASTRON ASTROPHYS, V240, P429; BARNUN A, 1985, ICARUS, V63, P317, DOI 10.1016/0019-1035(85)90048-X; BIZID A, 1987, J CHEM PHYS, V87, P2225, DOI 10.1063/1.453149; BLAKE DF, 1991, MICROBEAM ANAL 1991, P293; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; FESTOU MC, 1993, ASTRON ASTROPHYS REV, V5, P37, DOI 10.1007/BF00872923; GHORMLEY JA, 1968, J CHEM PHYS, V48, P503, DOI 10.1063/1.1667954; GHORMLEY JA, 1967, J CHEM PHYS, V46, P1321, DOI 10.1063/1.1840851; GREENBERG JM, 1972, MEM SOC ROY SCI LI 6, V3, P425; GREENBERG JM, 1991, CHEM SPACE, P227; HAGEN W, 1979, ASTROPHYS SPACE SCI, V65, P215, DOI 10.1007/BF00643502; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HALLBRUCKER A, 1989, J PHYS CHEM-US, V93, P7751, DOI 10.1021/j100360a003; HALLBRUCKER A, 1991, ICARUS, V90, P176, DOI 10.1016/0019-1035(91)90078-8; HANDA YP, 1986, J CHEM PHYS, V84, P2766, DOI 10.1063/1.450301; HEIDE HG, 1985, ULTRAMICROSCOPY, V16, P151, DOI 10.1016/0304-3991(85)90070-1; HEIDE HG, 1984, ULTRAMICROSCOPY, V14, P271, DOI 10.1016/0304-3991(84)90095-0; JENNISKENS P, 1993, ASTRON ASTROPHYS, V273, P583; Jichen Li, 1993, Nature, V365, P327, DOI 10.1038/365327a0; KAMB B, 1973, WATER AQUEOUS SOLUTI, P9; KOUCHI A, 1990, J CRYST GROWTH, V99, P1220, DOI 10.1016/S0022-0248(08)80112-1; KOUCHI A, 1990, NATURE, V344, P134, DOI 10.1038/344134a0; KOUCHI A, 1987, NATURE, V330, P550, DOI 10.1038/330550a0; KOUCHI A, 1990, SP315 EUR SPAC AG, P193; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; NARTEN AH, 1976, J CHEM PHYS, V64, P1106, DOI 10.1063/1.432298; Pauling L., 1960, NATURE CHEM BOND, P449; POHORILLE A, 1987, J CHEM PHYS, V87, P6070, DOI 10.1063/1.453481; ROWLAND B, 1991, J CHEM PHYS, V95, P1378, DOI 10.1063/1.461119; SACK NJ, 1993, PHYS REV B, V48, P9973, DOI 10.1103/PhysRevB.48.9973; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; Sceats M.G., 1982, WATER COMPREHENSIVE, V7, P83; SCHMITT B, 1989, ESASP302, P65; SCHUTTE WA, 1988, THESIS U LEIDEN LEID; SCIORTINO F, 1992, J CHEM PHYS, V96, P3857, DOI 10.1063/1.461890; SCIORTINO F, 1991, NATURE, V354, P218, DOI 10.1038/354218a0; SIVAKUMAR TC, 1978, J CHEM PHYS, V69, P3468, DOI 10.1063/1.437079; SPEEDY RJ, 1992, J PHYS CHEM-US, V96, P2322, DOI 10.1021/j100184a056; TIELENS AGG, 1988, INTERSTELLAR DUST, V135, P239; TIELENS AGGM, 1983, J PHYS CHEM-US, V87, P4220, DOI 10.1021/j100244a049; TSE JS, 1992, J CHEM PHYS, V96, P5482, DOI 10.1063/1.462732	45	389	388	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					753	756		10.1126/science.11539186	http://dx.doi.org/10.1126/science.11539186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539186	Green Submitted			2022-12-28	WOS:A1994PA37200024
J	DIBROZOLO, FR; BUNCH, TE; FLEMING, RH; MACKLIN, J				DIBROZOLO, FR; BUNCH, TE; FLEMING, RH; MACKLIN, J			FULLERENES IN AN IMPACT CRATER ON THE LDEF SPACECRAFT	NATURE			English	Article							ENVIRONMENT; C-60	THE fullerenes C-60 (ref. 1) and C-70 have been found to occur naturally on Earth(2,3), and have also been invoked to explain features in the absorption spectra of interstellar clouds(1,4). But no definitive spectroscopic evidence exists for fullerenes in space and attempts to find fullerenes in carbonaceous chondrites have been unsuccessful(5,6), Here we report the observation of fullerenes associated with carbonaceous impact residue in a crater on the Long Duration Exposure Facility (LDEF) spacecraft. Laser ionization mass spectrometry and Raman spectroscopy indicate the presence of fullerenes in the crater and in adjacent ejecta. Man-made fullerenes survive experimental hypervelocity (similar to 6.1 km s(-1)) impacts into aluminium targets, suggesting that space fullerenes contained in a carbonaceous micrometeorite could have survived the LDEF impact at velocities towards the lower end of the natural particle encounter range (<13 km s(-1)). We also demonstrate that the fullerenes were unlikely to have formed as instrumental artefacts, nor are they present as contaminants. Although we cannot specify the origin of the fullerenes with certainty, the most plausible source is the chondritic impactor. If, alternatively, the impact produced the fullerenes in situ on LDEF, then this suggests a viable mechanism for fullerene production in space.	NASA, AMES RES CTR, PLANETARY BIOL BRANCH, MOFFETT FIELD, CA 94035 USA; UNIV WASHINGTON, DEPT CHEM, SEATTLE, WA 98195 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle	DIBROZOLO, FR (corresponding author), CHARLES EVANS & ASSOCIATES, REDWOOD CITY, CA 94063 USA.							BETHUNE DS, 1990, CHEM PHYS LETT, V174, P219, DOI 10.1016/0009-2614(90)85335-A; BROWNLEE DE, 1993, NASA CP3194 C P, P577; BUNCH TE, 1993, NASA CP3194 C P, P453; BUNCH TE, 1992, NASA CP3134 C P; BUSECK PR, 1992, SCIENCE, V257, P215, DOI 10.1126/science.257.5067.215; COOMBS CR, 1993, NASA CP3194 C P, P595; DALY CF, 1993, SCIENCE, V259, P1599; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; GILMOUR L, 1991, LUNAR PLANET SCI, V22, P445; HCELVANY SH, 1992, J AM SOC MASS SPECTR, V3, P268; HORZ F, 1992, NASA CP3134 C P, P487; KESSLER DJ, 1991, J SPACECRAFT ROCKETS, V28, P347, DOI 10.2514/3.26250; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P33; ONEAL RL, 1992, NASA CP3134 C P, P3; WEEKS S, 1990, LASERS MASS SPECTROM, P510; [No title captured]	17	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	1994	369	6475					37	40		10.1038/369037a0	http://dx.doi.org/10.1038/369037a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NJ860	11541208				2022-12-28	WOS:A1994NJ86000044
J	Blackburn, JM; Long, DP; Cabanas, A; Watkins, JJ				Blackburn, JM; Long, DP; Cabanas, A; Watkins, JJ			Deposition of conformal copper and nickel films from supercritical carbon dioxide	SCIENCE			English	Article							CHEMICAL FLUID DEPOSITION; REACTIVE DEPOSITION	Device-quality copper and nickel films were deposited onto planar and etched silicon substrates by the reduction of soluble organometallic compounds with hydrogen in a supercritical carbon dioxide solution. Exceptional step coverage on complex surfaces and complete filling of high-aspect-ratio features of less than 100 nanometers width were achieved. Nickel was deposited at 60 degreesC by the reduction of bis(cyclopentadienyl) nickel and copper was deposited from either copper(I) or copper(II) compounds onto the native oxide of silicon or metal nitrides with seed layers at temperatures up to 200 degreesC and directly on each surface at temperatures above 250 degreesC. The latter approach provides a single-step means for achieving high-aspect-ratio feature fill necessary for copper interconnect structures in future generations of integrated circuits.	Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Watkins, JJ (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.		Cabañas, Albertina/C-1776-2016	Cabañas, Albertina/0000-0001-7922-5752; Watkins, James/0000-0001-8302-825X				Blackburn JM, 2000, CHEM MATER, V12, P2625, DOI 10.1021/cm000118e; Hampden-Smith M.J., 1994, CHEM METAL CVD; Long DP, 2000, ADV MATER, V12, P913, DOI 10.1002/1521-4095(200006)12:12<913::AID-ADMA913>3.0.CO;2-#; Watkins JJ, 1999, CHEM MATER, V11, P213, DOI 10.1021/cm981016f; WATKINS JJ, 1998, Patent No. 5789027	5	364	421	4	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					141	145		10.1126/science.1064148	http://dx.doi.org/10.1126/science.1064148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11557842				2022-12-28	WOS:000171448800046
J	Pan, SH; O'Neal, JP; Badzey, RL; Chamon, C; Ding, H; Engelbrecht, JR; Wang, Z; Eisaki, H; Uchida, S; Guptak, AK; Ng, KW; Hudson, EW; Lang, KM; Davis, JC				Pan, SH; O'Neal, JP; Badzey, RL; Chamon, C; Ding, H; Engelbrecht, JR; Wang, Z; Eisaki, H; Uchida, S; Guptak, AK; Ng, KW; Hudson, EW; Lang, KM; Davis, JC			Microscopic electronic inhomogeneity in the high-T-c superconductor Bi2Sr2CaCu2O8+x	NATURE			English	Article							VORTEX CORES; SCATTERING; PSEUDOGAP; BEHAVIOR; DENSITY; SCALE	The parent compounds of the copper oxide high-transition-temperature (high-T-c) superconductors are unusual insulators (so-called Mott insulators). Superconductivity arises when they are 'doped' away from stoichiometry(1). For the compound Bi2Sr2CaCu2O8+x, doping is achieved by adding extra oxygen atoms, which introduce positive charge carriers ('holes') into the CuO2 planes where the superconductivity is believed to originate. Aside from providing the charge carriers, the role of the oxygen dopants is not well understood, nor is it clear how the charge carriers are distributed on the planes. Many models of high-T-c superconductivity accordingly assume that the introduced carriers are distributed uniformly, leading to an electronically homogeneous system as in ordinary metals. Here we report the presence of an electronic inhomogeneity in Bi2Sr2CaCu2O8+x, on the basis of observations using scanning tunnelling microscopy and spectroscopy. The inhomogeneity is manifested as spatial variations in both the local density of states spectrum and the superconducting energy gap. These variations are correlated spatially and vary on the surprisingly short length scale of similar to 14 Angstrom. Our analysis suggests that this inhomogeneity is a consequence of proximity to a Mott insulator resulting in poor screening of the charge potentials associated with the oxygen ions left in the BiO plane after doping, and is indicative of the local nature of the superconducting state.	Boston Univ, Dept Phys, Boston, MA 02215 USA; Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; Univ Tokyo, Dept Superconduct, Tokyo 1138656, Japan; Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Boston University; Boston College; University of Tokyo; University of Kentucky; University of California System; University of California Berkeley	Pan, SH (corresponding author), Boston Univ, Dept Phys, Boston, MA 02215 USA.		Hudson, Eric/C-2746-2008; Hudson, Eric/C-4170-2017; Eisaki, Hiroshi/F-6317-2018; Gupta, Anjan/E-3805-2010	Hudson, Eric/0000-0001-7064-0351; Hudson, Eric/0000-0001-7064-0351; Eisaki, Hiroshi/0000-0002-8299-6416; Gupta, Anjan/0000-0001-9430-300X; Ding, Hong/0000-0003-4422-9248; O'Neal, Jared/0000-0003-2603-7314; Chamon, Claudio/0000-0002-8275-2024				Anderson P. W., 1997, THEORY SUPERCONDUCTI; Bogdanov PV, 2000, PHYS REV LETT, V85, P2581, DOI 10.1103/PhysRevLett.85.2581; DING H, 2000, CONDMAT0006143; Feng DL, 2000, SCIENCE, V289, P277, DOI 10.1126/science.289.5477.277; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; HASEGAWA H, 1992, PHYSICAL PROPERTIES, pCH7; Hudson EW, 1999, SCIENCE, V285, P88, DOI 10.1126/science.285.5424.88; Ino A, 1998, PHYS REV LETT, V81, P2124, DOI 10.1103/PhysRevLett.81.2124; Kaminski A, 2000, PHYS REV LETT, V84, P1788, DOI 10.1103/PhysRevLett.84.1788; Miyakawa N, 1999, PHYS REV LETT, V83, P1018, DOI 10.1103/PhysRevLett.83.1018; PALSTRA TTM, 1988, PHYS REV B, V38, P5102, DOI 10.1103/PhysRevB.38.5102; Pan SH, 2000, PHYS REV LETT, V85, P1536, DOI 10.1103/PhysRevLett.85.1536; Pan SH, 2000, NATURE, V403, P746, DOI 10.1038/35001534; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; Valla T, 2000, PHYS REV LETT, V85, P828, DOI 10.1103/PhysRevLett.85.828; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; WOLF EL, 1994, J SUPERCOND, V7, P355, DOI 10.1007/BF00724568; ZHANG Y, 2000, CONDMAT0008140	19	743	750	3	191	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					282	285		10.1038/35095012	http://dx.doi.org/10.1038/35095012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565024	Green Submitted			2022-12-28	WOS:000171040500031
J	Owen, J; Yost, N; Berghella, V; Thom, E; Swain, M; Dildy, GA; Miodovnik, M; Langer, O; Sibai, B; McNellis, D				Owen, J; Yost, N; Berghella, V; Thom, E; Swain, M; Dildy, GA; Miodovnik, M; Langer, O; Sibai, B; McNellis, D		Natl Inst Child Hlth Human Dev Mat	Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ULTRASONOGRAPHIC CERVICAL LENGTH; TRANSVAGINAL ULTRASONOGRAPHY; PREMATURE DELIVERY; GESTATIONAL-AGE; UTERINE CERVIX; PREDICTION; PREVENTION; PREGNANCY; CERCLAGE; INCOMPETENCE	Context Although shortened cervical length has been consistently associated with spontaneous preterm birth, it is not known when in gestation this risk factor becomes apparent. Objective To determine whether sonographic cervical findings between 16 weeks' and 18 weeks 6 days' gestation predict spontaneous preterm birth and whether serial evaluations up to 23 weeks 6 days' gestation improve prediction in high-risk women. Design, Setting, and Participants Blinded observational study performed between March 1997 and November 1999 at 9 university-affiliated medical centers in the United States in 183 women with singleton gestations who previously had experienced a spontaneous birth before 32 weeks' gestation. Observation Certified sonologists performed 590 endovaginal sonographic examinations at 2-week intervals. Cervical length was measured from the external os to the functional internal os along a closed endocervical canal. Funneling and dynamic cervical shortening were also recorded. Main Outcome Measure Spontaneous preterm birth before 35 weeks' gestation, analyzed by selected cutoff values of cervical length. Results Forty-eight women (26%) experienced spontaneous preterm birth before 35 weeks' gestation. A cervical length of less than 25 mm at the initial sonographic examination was associated with a relative risk (RR) for spontaneous preterm birth of 3.3.(95% confidence interval [CI], 2.1-5.0; sensitivity=19%; specificity=98%; positive predictive value=75%). After controlling for cervical length, neither funneling (P=.24) nor dynamic shortening (P=.054) were significant independent predictors of spontaneous preterm birth. However, using the shortest ever observed cervical length on serial evaluations, after any dynamic shortening, the RR of a cervical length of less than 25 mm for spontaneous preterm birth increased to 4.5 (95% CI, 2.7-7.6; sensitivity=69%; specificity=80%; positive predictive value=55%). Compared with a single cervical measurement at 16 weeks' to 18 weeks 6 days' gestation, serial measurements at up to 23 weeks 6 days significantly improved the prediction of spontaneous preterm birth in a receiver operating characteristic curve analysis (P=.03). Conclusions Cervical length assessed by endovaginal sonography between 16 weeks' and 18 weeks 6 days' gestation, augmented by serial evaluations, predicts spontaneous preterm birth before 35 weeks' gestation in high-risk women.	Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35249 USA; Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Dallas, TX 75235 USA; Thomas Jefferson Univ, Dept Obstet & Gynecol, Philadelphia, PA 19107 USA; George Washington Univ, Ctr Biostat, Bethesda, MD USA; Wake Forest Univ, Dept Obstet & Gynecol, Winston Salem, NC 27109 USA; Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH 45221 USA; Univ Texas, Dept Obstet & Gynecol, San Antonio, TX 78285 USA; Univ Tennessee, Dept Obstet & Gynecol, Memphis, TN USA; NICHHD, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Jefferson University; George Washington University; Wake Forest University; Utah System of Higher Education; University of Utah; University System of Ohio; University of Cincinnati; University of Texas System; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Owen, J (corresponding author), Univ Alabama, Dept Obstet & Gynecol, 619 19th St S,OHB 458, Birmingham, AL 35249 USA.			Dildy, Gary/0000-0003-1586-4357; Berghella, Vincenzo/0000-0003-2854-0239	NICHD NIH HHS [HD36801, HD34208, HD27860, HD34201, HD34136, HD27869, HD34116, HD27905, HD21414] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD034208, UG1HD027869, U10HD036801, UG1HD034116, U10HD034116, UG1HD034208, U10HD027869] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021414, U01HD036801, U10HD027860, U10HD027905, U01HD021414, U10HD034136] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Althuisius SM, 2000, AM J OBSTET GYNECOL, V183, P823, DOI 10.1067/mob.2000.108874; ANDERSEN HF, 1990, AM J OBSTET GYNECOL, V163, P859, DOI 10.1016/0002-9378(90)91084-P; ANDERSEN HF, 1991, J CLIN ULTRASOUND, V19, P77, DOI 10.1002/jcu.1870190204; Andrews WW, 2000, OBSTET GYNECOL, V95, P222, DOI 10.1016/S0029-7844(99)00483-4; AYERS JWT, 1988, OBSTET GYNECOL, V71, P939; Berghella V, 1999, AM J OBSTET GYNECOL, V181, P809, DOI 10.1016/S0002-9378(99)70306-6; Berghella V, 1997, ULTRASOUND OBST GYN, V10, P161, DOI 10.1046/j.1469-0705.1997.10030161.x; Berghella V, 1997, AM J OBSTET GYNECOL, V177, P723, DOI 10.1016/S0002-9378(97)70259-X; BUCKINGHAM JC, 1965, AM J OBSTET GYNECOL, V91, P232, DOI 10.1016/0002-9378(65)90205-X; Burger M, 1997, ULTRASOUND OBST GYN, V9, P188, DOI 10.1046/j.1469-0705.1997.09030188.x; Cook CM, 2000, ULTRASOUND OBST GYN, V15, P109, DOI 10.1046/j.1469-0705.2000.00050.x; Craigo SD, 1996, NEW ENGL J MED, V334, P595, DOI 10.1056/NEJM199602293340910; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; GOLDENBERG RL, 1993, OBSTET GYNECOL, V81, P444; GUZMAN ER, 1994, OBSTET GYNECOL, V83, P248; Guzman ER, 1998, OBSTET GYNECOL, V92, P31, DOI 10.1016/S0029-7844(98)00120-3; Hassan SS, 2001, AM J OBSTET GYNECOL, V184, P1325, DOI 10.1067/mob.2001.115119; Hassan SS, 2000, AM J OBSTET GYNECOL, V182, P1458, DOI 10.1067/mob.2000.106851; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; Iams JD, 1997, ULTRASOUND OBST GYN, V10, P156, DOI 10.1046/j.1469-0705.1997.10030156.x; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; OKITSU O, 1992, ULTRASOUND OBST GYN, V2, P402, DOI 10.1046/j.1469-0705.1992.02060402.x; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; Rust OA, 2000, AM J OBSTET GYNECOL, V183, P830, DOI 10.1067/mob.2000.109040; Seubert DE, 1999, AM J OBSTET GYNECOL, V181, P1087, DOI 10.1016/S0002-9378(99)70086-4; Taipale P, 1998, OBSTET GYNECOL, V92, P902, DOI 10.1016/S0029-7844(98)00346-9; TONGSONG T, 1995, OBSTET GYNECOL, V86, P184, DOI 10.1016/0029-7844(95)00152-H; TUCKER JM, 1991, OBSTET GYNECOL, V77, P343; Ventura S. J., 1997, MONTHLY VITAL STAT R, V45, P1; Watson W J, 1999, J Matern Fetal Med, V8, P17, DOI 10.1002/(SICI)1520-6661(199901/02)8:1<17::AID-MFM4>3.0.CO;2-R	32	292	307	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1340	1348		10.1001/jama.286.11.1340	http://dx.doi.org/10.1001/jama.286.11.1340			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560539	Bronze			2022-12-28	WOS:000171024500027
J	Rabow, MW; Markowitz, AJ				Rabow, MW; Markowitz, AJ			Serving patients who may die soon and their families	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article														Markowitz, Amy/0000-0001-9314-2814				Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925	1	1	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1377	1377		10.1001/jama.286.11.1377	http://dx.doi.org/10.1001/jama.286.11.1377			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560544				2022-12-28	WOS:000171024500032
J	Schoenbaum, M; Unutzer, J; Sherbourne, C; Duan, NH; Rubenstein, LV; Miranda, J; Meredith, LS; Carney, MF; Wells, K				Schoenbaum, M; Unutzer, J; Sherbourne, C; Duan, NH; Rubenstein, LV; Miranda, J; Meredith, LS; Carney, MF; Wells, K			Cost-effectiveness of practice-initiated quality improvement for depression - Results of a randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE PRACTICES; MANAGED PRIMARY-CARE; MAJOR DEPRESSION; HEALTH; OUTCOMES; UTILITIES; IMPACT; SF-12; LIFE	Context Depression is a leading cause of disability worldwide, but treatment rates in primary care are low. Objective To determine the cost-effectiveness from a societal perspective of 2 quality improvement (QI) interventions to improve treatment of depression in primary care and their effects on patient employment. Design Group-level randomized controlled trial conducted June 1996 to July 1999. Setting Forty-six primary care clinics in 6-community-based managed care organizations. Participants One hundred eighty-one primary care clinicians and 1356 patients with positive screening results for current depression. Interventions Matched practices were randomly assigned to provide usual care (n=443 patients) or to 1 of 2 QI interventions offering training to practice leaders and nurses, enhanced educational and assessment resources, and either nurses for medication follow-up (QI-meds; n=424 patients) or trained local psychotherapists (QI-therapy; n=489). Practices could flexibly implement the interventions, which did not assign type of treatment. Main Outcome Measures Total health care costs, costs per quality-adjusted life-year (QALY), days with depression burden, and employment over 24 months, compared between usual care and the 2 interventions. Results Relative to usual care, average health care costs increased $419 (11%) in QI-meds (P=.35) and $485 (13%) in QI-therapy (P=.28); estimated costs per QALY gained were between $15331 and $36467 for QI-meds and $9478 and $21478 for QI-therapy; and patients had 25 (P=.19) and 47 (P=.01) fewer days with depression burden and were employed 17.9 (P=.07) and 20.9 (P=.03) more days during the study period. Conclusions Societal cost-effectiveness of practice-initiated QI efforts for depression is comparable with that of accepted medical interventions. The intervention effects on employment may be of particular interest to employers and other stakeholders.	RAND Corp, Hlth Program, Arlington, VA 22202 USA; RAND Corp, Hlth Program, Santa Monica, CA USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90024 USA; Sepulveda VA Med Ctr, HSR&D Ctr Excellence Study Healthcare Provider Be, Sepulveda, CA USA	RAND Corporation; RAND Corporation; University of California System; University of California Los Angeles	Schoenbaum, M (corresponding author), RAND Corp, Hlth Program, 1200 S Hayes St, Arlington, VA 22202 USA.		Schoenbaum, Michael/GRR-3988-2022; Unutzer, Jurgen/N-4048-2018	Duan, Naihua/0000-0001-9411-2924	AHRQ HHS [R01-HS08349] Funding Source: Medline; NIMH NIH HHS [MH01170-05, P50 MH54623, 5R01 MH57992] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057992, K05MH001170, P50MH054623] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 1997, COMP INT DIAGN INT C; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1996, COST EFFECTIVENESS H; Henk HJ, 1996, ARCH GEN PSYCHIAT, V53, P899; Hunkeler EM, 2000, ARCH FAM MED, V9, P700, DOI 10.1001/archfami.9.8.700; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Keeler EB, 2001, J HEALTH ECON, V20, P141, DOI 10.1016/S0167-6296(00)00070-9; Lave JR, 1998, ARCH GEN PSYCHIAT, V55, P645, DOI 10.1001/archpsyc.55.7.645; Lenert LA, 2000, MED CARE, V38, P763, DOI 10.1097/00005650-200007000-00008; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; MILLER RG, 1981, SIMULTANEOUS STAT IN; MUNOZ RF, 2000, MR11984 RAND; MUNOZ RF, 2000, MR11985 RAND; Pyne JM, 1997, PSYCHOPHARMACOL BULL, V33, P23; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Revicki DA, 1998, J AFFECT DISORDERS, V48, P25, DOI 10.1016/S0165-0327(97)00117-1; Rubenstein LV, 1999, HEALTH AFFAIR, V18, P89, DOI 10.1377/hlthaff.18.5.89; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P181, DOI 10.1001/archpsyc.58.2.181; Simon GE, 1999, PSYCHIATR SERV, V50, P1303, DOI 10.1176/ps.50.10.1303; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Sturm R, 1999, GEN HOSP PSYCHIAT, V21, P274, DOI 10.1016/S0163-8343(99)00024-9; STURM R, 1995, JAMA-J AM MED ASSOC, V273, P51; Sugar CA, 1998, HEALTH SERV RES, V33, P911; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Unutzer J, 2000, INT PSYCHOGERIATR, V12, P15, DOI 10.1017/S1041610200006177; Von Korff M, 1998, PSYCHOSOM MED, V60, P143, DOI 10.1097/00006842-199803000-00005; WELLS K, 1996, CARING DEPRESSION; Wells KB, 1999, ARCH GEN PSYCHIAT, V56, P897, DOI 10.1001/archpsyc.56.10.897; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	43	257	257	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1325	1330		10.1001/jama.286.11.1325	http://dx.doi.org/10.1001/jama.286.11.1325			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DJ	11560537	Bronze			2022-12-28	WOS:000171024500025
J	Yoon, JC; Puigserver, P; Chen, GX; Donovan, J; Wu, ZD; Rhee, J; Adelmant, G; Stafford, J; Kahn, CR; Granner, DK; Newgard, CB; Spiegelman, BM				Yoon, JC; Puigserver, P; Chen, GX; Donovan, J; Wu, ZD; Rhee, J; Adelmant, G; Stafford, J; Kahn, CR; Granner, DK; Newgard, CB; Spiegelman, BM			Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT; RECEPTOR-GAMMA COACTIVATOR-1; RESPONSE UNIT; GLUCOCORTICOID RESPONSE; NUCLEAR RECEPTORS; METABOLIC IMPACT; CAMP INDUCTION; BINDING-SITES; GTP GENE	Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4 alpha (hepatic nuclear factor-4 alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dept Biochem, Dallas, TX USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dept Internal Med, Dallas, TX USA; Vanderbilt Univ, Dept Mol Biol & Biophys, Sch Med, Nashville, TN 37232 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Kahn, Ronald/AAY-2435-2021; Rhee, James/V-9973-2019; Stafford, John/K-7763-2017	Kahn, Ronald/0000-0002-7583-9228; Wu, Zhidan/0000-0001-7289-9420; Stafford, John/0000-0001-6527-959X				Antinozzi PA, 1999, ANNU REV NUTR, V19, P511, DOI 10.1146/annurev.nutr.19.1.511; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DeFronzo RA, 1997, DIABETES REV, V5, P177; Glass CK, 2000, GENE DEV, V14, P121; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; McNeill J. H, 1999, EXPT MODELS DIABETES; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROESLER WJ, 1994, J BIOL CHEM, V269, P14276; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeagley D, 1998, J BIOL CHEM, V273, P18743, DOI 10.1074/jbc.273.30.18743	33	1443	1524	4	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					131	138		10.1038/35093050	http://dx.doi.org/10.1038/35093050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557972				2022-12-28	WOS:000170918800038
J	Schwetz, BA				Schwetz, BA			Novel imaging device	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-28	WOS:000170910400005
J	Baganoff, FK; Bautz, MW; Brandt, WN; Chartas, G; Feigelson, ED; Garmire, GP; Maeda, Y; Morris, M; Ricker, GR; Townsley, LK; Walter, F				Baganoff, FK; Bautz, MW; Brandt, WN; Chartas, G; Feigelson, ED; Garmire, GP; Maeda, Y; Morris, M; Ricker, GR; Townsley, LK; Walter, F			Rapid X-ray flaring from the direction of the supermassive black hole at the Galactic Centre	NATURE			English	Article							SAGITTARIUS-A-ASTERISK; ADVECTION-DOMINATED ACCRETION; SPECTRAL MODELS; VARIABILITY; MILLIMETER; RADIO; STARS; DUST	The nuclei of most galaxies are now believed to harbour supermassive black holes(1). The motions of stars in the central few light years of our Milky Way Galaxy indicate the presence of a dark object with a mass of about 2.6 x 10(6) solar masses (refs 2, 3). This object is spatially coincident with the compact radio source Sagittarius A* (Sgr A*) at the dynamical centre of the Galaxy, and the radio emission is thought to be powered by the gravitational potential energy released by matter as it accretes onto a supermassive black hole(4,5). Sgr A* is, however, much fainter than expected at all wavelengths, especially in X-rays, which has cast some doubt on this model. The first strong evidence for X-ray emission was found only recently(6). Here we report the discovery of rapid X-ray flaring from the direction of Sgr A*, which, together with the previously reported steady X-ray emission, provides compelling evidence that the emission is coming from the accretion of gas onto a supermassive black hole at the Galactic Centre.	MIT, Ctr Space Res, Cambridge, MA 02139 USA; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298501, Japan; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; CALTECH, Dept Astron, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of California System; University of California Los Angeles; California Institute of Technology	Baganoff, FK (corresponding author), MIT, Ctr Space Res, Cambridge, MA 02139 USA.	fkb@space.mit.edu	Brandt, William N/N-2844-2015	Brandt, William N/0000-0002-0167-2453; Baganoff, Frederick/0000-0003-3852-6545; Morris, Mark/0000-0002-6753-2066; Walter, Fabian/0000-0003-4793-7880				BAGANOFF FK, 2001, UNPUB ASTROPHYS J; Ball GH, 2001, ASTROPHYS J, V552, P221, DOI 10.1086/320465; Blandford RD, 1999, MON NOT R ASTRON SOC, V303, pL1, DOI 10.1046/j.1365-8711.1999.02358.x; Davies MB, 1998, MON NOT R ASTRON SOC, V301, P745, DOI 10.1046/j.1365-8711.1998.02027.x; Falcke H, 2000, ASTRON ASTROPHYS, V362, P113; Falcke H, 1998, ASTROPHYS J, V499, P731, DOI 10.1086/305687; Genzel R, 2000, MON NOT R ASTRON SOC, V317, P348, DOI 10.1046/j.1365-8711.2000.03582.x; Ghez AM, 2000, NATURE, V407, P349, DOI 10.1038/35030032; Haardt F, 1997, ASTROPHYS J, V476, P620, DOI 10.1086/303656; LYNDENBELL D, 1971, MON NOT R ASTRON SOC, V152, P461, DOI 10.1093/mnras/152.4.461; MELIA F, 1994, ASTROPHYS J, V426, P577, DOI 10.1086/174094; Melia F, 2001, ANNU REV ASTRON ASTR, V39, P309, DOI 10.1146/annurev.astro.39.1.309; Melia F, 2000, ASTROPHYS J, V545, pL117, DOI 10.1086/317888; Menten KM, 1997, ASTROPHYS J, V475, pL111, DOI 10.1086/310472; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; MUSHOTZKY RF, 1993, ANNU REV ASTRON ASTR, V31, P717; Nandra K, 1997, ASTROPHYS J, V476, P70, DOI 10.1086/303600; Narayan R, 1998, ASTROPHYS J, V492, P554, DOI 10.1086/305070; PREDEHL P, 1995, ASTRON ASTROPHYS, V293, P889; Ptak A, 1998, ASTROPHYS J, V501, pL37, DOI 10.1086/311444; Quataert E, 1999, ASTROPHYS J, V520, P298, DOI 10.1086/307439; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; REID MJ, 1993, ANNU REV ASTRON ASTR, V31, P345; Richstone D, 1998, NATURE, V395, pA14; Serabyn E, 1997, ASTROPHYS J, V490, pL77, DOI 10.1086/311010; Tsuboi M, 1999, ASTR SOC P, V186, P105; Weisskopf MC, 1996, PROC SPIE, V2805, P2, DOI 10.1117/12.245079; WRIGHT MCH, 1993, ASTROPHYS J, V417, P560, DOI 10.1086/173335; Zhao JH, 2001, ASTROPHYS J, V547, pL29, DOI 10.1086/318877	30	496	499	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					45	48		10.1038/35092510	http://dx.doi.org/10.1038/35092510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544519				2022-12-28	WOS:000170801200032
J	Tillmann, HL; Heiken, H; Knapik-Botor, A; Heringlake, S; Ockenga, J; Wilber, JC; Goergen, B; Detmer, J; McMorrow, M; Stoll, M; Schmidt, RE; Manns, MP				Tillmann, HL; Heiken, H; Knapik-Botor, A; Heringlake, S; Ockenga, J; Wilber, JC; Goergen, B; Detmer, J; McMorrow, M; Stoll, M; Schmidt, RE; Manns, MP			Infection with GB virus C and reduced mortality among HIV-infected patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; CLINICAL PROGRESSION; NATURAL-HISTORY; HOMOSEXUAL MEN; LIVER-DISEASE; COINFECTION; ANTIBODIES; COHORT	Background: The flavivirus GB virus C (GBV-C, also designated hepatitis G virus) was identified in a search for hepatitis viruses, but no disease is currently known to be associated with it. We investigated the relation between coinfection with GBV-C and the long-term outcome in patients infected with the human immunodeficiency virus (HIV). Methods: A total of 197 HIV-positive patients were followed prospectively beginning in 1993 or 1994. Of these patients, 33 (16.8 percent) tested positive for GBV-C RNA, 112 (56.9 percent) had detectable antibodies against the GBV-C envelope protein E2, and 52 (26.4 percent) had no marker of GBV-C infection and were considered unexposed. We assessed the relation between GBV-C infection and the progression of HIV disease. We also tested 169 GBV-C-positive plasma samples with a quantitative branched-chain DNA (bDNA) assay in order to investigate possible correlations between GBV-C viral load and both the CD4+ cell count and the HIV load. Results: Among the patients who tested positive for GBV-C RNA, survival was significantly longer, and there was a slower progression to the acquired immunodeficiency syndrome (AIDS) (P<0.001 for both comparisons). Survival after the development of AIDS was also better among the GBV-C-positive patients. The association of GBV-C viremia with reduced mortality remained significant in analyses stratified according to age and CD4+ cell count. In an analysis restricted to the years after highly active antiretroviral therapy became available, the presence of GBV-C RNA remained predictive of longer survival (P=0.02). The HIV load was lower in the GBV-C-positive patients than in the GBV-C-negative patients. The GBV-C load correlated inversely with the HIV load (r=-0.33, P<0.001) but did not correlate with the CD4+ cell count. Conclusions: Coinfection with GBV-C is associated with a reduced mortality rate in HIV-infected patients. GBV-C is not known to cause any disease, but it is possible that its presence leads to an inhibition of HIV replication. However, GBV-C infection could also be a marker for the presence of other factors that lead to a favorable HIV response.	Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany; Hannover Med Sch, Dept Clin Immunol, D-30623 Hannover, Germany; Bayer Diagnost, Emeryville, CA USA	Hannover Medical School; Hannover Medical School; Bayer AG	Tillmann, HL (corresponding author), Hannover Med Sch, Dept Gastroenterol & Hepatol, Neuberg Str 1, D-30623 Hannover, Germany.							Alter HJ, 1996, NEW ENGL J MED, V334, P1536, DOI 10.1056/NEJM199606063342310; BARTHOLOMEW C, 1987, LANCET, V2, P1469; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Casoli C, 2000, BLOOD, V95, P2760, DOI 10.1182/blood.V95.9.2760.009k04_2760_2769; Dille BJ, 1997, J INFECT DIS, V175, P458, DOI 10.1093/infdis/175.2.458; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Fischer HP, 1996, J HEPATOL, V24, P35; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Lesens O, 1999, J INFECT DIS, V179, P1254, DOI 10.1086/314720; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; MARTIN P, 1989, GASTROENTEROLOGY, V97, P1559, DOI 10.1016/0016-5085(89)90405-8; MCNAIR ANB, 1992, SEMIN LIVER DIS, V12, P188, DOI 10.1055/s-2007-1007390; Ockenga J, 1997, J HEPATOL, V27, P18, DOI 10.1016/S0168-8278(97)80274-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pol S, 1998, J HEPATOL, V29, P12, DOI 10.1016/S0168-8278(98)80173-6; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Rambusch EG, 1998, Z GASTROENTEROL, V36, P41; Sabin CA, 1998, J ACQ IMMUN DEF SYND, V19, P546, DOI 10.1097/00042560-199812150-00016; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sherlock S, 1999, J VIRAL HEPATITIS, V6, P1, DOI 10.1046/j.1365-2893.1999.00007.x; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; TELFER P, 1994, BRIT J HAEMATOL, V87, P555, DOI 10.1111/j.1365-2141.1994.tb08312.x; Tillmann HL, 1998, HEPATOLOGY, V28, P379, DOI 10.1002/hep.510280213; TILLMANN HL, IN PRESS ANTIVIRAL R; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Wachtler M, 2000, INFECTION, V28, P297, DOI 10.1007/s150100070022; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006	32	300	323	1	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					715	724		10.1056/NEJMoa010398	http://dx.doi.org/10.1056/NEJMoa010398			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547740	Bronze			2022-12-28	WOS:000170772900002
J	van den Ent, F; Amos, LA; Lowe, J				van den Ent, F; Amos, LA; Lowe, J			Prokaryotic origin of the actin cytoskeleton	NATURE			English	Article							F-ACTIN; CRYSTAL-STRUCTURE; ATPASE FRAGMENT; ATOMIC MODEL; CELL-SHAPE; PROTEINS; DOMAIN; REFINEMENT; PARAMETERS; SEQUENCE	It was thought until recently that bacteria lack the actin or tubulin filament networks that organize eukaryotic cytoplasm. However, we show here that the bacterial MreB protein assembles into filaments with a subunit repeat similar to that of F-actin-the physiological polymer of eukaryotic actin. By elucidating the MreB crystal structure we demonstrate that MreB and actin are very similar in three dimensions. Moreover, the crystals contain protofilaments, allowing visualization of actin-like strands at atomic resolution. The structure of the MreB protofilament is in remarkably good agreement with the model for F-actin, showing that the proteins assemble in identical orientations. The actin-like properties of MreB explain the finding that MreB forms large fibrous spirals under the cell membrane of rod-shaped cells, where they are involved in cell-shape determination. Thus, prokaryotes are now known to possess homologues both of tubulin, namely FtsZ, and of actin.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	van den Ent, F (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	fent@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Löwe, Jan/B-3882-2011	Amos, Linda/0000-0001-8305-5346; Lowe, Jan/0000-0002-5218-6615				AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; ANDERSON PK, 1978, AUST WILDLIFE RES, V5, P1; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, RECENT CHANGES MOSFL; LEVIN PA, 1992, J BACTERIOL, V174, P6717, DOI 10.1128/JB.174.21.6717-6728.1992; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717; Straub F.B., 1942, STUDIES I MED CHEM U, P3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; TURK D, 1992, THESIS TU MUNCHEN; van den Ent F, 1999, STRUCTURE, V7, P1181, DOI 10.1016/S0969-2126(00)80052-0; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987	39	591	606	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					39	44		10.1038/35092500	http://dx.doi.org/10.1038/35092500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544518				2022-12-28	WOS:000170801200031
J	Jaeger, NI				Jaeger, NI			Surface science - Bridging gaps and opening windows	SCIENCE			English	Editorial Material							SUM-FREQUENCY GENERATION; CATALYTIC REACTIONS; PRESSURE		Univ Bremen, Inst Angew & Phys Chem, D-28334 Bremen, Germany	University of Bremen	Jaeger, NI (corresponding author), Univ Bremen, Inst Angew & Phys Chem, FB2, D-28334 Bremen, Germany.							Cremer PS, 1996, J PHYS CHEM-US, V100, P16302, DOI 10.1021/jp9613394; Dellwig T, 2000, PHYS REV LETT, V85, P776, DOI 10.1103/PhysRevLett.85.776; Kim M, 2001, SCIENCE, V292, P1357, DOI 10.1126/science.1059478; KIRSCHER K, 1999, MOD ASPECT ELECTROC, V32, P1; Li YJ, 2001, SCIENCE, V291, P2395, DOI 10.1126/science.1057830; Sachs C, 2001, SCIENCE, V293, P1635, DOI 10.1126/science.1062883; Sankar G, 1999, TOP CATAL, V8, P1, DOI 10.1023/A:1019188422574; Schutz E, 1998, CATAL LETT, V54, P181, DOI 10.1023/A:1019025316038; Somorjai GA, 1999, J PHYS CHEM B, V103, P1623, DOI 10.1021/jp983721h; Wang W, 2000, CHAOS, V10, P248, DOI 10.1063/1.166470	10	17	17	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1601	1602		10.1126/science.1064595	http://dx.doi.org/10.1126/science.1064595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533465				2022-12-28	WOS:000170802900035
J	Ezzati, M; Kammen, DM				Ezzati, M; Kammen, DM			Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study	LANCET			English	Article							DOMESTIC SMOKE POLLUTION; YOUNG GAMBIAN CHILDREN; DEVELOPING-COUNTRIES; RURAL-COMMUNITY; HILL REGION; EMISSIONS; HEALTH; WOMEN; NEPAL	Background Acute respiratory infections (ARI) are the leading cause of the global burden of disease and have been causally linked with exposure to pollutants from domestic biomass fuels in less-developed countries. We used longitudinal health data coupled with detailed monitoring of personal exposure from more than 2 years of field measurements in rural Kenya to estimate the exposure-response relation for particulates smaller than 10 mum in diameter (PM10) generated from biomass combustion. Methods 55 randomly-selected households (including 93 infants and children, 229 individuals between 5 and 49 years of age, and 23 aged 50 or older) in central Kenya were followed up for more than 2 years. Longitudinal data on ARI and acute lower respiratory infections (ALRI) were recorded at weekly clinical examinations. Exposure to PM10 was monitored by measurement of PM10 emission concentration and time-activity budgets. Findings With the best estimate of the exposure-response relation, we found that ARI and ALRI are increasing concave functions of average daily exposure to PM10, with the rate of increase declining for exposures above about 1000-2000 mug/m(3). After we had included high-intensity exposure episodes, sex was no longer a significant predictor of ARI and ALRI. Interpretation The benefits of reduced exposure to PM10 are larger for average exposure less than about 1000-2000 mug/m(3). Our findings have important consequences for international public-health policies, energy and combustion research, and technology transfer efforts that affect more than 2 billion people worldwide.	Resources Future Inc, Ctr Risk Management, Washington, DC 20036 USA; WHO, Global Programme Evidence Hlth Policy, Epidemiol & Burden Dis Unit, CH-1211 Geneva, Switzerland; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	Resources for the Future; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Resources Future Inc, Ctr Risk Management, 1616 P St NW, Washington, DC 20036 USA.							ARMSTRONG JRM, 1991, INT J EPIDEMIOL, V20, P424, DOI 10.1093/ije/20.2.424; Awasthi S, 1996, AM J TROP MED HYG, V55, P48, DOI 10.4269/ajtmh.1996.55.48; BallardTremeer G, 1996, BIOMASS BIOENERG, V11, P419, DOI 10.1016/S0961-9534(96)00040-2; Barnes D. F., 1994, WHAT MAKES PEOPLE CO; BERMAN S, 1991, REV INFECT DIS, V13, pS454; BOLEIJ JSM, 1989, ATMOS ENVIRON, V23, P1677, DOI 10.1016/0004-6981(89)90052-8; Bruce N, 1998, INT J EPIDEMIOL, V27, P454, DOI 10.1093/ije/27.3.454; Campbell H, 1997, Health Bull (Edinb), V55, P20; CERQUEIRO MC, 1990, REV INFECT DIS, V12, pS1021; CHEN B H, 1990, World Health Statistics Quarterly, V43, P127; CRUZ JR, 1990, REV INFECT DIS, V12, pS1029; DEFRANCISCO A, 1993, INT J EPIDEMIOL, V22, P1174, DOI 10.1093/ije/22.6.1174; Ellegard A, 1996, ENVIRON HEALTH PERSP, V104, P980, DOI 10.2307/3433146; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; Ezzati M, 2000, ENVIRON SCI TECHNOL, V34, P578, DOI 10.1021/es9905795; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; OYEJIDE CO, 1990, REV INFECT DIS, V12, pS1042; PANDEY MR, 1984, THORAX, V39, P337, DOI 10.1136/thx.39.5.337; PANDEY MR, 1989, ENVIRON INT, V15, P337, DOI 10.1016/0160-4120(89)90046-9; SAKSENA S, 1992, ATMOS ENVIRON A-GEN, V26, P2125, DOI 10.1016/0960-1686(92)90096-4; Sharma S, 1998, ENVIRON HEALTH PERSP, V106, P291, DOI 10.2307/3434017; Smith K.R, 1988, ENVIRONMENT, V30, P16, DOI 10.1080/00139157.1988.9930921; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; SMITH KR, 1993, ANNU REV ENERG ENV, V18, P529, DOI 10.1146/annurev.eg.18.110193.002525; STANEK EJ, 1994, CLIN INFECT DIS, V18, P639, DOI 10.1093/clinids/18.4.639; *WHO, 1998, WORLD HLTH REP; Wilson R., 1996, PARTICLES OUR AIR CO; World Health Organization, 2000, HLTH SYST IMPR PERF; World Health Organization , 1999, WORLD HLTH REP 1999; World Health Organization, 1990, AC RESP INF CHILDR C	30	316	332	1	58	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					619	624		10.1016/S0140-6736(01)05777-4	http://dx.doi.org/10.1016/S0140-6736(01)05777-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530148				2022-12-28	WOS:000170615500009
J	Dummer, R				Dummer, R			Clinical picture: Hair repigmentation in lentigo maligna	LANCET			English	Article									Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Dummer, R (corresponding author), Univ Zurich Hosp, Dept Dermatol, Gloriastr 31, CH-8091 Zurich, Switzerland.								0	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					598	598		10.1016/S0140-6736(00)04059-9	http://dx.doi.org/10.1016/S0140-6736(00)04059-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558486				2022-12-28	WOS:000167119100012
J	VanCappellen, P; Ingall, ED				VanCappellen, P; Ingall, ED			Redox stabilization of the atmosphere and oceans by phosphorus-limited marine productivity	SCIENCE			English	Article							OXYGEN; CARBON; PRESERVATION; WATER; TIME	Data from modern and ancient marine sediments demonstrate that burial of the limiting nutrient phosphorus is less efficient when bottom waters are low in oxygen. Mass-balance calculations using a coupled model of the biogeochemical cycles of carbon, phosphorus, oxygen, and iran indicate that the redox dependence of phosphorus burial in the oceans provides a powerful forcing mechanism for balancing production and consumption of atmospheric oxygen over geologic time. The oxygen-phosphorus coupling further guards against runaway ocean anoxia. Phosphorus-mediated redox stabilization of the atmosphere and oceans may have been crucial to the radiation of higher life forms during the Phanerozoic.	UNIV TEXAS,INST MARINE SCI,PORT ARANSAS,TX 78373	University of Texas System	VanCappellen, P (corresponding author), GEORGIA INST TECHNOL,SCH EARTH & ATMOSPHER SCI,ATLANTA,GA 30332, USA.		Van Cappellen, Philippe/A-2906-2013; Ingall, Ellery/A-5447-2008	Van Cappellen, Philippe/0000-0001-5476-0820; Ingall, Ellery/0000-0003-1954-0317	NCIPC CDC HHS [OCE94-15563] Funding Source: Medline	NCIPC CDC HHS		BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BERNER RA, 1989, PALAEOGEOGR PALAEOCL, V75, P97, DOI DOI 10.1016/0031-0182(89)90186-7; Broecker W.S., 1982, TRACERS SEA; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; FILIPPELLI GM, 1994, PALEOCEANOGRAPHY, V9, P643, DOI 10.1029/94PA01453; FOLLMI KB, 1995, GEOLOGY, V23, P859, DOI 10.1130/0091-7613(1995)023<0859:MYROMS>2.3.CO;2; HERBERT TD, 1991, GEOLOGY, V19, P702, DOI 10.1130/0091-7613(1991)019<0702:ONDAOL>2.3.CO;2; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; HOLLAND HD, 1990, NATURE, V347, P17, DOI 10.1038/347017a0; Holland HD., 1984, CHEM EVOLUTION ATMOS; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL E, IN PRESS MAR GEOL; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; JONES TP, 1978, PALAEOGEOGR PALAEOCL, V77, P51; JONES TP, 1991, PALAEOGEOGR PALAEOCL, V77, P39; Kump L. R, 1993, INTERACTIONS C N P S, P475; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6	27	271	274	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 26	1996	271	5248					493	496		10.1126/science.271.5248.493	http://dx.doi.org/10.1126/science.271.5248.493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TR322	11541251				2022-12-28	WOS:A1996TR32200038
J	GIESEN, TF; VANORDEN, A; HWANG, HJ; FELLERS, RS; PROVENCAL, RA; SAYKALLY, RJ				GIESEN, TF; VANORDEN, A; HWANG, HJ; FELLERS, RS; PROVENCAL, RA; SAYKALLY, RJ			INFRARED-LASER SPECTROSCOPY OF THE LINEAR C-13 CARBON CLUSTER	SCIENCE			English	Article							MULTIREFERENCE CONFIGURATION-INTERACTION; ELECTRON-SPIN-RESONANCE; MOLECULAR-STRUCTURE; CHAIN MOLECULES; GAS-PHASE; ISOMERS; SPECTRA; C-6; FULLERENES; STABILITY	The infrared absorption spectrum of a linear, 13-atom carbon cluster (C-13) has been observed by the use of a supersonic cluster beam-diode laser spectrometer. Seventy-six rovibrational transitions were measured near 1809 wave numbers and assigned to an antisymmetric stretching fundamental in the (1) Sigma(g)(+) ground state of C-13. This definitive structural characterization of a carbon cluster in the intermediate size range between C-10 and C-20 is in apparent conflict with theoretical calculations, which predict that clusters of this size should exist as planar monocyclic rings.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley			Giesen, Thomas/B-9476-2015; Van Orden, Alan K/N-4219-2015	Giesen, Thomas/0000-0002-2401-0049; SAYKALLY, RICHARD/0000-0001-8942-3656				ACHIBA Y, 1991, Z PHYS D ATOM MOL CL, V19, P427, DOI 10.1007/BF01448344; ARNOLD DW, 1991, J CHEM PHYS, V95, P8753, DOI 10.1063/1.461211; BAKOWIES D, 1991, J AM CHEM SOC, V113, P3704, DOI 10.1021/ja00010a012; BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; BERNHOLDT DE, 1988, J CHEM PHYS, V89, P3612, DOI 10.1063/1.454881; BOWERS MT, 1993, SCIENCE, V260, P1446, DOI 10.1126/science.260.5113.1446; CHELIKOWSKY JR, 1991, PHYS REV LETT, V67, P2970, DOI 10.1103/PhysRevLett.67.2970; FEYEREISEN M, 1992, J CHEM PHYS, V96, P2926, DOI 10.1063/1.461989; Guelachvili G, 1986, HDB INFRARED STANDAR; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; HEATH JR, 1993, CLUSTERS CLUSTERING, P7; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; HOFFMANN R, 1966, TETRAHEDRON, V22, P521, DOI 10.1016/0040-4020(66)80020-0; HUTTER J, 1993, 93107 SWISS FED I TE; HWANG HJ, 1993, MOL PHYS, V79, P769, DOI 10.1080/00268979300101611; JIAO CQ, 1993, RAPID COMMUN MASS SP, V7, P404, DOI 10.1002/rcm.1290070518; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; KROTO HW, 1987, ASTROPHYS J, V314, P352, DOI 10.1086/165065; KURTZ J, 1991, ASTROPHYS J, V370, P784, DOI 10.1086/169862; LIANG CX, 1990, J CHEM PHYS, V93, P8844, DOI 10.1063/1.459223; MARTIN JML, 1991, CHEM PHYS LETT, V187, P367, DOI 10.1016/0009-2614(91)80267-2; MARTIN JML, 1991, J CHEM PHYS, V94, P3753, DOI 10.1063/1.459747; MARTIN JML, 1990, J CHEM PHYS, V93, P8850, DOI 10.1063/1.459224; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MOAZZENAHMADI N, 1994, J CHEM PHYS, V100, P4033, DOI 10.1063/1.466340; MOAZZENAHMADI N, 1993, J CHEM PHYS, V98, P7757, DOI 10.1063/1.464583; MOAZZENAHMADI N, 1991, CHEM PHYS LETT, V186, P291, DOI 10.1016/S0009-2614(91)85144-L; NORTHRUP FJ, 1991, J MOL SPECTROSC, V145, P74, DOI 10.1016/0022-2852(91)90352-B; PARASUK V, 1991, J CHEM PHYS, V94, P8172, DOI 10.1063/1.460100; PARASUK V, 1989, J CHEM PHYS, V91, P1137, DOI 10.1063/1.457186; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1993, CHEM PHYS LETT, V214, P357, DOI 10.1016/0009-2614(93)85650-D; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; SLANINA Z, 1992, MOL PHYS, V76, P387, DOI 10.1080/00268979200101401; SOWA MB, 1992, J CHEM PHYS, V97, P8164, DOI 10.1063/1.463438; VANORDEN A, 1993, J CHEM PHYS, V98, P6678, DOI 10.1063/1.464785; VANZEE RJ, 1988, J CHEM PHYS, V88, P3465, DOI 10.1063/1.453895; VANZEE RJ, 1987, J CHEM PHYS, V86, P5212, DOI 10.1063/1.452643; VON HELDEN G, 1993, CHEM PHYS LETT, V212, P241, DOI 10.1016/0009-2614(93)89320-H; VON HELDEN G, 1993, CHEM PHYS LETT, V212, P247, DOI 10.1016/0009-2614(93)89321-8; VON HELDEN G, 1993, J PHYS CHEM-US, V97, P8182, DOI 10.1021/j100133a011; VON HELDEN G, 1993, CHEM PHYS LETT, V204, P15, DOI 10.1016/0009-2614(93)85599-J; VON HELDEN G, 1993, NATURE, V363, P60, DOI 10.1038/363060a0; VON HELDEN G, 1993, SCIENCE, V259, P1300, DOI 10.1126/science.259.5099.1300; WATTS JD, 1992, CHEM PHYS LETT, V190, P19, DOI 10.1016/0009-2614(92)86095-Y; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; ZAJFMAN D, 1992, SCIENCE, V258, P1129, DOI 10.1126/science.258.5085.1129	47	106	106	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					756	759		10.1126/science.11539187	http://dx.doi.org/10.1126/science.11539187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539187				2022-12-28	WOS:A1994PA37200025
J	SANDFORD, SA; ALLAMANDOLA, LJ; GEBALLE, TR				SANDFORD, SA; ALLAMANDOLA, LJ; GEBALLE, TR			RETRACTED: SPECTROSCOPIC DETECTION OF MOLECULAR-HYDROGEN FROZEN IN INTERSTELLAR ICES (RETRACTED ARTICLE. SEE VOL 287, PG 976, 2000)	SCIENCE			English	Article; Retracted Publication							DENSE CLOUDS; FEATURES; GAS	A weak infrared absorption feature near 4141 wavenumbers (2.415 micrometers) in the spectrum of WL5, an infrared source in the rho Ophiuchus cloud complex, has been detected. It is attributed to molecular hydrogen created by irradiation and frozen in situ into water-rich ices. A second, broader absorption at 4125 wavenumbers centimeters (2.424 micrometers) is probably due to methanol in the ices. The column densities of frozen molecular hydrogen and methanol are inferred to be about 2.5 x 10(18) and 3.0 x 10(19), respectively. There is about three times more frozen molecular hydrogen than frozen carbon monoxide along this line of sight.	JOINT ASTRON CTR, HILO, HI 96720 USA		SANDFORD, SA (corresponding author), NASA, AMES RES CTR, MAIL STOP 245-6, MOFFETT FIELD, CA 94035 USA.							ALLAMANDOLA LJ, 1992, ASTROPHYS J, V399, P134, DOI 10.1086/171909; ALLAMANDOLA LJ, 1988, DUST UNIVERSE, P229; BRAND PWJL, 1993, J CHEM SOC FARADAY T, V89, P2131, DOI 10.1039/ft9938902131; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; DEREMIGIS J, 1970, CAN J PHYS, V48, P1622, DOI 10.1139/p70-204; DHENDECOURT LB, 1982, ASTRON ASTROPHYS, V109, pL12; FLOWER DR, 1990, MON NOT R ASTRON SOC, V247, P500; Hagen W., 1983, Astronomy & Astrophysics Supplement Series, V51, P389; HOLLENBACH D, 1971, ASTROPHYS J, V163, P155, DOI 10.1086/150754; HOLLENBACH D, 1970, J CHEM PHYS, V53, P79, DOI 10.1063/1.1673836; HUDGINS DM, 1993, ASTROPHYS J SUPPL S, V86, P713, DOI 10.1086/191796; HUDSON RL, 1992, J PHYS CHEM-US, V96, P6500, DOI 10.1021/j100194a072; KERR TH, 1991, MON NOT R ASTRON SOC, V251, pP60, DOI 10.1093/mnras/251.1.60P; KERR TH, UNPUB; LEE TJ, 1971, NATURE-PHYS SCI, V231, P193, DOI 10.1038/physci231193a0; LEE TJ, 1972, NATURE-PHYS SCI, V237, P99, DOI 10.1038/physci237099a0; PIRRONELLO V, 1988, ASTRON ASTROPHYS, V196, P201; SANDFORD SA, 1993, ASTROPHYS J, V409, pL65, DOI 10.1086/186861; SANDFORD SA, 1992, FARADAY S, V28; SANDFORD SA, UNPUB; SANDFORD SA, IN PRESS ASTROPHYS J; SCHUTTE WA, 1991, ASTRON ASTROPHYS, V244, P190; SHULL JM, 1982, ANNU REV ASTRON ASTR, V20, P163, DOI 10.1146/annurev.aa.20.090182.001115; SMITH GR, 1976, J CHEM PHYS, V65, P1591, DOI 10.1063/1.433218; Souers P. C., 1986, HYDROGEN PROPERTIES; TANAKA M, 1990, ASTROPHYS J, V352, P724, DOI 10.1086/168574; van de Hulst H.C., 1949, RECH ASTRON OBS UT 1, V11, P1; WARREN JA, 1980, J CHEM PHYS, V72, P4901, DOI 10.1063/1.439774; WILKING BA, 1983, ASTROPHYS J, V274, P698, DOI 10.1086/161482	29	69	69	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	1993	262	5132					400	404		10.1126/science.11542874	http://dx.doi.org/10.1126/science.11542874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	11542874				2022-12-28	WOS:A1993MB85900050
J	SCHOPF, JW				SCHOPF, JW			MICROFOSSILS OF THE EARLY ARCHEAN APEX CHERT - NEW EVIDENCE OF THE ANTIQUITY OF LIFE	SCIENCE			English	Article							BARBERTON MOUNTAIN LAND; WESTERN-AUSTRALIA; SOUTH-AFRICA; STROMATOLITIC MICROBIOTAS; NORTH-POLE; OLD	Eleven taxa (including eight heretofore undescribed species) of cellularly preserved filamentous microbes, among the oldest fossils known, have been discovered in a bedded chert unit of the Early Archean Apex Basalt of northwestern Western Australia. This prokaryotic assemblage establishes that trichomic cyanobacterium-like microorganisms were extant and morphologically diverse at least as early as approximately 3465 million years ago and suggests that oxygen-producing photoautotrophy may have already evolved by this early stage in biotic history.	UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT EARTH & SPACE SCI,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	SCHOPF, JW (corresponding author), UNIV CALIF LOS ANGELES,CTR STUDY EVOLUT & ORIGIN LIFE,LOS ANGELES,CA 90024, USA.							AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BARGHOOR.ES, 1966, SCIENCE, V152, P758, DOI 10.1126/science.152.3723.758; BARGHOORN ES, 1965, SCIENCE, V147, P563, DOI 10.1126/science.147.3658.563; BLAKE TS, 1984, U W AUST GEOL DEP U, V9, P1; Buchanan R.E, 1974, BERGEYS MANUAL DETER, V8th ed., DOI 10.1007/bergeysoutline200405; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1991, PALAIOS, V5, P441; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; CLOUD P, 1980, GEOMICROBIOL J, V2, P161, DOI 10.1080/01490458009377759; CLOUD PE, 1965, SCIENCE, V148, P27, DOI 10.1126/science.148.3666.27; Desikachary T. V., 1959, CYANOPHYTA DESIKACHA; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HICKMAN AH, 1983, AUST GEOL SURV B, V127, P1; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; HOFMANN HJ, 1991, ECON GEOL BULL SOC, V86, P1023, DOI 10.2113/gsecongeo.86.5.1023; Klein C, 1992, PROTEROZOIC BIOSPHER, P603; KNOLL AH, 1977, SCIENCE, V198, P396, DOI 10.1126/science.198.4315.396; KNOLL AH, 1988, PRECAMBRIAN RES, V38, P257, DOI 10.1016/0301-9268(88)90005-8; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; Mendelson C.V., 1992, PROTEROZOIC BIOSPHER, P865, DOI 10.1017/CBO9780511601064.024; MENDELSON CV, 1982, J PALEONTOL, V56, P42; Muir M.D., 1976, EARLY HIST EARTH, P595; NYBERG AV, 1981, PRECAMBRIAN RES, V16, P129, DOI 10.1016/0301-9268(81)90008-5; Oehler JH, 1977, ALCHERINGA, V1, P315, DOI 10.1080/03115517708527768; Pflug H.D., 1992, EARLY ORGANIC EVOLUT, P509; PFLUG HD, 1966, U WITWATERSRAND EC G, V28, P1; Schopf J.W., 1992, P583; SCHOPF J W, 1968, Journal of Paleontology, V42, P651; Schopf J.W., 1983, P214; Schopf J.W., 1992, P1055; Schopf J.W., 1992, PROTEROZOIC BIOSPHER, P195, DOI DOI 10.1017/CBO9780511601064; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SCHOPF JW, 1977, PRECAMBRIAN RES, V4, P269, DOI 10.1016/0301-9268(77)90017-1; SCHOPF JW, 1984, PRECAMBRIAN RES, V24, P335, DOI 10.1016/0301-9268(84)90064-0; SCHOPF JW, 1986, 5TH M INT SOC STUD O, P163; SCHOPF JW, IN PRESS EARLY LIFE; SCHOPF JW, 1992, PROTEROZOIC BIOSPHER, P179; SCHOPF JW, 1976, SCIENCE, V193, P43; Shukla M., 1986, PALAEOBOTANIST, V35, P347; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; Towe KM, 1991, PALAEOGEOGR PALAEOCL, V97, P113, DOI 10.1016/0031-0182(91)90187-V; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0; WALTER MR, 1992, PROTEROZOIC BIOSPHER, P253; Ward D. M., 1992, PROTEROZOIC BIOSPHER, P309	50	861	916	4	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 30	1993	260	5108					640	646		10.1126/science.260.5108.640	http://dx.doi.org/10.1126/science.260.5108.640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ641	11539831				2022-12-28	WOS:A1993KZ64100022
J	UGARTE, D				UGARTE, D			CURLING AND CLOSURE OF GRAPHITIC NETWORKS UNDER ELECTRON-BEAM IRRADIATION	NATURE			English	Article							CARBON; C-60; FULLERENES	THE discovery1 of buckminsterfullerene (C60) and its production in macroscopic quantities2 has stimulated a great deal of research. More recently, attention has turned towards other curved graphitic networks, such as the giant fullerenes (C(n), n > 100)3,4 and carbon nanotubes5-8. A general mechanism has been proposed9 in which the graphitic sheets bend in an attempt to eliminate the highly energetic dangling bonds present at the edge of the growing structure. Here, I report the response of carbon soot particles and tubular graphitic structures to intense electron-beam irradiation in a high-resolution electron microscope; such conditions resemble a high-temperature regime, permitting a degree of structural fluidity. With increased irradiation, there is a gradual reorganization of the initial material into quasi-spherical particles composed of concentric graphitic shells. This lends weight to the nucleation scheme proposed9 for fullerenes, and moreover, suggests that planar graphite may not be the most stable allotrope of carbon in systems of limited size.			UGARTE, D (corresponding author), ECOLE POLYTECH FED LAUSANNE,INST PHYS EXPTL,CH-1015 LAUSANNE,SWITZERLAND.		Ugarte, Daniel/C-2326-2012	Ugarte, Daniel Mario/0000-0003-3332-9139				ADAMS GB, 1992, SCIENCE, V256, P1792, DOI 10.1126/science.256.5065.1792; BUNDY FP, 1989, PHYSICA A, V156, P169, DOI 10.1016/0378-4371(89)90115-5; CHAI Y, 1991, J PHYS CHEM-US, V95, P7564, DOI 10.1021/j100173a002; Curl R. F., 1991, Scientific American (International Edition), V265, P32, DOI 10.1038/scientificamerican1091-54; EBBESEN TW, 1992, NATURE, V358, P2200; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; IIJIMA S, 1987, J PHYS CHEM-US, V91, P3466, DOI 10.1021/j100297a002; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; IIJIMA S, 1980, J CRYST GROWTH, V50, P657; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; KROTO HW, 1988, NATURE, V331, P328, DOI 10.1038/331328a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; LAMB LD, 1992, SCIENCE, V255, P1413, DOI 10.1126/science.255.5050.1413; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; ROBERTSON DH, 1992, J PHYS CHEM-US, V96, P6133, DOI 10.1021/j100194a011; SCUSERIA GE, IN PRESS BUCKMINSTER; TANAKA K, 1992, CHEM PHYS LETT, V191, P469, DOI 10.1016/0009-2614(92)85410-C; ZHANG QL, 1986, J PHYS CHEM-US, V90, P525, DOI 10.1021/j100276a001	19	1719	1773	12	319	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 22	1992	359	6397					707	709		10.1038/359707a0	http://dx.doi.org/10.1038/359707a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	11536508				2022-12-28	WOS:A1992JU65000048
J	Noonan, FP; Recio, JA; Takayama, H; Duray, P; Anver, MR; Rush, WL; De Fabo, EC; Merlino, G				Noonan, FP; Recio, JA; Takayama, H; Duray, P; Anver, MR; Rush, WL; De Fabo, EC; Merlino, G			Neonatal sunburn and melanoma in mice - Severe sunburn in newborn, but not adult, mice is linked with melanoma in later life.	NATURE			English	Article							FACTOR SCATTER FACTOR; MALIGNANT-MELANOMA		George Washington Univ, Sch Med, Dept Dermatol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Immunol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; NCI, Mol Biol Lab, Bethesda, MD 20892 USA; NCI, Pathol Lab, Bethesda, MD 20892 USA; NCI, Pathol Histotechnol Lab, Sci Applicat Int Corp, Frederick, MD 21702 USA; Armed Forces Inst Pathol, Dept Dermatopathol, Washington, DC 20306 USA	George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); United States Department of Defense	Noonan, FP (corresponding author), George Washington Univ, Sch Med, Dept Dermatol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA.			Recio, Juan Angel/0000-0002-7320-3832; Noonan, Frances/0000-0002-3302-7280	NATIONAL CANCER INSTITUTE [Z01BC008756] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; DEFABO EC, 1990, PHOTOCHEM PHOTOBIOL, V52, P811; HIROBE T, 1988, DEVELOPMENT, V102, P567; HOLMAN CDJ, 1983, JNCI-J NATL CANCER I, V71, P651; International Agency for Research on Cancer IARC Monographs, 1992, IARC MON, V55; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; Noonan FP, 2000, CANCER RES, V60, P3738; NOONAN FP, 1990, PHOTOCHEM PHOTOBIOL, V52, P801, DOI 10.1111/j.1751-1097.1990.tb08685.x; Otsuka T, 1998, CANCER RES, V58, P5157; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928	13	285	289	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					271	272		10.1038/35095108	http://dx.doi.org/10.1038/35095108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565020				2022-12-28	WOS:000171040500027
J	Lipton, AJ; Johnson, MA; Macdonald, T; Lieberman, MW; Gozal, D; Gaston, B				Lipton, AJ; Johnson, MA; Macdonald, T; Lieberman, MW; Gozal, D; Gaston, B			S-nitrosothiols signal the ventilatory response to hypoxia	NATURE			English	Article							NUCLEUS-TRACTUS-SOLITARII; NITRIC-OXIDE SYNTHASE; RAT; NITROSOGLUTATHIONE	Increased ventilation in response to hypoxia has been appreciated for over a century(1), but the biochemistry underlying this response remains poorly understood. Here we define a pathway in which increased minute ventilation ((V)over dot(E)) is signalled by deoxyhaemoglobin-derived S-nitrosothiols (SNOs). Specifically, we demonstrate that S-nitrosocysteinyl glycine (CGSNO) and S-nitroso-L-cysteine (L-CSNO)-but not S-nitroso-D-cysteine (D-CSNO)-reproduce the ventilatory effects of hypoxia at the level of the nucleus tractus solitarius (NTS). We show that plasma from deoxygenated, but not from oxygenated, blood produces the ventilatory effect of both SNOs and hypoxia. Further, this activity is mediated by S-nitrosoglutathione (GSNO), and GSNO activation by gamma -glutamyl transpeptidase (gamma -GT) is required. The normal response to hypoxia is impaired in a knockout mouse lacking gamma GT. These observations suggest that S-nitrosothiol biochemistry is of central importance to the regulation of breathing.	Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA; Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pediat, Louisville, KY 40202 USA; Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22906 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA	University of Virginia; University of Louisville; University of Louisville; University of Virginia; Baylor College of Medicine; Baylor College of Medicine; University of Virginia	Gaston, B (corresponding author), Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA.		Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020	Johnson, Michael/0000-0001-5078-9896				ANWAR M, 1990, CIRC RES, V67, P1365, DOI 10.1161/01.RES.67.6.1365; ASKEW SC, 1995, BIOORGAN MED CHEM, V3, P1, DOI 10.1016/0968-0896(94)00139-T; BISGARD GE, 1995, REGULATION BREATHING; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Davisson RL, 1997, AM J PHYSIOL-HEART C, V272, pH2361, DOI 10.1152/ajpheart.1997.272.5.H2361; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Gaston B, 1998, BIOCHEM BIOPH RES CO, V253, P899, DOI 10.1006/bbrc.1998.9865; Gozal D, 1996, J APPL PHYSIOL, V81, P2068, DOI 10.1152/jappl.1996.81.5.2068; Gozal D, 1997, AM J RESP CRIT CARE, V155, P1755, DOI 10.1164/ajrccm.155.5.9154888; Haldane J, 1892, J PATHOL BACTERIOL, V1, P168; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kline DD, 2000, J APPL PHYSIOL, V88, P1496, DOI 10.1152/jappl.2000.88.4.1496; Kluge I, 1997, J NEUROCHEM, V69, P2599; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lin LH, 2000, NEUROSCIENCE, V96, P341, DOI 10.1016/S0306-4522(99)00560-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Menendez AA, 1999, J APPL PHYSIOL, V86, P1478, DOI 10.1152/jappl.1999.86.5.1478; Ohta H, 1997, BRAIN RES, V746, P98, DOI 10.1016/S0006-8993(96)01188-2; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Schmidt HHHW, 1996, P NATL ACAD SCI USA, V93, P14492, DOI 10.1073/pnas.93.25.14492; SMITH TK, 1995, P NATL ACAD SCI USA, V92, P2360, DOI 10.1073/pnas.92.6.2360; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; Torres JE, 1997, NEUROSCI LETT, V232, P175, DOI 10.1016/S0304-3940(97)00598-3	26	265	279	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					171	174		10.1038/35093117	http://dx.doi.org/10.1038/35093117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557982				2022-12-28	WOS:000170918800048
J	Knight, J				Knight, J			Celera and Motorola brought in to aid hunt for disease genes	NATURE			English	News Item																		2001, NATURE, V412, P105	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					9	9		10.1038/35092692	http://dx.doi.org/10.1038/35092692			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544494	Bronze			2022-12-28	WOS:000170801200011
J	Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA				Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA			Loss of p16(Ink4a) with retention of p19(Arf) predisposes mice to tumorigenesis	NATURE			English	Article							PLASMACYTOMA SUSCEPTIBILITY; TUMOR SUPPRESSION; G(1) CONTROL; INK4A LOCUS; MOUSE SKIN; IN-VIVO; IMMORTALIZATION; CELLS; GENE; FIBROBLASTS	The cyclin-dependent kinase inhibitor p16(INK4a) can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer(1,2). Overlapping reading frames in the INK4A/ARF gene encode p16(INK4a) and a distinct tumour-suppressor protein, p19(ARF) (ref. 3). Here we describe the generation and characterization of a p16(Ink4a)-specific knockout mouse that retains normal p19(Arf) function. Mice lacking p16(Ink4a) were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16(Ink4a) exhibited enhanced mitogenic responsiveness, consistent with the established role of p16(Ink4a) in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19(Arf) (ref. 4), p16(Ink4a)-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16(Ink4a) null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19(Arf) or p53 (refs 4, 5). Furthermore, p16(Ink4a) deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16(Ink4a), along with p19(Arf), functions as a tumour suppressor in mice.	Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA.			Sharpless, Norman/0000-0001-7078-9455; DePinho, Ronald/0000-0002-5625-577X				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BUCHMANN A, 1991, CANCER RES, V51, P4097; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Carrasco D, 1998, J EXP MED, V187, P973, DOI 10.1084/jem.187.7.973; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Groth A, 2000, J BIOL CHEM, V275, P27473; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herzog CR, 1999, MOL CARCINOGEN, V25, P92, DOI 10.1002/(SICI)1098-2744(199906)25:2<92::AID-MC3>3.0.CO;2-2; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Patel AC, 2000, CARCINOGENESIS, V21, P1691, DOI 10.1093/carcin/21.9.1691; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; QUELLE DE, 1995, CELL, V83, P993; Reznikoff CA, 1996, CANCER RES, V56, P2886; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Ruas M, 1998, BIOCHIM BIOPHYS ACTA, V1378, P115, DOI 10.1016/s0304-419x(98)00017-1; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Swafford DS, 1997, MOL CELL BIOL, V17, P1366, DOI 10.1128/MCB.17.3.1366; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429; Zhang SL, 2001, MOL CELL BIOL, V21, P310, DOI 10.1128/MCB.21.1.310-318.2001; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	30	601	615	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					86	91		10.1038/35092592	http://dx.doi.org/10.1038/35092592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544531				2022-12-28	WOS:000170801200044
J	Steinle-Neumann, G; Stixrude, L; Cohen, RE; Gulseren, O				Steinle-Neumann, G; Stixrude, L; Cohen, RE; Gulseren, O			Elasticity of iron at the temperature of the Earth's inner core	NATURE			English	Article							SITU X-RAY; HIGH-PRESSURE; IN-SITU; ANISOTROPY; TRANSITION; MODEL; GPA	Seismological body-wave(1) and free-oscillation(2) studies of the Earth's solid inner core have revealed that compressional waves traverse the inner core faster along near-polar paths than in the equatorial plane. Studies have also documented local deviations from this first-order pattern of anisotropy on length scales ranging from 1 to 1,000 km (refs 3, 4). These observations, together with reports of the differential rotation(5) of the inner core, have generated considerable interest in the physical state and dynamics of the inner core, and in the structure and elasticity of its main constituent, iron, at appropriate conditions of pressure and temperature. Here we report first-principles calculations of the structure and elasticity of dense hexagonal close-packed (h.c.p.) iron at high temperatures. We find that the axial ratio c/a of h.c.p. iron increases substantially with increasing temperature, reaching a value of nearly 1.7 at a temperature of 5,700 K, where aggregate bulk and shear moduli match those of the inner core. As a consequence of the increasing c/a ratio, we have found that the single-crystal longitudinal anisotropy of h.c.p. iron at high temperature has the opposite sense from that at low temperature(6,7). By combining our results with a simple model of polycrystalline texture in the inner core, in which basal planes are partially aligned with the rotation axis, we can account for seismological observations of inner-core anisotropy.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Carnegie Inst Washington, Washington, DC 20015 USA; Ctr High Pressure Res, Washington, DC 20015 USA; CALTECH, Seismol Lab, Pasadena, CA 91125 USA; NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; Carnegie Institution for Science; California Institute of Technology; National Institute of Standards & Technology (NIST) - USA; University of Pennsylvania	Steinle-Neumann, G (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.		Cohen, Ronald/B-3784-2010; Stixrude, Lars/C-5625-2012; Steinle-Neumann, Gerd/D-8805-2012; Cohen, Ronald/AAY-2570-2020	Cohen, Ronald/0000-0001-5871-2359; Stixrude, Lars/0000-0003-3778-2432; Steinle-Neumann, Gerd/0000-0001-7455-6149; Gulseren, Oguz/0000-0002-7632-0954				Alfe D, 1999, NATURE, V401, P462, DOI 10.1038/46758; Andrault D, 1997, SCIENCE, V278, P831, DOI 10.1126/science.278.5339.831; Bergman MI, 1997, NATURE, V389, P60, DOI 10.1038/37962; Boehler R, 2000, REV GEOPHYS, V38, P221, DOI 10.1029/1998RG000053; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Buffett BA, 1997, NATURE, V388, P571, DOI 10.1038/41534; Buffett BA, 2001, NATURE, V413, P60, DOI 10.1038/35092543; Creager KC, 1999, J GEOPHYS RES-SOL EA, V104, P23127, DOI 10.1029/1999JB900162; Dubrovinsky LS, 2000, PHYS REV LETT, V84, P1720, DOI 10.1103/PhysRevLett.84.1720; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Funamori N, 1996, GEOPHYS RES LETT, V23, P953, DOI 10.1029/96GL00943; GULSEREN O, 1999, B AM PHYS SOC, V44, P1490; HUANG E, 1987, J GEOPHYS RES-SOLID, V92, P8129, DOI 10.1029/JB092iB08p08129; JEANLOZ R, 1988, GEOPHYS RES LETT, V15, P72, DOI 10.1029/GL015i001p00072; Karato S, 1999, NATURE, V402, P871, DOI 10.1038/47235; Laio A, 2000, SCIENCE, V287, P1027, DOI 10.1126/science.287.5455.1027; MAO HK, 1990, J GEOPHYS RES-SOLID, V95, P21737, DOI 10.1029/JB095iB13p21737; Shen GY, 1998, GEOPHYS RES LETT, V25, P373, DOI 10.1029/97GL03776; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; SONG XD, 1993, GEOPHYS RES LETT, V20, P2591, DOI 10.1029/93GL02812; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; Steinle-Neumann G, 1999, PHYS REV B, V60, P791, DOI 10.1103/PhysRevB.60.791; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P24729, DOI 10.1029/97JB02125; STIXRUDE L, 1995, SCIENCE, V267, P1972, DOI 10.1126/science.267.5206.1972; TROMP J, 1993, NATURE, V366, P678, DOI 10.1038/366678a0; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059; Vocadlo L, 2000, PHYS EARTH PLANET IN, V117, P123, DOI 10.1016/S0031-9201(99)00092-8; Wasserman E, 1996, PHYS REV B, V53, P8296, DOI 10.1103/PhysRevB.53.8296; Wenk HR, 2000, NATURE, V405, P1044, DOI 10.1038/35016558; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700	30	199	205	2	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					57	60		10.1038/35092536	http://dx.doi.org/10.1038/35092536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544523	Green Published			2022-12-28	WOS:000170801200036
J	Johns, MME				Johns, MME			The time has come to reform graduate medical education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA	Emory University	Johns, MME (corresponding author), Emory Univ, Woodruff Hlth Sci Ctr, 1440 Clifton Rd NE, Atlanta, GA 30322 USA.							*ASS AM MED COLL, 1999, MED SCH GRAD FIN SCO; Barzansky B, 2001, JAMA-J AM MED ASSOC, V286, P1049, DOI 10.1001/jama.286.9.1049; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; GEHEB MA, 2000, FORUM FUTURE GME MIL; JOHNS ME, 2001, ACAD OTOLARYNGOL HEA, V20, P11; Long DM, 2000, ACAD MED, V75, P1178, DOI 10.1097/00001888-200012000-00009; Medina JE, 2001, ARCH OTOLARYNGOL, V127, P749	7	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1075	1076		10.1001/jama.286.9.1075	http://dx.doi.org/10.1001/jama.286.9.1075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559293				2022-12-28	WOS:000170802500022
J	Chiu, CH; Chuang, YY; Su, LH				Chiu, CH; Chuang, YY; Su, LH			Subconjunctival haemorrhage and respiratory distress	LANCET			English	Editorial Material							ADENOVIRUS		Chang Gung Childrens Hosp, Div Paediat Infect Dis, Dept Paediat, Taoyuan, Taiwan; Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chiu, CH (corresponding author), Chang Gung Childrens Hosp, Div Paediat Infect Dis, Dept Paediat, Taoyuan, Taiwan.							CHERRY JD, 1998, TXB PEDIAT INFECT DI, P1666; ODIO C, 1984, PEDIATR INFECT DIS J, V3, P46, DOI 10.1097/00006454-198401000-00011; Ruttum MS, 1996, PEDIATR INFECT DIS J, V15, P266, DOI 10.1097/00006454-199603000-00019; TAYLOR JW, 1975, NEW ENGL J MED, V292, P978, DOI 10.1056/NEJM197505012921819	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					724	724		10.1016/S0140-6736(01)05841-X	http://dx.doi.org/10.1016/S0140-6736(01)05841-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551580				2022-12-28	WOS:000170729500013
J	Pavis, H; Wilcock, A				Pavis, H; Wilcock, A			Prescribing of drugs for use outside their licence in palliative care: survey of specialists in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article							MEDICATION		Univ Nottingham, Nottingham NG7 2RD, England; Nottingham City Hosp NHS Trust, Hayward House Macmillan Specialist Palliat Care U, Nottingham NG5 1PB, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Wilcock, A (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.		Wilcock, Andrew/A-9396-2012	Wilcock, Andrew/0000-0002-3214-1188				Atkinson CV, 1999, PALLIATIVE MED, V13, P145, DOI 10.1191/026921699676057177; Cohen PJ, 1997, EUR J ANAESTH, V14, P231, DOI 10.1046/j.1365-2346.1997.00112.x; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; *ROYAL COLL PAED C, 1999, MED CHILDR; Todd J, 1999, PALLIATIVE MED, V13, P446, DOI 10.1177/026921639901300517	5	16	16	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					484	485		10.1136/bmj.323.7311.484	http://dx.doi.org/10.1136/bmj.323.7311.484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532839	Green Published, Bronze			2022-12-28	WOS:000170838500016
J	Shannon, P; Becker, L				Shannon, P; Becker, L			Mechanisms of brain injury in infantile child abuse	LANCET			English	Editorial Material							SHAKEN BABY SYNDROME; DIFFUSE AXONAL INJURY; TRAUMA		Univ Hlth Network, Dept Pathol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Becker, L (corresponding author), Univ Hlth Network, Dept Pathol, Toronto, ON M5G 1X8, Canada.							CAFFEY J, 1974, PEDIATRICS, V54, P396; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Gleckman AM, 2000, J FORENSIC SCI, V45, P1151; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Kairys SW, 2001, PEDIATRICS, V108, P206; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; *US DEP HHS, 1995, 5 US DEP HHS US ADV; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185	17	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					686	687		10.1016/S0140-6736(01)05849-4	http://dx.doi.org/10.1016/S0140-6736(01)05849-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551572				2022-12-28	WOS:000170729500005
J	Jamison, DT; Sandbu, ME				Jamison, DT; Sandbu, ME			Global health - WHO ranking of health system performance	SCIENCE			English	Editorial Material									Univ Calif Los Angeles, Sch Publ Hlth, Program Global Hlth & Educ, Los Angeles, CA 90095 USA; Harvard Univ, John F Kennedy Sch Govt, Ctr Int Dev, Cambridge, MA 02138 USA	University of California System; University of California Los Angeles; Harvard University	Jamison, DT (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Program Global Hlth & Educ, Los Angeles, CA 90095 USA.							[Anonymous], 1999, WORLD HLTH REPORT 19; Blendon RJ, 2001, HEALTH AFFAIR, V20, P10, DOI 10.1377/hlthaff.20.3.10; Bryk A. S., 1992, HIERARCHICAL LINEAR; GALLUP JL, 1998, BROOKINGS PAP EC ACT, V2, P207; LUFT HS, 1996, 2 REPORT CALIFORNIA, V2; LUFT HS, 1996, 2 REPORT CALIFORNIA, V1; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; *WHO, 2000, 29 WHO; Williams A, 2001, HEALTH ECON, V10, P93, DOI 10.1002/hec.594; World Health Organization, 2000, WORLD HLTH REP 2000	10	31	34	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1595	1596		10.1126/science.1059029	http://dx.doi.org/10.1126/science.1059029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533463				2022-12-28	WOS:000170802900031
J	PRICE, LC; SCHOELL, M				PRICE, LC; SCHOELL, M			CONSTRAINTS ON THE ORIGINS OF HYDROCARBON-GAS FROM COMPOSITIONS OF GASES AT THEIR SITE OF ORIGIN	NATURE			English	Article							NATURAL GASES; KEROGEN	It is widely accepted that natural gas is formed from thermal decomposition of both oil in reservoirs and, to a lesser extent, the organic matter in shales from which the oil was derived(1-6). But laboratory pyrolysis experiments on shales do not reproduce the methane-rich composition typical of most gas reservoirs(7), leading to suggestions(7) that other mechanisms, such as transition-metal catalysis, may be important. The discrepancy might, however, instead arise because gas (and oil) deposits have migrated from their source rocks, so that the reservoir composition might not be representative of the composition in the source rocks where the hydrocarbons were generated. To address this question, we have analysed gas samples coproduced with oils directly from a source rock (the Bakken shales, North Dakota, USA) where the local geology has prevented significant hydrocarbon migration. The methane contents of these Bakken-shale gases are much lower than that of conventional gas reservoirs, but are consistent with that from pyrolysis experiments(8,9) on these shales. Thus, because these Bakken gases form with (rather than from) oils, we argue that compositional differences between gases from source rocks and conventional gas deposits result from fractionation processes occurring after hydrocarbon expulsion from the source rock.	CHEVRON PETR TECHNOL CO,LA HABRA,CA 90633	Chevron	PRICE, LC (corresponding author), US GEOL SURVEY,DENVER FED CTR,MS-940,DENVER,CO 80225, USA.							CHUNG HM, 1988, CHEM GEOL, V71, P97, DOI 10.1016/0009-2541(88)90108-8; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; FUEX AN, 1977, J GEOCHEM EXPLOR, V7, P155, DOI 10.1016/0375-6742(77)90080-2; GALIMOV EM, 1988, CHEM GEOL, V71, P77, DOI 10.1016/0009-2541(88)90107-6; GUSSOW WC, 1954, AAPG BULL, V38, P816; JAMES AT, 1983, AAPG BULL, V67, P1176; JENDEN PD, 1988, CHEM GEOL, V71, P117, DOI 10.1016/0009-2541(88)90110-6; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; MCNEIL RI, IN PRESS ENERGY FUEL; NAMAK JE, 1991, 9301 US DEP INT BUR; PRICE LC, 1994, B CAN PETROL GEOL, V42, P187; PRICE LC, 1985, J PETROL GEOL, V8, P59, DOI 10.1111/j.1747-5457.1985.tb00191.x; PRICE LC, 1992, GEOLOGICAL STUDIES R, P199; PRICE LC, SOURCES NATURAL GAS; RICE DD, 1988, 88391 US GEOL SURV O; SALISBURY GP, 1968, MEM AM ASS PETROL 9, V2, P1433; SCHOELL M, 1983, AAPG BULL, V67, P2225; SCHOELL M, 1988, CHEM GEOL, V71, P1, DOI 10.1016/0009-2541(88)90101-5; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; WENGER LM, 1991, ORGANIC GEOCHEMISTRY, P335	20	79	91	3	48	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					368	371		10.1038/378368a0	http://dx.doi.org/10.1038/378368a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	11536709				2022-12-28	WOS:A1995TF89300052
J	RAUP, DM; JABLONSKI, D				RAUP, DM; JABLONSKI, D			GEOGRAPHY OF END-CRETACEOUS MARINE BIVALVE EXTINCTIONS	SCIENCE			English	Article							MASS EXTINCTIONS; BOUNDARY	Analysis of the end-Cretaceous mass extinction, based on 3514 occurrences of 340 genera of marine bivalves (Mollusca), suggests that extinction intensities were uniformly global; no latitudinal gradients or other geographic patterns are detected. Elevated extinction intensities in some tropical areas are entirely a result of the distribution of one extinct group of highly specialized bivalves, the rudists. When rudists are omitted, intensities at those localities are statistically indistinguishable from those of both the rudist-free tropics and extratropical localities.			RAUP, DM (corresponding author), UNIV CHICAGO,DEPT GEOPHYS SCI,5734 ELLIS AVE,CHICAGO,IL 60637, USA.							ERWIN D H, 1989, Palaios, V4, P424, DOI 10.2307/3514587; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D., 1986, P183; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1989, PHILOS T ROY SOC B, V325, P357, DOI 10.1098/rstb.1989.0093; JOHNSON CC, 1990, EXTINCTION EVENTS EA, P305; KAUFFMAN E G, 1988, Palaios, V3, P194, DOI 10.2307/3514530; KAUFFMAN EG, 1986, GLOBAL BIOEVENTS, P279; KELLER G, 1989, GEOL SOC AM BULL, V101, P1408, DOI 10.1130/0016-7606(1989)101<1408:EPOEAT>2.3.CO;2; Lipps J.H., 1986, P87; MACLEOD KG, 1990, GEOLOGICAL SOC AM SP, V247, P509; MARINCOVICH L, 1985, GEOLOGY, V13, P770, DOI 10.1130/0091-7613(1985)13<770:ETMFFN>2.0.CO;2; Masse J.-P., 1986, Bulletin du Centre de Recherches Exploration-Production Elf-Aquitaine, V10, P437; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; PERCHNIELSEN K, 1982, GEOL SOC AM SPEC PAP, V190, P353; Rosen B.R., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P355; SEPKOSKI JJ, 1989, J GEOL SOC LONDON, V146, P7, DOI 10.1144/gsjgs.146.1.0007; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; SOHL NF, 1987, J PALEONTOL, V61, P1085, DOI 10.1017/S0022336000029486; Stanley S.M., 1984, P69; STANLEY SM, 1988, AM J SCI, V288, P334, DOI 10.2475/ajs.288.4.334; WALLER TR, 1992, J PALEONTOL, V66, P215, DOI 10.1017/S0022336000033746; WESTROP SR, 1989, PALEOBIOLOGY, V15, P46, DOI 10.1017/S0094837300009179; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005; ZINSMEISTER WJ, 1989, J PALEONTOL, V63, P731, DOI 10.1017/S0022336000036453; [No title captured]; [No title captured]	27	87	90	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 14	1993	260	5110					971	973		10.1126/science.11537491	http://dx.doi.org/10.1126/science.11537491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB791	11537491				2022-12-28	WOS:A1993LB79100039
J	SALAMA, F; ALLAMANDOLA, LJ				SALAMA, F; ALLAMANDOLA, LJ			IS A PYRENE-LIKE MOLECULAR ION THE CAUSE OF THE 4,430-ANGSTROM DIFFUSE INTERSTELLAR ABSORPTION-BAND	NATURE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EMISSION; SPECTRA; NAPHTHALENE; FEATURES; RADICALS	THE diffuse interstellar bands (DIBs), ubiquitous absorption features in astronomical spectra, have been known since early this century 1 and now number more than a hundred. Ranging from 4,400 angstrom to the near infrared 2, they differ markedly in depth, width and shape, making the concept of a single carrier unlikely. Whether they are due to gas or grains is not settled, but recent results 3 suggest that the DIB carriers are quite separate from the grains that cause visual extinction. Among molecular candidates the polycyclic aromatic hydrocarbons (PAHs) have been proposed as the possible carriers of some of the DIBs 4-7, and we present here laboratory measurements of the optical spectrum of the pyrene cation C16H10+ in neon and argon. matrices. The strongest absorption feature falls at 4,435 +/- 5 angstrom in the argon matrix and 4,395 +/- 5 angstrom in the neon matrix, both close to the strong 4,430-angstrom DIB. If this or a related pyrene-like species is responsible for this particular band, it must account for 0.2% of all cosmic carbon. The ion also shows an intense but puzzling broad continuum, extending from the ultraviolet to the visible, similar to what is seen in the naphthalene cation 8 and perhaps therefore a common feature of all PAH cations. This may provide an explanation of how PAHs convert a large fraction of interstellar radiation from ultraviolet and visible wavelengths down to the infrared.			SALAMA, F (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MS 245-6,MOFFETT FIELD,CA 94035, USA.		Salama, Farid/A-8787-2009	Salama, Farid/0000-0002-6064-4401				AITKEN DK, 1983, MON NOT R ASTRON SOC, V202, P1233, DOI 10.1093/mnras/202.4.1233; ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; ANDREWS L, 1982, J PHYS CHEM-US, V86, P2916, DOI 10.1021/j100212a023; Bondybey V. E., 1983, Molecular ions: Spectroscopy, structure and chemistry, P125; CLAR E, 1976, TETRAHEDRON, V32, P2563, DOI 10.1016/0040-4020(76)88027-1; CRAWFORD MK, 1985, ASTROPHYS J, V293, pL45, DOI 10.1086/184488; Hayes D. S., 1973, International Astronomical Union Symposium No.52, Interstellar Dust and Related Topics, P83; HERBIG GH, 1991, ASTROPHYS J, V382, P193, DOI 10.1086/170708; HERBIG GH, 1975, ASTROPHYS J, V196, P129, DOI 10.1086/153400; KARCHER W, 1983, SPECTRAL ATLAS POLYC, P92; KIRA A, 1976, J PHYS CHEM-US, V80, P1445, DOI 10.1021/j100554a011; KRELOWSKI J, 1989, INTERSTELLAR DUST, P67; LEGER A, 1985, ASTRON ASTROPHYS, V146, P81; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; PANKASEM S, 1991, J PHYS CHEM-US, V95, P7385, DOI 10.1021/j100172a051; SALAMA F, 1991, J CHEM PHYS, V94, P6964, DOI 10.1063/1.460230; SALAMA F, 1991, J CHEM PHYS, V95, P6190, DOI 10.1063/1.461827; SALAMA F, IN PRESS ASTROPHYS J; SELLGREN K, 1990, ASTROPHYS J, V359, P384, DOI 10.1086/169072; SELLGREN K, 1984, ASTROPHYS J, V277, P623, DOI 10.1086/161733; SHIDA T, 1973, J AM CHEM SOC, V95, P3473, DOI 10.1021/ja00792a005; SNOW TP, 1991, ASTROPHYS J, V382, P189, DOI 10.1086/170707; VANBREDA IG, 1981, MON NOT R ASTRON SOC, V195, P79, DOI 10.1093/mnras/195.1.79; VANDERZWET GP, 1985, ASTRON ASTROPHYS, V146, P76	24	94	94	0	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					42	43		10.1038/358042a0	http://dx.doi.org/10.1038/358042a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB341	11536498				2022-12-28	WOS:A1992JB34100045
J	JASPER, JP; HAYES, JM				JASPER, JP; HAYES, JM			A CARBON ISOTOPE RECORD OF CO2 LEVELS DURING THE LATE QUATERNARY	NATURE			English	Article									INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	JASPER, JP (corresponding author), INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405, USA.							BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BERGER WH, 1978, OCEANOL ACTA, V1, P203; BOUMA AH, 1983, AM ASS PET GEOL MEM, V34, P567; BOUMA AH, 1986, INITIAL REPORTS DSDP, V96, P777; BOYLE EA, 1988, J GEOPHYS RES-OCEANS, V93, P15701, DOI 10.1029/JC093iC12p15701; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; CONSTANS RE, 1986, INITIAL REP DEEP SEA, V96, P601; de Leeuw J., 1980, PHYS CHEM EARTH, V12, P211, DOI 10.1016/0079-1946(79)90105-8; EWING M., 1958, HABITAT OIL, P995; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; FARRIMOND P, 1985, ADV ORG GEOCHEM, P897; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HAYES JM, 1989, GEOCHIM COSMOCHIM AC, V53, P2961, DOI 10.1016/0016-7037(89)90172-5; Jasper JP, 1989, PALEOCEANOGRAPHY, V4, P603, DOI 10.1029/PA004i006p00603; JASPER JP, 1989, NATURE, V342, P60, DOI 10.1038/342060a0; JASPER JP, 1990, GEOCHIM COSMOCHIM AC, V54, P1117, DOI 10.1016/0016-7037(90)90443-O; KOHL B, 1986, INITIAL REP DEEP SEA, V96, P657; LEDBETTER MT, 1986, INITIAL REP DEEP SEA, V96, P685; LORIUS C, 1985, NATURE, V316, P591, DOI 10.1038/316591a0; MARLOWE IT, 1984, BRIT PHYCOL J, V19, P203, DOI 10.1080/00071618400650221; MCCABE B, 1985, THESIS U WAIKATO; NEWMAN JW, 1973, GEOCHIM COSMOCHIM AC, V37, P225, DOI 10.1016/0016-7037(73)90130-0; OKADA H, 1977, Micropaleontology (New York), V23, P1, DOI 10.2307/1485309; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; RECHKA JA, 1988, TETRAHEDRON LETT, V29, P2599, DOI 10.1016/S0040-4039(00)86122-5; SHACKLETON NJ, 1983, NATURE, V306, P319, DOI 10.1038/306319a0; Steeman Nielsen E., 1975, MARINE PHOTOSYNTHESI; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; WILLIAMS DF, 1986, INITIAL REP DEEP SEA, V96, P671	32	248	266	3	44	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 4	1990	347	6292					462	464		10.1038/347462a0	http://dx.doi.org/10.1038/347462a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB446	11536468				2022-12-28	WOS:A1990EB44600066
J	SANDER, SP; FRIEDL, RR; YUNG, YL				SANDER, SP; FRIEDL, RR; YUNG, YL			RATE OF FORMATION OF THE CLO DIMER IN THE POLAR STRATOSPHERE - IMPLICATIONS FOR OZONE LOSS	SCIENCE			English	Article									CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125	California Institute of Technology	SANDER, SP (corresponding author), CALTECH,JET PROP LAB,PASADENA,CA 91109, USA.		Yung, Yuk/AAM-4850-2021	Yung, Yuk/0000-0002-4263-2562				ALLEN M, 1981, J GEOPHYS RES-SPACE, V86, P3617, DOI 10.1029/JA086iA05p03617; ANDERSON JG, 1988, MAY NAT AER SPAC ADM; BARRETT JW, 1988, NATURE, V336, P455, DOI 10.1038/336455a0; Benson S.W, 1976, THERMOCHEMICAL KINET; BURKHOLDER JV, IN PRESS J PHYS CHEM; CRUTZEN PJ, 1986, NATURE, V324, P651, DOI 10.1038/324651a0; DEMORE WB, 1987, JPL PUBL, V8741; DEZAFRA RL, 1987, NATURE, V328, P408, DOI 10.1038/328408a0; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; FARMER CB, 1987, NATURE, V329, P126, DOI 10.1038/329126a0; FRIEDL RR, 1989, J PHYS CHEM-US, V93, P4756, DOI 10.1021/j100349a016; FROIDEVAUX L, 1985, J GEOPHYS RES-ATMOS, V90, P2999, DOI 10.1029/JD090iD07p12999; HARTMANN DL, IN PRESS J GEOPHYS R; HAYMAN GD, 1989, CHEM PHYS LETT, V155, P1, DOI 10.1016/S0009-2614(89)87350-6; HAYMAN GD, 1986, GEOPHYS RES LETT, V13, P1347, DOI 10.1029/GL013i012p01347; HILLS AJ, 1987, NATURE, V328, P405, DOI 10.1038/328405a0; HOFMANN DJ, 1988, NASA10014 C PUBL; LUTHER K, 1979, S INT COMBUST P, V17, P535; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MCELROY MB, 1989, SCIENCE, V243, P763, DOI 10.1126/science.243.4892.763; MCELROY MB, 1988, PLANET SPACE SCI, V36, P73, DOI 10.1016/0032-0633(88)90148-1; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; PATRICK R, 1983, INT J CHEM KINET, V15, P1189, DOI 10.1002/kin.550151107; PERMIEN T, 1988, SEP COOP SCI TECHN 6; RODRIGUEZ JM, 1986, GEOPHYS RES LETT, V13, P1292, DOI 10.1029/GL013i012p01292; SALAWITCH RJ, 1988, PLANET SPACE SCI, V36, P213, DOI 10.1016/0032-0633(88)90058-X; SANDER S, UNPUB; SANDER SP, 1988, GEOPHYS RES LETT, V15, P887, DOI 10.1029/GL015i008p00887; SANDER SP, 1989, J PHYS CHEM-US, V93, P4764, DOI 10.1021/j100349a017; SIMON FG, IN PRESS J PHYS CHEM; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; SOLOMON S, 1987, J GEOPHYS RES-ATMOS, V92, P8329, DOI 10.1029/JD092iD07p08329; SOLOMON SC, IN PRESS J GEOPHYS R; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; Toon GC, COMMUNICATION; TROE J, 1979, J PHYS CHEM-US, V83, P114, DOI 10.1021/j100464a019; WATSON RT, 1979, J PHYS CHEM-US, V83, P2936, DOI 10.1021/j100486a002; YUNG YL, IN PRESS	38	150	150	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 8	1989	245	4922					1095	1098		10.1126/science.245.4922.1095	http://dx.doi.org/10.1126/science.245.4922.1095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN702	11538343				2022-12-28	WOS:A1989AN70200031
J	Nielsen, EE; Hansen, MM; Schmidt, C; Meldrup, D; Gronkjaer, P				Nielsen, EE; Hansen, MM; Schmidt, C; Meldrup, D; Gronkjaer, P			Fisheries - Population of origin of Atlantic cod	NATURE			English	Article									Danish Inst Fisheries Res, Dept Inland Fisheries, DK-8600 Silkeborg, Denmark; Univ Aarhus, Dept Marine Ecol, DK-8200 Aarhus, Denmark	Aarhus University	Nielsen, EE (corresponding author), Danish Inst Fisheries Res, Dept Inland Fisheries, DK-8600 Silkeborg, Denmark.		Hansen, Michael/I-5979-2013; Hansen, Michael M./Z-5047-2019; Hansen, Michael/C-3336-2008; Nielsen, Einar/AAT-1737-2021; Grønkjær, Peter/A-3697-2008	Hansen, Michael/0000-0001-5372-4828; Hansen, Michael M./0000-0001-5372-4828; Nielsen, Einar/0000-0002-7009-9814; Grønkjær, Peter/0000-0003-1337-4661				BAKER CS, 1994, SCIENCE, V265, P1538, DOI 10.1126/science.265.5178.1538; *INT COUNC EXPL SE, 200 AFCM INT COUNC E; Pritchard JK, 2000, GENETICS, V155, P945; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503	5	108	112	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					272	272		10.1038/35095112	http://dx.doi.org/10.1038/35095112			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565021				2022-12-28	WOS:000171040500028
J	Freiman, RN; Albright, SR; Zheng, S; Sha, WC; Hammer, RE; Tjian, R				Freiman, RN; Albright, SR; Zheng, S; Sha, WC; Hammer, RE; Tjian, R			Requirement of tissue-selective TBP-associated factor TAF(II)105 in ovarian development	SCIENCE			English	Article							POLYMERASE-II TRANSCRIPTION; MOLECULAR-CLONING; TFIID COMPLEX; C-ELEGANS; ACTIVATION; SUBUNITS; DNA	Transcription factor TFIID, composed of TBP and TAF(11) subunits, is a central component of the RNA polymerase II machinery. Here, we report that the tissue-selective TAF(11)105 subunit of TFIID is essential for proper development and function of the mouse ovary. Female mice lacking TAF(11)105 are viable but infertile because of a defect in folliculogenesis correlating with restricted expression of TAF(11)105 in the granulosa cells of the ovarian follicle. Gene expression profiling has uncovered a defective inhibin-activin signaling pathway in TAF(11)105-deficient ovaries. Together, these studies suggest that TAF(11)105 mediates the transcription of a subset of genes required for proper folliculogenesis in the ovary and establishes TAF(11)105 as a cell type-specific component of the mammalian transcriptional machinery.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Hammer, Robert E./0000-0001-5487-7551				BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; FREIMAN RN, UNPUB; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Wolstein O, 2000, J BIOL CHEM, V275, P16459, DOI 10.1074/jbc.275.22.16459; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	19	158	162	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2084	2087		10.1126/science.1061935	http://dx.doi.org/10.1126/science.1061935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557891				2022-12-28	WOS:000171028700073
J	Gifford, DK				Gifford, DK			Blazing pathways through genetic mountains	SCIENCE			English	Editorial Material								It is now widely accepted that high-throughput data sources will shed essential understanding on the inner workings of cellular and organism function. One key challenge is to distill the results of such experiments into an interpretable computational form that will be the basis of a predictive model. A predictive model represents the gold standard in understanding a biological system and will permit us to investigate the underlying cause of diseases and help us to develop therapeutics. Here I explore how discoveries can be based on high-throughput data sources and discuss how independent discoveries can be assembled into a comprehensive picture of cellular function.	MIT, Dept Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gifford, DK (corresponding author), MIT, Dept Comp Sci, 200 Technol Sq, Cambridge, MA 02139 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				HARTEMINK A, 2000, PAC S BIOC 2000 OAH; Hartemink A.J., 2001, THESIS MIT CAMBRIDGE; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; PEER D, 2001, 9 C INT SYST MOL BIO	5	18	21	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2049	2051		10.1126/science.1065113	http://dx.doi.org/10.1126/science.1065113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557882				2022-12-28	WOS:000171028700063
J	Sachs, JP; Anderson, RF; Lehman, SJ				Sachs, JP; Anderson, RF; Lehman, SJ			Glacial surface temperatures of the southeast Atlantic Ocean	SCIENCE			English	Article							NORTH-ATLANTIC; DEUTERIUM EXCESS; GEOMAGNETIC PALEOINTENSITY; ANTARCTIC PRECIPITATION; INTERGLACIAL CHANGES; CLIMATE-CHANGE; ICE AGES; LAST; SECTOR; ORIGIN	A detailed record of sea surface temperature from sediments of the Cape Basin in the subtropical South Atlantic indicates a previously undocumented progression of marine climate change between 41 and 18 thousand years before the present (ky B.P.), during the last glacial period. Whereas marine records typically indicate a tong-term cooling into the Last Glacial Maximum (around 21 ky B.P.) consistent with gradually increasing global ice volume, the Cape Basin record documents an interval of substantial temperate ocean warming from 41 to 25 ky B.P. The pattern is similar to that expected in response to changes in insolation owing to variations in Earth's tilt.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	Massachusetts Institute of Technology (MIT); Columbia University; University of Colorado System; University of Colorado Boulder	Sachs, JP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave,Room E34-254, Cambridge, MA 02139 USA.			Anderson, Robert/0000-0002-8472-2494				Abelmann A, 1999, PALEOCEANOGRAPHY, V14, P410, DOI 10.1029/1998PA900024; Armengaud A, 1998, J GEOPHYS RES-ATMOS, V103, P8947, DOI 10.1029/98JD00274; BACON MP, 1984, ISOT GEOSCI, V2, P97; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; BOYLE EA, 1984, CLIMATE PROCESSES CL, V5, P360; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; Brathauer U, 1999, PALEOCEANOGRAPHY, V14, P135, DOI 10.1029/1998PA900020; Channell JET, 2000, EARTH PLANET SC LETT, V175, P145, DOI 10.1016/S0012-821X(99)00285-X; Chapman MR, 2000, PALAEOGEOGR PALAEOCL, V157, P1, DOI 10.1016/S0031-0182(99)00168-6; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; Delaygue G, 2000, TELLUS B, V52, P19, DOI 10.1034/j.1600-0889.2000.00951.x; DERUIJTER WPM, 1985, DEEP-SEA RES, V32, P557, DOI 10.1016/0198-0149(85)90044-5; GALLIMORE RG, 1995, J GEOPHYS RES-ATMOS, V100, P1103, DOI 10.1029/94JD02686; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Johnsen SJ, 1989, TELLUS B, V41, P452, DOI 10.1111/j.1600-0889.1989.tb00321.x; JOUZEL J, 1982, NATURE, V299, P688, DOI 10.1038/299688a0; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; KOSTER RD, 1992, CLIM DYNAM, V7, P195, DOI 10.1007/BF00206861; Labeyrie L, 1996, PALEOCEANOGRAPHY, V11, P57, DOI 10.1029/95PA02255; LABEYRIE LD, 1985, PALAEOGEOGR PALAEOCL, V50, P217, DOI 10.1016/0031-0182(85)90069-0; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; MARSHALL JC, 1993, J PHYS OCEANOGR, V23, P1315, DOI 10.1175/1520-0485(1993)023<1315:ITSRAP>2.0.CO;2; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Mazaud A, 2000, EARTH PLANET SC LETT, V177, P219, DOI 10.1016/S0012-821X(00)00040-6; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Ninnemann US, 1999, GEOPH MONOG SERIES, V112, P99; PETIT JR, 1991, J GEOPHYS RES-ATMOS, V96, P5113, DOI 10.1029/90JD02232; Pichon JJ, 1992, PALEOCEANOGRAPHY, V7, P289, DOI 10.1029/92PA00709; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stoner JS, 2000, EARTH PLANET SC LETT, V183, P161, DOI 10.1016/S0012-821X(00)00272-7; TUCHOLKE BE, 1984, MEM AM ASS PET GEOL, V36, P145; Vimeux F, 2001, CLIM DYNAM, V17, P503, DOI 10.1007/PL00007928; Vimeux F, 1999, NATURE, V398, P410, DOI 10.1038/18860	40	62	66	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2077	2079		10.1126/science.1063584	http://dx.doi.org/10.1126/science.1063584			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557890				2022-12-28	WOS:000171028700071
J	Green, JA; Kirwan, JM; Tierney, JF; Symonds, P; Fresco, L; Collingwood, M; Williams, CJ				Green, JA; Kirwan, JM; Tierney, JF; Symonds, P; Fresco, L; Collingwood, M; Williams, CJ			Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis	LANCET			English	Article							CONCURRENT CHEMOTHERAPY; RADIATION-THERAPY; RANDOMIZED TRIAL; PELVIC RADIATION; CARCINOMA; CISPLATIN; ADJUNCT	Background The US National Cancer Institute alert in February, 1999, stated that concomitant chemotherapy and radiotherapy should be considered for all patients with cervical cancer. Our aim was to review the effects of chemoradiotherapy on overall and progression-free survival, local and distant control, and acute and late toxicity in patients with cervical cancer. Methods With the methodology of the Cochrane Collaboration, we did a systematic review of all known randomised controlled trials done between 1981 and 2000 (17 published, two unpublished) of chemoradiation for cervical cancer. Findings The trials included 4580 randomised patients, and 2865-3611 patients (62-78%) were available for analysis. Cisplatin was the most common agent used. The findings suggest that chemoradiation improves overall survival (hazard ratio 0.71, p<0.0001), whether platinum was used (0.70, p<0.0001) or not (0.81, p=0.20). A greater beneficial effect was seen in trials that included a high proportion of stage I and II patients (p=0.009). An improvement in progression-free survival was also seen with chemoradiation (0.61, p<0.0001). Thus, the absolute benefit in progression-free and overall survival was 16% (95% Cl 13-19) and 12% (8-16), respectively. A significant benefit of chemoradiation on both local (odds ratio 0.61, p<0.0001) and distant recurrence (0.57, p<0.0001) was also recorded. Grade 3 or 4 haematological (odds ratio 1.49-8.60) and gastrointestinal (2.22) toxicities were significantly greater in the concomitant chemoradiation group than the control group. There was insufficient data to establish whether late toxicity was increased in the concomitant chemoradiation group. Interpretation Concomitant chemotherapy and radiotherapy improves overall and progress I on-free survival and reduces local and distant recurrence in selected patients with cervical cancer, which may give a cytotoxic and sensitisation effect.	Univ Liverpool, Dept Med, Liverpool L69 3GA, Merseyside, England; Liverpool Womens Hosp, Liverpool, Merseyside, England; MRC, Clin Trials Unit, Meta Anal Grp, London, England; Univ Leicester, Leicester Royal Infirm, Dept Clin Oncol, Leicester, Leics, England; Inst Hlth Sci, Cochrane Gynaecol Canc Review Grp, Oxford, England; Inst Hlth Sci, Gynaecol Canc Grp, Oxford, England	University of Liverpool; University of Liverpool; Medical Research Council Clinical Trials Unit; University of Leicester; University of Oxford; University of Oxford	Green, JA (corresponding author), Univ Liverpool, Dept Med, Liverpool L69 3GA, Merseyside, England.			Tierney, Jayne/0000-0002-4734-3014				BENEDET J, 1998, J EPIDEMIOL BIOSTAT, V3, P1; CHALMERS I, 1997, NONRANDOM REFLECTION, P231; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; FERNANDEZ DJ, 1995, P 16 ANN M ASS RAD O, P97; GREEN J, 2000, COCHRANE LIB; HERNANDEZ JRA, 1991, GINECOL OBSTET MEX, V59, P238; Hong F, 1997, J SPORT HIST, V24, P1; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; LIRAPUERTO V, 1990, P AN M AM SOC CLIN, V9, P633; Lorvidhaya V, 1995, Gan To Kagaku Ryoho, V22 Suppl 3, P244; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Omura G A, 1996, J Natl Cancer Inst Monogr, P123; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PEARCY RG, 2000, P AN M AM SOC CLIN, V19, P378; PEREZ CA, 1995, INT J RADIAT ONCOL, V32, P1275, DOI 10.1016/0360-3016(95)00220-S; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Roberts KB, 2000, INT J CANCER, V90, P206, DOI 10.1002/1097-0215(20000820)90:4<206::AID-IJC4>3.0.CO;2-O; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Singh P, 1985, Southeast Asian J Trop Med Public Health, V16, P665; Thomas G, 1998, GYNECOL ONCOL, V69, P137, DOI 10.1006/gyno.1998.4990; Thomas GM, 1999, NEW ENGL J MED, V340, P1198, DOI 10.1056/NEJM199904153401509; Tierney JF, 1999, EUR J CANCER, V35, P406, DOI 10.1016/S0959-8049(98)00404-3; Tseng CJ, 1997, GYNECOL ONCOL, V66, P52, DOI 10.1006/gyno.1997.4721; WALLNER KE, 1987, INT J RADIAT ONCOL, V13, P587, DOI 10.1016/0360-3016(87)90076-9; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; WONG LC, 1989, GYNECOL ONCOL, V35, P159, DOI 10.1016/0090-8258(89)90035-8; Wong LC, 1999, J CLIN ONCOL, V17, P2055, DOI 10.1200/JCO.1999.17.7.2055; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	29	834	893	1	36	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					781	786		10.1016/S0140-6736(01)05965-7	http://dx.doi.org/10.1016/S0140-6736(01)05965-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564482				2022-12-28	WOS:000170989300008
J	Kingston, M; Warren, C; Carlin, E				Kingston, M; Warren, C; Carlin, E			Tropical warts	LANCET			English	Editorial Material							FEMALE GENITAL SCHISTOSOMIASIS		City Hosp Nottingham, Dept Genitourinary Med, Nottingham NG6 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital	Kingston, M (corresponding author), City Hosp Nottingham, Dept Genitourinary Med, Hucknall Rd, Nottingham NG6 1PB, England.							FELDMEIER H, 1994, INT J STD AIDS, V5, P368, DOI 10.1177/095646249400500517; Leutscher P, 1998, TROP MED INT HEALTH, V3, P327, DOI 10.1046/j.1365-3156.1998.00230.x; MADDEN FC, 1899, LANCET, V1, P1716; PORGGENSEE G, 1999, PARISITOLOGY TODAY, V15, P378	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					808	808		10.1016/S0140-6736(01)05972-4	http://dx.doi.org/10.1016/S0140-6736(01)05972-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564489				2022-12-28	WOS:000170989300015
J	Buffett, BA; Wenk, HR				Buffett, BA; Wenk, HR			Texturing of the Earth's inner core by Maxwell stresses	NATURE			English	Article							ANISOTROPY; IRON; DEFORMATION; HETEROGENEITY; ELASTICITY; RECRYSTALLIZATION; MODEL	Elastic anisotropy in the Earth's inner core has been attributed to a preferred lattice orientation(1), which may be acquired during solidification of the inner core(2) or developed subsequent to solidification as a result of plastic deformation(3-5). But solidification texturing alone cannot explain the observed depth dependence of anisotropy(6-8), and previous suggestions for possible deformation processes have all relied on radial flow, which is inhibited by thermal(9) and chemical stratification(10). Here we investigate the development of anisotropy as the inner core deforms plastically under the influence of electromagnetic (Maxwell) shear stresses. We estimate the flow caused by a representative magnetic field using polycrystal plasticity simulations for epsilon -iron, where the imposed deformation is accommodated by basal and prismatic slip(11). We find that individual grains in an initially random polycrystal become preferentially oriented with their c axes parallel to the equatorial plane. This pattern is accentuated if deformation is accompanied by recrystallization. Using the single-crystal elastic properties of epsilon -iron at core pressure and temperature(12), we average over the simulated orientation distribution to obtain a pattern of elastic anisotropy which is similar to that observed seismologically(13,14).	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of British Columbia; University of California System; University of California Berkeley	Buffett, BA (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.	buffett@geop.ubc.ca						Bergman MI, 1997, NATURE, V389, P60, DOI 10.1038/37962; Buffett BA, 1997, NATURE, V388, P571, DOI 10.1038/41534; Buffett BA, 2000, GEOPHYS RES LETT, V27, P4001, DOI 10.1029/2000GL011790; Creager KC, 1999, J GEOPHYS RES-SOL EA, V104, P23127, DOI 10.1029/1999JB900162; CREAGER KC, 1992, NATURE, V356, P309, DOI 10.1038/356309a0; Garcia R, 2000, GEOPHYS RES LETT, V27, P3121, DOI 10.1029/2000GL008520; Glatzmaier GA, 1996, SCIENCE, V274, P1887, DOI 10.1126/science.274.5294.1887; Karato S, 1999, NATURE, V402, P871, DOI 10.1038/47235; Lebensohn RA, 1998, ACTA MATER, V46, P2683, DOI 10.1016/S1359-6454(97)00477-1; Mao HK, 1998, NATURE, V396, P741, DOI 10.1038/25506; MOLINARI A, 1987, ACTA METALL MATER, V35, P2983, DOI 10.1016/0001-6160(87)90297-5; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; SONG XD, 1995, J GEOPHYS RES-SOL EA, V100, P9805, DOI 10.1029/95JB00244; Song XD, 1997, REV GEOPHYS, V35, P297, DOI 10.1029/97RG01285; STACEY FD, 1995, PHYS EARTH PLANET IN, V89, P219, DOI 10.1016/0031-9201(94)03005-4; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; STIXRUDE L, 1995, SCIENCE, V267, P1972, DOI 10.1126/science.267.5206.1972; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; TROMP J, 1993, NATURE, V366, P678, DOI 10.1038/366678a0; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059; Wenk HR, 2000, NATURE, V405, P1044, DOI 10.1038/35016558; Wenk HR, 1999, J GEOPHYS RES-SOL EA, V104, P25513, DOI 10.1029/1999JB900261; Wenk HR, 2000, J GEOPHYS RES-SOL EA, V105, P5663, DOI 10.1029/1999JB900346; Wenk HR, 1998, J APPL CRYSTALLOGR, V31, P262, DOI 10.1107/S002188989700811X; YOO CS, 1995, SCIENCE, V270, P1473, DOI 10.1126/science.270.5241.1473; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Yukutake T, 1998, PHYS EARTH PLANET IN, V108, P1, DOI 10.1016/S0031-9201(98)00097-1	27	91	92	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					60	63		10.1038/35092543	http://dx.doi.org/10.1038/35092543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544524				2022-12-28	WOS:000170801200037
J	George, AM; Iniguez, J; Bellaiche, L				George, AM; Iniguez, J; Bellaiche, L			Anomalous properties in ferroelectrics induced by atomic ordering	NATURE			English	Article							FINITE-TEMPERATURE PROPERTIES; BEHAVIOR; PHASE	Complex insulating perovskite alloys are of considerable technological interest because of their large dielectric and piezoelectric responses. Examples of such alloys include (Ba1-xSrx)TiO3, which has emerged as a leading candidate dielectric material for the memory-cell capacitors in dynamic random access memories(1); and Pb(Zr1-xTix)O-3 (PZT), which is widely used in transducers and actuators(2). The rich variety of structural phases that these alloys can exhibit, and the challenge of relating their anomalous properties to the microscopic structure, make them attractive from a fundamental point of view. Theoretical investigations of modifications to the atomic ordering of these alloys suggest the existence of further unexpected structural properties(3) and hold promise for the development of new functional materials with improved electromechanical properties. Here we report ab initio calculations that show that a certain class of atomic rearrangement should lead simultaneously to large electromechanical responses and to unusual structural phases in a given class of perovskite alloys. Our simulations also reveal the microscopic mechanism responsible for these anomalies.	Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Bellaiche, L (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	laurent@comp.uark.edu	Íñiguez, Jorge/B-6856-2009; Íñiguez, Jorge/K-3828-2019	Íñiguez, Jorge/0000-0001-6435-3604; Íñiguez, Jorge/0000-0001-6435-3604				ABE K, 1995, J APPL PHYS, V77, P6461, DOI 10.1063/1.359120; Bellaiche L, 2000, PHYS REV B, V61, P7877, DOI 10.1103/PhysRevB.61.7877; Bellaiche L, 2000, PHYS REV LETT, V84, P5427, DOI 10.1103/PhysRevLett.84.5427; Brazier M, 1998, APPL PHYS LETT, V72, P1121, DOI 10.1063/1.120943; CHU F, 1995, J APPL PHYS, V77, P1671, DOI 10.1063/1.358856; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; Hemphill R, 2000, APPL PHYS LETT, V77, P3642, DOI 10.1063/1.1328765; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Noheda B, 1999, APPL PHYS LETT, V74, P2059, DOI 10.1063/1.123756; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Ramer NJ, 2000, J PHYS CHEM SOLIDS, V61, P315, DOI 10.1016/S0022-3697(99)00300-5; Sai N, 2000, PHYS REV LETT, V84, P5636, DOI 10.1103/PhysRevLett.84.5636; Service RF, 1997, SCIENCE, V275, P1878, DOI 10.1126/science.275.5308.1878; Uchino K, 1996, PIEZOELECTRIC ACTUAT; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Vanderbilt D, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094108	17	107	109	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					54	57		10.1038/35092530	http://dx.doi.org/10.1038/35092530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544522				2022-12-28	WOS:000170801200035
J	Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A				Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A			Loss of p16(Ink4a) confers susceptibility to metastatic melanoma in mice	NATURE			English	Article							TUMOR SUPPRESSION; G(1) CONTROL; INK4A LOCUS; IN-VITRO; SENESCENCE; MUTATIONS; GROWTH; DISRUPTION; P14(ARF); DELETION	CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours(1). However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16(INK4a) and p14(ARF) (p19(Arf) in mice)(2), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19(Arf)) (hereafter Arf) alone predisposes mice to tumorigenesis(3), demonstrating that Arf is a tumour-suppressor gene in mice. We mutated mice specifically in Cdkn2a(p16(Ink4a)) (hereafter Ink4a). Here we demonstrate that these mice, designated Ink4a*/*, do not show a significant predisposition to spontaneous tumour formation within 17 months. Embryo fibroblasts derived from them proliferate normally, are mortal, and are not transformed by oncogenic HRAS. The very mild phenotype of the Ink4a*/* mice implies that the very strong phenotypes of the original Ink4a/Arf(Delta2,3) mice were primarily or solely due to loss of Arf. However, Ink4a*(/2 Delta ,3) mice that are deficient for Ink4a and heterozygous for Arf spontaneously develop a wide spectrum of tumours, including melanoma. Treatment of these mice with the carcinogen 7,12-dimethylbenzanthracene (DMBA) results in an increased incidence of melanoma, with frequent metastases. Our results show that, in the mouse, Ink4a is a tumour-suppressor gene that, when lost, can recapitulate the tumour predisposition seen in humans.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	tberns@nki.nl						Arap W, 1997, ONCOGENE, V14, P603, DOI 10.1038/sj.onc.1200870; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; HARVEY M, 1993, ONCOGENE, V8, P2457; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Rizos H, 1997, ONCOGENE, V15, P515, DOI 10.1038/sj.onc.1201217; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	27	427	436	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					83	86		10.1038/35092584	http://dx.doi.org/10.1038/35092584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544530				2022-12-28	WOS:000170801200043
J	Barlow, WE; Davis, RL; Glasser, JW; Rhodes, PH; Thompson, RS; Mullooly, JP; Black, SB; Shinefield, HR; Ward, JI; Marcy, SM; DeStefano, F; Chen, RT; Immanuel, V; Pearson, JA; Vadheim, CM; Rebolledo, V; Christakis, D; Benson, PJ; Lewis, N				Barlow, WE; Davis, RL; Glasser, JW; Rhodes, PH; Thompson, RS; Mullooly, JP; Black, SB; Shinefield, HR; Ward, JI; Marcy, SM; DeStefano, F; Chen, RT; Immanuel, V; Pearson, JA; Vadheim, CM; Rebolledo, V; Christakis, D; Benson, PJ; Lewis, N		Ctr Dis Control Preventive Vaccine	The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIPHTHERIA-TETANUS-PERTUSSIS; ADVERSE EVENTS; UNITED-STATES; IMMUNIZATION; SYSTEM; SURVEILLANCE; CHILDREN; COHORT; SAFETY; SWITCH	Background: The administration of the diphtheria and tetanus toxoids and whole-cell pertussis (DTP) vaccine and measles, mumps, and rubella (MMR) vaccine has been associated with seizures. We studied the relation between these vaccinations and the risk of a first seizure, subsequent seizures, and neurodevelopmental disability in children. Methods: This cohort study was conducted at four large health maintenance organizations and included reviews of the medical records of children with seizures. We calculated the relative risks of febrile and nonfebrile seizures among 679,942 children after 340,386 vaccinations with DTP vaccine, 137,457 vaccinations with MMR vaccine, or no recent vaccination. Children who had febrile seizures after vaccination were followed to identify the risk of subsequent seizures and other neurologic disabilities. Results: Receipt of DTP vaccine was associated with an increased risk of febrile seizures only on the day of vaccination (adjusted relative risk, 5.70; 95 percent confidence interval, 1.98 to 16.42). Receipt of MMR vaccine was associated with an increased risk of febrile seizures 8 to 14 days after vaccination (relative risk, 2.83; 95 percent confidence interval, 1.44 to 5.55). Neither vaccination was associated with an increased risk of nonfebrile seizures. The number of febrile seizures attributable to the administration of DTP and MMR vaccines was estimated to be 6 to 9 and 25 to 34 per 100,000 children, respectively. As compared with other children with febrile seizures that were not associated with vaccination, the children who had febrile seizures after vaccination were not found to be at higher risk for subsequent seizures or neurodevelopmental disabilities. Conclusions: There are significantly elevated risks of febrile seizures after receipt of DTP vaccine or MMR vaccine, but these risks do not appear to be associated with any long-term, adverse consequences. (N Engl J Med 2001;345:656-61.) Copyright (C) 2001 Massachusetts Medical Society.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Immunizat Studies Program, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; NW Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; Kaiser Permanente No Calif, Div Res, Oakland, CA USA; Harbor UCLA Med Ctr, Ctr Vaccine Res, Torrance, CA 90509 USA; So Calif Kaiser Permanente, Kaiser UCLA Vaccine Res Grp, Panorama City, CA USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; Kaiser Permanente; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Kaiser Permanente; University of Washington; University of Washington Seattle	Davis, RL (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Immunizat Studies Program, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.		Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367				BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; BINDER DA, 1992, BIOMETRIKA, V79, P139, DOI 10.1093/biomet/79.1.139; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Davis R L, 1997, HMO Pract, V11, P13; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; ELLENBERG JH, 1978, ARCH NEUROL-CHICAGO, V35, P17, DOI 10.1001/archneur.1978.00500250021004; Elliman D, 2000, BRIT MED J, V321, P451; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Finn A, 2000, BMJ-BRIT MED J, V320, P875; GALE JL, 1994, JAMA-J AM MED ASSOC, V271, P37, DOI 10.1001/jama.271.1.37; GRIFFIN MR, 1990, JAMA-J AM MED ASSOC, V263, P1641, DOI 10.1001/jama.263.12.1641; GRIFFIN MR, 1991, PEDIATRICS, V88, P881; HINMAN AR, 1994, VACCINES, P903; Institute of Medicine Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines, 1991, ADV EFF PERT RUB VAC; Koskiniemi M, 1997, EUR J PEDIATR, V156, P541, DOI 10.1007/s004310050658; Liebert UG, 1997, INTERVIROLOGY, V40, P176, DOI 10.1159/000150544; Madsen T, 1933, J AMER MED ASSOC, V101, P187, DOI 10.1001/jama.1933.02740280007003; MILLER D, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P145; Mullooly J, 1999, AM J EPIDEMIOL, V149, P186; PAYNE T, 1993, AM J PREV MED, V9, P96, DOI 10.1016/S0749-3797(18)30747-5; Roberts JD, 1996, J CLIN EPIDEMIOL, V49, P51, DOI 10.1016/0895-4356(95)00522-6; ROMANUS V, 1987, PEDIATR INFECT DIS J, V6, P364, DOI 10.1097/00006454-198704000-00005; Thompson RS, 1996, MILBANK Q, V74, P469, DOI 10.2307/3350390; VANDENBERG BJ, 1969, PEDIATR RES, V3, P298, DOI 10.1203/00006450-196907000-00005; Verity CM, 1998, NEW ENGL J MED, V338, P1723, DOI 10.1056/NEJM199806113382403; WALKER AM, 1988, PEDIATRICS, V81, P345	27	209	225	0	22	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					656	661		10.1056/NEJMoa003077	http://dx.doi.org/10.1056/NEJMoa003077			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466XG	11547719				2022-12-28	WOS:000170671000004
J	Salmeron, S; Liard, R; Elkharrat, D; Muir, JF; Neukirch, F; Ellrodt, A				Salmeron, S; Liard, R; Elkharrat, D; Muir, JF; Neukirch, F; Ellrodt, A		ASUR; SFMU; SPLF	Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study	LANCET			English	Article							ADULT ASTHMA; ROOM VISITS; THERAPY; CARE; CORTICOSTEROIDS; PREVENTION; ALBUTEROL; CHICAGO; COST; SEX	Background Recent guidelines have enabled doctors to establish accident and emergency department management strategies for acute asthma on the basis of severity of exacerbations at presentation. However, there is no available information on acute asthma patients classified according to severity of disease. Our aim was to describe the severity of such exacerbations at presentation, and the adequacy of treatment and management. Methods We did a 12-month multicentre cross-sectional observational cohort study in adult patients with acute asthma who attended one of 37 accident and emergency departments in France. The doctors who examined the patients obtained information using a formatted chart. We classified exacerbations according to severity (life-threatening, severe, or mild to moderate), on the basis of clinical findings and peak expiratory flour value, as defined by currently used guidelines. Findings Of 3772 patients with acute asthma, 975 (26%) had life-threatening attacks, 1834 (49%) had severe exacerbations without life-threatening features, and 963 (26%) had mild to moderate exacerbations. Initial treatment included nebulised beta2 agonists, anticholinergics, and systemic corticosteroids in 3492 (93%), 1841 (49%), and 2252 (60%), respectively. According to severity classification, anticholinergics were used in 494 (51%), 913 (50%), and 434 (45%) of patients in life-threatening, severe, and mild to moderate exacerbations groups, respectively; corticosteroids were given in 666 (68%), 1117 (61%), and 468 (49%), respectively. The overall admission rate was 54.2%, and mean stay was 6.1 (SD 6.0) days. Patients were admitted in 747 (77%), 1018 (55%), and 278 (29%) of cases in life-threatening, severe, and mild to moderate groups, respectively. Three patients died in hospital. Interpretation Acute asthma exacerbations are often life-threatening in patients who attend accident and emergency departments, and management of patients is not ideal, mainly because of underuse of corticosteroids and inappropriate admission rates according to severity.	Hop Univ Bicetre, Serv Med Interne, Unite Pneumol, F-94275 Le Kremlin Bicetre, France; Hop Univ Bicetre, Serv Urgences, F-94275 Le Kremlin Bicetre, France; Assistance Publ Hop Paris, Hop Lariboisiere, Serv Urgences, Paris, France; Hop Bois Guillaume, Serv Pneumol, Rouen, France; INSERM, U408, Unite Epidemiol Malad Resp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salmeron, S (corresponding author), Hop Univ Bicetre, Serv Med Interne, Unite Pneumol, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	sergio.salmeron@bct.ap-hop-paris.fr						Barr RG, 2000, EUR RESPIR J, V15, P266, DOI 10.1034/j.1399-3003.2000.15b08.x; BARRIOT P, 1987, CHEST, V92, P460, DOI 10.1378/chest.92.3.460; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Blais L, 1998, AM J RESP CRIT CARE, V158, P126, DOI 10.1164/ajrccm.158.1.9707107; *BRIT GUID ASTHM M, 1997, THORAX S, V48, pS21; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; EDMOND SD, 1999, ANN EMERG MED, V34, P321; Emerman CL, 1996, CHEST, V109, P708, DOI 10.1378/chest.109.3.708; Hanania NA, 1997, CHEST, V111, P290, DOI 10.1378/chest.111.2.290; Hartert TV, 1996, AM J MED, V100, P386, DOI 10.1016/S0002-9343(97)89513-7; KWONG T, 1989, NZ MED J, V102, P700; Lagerlov P, 2000, EUR RESPIR J, V15, P25, DOI 10.1034/j.1399-3003.2000.15a06.x; Lin RY, 1998, ANN EMERG MED, V31, P208, DOI 10.1016/S0196-0644(98)70308-7; McDermott MF, 1999, CHEST, V116, p167S, DOI 10.1378/chest.116.suppl_2.167S; McDermott MF, 1997, ARCH INTERN MED, V157, P2055, DOI 10.1001/archinte.157.18.2055; MCFADDEN ER, 1995, AM J MED, V99, P651, DOI 10.1016/S0002-9343(99)80253-8; Milks CJ, 1999, ANN ALLERG ASTHMA IM, V83, P208, DOI 10.1016/S1081-1206(10)62641-5; NEWCOMB RW, 1986, J ALLERGY CLIN IMMUN, V77, P309, DOI 10.1016/S0091-6749(86)80109-9; *NIH, 1997, 974051 NIH NAT ASTHM; Partridge MR, 1997, J ACCID EMERG MED, V14, P16; Quadrelli SA, 1998, RESPIRATION, V65, P347, DOI 10.1159/000029294; Rodrigo G, 1999, AM J MED, V107, P363, DOI 10.1016/S0002-9343(99)00243-0; Rodrigo G, 1999, CHEST, V116, P285, DOI 10.1378/chest.116.2.285; Rodrigo G, 1998, CHEST, V114, P1016, DOI 10.1378/chest.114.4.1016; ROSSI OVJ, 1991, RESPIRATION, V58, P21, DOI 10.1159/000195890; Rowe BH, 2000, COCHRANE DATABASE SY; SALMERON S, 1994, AM J RESP CRIT CARE, V149, P1466, DOI 10.1164/ajrccm.149.6.8004299; SALMERON S, 1994, REAN URG, V3, P95; Singh AK, 1999, ARCH INTERN MED, V159, P1237, DOI 10.1001/archinte.159.11.1237; SITBON O, 1993, AM REV RESPIR DIS, V147, pA380; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Stanford R, 1999, AM J RESP CRIT CARE, V160, P211, DOI 10.1164/ajrccm.160.1.9811040; Taylor DM, 1999, CHEST, V116, P1638, DOI 10.1378/chest.116.6.1638; Thomas SD, 1999, CHEST, V116, p135S, DOI 10.1378/chest.116.suppl_2.135S; Turner MO, 1998, AM J RESP CRIT CARE, V157, P1804, DOI 10.1164/ajrccm.157.6.9708092	35	99	105	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					629	635		10.1016/S0140-6736(01)05779-8	http://dx.doi.org/10.1016/S0140-6736(01)05779-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530150				2022-12-28	WOS:000170615500011
J	Owen-Davies, J				Owen-Davies, J			North Korea's public health tragedy	LANCET			English	Article											Owen-Davies, J (corresponding author), 9 Cleveland Rd, London SW13 0AA, England.								0	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					628	630		10.1016/S0140-6736(00)04062-9	http://dx.doi.org/10.1016/S0140-6736(00)04062-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558502				2022-12-28	WOS:000167119100036
J	CALDEIRA, K; KASTING, JF				CALDEIRA, K; KASTING, JF			THE LIFE-SPAN OF THE BIOSPHERE REVISITED	NATURE			English	Article							EARTHS EARLY ATMOSPHERE; DISSOLUTION; EVOLUTION; CO2; TEMPERATURES; FEEDBACK; GROWTH; CLOUD; VENUS	A DECADE ago, Lovelock and Whitfield1 raised the question of how much longer the biosphere can survive on Earth. They pointed out that, despite the current fossil-fuel induced increase in the atmospheric CO2 concentration, the long-term trend should be in the opposite direction: as increased solar luminosity warms the Earth, silicate rocks should weather more readily, causing atmospheric CO2 to decrease. In their model1, atmospheric CO2 falls below the critical level for C3 photosynthesis, 150 parts per million (p.p.m.), in only 100 Myr, and this is assumed to mark the demise of the biosphere as a whole. Here, we re-examine this problem using a more elaborate model that includes a more accurate treatment of the greenhouse effect of CO2 (refs 2-4), a biologically mediated weathering parameterization, and the realization that C4 photosynthesis can persist to much lower concentrations of atmospheric CO2(<10 p.p.m.)5,6. We find that a C4-plant-based biosphere could survive for at least another 0.9 Gyr to 1.5 Gyr after the present time, depending respectively on whether CO2 or temperature is the limiting factor. Within an additional 1 Gyr, Earth may lose its water to space, thereby following the path of its sister planet, Venus.	PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CALDEIRA, K (corresponding author), PENN STATE UNIV,CTR EARTH SYST SCI,UNIV PK,PA 16802, USA.		Caldeira, Ken/E-7914-2011; Kasting, James/AAF-6851-2020	Caldeira, Ken/0000-0002-4591-643X; 				BAROSS JA, 1983, NATURE, V303, P423, DOI 10.1038/303423a0; BLUM A, 1988, NATURE, V331, P431, DOI 10.1038/331431a0; BROCK TD, 1985, SCIENCE, V230, P132, DOI 10.1126/science.230.4722.132; CALDEIRA K, 1991, GEOLOGY, V19, P204, DOI 10.1130/0091-7613(1991)019<0204:CPCPAT>2.3.CO;2; CHAMEIDES WL, 1984, J GEOPHYS RES-ATMOS, V89, P4739, DOI 10.1029/JD089iD03p04739; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Heath O. V. S., 1969, PHYSL ASPECTS PHOTOS; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, IN PRESS ICARUS; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; LAGACHE M, 1976, GEOCHIM COSMOCHIM AC, V40, P157, DOI 10.1016/0016-7037(76)90173-3; LAGACHE M, 1965, B SOC FR MINERAL CR, V88, P223, DOI 10.3406/bulmi.1965.5840; LOVELOCK JE, 1982, NATURE, V296, P561, DOI 10.1038/296561a0; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MILLER AG, 1984, PLANT PHYSIOL, V75, P1064, DOI 10.1104/pp.75.4.1064; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SACKMANN IJ, 1990, ASTROPHYS J, V360, P727, DOI 10.1086/169158; SILLEN LG, 1961, OCEANOGRAPHY, P549; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; STETTER KO, 1986, THERMOPHILES GENERAL, P39; Stumm W., 1981, AQUATIC CHEM; VOLK T, 1987, AM J SCI, V287, P763, DOI 10.2475/ajs.287.8.763; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; WOGELIUS RA, 1991, GEOCHIM COSMOCHIM AC, V55, P943, DOI 10.1016/0016-7037(91)90153-V	28	165	168	1	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 24	1992	360	6406					721	723		10.1038/360721a0	http://dx.doi.org/10.1038/360721a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KE472	11536510				2022-12-28	WOS:A1992KE47200027
J	STUART, JJ; BROWN, SJ; BEEMAN, RW; DENELL, RE				STUART, JJ; BROWN, SJ; BEEMAN, RW; DENELL, RE			A DEFICIENCY OF THE HOMEOTIC COMPLEX OF THE BEETLE TRIBOLIUM	NATURE			English	Article							GENE FUSHI-TARAZU; DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; MOLECULAR ANALYSIS; ANTENNAPEDIA GENE; SEGMENTATION; EMBRYO; ACTIVATION; HEAD	IN Drosophila, the establishment of regional commitments along most of the anterior/posterior axis of the developing embryo depends on two clusters of homeotic genes: the Antennapedia complex (ANT-C) and the bithorax complex (BX-C). The red flour beetle has a single complex (HOM-C) representing the homologues of the ANT-C and BX-C in juxtaposition 1. Beetles trans-heterozygous for two particular HOM-C mutations spontaneously generate a large deficiency, presumably by an exchange within the common region of two overlapping inversions. Genetic and molecular results indicate that this deficiency spans at least the interval between the Deformed and abdominal-A homologues. In deficiency homozygous embryos, all gnathal, thoracic and abdominal segments develop antennal appendages, suggesting that a gene(s) has been deleted that acts to distinguish trunk from head. There is no evidence that beetles have a homologue of the segmentation gene fushi tarazu of similar genomic location and function. On the basis of the genetic tractability 2, convenient genome size and organization of Tribolium 3, and its relatively long phylogenetic divergence from Drosophila (> 300 million years), we have integrated developmental genetic and molecular analyses of the HOM-C. We isolated about 70 mutations in the complex representing at least six complementation groups. The homeotic phenotypes of adults 2 and lethal embryos lead us to believe that these beetle genes are homologous with the Drosophila genes indicated in Fig. 1.	KANSAS STATE UNIV AGR & APPL SCI,DIV BIOL,ACKERT HALL,MANHATTAN,KS 66506; USDA ARS,N CENT REG,US GRAIN MKT RES LAB,MANHATTAN,KS 66502	Kansas State University; United States Department of Agriculture (USDA)				Brown, Susan/0000-0002-7984-0445				AKAM M, 1988, DEVELOPMENT, V104, P123; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; BROWN SJ, 1990, INSECT BIOCHEM, V20, P185, DOI 10.1016/0020-1790(90)90011-I; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; DUNCAN I, 1986, CELL, V47, P297, DOI 10.1016/0092-8674(86)90452-6; INGHAM PW, 1986, NATURE, V324, P592, DOI 10.1038/324592a0; LEWIS E, 1978, NATURE, V276, P141; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; MAHAFFEY JW, 1989, DEV GENETICS HIGHER, P329; MARTINEZARIAS A, 1986, EMBO J, V5, P135, DOI 10.1002/j.1460-2075.1986.tb04187.x; MERRILL VKL, 1987, DEV BIOL, V122, P379, DOI 10.1016/0012-1606(87)90303-4; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; Sturtevant AH, 1936, GENETICS, V21, P554; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WALLDORF U, 1989, P NATL ACAD SCI USA, V86, P9971, DOI 10.1073/pnas.86.24.9971; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	24	146	148	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 7	1991	350	6313					72	74		10.1038/350072a0	http://dx.doi.org/10.1038/350072a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA693	11536480				2022-12-28	WOS:A1991FA69300068
J	GEHRING, CA; WILLIAMS, DA; CODY, SH; PARISH, RW				GEHRING, CA; WILLIAMS, DA; CODY, SH; PARISH, RW			PHOTOTROPISM AND GEOTROPISM IN MAIZE COLEOPTILES ARE SPATIALLY CORRELATED WITH INCREASES IN CYTOSOLIC FREE CALCIUM	NATURE			English	Article									LA TROBE UNIV, CTR PROT & ENZYME TECHNOL, BUNDOORA, VIC 3083, AUSTRALIA; UNIV MELBOURNE, DEPT PHYSIOL, PARKVILLE, VIC 3052, AUSTRALIA	La Trobe University; University of Melbourne	GEHRING, CA (corresponding author), LA TROBE UNIV, DEPT BOT, BUNDOORA, VIC 3083, AUSTRALIA.			Gehring, Christoph/0000-0003-4355-4591				BASKIN TI, 1986, PLANT PHYSIOL, V81, P306, DOI 10.1104/pp.81.1.306; BLOWERS DP, 1988, 2ND MESSENGERS PLANT, P1; BRIGGS WR, 1963, ANNU REV PLANT PHYS, V14, P311, DOI 10.1146/annurev.pp.14.060163.001523; BRUMMER B, 1985, FEBS LETT, V189, P109, DOI 10.1016/0014-5793(85)80852-8; Darwin C, 1880, POWER MOVEMENT PLANT; ETTLINGER C, 1988, NATURE, V331, P176, DOI 10.1038/331176a0; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; FELLE H, 1986, P NATL ACAD SCI USA, V83, P8992, DOI 10.1073/pnas.83.23.8992; FILNER B, 1970, PLANTA, V94, P333, DOI 10.1007/BF00385765; GILLESPIE B, 1963, PLANT PHYSIOL, V38, P214, DOI 10.1104/pp.38.2.214; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; HILD V, 1972, PLANTA, V108, P245, DOI 10.1007/BF00384112; IINO M, 1984, PLANT CELL ENVIRON, V7, P97, DOI 10.1111/j.1365-3040.1984.tb01562.x; MARME D, 1988, 2ND MESSENGERS PLANT, P57; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; SCANLON M, 1987, J BIOL CHEM, V262, P6308; TREWAVAS A, 1981, PLANT CELL ENVIRON, V4, P203, DOI 10.1111/j.1365-3040.1981.tb01048.x; Went FW., 1937, PHYTOHORMONES; WILLIAMS DA, IN PRESS CELL CALCIU	20	129	137	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	1990	345	6275					528	530		10.1038/345528a0	http://dx.doi.org/10.1038/345528a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH143	11540625				2022-12-28	WOS:A1990DH14300061
J	Satcher, D				Satcher, D			Sharing an agenda for children - Progress and challenges related to the 1990 World Summit for Children goals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1305	1305		10.1001/jama.286.11.1305	http://dx.doi.org/10.1001/jama.286.11.1305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560520				2022-12-28	WOS:000171024500004
J	Gershenfeld, N				Gershenfeld, N			A quantum conversation	SCIENCE			English	Editorial Material							ERROR-CORRECTING CODES; COMPUTATION; COMPUTER; QUBIT		MIT, Media Lab, Phys & Media Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gershenfeld, N (corresponding author), MIT, Media Lab, Phys & Media Grp, Cambridge, MA 02139 USA.							ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; KITAEV AY, 1997, RUSS MATH SURV, V52, P1991; Linden N, 1999, CHEM PHYS LETT, V307, P198, DOI 10.1016/S0009-2614(99)00516-3; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Wieman CE, 1999, REV MOD PHYS, V71, pS253, DOI 10.1103/RevModPhys.71.S253; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987	24	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2035	2037		10.1126/science.293.5537.2035	http://dx.doi.org/10.1126/science.293.5537.2035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557878				2022-12-28	WOS:000171028700059
J	Pertsinidis, A; Ling, XS				Pertsinidis, A; Ling, XS			Diffusion of point defects in two-dimensional colloidal crystals	NATURE			English	Article							PARTICLES	Uniform colloidal microspheres dispersed in a solvent will, under appropriate conditions, self-assemble into ordered crystalline structures(1). Using these colloidal crystals as a model system, a great variety of problems of interest to materials science, physical chemistry, and condensed-matter physics have been investigated during the past two decades. Recently, it has been demonstrated(2) that point defects can be created in two-dimensional colloidal crystals(3) by manipulating individual particles with optical tweezers. Direct imaging of these defects verified that their stable configurations have lower symmetry than the underlying triangular lattice, as predicted by numerical simulations for a number of two-dimensional systems(4-7). It was also observed that point defects can dissociate into pairs of well-separated dislocations, a topological excitation especially important in two dimensions. Here we use a similar experimental system to study the dynamics of mono- and di-vacancies in two-dimensional colloidal crystals. We see evidence that the excitation of point defects into dislocation pairs enhances the diffusion of di-vacancies. Moreover, the hopping of the defects does not follow a pure random walk, but exhibits surprising memory effects. We expect the results presented in this work to be relevant for explaining the dynamics of other two-dimensional systems.	Brown Univ, Dept Phys, Providence, RI 02912 USA	Brown University	Pertsinidis, A (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.		Ling, Xinsheng/A-9219-2008					ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; COCKAYNE E, 1991, PHYS REV B, V43, P623, DOI 10.1103/PhysRevB.43.623; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; FISHER DS, 1979, PHYS REV B, V20, P4692, DOI 10.1103/PhysRevB.20.4692; FREY E, 1994, PHYS REV B, V49, P9723, DOI 10.1103/PhysRevB.49.9723; Gast AP, 1998, PHYS TODAY, V51, P24, DOI 10.1063/1.882495; Jain S, 2000, PHYS REV E, V61, P1599, DOI 10.1103/PhysRevE.61.1599; Murray Colin, 1992, BOND ORIENTATIONAL O; Pertsinidis A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.098303	9	106	107	2	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					147	150		10.1038/35093077	http://dx.doi.org/10.1038/35093077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557976	Green Submitted			2022-12-28	WOS:000170918800042
J	Linder, JA; Stafford, RS				Linder, JA; Stafford, RS			Antibiotic treatment of adults with sore throat by community primary care physicians - A national survey, 1989-1999	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	24th Annual Meeting of the Society-of-General-Internal-Medicine	MAY   04, 2001	SAN DIEGO, CALIFORNIA	Soc Gen Internal Med			RESPIRATORY-TRACT INFECTIONS; GROUP-A STREPTOCOCCI; ERYTHROMYCIN RESISTANCE; PHARYNGITIS; SUSCEPTIBILITY; MANAGEMENT; BRONCHITIS; PENICILLIN; DIAGNOSIS; PYOGENES	Context Most sore throats are due to viral upper respiratory tract infections. Group A beta -hemolytic streptococci (GABHS), the only common cause of sore throat warranting antibiotics, is cultured in 5% to 17% of adults with sore throat. The frequency of antibiotic use for pharyngitis has greatly exceeded the prevalence of GABHS, but less is known about specific classes of antibiotics used. Only penicillin and erythromycin are recommended as first-line antibiotics against GABHS. Objectives To measure trends in antibiotic use for adults with sore throat and to determine predictors of antibiotic use and nonrecommended antibiotic use. Design, Setting, and Subjects Retrospective analysis of 2244 visits to primary care physicians in off ice-based practices in the National Ambulatory Medical Care Survey, 1989-1999, by adults with a chief complaint of sore throat. Main Outcome Measures Treatment with antibiotics and treatment with nonrecommended antibiotics, extrapolated to US annual national rates. Results There were an estimated 6.7 million annual visits in the United States by adults with sore throat between 1989 and 1999. Antibiotics were used in 73% (95% confidence interval [CI] 70%-76%) of visits. Patients treated with antibiotics were given nonrecommended antibiotics in 68% (95% CI, 64%-72%) of visits. From 1989 to 1999, there was a significant decrease in use of penicillin and erythromycin and an increase in use of nonrecommended antibiotics, especially extended-spectrum macrolides and extended-spectrum fluoroquinolones (P<.001 for all trends). In multivariable modeling, increasing patient age (odds ratio [OR], 0.86 per decade; 95% CI, 0.79-0.94) and general practice specialty (OR, 1.54 compared with family practice specialty; 95% CI, 1.10-2.14) were independent predictors of antibiotic use. Among patients receiving antibiotics, nonrecommended antibiotic use became more frequent over time (OR, 1.17 per year; 95% CI, 1.11-1.24). Conclusions More than half of adults are treated with antibiotics for sore throat by community primary care physicians. Use of nonrecommended, more expensive, broader-spectrum antibiotics is frequent.	Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; Stanford Univ, Sch Med, Stanford Ctr Res Dis Prevent, Palo Alto, CA 94304 USA	Harvard University; Massachusetts General Hospital; Stanford University	Linder, JA (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Linder, Jeffrey/AAF-3424-2021; Stafford, Randall/F-3974-2017	Linder, Jeffrey/0000-0003-2217-184X; Stafford, Randall/0000-0003-1805-1271	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003548] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08-HL03548] Funding Source: Medline; BHP HRSA HHS [5T32PE11001-12] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BHP HRSA HHS		Betriu C, 1999, DIAGN MICR INFEC DIS, V33, P255, DOI 10.1016/S0732-8893(98)00155-2; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; Boos M, 2001, ANTIMICROB AGENTS CH, V45, P938, DOI 10.1128/AAC.45.3.938-942.2001; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; DELMAR CB, 2001, COCHRANE LIB; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; *FDA, 1995, NAT DRUG COD DIR 199; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; GWALTNEY JM, 2000, MANDELL DOUGLAS BENN, P656; HOOTON TM, 1991, AM J MED S3A, V91, P23; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; KLJAKOVIC M, 1993, NEW ZEAL MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Macris MH, 1998, PEDIATR INFECT DIS J, V17, P377, DOI 10.1097/00006454-199805000-00006; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; *MED EC DAT, 1999, DRUG TOP RED BOOK; *NAT CTR HLTH STAT, 1999, PUBL US MICR DOC; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; PASKO T, 2000, PHYSICIAN CHARACTERI; PICHICHERO ME, 1991, PEDIATR INFECT DIS J, V10, P275, DOI 10.1097/00006454-199104000-00002; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; POTTHOFF RF, 1992, J AM STAT ASSOC, V87, P383, DOI 10.2307/2290269; SCHATZ RT, 1992, POLIT PSYCHOL, V13, P1, DOI 10.2307/3791421; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; WOODWELL DA, 2000, VITAL HLTH STAT, V315; York MK, 1999, J CLIN MICROBIOL, V37, P1727, DOI 10.1128/JCM.37.6.1727-1731.1999; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	34	143	157	5	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1181	1186		10.1001/jama.286.10.1181	http://dx.doi.org/10.1001/jama.286.10.1181			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559262	Bronze			2022-12-28	WOS:000170910400027
J	Bista, MB; Banerjee, MK; Shin, SH; Tandan, JB; Kim, MH; Sohn, YM; Ohrr, HC; Tang, JL; Halstead, SB				Bista, MB; Banerjee, MK; Shin, SH; Tandan, JB; Kim, MH; Sohn, YM; Ohrr, HC; Tang, JL; Halstead, SB			Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study	LANCET			English	Article							SA14-14-2; TRIAL	Background: In China, since 1989, an estimated 120 million children have been immunised with the SA 14-14-2 live-attenuated Japanese encephalitis (JE) vaccine at ages 1, 2, and 6 years. A case-control study of licensed vaccine found two doses to be 98% effective. Subsequently, researchers found that single-dose vaccine efficacy was high; we aimed to confirm this result. Methods: During July 11-24, 1999, 160 000 doses of JE vaccine were given to children aged 1-15 years, resident in three districts of Nepal. Several cases of JE were admitted to hospital from early August. We obtained names and addresses of cases with serological evidence of a recent infection from Bheri Zonal Hospital, Nepalgunj. We did a matched case-control study and calculated the odds ratio of vaccination among JE cases and age-sex matched village controls. Findings: 20 children, aged 1-15 years, were identified whose illness conformed with the JE case definition and were resident in villages receiving the vaccine. None of 20 JE cases had received JE vaccine compared with 326 of 557 age-sex matched village controls. The efficacy of a single dose of JE vaccine was 99.3% (CI 94.9-100%). Interpretation: A single dose of JE vaccine is highly efficacious in preventing Japanese encephalitis when administered only days or weeks before exposure to infection.	Glovax Co Ltd, Kyryo Academytel, Seoul, South Korea; Minist Hlth, Epidemiol & Dis Control Div, Kathmandu, Nepal; Sch Hlth Sci, Bharatpur, Nepal; Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; Chinese Univ Hong Kong, Dept Community & Family Med, Shatin, Hong Kong, Peoples R China; Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chinese University of Hong Kong; Uniformed Services University of the Health Sciences - USA	Shin, SH (corresponding author), Glovax Co Ltd, Kyryo Academytel, 437-3 Ahyun Dong, Seoul, South Korea.	sunheang@soback.kornet2l.net	Tang, JL/G-1759-2013; Tang, Jin-Ling/AAJ-4090-2021					AO J, 1983, CHIN J MICROBIOL IMM, V3, P245; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; HIRJI KF, 1988, BIOMETRICS, V44, P803, DOI 10.2307/2531592; HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Liu ZL, 1997, J INFECT DIS, V176, P1366, DOI 10.1086/517323; MA W X, 1993, CHINESE J BIOL, V6, P188; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P297; Shepard D.S., 1993, DIS CONTROL PRIORITI, P303; Sohn YM, 1999, VACCINE, V17, P2259, DOI 10.1016/S0264-410X(99)00006-7; SOKHEY J, 1998, INVESTIGATION CONTRO; Takahashi H, 2000, VACCINE, V18, P2963, DOI 10.1016/S0264-410X(00)00111-0; Tsai TF, 1998, J INFECT DIS, V177, P221, DOI 10.1086/517358; TSAI TF, 1999, VACCINES, P672; UNICEF, 1994, STAT WORLDS CHILDR, P82; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; YU YX, 1988, AM J TROP MED HYG, V39, P214, DOI 10.4269/ajtmh.1988.39.214; 1993, MMWR, V42, P1	22	117	128	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					791	795		10.1016/S0140-6736(01)05967-0	http://dx.doi.org/10.1016/S0140-6736(01)05967-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564484				2022-12-28	WOS:000170989300010
J	Cohen, J				Cohen, J			TREM-1 in sepsis	LANCET			English	Editorial Material							INNATE IMMUNITY; LIPOPOLYSACCHARIDE; ENDOTOXIN; STIMULATION; ACTIVATION; RESPONSES; MONOCYTES; SHOCK		Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England	Imperial College London	Cohen, J (corresponding author), Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England.							Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bunnell E, 2000, CRIT CARE MED, V28, P2713, DOI 10.1097/00003246-200008000-00005; Cauwels A, 1997, INFECT IMMUN, V65, P3255, DOI 10.1128/IAI.65.8.3255-3260.1997; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; SRISKANDAN S, 1995, J INFECTION, V30, P201, DOI 10.1016/S0163-4453(95)90647-9; Ulevitch RJ, 1999, NAT MED, V5, P144, DOI 10.1038/5504; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051	20	48	66	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					776	778		10.1016/S0140-6736(01)06007-X	http://dx.doi.org/10.1016/S0140-6736(01)06007-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564478				2022-12-28	WOS:000170989300004
J	Jacobs, K; Zaziski, D; Scher, EC; Herhold, AB; Alivisatos, AP				Jacobs, K; Zaziski, D; Scher, EC; Herhold, AB; Alivisatos, AP			Activation volumes for solid-solid transformations in nanocrystals	SCIENCE			English	Article							PHASE-TRANSITIONS; THIN-FILM; II-VI; PRESSURE; METASTABILITY; KINETICS; SYSTEM; FORCE	The transition between four- and six-coordinate structures in CdSe nanocrystals displays simple transition kinetics as compared with the extended solid, and we determined activation volumes from the pressure dependence of the relaxation times. Our measurements indicate that the transformation takes place by a nucleation mechanism and place strong constraints on the type of microscopic motions that lead to the transformation. The type of analysis presented here is difficult for extended solids, which transform by complicated kinetics and involve ill-defined domain volumes. Solids patterned on the nanoscale may prove to be powerful models for the general study of structural transitions in small systems, as welt as in extended solids.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	alivis@uclink4.berkeley.edu	Alivisatos, Paul/N-8863-2015	Alivisatos, Paul/0000-0001-6895-9048				BARNETT JD, 1973, REV SCI INSTRUM, V44, P1, DOI 10.1063/1.1685943; Berry RS, 2000, J CHEM PHYS, V113, P728, DOI 10.1063/1.481848; BROWN WF, 1969, ANN NY ACAD SCI, V147, P463, DOI 10.1111/j.1749-6632.1969.tb41269.x; Brus LE, 1996, J AM CHEM SOC, V118, P4834, DOI 10.1021/ja954166p; BUNDY FP, 1969, PROC K NED AKAD B-PH, V72, P302; CHANG T, 1993, J APPL PHYS, V73, P6716, DOI 10.1063/1.352512; Chen CC, 1997, SCIENCE, V276, P398, DOI 10.1126/science.276.5311.398; Christian J.W., 1965, THEORY TRANSFORMAT 1; Evans M. G., 1935, T FARADAY SOC; HERHOLD AB, 1997, THESIS U CALIFORNIA; Hill T.L., 1963, THERMODYNAMICS SMALL; JACOBS KE, UNPUB; KIRBY SH, 1991, SCIENCE, V252, P216, DOI 10.1126/science.252.5003.216; Kodiyalam S, 2001, PHYS REV LETT, V86, P55, DOI 10.1103/PhysRevLett.86.55; LANDAU LD, 1980, STAT PHYSICS; Leoni S, 2000, ACTA CRYSTALLOGR A, V56, P383, DOI 10.1107/S0108767300005171; LI XY, 1987, PHYS REV B, V36, P474, DOI 10.1103/PhysRevB.36.474; LUBORSKY FE, 1960, J APPL PHYS, V31, pS68, DOI 10.1063/1.1984606; Molteni C, 2001, J CHEM PHYS, V114, P5358, DOI 10.1063/1.1345497; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; NEEL L, 1949, CR HEBD ACAD SCI, V228, P664; O'Shea MJ, 2000, J APPL PHYS, V87, P6137, DOI 10.1063/1.372634; OSUGI J, 1966, REV PHYS CHEM JPN, V36, P59; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Porter D. A., 1981, PHASE TRANSFORMATION; Putnis A., 1992, INTRO MINERAL SCI; Richards HL, 1997, PHYS REV B, V55, P11521, DOI 10.1103/PhysRevB.55.11521; Richter HJ, 1999, J PHYS D APPL PHYS, V32, pR147, DOI 10.1088/0022-3727/32/21/201; Shekar NVC, 2001, B MATER SCI, V24, P1, DOI 10.1007/BF02704834; Smith W.F., 1996, PRINCIPLES MAT SCI E; TAKEUCHI S, 1984, PHILOS MAG A, V50, P171, DOI 10.1080/01418618408244220; TOLBERT SH, 1995, J CHEM PHYS, V102, P4642, DOI 10.1063/1.469512; Wickham JN, 2000, PHYS REV LETT, V84, P4515, DOI 10.1103/PhysRevLett.84.4515	34	225	227	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1803	1806		10.1126/science.1063581	http://dx.doi.org/10.1126/science.1063581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546866				2022-12-28	WOS:000170894400039
J	Kachroo, A; Schopfer, CR; Nasrallah, ME; Nasrallah, JB				Kachroo, A; Schopfer, CR; Nasrallah, ME; Nasrallah, JB			Allele-specific receptor-ligand interactions in Brassica self-incompatibility	SCIENCE			English	Article							S-LOCUS; TRANSGENIC TOBACCO; MALE DETERMINANT; SLG ALLELES; OLERACEA; KINASE; CAMPESTRIS; GENE; GLYCOPROTEINS; HAPLOTYPES	Genetic self-incompatibility in Brassica is determined by alleles of the transmembrane serine-threonine kinase SRK, which functions in the stigma epidermis, and of the cysteine-rich peptide SCR, which functions in pollen. Using tagged versions of SRK and SCR as well as endogenous stigma and pollen proteins, we show that SCR binds the SRK ectodomain and that this binding is allele,specific. Thus, SRK and SCR function as a receptor-Ligand pair in the recognition of self pollen. Specificity in the self-incompatibility response derives from allele-specific formation of SRK-SCR complexes at the pollen-stigma interface.	Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University	Nasrallah, JB (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	jnb2@cornell.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057527] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57527] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Conner JA, 1997, PLANT J, V11, P809, DOI 10.1046/j.1365-313X.1997.11040809.x; Dixit R, 2000, PLANT PHYSIOL, V124, P297, DOI 10.1104/pp.124.1.297; DOUGHTY J, 1993, P NATL ACAD SCI USA, V90, P467, DOI 10.1073/pnas.90.2.467; Kusaba M, 1999, PLANT J, V17, P83, DOI 10.1046/j.1365-313X.1999.00355.x; Kusaba M, 1997, P NATL ACAD SCI USA, V94, P7673, DOI 10.1073/pnas.94.14.7673; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; Schopfer CR, 2000, PLANT PHYSIOL, V124, P935, DOI 10.1104/pp.124.3.935; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Stein JC, 1996, PLANT CELL, V8, P429, DOI 10.1105/tpc.8.3.429; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Tantikanjana T, 1996, SEX PLANT REPROD, V9, P107; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; UMBACH AL, 1990, PLANT PHYSIOL, V93, P739, DOI 10.1104/pp.93.2.739; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3	22	228	264	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1824	1826		10.1126/science.1062509	http://dx.doi.org/10.1126/science.1062509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546871				2022-12-28	WOS:000170894400045
J	Webster, RG				Webster, RG			Virology - A molecular whodunit	SCIENCE			English	Editorial Material							INFLUENZA-VIRUS; GENE; HEMAGGLUTININ; RECOMBINATION		St Jude Childrens Res Hosp, Dept Virol & Mol Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Virol & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org						[Anonymous], FIELDS VIROLOGY; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; BRIDGES CB, 2001, IN PRESS OPTIONS CON, V4; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; ROTA PA, 1989, J CLIN MICROBIOL, V27, P1413, DOI 10.1128/JCM.27.6.1413-1416.1989; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; TYLER KL, 2001, FIELDS VIROLOGY, P199	11	24	28	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1773	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546856				2022-12-28	WOS:000170894400029
J	Bengel, FM; Ueberfuhr, P; Schiepel, N; Nekolla, SG; Reichart, B; Schwaiger, M				Bengel, FM; Ueberfuhr, P; Schiepel, N; Nekolla, SG; Reichart, B; Schwaiger, M			Effect of sympathetic reinnervation on cardiac performance after heart transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EXERCISE CAPACITY; SERIAL ASSESSMENT; RECIPIENTS; HUMANS; INNERVATION	Background: Late after cardiac transplantation, limited reinnervation of the transplanted heart may occur, but little is known about the effect of reinnervation on cardiac function and exercise performance. Methods: We quantified the extent of myocardial reinnervation noninvasively in 29 cardiac-transplant recipients, using positron-emission tomography and the catecholamine analogue [C-11]hydroxyephedrine. Global and regional ventricular function at rest and during standardized exercise testing was measured with the use of radionuclide angiography, and the results were compared with those in 10 healthy controls. Results: Sympathetic reinnervation, mainly in the anteroseptal wall, was present in 16 of the 29 transplant recipients. At rest, hemodynamic differences were not observed between the patients with reinnervation and those with denervation. However, the latter group had a shorter mean (+/-SD) exercise time (6.1+/-1.5 minutes, vs. 8.2+/-1.2 in the group with reinnervation; P<0.01) and a lower peak heart rate (121+/-13 vs. 143+/-15 beats per minute, P<0.01). The contractile response to exercise was significantly enhanced in transplant recipients with reinnervation and similar to that of normal controls. In a multivariate analysis, hydroxyephedrine retention was the only independent determinant of the exercise-induced increase in the ejection fraction. Conclusions: In heart-transplant recipients, the restoration of sympathetic innervation is associated with improved responses of the heart rate and contractile function to exercise. These results support the functional importance of reinnervation in transplanted hearts.	Tech Univ Munich, Nukl Med Klin & Poliklin, D-8000 Munich, Germany; Univ Munich, Herzchirurg Klin, Munich, Germany	Technical University of Munich; University of Munich	Bengel, FM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, Ismaninger Str 22, D-81675 Munich, Germany.		Bengel, Frank/AAR-7353-2020; Nekolla, Stephan G/L-1857-2013	Nekolla, Stephan G/0000-0002-8817-1482; schwaiger, markus/0000-0002-2305-7144				American Society of Nuclear Cardiology, 1996, J NUCL CARDIOL, V3, pG26; Bengel FM, 2000, EUR J NUCL MED, V27, P1650, DOI 10.1007/s002590000366; Bengel FM, 1999, CIRCULATION, V99, P1866, DOI 10.1161/01.CIR.99.14.1866; Bengel FM, 2001, CIRCULATION, V103, P1881; BURKE MN, 1995, CIRCULATION, V91, P72, DOI 10.1161/01.CIR.91.1.72; COOPER T, 1962, SCIENCE, V138, P40, DOI 10.1126/science.138.3536.40; DEMARCO T, 1995, J AM COLL CARDIOL, V25, P927, DOI 10.1016/0735-1097(94)00463-Z; DiCarli MF, 1997, NEW ENGL J MED, V336, P1208, DOI 10.1056/NEJM199704243361703; GILBERT EM, 1989, CIRCULATION, V79, P344, DOI 10.1161/01.CIR.79.2.344; Givertz MM, 1997, CIRCULATION, V96, P232; KAO AC, 1994, CIRCULATION, V89, P2605, DOI 10.1161/01.CIR.89.6.2605; KAYE DM, 1993, CIRCULATION, V88, P1110, DOI 10.1161/01.CIR.88.3.1110; LEENEN FHH, 1995, CIRCULATION, V91, P685, DOI 10.1161/01.CIR.91.3.685; Mancini D, 1997, CIRCULATION, V96, P6; MANDAK JS, 1995, J HEART LUNG TRANSPL, V14, P468; MARTI V, 1992, TRANSPLANT P, V24, P16; Nekolla SG, 1998, EUR J NUCL MED, V25, P1313, DOI 10.1007/s002590050301; Odaka K, 2001, J NUCL MED, V42, P1011; OPIE LH, 1998, HEART PHYSL CELL CIR, P193; OSTLE B, 1975, STAT RES BASIC CONCE, P321; OYER PE, 1983, TRANSPLANT P, V15, P2546; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; PAULUS WJ, 1992, CIRCULATION, V86, P1175, DOI 10.1161/01.CIR.86.4.1175; QUIGG RJ, 1989, J AM COLL CARDIOL, V14, P338, DOI 10.1016/0735-1097(89)90183-6; ROSENSPIRE KC, 1990, J NUCL MED, V31, P1328; Schwaiblmair M, 1999, J HEART LUNG TRANSPL, V18, P838, DOI 10.1016/S1053-2498(99)00048-0; SCHWAIGER M, 1991, J CLIN INVEST, V87, P1681, DOI 10.1172/JCI115185; STARK RP, 1991, NEW ENGL J MED, V324, P1791, DOI 10.1056/NEJM199106203242507; STEVENSON LW, 1990, CIRCULATION, V81, P78, DOI 10.1161/01.CIR.81.1.78; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; VERANI MS, 1994, J HEART LUNG TRANSPL, V13, P181; WILSON RF, 1993, CIRCULATION, V88, P165, DOI 10.1161/01.CIR.88.1.165; WILSON RF, 1991, CIRCULATION, V83, P1210, DOI 10.1161/01.CIR.83.4.1210; Wilson RF, 2000, CIRCULATION, V101, P2727, DOI 10.1161/01.CIR.101.23.2727	34	184	189	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					731	738		10.1056/NEJMoa010519	http://dx.doi.org/10.1056/NEJMoa010519			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547742	Bronze			2022-12-28	WOS:000170772900004
J	Fost, N				Fost, N			Ethical issues in whistleblowing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE EVENTS		Univ Wisconsin, Sch Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fost, N (corresponding author), Univ Wisconsin, Sch Med, Madison, WI 53706 USA.							Bosk CL, 1979, FORGIVE REMEMBER MAN, DOI DOI 10.7208/CHICAGO/9780226924687.001.0001; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; HILFIKER D, 1985, HEALING WOUNDS PHYSI; HOWE EG, 2000, MARGIN ERROR ETHICS, P165; Krizek TJ, 2000, ARCH SURG-CHICAGO, V135, P1359, DOI 10.1001/archsurg.135.11.1359; RUBIN SB, 2000, MARGIN ERROR INEVITA	6	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1079	1079		10.1001/jama.286.9.1079	http://dx.doi.org/10.1001/jama.286.9.1079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559296				2022-12-28	WOS:000170802500024
J	Bath, PMW; Lindenstrom, E; Boysen, G; De Deyn, P; Friis, P; Leys, D; Marttila, R; Olsson, JE; O'Neill, D; Orgogozo, JM; Ringelstein, B; van der Sande, JJ; Turpie, AGG				Bath, PMW; Lindenstrom, E; Boysen, G; De Deyn, P; Friis, P; Leys, D; Marttila, R; Olsson, JE; O'Neill, D; Orgogozo, JM; Ringelstein, B; van der Sande, JJ; Turpie, AGG		TAIST Investigators	Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial	LANCET			English	Article							ACUTE ISCHEMIC STROKE; MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; CLINICAL-TRIAL; THROMBOSIS; CLASSIFICATION; THERAPY	Background Low-molecular-weight heparins and heparinoids are superior to unfractionated heparin in the prevention and treatment of venous thromboembolism, but their safety and efficacy in acute ischaemic stroke are inadequately defined. Methods This randomised, double-blind, aspirin-controlled trial tested the safety and efficacy of treatment with high-dose tinzaparin (175 anti-Xa IU/kg daily; 487 patients), medium-dose tinzaparin (100 anti-Xa IU/kg daily; 508 patients), or aspirin (300 mg daily; 491 patients) started within 48 h of acute ischaemic stroke and given for up to 10 days. Primary intracerebral haemorrhage was excluded by computed tomography. Outcome was assessed, with treatment allocation concealed, by the modified Rankin scale at 6 months (independence [scores 0-2] vs dependence or death [scores 3-6]). Findings Of 1486 randomised patients, two did not receive treatment and 46 were lost to follow-up. The proportions independent at 6 months were similar In the groups assigned high-dose tinzaparin (194/468 [41.5%]), medium-dose tinzaparin (206/486 [42.4%]), or aspirin (205/482 [42.5%]). There was no difference in effect in any predefined subgroup, including patients with presumed cardioembolic stroke. Other outcome measures were similar between the treatment groups (disability, case-fatality, and neurological deterioration rates). During the in-hospital treatment period no patient assigned high-dose tinzaparin developed a symptomatic deep-vein thrombosis compared with nine assigned aspirin. Conversely, seven patients assigned high-dose tinzaparin developed symptomatic intracerebral haemorrhage compared with one in the aspirin group. Interpretation Treatment with tinzaparin, at high or medium dose, within 48 h of acute ischaemic stroke did not improve functional outcome compared with aspirin. Although high-dose tinzaparin was superior in preventing deep-vein thrombosis, it was associated with a higher rate of symptomatic intracranial haemorrhage.	Univ Nottingham, Ctr Vasc Res, Div Stroke Med, Nottingham NG5 1PB, England; Leo Pharmaceut Prod, DK-2750 Ballerup, Denmark; Bispebjerg Hosp, Dept Neurol, DK-2400 Copenhagen, Denmark; Univ Antwerp, AZ Middelheim, Dept Neurol, B-2020 Antwerp, Belgium; Vest Agder Sentralsykehus, Kristiansand, Norway; CHRU Lille, Neurol Clin, Lille, France; Turku Univ, Cent Hosp, Dept Neurol, Turku, Finland; Univ Sjukhuset, Inst Neurol, Linkoping, Sweden; Adelaide & Meath Hosp, Dept Age Related Hlth Care, Dublin, Ireland; Univ Bordeaux, Dept Neurol, Bordeaux, France; Univ Munster, Neurol Klin, D-4400 Munster, Germany; Slotervaartziekenhuis, Amsterdam, Netherlands; Hamilton Gen Hosp, Hamilton, ON, Canada	University of Nottingham; University of Copenhagen; Bispebjerg Hospital; University of Antwerp; Universite de Lille - ISITE; CHU Lille; University of Turku; Linkoping University; Trinity College Dublin; UDICE-French Research Universities; Universite de Bordeaux; University of Munster; Slotervaart Hospital; McMaster University	Bath, PMW (corresponding author), Univ Nottingham, Ctr Vasc Res, Div Stroke Med, City Hosp Campus, Nottingham NG5 1PB, England.		Kovacs, Michael/G-3315-2011; LEYS, Didier/G-2955-2016; Bath, Philip/F-9020-2011; O'Neill, Desmond/D-1486-2013	LEYS, Didier/0000-0003-4408-4392; Bath, Philip/0000-0003-2734-5132; O'Neill, Desmond/0000-0002-5542-9897				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adams HP, 1998, JAMA-J AM MED ASSOC, V279, P1265, DOI 10.1001/jama.279.16.1265; Albers GW, 1998, CHEST, V114, p683S, DOI 10.1378/chest.114.5_Supplement.683S; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bath P M, 1998, Expert Opin Investig Drugs, V7, P1323, DOI 10.1517/13543784.7.8.1323; Bath PM, 2000, STROKE, V31, P311; Berge E, 2000, LANCET, V355, P1205, DOI 10.1016/S0140-6736(00)02085-7; Bogousslavsky J, 1996, CEREBROVASC DIS, V6, P315; Chamorro A, 1999, CEREBROVASC DIS, V9, P16, DOI 10.1159/000047550; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; GUBITZ G, 2000, COCHRANE LIB; Hacke W, 2000, CEREBROVASC DIS, V10, P22, DOI 10.1159/000047578; Hankey GJ, 1998, MED J AUSTRALIA, V169, P534, DOI 10.5694/j.1326-5377.1998.tb123401.x; Hommel M, 1998, CEREBROVASC DIS, V8, P19; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; KAY R, 1995, NEW ENGL J MED, V333, P1588, DOI 10.1056/NEJM199512143332402; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LEIZOROVICZ A, 1992, BMJ-BRIT MED J, V305, P913, DOI 10.1136/bmj.305.6859.913; LENSING AWA, 1995, ARCH INTERN MED, V155, P601, DOI 10.1001/archinte.155.6.601; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Sandercock P, 1997, LANCET, V349, P1569; SANDERCOCK PAG, 1993, J NEUROL NEUROSUR PS, V56, P17, DOI 10.1136/jnnp.56.1.17; Sherman DG, 2000, JAMA-J AM MED ASSOC, V283, P2395, DOI 10.1001/jama.283.18.2395; SHERMAN DG, 1995, CHEST S4, V108, P444; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538	29	194	201	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					702	710		10.1016/S0140-6736(01)05837-8	http://dx.doi.org/10.1016/S0140-6736(01)05837-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551576				2022-12-28	WOS:000170729500009
J	Jacobs, A; Voges, J; Reszka, R; Lercher, M; Gossmann, A; Kracht, L; Kaestle, C; Wagner, R; Wienhard, K; Heiss, WD				Jacobs, A; Voges, J; Reszka, R; Lercher, M; Gossmann, A; Kracht, L; Kaestle, C; Wagner, R; Wienhard, K; Heiss, WD			Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas	LANCET			English	Article							IN-VIVO	In clinical gene-therapy trials for recurrent glioblastomas, transduction of the herpes simplex virus type-1 thymidine kinase (HSV-1-tk) gene with subsequent prodrug activation by ganciclovir was found to be safe, but clinical response was poor. We used positron-emission tomography (PET) with I-124-labelled 2'-fluoro-2'-deoxy-1 beta -D-arabino-furanosyl-5-lodo-uracil ( [I-124]- FIAU)-a specific marker substrate for gene expression of HSV-1-tk-to identify the location, magnitude, and extent of vector-mediated HSV-1-tk gene expression in a phase I/II clinical trial of gene therapy for recurrent glioblastoma in five patients. The extent of HSV-1-tk gene expression seemed to predict the therapeutic response. The expression of an exogenous gene introduced by gene therapy into patients with gliomas can be monitored non-invasively by PET.	Max Planck Inst Neurol Res, D-50931 Cologne, Germany; Univ Cologne, Dept Neurol, Cologne, Germany; Univ Cologne, Dept Stereotact & Funct Neurosurg, Cologne, Germany; Univ Cologne, Dept Radiol, Cologne, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Heiss, WD (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.		Jacobs, Andreas H./AAA-6794-2020; Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621				Gambhir SS, 2000, NEOPLASIA, V2, P118, DOI 10.1038/sj.neo.7900083; Jacobs A, 2001, CANCER RES, V61, P2983; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219; Zhu J, 1996, GENE THER, V3, P472	5	280	301	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					727	729		10.1016/S0140-6736(01)05904-9	http://dx.doi.org/10.1016/S0140-6736(01)05904-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551583				2022-12-28	WOS:000170729500016
J	Benson, DE; Conrad, DW; de Lorimer, RM; Trammell, SA; Hellinga, HW				Benson, DE; Conrad, DW; de Lorimer, RM; Trammell, SA; Hellinga, HW			Design of bioelectronic interfaces by exploiting hinge-bending motions in proteins	SCIENCE			English	Article							BIOSENSOR; NANOBIOTECHNOLOGY; CONSTRUCTION	We report a flexible strategy for transducing ligand-binding events into electrochemical responses for a wide variety of proteins. The method exploits ligand-mediated hinge-bending motions, intrinsic to the bacterial periplasmic binding protein superfamily, to establish allosterically controlled interactions between electrode surfaces and redox-active, Ru(II)labeled proteins. This approach allows the development of protein-based bioelectronic interfaces that respond to a diverse set of analytes. Families of these interfaces can be generated either by exploiting natural binding diversity within the superfamily or by reengineering the specificity of individual proteins. These proteins may have numerous medical, environmental, and defense applications.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	Duke University; United States Department of Defense; United States Navy; Naval Research Laboratory	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hwh@biochem.duke.edu	Trammell, Scott A./ABB-7140-2020; Wood, David W/B-2992-2012	Trammell, Scott A./0000-0002-7996-590X; 				Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Bard A. J., 1980, ELECTROCHEMICAL METH; Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301; BURTIS CA, 1994, CLIN CHEM; Cass AEG, 1990, BIOSENSORS PRACTICAL; Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268; Cheng Q, 1997, ADV MATER, V9, P481, DOI 10.1002/adma.19970090605; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Creager SE, 1998, ANAL CHEM, V70, P4257, DOI 10.1021/ac980482l; Edelstein RL, 2000, BIOSENS BIOELECTRON, V14, P805, DOI 10.1016/S0956-5663(99)00054-8; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gu LQ, 2001, SCIENCE, V291, P636, DOI 10.1126/science.291.5504.636; Hellinga HW, 1998, TRENDS BIOTECHNOL, V16, P183, DOI 10.1016/S0167-7799(98)01174-3; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laval JM, 2000, ANALYST, V125, P29, DOI 10.1039/a907827d; Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X; Marvin JS, 1997, P NATL ACAD SCI USA, V94, P4366, DOI 10.1073/pnas.94.9.4366; Marvin JS, 1998, J AM CHEM SOC, V120, P7, DOI 10.1021/ja972993f; Marvin JS, 2001, P NATL ACAD SCI USA, V98, P4955, DOI 10.1073/pnas.091083898; Perutz M. F., 1990, MECH COOPERATIVITY A; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Schutz S, 2000, SENSOR ACTUAT B-CHEM, V65, P291, DOI 10.1016/S0925-4005(99)00325-1; SHEN Y, 1993, NATURE, V366, P48, DOI 10.1038/366048a0; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang Y, 1998, ADV MATER, V10, P1536, DOI 10.1002/(SICI)1521-4095(199812)10:18<1536::AID-ADMA1536>3.3.CO;2-W; Thomson NH, 1999, BIOPHYS J, V76, P1024, DOI 10.1016/S0006-3495(99)77267-X; Trammell SA, 2001, BIOCONJUGATE CHEM, V12, P643, DOI 10.1021/bc010022q; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E	32	127	136	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1641	1644		10.1126/science.1062461	http://dx.doi.org/10.1126/science.1062461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533486				2022-12-28	WOS:000170802900058
J	Neth, O; Hann, I; Turner, MW; Klein, NJ				Neth, O; Hann, I; Turner, MW; Klein, NJ			Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study	LANCET			English	Article							SERINE-PROTEASE; GENE; ASSOCIATION; MUTATIONS; COMPLEMENT; POPULATIONS; INDUCTION; PROMOTER; LEUKEMIA; MBL	Background Infection is a major cause of morbidity and mortality in children with malignancy. Individuals with serum deficient in mannose-binding lectin (MBL)-an important component of the innate immune system-are more susceptible to infection than those with adequate concentrations. In this study, we investigated the capacity of this protein to influence infectious complications in children undergoing treatment for malignancy. Methods We enrolled 100 children receiving chemotherapy for malignancy at a children's hospital in London, UK. The frequency, duration, and causes of febrile neutropenic episodes were recorded, and MBL genotype and phenotype were determined by heteroduplex analysis and ELISAs, respectively. Serial MBL concentrations were also measured in patients during febrile episodes, and the results correlated with the MBL genotype (A/A indicating wild type, O/O indicating homozygous for MBL structural-gene mutations, and A/O indicating heterozygous for such mutations). Findings In the A/A patients, MBL concentrations almost doubled by day 7 of the febrile neutropenic episode before declining by day 14 (p=0.004). By contrast, fn patients with MBL mutations, concentrations did not alter significantly during the neutropenic episode. In the 6 months after initial diagnosis, most patients had at least one febrile neutropenic episode, but the median duration in patients with MBL mutations was twice as long as that in children with the wildtype genotype (20.5 days vs 10.0 days; p=0.014). Individuals with the lowest serum MBL concentrations at the time of diagnosis (<1000 <mu>g/L) had a higher median number of days of febrile neutropenia than did individuals with higher concentrations of MBL (p=0.012). Interpretation MBL deficiency seems to have an important influence on the duration of febrile neutropenic episodes in children with malignancy. This finding suggests that MBL infusions could represent a new therapeutic approach which would aid the management of chemotherapy-induced complications in this population of children.	Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Inst Child Hlth, Mol Haematol Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Klein, NJ (corresponding author), Inst Child Hlth, Immunobiol Unit, 30 Guilford St, London WC1N 1EH, England.		Neth, Olaf/F-1167-2015; IBIS, INMUNODEFICIEN/C-1245-2016	Neth, Olaf/0000-0001-5018-0466; Klein, Nigel/0000-0003-3925-9258				Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Graudal NA, 1998, J RHEUMATOL, V25, P629; Hann I, 1997, BRIT J HAEMATOL, V99, P580, DOI 10.1046/j.1365-2141.1997.4453255.x; Hargrave DR, 2001, BRIT J HAEMATOL, V112, P293, DOI 10.1046/j.1365-2141.2001.02543.x; Jack D, 1997, HUM MUTAT, V9, P41, DOI 10.1002/(SICI)1098-1004(1997)9:1<41::AID-HUMU7>3.0.CO;2-S; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Pui CH, 1997, NEW ENGL J MED, V336, P1781, DOI 10.1056/NEJM199706193362503; Riley LC, 1999, BRIT J HAEMATOL, V106, P436, DOI 10.1046/j.1365-2141.1999.01550.x; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; STILLER CA, 1997, PAEDIAT ONCOLOGY CLI, P3; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Turner MW, 2000, HUM MOL GENET, V9, P1481, DOI 10.1093/hmg/9.10.1481; Valdimarsson H, 1998, SCAND J IMMUNOL, V48, P116; vanPelt LJ, 1997, PEDIATR HEMAT ONCOL, V14, P539, DOI 10.3109/08880019709030910	25	238	251	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					614	618		10.1016/S0140-6736(01)05776-2	http://dx.doi.org/10.1016/S0140-6736(01)05776-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530147				2022-12-28	WOS:000170615500008
J	SCHUTTE, WA; ALLAMANDOLA, LJ; SANDFORD, SA				SCHUTTE, WA; ALLAMANDOLA, LJ; SANDFORD, SA			FORMALDEHYDE AND ORGANIC-MOLECULE PRODUCTION IN ASTROPHYSICAL ICES AT CRYOGENIC TEMPERATURES	SCIENCE			English	Article							MU-M; COMET; EMISSION	Thermally promoted formaldehyde (H2CO) reactions in cryogenic ices have been studied to test their importance as a source of organic molecules in comets and interstellar ices. Ices containing H2CO, H2O, CH3OH, CO, and NH3 were investigated by using infrared spectroscopy. Small traces of NH3 (NH3/H2CO greater-than-or-equal-to 0.005) are sufficient to convert significant fractions (greater-than-or-equal-to 40%) of the H2CO into more complex organics. However, H2CO reactions do not proceed without NH3. Spectral evidence for reaction onset appeared between 40 and 80 kelvin, depending on the ice. Five distinct products were formed. These principally consist of polyoxymethylene and related derivatives. Polyoxymethylene itself was not made in significant amounts in cometary analogs. These products differ from those produced by ultraviolet and particle irradiation. The nature and relative amounts of the products depend on the initial composition, making these materials excellent tracers of a comet's history. About 3% of the organics in p-Halley's coma could have been produced by thermal H2CO reactions.			SCHUTTE, WA (corresponding author), NASA,AMES RES CTR,MS 245-6,MOFFETT FIELD,CA 94035, USA.							AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROCHEMISTRY COSMI, P65; BROOKE TY, 1991, ASTRON J, V101, P268, DOI 10.1086/115686; DANKS AC, 1987, ASTRON ASTROPHYS, V184, P329; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; SANDFORD SA, IN PRESS ASTRONOMICA; SCHUTTE W, UNPUB; SCHUTTE WA, 1988, THESIS U LEIDEN LEID; SNYDER LE, 1989, ASTRON J, V97, P246, DOI 10.1086/114976; TADOKORO H, 1963, J CHEM PHYS, V38, P703, DOI 10.1063/1.1733727; TIELENS AGGM, 1982, ASTRON ASTROPHYS, V114, P245; Walker J. F., 1964, FORMALDEHYDE; WALSMLEY C, 1989, INTERSTELLAR DUST, P263; ZHAO NS, 1990, THESIS U LEIDEN LEID	15	75	75	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 19	1993	259	5098					1143	1145		10.1126/science.11540093	http://dx.doi.org/10.1126/science.11540093			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KM917	11540093				2022-12-28	WOS:A1993KM91700033
J	KNOLL, AH; WALTER, MR				KNOLL, AH; WALTER, MR			LATEST PROTEROZOIC STRATIGRAPHY AND EARTH HISTORY	NATURE			English	Review							SEQUENCE STRATIGRAPHY; CENTRAL AUSTRALIA; EAST GREENLAND; TRACE FOSSILS; CARBONATES; BIOSTRATIGRAPHY; SUCCESSIONS; SVALBARD; METAZOA; AMADEUS	The end of the Proterozoic Eon was a time of pronounced biological, biogeochemical, climatic and tectonic change. New bio- and chemostratigraphic data provide an improved framework for stratigraphic correlation, making possible a deeper understanding of latest Proterozoic Earth history and providing tools for a chronostratigraphic division of late Proterozoic time.	MACQUARIE UNIV,SCH EARTH SCI,MACQUARIE,NSW 2109,AUSTRALIA	Macquarie University	KNOLL, AH (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.							AHARON P, 1987, NATURE, V327, P699, DOI 10.1038/327699a0; [Anonymous], 1978, BUREAU MINERAL RESOU; ASMEROM Y, 1991, GEOCHIM COSMOCHIM AC, V55, P2883, DOI 10.1016/0016-7037(91)90453-C; BEANUS MA, 1985, GEOL SOC AM BULL, V96, P737; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; CHRISTIEBLICK N, 1991, MAR GEOL, V97, P35, DOI 10.1016/0025-3227(91)90018-Y; CHRISTIEBLICK N, 1990, AM J SCI, V290A, P295; CHRISTIEBLICK N, 1988, GEOLOGY, V16, P100, DOI 10.1130/0091-7613(1988)016<0100:SSIPS>2.3.CO;2; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; CLOUD P, 1982, SCIENCE, V217, P783, DOI 10.1126/science.217.4562.783; COMPSTON W, 1990, RES SCH EARTH SCI AU, P26; COWIE JW, 1989, PRECAMBRIAN CAMBRIAN, P186; CRIMES TP, 1987, GEOL MAG, V124, P97; Darwin C., 1877, ORIGIN SPECIES; DERRY LA, 1989, GEOCHIM COSMOCHIM AC, V53, P2331, DOI 10.1016/0016-7037(89)90355-4; DERRY LA, IN PRESS GEOCHIM COS; DONNELLY TH, 1990, GEOLOGICAL SOC SPECI, V52, P273; FAIRCHILD IJ, 1987, SEDIMENTOLOGY, V34, P973, DOI 10.1111/j.1365-3091.1987.tb00587.x; FAIRCHILD IJ, 1990, AM J SCI, V290A, P46; FEDONKIN MA, 1990, VENDIAN SYSTEM, V1, P112; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; Glaessner M.F., 1984, DAWN ANIMAL LIFE; Gnilovskaya M.B., 1988, VENDOTAENIDS E EUROP; GRANT SWF, 1990, AM J SCI, V290A, P261; HAMBREY MJ, 1981, EARTHS PREPLEISTOCEN; Harland W.B., 1990, GEOLOGIC TIME SCALE; Harland W.B., 1964, INT J EARTH SCI, V54, P45, DOI [10.1007/BF01821169, DOI 10.1007/BF01821169]; HARLAND WB, 1975, ICE AGES ANCIENT MOD, P189; HOFMANN HJ, 1990, GEOLOGY, V18, P1199, DOI 10.1130/0091-7613(1990)018<1199:ERFIBI>2.3.CO;2; HOFMANN HJ, 1987, GEOSCI CAN, V14, P135; Holser W.T., 1984, PATTERNS CHANGE EART, P123, DOI DOI 10.1007/978-3-642-69317-5_8; JENKINS RJF, 1984, GEOL MAG, V121, P635, DOI 10.1017/S0016756800030788; JENKINS RJF, 1984, T R SOC S AUST, V105, P179; KAUFMAN AJ, 1991, PRECAMBRIAN RES, V49, P301, DOI 10.1016/0301-9268(91)90039-D; KAUFMAN AJ, IN PRESS EARTH PLANE; KHOMENTOVSKY AA, 1990, VENDIAN SYSTEM, V2, P102; Kirschvink J.L., 1991, GSA TODAY, V1, P69; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1989, NATURE, V337, P602, DOI 10.1038/337602a0; KNOLL AH, IN PRESS PALAEONTOLO; KNOLL AH, 1991, SCI AM, V265, P65; KROGH TE, 1988, CAN J EARTH SCI, V25, P442, DOI 10.1139/e88-045; LAMBERT IB, 1987, NATURE, V325, P140, DOI 10.1038/325140a0; Lindsay J. F., 1989, BASIN RES, V2, P3; LINDSAY JF, 1987, AAPG BULL, V71, P1387; Moczydlowska M., 1991, FOSSILS STRATA, V29, P1; MORRIS SC, 1990, AM J SCI, V290A, P245; MORRIS SC, 1989, PRECAMBRIAN CAMBRIAN, P7; NARBONNE GM, 1988, B NEW YORK STATE MUS, V463, P72; PLUMB KA, 1991, EPISODES, V14, P139, DOI 10.18814/epiiugs/1991/v14i2/005; ROSS GM, 1988, GEOLOGY, V16, P139, DOI 10.1130/0091-7613(1988)016<0139:TSAARC>2.3.CO;2; ROSS GM, 1991, GEOLOGICAL ASS CANAD, V16, P108; Schopf JW, 1983, EARTHS EARLIEST BIOS; Sokolov B. S., 1952, IZV AN SSSR GEOL, V5, P21; SOKOLOV BS, 1990, VENDIAN SYSTEM, V1; VEIZER J, 1983, GEOCHIM COSMOCHIM AC, V47, P295, DOI 10.1016/0016-7037(83)90142-4; VIDAL G, 1990, PALAEONTOLOGY, V33, P287; VONDERBORCH CC, 1988, AUST J EARTH SCI, V35, P59, DOI 10.1080/08120098808729439; Walter M. R., 1976, STROMATOLITES; WALTER MR, 1985, PRECAMBRIAN RES, V29, P149, DOI 10.1016/0301-9268(85)90066-X; WALTER MR, 1989, ALCHERINGA, V13, P209, DOI 10.1080/03115518908527821; WHITTAKER A, 1991, J GEOL SOC LONDON, V148, P813, DOI 10.1144/gsjgs.148.5.0813; Willis BJ, 1907, RES CHINA; Yin L., 1985, PALAEONTOLOGIA CATHA, V2, P229; ZANG W, 1989, NATURE, V337, P632	65	238	260	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1992	356	6371					673	678		10.1038/356673a0	http://dx.doi.org/10.1038/356673a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ146	11537861				2022-12-28	WOS:A1992HQ14600048
J	MCKAY, CP; POLLACK, JB; COURTIN, R				MCKAY, CP; POLLACK, JB; COURTIN, R			THE GREENHOUSE AND ANTIGREENHOUSE EFFECTS ON TITAN	SCIENCE			English	Article							ATMOSPHERE; OCEAN	There are many parallels between the atmospheric thermal structure of the Saturnian satellite Titan and the terrestrial greenhouse effect; these parallels provide a comparison for theories of the heat balance of Earth. Titan's atmosphere has a greenhouse effect caused primarily by pressure-induced opacity of N2, CH4, and H-2. H-2 is a key absorber because it is primarily responsible for the absorption in the wave number 400 to 600 cm-1 "window" region of Titan's infrared spectrum. The concentration of CH4, also an important absorber, is set by the saturation vapor pressure and hence is dependent on temperature. In this respect there is a similarity between the role of H-2 and CH4 on Titan and that of CO2 and H2O on Earth. Titan also has an antigreenhouse effect that results from the presence of a high-altitude haze layer that is absorbing at solar wavelengths but transparent in the thermal infrared. The antigreenhouse effect on Titan reduces the surface temperature by 9 K whereas the greenhouse effect increases it by 21 K. The net effect is that the surface temperature (94 K) is 12 K warmer than the effective temperature (82 K). If the haze layer were removed, the antigreenhouse effect would be greatly reduced, the greenhouse effect would become even stronger, and the surface temperature would rise by over 20 K.	OBSERV PARIS,RECH SPATIALE LAB,F-92195 MEUDON,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	MCKAY, CP (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035, USA.							DANIELSON RE, 1973, ICARUS, V20, P437, DOI 10.1016/0019-1035(73)90016-X; Hunten D.M, 1984, SATURN, P671; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; MUHLEMAN DO, 1990, SCIENCE, V248, P975, DOI 10.1126/science.248.4958.975; POLLACK JB, 1991, ICARUS, V91, P173, DOI 10.1016/0019-1035(91)90017-N; POLLACK JB, 1983, SCIENCE, V219, P287, DOI 10.1126/science.219.4582.287; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; RAGES K, 1979, ICARUS, V41, P119; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SAMUELSON RE, 1981, NATURE, V292, P688, DOI 10.1038/292688a0; SAMUELSON RE, 1983, ICARUS, V53, P364, DOI 10.1016/0019-1035(83)90156-2; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X; TOON OB, 1982, P C LARGE BODY IMPAC, P187; TURCO RP, 1983, SCIENCE, V222, P1283, DOI 10.1126/science.222.4630.1283; WEST RA, 1983, J GEOPHYS RES-SPACE, V88, P8699, DOI 10.1029/JA088iA11p08699	18	157	160	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 6	1991	253	5024					1118	1121		10.1126/science.11538492	http://dx.doi.org/10.1126/science.11538492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD808	11538492				2022-12-28	WOS:A1991GD80800025
J	SCHWARTZ, AW; BAKKER, CG				SCHWARTZ, AW; BAKKER, CG			WAS ADENINE THE 1ST PURINE	SCIENCE			English	Article											SCHWARTZ, AW (corresponding author), CATHOLIC UNIV NIJMEGEN,FAC SCI,EXOBIOL LAB,6525 ED NIJMEGEN,NETHERLANDS.							Cronin JR., 1988, ORGANIC MATTER CARBO, P819; FERRIS JP, 1978, J MOL EVOL, V11, P293, DOI 10.1007/BF01733839; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Miller S. L., 1974, ORIGINS LIFE EARTH; ORO J, 1960, BIOCHEM BIOPH RES CO, V2, P407, DOI 10.1016/0006-291X(60)90138-8; SANCHEZ RA, 1967, J MOL BIOL, V30, P223; SCHWARTZ AW, 1983, NATURWISSENSCHAFTEN, V70, P373, DOI 10.1007/BF01047172; SCHWARTZ AW, 1984, ORIGINS LIFE EVOL B, V14, P91, DOI 10.1007/BF00933644; SCHWARTZ AW, 1982, J MOL EVOL, V18, P351, DOI 10.1007/BF01733902; SCHWARTZ AW, 1985, SCIENCE, V228, P585, DOI 10.1126/science.228.4699.585; SMITH CVZ, 1973, CHEM SOC PERKIN T 1, P1855; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; VISSCHER J, 1989, SCIENCE, V244, P329, DOI 10.1126/science.2540527; VISSCHER J, 1988, J MOL EVOL, V28, P3, DOI 10.1007/BF02143492; VOET AB, 1983, BIOORG CHEM, V12, P8, DOI 10.1016/0045-2068(83)90003-2	15	31	33	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 8	1989	245	4922					1102	1104		10.1126/science.11538344	http://dx.doi.org/10.1126/science.11538344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN702	11538344				2022-12-28	WOS:A1989AN70200034
J	Majeed, A; Bindman, AB; Weiner, JP				Majeed, A; Bindman, AB; Weiner, JP			Use of risk adjustment in setting budgets and measuring performance in primary care I: how it works	BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING BUDGETS; FORMULA; RATES; WILL	Healthcare systems in countries throughout the developed world are faced with the problem of limiting the growth in spending on health services while ensuring that their populations have access to appropriate care. The United Kingdom is no different in this respects and the past 20 years have seen the introduction of numerous initiatives aimed at improving the efficiency, of the NHS. Approaches adopted by the NHS to help improve efficiency include the introduction of capitation based budgets and increased monitoring of providers' performance. In the United States similar pressures to improve the efficiency of the healthcare system have led to the wide scale adoption of fixed budgets and monitoring of healthcare providers. Diagnosis based methods for adjusting risk are becoming increasingly common within the US managed healthcare industry. The objective of risk adjustment is to help ensure that budgetary allocations or provider assessments take into account the morbidity of individual patients. In this and a subsequent article, we will describe this still evolving process and discuss its possible implications for the NHS, particularly for the new primary care organisations. There are various methods for carrying out risk adjustment but we have used the Johns Hopkins adjusted clinical group system to show how risk adjustment works. The system is particularly relevant to,primary care and is the most widely used method of measuring population case mix in the United States.	UCL, Sch Publ Policy, London WC1H 9EZ, England; Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94110 USA; Johns Hopkins Sch Publ Hlth, Hlth Serv Res & Dev Ctr, Baltimore, MD 21025 USA	University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Majeed, A (corresponding author), UCL, Sch Publ Policy, London WC1H 9EZ, England.	a.majeed@ucl.ac.uk		Majeed, Azeem/0000-0002-2357-9858				Averill R. F., 1999, DEV EVALUATION CLIN; Baines DL, 2000, BRIT MED J, V320, P288, DOI 10.1136/bmj.320.7230.288; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1064, DOI 10.1056/NEJM200004063421422; Ellis RP, 1996, HEALTH CARE FINANC R, V17, P101; HippisleyCox J, 1997, BRIT MED J, V314, P1458, DOI 10.1136/bmj.314.7092.1458; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; Kronick R, 1996, HEALTH CARE FINANC R, V17, P7; Kuttner R, 1998, NEW ENGL J MED, V339, P1952, DOI 10.1056/NEJM199812243392625; Majeed A, 1998, BRIT MED J, V316, P748, DOI 10.1136/bmj.316.7133.748; MAJEED FA, 1996, HLTH TRENDS, V28, P52; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; Rice N, 2000, BRIT MED J, V320, P284, DOI 10.1136/bmj.320.7230.284; SCHEFFLER R, 1989, LANCET, V1, P950; Smith P., 1994, FORMULA DISTRIBUTING; *US DHHS, 1996, HLTH CARE FINANCIN S, V17; WEINER JP, 1991, MED CARE, V29, P453	17	19	20	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					604	607		10.1136/bmj.323.7313.604	http://dx.doi.org/10.1136/bmj.323.7313.604			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474CT	11557709	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000171087300020
J	Naumann, M; Lowe, NJ				Naumann, M; Lowe, NJ		Hyperhidrosis Clin Study Grp	Botulinum toxin type A in, treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial	BRITISH MEDICAL JOURNAL			English	Article							PALMAR HYPERHIDROSIS; FOCAL HYPERHIDROSIS; ENDOSCOPIC SYMPATHECTOMY; A TOXIN; INJECTION	Objectives To evaluate the safety and efficacy of. botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis. Design Multicentre, randomised, parallel group, placebo controlled trial. Setting 17 dermatology and neurology clinics in Belgium, Germany, Switzerland, and the United Kingdom. Participants Patients aged 18-75 years with bilateral primary axillary hyperhidrosis sufficient to interfere with daily living. 465 were screened, 320 randomised, and 307 completed the study. Interventions Patients received either botulinum toxin type A (Botox) 50 U per axilla or placebo by 10-15 intradermal injections evenly distributed within the hyperhidrotic area of each axilla, defined by Minor's iodine starch test. Main outcome measures Percentage of responders (patients with greater than or equal to 50% reduction from baseline of spontaneous axillary sweat production) at four weeks, patients' global assessment of treatment satisfaction score, and adverse events. Results At four weeks, 94% (227) of the botulinum toxin type A group had responded compared with 36% (28) of the placebo group. By week 16, response rates were 82% (198) and 21% (16), respectively. The results for all other measures of efficacy were significantly better in the botulinum toxin group than the placebo group. Significantly higher patient satisfaction was reported in the botulinum toxin type A group than the placebo group (3.3 v 0.8, P < 0.001 at 4 weeks). Treatment related adverse events were reported by only 27 patients (11%) in the botulinum. toxin group and four (5%) in the placebo group (P=0.13). Conclusion Botulinum toxin type A is a safe and effective treatment for primary axillary hyperhidrosis and produces high levels of patient satisfaction.	Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Cranley Clin Dermatol, London W1M 9AD, England	University of Wurzburg	Naumann, M (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.		Griffiths, Christopher E.M./P-5448-2014	Griffiths, Christopher E.M./0000-0001-5371-4427				Bushara KO, 1996, CLIN EXP DERMATOL, V21, P276, DOI 10.1111/j.1365-2230.1996.tb00093.x; DROTT C, 1995, J AM ACAD DERMATOL, V33, P78, DOI 10.1016/0190-9622(95)90015-2; Drott C, 1996, CARDIOVASC SURG, V4, P790; Glogau RG, 1998, DERMATOL SURG, V24, P817, DOI 10.1111/j.1524-4725.1998.tb04257.x; Hallett M, 1999, NEW ENGL J MED, V341, P118, DOI 10.1056/NEJM199907083410209; Heckmann M, 1999, J AM ACAD DERMATOL, V41, P987, DOI 10.1016/S0190-9622(99)70258-6; Heckmann M, 2001, NEW ENGL J MED, V344, P488, DOI 10.1056/NEJM200102153440704; HERBST F, 1994, ANN SURG, V220, P86, DOI 10.1097/00000658-199407000-00012; Kao MC, 1996, ARCH SURG-CHICAGO, V131, P1091; Lai YT, 1997, NEUROSURGERY, V41, P110, DOI 10.1097/00006123-199707000-00023; MINOR V, 1927, DTSCH Z NERVENHEILKD, V101, P301; Naumann M, 1997, LANCET, V349, P252, DOI 10.1016/S0140-6736(05)64861-1; Naumann M, 1998, ARCH DERMATOL, V134, P301, DOI 10.1001/archderm.134.3.301; Naumann M, 1999, EUR J NEUROL, V6, pS111, DOI 10.1111/j.1468-1331.1999.tb00027.x; Naver H, 1997, EUR J NEUROL, V4, pS75; Naver H, 1999, EUR J NEUROL, V6, pS117, DOI 10.1111/j.1468-1331.1999.tb00028.x; Odderson IR, 1998, ARCH PHYS MED REHAB, V79, P350, DOI 10.1016/S0003-9993(98)90020-X; Odderson IR, 1998, DERMATOL SURG, V24, P1237, DOI 10.1111/j.1524-4725.1998.tb04104.x; Schnider P, 1996, BRIT J DERMATOL, V134, P1160, DOI 10.1111/j.1365-2133.1996.tb07974.x; Schnider P, 1999, BRIT J DERMATOL, V140, P677; Shelley WB, 1998, J AM ACAD DERMATOL, V38, P227, DOI 10.1016/S0190-9622(98)70242-7; Stolman LP, 1998, DERMATOL CLIN, V16, P863, DOI 10.1016/S0733-8635(05)70062-0	22	214	216	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					596	599		10.1136/bmj.323.7313.596	http://dx.doi.org/10.1136/bmj.323.7313.596			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557704	Bronze, Green Published			2022-12-28	WOS:000171087300015
J	Volpi, E; Sheffield-Moore, M; Rasmussen, BB; Wolfe, RR				Volpi, E; Sheffield-Moore, M; Rasmussen, BB; Wolfe, RR			Basal muscle amino acid kinetics and protein synthesis in healthy young and older men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANCE EXERCISE; SKELETAL-MUSCLE; METABOLISM; SARCOPENIA; RATES	Context Sarcopenia is associated with loss of strength and function, eventually leading to loss of independence. Some studies suggest that basal muscle protein turnover is reduced with aging, but other studies do not confirm this finding. Objective To determine if aging per se affects basal muscle protein turnover in men. Design and Setting Cross-sectional study conducted from June 1997 to July 2000 in a general US community. Participants Twenty-six young (mean [SE] age, 28 [2] years) and 22 older (mean [SE] age, 70 [1] years) men, who were healthy and independent based on activities of daily living, physical examinations, and screening tests. Subjects were excluded if they had cardiac, pulmonary, liver, or kidney disease; any impairment in activities of daily living; or steroid use. Main Outcome Measures We measured basal muscle protein and amino acid kinetics, based on stable isotope techniques with femoral arteriovenous catheterization and muscle biopsies. Three models (arteriovenous balance, three-pool, and fractional synthesis rate) were used to estimate the metabolic parameters. Results Mean (SE) total leg volume was 9.60 (0.32) L in older men vs 10.83 (0.43) L in younger men, which suggests muscle loss in the older men. Net muscle protein balance was similar in both groups (older men, -19 [2] nmol/min per 100 mL of leg volume vs younger men, -21 [2] nmol/min per 100 ml. of leg volume; P = .51). Small differences were found in mean (SE) muscle protein synthesis in comparisons of older vs younger men: arteriovenous balance, 48 (5) nmol/min per 100 mL of leg volume vs 32 (3) nmol/min per 100 mL of leg volume; P = .004; three-pool, 58 (5) nmol/min per 100 mL of leg volume vs 43 (4) nmol/min per 100 mL of leg volume; P = .04; and fractional synthesis rate, 0.0601 (0.0046) %/h vs 0.0578 (0.0047) %/h; P = .73. Small differences were also found in mean (SE) muscle protein breakdown: arteriovenous balance, 66 (5) nmol/min per 100 mL of leg volume in older vs 53 (4) nmol/min per 100 mL of leg volume in younger men, P = .045; and three-pool, 76 (6) nmol/min per 100 mL of leg volume vs 64 (5) nmol/min per 100 mL of leg volume, P = .14. Conclusion Differences in basal muscle protein turnover between older and younger men do not appear to explain muscle loss that occurs with age.	Univ So Calif, Div Endocrinol & Diabet, Dept Med, 1333 San Pablo St,BMT-B11, Los Angeles, CA 90033 USA; Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Surg, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77550 USA; Shriners Hosp Children, Galveston, TX 77550 USA; Univ So Calif, Dept Kinesiol, Los Angeles, CA 90033 USA	University of Southern California; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California	Volpi, E (corresponding author), Univ So Calif, Div Endocrinol & Diabet, Dept Med, 1333 San Pablo St,BMT-B11, Los Angeles, CA 90033 USA.	volpi@usc.edu	Sheffield-Moore, Melinda/A-9794-2016; Volpi, Elena/I-4459-2012	Sheffield-Moore, Melinda/0000-0001-6579-4655; Volpi, Elena/0000-0001-8776-0384; Rasmussen, Blake/0000-0001-7854-5375	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, R01AG015780, R01AG018311, P60AG017231] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00073, M01 RR000073] Funding Source: Medline; NIA NIH HHS [P60 AG017231, P30 AG024832, R01 AG018311, P60 AG17231, R01 AG018311-01, R01 AG18311, R01 AG015780, R01 AG15780] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Bross R, 1999, J CLIN ENDOCR METAB, V84, P3420, DOI 10.1210/jc.84.10.3420; CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704; Campbell WW, 1996, EUR J CLIN NUTR, V50, pS180; CHINKES DL, 1993, CLIN SCI, V84, P177, DOI 10.1042/cs0840177; Dionne I J, 2000, J Nutr Health Aging, V4, P156; DUTTA C, 1995, J GERONTOL A-BIOL, V50, P1, DOI 10.1093/gerona/50A.Special_Issue.1; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P147; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JORFELDT L, 1978, METABOLISM, V27, P97, DOI 10.1016/0026-0495(78)90128-2; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; KATCH V, 1975, HUM BIOL, V47, P203; LEXELL J, 1995, J GERONTOL, V50; Pannemans DLE, 1998, AM J CLIN NUTR, V68, P1228, DOI 10.1093/ajcn/68.6.1228; Patterson BW, 1997, METABOLISM, V46, P943, DOI 10.1016/S0026-0495(97)90084-6; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; ROBERTS SB, 1995, J GERONTOL A-BIOL, V50, P101; Roubenoff R, 2000, J Nutr Health Aging, V4, P140; SHETTY KR, 1995, ENDOCRIN METAB CLIN, V24, P213, DOI 10.1016/S0889-8529(18)30039-2; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; WOLFE RR, 1992, RADIOACTIVE STABLE I, P167; WOLFE RR, 1992, RADIOACTIVE STABLE I, P417; WOLFE RR, 1992, RADIOACTIVE STABLE I, P119; WOLFSON L, 1995, J GERONTOL A-BIOL, V50, P64; Yarasheski KE, 1999, AM J PHYSIOL-ENDOC M, V277, pE118, DOI 10.1152/ajpendo.1999.277.1.E118; YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210	37	302	307	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1206	1212		10.1001/jama.286.10.1206	http://dx.doi.org/10.1001/jama.286.10.1206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	471CR	11559266	Green Accepted, Bronze			2022-12-28	WOS:000170910400031
J	Doherty, M				Doherty, M			Risk factors for progression of knee osteoarthritis	LANCET			English	Editorial Material							ALIGNMENT		City Hosp, Acad Dept Rheumatol, Nottingham NG5 1PB, England	University of Nottingham	Doherty, M (corresponding author), City Hosp, Acad Dept Rheumatol, Clin Sci Bldg, Nottingham NG5 1PB, England.	Michael.Doherty@nottingham.ac.uk		Doherty, Michael/0000-0002-5763-8326				Brandt KD, 1998, OSTEOARTHRITIS, P70; Creamer P, 2000, RHEUMATOLOGY, V39, P490, DOI 10.1093/rheumatology/39.5.490; DOHERTY M, 1983, LANCET, V2, P8; Elahi S, 2000, ARTHRITIS RHEUM, V43, P1874, DOI 10.1002/1529-0131(200008)43:8<1874::AID-ANR25>3.0.CO;2-2; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HUSKISSON EC, 1995, J RHEUMATOL, V22, P1941; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; Ogata K, 1997, INT ORTHOP, V21, P308, DOI 10.1007/s002640050174; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Sharma L, 2000, ARTHRITIS RHEUM, V43, P568, DOI 10.1002/1529-0131(200003)43:3<568::AID-ANR13>3.0.CO;2-E	13	64	66	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					775	776		10.1016/S0140-6736(01)06006-8	http://dx.doi.org/10.1016/S0140-6736(01)06006-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564477				2022-12-28	WOS:000170989300003
J	Wootton, R				Wootton, R			Recent advances - Telemedicine	BRITISH MEDICAL JOURNAL			English	Review							REALTIME TELEDERMATOLOGY; SERVICE; SYSTEM; CARE; TRIAL		Univ Queensland, Royal Childrens Hosp, Ctr Online Hlth, Herston, Qld 4029, Australia	Royal Children's Hospital Brisbane; University of Queensland	Wootton, R (corresponding author), Univ Queensland, Royal Childrens Hosp, Ctr Online Hlth, Herston, Qld 4029, Australia.		Wootton, Richard/F-7609-2014	Wootton, Richard/0000-0002-2666-3596				Armstrong I J, 1997, J Telemed Telecare, V3, P27, DOI 10.1258/1357633971930166; Bergmo T S, 1996, J Telemed Telecare, V2, P136, DOI 10.1258/1357633961929952; Bergmo TS, 2000, J TELEMED TELECARE, V6, P273, DOI 10.1258/1357633001935905; Chan WM, 2001, J TELEMED TELECARE, V7, P38, DOI 10.1258/1357633011936129; Currell R, 2000, COCHRANE DB SYST REV, V1; Hakansson S, 2000, J TELEMED TELECARE, V6, P133, DOI 10.1258/1357633001934438; Harno K, 2000, J TELEMED TELECARE, V6, P320, DOI 10.1258/1357633001935996; Harrison R, 1996, BRIT MED J, V313, P1377, DOI 10.1136/bmj.313.7069.1377; Haukipuro K, 2000, J TELEMED TELECARE, V6, P193, DOI 10.1258/1357633001935347; Hussain P, 1999, J TELEMED TELECARE, V5, P95, DOI 10.1258/1357633991932757; Johnston B, 2000, ARCH FAM MED, V9, P40, DOI 10.1001/archfami.9.1.40; Keen J, 2000, BRIT MED J, V321, P875, DOI 10.1136/bmj.321.7265.875; Larson A, 1998, AM J ROENTGENOL, V170, P19, DOI 10.2214/ajr.170.1.9423590; Li HK, 1999, TELEMED J, V5, P283, DOI 10.1089/107830299312032; Loane MA, 2000, BRIT J DERMATOL, V143, P1241, DOI 10.1046/j.1365-2133.2000.03895.x; McLaren P, 1999, J TELEMED TELECARE, V5, P100, DOI 10.1258/1357633991932766; Melzer SM, 1999, ARCH PEDIAT ADOL MED, V153, P858, DOI 10.1001/archpedi.153.8.858; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; Oakley AMM, 2000, J TELEMED TELECARE, V6, P97, DOI 10.1258/1357633001935112; Shanit D, 1996, J Telemed Telecare, V2, P7, DOI 10.1258/1357633961929105; Tachakra S, 2000, J TELEMED TELECARE, V6, P330, DOI 10.1258/1357633001936003; Vassallo DJ, 2001, J TELEMED TELECARE, V7, P125, DOI 10.1258/1357633011936273; Whitten P, 1998, J TELEMED TELECARE, V4, P152, DOI 10.1258/1357633981932136; Whitten P, 1997, SCI COMMUN, V19, P21, DOI 10.1177/1075547097019001002; Wootton R, 1998, J R Soc Med, V91, P614; Wootton R, 2000, BRIT MED J, V320, P1252, DOI 10.1136/bmj.320.7244.1252; Wootton R, 1998, J TELEMED TELECARE, V4, P214, DOI 10.1258/1357633981932262; Wootton R, 1996, BRIT MED J, V313, P1375, DOI 10.1136/bmj.313.7069.1375; YELLOWLEES PM, 1999, INTRO TELEMEDICINE, P93; 1999, J TELEMED TELECAR S3, V5, P1	30	189	190	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					557	560		10.1136/bmj.323.7312.557	http://dx.doi.org/10.1136/bmj.323.7312.557			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546704	Green Published			2022-12-28	WOS:000170934600025
J	Sambrano, GR; Weiss, EJ; Zheng, YW; Huang, W; Coughlin, SR				Sambrano, GR; Weiss, EJ; Zheng, YW; Huang, W; Coughlin, SR			Role of thrombin signalling in platelets in haemostasis and thrombosis	NATURE			English	Article							GLYCOPROTEIN IB-ALPHA; COLLAGEN RECEPTOR; ACTIVATION; MODEL; GENE; ANTIBODY; IIB/IIIA; FAMILY; DEATH; MICE	Platelets are critical in haemostasis and in arterial thrombosis, which causes heart attacks and other events triggered by abnormal clotting(1-5). The coagulation protease thrombin is a potent activator of platelets ex vivo(6). However, because thrombin also mediates fibrin deposition and because multiple agonists can trigger platelet activation(7), the relative importance of platelet activation by thrombin in haemostasis and thrombosis is unknown. Thrombin triggers cellular responses at least in part through protease-activated receptors (PARs)(8). Mouse platelets express PAR3 and PAR4 (ref. 9). Here we show that platelets from PAR4-deficient mice failed to change shape, mobilize calcium, secrete ATP or aggregate in response to thrombin. This result demonstrates that PAR signalling is necessary for mouse platelet activation by thrombin and supports the model that mouse PAR3 (mPAR3) does not by itself mediate transmembrane signalling but instead acts as a cofactor for thrombin cleavage and activation of mPAR4 (ref. 10). Importantly, PAR4-deficient mice had markedly prolonged bleeding times and were protected in a model of arteriolar thrombosis. Thus platelet activation by thrombin is necessary for normal haemostasis and may be an important target in the treatment of thrombosis.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.							Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; COLLER BS, 1986, BLOOD, V68, P783; Colman RW, 1994, HEMOSTASIS THROMBOSI, P3; COOK JJ, 1995, CIRCULATION, V91, P2961, DOI 10.1161/01.CIR.91.12.2961; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; DAVIES MJ, 1989, EUR HEART J, V10, P203, DOI 10.1093/oxfordjournals.eurheartj.a059467; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, J BIOL CHEM, V273, P23290, DOI 10.1074/jbc.273.36.23290; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kehrel B, 1998, BLOOD, V91, P491; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MORTENSEN R, 1993, CURRENT PROTOCOLS S, V23; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Offermanns S, 2000, BIOL CHEM, V381, P389, DOI 10.1515/BC.2000.051; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; SAUER B, 1993, GUIDE TECHNIQUES MOU, P890; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Topol E, 1998, NEW ENGL J MED, V339, P436; WARE J, 1990, P NATL ACAD SCI USA, V87, P2026, DOI 10.1073/pnas.87.5.2026; Watson S, 2000, PLATELETS, V11, P252	30	407	424	1	49	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					74	78		10.1038/35092573	http://dx.doi.org/10.1038/35092573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544528				2022-12-28	WOS:000170801200041
J	Simon, A; Cuisset, L; Vincent, MF; van der Velde-Visser, SD; Delpech, M; van der Meer, JWM; Drenth, JPH				Simon, A; Cuisset, L; Vincent, MF; van der Velde-Visser, SD; Delpech, M; van der Meer, JWM; Drenth, JPH		HIDS Study Grp	Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-IgD and periodic fever syndrome: Its application as a diagnostic tool	ANNALS OF INTERNAL MEDICINE			English	Article							HYPERIMMUNOGLOBULINEMIA-D; UNKNOWN ORIGIN; MUTATIONS; ATTACKS; MVK	Background: The hyper-IgD and periodic fever syndrome (HIDS) is characterized by recurrent attacks of fever, abdominal distress, and arthralgia and is caused by mevalonate kinase mutations. Objective: To ascertain the role of mevalonate kinase and the usefulness of molecular diagnosis in HIDS. Design: Cross-sectional study. Setting: The international Nijmegen HIDS registry. Patients: 54 patients from 41 families who met the clinical criteria for HIDS. Measurements: Clinical symptoms and signs, immunoglobulin concentration, leukocyte count, erythrocyte sedimentation rate, mutation analysis, and mevalonate kinase enzyme activity assay. Results: There were two groups of patients: 41 patients with mevalonate kinase mutations (classic-type HIDS) and 13 patients without mutations (variant-type HIDS). Patients with classic-type HIDS had a lower mevalonate kinase enzyme activity, a higher IgD level, and more additional symptoms with attacks. The IgD level did not correlate with disease severity, mevalonate kinase enzyme activity, or genotype. Conclusion: Genetic heterogeneity exists among patients with a clinical diagnosis of HIDS.	Radboud Univ Nijmegen Med Ctr, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Genet & Physiopathol Malad Inflammatoires Heredit, Paris, France; Hop Cochin, F-75674 Paris, France; Catholic Univ Louvain, B-1200 Brussels, Belgium	Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain	Simon, A (corresponding author), Radboud Univ Nijmegen Med Ctr, Div Gen Internal Med, Box 9101, NL-6500 HB Nijmegen, Netherlands.	a.simon@worldonline.nl	Drenth, Joost/V-7436-2019; van der Meer, Jos W.M./C-8521-2013; Drenth, J.P.H./H-8025-2014; Simon, Anna/D-3757-2009	van der Meer, Jos W.M./0000-0001-5120-3690; Simon, Anna/0000-0002-6141-7921				Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; de Kleijn EMH, 1997, MEDICINE, V76, P392, DOI 10.1097/00005792-199711000-00002; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drenth JPH, 2000, BRIT MED J, V320, P1091, DOI 10.1136/bmj.320.7242.1091; DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586; DRENTH JPH, 1995, EUR J CLIN INVEST, V25, P683, DOI 10.1111/j.1365-2362.1995.tb01986.x; Eisenberg S, 1998, ANN INTERN MED, V129, P539, DOI 10.7326/0003-4819-129-7-199810010-00005; GIBSON KM, 1989, ENZYME, V41, P47, DOI 10.1159/000469050; Grose C, 1996, PEDIATR INFECT DIS J, V15, P72, DOI 10.1097/00006454-199601000-00016; HARALDSSON A, 1992, J CLIN IMMUNOL, V12, P424, DOI 10.1007/BF00918854; HOFFMANN GF, 1992, J INHERIT METAB DIS, V15, P738, DOI 10.1007/BF01800016; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; KNOCKAERT DC, 1993, MEDICINE, V72, P184; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Palinski W, 2000, NAT MED, V6, P1311, DOI 10.1038/82107; VANDERMEER JWM, 1984, LANCET, V1, P1087	19	63	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					338	343		10.7326/0003-4819-135-5-200109040-00010	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529697				2022-12-28	WOS:000170780600004
J	Gonzalez, C				Gonzalez, C			Undergraduate research, graduate mentoring, and the university's mission	SCIENCE			English	Editorial Material								Undergraduate research and graduate mentoring have received a great deal of attention in recent times. What do these activities have in common? They both speak to the primary mission of the research university, which is not merely carrying out research but training students to do research. The knowledge-based global economy, with its wealth of information and opportunities, has increased undergraduate students' need for research skills as well as graduate students' desire for personal guidance. As the research university matures, the boundaries between graduate and undergraduate education are blurring. Indeed, if we focus on the learning process, we find not two but five levels of learning at the research university: tower division, upper division, master's, doctoral, and postdoctoral. Alt five levels form a continuum, a series of gradual steps. The mission of the university is to introduce students to research, to inspire in them a passion for discovery at each of these levels.	Univ Calif Davis, Off Grad Studies, Davis, CA 95616 USA	University of California System; University of California Davis	Gonzalez, C (corresponding author), Univ Calif Davis, Off Grad Studies, Davis, CA 95616 USA.							*ASS AM U, 1998, COMM POSTD ED REP RE; *ASS AM U, 1998, COMM GRAD ED REP REC; *BOY COMM ED UND R, 1998, REINV UND ED BLUEPR; Committee on Science Engineering and Public Policy, 1995, RESH GRAD ED SCI ENG; Committee on Science Engineering and Public Policy., 2000, ENH POSTD EXP SCI EN; Golde C., 2001, CROSS PURPOSES WHAT; *NAT SCI BOARD, 1998, FED ROL SCI ENG GRAD; POSTDOC NETWORK	8	73	75	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1624	1626		10.1126/science.1062714	http://dx.doi.org/10.1126/science.1062714			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533483				2022-12-28	WOS:000170802900053
J	Pastores, GM; Thadhani, R				Pastores, GM; Thadhani, R			Enzyme-replacement therapy for Anderson-Fabry disease	LANCET			English	Editorial Material									NYU, Sch Med, Dept Neurol & Pediat, Neurogenet Program, New York, NY 10003 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA	New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pastores, GM (corresponding author), NYU, Sch Med, Dept Neurol & Pediat, Neurogenet Program, New York, NY 10003 USA.		Pastores, Gregory M./AAE-8647-2020					Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; DESNIEK RJ, 2000, METABOLIC MOL BASES, V3, P3733; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Jung SC, 2001, P NATL ACAD SCI USA, V98, P2676, DOI 10.1073/pnas.051634498; KUHN H, 1982, CIRCULATION, V66, P117; MACDERMOT KD, IN PRESS J MED GENET; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; PASTORES GM, 1999, ENFERMEDAD GAUCHER E, P13; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743	12	50	55	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					601	603		10.1016/S0140-6736(01)05816-0	http://dx.doi.org/10.1016/S0140-6736(01)05816-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530143				2022-12-28	WOS:000170615500004
J	Smilde, TJ; van Wissen, S; Wollersheim, H; Trip, MD; Kastelein, JJP; Stalenhoef, AFH				Smilde, TJ; van Wissen, S; Wollersheim, H; Trip, MD; Kastelein, JJP; Stalenhoef, AFH			Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial	LANCET			English	Article							INTIMA-MEDIA THICKNESS; ARTERIAL-WALL THICKNESS; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CHOLESTEROL; ATORVASTATIN; POPULATION; PREVENTION	Background High LDL-cholesterol is a risk factor for atherosclerosis. We aimed to determine whether aggressive cholesterol lowering with statins was more effective than conventional statin treatment in this disease. We investigated the effect of high-dose atorvastatin on carotid atherosclerosis progression. Methods We did a randomised, double-blind clinical trial in 325 patients with familial hypercholesterolaemia. Patients were given either atorvastatin 80 mg (n=160) or simvastatin 40 mg (n=165) daily, on an intent-to-treat basis. The primary endpoint was the change of carotid intima media thickness (IMT), as measured by quantitative B-mode ultrasound, over 2 years. Findings The overall baseline IMT, combining the measurements of the common and internal carotid artery and the carotid bifurcation on both sides, was 0.93 mm (SD 0.22) and 0.92 mm (0.21) in the atorvastatin and simvastatin groups, respectively. After treatment with atorvastatin for 2 years, IMT decreased (-0.031 mm [95% CI -0.007 to -0.055]; p=0.0017), whereas in the simvastatin group it increased (0.036 [0.014-0.058]; p=0.0005). The change in thickness differed significantly between the two groups (p=0.0001). Atorvastatin showed greater reductions in cholesterol concentrations than did simvastatin. HDL-cholesterol concentrations increased in both groups. Both drugs were equally well tolerated. Interpretation Our results show that aggressive LDL-cholesterol reduction by atorvastatin was accompanied by regression of carotid intima media thickness in patients with familial hypercholesterolaemia, whereas conventional LDL lowering was not.	Univ Nijmegen, Med Ctr, Dept Med, Div Gen Internal Med 541, NL-6500 HB Nijmegen, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Smilde, TJ (corresponding author), Univ Nijmegen, Med Ctr, Dept Med, Div Gen Internal Med 541, POB 9101, NL-6500 HB Nijmegen, Netherlands.	t.smilde@worldonline.nl	Stalenhoef, A.F.H./H-8094-2014; Kastelein, John/AAF-7950-2020; Wollersheim, H.C.H./L-4769-2015					Aminbakhsh A, 1999, CLIN INVEST MED, V22, P149; BOTS ML, 1992, HYPERTENSION, V19, P717, DOI 10.1161/01.HYP.19.6.717; Brown WV, 2000, AM J CARDIOL, V86, p29H, DOI 10.1016/S0002-9149(00)01097-3; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Campeau L, 1997, NEW ENGL J MED, V336, P153; Chambless LE, 1996, ULTRASOUND MED BIOL, V22, P545, DOI 10.1016/0301-5629(96)00039-7; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 1996, ANN INTERN MED, V124, P548, DOI 10.7326/0003-4819-124-6-199603150-00002; Jacobson TA, 2000, ANN INTERN MED, V133, P549, DOI 10.7326/0003-4819-133-7-200010030-00015; KANE JP, 1990, JAMA-J AM MED ASSOC, V264, P3007, DOI 10.1001/jama.264.23.3007; Kroon AA, 1996, ANN INTERN MED, V125, P945, DOI 10.7326/0003-4819-125-12-199612150-00001; LEUS FR, 1994, CLIN BIOCHEM, V27, P449, DOI 10.1016/0009-9120(94)00052-W; LOPESVIRELLA MFL, 1980, CLIN CHEM, V26, P1205; Mannami T, 1997, STROKE, V28, P518, DOI 10.1161/01.STR.28.3.518; NAWROCKI JW, 1995, ARTERIOSCL THROM VAS, V15, P678, DOI 10.1161/01.ATV.15.5.678; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Pedersen TR, 1999, ATHEROSCLEROSIS, V144, P38, DOI 10.1016/S0021-9150(99)80143-9; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Schectman G, 1996, AM J MED, V100, P197, DOI 10.1016/S0002-9343(97)89459-4; Smilde TJ, 2000, CLIN DRUG INVEST, V20, P67, DOI 10.2165/00044011-200020020-00001; Smilde TJ, 2000, EUR J CLIN INVEST, V30, P473; Smilde TJ, 1998, ARTERIOSCL THROM VAS, V18, P1958, DOI 10.1161/01.ATV.18.12.1958; Tonstad S, 1998, EUR J CLIN INVEST, V28, P971; TOUBOUL PJ, 1992, J HYPERTENS, V10, pS37, DOI 10.1097/00004872-199207005-00006; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	29	745	775	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					577	581		10.1016/S0140-6736(00)04053-8	http://dx.doi.org/10.1016/S0140-6736(00)04053-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558482				2022-12-28	WOS:000167119100008
J	Stewart, SF; Hudson, M; Talbot, D; Manas, D; Day, CP				Stewart, SF; Hudson, M; Talbot, D; Manas, D; Day, CP			Mycophenolate mofetil monotherapy in liver transplantation	LANCET			English	Article								Chronic renal failure is a major cause of morbidity and mortality after orthotopic liver transplantation. We did a randomised controlled trial of mycophenolate mofetil monotherapy in liver transplant patients who developed renal failure associated with calcineurin-inhibitor (ciclosporin or tacrolimus) immunosuppressive therapy. Although renal failure improved when the calcineurin-inhibitor dose was reduced and ultimately stopped, the trial was stopped when three of five patients on monotherapy developed organ rejection requiring a second transplantation.	Freeman Hosp, Liver Unit, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle Freeman Hospital	Day, CP (corresponding author), Freeman Hosp, Liver Unit, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Day, Christopher/Z-3305-2019					Fisher NC, 1998, TRANSPLANTATION, V66, P59, DOI 10.1097/00007890-199807150-00010; Hebert MF, 1999, TRANSPLANTATION, V67, P707, DOI 10.1097/00007890-199903150-00011; Papatheodoridis GV, 1999, TRANSPLANTATION, V68, P155, DOI 10.1097/00007890-199907150-00029	3	93	94	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					609	610		10.1016/S0140-6736(00)04065-4	http://dx.doi.org/10.1016/S0140-6736(00)04065-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558493				2022-12-28	WOS:000167119100019
J	SHEEHAN, PM; FASTOVSKY, DE; HOFFMANN, RG; BERGHAUS, CB; GABRIEL, DL				SHEEHAN, PM; FASTOVSKY, DE; HOFFMANN, RG; BERGHAUS, CB; GABRIEL, DL			SUDDEN EXTINCTION OF THE DINOSAURS - LATEST CRETACEOUS, UPPER GREAT-PLAINS, USA	SCIENCE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTIONS	Results of a three-year field study of family-level patterns of ecological diversity of dinosaurs in the Hell Creek Formation of Montana and North Dakota show no evidence (probability P < 0.05) of a gradual decline of dinosaurs at the end of the Cretaceous. Stratigraphic reliability was maintained through a tripartite division of the Hell Creek, and preservational biases were corrected for by comparison of results only from similar facies as well as through the use of large-scale, statistically rigorous survey and collection procedures. The findings are in agreement with an abrupt extinction event such as one caused by an asteroid impact.	UNIV RHODE ISL, DEPT GEOL, KINGSTON, RI 02881 USA; MED COLL WISCONSIN, DIV BIOSTAT, MILWAUKEE, WI 53226 USA	University of Rhode Island; Medical College of Wisconsin	SHEEHAN, PM (corresponding author), MILWAUKEE PUBL MUSEUM, DEPT GEOL, MILWAUKEE, WI 53233 USA.							ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1987, PHYS TODAY, V40, P24, DOI 10.1063/1.881078; ALVAREZ LW, 1983, P NATL ACAD SCI USA, V80, P627, DOI 10.1073/pnas.80.2.627; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; ARCHIBALD JD, 1982, AM SCI, V70, P377; ARCHIBALD JD, 1987, MEM SOC GEOL FR, V150, P45; Behrensmeyer A.K., 1980, P72; BOHOR BF, 1984, SCIENCE, V224, P867, DOI 10.1126/science.224.4651.867; BOHOR BF, 1987, GEOLOGY, V15, P896, DOI 10.1130/0091-7613(1987)15<896:DSATML>2.0.CO;2; CARPENTER K, 1983, NATURWISSENSCHAFTEN, V70, P611, DOI 10.1007/BF00377404; Clemens W.A., 1986, P63; CLEMENS WA, 1981, PALEOBIOLOGY, V7, P293, DOI 10.1017/S0094837300004589; CLEMENS WA, 1980, MEM SOC GEOL FR, V139, P67; CLEMENS WA, 1982, GEOL SOC AM SPEC PAP, V190, P407; Cody M. L., 1975, ECOLOGY EVOLUTION CO; FASTOVSKY D E, 1987, Palaios, V2, P282, DOI 10.2307/3514678; FASTOVSKY DE, 1986, GEOLOGY, V14, P279, DOI 10.1130/0091-7613(1986)14<279:SSAEDT>2.0.CO;2; Fastovsky DE, 1990, GEOLOGICAL SOC AM SP, V247, P541, DOI [10.1130/SPE247-p541, DOI 10.1130/SPE247-P541]; GABRIEL DL, 1980, LORE, V30, P24; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; Hutchinson G.E., 1978, INTRO POPULATION ECO; JOHNSON KR, 1987, GEOL SOC AM ABSTR, V19, P718; JOHNSON KR, 1990, GEOL SOC AM ABSTR, V22, pA323; Kraus M.J., 1986, PALEOSOLS THEIR RECO, P180; MacArthur R.H., 1972, pvii; May R.M., 1975, P81; MORRIS PJ, 1990, GEOL SOC AM SPEC PAP, V247, P433; OFFICER CB, 1987, NATURE, V326, P143, DOI 10.1038/326143a0; OFFICER CB, 1990, J GEOL EDUC, V38, P402; Padian K., 1985, P41; PADIAN K, 1989, AGE DINOSAURS SHORT, V2; PIELOU E C, 1969, P286; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; RETALLACK G, 1986, SCIENCE, V234, P1170, DOI 10.1126/science.234.4781.1170; RUSSELL DA, 1984, NATURE, V307, P360, DOI 10.1038/307360a0; RUSSELL DA, 1982, SCI AM, V246, P58, DOI 10.1038/scientificamerican0182-58; RUSSELL LORE S., 1965, J PALEONTOL, V39, P497; RUSSELL LS, 1973, CAN J EARTH SCI, V10, P140, DOI 10.1139/e73-016; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SCHOPF TJM, 1982, GEOL SOC AM SPEC PAP, V190, P415; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SHEEHAN PM, 1986, SCIENCE, V234, P1171, DOI 10.1126/science.234.4781.1171; Simberloff D., 1978, BIOLOGICAL DATA WATE, P150; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; SLOAN RE, 1976, ATHLON ESSAYS PALAEO, P134; SLOAN RE, 1987, GEOL SOC AM ABSTR, V19, P848; SMIT J, 1984, SCIENCE, V223, P1177, DOI 10.1126/science.223.4641.1177; Smit J., 1987, MEM SOC GEOL FR, V150, P53; SMITH AB, 1988, EVOL BIOL, V23, P127; Strong D.R., 1984, ECOLOGICAL COMMUNITI; TAMM V, 1991, GEOL ASS CAN ABSTR, V16, pA122; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; van Valen L, 1977, Evolutionary Theory, V2, P37; VANVALEN L, 1977, NATURE, V270, P193, DOI 10.1038/270193a0; WARD PD, 1990, GEOL SOC AM ABSTR, V22, pA356; Weishampel D.B., 1990, DINOSAURIA; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; ZACHOS JC, 1989, NATURE, V337, P61, DOI 10.1038/337061a0; ZALEHA MJ, 1987, SEPM ANN MIDYEAR M, V4, P94	62	93	98	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	1991	254	5033					835	839		10.1126/science.11536489	http://dx.doi.org/10.1126/science.11536489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	11536489				2022-12-28	WOS:A1991GN83300038
J	ZAHNLE, K; GRINSPOON, D				ZAHNLE, K; GRINSPOON, D			COMET DUST AS A SOURCE OF AMINO-ACIDS AT THE CRETACEOUS TERTIARY BOUNDARY	NATURE			English	Article											ZAHNLE, K (corresponding author), NASA,AMES RES CTR,MS 245-3,MOFFETT FIELD,CA 94035, USA.							ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BROMLEY R, 1979, CRETACEOUS TERTIARY, P16; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; CLUBE SVM, 1986, GALAXY SOLAR SYSTEM, P260; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; CRONIN JR, 1989, NATURE, V339, P423, DOI 10.1038/339423a0; DONNISON JR, 1986, ASTRON ASTROPHYS, V167, P359; GILMOUR I, 1989, GEOCHIM COSMOCHIM AC, V53, P503, DOI 10.1016/0016-7037(89)90401-8; HEISLER J, 1987, ICARUS, V70, P269, DOI 10.1016/0019-1035(87)90135-7; Hills J. G., 1986, GALAXY SOLAR SYSTEM, P397; HUGHES DW, 1987, ASTRON ASTROPHYS, V187, P879; HUT P, 1987, NATURE, V329, P118, DOI 10.1038/329118a0; Jessberger E. K., 1989, ORIGIN EVOLUTION PLA, P167; KASTNER M, 1984, SCIENCE, V226, P137, DOI 10.1126/science.226.4671.137; OBERBECK V, 1988, ORIG LIFE, V19, P39; OLSSONSTEEL D, 1987, MON NOT R ASTRON SOC, V227, P501, DOI 10.1093/mnras/227.2.501; OLSSONSTEEL D, 1988, ICARUS, V75, P64, DOI 10.1016/0019-1035(88)90127-3; PREISINGER A, 1986, NATURE, V322, P794, DOI 10.1038/322794a0; SEKANINA Z, 1984, ICARUS, V58, P81, DOI 10.1016/0019-1035(84)90099-X; STOHL J, 1987, ASTRON ASTROPHYS, V187, P933; SURLYK F, 1979, CRETACEOUS TERTIARY, P164; VICKERY A, IN PRESS GLOBAL CATA; WHIPPLE F, 1976, MEM SOC R LIEGE 6, V55, P101; WHIPPLE FL, 1951, ASTROPHYS J, V113, P464, DOI 10.1086/145416; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; ZAHNLE K, 1989, B AM ASTRON SOC, V21, P923; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0	28	60	61	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 8	1990	348	6297					157	160		10.1038/348157a0	http://dx.doi.org/10.1038/348157a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG776	11536472				2022-12-28	WOS:A1990EG77600054
J	Hirsch, AT; Criqui, MH; Treat-Jacobson, D; Regensteiner, JG; Creager, MA; Olin, JW; Krook, SH; Hunninghake, DB; Comerota, AJ; Walsh, ME; McDermott, MM; Hiatt, WR				Hirsch, AT; Criqui, MH; Treat-Jacobson, D; Regensteiner, JG; Creager, MA; Olin, JW; Krook, SH; Hunninghake, DB; Comerota, AJ; Walsh, ME; McDermott, MM; Hiatt, WR			Peripheral arterial disease detection, awareness, and treatment in primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; INTERMITTENT CLAUDICATION; CHOLESTEROL LEVELS; RISK-FACTORS; ARM INDEX; MORTALITY; PREVALENCE; PREDICTOR; PRESSURE	Context Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that is common and is associated with an increased risk of death and ischemic events, yet may be underdiagnosed in primary care practice. Objective To assess the feasibility of detecting PAD in primary care clinics, patient and physician awareness of PAD, and intensity of risk factor treatment and use of antiplatelet therapies in primary care clinics. Design and Setting The PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, a multicenter, cross-sectional study conducted at 27 sites in 25 cities and 350 primary care practices throughout the United States in June-October 1999. Patients A total of 6979 patients aged 70 years or older or aged 50 through 69 years with history of cigarette smoking or diabetes were evaluated by history and by measurement of the ankle-brachial index (ABI). PAD was considered present if the ABI was 0.90 or less, if it was documented in the medical record, or if there was a history of limb revascularization. Cardiovascular disease (CVD) was defined as a history of atherosclerotic coronary, cerebral, or abdominal aortic aneurysmal disease. Main Outcome Measures Frequency of detection of PAD; physician and patient awareness of PAD diagnosis; treatment intensity in PAD patients compared with treatment of other forms of CVD and with patients without clinical evidence of atherosclerosis. Results PAD was detected in 1865 patients (29%); 825 of these (44%) had PAD only, without evidence of CVD. Overall, 13% had PAD only, 16% had PAD and CVD, 24% had CVD only, and 47% had neither PAD nor CVD (the reference group). There were 457 patients (55%) with newly diagnosed PAD only and 366 (35%) with PAD and CVD who were newly diagnosed during the survey. Eighty-three percent of patients with prior PAD were aware of their diagnosis, but only 49% of physicians were aware of this diagnosis. Among patients with PAD, classic claudication was distinctly uncommon (11%). Patients with PAD had similar atherosclerosis risk factor profiles compared with those who had CVD. Smoking behavior was more frequently treated in patients with new (53%) and prior PAD (51%) only than in those with CVD only (35%; P<.001). Hypertension was treated less frequently in new (84%) and prior PAD (88%) only vs CVD only (95%; P<.001) and hyperlipidemia was treated less frequently in new (44%) and prior PAD (56%) only vs CVD only (73%, P<.001). Antiplatelet medications were prescribed less often in patients with new (33%) and prior PAD (54%) only vs CVD only (71%, P<.001). Treatment intensity for diabetes and use of hormone replacement therapy in women were similar across all groups. Conclusions Prevalence of PAD in primary care practices is high, yet physician awareness of the PAD diagnosis is relatively low. A simple ABI measurement identified a large number of patients with previously unrecognized PAD. Atherosclerosis risk factors were very prevalent in PAD patients, but these patients received less intensive treatment for lipid disorders and hypertension and were prescribed antiplatelet therapy less frequently than were patients with CVD. These results demonstrate that underdiagnosis of PAD in primary care practice may be a barrier to effective secondary prevention of the high ischemic cardiovascular risk associated with PAD.	Univ Minnesota, Sch Med, Minnesota Vasc Dis Ctr, Vasc Med Program, Minneapolis, MN 55455 USA; Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA; Univ Colorado, Hlth Sci Ctr, Div Geriatr, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Inst Heart & Vasc, Morristown, NJ USA; Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA; Jobst Ctr, Toledo, OH USA; Northwestern Univ, Sch Med, Chicago, IL USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Northwestern University	Hirsch, AT (corresponding author), Univ Minnesota, Sch Med, Minnesota Vasc Dis Ctr, Vasc Med Program, Mayo Mail Code 508,420 Delaware St SE, Minneapolis, MN 55455 USA.	Hirsc005@umn.edu		Treat-Jacobson, Diane/0000-0003-3296-8764	NHLBI NIH HHS [1-K07-HL03435-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K07HL003435] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM HEART ASS, 1999, 550532991118D AM HEA; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; ARONOW WS, 1994, AM J CARDIOL, V74, P64, DOI 10.1016/0002-9149(94)90493-6; Black HR, 1998, ARCH INTERN MED, V158, P573; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; *BRIST MYERS SQUIB, 1999, TAK STEPS PER ART DI; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Criqui M H, 1997, Vasc Med, V2, P221; Criqui M H, 1996, Vasc Med, V1, P65; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fowkes FGR, 1997, ATHEROSCLEROSIS, V131, pS29, DOI 10.1016/S0021-9150(97)06122-4; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hirsch A T, 1997, Vasc Med, V2, P243; Hirsch AT, 2001, VASC MED, V6, P87, DOI 10.1191/135886301701568756; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jackson MR, 1998, CHEST, V114, p666S, DOI 10.1378/chest.114.5_Supplement.666S; JONASON T, 1987, ACTA MED SCAND, V221, P253; KANNEL WB, 1970, CIRCULATION, V41, P875, DOI 10.1161/01.CIR.41.5.875; McDermott MM, 1999, J LAB CLIN MED, V133, P33, DOI 10.1053/lc.1999.v133.a94240; McDermott MM, 1997, J GEN INTERN MED, V12, P209, DOI 10.1046/j.1525-1497.1997.012004209.x; MCKENNA M, 1991, ATHEROSCLEROSIS, V87, P119, DOI 10.1016/0021-9150(91)90014-T; Meijer WT, 1998, ARTERIOSCL THROM VAS, V18, P185, DOI 10.1161/01.ATV.18.2.185; NEWMAN AB, 1991, J CLIN EPIDEMIOL, V44, P15, DOI 10.1016/0895-4356(91)90196-G; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; OURIEL K, 1982, SURGERY, V91, P686; Papademetriou V, 1998, AM HEART J, V136, P734, DOI 10.1016/S0002-8703(98)70023-7; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; *US DHHS FDA, 1998, FED REGISTER, V63, P56802; VOGT MT, 1993, JAMA-J AM MED ASSOC, V270, P465, DOI 10.1001/jama.270.4.465; YAO ST, 1969, BRIT J SURG, V56, P676, DOI 10.1002/bjs.1800560910; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9	38	1898	1995	2	69	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1317	1324		10.1001/jama.286.11.1317	http://dx.doi.org/10.1001/jama.286.11.1317			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560536	Bronze			2022-12-28	WOS:000171024500024
J	Hylek, EM; Regan, S; Go, AS; Hughes, RA; Singer, DE; Skates, SJ				Hylek, EM; Regan, S; Go, AS; Hughes, RA; Singer, DE; Skates, SJ			Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; BLEEDING COMPLICATIONS; DRUG-METABOLISM; PROTEIN-BINDING; AGING LIVER; AGE; DISCONTINUATION; OUTPATIENTS; CLEARANCE	Background: An elevated international normalized ratio (INR) increases the risk for major hemorrhage during warfarin therapy. Optimal management of patients with asymptomatic elevations in INR is hampered by the lack of understanding of the time course of INR decay after cessation of warfarin therapy. Objective: To identify predictors of the rate of INR normalization after excessive anticoagulation. Design: Retrospective cohort study. Setting: Outpatient anticoagulant therapy unit. Patients: Outpatients with an INR greater than 6.0 were identified from August 1993 to September 1998. Patients in whom two doses of warfarin were withheld and a follow-up INR was obtained on the second calendar day were enrolled. No patient received vitamin K-tau. Measurements: The INR was measured 2 days after an INR greater than 6.0 was recorded. Results: Of 633 study patients with an initial INR greater than 6.0, 232 (37%) still had an INR of 4.0 or greater after two doses of warfarin were withheld. Patients who required larger weekly maintenance doses of warfarin were less likely to have an INR of 4.0 or greater on day 2 (adjusted odds ratio per 10 mg of warfarin, 0.87 [95% Cl, 0.79 to 0.97]). Other risk factors for having an INR of 4.0 or greater on day 2 included age (odds ratio per decade of life, 1.18 [Cl, 1.01 to 1.38]), index INR (odds ratio per unit, 1.25 [Cl, 1.14 to 1.37]), decompensated congestive heart failure (odds ratio, 2.79 [Cl, 1.30 to 5.98]), and active cancer (odds ratio, 2.48 [Cl, 1.11 to 5.57]). Conclusions: Steady-state warfarin dose, advanced age, and extreme elevation in INR are risk factors for prolonged delay in return of the INR to within the therapeutic range. Decompensated congestive heart failure and active cancer greatly increase this risk.	Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Kaiser Permanente Med Care Program, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kaiser Permanente; University of California System; University of California San Francisco	Hylek, EM (corresponding author), Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [AG15478] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1998, Br J Haematol, V101, P374; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; BRADBURY H, 1994, BRIT J PHARMACOL, V37, P563; CHAN E, 1994, BRIT J CLIN PHARMACO, V37, P563, DOI 10.1111/j.1365-2125.1994.tb04305.x; Chesebro JH, 1996, ARCH INTERN MED, V156, P409; Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Grandison MK, 2000, CLIN PHARMACOKINET, V38, P271, DOI 10.2165/00003088-200038030-00005; Hammerlein A, 1998, CLIN PHARMACOKINET, V35, P49; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; HIRSH J, 1995, CHEST, V108, pS231, DOI 10.1378/chest.108.4_Supplement.231S; Hosmer DW, 1989, APPL LOGISTIC REGRES, P140; Hylek E. M., 1999, JGIM, V14, P42; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; JAMES OFW, 1985, J HEPATOL, V1, P431, DOI 10.1016/S0168-8278(85)80780-7; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P299; LANDEFELD CS, 1989, AM J MED, V87, P144; Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Lousberg TR, 1998, ARCH INTERN MED, V158, P528, DOI 10.1001/archinte.158.5.528; NOTARI RE, 1987, BIOPHARMACEUTICS CLI, P7; Palareti G, 2000, ARCH INTERN MED, V160, P470, DOI 10.1001/archinte.160.4.470; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PENGO V, 1993, BLOOD COAGUL FIBRIN, V4, P739, DOI 10.1097/00001721-199304050-00010; ROUTLEDGE PA, 1979, BRIT J CLIN PHARMACO, V8, P243, DOI 10.1111/j.1365-2125.1979.tb01009.x; SCHOFIELD KP, 1987, CLIN LAB HAEMATOL, V9, P255, DOI 10.1111/j.1365-2257.1987.tb00089.x; SHEPHERD AM, 1979, DRUGS ELDERLY PERSPE; SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228; WALLACE SM, 1987, CLIN PHARMACOKINET, V12, P41, DOI 10.2165/00003088-198712010-00004; Weibert RT, 1997, ANN INTERN MED, V126, P959, DOI 10.7326/0003-4819-126-12-199706150-00005; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; WHITE RH, 1995, ANN INTERN MED, V122, P40, DOI 10.7326/0003-4819-122-1-199501010-00006; WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222	39	138	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					393	400		10.7326/0003-4819-135-6-200109180-00008	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560452				2022-12-28	WOS:000170972500001
J	Meghraoui, M; Delouis, B; Ferry, M; Giardini, D; Huggenberger, P; Spottke, I; Granet, M				Meghraoui, M; Delouis, B; Ferry, M; Giardini, D; Huggenberger, P; Spottke, I; Granet, M			Active normal faulting in the upper Rhine graben and paleoseismic identification of the 1356 Basel earthquake	SCIENCE			English	Article							STRESS-FIELD; RHINEGRABEN; AREA	We have identified an active normal fault in the epicentral area of the Basel. (Switzerland) earthquake of 18 October 1356, the largest historical seismic event in central Europe. The event of 1356 and two prehistoric events have been characterized on the fault with geomorphological analysis, geophysical prospecting, and trenching. Carbon-14 dating indicates that the youngest event occurred in the interval 610 to 1475 A.D. and may correspond to the 1356 Basel earthquake. The occurrence of the three earthquakes induced a total of 1.8 meters of vertical displacement in the past 8500 years for a mean uplift rate of 0.21 millimeters per year. These successive ruptures on the normal fault indicate the potential for strong ground movements in the Basel region and should be taken into account to refine the seismic hazard estimates along the Rhine graben.	IPAS, EOST, Inst Phys Globe, Ecole & Observ Sci Terre, F-67084 Strasbourg, France; Swiss Fed Inst Technol, Dept Seismol & Geodynam, Inst Geophys, CH-8093 Zurich, Switzerland; Univ Basel, Inst Geol Palaontol, CH-4056 Basel, Switzerland	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Meghraoui, M (corresponding author), IPAS, EOST, Inst Phys Globe, Ecole & Observ Sci Terre, 5 Rue Rene Descartes, F-67084 Strasbourg, France.	mustapha@eost.u-strasbg.fr	Meghraoui, Mustapha/K-4206-2015; Huggenberger, Peter/N-9572-2016; Ferry, Matthieu/AAB-7753-2020; Ferry, Matthieu/D-2047-2009; Giardini, Domenico/F-5406-2011	Huggenberger, Peter/0000-0002-4736-7876; Ferry, Matthieu/0000-0002-6498-7807; Ferry, Matthieu/0000-0002-6498-7807; 				AHORNER L, 1975, TECTONOPHYSICS, V29, P233, DOI 10.1016/0040-1951(75)90148-1; Bonjer KP, 1997, TECTONOPHYSICS, V275, P41, DOI 10.1016/S0040-1951(97)00015-2; BRUN JP, 1991, GEOLOGY, V19, P758, DOI 10.1130/0091-7613(1991)019<0758:CSSOTS>2.3.CO;2; CADIOT B, 1979, MEM BUR RECHERCHE GE, V96, P154; Camelbeeck T, 1998, GEOPHYS J INT, V132, P347, DOI 10.1046/j.1365-246x.1998.00428.x; DELOUIS B, 1993, TECTONOPHYSICS, V221, P413, DOI 10.1016/0040-1951(93)90171-F; ILLIES JH, 1978, GEOL SOC AM BULL, V89, P770, DOI 10.1130/0016-7606(1978)89<770:RATAS>2.0.CO;2; KANAMORI H, 1975, B SEISMOL SOC AM, V65, P1073; Karnik V., 1969, SEISMICITY EUROPEA 1; Lemeille F, 1999, GEODIN ACTA, V12, P179, DOI 10.1016/S0985-3111(00)88657-X; MAYERROSA D, 1979, TECTONOPHYSICS, V53, P325, DOI 10.1016/0040-1951(79)90077-5; Meghraoui M, 2000, J GEOPHYS RES-SOL EA, V105, P13809, DOI 10.1029/1999JB900236; MEYER B, 1994, TERRA NOVA, V6, P54, DOI 10.1111/j.1365-3121.1994.tb00633.x; Niviere B, 2000, GLOBAL PLANET CHANGE, V27, P263, DOI 10.1016/S0921-8181(01)00070-4; Nocquet JM, 2001, J GEOPHYS RES-SOL EA, V106, P11239, DOI 10.1029/2000JB900410; Plenefisch T, 1997, TECTONOPHYSICS, V275, P71, DOI 10.1016/S0040-1951(97)00016-4; Ramsey CB, 1998, RADIOCARBON, V40, P461; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974	19	99	100	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2070	2073		10.1126/science.1010618	http://dx.doi.org/10.1126/science.1010618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557888				2022-12-28	WOS:000171028700069
J	Wales, DJ				Wales, DJ			A microscopic basis for the global appearance of energy landscapes	SCIENCE			English	Article							STRUCTURAL RELAXATION; ATOMIC CLUSTERS; LIQUIDS; DYNAMICS; RANGE; STABILITY; SURFACES; GLASSES; FUNNELS; MODEL	It is shown that the appearance of a multidimensional potential energy surface, or potential energy landscape, can be related to the form of the interatomic or intermolecular potential. Catastrophe theory enables us to describe how the geometry of the surface changes with parameters in the potential, and provides universal scaling relations that explain, for example, the asymmetric reaction profiles observed for systems bound by long-range forces. The principal result is an unexpected connection between barrier heights, path lengths, and vibrational frequencies, with applications to a wide variety of problems in chemical physics, ranging from Hammond's postulate in organic chemistry, to the relaxation dynamics of complex systems such as glasses and biomolecules.	Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of Cambridge	Wales, DJ (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.							ANDERSON PW, 1972, PHILOS MAG, V25, P1, DOI 10.1080/14786437208229210; Angell CA, 2000, J PHYS-CONDENS MAT, V12, P6463, DOI 10.1088/0953-8984/12/29/318; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Ball KD, 1996, SCIENCE, V271, P963, DOI 10.1126/science.271.5251.963; Berry RS, 1997, P NATL ACAD SCI USA, V94, P9520, DOI 10.1073/pnas.94.18.9520; BRAIER PA, 1990, J CHEM PHYS, V93, P8745, DOI 10.1063/1.459263; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Doye JPK, 1996, J PHYS B-AT MOL OPT, V29, P4859, DOI 10.1088/0953-4075/29/21/002; Doye JPK, 1996, SCIENCE, V271, P484, DOI 10.1126/science.271.5248.484; Doye JPK, 1997, J CHEM SOC FARADAY T, V93, P4233, DOI 10.1039/a706221d; Doye JPK, 1996, J CHEM PHYS, V105, P8428, DOI 10.1063/1.472697; FERSHT A, 1999, STRUCTURE MECHANISM; GIMORE R, 1981, CATASTROPHE THEORY S; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Liu K, 1996, SCIENCE, V271, P929, DOI 10.1126/science.271.5251.929; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; Mezey PG., 1987, POTENTIAL ENERGY HYP; Middleton TF, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024205; Miller MA, 1999, PHYS REV E, V60, P3701, DOI 10.1103/PhysRevE.60.3701; Miller MA, 1999, J CHEM PHYS, V110, P328, DOI 10.1063/1.478067; Morse PM, 1929, PHYS REV, V34, P57, DOI 10.1103/PhysRev.34.57; Phillips WA, 1972, J LOW TEMP PHYS, V7, P351, DOI 10.1007/BF00660072; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Thom R., 1983, PARABOLES CATASTROPH; Wales DJ, 2000, ADV CHEM PHYS, V115, P1, DOI 10.1002/9780470141748.ch1; WOLYNES PG, 1995, J CHEM PHYS, V102, P1619; ZELLER RC, 1971, PHYS REV B, V4, P2029, DOI 10.1103/PhysRevB.4.2029	31	170	172	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2067	2070		10.1126/science.1062565	http://dx.doi.org/10.1126/science.1062565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557887				2022-12-28	WOS:000171028700068
J	Giribet, G; Edgecombe, GD; Wheeler, WC				Giribet, G; Edgecombe, GD; Wheeler, WC			Arthropod phylogeny based on eight molecular loci and morphology	NATURE			English	Article							SEQUENCE ALIGNMENT; DNA-SEQUENCES; HISTONE H3; CRUSTACEANS; INSECTS; ORIGIN; HYPOTHESIS; PATTERN	The interrelationships of major clades within the Arthropoda remain one of the most contentious issues in systematics, which has traditionally been the domain of morphologists(1,2). A growing body of DNA sequences and other types of molecular data has revitalized study of arthropod phylogeny(3-7) and has inspired new considerations of character evolution(8,9). Novel hypotheses such as a crustacean-hexapod affinity(4,10-12) were based on analyses of single or few genes and limited taxon sampling, but have received recent support from mitochondrial gene order(13), and eye and brain ultrastructure and neurogenesis(14,15). Here we assess relationships within Arthropoda based on a synthesis of all well sampled molecular loci together with a comprehensive data set of morphological, developmental, ultrastructural and gene-order characters. The molecular data include sequences of three nuclear ribosomal genes, three nuclear protein-coding genes, and two mitochondrial genes (one protein coding, one ribosomal). We devised new optimization procedures(16,17) and constructed a parallel computer cluster with 256 central processing units(18) to analyse molecular data on a scale not previously possible. The optimal 'total evidence' cladogram supports the crustacean-hexapod clade, recognizes pycnogonids as sister to other euarthropods, and indicates monophyly of Myriapoda and Mandibulata.	Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; Australian Museum, Sydney, NSW 2010, Australia; Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Harvard University; Australian Museum; American Museum of Natural History (AMNH)	Giribet, G (corresponding author), Harvard Univ, Dept Organism & Evolut Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	ggiribet@oeb.harvard.edu	Giribet, Gonzalo/P-1086-2015	Giribet, Gonzalo/0000-0002-5467-8429; Edgecombe, Gregory/0000-0002-9591-8011				Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Edgecombe GD, 2000, CLADISTICS, V16, P155, DOI 10.1111/j.1096-0031.2000.tb00352.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Gee H, 2000, NATURE, V404, P214, DOI 10.1038/35005235; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 1998, NONA V 2 0; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Popadic A, 1998, DEV GENES EVOL, V208, P142, DOI 10.1007/s004270050165; Regier JC, 1998, AM ZOOL, V38, P918; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Scholtz G, 1998, INT J DEV BIOL, V42, P801; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Spears T., 1998, Systematics Association Special Volume Series, V55, P169; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler W, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P9; WHEELER WC, 1993, CLADISTICS, V9, P1, DOI 10.1111/j.1096-0031.1993.tb00207.x; WHEELER WC, 1995, SYST BIOL, V44, P321, DOI 10.2307/2413595; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Zrzavy J., 1998, Arthropod relationships., P97; Zrzavy J, 1997, J EVOLUTION BIOL, V10, P353, DOI 10.1007/s000360050029	29	437	469	4	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					157	161		10.1038/35093097	http://dx.doi.org/10.1038/35093097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557979				2022-12-28	WOS:000170918800045
J	Walsh, EC; Stainier, DYR				Walsh, EC; Stainier, DYR			UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish	SCIENCE			English	Article							ENDOCARDIAL CUSHION FORMATION; TGF-BETA RECEPTOR; CELL-TRANSFORMATION; NEUREGULIN RECEPTOR; HEART; GENE; BIOSYNTHESIS; DROSOPHILA; MORPHOGENESIS; PROTEOGLYCANS	Cardiac valve formation is a complex process that involves cell signaling events between the myocardial and endocardial layers of the heart across an elaborate extracellular matrix. These signals lead to marked morphogenetic movements and transdifferentiation of the endocardial cells at chamber boundaries. Here we identify the genetic defect in zebrafish jekyll mutants, which are deficient in the initiation of heart valve formation. The jekyll mutation disrupts a homolog of Drosophila Sugarless, a uridine 5'-diphosphate (UDP)-glucose dehydrogenase required for heparan sulfate, chondroitin sulfate, and hyaluronic acid production, The atrioventricular border cells do not differentiate from their neighbors in jekyll mutants, suggesting that Jekyll is required in a cell signaling event that establishes a boundary between the atrium and ventricle.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54737] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Binari RC, 1997, DEVELOPMENT, V124, P2623; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Kim C., UNPUB; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 1999, DEVELOPMENT, V126, P3715; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Postlethwait JH, 1997, TRENDS GENET, V13, P183, DOI 10.1016/S0168-9525(97)01129-3; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; SAQI MAS, 1994, COMPUT APPL BIOSCI, V10, P545; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C, 1999, DEVELOPMENT, V126, P229; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; WALSH EC, UNPUB; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	34	230	233	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1670	1673		10.1126/science.293.5535.1670	http://dx.doi.org/10.1126/science.293.5535.1670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533493				2022-12-28	WOS:000170802900066
J	Alldredge, BK; Gelb, AM; Isaacs, SM; Corry, MD; Allen, F; Ulrich, S; Gottwald, MD; O'Neil, N; Neuhaus, JM; Segal, MR; Lowenstein, DH				Alldredge, BK; Gelb, AM; Isaacs, SM; Corry, MD; Allen, F; Ulrich, S; Gottwald, MD; O'Neil, N; Neuhaus, JM; Segal, MR; Lowenstein, DH			A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIALS	Background: It is uncertain whether the administration of benzodiazepines by paramedics is an effective and safe treatment for out-of-hospital status epilepticus. Methods: We conducted a randomized, double-blind trial to evaluate intravenous benzodiazepines administered by paramedics for the treatment of out-of-hospital status epilepticus. Adults with prolonged (lasting five minutes or more) or repetitive generalized convulsive seizures received intravenous diazepam (5 mg), lorazepam (2 mg), or placebo. An identical second injection was given if needed. Results: Of the 205 patients enrolled, 66 received lorazepam, 68 received diazepam, and 71 received placebo. Status epilepticus had been terminated on arrival at the emergency department in more patients treated with lorazepam (59.1 percent) or diazepam (42.6 percent) than patients given placebo (21.1 percent) (P=0.001). After adjustment for covariates, the odds ratio for termination of status epilepticus by the time of arrival in the lorazepam group as compared with the placebo group was 4.8 (95 percent confidence interval, 1.9 to 13.0). The odds ratio was 1.9 (95 percent confidence interval, 0.8 to 4.4) in the lorazepam group as compared with the diazepam group and 2.3 (95 percent confidence interval, 1.0 to 5.9) in the diazepam group as compared with the placebo group. The rates of respiratory or circulatory complications after the study treatment was administered were 10.6 percent for the lorazepam group, 10.3 percent for the diazepam group, and 22.5 percent for the placebo group (P=0.08). Conclusions: Benzodiazepines are safe and effective when administered by paramedics for out-of-hospital status epilepticus in adults. Lorazepam is likely to be a better therapy than diazepam. (N Engl J Med 2001;345:631-7.) Copyright (C) 2001 Massachusetts Medical Society.	San Francisco Gen Hosp, Dept Clin Pharm, San Francisco, CA 94110 USA; San Francisco Gen Hosp, Dept Neurol, San Francisco, CA 94110 USA; San Francisco Gen Hosp, Dept Surg, San Francisco, CA 94110 USA; San Francisco Gen Hosp, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA; San Francisco Gen Hosp, Dept Emergency Serv, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Fire Dept, Emergency Med Serv Div, San Francisco, CA USA; Carondelet Hlth Network, Tucson, AZ USA	San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Lowenstein, DH (corresponding author), Harvard Univ, Sch Med, Gordon Hall,Rm 103,25 Shattuck St, Boston, MA 02115 USA.				PHS HHS [R01 31403] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLDREDGE BK, 1995, PEDIATR NEUROL, V12, P213, DOI 10.1016/0887-8994(95)00044-G; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brazier H, 1999, J ACCID EMERG MED, V16, P18; CUMMINS RO, 1993, NEW ENGL J MED, V328, P1377, DOI 10.1056/NEJM199305133281903; Gottwald MD, 1999, AM J EMERG MED, V17, P333, DOI 10.1016/S0735-6757(99)90079-7; HONIGMAN B, 1990, ANN EMERG MED, V19, P145, DOI 10.1016/S0196-0644(05)81799-8; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; LEPPIK IE, 1983, JAMA-J AM MED ASSOC, V249, P1452, DOI 10.1001/jama.249.11.1452; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Lowenstein DH, 2001, CONTROL CLIN TRIALS, V22, P290, DOI 10.1016/S0197-2456(01)00120-9; LOWENSTEIN DH, 1993, NEUROLOGY, V43, P483, DOI 10.1212/WNL.43.3_Part_1.483; MATTOX KL, 1989, J TRAUMA, V29, P1104, DOI 10.1097/00005373-198908000-00007; MILLER RG, 1981, SIMULTANEOUS STAT IN; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PHILLIPS SA, 1989, ANN NEUROL, V26, P472; SHANER DM, 1988, NEUROLOGY, V38, P202, DOI 10.1212/WNL.38.2.202; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202	19	568	579	0	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					631	637		10.1056/NEJMoa002141	http://dx.doi.org/10.1056/NEJMoa002141			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466XG	11547716	Bronze			2022-12-28	WOS:000170671000001
J	Tattersfield, AE; Harrison, TW				Tattersfield, AE; Harrison, TW			Exacerbations of asthma - still room for improvement	LANCET			English	Editorial Material							INHALED CORTICOSTEROIDS; IPRATROPIUM BROMIDE; MANAGEMENT; AGONISTS		City Hosp, Div Resp Med, Nottingham NG5 1PB, England	University of Nottingham	Tattersfield, AE (corresponding author), City Hosp, Div Resp Med, Nottingham NG5 1PB, England.	anne.tattersfield@nottingham.ac.uk						Abramson MJ, 2001, AM J RESP CRIT CARE, V163, P12, DOI 10.1164/ajrccm.163.1.9910042; [Anonymous], 1995, NHLBI WHO WORKSH REP; CHERVINSKY P, 1994, J ALLERGY CLIN IMMUN, V94, P676, DOI 10.1016/0091-6749(94)90174-0; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; HIGGINS RM, 1988, CHEST, V94, P718, DOI 10.1378/chest.94.4.718; Neville RG, 1997, THORAX, V52, P153, DOI 10.1136/thx.52.2.153; *NIH, 1997, 974051 NIH; Pearson M G, 1995, Qual Health Care, V4, P24, DOI 10.1136/qshc.4.1.24; Pearson MG, 1997, THORAX, V52, pS1; Plotnick LH, 1998, BMJ-BRIT MED J, V317, P971, DOI 10.1136/bmj.317.7164.971; Rodrigo CJ, 2000, AM J RESP CRIT CARE, V161, P1862; ROWE BH, 2000, COCHRANE DATABASE SY, V2; Scottish Environment Protection Agency, 1999, EM MAN AC ASTHM, P1; Simpson AJ, 2000, THORAX, V55, P97, DOI 10.1136/thorax.55.2.97; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Tattersfield AE, 2001, THORAX, V56, P272, DOI 10.1136/thorax.56.4.272; 1986, LANCET, V1, P131	17	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					599	601		10.1016/S0140-6736(01)05815-9	http://dx.doi.org/10.1016/S0140-6736(01)05815-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530142				2022-12-28	WOS:000170615500003
J	SAGAN, C; THOMPSON, WR; CARLSON, R; GURNETT, D; HORD, C				SAGAN, C; THOMPSON, WR; CARLSON, R; GURNETT, D; HORD, C			A SEARCH FOR LIFE ON EARTH FROM THE GALILEO SPACECRAFT	NATURE			English	Article							SPECTROMETER EXPERIMENT	In its December 1990 fly-by of Earth, the Galileo spacecraft found evidence of abundant gaseous oxygen, a widely distributed surface pigment with a sharp absorption edge in the red part of the visible spectrum, and atmospheric methane in extreme thermodynamic disequilibrium; together, these are strongly suggestive of life on Earth. Moreover, the presence of narrow-band, pulsed, amplitude-modulated radio transmission seems uniquely attributable to intelligence. These observations constitute a control experiment for the search for extraterrestrial life by modern interplanetary spacecraft.	JET PROP LAB,ATMOSPHER & COMETARY SCI SECT,PASADENA,CA 91109; UNIV IOWA,DEPT PHYS & ASTRON,IOWA CITY,IA 52242; UNIV COLORADO,ATMOSPHER & SPACE PHYS LAB,BOULDER,CO 80309	National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Iowa; University of Colorado System; University of Colorado Boulder	SAGAN, C (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							BELTON MJS, 1992, SPACE SCI REV, V60, P413, DOI 10.1007/BF00216864; BOWKER DE, 1985, REF PUBL NASA, V1139; CARLSON RW, 1992, SPACE SCI REV, V60, P457, DOI 10.1007/BF00216865; CARLSON RW, IN PRESS ANTARCT J U; CHAMEIDES WL, 1992, CHEM ENG NEWS, V60, P38; Chapman S, 1931, P PHYS SOC, V43, P483, DOI 10.1088/0959-5309/43/5/302; DROSSART PJ, UNPUB PLANET SPACE S; FAINBERG J, 1974, SPACE SCI REV, V16, P145, DOI 10.1007/BF00240885; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; GURNETT DA, 1992, SPACE SCI REV, V60, P341, DOI 10.1007/BF00216861; GURNETT DA, 1974, J GEOPHYS RES, V79, P4227, DOI 10.1029/JA079i028p04227; Henderson L.J., 1913, FITNESS ENV INQUIRY; HINES CO, 1965, PHYSICS EARTHS UPPER; HOGAN KB, 1991, NATURE, V354, P181, DOI 10.1038/354181a0; HORD CW, 1992, SPACE SCI REV, V60, P503, DOI 10.1007/BF00216866; KELLER A, 1990, THESIS U IOWA; KILSTON SD, 1966, ICARUS, V5, P79, DOI 10.1016/0019-1035(66)90010-8; LABELLE J, 1989, RADIO SCI, V24, P725, DOI 10.1029/RS024i006p00725; LEDERBERG J, 1965, NATURE, V207, P9, DOI 10.1038/207009a0; LEDERBERG J, 1962, P NATL ACAD SCI USA, V48, P1473, DOI 10.1073/pnas.48.9.1473; LEGER A, IN PRESS ASTR ASTROP; Lewis JS., 1984, PLANETS THEIR ATMOSP; LIPPINCOTT ER, 1967, ASTROPHYS J, V147, P753, DOI 10.1086/149051; LOVELOCK JE, 1975, PROC R SOC SER B-BIO, V189, P167, DOI 10.1098/rspb.1975.0051; LOVELOCK JE, 1965, NATURE, V207, P568, DOI 10.1038/207568a0; Owen T., 1980, STRATEGIES SEARCH LI, V83, P177, DOI DOI 10.1007/978-94-009-9115-6_17; SAGAN C, 1975, PROC R SOC SER B-BIO, V189, P143, DOI 10.1098/rspb.1975.0048; SAGAN C, 1971, ICARUS, V15, P515, DOI 10.1016/0019-1035(71)90132-1; SAGAN C, 1966, BIOL EXPLORATION MAR, pCH9; Shklovskii IS, 1966, INTELLIGENT LIFE UNI, V399, P639; SULLIVAN WT, 1978, SCIENCE, V199, P377, DOI 10.1126/science.199.4327.377; VONZAHN U, 1983, VENUS, pCH13; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; [No title captured]	34	248	248	1	56	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 21	1993	365	6448					715	721		10.1038/365715a0	http://dx.doi.org/10.1038/365715a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC812	11536539				2022-12-28	WOS:A1993MC81200051
J	BUTTERFIELD, NJ; KNOLL, AH; SWETT, K				BUTTERFIELD, NJ; KNOLL, AH; SWETT, K			A BANGIOPHYTE RED ALGA FROM THE PROTEROZOIC OF ARCTIC CANADA	SCIENCE			English	Article									UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242	University of Iowa	BUTTERFIELD, NJ (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.		Butterfield, Nicholas/AAV-8215-2021	Butterfield, Nicholas/0000-0002-3046-7520				[Anonymous], 1985, PALEOALGOLOGY; BEEUNAS MA, 1985, GEOL SOC AM BULL, V96, P737, DOI 10.1130/0016-7606(1985)96<737:PSISOS>2.0.CO;2; BHATTACHARYA D, 1987, J PHYCOL, V26, P181; BOLD HC, 1986, INTRO ALGAE; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; BUTTERFIELD NJ, 1988, NATURE, V334, P424, DOI 10.1038/334424a0; BUTTERFIELD NJ, 1989, GEOL SOC AM ABSTR, V21, pA146; BUTTERFIELD NJ, UNPUB; CAMPBELL SE, 1980, PHYCOLOGIA, V19, P25, DOI 10.2216/i0031-8884-19-1-25.1; COLE K, 1975, Phycologia, V14, P239, DOI 10.2216/i0031-8884-14-4-239.1; COLE KM, 1985, J PHYCOL, V21, P585; DU RL, 1986, ACTA GEOL SINICA, P115; FRITSCH FE, 1965, STRUCTURE REPRODUCTI; FRY WL, 1983, REV PALAEOBOT PALYNO, V39, P313, DOI 10.1016/0034-6667(83)90018-0; GARBARY DJ, 1980, SYESIS, V13, P137; GERMAN TN, 1981, PALEONTOLOG J, P100; Gnilovskaya M.B., 1988, VENDOTAENIDS E EUROP; GOLUBIC S, COMMUNICATION; GRANT SWF, 1987, GEOL SOC AM ABSTR, V19, P681; GREY K, 1990, PRECAMBRIAN RES, V46, P307, DOI 10.1016/0301-9268(90)90018-L; Heaman L.M., 1990, GEOLOGICAL ASS CANAD, V15, pA55; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; LECHEMINANT AN, 1989, EARTH PLANET SC LETT, V96, P38, DOI 10.1016/0012-821X(89)90122-2; MARTIN TC, 1974, J PHYCOL, V10, P57, DOI 10.1111/j.1529-8817.1974.tb02678.x; PERASSO R, 1989, NATURE, V339, P142, DOI 10.1038/339142a0; SHEATH RG, 1985, J PHYCOL, V21, P297; SHEATH RG, 1980, J PHYCOL, V16, P412; SHEATH RG, 1984, PHYCOLOGIA, V23, P383, DOI 10.2216/i0031-8884-23-3-383.1; STEWART WD, 1987, 8326 GEOL SURV CAN P; TAPPAN H, 1976, GEOL SOC AM BULL, V87, P633, DOI 10.1130/0016-7606(1976)87<633:PEABAE>2.0.CO;2; VIDAL G, 1989, LETHAIA, V22, P375, DOI 10.1111/j.1502-3931.1989.tb01437.x; Walcott C.D., 1919, SMITHSONIAN MISCELLA, V67, P217; WALTER MR, 1976, J PALEONTOL, V50, P872; WHELAN JF, 1990, AM J SCI, V290, P396, DOI 10.2475/ajs.290.4.396; Zhang Y., 1989, LETHAIA, V22, P113	35	135	147	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 5	1990	250	4977					104	107		10.1126/science.11538072	http://dx.doi.org/10.1126/science.11538072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB467	11538072				2022-12-28	WOS:A1990EB46700030
J	ROTHSCHILD, LJ; MANCINELLI, RL				ROTHSCHILD, LJ; MANCINELLI, RL			MODEL OF CARBON FIXATION IN MICROBIAL MATS FROM 3,500 MYR AGO TO THE PRESENT	NATURE			English	Article											ROTHSCHILD, LJ (corresponding author), NASA,AMES RES CTR,SOLAR SYST EXPLORAT BRANCH,MAIL STOP 239-12,MOFFETT FIELD,CA 94035, USA.		Mancinelli, Rocco/L-8971-2016					AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Awramik SM, 1984, MICROBIAL MATS STROM, P1; BADGER MR, 1982, PLANT PHYSIOL, V70, P517, DOI 10.1104/pp.70.2.517; Brasier M. D., 1980, MICROFOSSILS; DAMELIO ED, 1987, ARCH MICROBIOL, V147, P528; Des Marais D. J., 1989, MICROBIAL MATS PHYSL, P191; GARRETT P, 1970, SCIENCE, V169, P171, DOI 10.1126/science.169.3941.171; Glaessner M.F., 1984, DAWN ANIMAL LIFE; JAVOR BJ, 1981, GEOMICROBIOL J, V2, P237, DOI 10.1080/01490458109377766; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187	16	26	26	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					710	712		10.1038/345710a0	http://dx.doi.org/10.1038/345710a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK399	11536465				2022-12-28	WOS:A1990DK39900063
J	SHOCK, EL; SCHULTE, MD				SHOCK, EL; SCHULTE, MD			AMINO-ACID SYNTHESIS IN CARBONACEOUS METEORITES BY AQUEOUS ALTERATION OF POLYCYCLIC AROMATIC-HYDROCARBONS	NATURE			English	Article											SHOCK, EL (corresponding author), WASHINGTON UNIV,DEPT EARTH & PLANETARY SCI,ST LOUIS,MO 63130, USA.			Shock, Everett/0000-0002-4283-0163; Schulte, Mitchell/0000-0001-8141-2020				ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; Basile B. P., 1984, ORG GEOCHEM, V5, P211, DOI 10.1016/0146-6380(84)90008-1; BECKER RH, 1982, GEOCHIM COSMOCHIM AC, V46, P97, DOI 10.1016/0016-7037(82)90294-0; BERNATOWICZ T, 1987, NATURE, V330, P728, DOI 10.1038/330728a0; Bradley J. P., 1988, METEORITES EARLY SOL, P861; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CHANG S, 1986, P116; CHANG S, 1978, LUNAR PLANET SCI, V9, P157; CLAYTON RN, 1963, SCIENCE, V140, P192, DOI 10.1126/science.140.3563.192; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; Cronin JR., 1988, ORGANIC MATTER CARBO, P819; DAYHOFF MO, 1967, NASA SP3040; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1085, DOI 10.1016/0016-7037(62)90047-9; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FRENKLACH M, 1989, NATURE, V339, P196, DOI 10.1038/339196a0; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; HERBERT F, 1989, ICARUS, V78, P402, DOI 10.1016/0019-1035(89)90187-5; HERBST E, 1985, ORIGINS LIFE EVOL B, V16, P3, DOI 10.1007/BF01808046; HUSS GR, 1987, EARTH MOON PLANETS, V40, P165; Kerridge J.F., 1979, ASTEROIDS, P745; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LANGE MA, 1985, GEOCHIM COSMOCHIM AC, V49, P1715, DOI 10.1016/0016-7037(85)90142-5; LARIMER JW, 1967, GEOCHIM COSMOCHIM AC, V31, P1239, DOI 10.1016/S0016-7037(67)80014-0; MCSWEEN HY, 1987, GEOCHIM COSMOCHIM AC, V51, P2469, DOI 10.1016/0016-7037(87)90298-5; MCSWEEN HY, 1979, GEOCHIM COSMOCHIM AC, V43, P1761, DOI 10.1016/0016-7037(79)90024-3; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; SHOCK E L, 1989, Origins of Life and Evolution of the Biosphere, V19, P538, DOI 10.1007/BF02388991; SHOCK EL, 1988, GEOLOGY, V16, P886, DOI 10.1130/0091-7613(1988)016<0886:OAMISB>2.3.CO;2; SHOCK EL, 1989, GEOLOGY, V17, P572, DOI 10.1130/0091-7613(1989)017<0572:CTOAMI>2.3.CO;2; SHOCK EL, IN PRES GEOCHIM COSM; Stull D.R., 1969, CHEM THERMODYN; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; WONG WK, 1971, J CHEM THERMODYN, V3, P105, DOI 10.1016/S0021-9614(71)80071-X; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; ZENOBI R, 1989, SCIENCE, V1246, P1026; Zinner E., 1988, METEORITES EARLY SOL; Zolensky M., 1988, METEORITES EARLY SOL, P114; ZOLENSKY ME, 1989, ICARUS, V78, P411, DOI 10.1016/0019-1035(89)90188-7	40	74	74	1	26	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 22	1990	343	6260					728	731		10.1038/343728a0	http://dx.doi.org/10.1038/343728a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	11536464				2022-12-28	WOS:A1990CP80700051
J	ROUGHGARDEN, J; GAINES, S; POSSINGHAM, HP				ROUGHGARDEN, J; GAINES, S; POSSINGHAM, HP			RECRUITMENT DYNAMICS IN COMPLEX LIFE-CYCLES	SCIENCE			English	Article									BROWN UNIV, GRAD PROGRAM ECOL & EVOLUT BIOL, PROVIDENCE, RI 02912 USA; HOPKINS MARINE STN, PACIFIC GROVE, CA 93950 USA	Brown University	ROUGHGARDEN, J (corresponding author), STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA.		Gaines, Steven/Y-3234-2019; POSSINGHAM, HUGH/R-8310-2019; Possingham, Hugh/B-1337-2008	POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X	NCI NIH HHS [NCA2-258] Funding Source: Medline; NIDCR NIH HHS [DE-FG03-85ER60362] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BAILEY KM, 1981, MAR ECOL PROG SER, V6, P1, DOI 10.3354/meps006001; BAKUN A, 1973, NMFS SSRF671 TECH RE; BAKUN A, 1975, NMFS SSRF693 TECH RE; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; BERNSTEIN BB, 1979, ECOL MONOGR, V49, P335, DOI 10.2307/1942488; BOWDEN KF, 1983, PHYSICAL OCEANOGRAPH; BRANSCOMB ES, 1982, CRUSTACEANA, V42, P83, DOI 10.1163/156854082X00722; BRAY RN, 1980, FISH B-NOAA, V78, P829; BROWN SK, 1985, J CRUSTACEAN BIOL, V5, P574, DOI 10.2307/1548236; CHELTON DB, 1982, J MAR RES, V40, P1095; COLEBROOK JM, 1977, FISH B-NOAA, V75, P357; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CONNELL JH, 1970, ECOL MONOGR, V40, P49, DOI 10.2307/1942441; D'Ancona U., 1954, Bibliotheca Biotheoretica Leiden, V6D, P1; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Ekman V.W., 1905, ARK MATEMATIK ASTRON, V2, P1; FIEDLER PC, 1984, SCIENCE, V224, P1251, DOI 10.1126/science.224.4654.1251; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; GAINES S, 1985, OECOLOGIA, V67, P267, DOI 10.1007/BF00384297; GAINES SD, 1987, SCIENCE, V235, P397; HALLIWELL G, J GEOPHYS RES, V92, P1861; HALPERN D, 1976, DEEP-SEA RES, V23, P495, DOI 10.1016/0011-7471(76)90861-5; Hart T. J., 1960, Discovery Reports, V31, P123; Hines A. H, 1979, REPRODUCTIVE ECOLOGY, P213; Iwasa Y, 1985, IMA J Math Appl Med Biol, V2, P93; IWASA Y, 1986, THEOR POPUL BIOL, V30, P194, DOI 10.1016/0040-5809(86)90033-X; LASSIUS H, IN PRESS ANN REV ECO; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; MASON J, 1986, NOAA NMFS SWFC67 TEC; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; NORTON J, 1987, ALASKA SEA GRANT REP, V87, P73; PAINE RT, 1969, LIMNOL OCEANOGR, V14, P710, DOI 10.4319/lo.1969.14.5.0710; PETERSON W, 1976, ORESUT76002 SEA GRAN; PETERSON WT, 1979, DEEP-SEA RES, V26, P467, DOI 10.1016/0198-0149(79)90091-8; PRICE JF, 1987, SCIENCE, V238, P1534, DOI 10.1126/science.238.4833.1534; REID J, 1956, CALCOFI PROG REP; Rothschild B.J., 1986, DYNAMICS MARINE FISH; ROUGHGARDEN J, 1986, THEOR POPUL BIOL, V29, P235, DOI 10.1016/0040-5809(86)90010-9; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; ROUGHGARDEN J, 1988, MATH EVOLUTIONARY TH, pCH12; ROUGHGARDEN J, 1981, PALEOBIOLOGY, V7, P553; Scudo F.M., 1978, GOLDEN AGE THEORETIC; SIMPSON JJ, 1984, GEOPHYS RES LETT, V11, P241; SMITH R L, 1968, Oceanography and Marine Biology an Annual Review, V6, P11; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; STRUB P, J GEOPHYS RES, V92, P1507; Sverdrup HU, 1938, J MAR RES, V1, P155, DOI 10.1357/002224038806440638; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; UNDERWOOD AJ, 1983, OECOLOGIA, V56, P202, DOI 10.1007/BF00379692; VOLTERRA V, 1931, LECONS THEORIE LUTTE; [No title captured]	52	999	1006	3	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	1988	241	4872					1460	1466		10.1126/science.11538249	http://dx.doi.org/10.1126/science.11538249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q0479	11538249				2022-12-28	WOS:A1988Q047900029
J	Glazener, CMA; Herbison, GP; Wilson, PD; MacArthur, C; Lang, GD; Gee, H; Grant, AM				Glazener, CMA; Herbison, GP; Wilson, PD; MacArthur, C; Lang, GD; Gee, H; Grant, AM			Conservative management of persistent postnatal urinary and faecal incontinence: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; DELIVERY	Objectives To assess the effect of nurse assessment with reinforcement of pelvic floor muscle training exercises and bladder training compared with standard management among women with persistent incontinence three months postnatally. Design Randomised controlled trial with nine months' follow up. Setting Community intervention in three centres (Dunedin, New Zealand; Birmingham; Aberdeen). Participants 747 women with urinary incontinence three months postnatally, allocated at random to intervention (371) or control (376) groups. Intervention Assessment by nurses of urinary incontinence with conservative advice on pelvic floor exercises at five, seven, and nine months after delivery supplemented with bladder training if appropriate at seven and nine months. Main outcome measures Primary: persistence and severity of urinary incontinence 12 months after delivery. Secondary: performance of pelvic floor exercises, change in coexisting faecal incontinence, wellbeing, anxiety, and depression. Results Women in the intervention group had significantly less urinary incontinence: 167/279 (59.9%) v 169/245 (69.0%), difference 9.1% (95% confidence interval 1.0% to 17.3%, P = 0.037) for any incontinence and 55/279 (19.7%) v 78/245 (31.8%), difference 12.1% (4.7% to 19.6%, P = 0.002) for severe incontinence. Faecal incontinence was also less common: 12/273 (4.4%) v 25/237 (10.5%), difference 6.1% (1.6% to 10.8%, P = 0.012). At 12 months women in the intervention group were more likely to be performing pelvic floor exercises (218/278 (79%) v 118/244 (48% P < 0.001). Conclusions A third of women may have some urinary incontinence three months after childbirth. Conservative management provided by nurses seems to reduce the likelihood of urinary and coexisting faecal incontinence persisting 12 months postpartum. Further trials for faecal incontinence are needed.	Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Cranley Clin Dermatol, London W1M 9AD, England; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin, New Zealand; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Wurzburg; University of Aberdeen; University of Otago; University of Otago; University of Birmingham	Glazener, CMA (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.		MacArthur, Christine/ABA-8601-2021	MacArthur, Christine/0000-0003-0434-2158	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berghmans LCM, 1998, BRIT J UROL, V82, P181; CARTWRIGHT A, 1986, J EPIDEMIOL COMMUN H, V40, P267, DOI 10.1136/jech.40.3.267; HAYSMITH EJC, 2001, COCHRANE DATABASE SY; HOSKER G, 2000, COCHRANE DATABASE SY; Jozwik M, 1998, BRIT J OBSTET GYNAEC, V105, P1046, DOI 10.1111/j.1471-0528.1998.tb09934.x; MacArthur C, 1997, BRIT J OBSTET GYNAEC, V104, P46, DOI 10.1111/j.1471-0528.1997.tb10648.x; MACARTHUR C, 1991, HLTH CHILDBIRTH; MACARTHUR C, 1993, BR J MIDWIFERY, V1, P207; Mason L, 2001, MIDWIFERY, V17, P55, DOI 10.1054/midw.2000.0235; MILLARD RJ, 1968, BLADDER CONTROL SIMP; MILLARD RJ, 1987, BLADDER CONTROL SIMP; NORTON C, 2000, COCHRANE DATABASE SY; OBRIEN J, 1991, BRIT MED J, V303, P1308, DOI 10.1136/bmj.303.6813.1308; Sleep J, 1987, Midwifery, V3, P158, DOI 10.1016/S0266-6138(87)80035-9; SNOOKS SJ, 1985, BRIT J UROL, V57, P422, DOI 10.1111/j.1464-410X.1985.tb06302.x; SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601; Wilson P D, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P257, DOI 10.1007/BF01901501; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	19	90	92	3	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					593	596		10.1136/bmj.323.7313.593	http://dx.doi.org/10.1136/bmj.323.7313.593			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557703	Green Published, Bronze			2022-12-28	WOS:000171087300014
J	Steig, EJ				Steig, EJ			Paleoclimate - No two latitudes alike	SCIENCE			English	Editorial Material							TEMPERATURE		Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Steig, EJ (corresponding author), Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA.	steig@ess.washington.edu	Steig, Eric J/G-9088-2015	Steig, Eric J/0000-0002-8191-5549				Cuffey KM, 2001, NATURE, V412, P523, DOI 10.1038/35087544; Jouzel J, 1999, SCIENCE, V286, P910, DOI 10.1126/science.286.5441.910; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Stenni B, 2001, SCIENCE, V293, P2074, DOI 10.1126/science.1059702; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Vimeux F, 1999, NATURE, V398, P410, DOI 10.1038/18860	9	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2015	2016		10.1126/science.1061941	http://dx.doi.org/10.1126/science.1061941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557869				2022-12-28	WOS:000171028700050
J	Gillespie, PG; Walker, RG				Gillespie, PG; Walker, RG			Molecular basis of mechanosensory transduction	NATURE			English	Review							EPITHELIAL SODIUM-CHANNEL; HAIR CELL STEREOCILIA; P2X(2) RECEPTOR SUBUNIT; CAENORHABDITIS-ELEGANS; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; MYOSIN VIIA; BULLFROGS SACCULUS; C-ELEGANS; TOUCH SENSITIVITY	Mechanotransduction-a cell's conversion of a mechanical stimulus into an electrical signal-reveals vital features of an organism's environment. From hair cells and skin mechanoreceptors in vertebrates, to bristle receptors in flies and touch receptors in worms, mechanically sensitive cells are essential in the life of an organism. The scarcity of these cells and the uniqueness of their transduction mechanisms have conspired to slow molecular characterization of the ensembles that carry out mechanotransduction. But recent progress in both invertebrates and vertebrates is beginning to reveal the identities of proteins essential for transduction.	Oregon Hlth Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Gillespie, PG (corresponding author), Oregon Hlth Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.			Barr-Gillespie, Peter/0000-0002-9787-5860				Adam J, 1998, DEVELOPMENT, V125, P4645; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; BAUMANN M, 1986, J COMP PHYSIOL A, V158, P681, DOI 10.1007/BF00603825; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; Benser ME, 1996, J NEUROSCI, V16, P5629; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie M, 1997, BIOL BULL, V192, P125, DOI 10.2307/1542584; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colbert HA, 1997, J NEUROSCI, V17, P8259; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Duggan A, 1998, DEVELOPMENT, V125, P4107; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; Fricke B, 2000, CELL TISSUE RES, V299, P327; Fukushige T, 1999, J CELL SCI, V112, P395; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; Glowatzki E, 1997, NEUROPHARMACOLOGY, V36, P1269, DOI 10.1016/S0028-3908(97)00108-1; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Housley GD, 1998, J COMP NEUROL, V393, P403; Housley GD, 1999, J NEUROSCI, V19, P8377; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jorgensen F, 1995, ACTA PHYSIOL SCAND, V155, P363; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; Kloda A, 2001, BIOPHYS J, V80, P229, DOI 10.1016/S0006-3495(01)76009-2; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Richardson GP, 1999, ANN NY ACAD SCI, V884, P110; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; Rusch A, 1999, HEARING RES, V131, P170, DOI 10.1016/S0378-5955(99)00030-1; RUSCH A, 1994, J PHYSIOL-LONDON, V474, P75; SAND O, 1975, J COMP PHYSIOL, V102, P27, DOI 10.1007/BF00657483; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Schweisguth F, 1996, DEV GENET, V18, P28, DOI 10.1002/(SICI)1520-6408(1996)18:1&lt;28::AID-DVG4&gt;3.0.CO;2-3; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Takahashi K, 1999, BIOCHEM BIOPH RES CO, V261, P773, DOI 10.1006/bbrc.1999.1102; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; TILNEY MS, 1989, J CELL BIOL, V109, P1711, DOI 10.1083/jcb.109.4.1711; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	97	496	530	2	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					194	202		10.1038/35093011	http://dx.doi.org/10.1038/35093011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557988				2022-12-28	WOS:000170918800054
J	Kelkar, PS; Li, JTC				Kelkar, PS; Li, JTC			Cephalosporin allergy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BETA-LACTAM ANTIBIOTICS; PENICILLIN ALLERGY; CROSS-REACTIVITY; ANAPHYLACTIC REACTION; CLINICAL-EXPERIENCE; ADVERSE REACTIONS; CYSTIC-FIBROSIS; HYPERSENSITIVITY; DESENSITIZATION; HISTORY		Mayo Clin & Mayo Fdn, Div Allergy & Outpatient Infect Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Li, JTC (corresponding author), Mayo Clin & Mayo Fdn, Div Allergy & Outpatient Infect Dis, 200 1st St SW, Rochester, MN 55905 USA.							*AM AC ALL ASTHM I, 1999, ANN ALLERG ASTHMA IM, V83, P665; ARNDT KA, 1976, JAMA-J AM MED ASSOC, V235, P918, DOI 10.1001/jama.235.9.918; ASSEM ESK, 1974, IMMUNOLOGY, V27, P255; AUDICANA M, 1994, ALLERGY, V49, P108, DOI 10.1111/j.1398-9995.1994.tb00809.x; BARNETT AS, 1979, ANESTH ANALG, V58, P337; BATCHELOR FR, 1966, IMMUNOLOGY, V10, P21; BLANCA M, 1989, J ALLERGY CLIN IMMUN, V83, P381, DOI 10.1016/0091-6749(89)90122-X; BLOOMBERG RJ, 1988, AM J OBSTET GYNECOL, V159, P125, DOI 10.1016/0002-9378(88)90506-6; Dash C H, 1975, J Antimicrob Chemother, V1, P107; Deswarte Richard D., 1997, P317; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; Ghosal S, 1997, J ANTIMICROB CHEMOTH, V39, P556, DOI 10.1093/jac/39.4.556; GIRARD JP, 1968, INT ARCH ALLER A IMM, V33, P428, DOI 10.1159/000230058; GROUHI M, 1999, PEDIATRICS, V103, P809; HAMILTONMILLER JM, 1971, BIOCHEM J, V123, P183, DOI 10.1042/bj1230183; HOFFMAN DR, 1989, ANN ALLERGY, V62, P91; KANNANGARA DW, 1982, ARCH INTERN MED, V142, P1031, DOI 10.1001/archinte.142.5.1031; KAPLAN K, 1967, J AMER MED ASSOC, V200, P75; Konno R, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P577; LEVINE BB, 1969, J ALLERGY, V43, P231, DOI 10.1016/0021-8707(69)90066-5; LEVINE BB, 1973, J INFECT DIS, V128, pS364, DOI 10.1093/infdis/128.Supplement_2.S364; Li JTC, 2000, MAYO CLIN PROC, V75, P902, DOI 10.4065/75.9.902; LIN RY, 1992, ARCH INTERN MED, V152, P930, DOI 10.1001/archinte.152.5.930; MASTELLA G, 1983, J ANTIMICROB CHEMOTH, V12, P297, DOI 10.1093/jac/12.suppl_A.297; MCARTHUR JE, 1975, NEW ZEAL MED J, V81, P390; Mendelson LM, 1998, IMMUNOL ALLERGY CLIN, V18, P745, DOI 10.1016/S0889-8561(05)70036-9; MEYERS BR, 1985, AM J MED, V79, P96, DOI 10.1016/0002-9343(85)90268-2; Mizutani H, 1996, CLIN EXP DERMATOL, V21, P246, DOI 10.1111/j.1365-2230.1996.tb00079.x; MURRAY DL, 1980, NEW ENGL J MED, V303, P1003; Nordt SP, 1999, AM J EMERG MED, V17, P492, DOI 10.1016/S0735-6757(99)90257-7; NORRBY SR, 1987, DRUGS, V34, P105, DOI 10.2165/00003495-198700342-00009; PAPAKONSTANTINOU G, 1993, CLIN INVESTIGATOR, V71, P165; PETZ LD, 1971, POSTGRAD MED J, V47, P64; PLATT R, 1982, J ANTIMICROB CHEMOTH, V10, P135, DOI 10.1093/jac/10.suppl_C.135; Pumphrey RSH, 1999, LANCET, V353, P1157, DOI 10.1016/S0140-6736(99)00449-3; Romano A, 1999, J ALLERGY CLIN IMMUN, V104, P1113, DOI 10.1016/S0091-6749(99)70100-4; ROTHSCHILD PD, 1966, J AMER MED ASSOC, V196, P372, DOI 10.1001/jama.1966.03100170114047; SALEH Y, 1974, MED J AUSTRALIA, V2, P490, DOI 10.5694/j.1326-5377.1974.tb70936.x; SANDERS CV, 1985, ANN INTERN MED, V103, P70, DOI 10.7326/0003-4819-103-1-70; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SHEPHERD GM, 1993, J ALLERGY CLIN IMMUN, V91, P262; SMITH JW, 1966, NEW ENGL J MED, V274, P998, DOI 10.1056/NEJM196605052741804; SOGN DD, 1992, ARCH INTERN MED, V152, P1025, DOI 10.1001/archinte.152.5.1025; SOLLEY GO, 1982, J ALLERGY CLIN IMMUN, V69, P238, DOI 10.1016/0091-6749(82)90105-1; SPRUILL FG, 1974, JAMA-J AM MED ASSOC, V229, P440, DOI 10.1001/jama.229.4.440; SULLIVAN TJ, 1981, J ALLERGY CLIN IMMUN, V68, P171, DOI 10.1016/0091-6749(81)90180-9; THOBURN R, 1966, J AMER MED ASSOC, V198, P345, DOI 10.1001/jama.198.4.345; WARRINGTON RJ, 1978, CAN MED ASSOC J, V118, P787; YOUNG EJ, 1982, REV INFECT DIS, V4, P69; ZEOK SS, 1980, ANESTH ANALG, V59, P393	50	225	236	0	16	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					804	809		10.1056/NEJMra993637	http://dx.doi.org/10.1056/NEJMra993637			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556301				2022-12-28	WOS:000170906800006
J	Lindemann, B				Lindemann, B			Receptors and transduction in taste	NATURE			English	Review							EPITHELIAL NA+ CHANNEL; SWEET TASTE; BITTER TASTE; CYCLIC-NUCLEOTIDES; ALPHA-GUSTDUCIN; INTRACELLULAR CALCIUM; BINDING PROTEIN; CHORDA TYMPANI; K+ CHANNELS; SOUR TASTE	Taste is the sensory system devoted primarily to a quality check of food to be ingested. Although aided by smell and visual inspection, the final recognition and selection relies on chemoreceptive events in the mouth. Emotional states of acute pleasure or displeasure guide the selection and contribute much to our quality of life. Membrane proteins that serve as receptors for the transduction of taste have for a long time remained elusive. But screening the mass of genome sequence data that have recently become available has provided a new means to identify key receptors for bitter and sweet taste. Molecular biology has also identified receptors for salty, sour and umami taste.	Univ Saarland, Dept Physiol, D-66421 Homburg, Germany	Saarland University	Lindemann, B (corresponding author), Univ Saarland, Dept Physiol, D-66421 Homburg, Germany.	phblin@uniklinik-saarland.de						Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; AVENET P, 1987, J MEMBRANE BIOL, V97, P223, DOI 10.1007/BF01869225; AVENET P, 1991, J MEMBRANE BIOL, V124, P33, DOI 10.1007/BF01871362; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Bigiani A, 1997, J NEUROPHYSIOL, V77, P3048, DOI 10.1152/jn.1997.77.6.3048; Brand JG, 2000, J NUTR, V130, p942S, DOI 10.1093/jn/130.4.942S; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Caicedo A, 2000, J COMP NEUROL, V417, P315; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; CUMMINGS TA, 1993, J NEUROPHYSIOL, V70, P2326, DOI 10.1152/jn.1993.70.6.2326; CUMMINGS TA, 1992, J GEN PHYSIOL, V99, P591, DOI 10.1085/jgp.99.4.591; Cummings TA, 1996, J NEUROPHYSIOL, V75, P1256, DOI 10.1152/jn.1996.75.3.1256; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Delay ER, 2000, CHEM SENSES, V25, P507, DOI 10.1093/chemse/25.5.507; Delay RJ, 1997, J NEUROPHYSIOL, V77, P2515, DOI 10.1152/jn.1997.77.5.2515; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; Erickson RP, 2000, PHYSIOL BEHAV, V69, P3, DOI 10.1016/S0031-9384(00)00193-1; GANCHROW JR, 1983, INFANT BEHAV DEV, V6, P189, DOI 10.1016/S0163-6383(83)80026-5; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Gilbertson TA, 2001, J NEUROSCI, V21, P4931, DOI 10.1523/JNEUROSCI.21-13-04931.2001; Hanig David, 1901, PHILOS STUD, V17, P576; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Herness MS, 1999, J NEUROPHYSIOL, V82, P260, DOI 10.1152/jn.1999.82.1.260; Herness S, 1997, NEUROREPORT, V8, P3257, DOI 10.1097/00001756-199710200-00014; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Ikeda Kikunae, 1909, J TOKYO CHEM SOC JAP, V30, P820, DOI DOI 10.1093/CHEMSE/27.9.847; Ishimaru Y, 2001, NEUROREPORT, V12, P233, DOI 10.1097/00001756-200102120-00011; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kretz O, 1998, HISTOCHEM J, V30, P293, DOI 10.1023/A:1003220125067; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Krimm RF, 2001, DEV BIOL, V232, P508, DOI 10.1006/dbio.2001.0190; Krizhanovsky V, 2000, AM J PHYSIOL-CELL PH, V279, pC120, DOI 10.1152/ajpcell.2000.279.1.C120; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Lindemann B, 1999, NAT MED, V5, P381, DOI 10.1038/7377; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Lindemann B, 1997, CURR OPIN NEPHROL HY, V6, P425, DOI 10.1097/00041552-199709000-00003; Lundy RF, 1999, J NEUROPHYSIOL, V82, P2970, DOI 10.1152/jn.1999.82.6.2970; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Misaka T, 1998, ANN NY ACAD SCI, V855, P150, DOI 10.1111/j.1749-6632.1998.tb10558.x; Mistretta CM, 1999, J COMP NEUROL, V409, P13; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Miyamoto T, 2000, PROG NEUROBIOL, V62, P135, DOI 10.1016/S0301-0082(99)00072-6; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; NAIM M, 1994, BIOCHEM J, V297, P451, DOI 10.1042/bj2970451; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NINOMIYA Y, IN PRESS VITAM HORM; NINOMIYA Y, 1987, P JPN S TASTE SMELL, V21, P153; Nofre C, 1996, FOOD CHEM, V56, P263, DOI 10.1016/0308-8146(96)00023-4; Ogura T, 1999, J NEUROPHYSIOL, V82, P2657, DOI 10.1152/jn.1999.82.5.2657; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; ROPER S, 1983, SCIENCE, V220, P1311, DOI 10.1126/science.6857254; Rosenzweig S, 1999, J NEUROPHYSIOL, V81, P1661, DOI 10.1152/jn.1999.81.4.1661; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SMITH DV, 1995, PHYSIOL BEHAV, V57, P773, DOI 10.1016/0031-9384(94)00329-7; Smith DV, 2001, SCI AM, V284, P32, DOI 10.1038/scientificamerican0301-32; SPICKOFSKY N, 1994, NAT STRUCT BIOL, V1, P771, DOI 10.1038/nsb1194-771; Spielman AI, 1996, AM J PHYSIOL-CELL PH, V270, pC926, DOI 10.1152/ajpcell.1996.270.3.C926; SPIELMAN AI, 1989, BRAIN RES, V503, P326, DOI 10.1016/0006-8993(89)91684-3; SPIELMAN AI, 1992, SOC GEN PHY, V47, P307; SPIELMAN AI, 1994, PHYSIOL BEHAV, V56, P1149, DOI 10.1016/0031-9384(94)90359-X; STEVENS DR, IN PRESS NATURE; STEVENS JC, 1995, CHEM SENSES, V20, P451, DOI 10.1093/chemse/20.4.451; Stewart RE, 1998, AM J PHYSIOL-CELL PH, V275, pC227, DOI 10.1152/ajpcell.1998.275.1.C227; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; STRIEM B J, 1991, Cellular Physiology and Biochemistry, V1, P46, DOI 10.1159/000154592; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; TONOSAKI K, 1988, NATURE, V331, P354, DOI 10.1038/331354a0; Tsunenari T, 1996, J GEN PHYSIOL, V108, P515, DOI 10.1085/jgp.108.6.515; Uchida Y, 1997, CHEM SENSES, V22, P163, DOI 10.1093/chemse/22.2.163; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Varkevisser B, 2000, J NEUROPHYSIOL, V83, P2526, DOI 10.1152/jn.2000.83.5.2526; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Yamamoto T, 1998, JPN J PHARMACOL, V76, P325, DOI 10.1254/jjp.76.325; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Zancanaro C, 1999, EUR J NEUROSCI, V11, P4473, DOI 10.1046/j.1460-9568.1999.00912.x; ZHU X, 1994, MOL PHARMACOL, V46, P460; Zviman MM, 1996, J MEMBRANE BIOL, V149, P81, DOI 10.1007/s002329900009	100	454	493	5	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					219	225		10.1038/35093032	http://dx.doi.org/10.1038/35093032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557991				2022-12-28	WOS:000170918800057
J	Lawrence, JM; Bennett, P; Young, A; Robinson, AM				Lawrence, JM; Bennett, P; Young, A; Robinson, AM			Screening for diabetes in general practice: cross sectional population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; OLDER-ADULTS; MELLITUS; GLUCOSE; PREVENTION; CRITERIA	Objective To assess the policy proposed by the American Diabetes Association of universal screening in general practice of all patients aged over 45 years for diabetes. Design Cross sectional Population study. Setting Local general practice in die United Kingdom. Participants All patients aged over 45 not known to have diabetes. Main outcome measures Prevalence of diabetes in the screened population, cardiovascular risk profile of patients diagnosed as having diabetes after screening. Results Of 2481 patients aged over 45 and not known to have diabetes, 876 attended for screening. There were no significant demographic differences between the screened and unscreened patients. Prevalence of diabetes in patients with age as a sole risk factor was 0.2% (95% confidence interval 0% to 1.4%). Prevalence of diabetes in patients with age and one or more other risk factors (hypertension, obesity, or a family history of diabetes) was 2.8% (1.6% to 4.7%). Four hours a week for a year would be needed to screen all people over 45 in the practice's population, about half this time would be needed to screen patients with risk factors other than age. More than 80% of patients newly diagnosed as having diabetes had a 10 year risk of coronary heart disease >15%. 73%) (45% to 92% were hypertensive, and 73% (45% to 92%) had a cholesterol concentration >5 mmol/l. Conclusions Screening for diabetes in general practice by measuring fasting blood glucose is feasible but has a very low yield in patients whose sole risk factor For diabetes is age over 45. Screening in a low risk population would best be targeted at patients with multiple risk factors.	Royal United Hosp, Dept Endocrinol & Diabet, Bath BA1 3NG, Avon, England; Batheaston Med Ctr, Bath BA1 7NP, Avon, England		Lawrence, JM (corresponding author), Royal United Hosp, Dept Endocrinol & Diabet, Bath BA1 3NG, Avon, England.	mpsjml@bath.ac.uk						Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1999, Diabetologia, V42, P647; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Barzilay JI, 1999, LANCET, V354, P622, DOI 10.1016/S0140-6736(98)12030-5; BLUNT BA, 1991, DIABETES CARE, V14, P989, DOI 10.2337/diacare.14.11.989; Borch-Johnsen K, 1999, LANCET, V354, P617; *DIAB UK, 2001, NEW DIAGN CRIT DIAB; GATLING W, 1985, J ROY COLL PHYS LOND, V19, P248; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Wood D, 1998, HEART, V80, pS1	14	77	81	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2001	323	7312					548	551		10.1136/bmj.323.7312.548	http://dx.doi.org/10.1136/bmj.323.7312.548			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546702	Green Published, Bronze			2022-12-28	WOS:000170934600023
J	Richter, JE				Richter, JE			Oesophageal motility disorders	LANCET			English	Review							LOWER ESOPHAGEAL SPHINCTER; NONCARDIAC CHEST PAIN; BOTULINUM TOXIN INJECTION; NUTCRACKER ESOPHAGUS; CONTRACTION ABNORMALITIES; GASTROESOPHAGEAL REFLUX; ISOSORBIDE DINITRATE; SYMPTOMATIC PATIENTS; PNEUMATIC DILATION; ACHALASIA	Oesophageal motility disorders comprise various abnormal manometric patterns which usually present with dysphagia or chest pain. Some, such as achalasia, are diseases with a well defined pathology, characteristic manometric features, and good response to treatments directed at the pathophysiological abnormalities. Other disorders, such as diffuse oesophageal spasm and hypercontracting oesophagus, have no well defined pathology and could represent a range of motility changes associated with subtle neuropathic changes, gastro-oesophageal reflux, and anxiety states. Although manometric patterns have been defined for these disorders, the relation with symptoms Is poorly defined and the response to medical or surgical therapy unpredictable. Hypocontracting oesophagus Is generally caused by weak musculature commonly associated with gastro-oesophageal reflux disease. Secondary oesophageal motility disorders can be caused by collagen vascular diseases, diabetes, Chagas' disease, amyloidosis, alcoholism, myxo-oedema, multiple sclerosis, Idiopathic pseudo-obstruction, or the ageing process.	Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Richter, JE (corresponding author), Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA.	richtej@ccf.org						Achem SR, 1997, DIGEST DIS SCI, V42, P2138, DOI 10.1023/A:1018843223263; ACHEM SR, 1993, AM J GASTROENTEROL, V88, P187; ANDERSON KO, 1989, DIGEST DIS SCI, V34, P83, DOI 10.1007/BF01536159; Bassotti G, 1997, ARTHRITIS RHEUM-US, V40, P2252, DOI 10.1002/art.1780401222; BEHAR J, 1993, GASTROENTEROLOGY, V105, P111, DOI 10.1016/0016-5085(93)90016-6; BENJAMIN SB, 1979, GASTROENTEROLOGY, V77, P478; Birgisson S, 1997, DIGEST DIS, V15, P1, DOI 10.1159/000171617; BORTOLOTTI M, 1994, ITAL J GASTROENTEROL, V26, P379; CANNON RO, 1994, NEW ENGL J MED, V330, P1411, DOI 10.1056/NEJM199405193302003; CHRISTENSEN J, 1967, GASTROENTEROLOGY, V52, P1130; Clouse R E, 1997, Gastroenterologist, V5, P112; CLOUSE RE, 1992, DIGEST DIS SCI, V37, P289, DOI 10.1007/BF01308186; CLOUSE RE, 1987, GASTROENTEROLOGY, V92, P1027, DOI 10.1016/0016-5085(87)90979-6; CLOUSE RE, 1986, DIGEST DIS SCI, V31, P236, DOI 10.1007/BF01318113; CLOUSE RE, 1992, AM J GASTROENTEROL, V87, pA1246; CODE CF, 1960, P STAFF M MAYO CLIN, V35, P392; COSTIGAN DJ, 1983, DIGEST DIS SCI, V28, P763, DOI 10.1007/BF01312569; DALY DD, 1962, NEUROLOGY, V12, P250, DOI 10.1212/WNL.12.4.250; DAVIES HA, 1987, DIGESTION, V36, P81; DEBAS HT, 1980, SURG GYNECOL OBSTET, V151, P593; deOliveira JM, 1997, AM J ROENTGENOL, V169, P473, DOI 10.2214/ajr.169.2.9242756; DIMARINO AJ, 1974, GASTROENTEROLOGY, V66, P1; EBERT EC, 1983, DIGEST DIS SCI, V28, P481, DOI 10.1007/BF01308147; ECKARDT VF, 1992, GASTROENTEROLOGY, V103, P1732, DOI 10.1016/0016-5085(92)91428-7; Ergun GA, 1996, AM J GASTROENTEROL, V91, P1077; Fishman VM, 1996, AM J GASTROENTEROL, V91, P1724; FOUAD YM, 1998, GASTROENTEROLOGY, V84, pA619; GELFOND M, 1982, GASTROENTEROLOGY, V83, P963; GOLDBLUM JR, 1994, AM J SURG PATHOL, V18, P327, DOI 10.1097/00000478-199404000-00001; GOLDENBERG SP, 1991, GASTROENTEROLOGY, V101, P743, DOI 10.1016/0016-5085(91)90534-R; HENDERSON RD, 1987, ANN THORAC SURG, V43, P25, DOI 10.1016/S0003-4975(10)60161-0; HEWSON EG, 1990, GASTROENTEROLOGY, V98, P626, DOI 10.1016/0016-5085(90)90281-5; HOLLIS JB, 1977, GASTROENTEROLOGY, V73, P1098; Hollis JB, 1974, ANN INTERN MED, V91, P897; HOLLOWAY RH, 1986, GASTROENTEROLOGY, V90, P924, DOI 10.1016/0016-5085(86)90869-3; HONGO M, 1984, DIGEST DIS SCI, V29, P300, DOI 10.1007/BF01318513; Horgan S, 1999, SURG ENDOSC-ULTRAS, V13, P576, DOI 10.1007/s004649901044; KADAKIA SC, 1993, AM J GASTROENTEROL, V88, P34; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V94, P73, DOI 10.1016/0016-5085(88)90612-9; KATZ PO, 1986, GASTROENTEROLOGY, V90, P978, DOI 10.1016/0016-5085(86)90876-0; KATZ PO, 1987, ANN INTERN MED, V106, P593, DOI 10.7326/0003-4819-106-4-593; KESHAVARZIAN A, 1987, GASTROENTEROLOGY, V92, P651, DOI 10.1016/0016-5085(87)90013-8; Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8; Leite LP, 1997, DIGEST DIS SCI, V42, P1859, DOI 10.1023/A:1018802908358; Lock G, 1997, AM J GASTROENTEROL, V92, P763; LONDON RL, 1981, GASTROENTEROLOGY, V81, P10; ORLANDO RC, 1973, NEW ENGL J MED, V289, P23, DOI 10.1056/NEJM197307052890106; Osgood H., 1889, BOSTON MED SURG J, V120, P401, DOI [10.1056/NEJM188904251201701, DOI 10.1056/NEJM188904251201701]; Pasricha PJ, 1996, GASTROENTEROLOGY, V110, P1410, DOI 10.1053/gast.1996.v110.pm8613045; PASRICHA PJ, 1995, NEW ENGL J MED, V332, P774, DOI 10.1056/NEJM199503233321203; Pellegrini CA, 1997, SURG ENDOSC-ULTRAS, V11, P1, DOI 10.1007/s004649900282; PETERS L, 1988, GASTROENTEROLOGY, V94, P878, DOI 10.1016/0016-5085(88)90542-2; RICHTER JE, 1984, ANN INTERN MED, V100, P242, DOI 10.7326/0003-4819-100-2-242; RICHTER JE, 1987, GASTROENTEROLOGY, V93, P21, DOI 10.1016/0016-5085(87)90308-8; Richter JE, 2000, CLEV CLIN J MED, V67, P471; RICHTER JE, 1987, DIGEST DIS SCI, V32, P583, DOI 10.1007/BF01296157; RICHTER JE, 1989, ANN INTERN MED, V110, P66, DOI 10.7326/0003-4819-110-1-66; RICHTER JE, 1986, GASTROENTEROLOGY, V91, P845, DOI 10.1016/0016-5085(86)90685-2; RICHTER JE, 1985, ANN INTERN MED, V103, P14, DOI 10.7326/0003-4819-103-1-14; SCHNEIDER HA, 1984, ANN INTERN MED, V100, P848, DOI 10.7326/0003-4819-100-6-848; SCHUFFLER MD, 1976, GASTROENTEROLOGY, V70, P677; SOERGEL KH, 1964, J CLIN INVEST, V43, P1472, DOI 10.1172/JCI105023; SRINIVASAN R, 1997, AM J GASTROENTEROL, V92, P1604; Vaezi MF, 1999, AM J GASTROENTEROL, V94, P1802; Vaezi MF, 2000, GASTROENTEROLOGY, V118, pA245, DOI 10.1016/S0016-5085(00)83056-5; Vaezi MF, 1999, AM J GASTROENTEROL, V94, P3406, DOI 10.1111/j.1572-0241.1999.01639.x; Vaezi MF, 1998, J CLIN GASTROENTEROL, V27, P21, DOI 10.1097/00004836-199807000-00006; WARD BW, 1987, AM J GASTROENTEROL, V82, P215; WATERMAN DC, 1989, J CLIN GASTROENTEROL, V11, P139, DOI 10.1097/00004836-198904000-00006; Willis 55Thomas, 1674, PHARMACEUTICE RATION, VII; WINSHIP DH, 1968, GASTROENTEROLOGY, V55, P173; WINTERS C, 1984, JAMA-J AM MED ASSOC, V252, P363; Wong RKH, 1999, ESOPHAGUS-TOKYO, V3rd, P185; ZAMOST BJ, 1987, GASTROENTEROLOGY, V92, P421, DOI 10.1016/0016-5085(87)90137-5	74	199	212	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					823	828		10.1016/S0140-6736(01)05973-6	http://dx.doi.org/10.1016/S0140-6736(01)05973-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564508				2022-12-28	WOS:000170989300034
J	Scheidtmann, K; Fries, W; Muller, F; Koenig, E				Scheidtmann, K; Fries, W; Muller, F; Koenig, E			Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study	LANCET			English	Article							SENSORIMOTOR CORTEX ABLATION; AMPHETAMINE; REHABILITATION; THERAPY; RATS; FLUOXETINE; PLASTICITY; DEPRESSION	Background Functional disability is generally caused by hemiplegia after stroke. Physiotherapy used to be the only way of improving motor function in such patients. However, administration of amphetamines in addition to exercise improves motor recovery in animals, probably by increasing the concentration of norepinephrine in the central nervous system. Our aim was to ascertain whether levodopa could enhance the efficacy of physiotherapy after hemiplegia. Methods We did a prospective, randomised, placebo-controlled, double-blind study in which we enrolled 53 primary stroke patients. For the first 3 weeks patients received single doses of levodopa 100 mg or placebo daily in combination with physiotherapy. For the second 3 weeks patients had only physiotherapy. We quantitatively assessed motor function every week with Rivermead motor assessment (IRMA). Findings Six patients were excluded from analyses because of non-neurological complications. Motor recovery was significantly improved after 3 weeks of drug intervention in those on levodopa (RMA improved by 6.4 points) compared with placebo (4.1), and the result was independent of initial degree of impairment (p<0.004). The advantage of the levodopa group was maintained at study endpoint 3 weeks after levodopa was stopped. At the end of the study the total RMA score gain for the levodopa group was 8.2 points compared with 5.7 in the placebo group (p=0.020). Interpretation A single dose of levodopa is well tolerated and, when given in combination with physiotherapy, enhances motor recovery in patients with hemiplegia. In view of its minimal side-effects, levodopa will be a possible add-on during stroke rehabilitation.	Neurol Clin, D-83043 Bad Aibling, Germany; Praxis Neurol Neuropsychol Rehabil, Munich, Germany		Scheidtmann, K (corresponding author), Neurol Clin, D-83043 Bad Aibling, Germany.							BJELKE B, 1993, NEUR ABST, V19, P1653; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; Dam M, 1996, STROKE, V27, P1211, DOI 10.1161/01.STR.27.7.1211; Duncan P W, 1997, Top Stroke Rehabil, V3, P1, DOI 10.1080/10749357.1997.11754126; FEENEY DM, 1998, CEREBROVASCULAR DIS; GOLD PE, 1984, BRAIN RES, V305, P103, DOI 10.1016/0006-8993(84)91124-7; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; KASAMATSU T, 1991, PROG BRAIN RES, V88, P599; Kikuchi K, 2000, BRAIN RES, V860, P130, DOI 10.1016/S0006-8993(00)02034-5; Liepert J, 1999, CURR OPIN NEUROL, V12, P709, DOI 10.1097/00019052-199912000-00009; Lincoln N, 1979, Physiotherapy, V65, P48; Majsak MJ, 1996, TOP STROKE REHABIL, V3, P27; Miyai I, 2000, NEUROREHAB NEURAL RE, V14, P141, DOI 10.1177/154596830001400207; NUTT JG, 1984, CLIN NEUROPHARMACOL, V7, P35; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Robinson RG, 2000, AM J PSYCHIAT, V157, P351, DOI 10.1176/appi.ajp.157.3.351; SCHEIDTMANN K, 2000, AKTUELLE NEUROLOGIE, V27, P227; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; WalkerBatson D, 1996, BRAIN LANG, V55, P27; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; WEINER N, 1980, PHARMACOL BASIS THER, P138	29	290	309	2	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					787	790		10.1016/S0140-6736(01)05966-9	http://dx.doi.org/10.1016/S0140-6736(01)05966-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564483				2022-12-28	WOS:000170989300009
J	Zwaan, MA; van Dokkum, PG; Verheijen, MAW				Zwaan, MA; van Dokkum, PG; Verheijen, MAW			Hydrogen 21-centimeter emission from a galaxy at cosmological distance	SCIENCE			English	Article							HUBBLE-SPACE-TELESCOPE; SPIRAL GALAXIES; CLUSTERS; EVOLUTION; POPULATIONS; ABELL-2218; Z=0.31; GAS	We have detected the neutral atomic hydrogen (HI) emission line at a cosmologically significant distance [redshift (z) = 0.18] in the rich galaxy cluster Abell 2218 with the Westerbork Synthesis Radio Telescope. The HI emission originates in a spiral galaxy 2.0 h(65)(-1) megaparsecs from the cluster core. No other significant detections have been made in the cluster, suggesting that the mechanisms that remove neutral gas from cluster galaxies are efficient. We infer that fewer than three gas-rich galaxies were accreted by Abell 2218 over the past 10(9) years. This low accretion rate is qualitatively consistent with low-density cosmological models in which clusters are largely assembled at z > 1.	Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; CALTECH, Pasadena, CA 91125 USA; Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA	University of Melbourne; California Institute of Technology; University of Wisconsin System; University of Wisconsin Madison; National Radio Astronomy Observatory (NRAO)	Zwaan, MA (corresponding author), Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia.	mzwaan@physics.unimelb.edu.au		Zwaan, Martin/0000-0003-0101-1804				Abadi MG, 1999, MON NOT R ASTRON SOC, V308, P947, DOI 10.1046/j.1365-8711.1999.02715.x; ABELL GO, 1989, ASTROPHYS J SUPPL S, V70, P1, DOI 10.1086/191333; Abraham RG, 1996, ASTROPHYS J, V471, P694, DOI 10.1086/177999; Barnes DG, 1997, MON NOT R ASTRON SOC, V288, P307, DOI 10.1093/mnras/288.2.307; Bravo-Alfaro H, 2000, ASTRON J, V119, P580, DOI 10.1086/301194; BUTCHER H, 1984, ASTROPHYS J, V285, P426, DOI 10.1086/162519; CAYATTE V, 1990, ASTRON J, V100, P604, DOI 10.1086/115545; COUCH WJ, 1987, MON NOT R ASTRON SOC, V229, P423, DOI 10.1093/mnras/229.3.423; Couch WJ, 1998, ASTROPHYS J, V497, P188, DOI 10.1086/305462; Cram L, 1998, ASTROPHYS J, V507, P155, DOI 10.1086/306333; Dickey JM, 1997, ASTRON J, V113, P1939, DOI 10.1086/118408; Dressler A, 1997, ASTROPHYS J, V490, P577, DOI 10.1086/304890; Ellingson E, 2001, ASTROPHYS J, V547, P609, DOI 10.1086/318423; HERNANDEZ X, 2001, ASTROPH0105092; KAUFFMANN G, 1995, MON NOT R ASTRON SOC, V274, P153, DOI 10.1093/mnras/274.1.153; Kneib JP, 1996, ASTROPHYS J, V471, P643, DOI 10.1086/177995; LEBORGNE JF, 1992, ASTRON ASTROPHYS SUP, V95, P87; LIU CT, 1995, ASTROPHYS J, V450, P547, DOI 10.1086/176165; Mihos JC, 1996, ASTROPHYS J, V464, P641, DOI 10.1086/177353; Moore B, 1996, NATURE, V379, P613, DOI 10.1038/379613a0; Mori M, 2000, ASTROPHYS J, V538, P559, DOI 10.1086/309140; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Quilis V, 2000, SCIENCE, V288, P1617, DOI 10.1126/science.288.5471.1617; ROBERTS MS, 1994, ANNU REV ASTRON ASTR, V32, P115; Squires G, 1996, ASTROPHYS J, V461, P572, DOI 10.1086/177085; van Dokkum PG, 2000, ASTROPHYS J, V541, P95, DOI 10.1086/309402; Zwaan MA, 1997, ASTROPHYS J, V490, P173, DOI 10.1086/304872	27	40	40	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1800	1802		10.1126/science.1063034	http://dx.doi.org/10.1126/science.1063034			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546865	Green Submitted			2022-12-28	WOS:000170894400038
J	Eisenberg, DM; Kessler, RC; Van Rompay, MI; Kaptchuk, TJ; Wilkey, SA; Appel, S; Davis, RB				Eisenberg, DM; Kessler, RC; Van Rompay, MI; Kaptchuk, TJ; Wilkey, SA; Appel, S; Davis, RB			Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey	ANNALS OF INTERNAL MEDICINE			English	Article							ALTERNATIVE MEDICINE; HEALTH-CARE; UNCONVENTIONAL MEDICINE; UNITED-STATES; RHEUMATOLOGISTS; PREVALENCE; PHYSICIANS; CHOICE	Background: Little is known about perceptions of complementary and alternative medical (CAM) therapy relative to conventional therapy among patients who use both. Objective: To document perceptions about CAM therapies among persons who use CAM and conventional therapies. Design: Nationally representative, random-household telephone survey. Setting: The 48 contiguous U.S. states. Participants: 831 adults who saw a medical doctor and used CAM therapies in 1997. Measurements: Perceptions about helpfulness and patterns of CAM therapy use relative to conventional therapy use and reasons for nondisclosure of CAM therapies. Results: Of 831 respondents who saw a medical doctor and used CAM therapies in the previous 12 months, 79% perceived the combination to be superior to either one alone. Of 411 respondents who reported seeing both a medical doctor and a CAM provider, 70% typically saw a medical doctor before or concurrent with their visits to a CAM provider; 15% typically saw a CAM provider before seeing a medical doctor. Perceived confidence in CAM providers was not substantially different from confidence in medical doctors. Among the 831 respondents who in the past year had used a CAM therapy and seen a medical doctor, 63% to 72% did not disclose at least one type of CAM therapy to the medical doctor. Among 507 respondents who reported their reasons for nondisclosure of use of 726 alternative therapies, common reasons for nondisclosure were "It wasn't important for the doctor to know" (61%), "The doctor never asked" (60%), "It was none of the doctor's business" (31%), and "The doctor would not understand" (20%). Fewer respondents (14%) thought their doctor would disapprove of or discourage CAM use, and 2% thought their doctor might not continue as their provider. Respondents judged CAM therapies to be more helpful than conventional care for the treatment of headache and neck and back conditions but considered conventional care to be more helpful than CAM therapy for treatment of hypertension. Conclusions: National survey data do not support the view that use of CAM therapy in the United States primarily reflects dissatisfaction with conventional care. Adults who use both appear to value both and tend to be less concerned about their medical doctor's disapproval than about their doctor's inability to understand or incorporate CAM therapy use within the context of their medical management.	Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Eisenberg, DM (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, 330 Brookline Ave, Boston, MA 02215 USA.	deisenbe@caregroup.harvard.edu	Van Rompay, Maria/G-9452-2012		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441-02S1A1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Beyerstein B, 1997, CAN J PUBLIC HEALTH, V88, P149, DOI 10.1007/BF03403878; CAMPION EW, 1993, NEW ENGL J MED, V328, P282, DOI 10.1056/NEJM199301283280413; CHERKIN DC, 1989, WESTERN J MED, V150, P351; Davidoff F, 1998, ANN INTERN MED, V129, P1068, DOI 10.7326/0003-4819-129-12-199812150-00014; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; GoldbeckWood S, 1996, BRIT MED J, V313, P131, DOI 10.1136/bmj.313.7050.131a; HENTSCHEL C, 1996, EUR J PHYS MED REHAB, V6, P144; Hilsden RJ, 1998, AM J GASTROENTEROL, V93, P697; Kelner M, 1997, SOC SCI MED, V45, P203, DOI 10.1016/S0277-9536(96)00334-6; Lazar JS, 1997, PRIMARY CARE, V24, P699, DOI 10.1016/S0095-4543(05)70305-5; MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4; McGregor KJ, 1996, SOC SCI MED, V43, P1317, DOI 10.1016/0277-9536(95)00405-X; MOORE J, 1985, BRIT MED J, V290, P28, DOI 10.1136/bmj.290.6461.28; MURRAY J, 1993, SOC SCI MED, V37, P983, DOI 10.1016/0277-9536(93)90432-4; MURRAY RH, 1992, NEW ENGL J MED, V326, P61, DOI 10.1056/NEJM199201023260113; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; RASMUSSEN NK, 1990, COMPLEMENT MED RES, V4, P16; *RES TRIANGL I, 1997, SUDAAN PROF SOFTW SU; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; VASKILAMPI T, 1993, CLIN RES METHODOLOGY; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; VISSER GJ, 1992, BRIT J RHEUMATOL, V31, P485	27	428	436	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					344	351		10.7326/0003-4819-135-5-200109040-00011	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529698				2022-12-28	WOS:000170780600005
J	Ezekowitz, RAB				Ezekowitz, RAB			Mannose-binding lectin in prediction of susceptibility to infection	LANCET			English	Editorial Material							INNATE IMMUNITY; NEUTROPENIA; FEVER		Harvard Univ, Mass Gen Hosp Children, Dept Pediat, Boston, MA 02114 USA	Harvard University	Ezekowitz, RAB (corresponding author), Harvard Univ, Mass Gen Hosp Children, Dept Pediat, Boston, MA 02114 USA.							Beutler B, 2001, NAT IMMUNOL, V2, P9, DOI 10.1038/83222; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Ezekowitz RAB, 1998, CURR OPIN IMMUNOL, V10, P9; Gadjeva M, 2001, CURR OPIN IMMUNOL, V13, P74, DOI 10.1016/S0952-7915(00)00185-0; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Matsushita M, 1998, CURR OPIN IMMUNOL, V10, P29, DOI 10.1016/S0952-7915(98)80027-7; Metchnikoff E., 1905, IMMUNITY INFECT DIS; Paesmans M, 2000, INT J ANTIMICROB AG, V16, P107, DOI 10.1016/S0924-8579(00)00213-2; Pizzo PA, 1999, NEW ENGL J MED, V341, P893, DOI 10.1056/NEJM199909163411207; Sumiya M, 1997, SEMIN LIVER DIS, V17, P311, DOI 10.1055/s-2007-1007207; Talcott JA, 2000, INT J ANTIMICROB AG, V16, P169, DOI 10.1016/S0924-8579(00)00235-1; TALCOTT JA, 1992, J CLIN ONCOL, V10, P316, DOI 10.1200/JCO.1992.10.2.316	15	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					598	599		10.1016/S0140-6736(01)05814-7	http://dx.doi.org/10.1016/S0140-6736(01)05814-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530141				2022-12-28	WOS:000170615500002
J	Clark, I; Whitten, R; Molyneux, M; Taylor, L				Clark, I; Whitten, R; Molyneux, M; Taylor, L			Salicylates, nitric oxide, malaria, and Reye's syndrome	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE CELLS; PLASMODIUM-FALCIPARUM MALARIA; ACTIVATED PROTEIN-KINASE; SYNTHASE EXPRESSION; CEREBRAL MALARIA; CHILDREN; ASPIRIN; INTOXICATION; INDUCTION	Reye's syndrome virtually disappeared from much of the world after the use of salicylate in febrile children was successfully discouraged. This severe sepsis-like disease was thought tot be caused by a hypersensitivity to salicylates in children with mild viral infections, although mo mechanism consistent with this proposal was ever established. Salicylate toxicity in African children has been noted to have many clinical features in common with severe falciparum malaria, including acidosis, altered consciousness, convulsions, and hypoglycaemia. Salicylates are widely available in various formulations in many African countries, and are commonly used for initial treatment of the symptoms that malaria shares with other diseases. There is now experimental evidence that salicylate increases and prolongs the activity of key elements along the signalling pathway through which interferon gamma generates inducible nitric oxide synthase (iNOS), and we have shown that INOS is strongly expressed in fatal malaria and other acute fevers in African children. We further propose that, in areas where salicyaltes are still used to treat the symptoms of febrile illnesses in children, this mechanism could exacerbate potentially serious infectious diseases, including falciparum malaria. In contrast, the absence of salicylate use in children in some Pacific islands could contribute to the milder outcome of falciparum malaria than is observed in Africa. Widespread expression of iNOS has also been seen in the tissues of a patient with fatal clinically defined Reye's syndrome. This finding suggests that Reye's syndrome can be mediated through salicylate enhancement of iNOS expression, the initial trigger in this instance usually being a viral infection.	Australian Natl Univ, Sch Life Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia; Black Hills Pathol, Olympia, WA USA; Univ Malawi, Coll Med, Wellcome Trust Res Labs, Zomba, Malawi; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; Univ Malawi, Coll Med, Malaria Project, Zomba, Malawi; Michigan State Univ, E Lansing, MI 48824 USA	Australian National University; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University	Clark, I (corresponding author), Australian Natl Univ, Sch Life Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia.							Chalasani N, 1996, SOUTHERN MED J, V89, P479, DOI 10.1097/00007611-199605000-00005; CHENLC, 1999, BIOCH J, V432, P503; CLARK IA, 1994, PARASITOL TODAY, V10, P410, DOI 10.1016/0169-4758(94)90237-2; CLARK IA, 1992, LANCET, V340, P894, DOI 10.1016/0140-6736(92)93295-X; CLARK IA, 1981, INFECT IMMUN, V32, P1058, DOI 10.1128/IAI.32.3.1058-1066.1981; Crocker JFS, 1998, CLIN INVEST MED, V21, P192; de Miguel LS, 1999, EUR J CLIN INVEST, V29, P93, DOI 10.1046/j.1365-2362.1999.00425.x; Durak I, 1999, CLIN CHIM ACTA, V288, P169, DOI 10.1016/S0009-8981(99)00134-5; English M, 1996, LANCET, V347, P1736, DOI 10.1016/S0140-6736(96)90809-0; Faure V, 1999, J BIOL CHEM, V274, P4794, DOI 10.1074/jbc.274.8.4794; GILES HM, 1965, LANCET, V1, P1075; Guan ZH, 1999, J BIOL CHEM, V274, P36200, DOI 10.1074/jbc.274.51.36200; HEMMER CJ, 1991, AM J TROP MED HYG, V45, P608, DOI 10.4269/ajtmh.1991.45.608; HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LARRICK JW, 1986, LANCET, V2, P132; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Marsh K, 1996, ANN TROP MED PARASIT, V90, P395, DOI 10.1080/00034983.1996.11813068; Melillo G, 1996, J IMMUNOL, V157, P2638; Nishio E, 1998, LIFE SCI, V63, P429, DOI 10.1016/S0024-3205(98)00292-6; PARTIN JS, 1984, HEPATOLOGY, V4, P687, DOI 10.1002/hep.1840040421; PARTIN JS, 1982, LANCET, V1, P191; REYE RDK, 1963, LANCET, V2, P749; Roczniak A, 1996, AM J PHYSIOL-RENAL, V270, pF106, DOI 10.1152/ajprenal.1996.270.1.F106; ROWE PC, 1988, JAMA-J AM MED ASSOC, V260, P3167, DOI 10.1001/jama.260.21.3167; Ruetten H, 1996, BRIT J PHARMACOL, V118, P261, DOI 10.1111/j.1476-5381.1996.tb15397.x; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; STARKO KM, 1980, PEDIATRICS, V66, P859; Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025; 1965, LANCET, V1, P941	32	25	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					625	627		10.1016/S0140-6736(00)04061-7	http://dx.doi.org/10.1016/S0140-6736(00)04061-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558501				2022-12-28	WOS:000167119100035
J	Tiwari, RK; Rao, KNN				Tiwari, RK; Rao, KNN			Periodicity in marine phosphorus burial rate	NATURE			English	Letter							CYCLE		Natl Geophys Res Inst, Theoret Geophys Grp, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Geophysical Research Institute (NGRI)	Tiwari, RK (corresponding author), Natl Geophys Res Inst, Theoret Geophys Grp, Hyderabad 500007, Andhra Pradesh, India.		Rajesh, Rekapalli/AAP-8508-2021					FILIPPELLI GM, 1994, PALEOCEANOGRAPHY, V9, P643, DOI 10.1029/94PA01453; FISCHER AG, 1977, DEEP WATER CARBONATE, P19, DOI DOI 10.2110/PEC.77.25; Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; HARLAND WB, 1989, GEOLOGICAL TIME SCAL; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Negi JG, 1996, MAR GEOL, V133, P113, DOI 10.1016/0025-3227(96)00003-5; RAMPINO MR, 1993, EARTH PLANET SC LETT, V114, P215, DOI 10.1016/0012-821X(93)90026-6; RAUP DM, 1988, SCIENCE, V241, P94, DOI 10.1126/science.241.4861.94; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; STIGLER SM, 1987, SCIENCE, V238, P940, DOI 10.1126/science.238.4829.940; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455	12	11	12	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	1999	400	6739					31	32		10.1038/21807	http://dx.doi.org/10.1038/21807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	213DA	11536905				2022-12-28	WOS:000081255700035
J	BLAKE, D; ALLAMANDOLA, L; SANDFORD, S; HUDGINS, D; FREUND, F				BLAKE, D; ALLAMANDOLA, L; SANDFORD, S; HUDGINS, D; FREUND, F			CLATHRATE HYDRATE FORMATION IN AMORPHOUS COMETARY ICE ANALOGS INVACUO	SCIENCE			English	Article							PHYSICO-CHEMICAL PHENOMENA; INFRARED-SPECTRA; SOLAR-SYSTEM; WATER; EROSION; OXIRANE; GRAINS; SNOWS	The presence of clathrate hydrates in cometary ice has been suggested to account for anomalous gas release at large radial distances from the sun as well as the retention of volatiles in comets to elevated temperatures. However, how clathrate hydrates can form in low-pressure environments, such as in cold interstellar molecular clouds, in the outer reaches of the early solar nebula, or in cometary ices, has been poorly understood. Experiments performed with the use of a modified electron microscope demonstrate that during the warming of vapor-deposited amorphous ices in vacuo, clathrate hydrates can form by rearrangements in the solid state. Phase separations and microporous textures that are the result of these rearrangements may account for a variety of anomalous cometary phenomena.	NASA,AMES RES CTR,ASTROPHYS BRANCH,MOFFETT FIELD,CA 94035; SAN JOSE STATE UNIV,DEPT PHYS,SAN JOSE,CA 95192	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California State University System; San Jose State University	BLAKE, D (corresponding author), NASA,AMES RES CTR,PLANETARY BIOL BRANCH,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.							ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1988, DUST UNIVERSE, P229; BARNUN A, 1987, PHYS REV B, V35, P2427, DOI 10.1103/PhysRevB.35.2427; BERTIE JE, 1978, J CHEM PHYS, V69, P4105, DOI 10.1063/1.437089; BERTIE JE, 1983, J CHEM PHYS, V78, P6340, DOI 10.1063/1.444563; BLAKE DF, 1990, 12 P INT C EL MICR S, V1, P594; BOCKELEEMORVAN D, 1991, NATURE, V350, P318, DOI 10.1038/350318a0; BOUTRON P, 1978, J CHEM PHYS, V68, P5032, DOI 10.1063/1.435619; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; Delsemme A., 1952, ANN ASTROPHYS, V15, P1; DELSEMME AH, 1970, PLANET SPACE SCI, V18, P717, DOI 10.1016/0032-0633(70)90053-X; DELSEMME AH, 1970, PLANET SPACE SCI, V18, P709, DOI 10.1016/0032-0633(70)90052-8; DHENDECOURT LB, 1986, ASTRON ASTROPHYS, V158, P119; ENGLE S, 1990, ICARUS, V85, P380; FLEYFEL F, 1991, J PHYS CHEM-US, V95, P3811, DOI 10.1021/j100162a068; Greenberg J., 1982, COMETS, P131; GUTZOW I, 1980, CONTEMP PHYS, V21, P121, DOI 10.1080/00107518008210949; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HALLBRUCKER A, 1991, ICARUS, V90, P176, DOI 10.1016/0019-1035(91)90078-8; HSUING P, 1990, LUNAR PLANET SCI, V21, P538; JOHNSON RE, 1983, ASTRON ASTROPHYS, V123, P343; JOHNSON RE, 1987, ASTRON ASTROPHYS, V187, P889; KOCHAN H, 1989, LUNAR PLANET SCI, V20, P524; KOUCHI A, 1990, J CRYST GROWTH, V99, P1220, DOI 10.1016/S0022-0248(08)80112-1; KOUCHI A, 1990, NATURE, V344, P134, DOI 10.1038/344134a0; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; MAK TCW, 1965, J CHEM PHYS, V42, P2732, DOI 10.1063/1.1703229; MILLER SL, 1973, PHYSICS CHEM ICE, P42; MOORE MH, 1983, ICARUS, V54, P388, DOI 10.1016/0019-1035(83)90236-1; RICHARDSON HH, 1985, J CHEM PHYS, V83, P4387, DOI 10.1063/1.449055; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; SANDFORD SA, 1990, ASTROPHYS J, V355, P357, DOI 10.1086/168770; STRAZZULLA G, 1983, ASTRON ASTROPHYS, V123, P93; Tielens A., 1989, IAU S, P239; Tielens A. G., 1987, PHYSICAL PROCESSES I, V333	35	151	151	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					548	551		10.1126/science.11538372	http://dx.doi.org/10.1126/science.11538372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	11538372				2022-12-28	WOS:A1991GL79900042
J	OTT, U; BEGEMANN, F; YANG, JM; EPSTEIN, S				OTT, U; BEGEMANN, F; YANG, JM; EPSTEIN, S			S-PROCESS KRYPTON OF VARIABLE ISOTOPIC COMPOSITION IN THE MURCHISON METEORITE	NATURE			English	Article									CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125	California Institute of Technology	OTT, U (corresponding author), MAX PLANCK INST CHEM,SAARSTR 23,D-6500 MAINZ 1,FED REP GER.		Ott, Ulrich/ABH-2337-2020	Ulrich, Ott/0000-0003-3574-9591				ALAERTS L, 1980, GEOCHIM COSMOCHIM AC, V44, P189, DOI 10.1016/0016-7037(80)90131-3; BAO ZY, 1987, ATOM DATA NUCL DATA, V36, P411, DOI 10.1016/0092-640X(87)90011-8; BEER H, 1986, NUCLEOSYNTHESIS ITS, P263; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; CLAYTON DD, 1978, ASTROPHYS J, V244, P1000; FOWLER WA, 1984, SCIENCE, V226, P922, DOI 10.1126/science.226.4677.922; KAPPELER F, 1982, ASTROPHYS J, V257, P821, DOI 10.1086/160033; MARTI K, 1967, EARTH PLANET SC LETT, V3, P243, DOI 10.1016/0012-821X(67)90044-1; MATHEWS GJ, 1985, REP PROG PHYS, V48, P1371, DOI 10.1088/0034-4885/48/10/002; MATSUDA J, 1980, ASTROPHYS J, V237, pL21, DOI 10.1086/183226; OTT U, 1985, METEORITICS, V20, P722; SRINIVASAN B, 1978, SCIENCE, V201, P51, DOI 10.1126/science.201.4350.51; TANG M, 1987, METEORITICS, V22, P462; WALTER G, 1986, ASTRON ASTROPHYS, V155, P247; WALTER G, 1986, ASTRON ASTROPHYS, V167, P186; WARD RA, 1976, ASTROPHYS J SUPPL S, V31, P33, DOI 10.1086/190373; YANG JM, 1984, NATURE, V311, P544, DOI 10.1038/311544a0	17	53	54	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 21	1988	332	6166					700	702		10.1038/332700a0	http://dx.doi.org/10.1038/332700a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	N0293	11542152				2022-12-28	WOS:A1988N029300046
J	Gerde, E; Marder, M				Gerde, E; Marder, M			Friction and fracture	NATURE			English	Article							FOAM RUBBER; INTERFACE; RUPTURE; SLIP; EARTHQUAKES; FAULTS; PULSES; CRACKS	Consider a block placed on a table and pushed sideways until it begins to slide. Amontons and Coulomb found that the force required to initiate sliding is proportional to the weight of the block (the constant of proportionality being the static coefficient of friction), but independent of the area of contact(1). This is commonly explained by asserting that, owing to the presence of asperities on the two surfaces, the actual area in physical contact is much smaller than it seems, and grows in proportion to the applied compressive force(1). Here we present an alternative picture of the static friction coefficient, which starts with an atomic description of surfaces in contact and then employs a multiscale analysis technique to describe how sliding occurs for large objects. We demonstrate the existence of self-healing cracks(2-4) that have been postulated to solve geophysical paradoxes about heat generated by earthquakes(5-11,25-27), and we show that, when such cracks are present at the atomic scale, they result in solids that slip in accord with Coulomb's law of friction. We expect that this mechanism for friction will be found to operate at many length scales, and that our approach for connecting atomic and continuum descriptions will enable more realistic first-principles calculations of friction coefficients.	Univ Texas, Ctr Nonlinear Dynam, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Marder, M (corresponding author), Univ Texas, Ctr Nonlinear Dynam, Austin, TX 78712 USA.							Adams GG, 1999, J TRIBOL-T ASME, V121, P455, DOI 10.1115/1.2834089; Anooshehpoor A, 1999, GEOPHYS RES LETT, V26, P2025, DOI 10.1029/1999GL900397; Ben-Zion Y, 1998, B SEISMOL SOC AM, V88, P1085; Brown SR, 1998, J GEOPHYS RES-SOL EA, V103, P7413, DOI 10.1029/98JB00200; BRUNE JN, 1993, TECTONOPHYSICS, V218, P59, DOI 10.1016/0040-1951(93)90259-M; Caroli C, 2000, PHYS REV E, V62, P1729, DOI 10.1103/PhysRevE.62.1729; Cochard A, 2000, J GEOPHYS RES-SOL EA, V105, P25891, DOI 10.1029/2000JB900230; COMNINOU M, 1978, J SOLID STRUCT, V14, P251; Das S, 1996, ENG FRACT MECH, V54, P523, DOI 10.1016/0013-7944(95)00202-2; DENG XM, 1992, ENG FRACT MECH, V42, P237, DOI 10.1016/0013-7944(92)90214-Y; Dhaliwal R. S., 1992, Journal of Mathematical and Physical Sciences, V26, P237; Eggermont P.P.B., 1994, J INTEGRAL EQUAT, V6, P335; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Holland D, 1999, ADV MATER, V11, P793, DOI 10.1002/(SICI)1521-4095(199907)11:10<793::AID-ADMA793>3.0.CO;2-B; MARDER M, 1995, J MECH PHYS SOLIDS, V43, P1, DOI 10.1016/0022-5096(94)00060-I; Mora P, 1999, GEOPHYS RES LETT, V26, P123, DOI 10.1029/1998GL900231; Muser MH, 2001, PHYS REV LETT, V86, P1295, DOI 10.1103/PhysRevLett.86.1295; Persson B. N. J., 1998, SLIDING FRICTION PHY; Place D, 1999, J COMPUT PHYS, V150, P332, DOI 10.1006/jcph.1999.6184; Ranjith K, 2001, J MECH PHYS SOLIDS, V49, P341, DOI 10.1016/S0022-5096(00)00029-6; SCOTT RS, 1996, NATURE, V381, P5922; Slepyan LI, 1982, IZV AKAD NAUK SSSR M, V16, P101; WEERTMAN J, 1980, J GEOPHYS RES, V85, P1455, DOI 10.1029/JB085iB03p01455; Williams ML, 1959, B SEISMOL SOC AM, V49, P199; WILSON GT, 1972, SIAM J APPL MATH, V23, P420, DOI 10.1137/0123044	26	111	115	3	85	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					285	288		10.1038/35095018	http://dx.doi.org/10.1038/35095018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565025				2022-12-28	WOS:000171040500032
J	Prigerson, HG; Jacobs, SC				Prigerson, HG; Jacobs, SC			Caring for bereaved patients - "All the doctors just suddenly go"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATED GRIEF; TRAUMATIC GRIEF; CONJUGAL BEREAVEMENT; DEPRESSIVE EPISODES; DIAGNOSTIC-CRITERIA; SPOUSAL BEREAVEMENT; BRIEF PSYCHOTHERAPY; LIFE EVENTS; NORTRIPTYLINE; WIDOWHOOD		Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT USA	Yale University; Yale University	Prigerson, HG (corresponding author), Connecticut Mental Hlth Ctr, Dept Psychiat, 34 Pk St,Room 522, New Haven, CT 06519 USA.	Holly.Prigerson@yale.edu	Prigerson, Holly/GWV-3283-2022; Prigerson, Holly/L-3800-2019	Prigerson, Holly/0000-0002-7075-4268	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056529] Funding Source: NIH RePORTER; NIA NIH HHS [P60-AG-10498] Funding Source: Medline; NIMH NIH HHS [MH56529] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, PRACT GUID DEPR; Bedell SE, 2001, NEW ENGL J MED, V344, P1162, DOI 10.1056/NEJM200104123441510; BIRTCHNELL J, 1970, BRIT J PSYCHIAT, V116, P307, DOI 10.1192/bjp.116.532.307; BONANNO GA, 1995, J PERS SOC PSYCHOL, V69, P975, DOI 10.1037/0022-3514.69.5.975; Bowlby J., 1980, LOSS SADNESS DEPRESS; Brown LF, 1996, PSYCHIAT RES, V62, P161, DOI 10.1016/0165-1781(96)02914-9; BRUCE ML, 1990, AM J PSYCHIAT, V147, P608; CLAYTON PJ, 1972, BRIT J PSYCHIAT, V120, P71, DOI 10.1192/bjp.120.554.71; ELIOT G, 1980, A BEDE, P460; ESTERLING BA, 1994, J CONSULT CLIN PSYCH, V62, P130, DOI 10.1037/0022-006X.62.1.130; FELBER M, 2001, SAY SOMEONE WHO GRIE; Freud S., 1957, STANDARD EDITION COM, V14, P152; GLASS TA, 1995, J GERONTOL B-PSYCHOL, V50, pS205, DOI 10.1093/geronb/50B.4.S205; GREGORY RJ, 1994, AM J PSYCHIAT, V151, P1815; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HOROWITZ MJ, 1984, ARCH GEN PSYCHIAT, V41, P438; Horowitz MJ, 1997, AM J PSYCHIAT, V154, P904; JACOBS S, 1994, PSYCHOSOM MED, V56, P557, DOI 10.1097/00006842-199411000-00012; KAPRIO J, 1987, AM J PUBLIC HEALTH, V77, P283, DOI 10.2105/AJPH.77.3.283; Klausner EJ, 1999, PSYCHIATR SERV, V50, P1198, DOI 10.1176/ps.50.9.1198; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; Lewis C. S., 1963, GRIEF OBSERVED; Lindemann E, 1944, AM J PSYCHIAT, V101, P141, DOI 10.1176/ajp.101.2.141; MADDISON D, 1968, J PSYCHOSOM RES, V12, P297, DOI 10.1016/0022-3999(68)90084-6; Main J, 2000, BRIT J GEN PRACT, V50, P863; Malacrida R, 1998, CRIT CARE MED, V26, P1187, DOI 10.1097/00003246-199807000-00018; MARMAR CR, 1988, AM J PSYCHIAT, V145, P203; MAWSON D, 1981, BRIT J PSYCHIAT, V138, P185, DOI 10.1192/bjp.138.3.185; McDermott OD, 1997, BIOL PSYCHIAT, V41, P710, DOI 10.1016/S0006-3223(96)00118-7; Middleton W, 1996, BRIT J PSYCHIAT, V169, P167, DOI 10.1192/bjp.169.2.167; MORGAN DL, 1989, GERONTOLOGIST, V29, P101, DOI 10.1093/geront/29.1.101; MURPHY SL, 2000, NATL VITAL STAT REPO, V48, P101; Parkes CM, 1983, RECOVERY BEREAVEMENT; PASTERNAK RE, 1991, J CLIN PSYCHIAT, V52, P307; PENNEBAKER JW, 2000, HDB BEREAVEMENT RES, P517; Prigerson H, 2001, PRIM PSYCHIAT, V8, P712; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P614; PRIGERSON HG, 1995, AM J PSYCHIAT, V152, P22; Prigerson HG, 1996, AM J PSYCHIAT, V153, P1484; PRIGERSON HG, 1994, PSYCHIAT RES, V51, P33, DOI 10.1016/0165-1781(94)90045-0; Prigerson HG, 2000, GERONTOLOGIST, V40, P349, DOI 10.1093/geront/40.3.349; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1999, AM J PSYCHIAT, V156, P1994; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Prigerson HG, 1997, AM J PSYCHIAT, V154, P1003; PRIGERSON HG, 2000, POSTTRAUMATIC STRESS, P163; RAPHAEL B, 1971, AUST NZ J PSYCHIAT, V5, P183, DOI 10.3109/00048677109159643; Reynolds CF, 1999, AM J PSYCHIAT, V156, P202; REYNOLDS CF, 1993, BIOL PSYCHIAT, V34, P791, DOI 10.1016/0006-3223(93)90068-O; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schneider D S, 1996, Ann Clin Psychiatry, V8, P51, DOI 10.3109/10401239609148802; Schut HA., 1991, ANXIETY RES, V4, P225, DOI DOI 10.1080/08917779108248776; SHEAR MK, IN PRESS AM J PSYCHI; Silverman GK, 2000, PSYCHOL MED, V30, P857, DOI 10.1017/S0033291799002524; STROEBE M, 1991, J CONSULT CLIN PSYCH, V59, P479, DOI 10.1037/0022-006X.59.3.479; Stroebe M. S., 2001, HDB BEREAVEMENT RES, P8; UMBERSON D, 1992, J HEALTH SOC BEHAV, V33, P10, DOI 10.2307/2136854; VIEDERMAN M, 1995, AM J PSYCHIAT, V152, P1; WORTMAN CB, 1989, J CONSULT CLIN PSYCH, V57, P349, DOI 10.1037/0022-006X.57.3.349; Zisook S, 1998, J CLIN PSYCHIAT, V59, P80; Zisook S, 1998, Ann Clin Psychiatry, V10, P157, DOI 10.3109/10401239809147032; ZISOOK S, 1987, BIOPSYCHOSOCIAL ASPE, P51; Zygmont M, 1998, J CLIN PSYCHIAT, V59, P241, DOI 10.4088/JCP.v59n0507	63	129	131	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1369	1376		10.1001/jama.286.11.1369	http://dx.doi.org/10.1001/jama.286.11.1369			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DJ	11560543				2022-12-28	WOS:000171024500031
J	Whiting, P; Bagnall, AM; Sowden, AJ; Cornell, JE; Mulrow, CE; Ramirez, G				Whiting, P; Bagnall, AM; Sowden, AJ; Cornell, JE; Mulrow, CE; Ramirez, G			Interventions for the treatment and management of chronic fatigue syndrome - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; PLACEBO-CONTROLLED TREATMENT; LOW-DOSE HYDROCORTISONE; ESSENTIAL FATTY-ACIDS; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; MYALGIC ENCEPHALOMYELITIS; GRADED-EXERCISE; GAMMA-GLOBULIN	Context A variety of interventions have been used in the treatment and management of chronic fatigue syndrome (CFS). Currently, debate exists among health care professionals and patients about appropriate strategies for management. Objective To assess the effectiveness of all interventions that have been evaluated for use in the treatment or management of CFS in adults or children. Data Sources Nineteen specialist databases were searched from inception to either January or July 2000 for published or unpublished studies in any language. The search was updated through October 2000 using PubMed. Other sources included scanning citations, Internet searching, contacting experts, and online requests for articles. Study Selection Controlled trials (randomized or non randomized) that evaluated interventions inpatients diagnosed as having CFS according to any criteria were included. Study inclusion was assessed independently by 2 reviewers. Of 350 studies initially identified, 44 met inclusion criteria, including 36 randomized controlled trials and 8 controlled trials. Data Extraction Data extraction was conducted by 1 reviewer and checked by a second. Validity assessment was carried out by 2 reviewers with disagreements resolved by consensus. A qualitative synthesis was carried out and studies were grouped according to type of intervention and outcomes assessed. Data Synthesis The number of participants included in each trial ranged from 12 to 326, with a total of 2801 participants included in the 44 trials combined. Across the studies, 38 different outcomes were evaluated using about 130 different scales or types of measurement. Studies were grouped into 6 different categories. In the behavioral category, graded exercise therapy and cognitive behavioral therapy showed positive results and also scored highly on the validity assessment. In the immunological category, both immunoglobulin and hydrocortisone showed some limited effects but, overall, the evidence was inconclusive. There was insufficient evidence about effectiveness in the other 4 categories (pharmacological, supplements, complementary/alternative, and other interventions). Conclusions Overall, the interventions demonstrated mixed results in terms of effectiveness. All conclusions about effectiveness should be considered together with the methodological inadequacies of the studies. Interventions which have shown promising results include cognitive behavioral therapy and graded exercise therapy. Further research into these and other treatments is required using Standardized outcome measures.	Univ York, Natl Hlth Serv Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio Evidence Based Practice Ctr, San Antonio, TX 78284 USA; S Texas Vet Hlth Care Syst, Vet Evidence Based Res Disseminat & Implementat C, San Antonio, TX USA; S Texas Vet Hlth Care Syst, Audie L Murphy Div, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA	University of York - UK; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Whiting, P (corresponding author), Univ York, Natl Hlth Serv Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	pfw2@york.ac.uk		Whiting, Penny/0000-0003-1138-5682	PHS HHS [290-97-0012] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ACHESON ED, 1959, AM J MED, V26, P569, DOI 10.1016/0002-9343(59)90280-3; Andersson M, 1998, EUR J PAIN-LONDON, V2, P133, DOI 10.1016/S1090-3801(98)90006-4; AWDRY R, 1996, INT J ALTERN COMPLEM, V14, P12; BEHAN PO, 1990, ACTA NEUROL SCAND, V82, P209, DOI 10.1111/j.1600-0404.1990.tb04490.x; BEST L, 1996, COGNITIVE BEHAV THER, P1; BROOK MG, 1993, J INFECT DIS, V168, P791, DOI 10.1093/infdis/168.3.791; Cleare AJ, 1999, LANCET, V353, P455, DOI 10.1016/S0140-6736(98)04074-4; COX IM, 1991, LANCET, V337, P757, DOI 10.1016/0140-6736(91)91371-Z; Deale A, 1997, AM J PSYCHIAT, V154, P408; DEALE A, IN PRESS AM J PSYCHI; DOWSETT EG, 1990, POSTGRAD MED J, V66, P526, DOI 10.1136/pgmj.66.777.526; DUBOIS RE, 1986, AIDS RES HUM RETROV, V2, pS191; Fields MW, 1997, ANAEROBE, V3, P43, DOI 10.1006/anae.1996.0064; Forsyth LM, 1999, ANN ALLERG ASTHMA IM, V82, P185, DOI 10.1016/S1081-1206(10)62595-1; FRIEDBERG F, 1994, CLIN INFECT DIS, V18, pS105, DOI 10.1093/clinids/18.Supplement_1.S105; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; GOUDSMIT E, 1996, THESIS BRUNEL U; HICKIE I, IN PRESS J CLIN PSYC; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Joyce J, 1997, QJM-MON J ASSOC PHYS, V90, P223, DOI 10.1093/qjmed/90.3.223; KASLOW JE, 1989, ARCH INTERN MED, V149, P2501, DOI 10.1001/archinte.149.11.2501; LLOYD A, 1990, AM J MED, V89, P561, DOI 10.1016/0002-9343(90)90173-B; LLOYD AR, 1993, AM J MED, V94, P197, DOI 10.1016/0002-9343(93)90183-P; Marlin R G, 1998, Am J Med, V105, p110S, DOI 10.1016/S0002-9343(98)00174-0; MARTONEN TB, 1994, STP PHARMA SCI, V4, P11; McKenzie R, 1998, JAMA-J AM MED ASSOC, V280, P1061, DOI 10.1001/jama.280.12.1061; Moorkens G, 1998, GROWTH HORM IGF RES, V8, P131, DOI 10.1016/S1096-6374(98)80037-3; *NAT HLTH SERV CTR, 1996, UND SYST REV RES EFF; *NAT HLTH SERV CTR, 2001, SYST REV INT TREATM; Natelson BH, 1996, PSYCHOPHARMACOLOGY, V124, P226, DOI 10.1007/BF02246661; Natelson BH, 1998, NEUROPSYCHOBIOLOGY, V37, P150, DOI 10.1159/000026494; Perrin RN, 1998, J MED ENG TECHNOL, V22, P1; PETERSON PK, 1990, AM J MED, V89, P554, DOI 10.1016/0002-9343(90)90172-A; Peterson PK, 1998, ARCH INTERN MED, V158, P908, DOI 10.1001/archinte.158.8.908; Powell P, 2001, BMJ-BRIT MED J, V322, P387, DOI 10.1136/bmj.322.7283.387; Prins JB, 2001, LANCET, V357, P841, DOI 10.1016/S0140-6736(00)04198-2; RAMIREZ G, 42 AG HLTH; Ridsdale L, 2001, BRIT J GEN PRACT, V51, P19; Rowe KS, 1997, J PSYCHIAT RES, V31, P133, DOI 10.1016/S0022-3956(96)00047-7; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; SCHLAES J, 1996, CFIDS CHRONICLE  WIN, P21; See DM, 1996, IMMUNOL INVEST, V25, P153, DOI 10.3109/08820139609059298; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Sharpe Michael, 1998, American Journal of Medicine, V105, p104S, DOI 10.1016/S0002-9343(98)00170-3; SNORRASON E, 1995, 1 WORLD C CHRON FAT; SNORRASON E, 1996, J CHRONIC FATIGUE SY, V2, P2; Steinberg P, 1996, J ALLERGY CLIN IMMUN, V97, P119, DOI 10.1016/S0091-6749(96)70290-7; STEWART W, 1987, J ALTERN COMPLEM MED, V5, P19; STRAUS SE, 1988, NEW ENGL J MED, V319, P1692, DOI 10.1056/NEJM198812293192602; STRAYER DR, 1994, CLIN INFECT DIS, V18, pS88, DOI 10.1093/clinids/18.Supplement_1.S88; Tiev KP, 1999, REV MED INTERNE, V20, P912, DOI 10.1016/S0248-8663(00)80096-X; Vercoulen JHMM, 1996, LANCET, V347, P858, DOI 10.1016/S0140-6736(96)91345-8; VollmerConna U, 1997, AM J MED, V103, P38, DOI 10.1016/S0002-9343(97)90045-0; Warren G, 1999, ACTA NEUROL SCAND, V99, P112, DOI 10.1111/j.1600-0404.1999.tb00667.x; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485	57	333	338	2	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1360	1368		10.1001/jama.286.11.1360	http://dx.doi.org/10.1001/jama.286.11.1360			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560542				2022-12-28	WOS:000171024500030
J	Fox, JE; Starcevic, M; Kow, KY; Burow, ME; McLachlan, JA				Fox, JE; Starcevic, M; Kow, KY; Burow, ME; McLachlan, JA			Nitrogen fixation - Endocrine disrupters and flavonoid signalling	NATURE			English	Article							MELILOTI NODULATION GENES; RHIZOBIUM-MELILOTI; EXPRESSION; INDUCTION; PROTEIN; NODD		Tulane Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Sch Med, New Orleans, LA 70112 USA; Xavier Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Cincinnati, OH 45207 USA; Tulane Univ, Mol & Cellular Biol Program, Sch Med, New Orleans, LA 70112 USA; Tulane Univ, Dept Pharmacol, Sch Med, New Orleans, LA 70112 USA	Tulane University; Xavier University; Tulane University; Tulane University	McLachlan, JA (corresponding author), Tulane Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Sch Med, New Orleans, LA 70112 USA.		Burow, Matthew/D-6351-2013	Burow, Matthew/0000-0002-0642-6630				Baker ME, 1998, ADV EXP MED BIOL, V439, P249; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; DJORDJEVIC MA, 1987, EMBO J, V6, P1173, DOI 10.1002/j.1460-2075.1987.tb02351.x; FIRMIN JL, 1986, NATURE, V324, P90, DOI 10.1038/324090a0; Gage DJ, 1996, J BACTERIOL, V178, P7159, DOI 10.1128/jb.178.24.7159-7166.1996; GYORGYPAL Z, 1991, MOL GEN GENET, V226, P337, DOI 10.1007/BF00273624; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; MULLIGAN JT, 1985, P NATL ACAD SCI USA, V82, P6609, DOI 10.1073/pnas.82.19.6609; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; PETERS NK, 1988, PLANT PHYSIOL, V88, P396, DOI 10.1104/pp.88.2.396; REDMOND JW, 1986, NATURE, V323, P632, DOI 10.1038/323632a0; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223	13	49	51	2	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					128	129		10.1038/35093163	http://dx.doi.org/10.1038/35093163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557969				2022-12-28	WOS:000170918800035
J	Gum, PA; Thamilarasan, M; Watanabe, J; Blackstone, EH; Lauer, MS				Gum, PA; Thamilarasan, M; Watanabe, J; Blackstone, EH; Lauer, MS			Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease - A propensity analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC STABLE ANGINA; HEART-RATE RECOVERY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; RANDOMIZED-TRIALS; UNSTABLE ANGINA; EXERCISE; ASSOCIATION; PREDICTOR	Context Although aspirin has been shown to reduce cardiovascular morbidity and short-term mortality following acute myocardial infarction, the association between its use and long-term all-cause mortality has not been well defined. Objectives To determine whether aspirin is associated with a mortality benefit in stable patients with known or suspected coronary disease and to identify patient characteristics that predict the maximum absolute mortality benefit from aspirin. Design and Setting Prospective, nonrandomized, observational cohort study conducted between 1990 and 1998 at an academic medical institution, with a median follow-up of 3.1 years. Patients Of 6174 consecutive adults undergoing stress echocardiography for evaluation of known or suspected coronary disease, 2310 (37%) were taking aspirin. Patients with significant valvular disease or documented contraindication to aspirin use, including peptic ulcer disease, renal insufficiency, and use of nonsteroidal antiinflammatory drugs, were excluded. Main Outcome Measure All-cause mortality according to aspirin use. Results During 3.1 years of follow-up, 276 patients (4.5%) died. In a simple univariable analysis, there was no association between aspirin use and mortality(4.5% vs 4.5%). However, after adjustment for age, sex, standard cardiovascular risk factors, use of other medications, coronary disease history, ejection fraction, exercise capacity, heart rate recovery, and echocardiographic ischemia, aspirin use was associated with reduced mortality (hazard ratio [HR], 0.67; 95% confidence interval [CI], 0.51-0.87; P = .002). In further analysis using matching by propensity score, 1351 patients who were taking aspirin were at lower risk for death than 1351 patients not using aspirin (4% vs 8%, respectively; HR, 0.53; 95% Cl, 0.38-0.74; P = .002). After adjusting for the propensity for using aspirin, as well as other possible confounders and interactions, aspirin use remained associated with a lower risk for death (adjusted HR, 0.56; 95% Cl, 0.40-0.78; P<.001). The patient characteristics associated with the most aspirin-related reductions in mortality were older age, known coronary artery disease, and impaired exercise capacity. Conclusion Aspirin use among patients undergoing stress echocardiography was independently associated with reduced long-term all-cause mortality, particularly among older patients, those with known coronary artery disease, and those with impaired exercise capacity.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177	NHLBI NIH HHS [HL 66004-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; BASTYR EJ, 1990, AM J MED, V88, P601, DOI 10.1016/0002-9343(90)90525-I; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Buffon A, 1999, J AM COLL CARDIOL, V34, P1512, DOI 10.1016/S0735-1097(99)00348-4; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; CAIRNS P, 1987, ARCH PATHOL LAB MED, V111, P80; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook NR, 2000, ARCH INTERN MED, V160, P921, DOI 10.1001/archinte.160.7.921; COX DR, 1972, J R STAT SOC B, V34, P187; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Harpaz D, 1998, AM J MED, V105, P494, DOI 10.1016/S0002-9343(98)00328-3; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Krumholz HM, 2001, ARCH INTERN MED, V161, P577, DOI 10.1001/archinte.161.4.577; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lauer MS, 2000, JAMA-J AM MED ASSOC, V283, P2988, DOI 10.1001/jama.283.22.2988; Lauer MS, 1998, J AM COLL CARDIOL, V32, P1280, DOI 10.1016/S0735-1097(98)00377-5; Leor J, 1999, J AM COLL CARDIOL, V33, P1920, DOI 10.1016/S0735-1097(99)00129-1; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Meade TW, 1998, LANCET, V351, P233; MOSES LE, 1995, MED CARE, V33, pAS8; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; RIDKER PM, 1991, ANN INTERN MED, V114, P835, DOI 10.7326/0003-4819-114-10-835; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; TOHGI H, 1992, STROKE, V23, P1400, DOI 10.1161/01.STR.23.10.1400; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; TSCHOEPE D, 1993, CIRCULATION, V88, P37, DOI 10.1161/01.CIR.88.1.37; WALLENTIN L, 1990, LANCET, V336, P827	49	183	190	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1187	1194		10.1001/jama.286.10.1187	http://dx.doi.org/10.1001/jama.286.10.1187			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559263				2022-12-28	WOS:000170910400028
J	Corbo, JC; Di Gregorio, A; Levine, M				Corbo, JC; Di Gregorio, A; Levine, M			The ascidian as a model organism in developmental and evolutionary biology	CELL			English	Review							CIONA-INTESTINALIS; CHORDATE; GENE; PROTOCHORDATE; EMBRYO		Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Corbo, JC (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	jcorbo@caregroup.harvard.edu; mlevine@uclink4.berkeley.edu	Di Gregorio, Anna/C-4766-2008	Corbo, Joseph/0000-0002-9323-7140; Levine, Michael/0000-0001-7629-0081				Carroll S. B., 2001, DNA DIVERSITY MOL GE; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P2335; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson E. H., 2001, DEV EVOLUTION; Di Gregorio A, 1999, DEVELOPMENT, V126, P5599; Di Gregorio A, 2001, DEV BIOL, V229, P31, DOI 10.1006/dbio.2000.9964; DIGREGORIO A, 1995, GENE, V156, P253, DOI 10.1016/0378-1119(95)00035-5; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Fujiwara S, 1998, DEVELOPMENT, V125, P2511; Kim GJ, 2000, DEVELOPMENT, V127, P2853; Meinertzhagen LA, 2001, TRENDS NEUROSCI, V24, P401, DOI 10.1016/S0166-2236(00)01851-8; Moody R, 1999, MOL GEN GENET, V262, P199, DOI 10.1007/s004380051075; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Nishizaki Y, 2001, MECH DEVELOP, V102, P57, DOI 10.1016/S0925-4773(01)00281-7; Satoh N., 1994, DEV BIOL ASCIDIANS; Simmen MW, 1998, P NATL ACAD SCI USA, V95, P4437, DOI 10.1073/pnas.95.8.4437; Sordino P, 2000, SARSIA, V85, P173, DOI 10.1080/00364827.2000.10414567; Wada H, 1998, DEVELOPMENT, V125, P1113	19	126	135	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					535	538		10.1016/S0092-8674(01)00481-0	http://dx.doi.org/10.1016/S0092-8674(01)00481-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551501	Bronze			2022-12-28	WOS:000170973200004
J	Hunt, A; Evan, G				Hunt, A; Evan, G			Apoptosis - Till death us do part	SCIENCE			English	Editorial Material							CYTOCHROME-C; BCL-2 FAMILY; PROMOTES APOPTOSIS; PROTEIN; MEMBER		Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hunt, A (corresponding author), Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA.							Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	15	46	51	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1784	1785		10.1126/science.1065206	http://dx.doi.org/10.1126/science.1065206			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546862				2022-12-28	WOS:000170894400035
J	Nardi, M; Tomlinson, S; Greco, MA; Karpatkin, S				Nardi, M; Tomlinson, S; Greco, MA; Karpatkin, S			Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia	CELL			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; CHRONIC GRANULOMATOUS-DISEASE; MICROPARTICLE FORMATION; PLASMA-MEMBRANE; PROCOAGULANT ACTIVITY; ANTIPLATETLET GPIIIA; ACTIVATED PLATELETS; HIV-1 INFECTION; HOMOSEXUAL MEN; PURPURA	Immunologic thrombocytopenia is seen commonly in HIV-1 infection. The pathogenesis of this problem has been unclear, but it is associated with circulating immune complexes that contain platelet membrane, components and anti-platelet membrane GPIIIa49-66 IgG antibodies. These antibodies cause acute thrombocytopenia when injected into mice. We now show, that purified anti-GPIIIa49-66 causes platelet fragmentation, in vitro in the absence of complement, and in vivo in wild-type and C3-deficient mice. The mechanism of complement-independent platelet lysis; is shown to be caused by the antibody-induced generation of H2O2, as indicated by in vitro experiments with inhibitors of reactive oxygen species, and in vivo studies carried out with p47phox-deficient mice. Thus, a novel mechanism of immunologic platelet clearance is described in which an anti-platelet IgG causes platelet fragmentation via the induction of reactive oxygen species.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University	Karpatkin, S (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.			Nardi, Michael/0000-0002-3276-3198	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004315] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-13336] Funding Source: Medline; NIDA NIH HHS [DA-04315] Funding Source: Medline; PHS HHS [A134451] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAMS CS, 1990, BLOOD, V75, P128; ARMSTRONG MJ, 1988, BIOCHIM BIOPHYS ACTA, V946, P106, DOI 10.1016/0005-2736(88)90462-2; Aupeix K, 1997, J CLIN INVEST, V99, P1546, DOI 10.1172/JCI119317; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; BASS DA, 1983, J IMMUNOL, V130, P1910; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; FADOK VA, 1992, J IMMUNOL, V149, P4029; FOX JEB, 1991, J BIOL CHEM, V266, P13289; GEMMELL CH, 1993, J BIOL CHEM, V268, P14586; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Holme PA, 1998, THROMB HAEMOSTASIS, V79, P389; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; Hughes M, 2000, BLOOD, V96, P188, DOI 10.1182/blood.V96.1.188.013k12_188_194; Inngjerdingen M, 1999, THROMB RES, V95, P215, DOI 10.1016/S0049-3848(99)00035-3; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; JOST J, 1988, SCHWEIZ MED WSCHR, V118, P206; JY W, 1992, J LAB CLIN MED, V119, P119; KARPATKI.S, 1969, J CLIN INVEST, V48, P1073, DOI 10.1172/JCI106063; Karpatkin S, 1997, LANCET, V349, P1531, DOI 10.1016/S0140-6736(96)12118-8; KARPATKIN S, 1988, P NATL ACAD SCI USA, V85, P9763, DOI 10.1073/pnas.85.24.9763; KARPATKIN S, 1995, P NATL ACAD SCI USA, V92, P2263, DOI 10.1073/pnas.92.6.2263; KARPATKIN S, 1992, P NATL ACAD SCI USA, V89, P1487, DOI 10.1073/pnas.89.4.1487; KARPATKIN S, 1992, BLOOD, V80, P3164; Kelton JG, 1996, BRIT J HAEMATOL, V93, P421, DOI 10.1046/j.1365-2141.1996.4891031.x; KHAN I, 1975, BRIT J HAEMATOL, V31, P449, DOI 10.1111/j.1365-2141.1975.tb00880.x; LEAF AN, 1988, ANN INTERN MED, V109, P194, DOI 10.7326/0003-4819-109-3-194; LEE YJ, 1993, THROMB RES, V72, P295, DOI 10.1016/0049-3848(93)90138-E; LIU LX, 1995, BRIT J HAEMATOL, V91, P976; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Miyamoto S, 1998, THROMB HAEMOSTASIS, V80, P225, DOI 10.1055/s-0037-1615177; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; MURPHY MF, 1987, BRIT J HAEMATOL, V66, P337, DOI 10.1111/j.1365-2141.1987.tb06920.x; NAJEAN Y, 1994, J LAB CLIN MED, V123, P415; Nardi M, 2000, J EXP MED, V191, P2093, DOI 10.1084/jem.191.12.2093; Nardi MA, 1997, P NATL ACAD SCI USA, V94, P7589, DOI 10.1073/pnas.94.14.7589; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nieuwland R, 1997, CIRCULATION, V96, P3534; NOMURA S, 1995, ATHEROSCLEROSIS, V116, P235, DOI 10.1016/0021-9150(95)05551-7; OWENS MR, 1992, THROMB RES, V66, P247, DOI 10.1016/0049-3848(92)90195-G; RATNOFF OD, 1983, NEW ENGL J MED, V308, P439, DOI 10.1056/NEJM198302243080808; SAVONA S, 1985, ANN INTERN MED, V102, P737, DOI 10.7326/0003-4819-102-6-737; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shcherbina A, 1999, BLOOD, V93, P4222, DOI 10.1182/blood.V93.12.4222.412k34_4222_4231; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; VARON D, 1983, P NATL ACAD SCI-BIOL, V80, P6992, DOI 10.1073/pnas.80.22.6992; WALSH CM, 1984, NEW ENGL J MED, V311, P635, DOI 10.1056/NEJM198409063111004; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; WEIDMER T, 1990, BIOCHEMISTRY-US, V29, P623; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; YANO Y, 1993, THROMB RES, V71, P385, DOI 10.1016/0049-3848(93)90163-I; YU JR, 1986, J CLIN INVEST, V77, P1756, DOI 10.1172/JCI112498; ZUCKERFRANKLIN D, 1977, NEW ENGL J MED, V297, P517, DOI 10.1056/NEJM197709082971001	59	110	110	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					551	561		10.1016/S0092-8674(01)00477-9	http://dx.doi.org/10.1016/S0092-8674(01)00477-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551503	Bronze			2022-12-28	WOS:000170973200006
J	Fitzgerald, KA; Palsson-McDermott, EM; Bowie, AG; Jefferies, CA; Mansell, AS; Brady, G; Brint, E; Dunne, A; Gray, P; Harte, MT; McMurray, D; Smith, DE; Sims, JE; Bird, TA; O'Neill, LAJ				Fitzgerald, KA; Palsson-McDermott, EM; Bowie, AG; Jefferies, CA; Mansell, AS; Brady, G; Brint, E; Dunne, A; Gray, P; Harte, MT; McMurray, D; Smith, DE; Sims, JE; Bird, TA; O'Neill, LAJ			Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction	NATURE			English	Article							DROSOPHILA TOLL; MYD88; ACTIVATION; FAMILY; IL-1; LIPOPROTEINS; RECOGNITION; PATHOGENS; ADAPTER; MEMBER	The recognition of microbial pathogens by the innate immune system involves Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns (1-9). Different TLRs recognize different pathogen-associated molecular patterns, with TLR-4 mediating the response to lipopolysaccharide from Gram-negative bacteria(5-7). All TLRs have a Toll/IL-1 receptor (TIR) domain, which is responsible for signal transduction(1,2). MyD88 is one such protein that contains a TIR domain(10,11). It acts as an adapter, being involved in TLR-2, TLR-4 and TLR-9 signalling(12-15); however, our understanding of how TLR-4 signals is incomplete(15,16). Here we describe a protein, Mal (MyD88-adapter-like), which joins MyD88 as a cytoplasmic TIR-domain-containing protein in the human genome. Mal activates NF-kappaB, Jun amino-terminal kinase and extracellular signal-regulated kinase-1 and -2. Mal can form homodimers and can also form heterodimers with MyD88. Activation of NF-kappaB by Mal requires IRAK-2, but not IRAK, whereas MyD88 requires both IRAKs. Mal associates with IRAK-2 by means of its TIR domain. A dominant negative form of Mal inhibits NF-kappaB, which is activated by TLR-4 or lipopolysaccharide, but it does not inhibit NF-kappaB activation by IL-1RI or IL-18R. Mal associates with TLR-4. Mal is therefore an adapter in TLR-4 signal transduction.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Immunex Res & Dev Corp, Seattle, WA 98101 USA	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.		Mansell, Ashley/B-9553-2008; Jefferies, Caroline/AAI-1543-2021; Fitzgerald, Katherine/ABE-6317-2020	Mansell, Ashley/0000-0002-6540-1281; Jefferies, Caroline/0000-0002-8879-6722; dunne, aisling/0000-0002-2342-9518; Brint, Elizabeth/0000-0001-9214-149X; Sims, John/0000-0002-5667-9185; Fitzgerald, Kate/0000-0003-3175-609X; Brady, Gareth/0000-0001-5376-0060; O'Neill, Luke/0000-0002-4333-2748; Bowie, Andrew/0000-0001-5316-4373				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jefferies C, 2001, MOL CELL BIOL, V21, P4544, DOI 10.1128/MCB.21.14.4544-4552.2001; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	23	945	1004	0	73	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					78	83		10.1038/35092578	http://dx.doi.org/10.1038/35092578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544529				2022-12-28	WOS:000170801200042
J	Blumenthal, D; Gokhale, M; Campbell, EG; Weissman, JS				Blumenthal, D; Gokhale, M; Campbell, EG; Weissman, JS			Preparedness for clinical practice - Reports of graduating residents at academic health centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNAL-MEDICINE; MANAGED CARE; PHYSICIANS; COMPETENCE; FACULTY; VIEWS	Context Medical educators are seeking improved measures to assess the clinical competency of residents as they complete their graduate medical education. Objective To assess residents' perceptions of their preparedness to provide common clinical services during their last year of graduate medical education. Design, Setting, and Participants A 1998 national survey of residents completing their training in 8 specialties (internal medicine, pediatrics, family practice, obstetrics/gynecology, general surgery, orthopedic surgery, psychiatry, and anesthesiology) at academic health centers in the United States. A total of 2626 residents responded (response rate, 65%). Main Outcome Measures Residents' reports of their preparedness to perform clinical and nonclinical tasks relevant to their specialties. Results Residents in all specialties rated themselves as prepared to manage most of the common conditions they would encounter in their clinical career. However, more than 10% of residents in each specialty reported that they felt unprepared to undertake 1 or more tasks relevant to their disciplines, such as caring for patients with human immunodeficiency virus/acquired immunodeficiency syndrome or substance abuse (family practice) or nursing home patients (internal medicine); performance of spinal surgery (orthopedic surgery) or abdominal aortic aneurysm repair (general surgery); and management of chronic pain (anesthesiology). Conclusions Overall, residents in their last year of training at academic health centers rate their clinical preparedness as high. However, opportunities for improvement exist in preparing residents for clinical practice.	Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Partners Hlth Care Syst, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, 50 Staniford St,9th Floor,Suite 901, Boston, MA 02114 USA.	dblumenthal@partners.org						*AM MED ASS, 1997, GRAD MED ED DIR 1997, P1244; *AM MED ASS, 1996, GRAD MED ED DAT 1996; Blumenthal D, 1997, NEW ENGL J MED, V337, P1550, DOI 10.1056/NEJM199711203372113; BLUMENTHAL D, IN PRESS AM J MED; Burns LR, 1997, HEALTH AFFAIR, V16, P204, DOI 10.1377/hlthaff.16.6.204; BURNS LR, 2000, PHYSICIAN RESPONSES; Campbell EG, 1997, JAMA-J AM MED ASSOC, V278, P222, DOI 10.1001/jama.278.3.222; CANTOR JC, 1993, JAMA-J AM MED ASSOC, V270, P1035, DOI 10.1001/jama.270.9.1035; Clark NM, 1998, PEDIATRICS, V101, P831, DOI 10.1542/peds.101.5.831; Clark NM, 2000, BMJ-BRIT MED J, V320, P572, DOI 10.1136/bmj.320.7234.572; Cordes DH, 1996, AM J PREV MED, V12, P172, DOI 10.1016/S0749-3797(18)30338-6; FINCHER RME, 1993, ACAD MED, V68, pS47, DOI 10.1097/00001888-199302000-00030; Gerrity MS, 1999, J FAM PRACTICE, V48, P949; Haas DM, 1997, J COMMUN HEALTH, V22, P401, DOI 10.1023/A:1025155914757; Hawkins RE, 1999, AM J MED, V106, P206, DOI 10.1016/S0002-9343(98)00392-1; LIEBELT EL, 1993, PEDIATRICS, V91, P360; Long DM, 2000, ACAD MED, V75, P1178, DOI 10.1097/00001888-200012000-00009; *MED, 1996, PPS IMP FIL; Norris T E, 1996, J Am Board Fam Pract, V9, P86; Ockene JK, 1997, ARCH INTERN MED, V157, P2334, DOI 10.1001/archinte.157.20.2334; OCKENE JK, 1995, PREV MED, V24, P563, DOI 10.1006/pmed.1995.1090; REUBEN DB, 1988, ARCH INTERN MED, V148, P914, DOI 10.1001/archinte.148.4.914; Roberts KB, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.4.e2; Schubert A, 1999, ANESTHESIOLOGY, V91, P288, DOI 10.1097/00000542-199907000-00037; Simon SR, 1999, NEW ENGL J MED, V340, P928, DOI 10.1056/NEJM199903253401206; *U HEALTHS CONS, 1997, 1996 MARK CLASS REV; von Gunten CF, 2000, JAMA-J AM MED ASSOC, V284, P3051, DOI 10.1001/jama.284.23.3051; Weissman JS, 1999, JAMA-J AM MED ASSOC, V281, P1093, DOI 10.1001/jama.281.12.1093; Wickstrom GC, 2000, J GEN INTERN MED, V15, P361, DOI 10.1046/j.1525-1497.2000.04118.x; Wright RJ, 1999, PEDIATR EMERG CARE, V15, P376, DOI 10.1097/00006565-199912000-00002	30	152	153	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1027	1034		10.1001/jama.286.9.1027	http://dx.doi.org/10.1001/jama.286.9.1027			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559286	Bronze			2022-12-28	WOS:000170802500015
J	McCusker, JK				McCusker, JK			Photocatalysis - Fuel from photons	SCIENCE			English	Editorial Material									Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	McCusker, JK (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.							GRAY HB, 1981, SCIENCE, V214, P1201, DOI 10.1126/science.214.4526.1201; Heyduk AF, 2001, SCIENCE, V293, P1639, DOI 10.1126/science.1062965; Sakata T., 1983, ENERGY RESOURCES PHO, P332; 2001, NATL ENERGY POLICY R, pCH6	4	18	18	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1599	+		10.1126/science.1064112	http://dx.doi.org/10.1126/science.1064112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533464				2022-12-28	WOS:000170802900034
J	ALVAREZ, W; ASARO, F; MONTANARI, A				ALVAREZ, W; ASARO, F; MONTANARI, A			IRIDIUM PROFILE FOR 10-MILLION YEARS ACROSS THE CRETACEOUS-TERTIARY BOUNDARY AT GUBBIO (ITALY)	SCIENCE			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	ALVAREZ, W (corresponding author), UNIV CALIF BERKELEY, DEPT GEOL & GEOPHYS, BERKELEY, CA 94720 USA.				NIDCR NIH HHS [DE-AC03-76SF00098] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1988, 196TH AM CHEM SOC NA; ALVAREZ W, 1985, J SEDIMENT PETROL, V55, P720; ALVAREZ W, 1977, GEOL SOC AM BULL, V88, P383, DOI 10.1130/0016-7606(1977)88<383:UCMSAG>2.0.CO;2; ALVAREZ W, 1990, SCI AM, V263, P78, DOI 10.1038/scientificamerican1090-78; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; ALVAREZ W, 1979, EOS, V60, P734; [Anonymous], [No title captured]; ARTHUR MA, 1977, GEOL SOC AM BULL, V88, P367, DOI 10.1130/0016-7606(1977)88<367:UCMSAG>2.0.CO;2; BERGGREN WA, 1985, GEOL SOC AM BULL, V96, P1407, DOI 10.1130/0016-7606(1985)96<1407:CG>2.0.CO;2; CROCKET JH, 1988, GEOLOGY, V16, P77, DOI 10.1130/0091-7613(1988)016<0077:DONMAT>2.3.CO;2; FISCHER AG, 1986, SOC GEOL ITAL MEM, V31, P45; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; HERBERT TD, 1986, NATURE, V321, P739, DOI 10.1038/321739a0; Herbert TD, 1986, PALEOCEANOGRAPHY, V1, P495, DOI 10.1029/PA001i004p00495; JOHNSSON MJ, 1986, J SEDIMENT PETROL, V56, P501; KENT DV, 1985, GEOL SOC AM BULL, V96, P1419, DOI 10.1130/0016-7606(1985)96<1419:ACAJG>2.0.CO;2; KOTAKE N, 1989, LETHAIA, V22, P327, DOI 10.1111/j.1502-3931.1989.tb01349.x; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LOWRIE W, 1990, EARTH PLANET SC LETT, V98, P303, DOI 10.1016/0012-821X(90)90032-S; LOWRIE W, 1981, GEOLOGY, V9, P392, DOI 10.1130/0091-7613(1981)9<392:OHMYOG>2.0.CO;2; LUTERBACHER H. P., 1962, RIV ITAL PALEONTOL E STRATIGR, V68, P253; MICHEL HV, 1985, INITIAL REP DEEP SEA, V86, P533; MICHEL HV, 1990, P OC DRILL PROGR SCI, V0113; ORTH CJ, 1984, SCIENCE, V223, P163, DOI 10.1126/science.223.4632.163; ROCCHIA R, 1990, EARTH PLANET SC LETT, V99, P206, DOI 10.1016/0012-821X(90)90111-A; Schwarzacher W, 1987, PALEOCEANOGRAPHY, V2, P79, DOI 10.1029/PA002i001p00079; SCHWARZACHER W, 1982, CYCLIC EVENT STRATIF, P72; SHARPTON VL, IN PRESS GEOL SOC AM, V247; SMIT J, COMMUNICATION; SMIT J, 1989, TERR ABS, V1, P421; TORNAGHI M E, 1989, Rivista Italiana di Paleontologia e Stratigrafia, V95, P223; VANNUCCI R, 1982, RENDICONTI SOC ITALI, V38, P413; WEZEL FC, 1981, CR ACAD SCI II, V293, P837	34	50	52	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	1990	250	4988					1700	1702		10.1126/science.11538083	http://dx.doi.org/10.1126/science.11538083			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN920	11538083				2022-12-28	WOS:A1990EN92000037
J	MELOSH, HJ				MELOSH, HJ			THE ROCKY ROAD TO PANSPERMIA	NATURE			English	Letter											MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.							Curran D. R., 1977, IMPACT EXPLOSION CRA, P1057; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; Melosh H.J., 1981, P 17 LUN PLAN SCI, V12A, P29; MELOSH HJ, 1984, ICARUS, V59, P234, DOI 10.1016/0019-1035(84)90026-5; MELOSH HJ, 1985, GEOLOGY, V13, P144, DOI 10.1130/0091-7613(1985)13<144:EORFFP>2.0.CO;2; Mitchell F.J., 1972, ANAL SURVEYOR 3 MAT, P239; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; RODDY DJ, 1987, INT J IMPACT ENG, V5, P525; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; VICKERY AM, 1987, SCIENCE, V237, P738, DOI 10.1126/science.237.4816.738; WETHERILL GW, 1984, METEORITICS, V19, P1	12	147	149	3	80	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 21	1988	332	6166					687	688		10.1038/332687a0	http://dx.doi.org/10.1038/332687a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	N0293	11536601				2022-12-28	WOS:A1988N029300038
J	Harden, PN; Reece, SM; Fryer, AA; Smith, AG; Ramsay, HM				Harden, PN; Reece, SM; Fryer, AA; Smith, AG; Ramsay, HM			Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice	BRITISH MEDICAL JOURNAL			English	Article									N Staffordshire Hosp, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England; N Staffordshire Hosp, Dept Biochem, Stoke On Trent ST4 7LN, Staffs, England; N Staffordshire Hosp, Dept Dermatol, Stoke On Trent ST4 7LN, Staffs, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust	Harden, PN (corresponding author), N Staffordshire Hosp, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England.			Fryer, Anthony/0000-0001-8678-0404				Harden PN, 2001, TRANSPLANT P, V33, P1302, DOI 10.1016/S0041-1345(00)02486-6; Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1; Ramsay HM, 2000, AM J KIDNEY DIS, V36, P167, DOI 10.1053/ajkd.2000.8290; Seukeran DC, 1998, BRIT J DERMATOL, V138, P301; SLADE J, 1995, J AM ACAD DERMATOL, V32, P479, DOI 10.1016/0190-9622(95)90073-X	5	17	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					600	601		10.1136/bmj.323.7313.600	http://dx.doi.org/10.1136/bmj.323.7313.600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557706	Green Published, Bronze			2022-12-28	WOS:000171087300017
J	Morgan, MG; Houghton, A; Gibbons, JH				Morgan, MG; Houghton, A; Gibbons, JH			Science and government - Improving science and technology advice for Congress	SCIENCE			English	Editorial Material									Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Morgan, MG (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.							Vig NormanJ., 2000, PARLIAMENTS TECHNOLO; 2001, NATURE, V411, P117	2	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					1999	2000		10.1126/science.1065128	http://dx.doi.org/10.1126/science.1065128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557862				2022-12-28	WOS:000171028700035
J	Szalay, A; Gray, J				Szalay, A; Gray, J			The world-wide telescope	SCIENCE			English	Editorial Material								All astronomy data and literature will soon be online and accessible via the Internet. The community is building the Virtual Observatory, an organization of this worldwide data into a coherent whole that can be accessed by anyone, in any form, from anywhere. The resulting system will dramatically improve our ability to do multi-spectral and temporal studies that integrate data from multiple instruments. The Virtual Observatory data also provide a wonderful base for teaching astronomy, scientific discovery, and computational science.	Johns Hopkins Univ, Baltimore, MD 21218 USA; Microsoft Bay Area Res Ctr, San Francisco, CA USA	Johns Hopkins University; Microsoft	Szalay, A (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.			Szalay, Alexander/0000-0002-4108-3282				BRUNNER RJ, 2001, AM SOC PHYSICS C SER, V25; FOSTER I, 1998, GRID BLUEPRINT NEW C	2	91	96	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2037	2040		10.1126/science.293.5537.2037	http://dx.doi.org/10.1126/science.293.5537.2037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557879				2022-12-28	WOS:000171028700060
J	Viola, L; Fortunato, EM; Pravia, MA; Knill, E; Laflamme, R; Cory, DG				Viola, L; Fortunato, EM; Pravia, MA; Knill, E; Laflamme, R; Cory, DG			Experimental realization of noiseless subsystems for quantum information processing	SCIENCE			English	Article							DECOHERENCE-FREE SUBSPACES; COMPUTATION	We demonstrate the protection of one bit of quantum information against all collective noise in three nuclear spins. Because no subspace of states offers this protection, the quantum bit was encoded in a proper noiseless subsystem. We therefore realize a general and efficient method for protecting quantum information. Robustness was verified for a full set of noise operators that do not distinguish the spins. Verification relied on the most complete exploration of engineered decoherence to date. The achieved fidelities show improved information storage for a large, noncommutative set of errors.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; MIT, Dept Nucl Engn, Cambridge, MA 02139 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Massachusetts Institute of Technology (MIT)	Viola, L (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	lviola@lanl.gov	Viola, Lorenza/A-2917-2010					Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Bennett CH, 1998, IEEE T INFORM THEORY, V44, P2724, DOI 10.1109/18.720553; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; Cory DG, 2000, FORTSCHR PHYS, V48, P875, DOI 10.1002/1521-3978(200009)48:9/11<875::AID-PROP875>3.0.CO;2-V; DiVincenzo DP, 2000, NATURE, V408, P339, DOI 10.1038/35042541; Duan LM, 1997, PHYS REV LETT, V79, P1953, DOI 10.1103/PhysRevLett.79.1953; Havel TF, 2001, PHYS LETT A, V280, P282, DOI 10.1016/S0375-9601(01)00083-4; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kempe J, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.042307; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; Kwiat PG, 2000, SCIENCE, V290, P498, DOI 10.1126/science.290.5491.498; Lidar DA, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.022306; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Lidar DA, 1999, PHYS REV LETT, V82, P4556, DOI 10.1103/PhysRevLett.82.4556; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Nielsen MA, 1998, NATURE, V396, P52, DOI 10.1038/23891; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; Sodickson A, 1998, PROG NUCL MAG RES SP, V33, P77, DOI 10.1016/S0079-6565(98)00021-1; TEKIEMARIAM G, 2001, PHYS REV LETT, V86, P5845; Viola L, 2001, J PHYS A-MATH GEN, V34, P7067, DOI 10.1088/0305-4470/34/35/331; Zanardi P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.077901; Zanardi P, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.012301; Zanardi P, 1997, PHYS REV LETT, V79, P3306, DOI 10.1103/PhysRevLett.79.3306; Zanardi P, 1998, PHYS REV LETT, V81, P4752, DOI 10.1103/PhysRevLett.81.4752	30	186	189	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2059	2063		10.1126/science.1064460	http://dx.doi.org/10.1126/science.1064460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557885				2022-12-28	WOS:000171028700066
J	Abbott, A				Abbott, A			WHO plans study of Gulf War fallout	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					97	97		10.1038/35093231	http://dx.doi.org/10.1038/35093231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557937	Bronze			2022-12-28	WOS:000170918800008
J	Bedry, R; Baudrimont, I; Deffieux, G; Creppy, EE; Pomies, JP; Ragnaud, JM; Dupon, M; Neau, D; Gabinski, C; De Witte, S; Chapalain, JC; Godeau, P				Bedry, R; Baudrimont, I; Deffieux, G; Creppy, EE; Pomies, JP; Ragnaud, JM; Dupon, M; Neau, D; Gabinski, C; De Witte, S; Chapalain, JC; Godeau, P			Wild-mushroom intoxication as a cause of rhabdomyolysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRICHOLOMA; MYOTOXIN; BODIES		Univ Bordeaux 2, Dept Toxicol, Fac Pharm, F-33076 Bordeaux, France; Univ Bordeaux 2, Dept Mycol, Fac Pharm, F-33076 Bordeaux, France; Univ Hosp Pellegrin, Poison Ctr, Bordeaux, France; Univ Hosp Pellegrin, Dept Infect Dis, Bordeaux, France; Univ Hosp St Andre, Dept Intens Care, Bordeaux, France; Univ Hosp St Andre, Dept Internal Med, Bordeaux, France; Hosp Montbrisson, Dept Gastroenterol, Montbrisson, France; Univ Hosp Pitie Salpetriere, Dept Internal Med, Paris, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Creppy, EE (corresponding author), Univ Bordeaux 2, Dept Toxicol, Fac Pharm, 146 Rue Leo Saignat, F-33076 Bordeaux, France.							AVERBUKH Z, 1989, HUM TOXICOL, V8, P345, DOI 10.1177/096032718900800502; BON M, 1984, TRICHOLOMES FRANCE E; BOURQUIA A, 1988, PRESSE MED, V17, P1798; DEBERNARDI M, 1991, TETRAHEDRON, V47, P7109, DOI 10.1016/S0040-4020(01)96164-2; DROMER C, 1992, REV RHUM, V59, P281; DUPOND JL, 1992, PRESSE MED, V21, P974; *EMPF DTSCH GES KL, 1972, Z KLIN CHEM KLIN BIO, V10, P182; Galli R, 1999, TRICOLOMI ATLANTE PR; Garlaschelli L, 1996, TETRAHEDRON LETT, V37, P6223, DOI 10.1016/0040-4039(96)01329-9; GARLASCHELLI L, 1994, TETRAHEDRON, V50, P3571, DOI 10.1016/S0040-4020(01)87033-2; GLUCHOFF K, 1972, CR ACAD SCI D NAT, V274, P1739; Gonzalez J, 1996, MUSCLE NERVE, V19, P790; GUTIERREZ JM, 1989, TOXICON, V27, P735, DOI 10.1016/0041-0101(89)90040-8; KING LA, 1985, HUM TOXICOL, V4, P355, DOI 10.1177/096032718500400401; Laaksonen R, 1996, AM J CARDIOL, V77, P851, DOI 10.1016/S0002-9149(97)89180-1; Miller OK Jr, 1972, MUSHROOMS N AM; Ohnuma N, 2000, CHEM PHARM BULL, V48, P749, DOI 10.1248/cpb.48.749; Ponraj D, 1997, KIDNEY INT, V51, P1956, DOI 10.1038/ki.1997.267; RIZZI D, 1991, NEPHROL DIAL TRANSPL, V6, P939, DOI 10.1093/ndt/6.12.939; STEGLICH W, 1972, PHYTOCHEMISTRY, V11, P3299, DOI 10.1016/S0031-9422(00)86393-1; YAGI H, 1991, E AFR MED J, V68, P404	21	101	110	3	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					798	802		10.1056/NEJMoa010581	http://dx.doi.org/10.1056/NEJMoa010581			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556299				2022-12-28	WOS:000170906800004
J	Chan, FP; Jones, TR				Chan, FP; Jones, TR			Paradoxical embolus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Chan, FP (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.								0	15	15	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					803	803		10.1056/NEJMicm010362	http://dx.doi.org/10.1056/NEJMicm010362			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556300				2022-12-28	WOS:000170906800005
J	Diefenbach, A; Jensen, ER; Jamieson, AM; Raulet, DH				Diefenbach, A; Jensen, ER; Jamieson, AM; Raulet, DH			Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity	NATURE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; T-CELLS; DEFICIENT MICE; COMMON ORIGIN; MURINE NKG2D; ACTIVATION; SURVEILLANCE; EXPRESSION; FAMILY	Natural killer (NK) cells attack many tumour cell lines, and are thought to have a critical role in anti-tumour immunity(1-7); however, the interaction between NK cells and tumour targets is poorly understood. The stimulatory lectin-like NKG2D receptor(8-13) is expressed by NK cells, activated CD8(+) T cells and by activated macrophages in mice(11). Several distinct cell-surface ligands that are related to class I major histocompatibility complex molecules have been identified(11-14), some of which are expressed at high levels by tumour cells but not by normal cells in adults(11,13,15,16). However, no direct evidence links the expression of these 'induced self' ligands with tumour cell rejection. Here we demonstrate that ectopic expression of the murine NKG2D ligands Rae1 beta or H60 in several tumour cell lines results in potent rejection of the tumour cells by syngeneic mice. Rejection is mediated by NK cells and/or CD8(+) T cells. The ligand-expressing tumour cells induce potent priming of cytotoxic T cells and sensitization of NK cells in vivo. Mice that are exposed to live or irradiated tumour cells expressing Rae1 beta or H60 are specifically immune to subsequent challenge with tumour cells that lack NKG2D ligands, suggesting application of the ligands in the design of tumour vaccines.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 485 Life Sci Addit, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu	Jamieson, Amanda/U-7169-2019; Diefenbach, Andreas/T-2589-2018	Jamieson, Amanda/0000-0002-5781-9231; Diefenbach, Andreas/0000-0002-9176-9530; Raulet, David/0000-0002-1257-8649	NIAID NIH HHS [R01 AI039642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Gays F, 2000, J IMMUNOL, V164, P5094, DOI 10.4049/jimmunol.164.10.5094; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Grufman P, 2000, EUR J IMMUNOL, V30, P1088, DOI 10.1002/(SICI)1521-4141(200004)30:4<1088::AID-IMMU1088>3.0.CO;2-O; HART IR, 1979, AM J PATHOL, V97, P587; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; SEAMAN WE, 1987, J IMMUNOL, V138, P4539; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Hall T, 2000, J IMMUNOL, V165, P869, DOI 10.4049/jimmunol.165.2.869; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	30	789	834	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					165	171		10.1038/35093109	http://dx.doi.org/10.1038/35093109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557981	Green Accepted			2022-12-28	WOS:000170918800047
J	Whitehead, M; Dahlgren, G; Evans, T				Whitehead, M; Dahlgren, G; Evans, T			Equity and health sector reforms: can low-income countries escape the medical poverty trap?	LANCET			English	Editorial Material							CARE; QUALITY; POOR; ORGANIZATION; SERVICES; POLICIES; VIETNAM; SYSTEMS; ACCESS; INDIA		Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England; Swedish Natl Inst Publ Hlth, Stockholm, Sweden; Rockefeller Fdn, Hlth Equity Div, New York, NY USA	University of Liverpool	Whitehead, M (corresponding author), Univ Liverpool, Dept Publ Hlth, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.							AKIN JS, 1987, FINANCING HLTH SERV; Bloom G, 1998, SOC SCI MED, V47, P1529, DOI 10.1016/S0277-9536(98)00233-0; BOJALIL R, 1994, J CLIN EPIDEMIOL, V47, P147, DOI 10.1016/0895-4356(94)90019-1; BRIGGS J, 2000, EC CONSEQUENCES INAD; Castel JM, 1997, CLIN PHARMACOL THER, V61, P488, DOI 10.1016/S0009-9236(97)90199-5; CREESE AL, 1995, 2 WHO; Ensor T, 1996, INT J HEALTH PLAN M, V11, P69; Evans T, 2001, CHALLENGING INEQUITI; EVANS TG, 1995, B WORLD HEALTH ORGAN, V73, P495; FARMER P, 1999, GLOBAL IMPACT DRUG R; FU W, 1999, HLTH CARE CHINAS RUR; Gottlieb S, 2000, BRIT MED J, V320, P1295, DOI 10.1136/bmj.320.7245.1295; GRIFFIN CC, 1992, HEALTH POLICY PLANN, V7, P177, DOI 10.1093/heapol/7.2.177; HAO Y, 1997, IDS B, P28; *HLTH SYST TRUST, 2000, REP INT M 17 20 AUG; IYER A, 2000, HLTH EQUITY TECHNICA; Kamat VR, 1998, SOC SCI MED, V47, P779, DOI 10.1016/S0277-9536(98)00134-8; Krause G, 1999, HEALTH POLICY PLANN, V14, P291, DOI 10.1093/heapol/14.3.291; Le Grand A, 1999, HEALTH POLICY PLANN, V14, P89, DOI 10.1093/heapol/14.2.89; McPake B, 1999, SOC SCI MED, V49, P849, DOI 10.1016/S0277-9536(99)00144-6; Nahar S, 1998, HEALTH POLICY PLANN, V13, P417, DOI 10.1093/heapol/13.4.417; Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0; PAPHASSARANG C, 1995, LANCET, V345, P433, DOI 10.1016/S0140-6736(95)90408-5; Phadke AR, 1996, NATL MED J INDIA, V9, P60; Pollock AM, 2000, LANCET, V356, P1995, DOI 10.1016/S0140-6736(00)03317-1; Prescott Nicholas, 1997, 376 WORLD BANK; Price D, 1999, LANCET, V354, P1889, DOI 10.1016/S0140-6736(99)11060-2; Russell S, 1997, INT J HEALTH SERV, V27, P359, DOI 10.2190/YHL2-F0EA-JW1M-DHEJ; Segall M, 2000, INT J HEALTH PLAN M, V15, P61, DOI 10.1002/(SICI)1099-1751(200001/03)15:1<61::AID-HPM573>3.0.CO;2-4; Segall M., 2000, 43 I DEV STUD; Sen K, 1998, INT J HEALTH PLAN M, V13, P199; Shaw P, 1995, FINANCING HLTH CARE; THEODORE K, 1999, HLTH SECTOR REFORM E; TIPPING G, 2000, SOCIAL IMPACT USERS; TIPPING G, 1994, 27 U SUSS I DEV STUD; Tornqvist N., 2000, EFFICIENT EQUITY ORI; *UN RES I SOC DEV, 2000, VIS HANDS TAK RESP S; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Velasquez G, 1998, DAP SERIES, V6; WOLFFERS I, 1995, SOC SCI MED, V41, P1325, DOI 10.1016/0277-9536(94)00415-P; *WORLD BANK, 1999, KYRGYZ REP PART POV; Yu H, 1997, IDS BULL-I DEV STUD, V28, P16; Zhan SK, 1997, IDS BULL-I DEV STUD, V28, P66; 2000, LANCET, V356, P1941	44	304	311	1	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					833	836		10.1016/S0140-6736(01)05975-X	http://dx.doi.org/10.1016/S0140-6736(01)05975-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564510				2022-12-28	WOS:000170989300036
J	Fyodorov, DV; Kadonaga, JT				Fyodorov, DV; Kadonaga, JT			The many faces of chromatin remodeling: SWItching beyond transcription	CELL			English	Review							DNA-REPLICATION; COMPLEX; ISWI; PROTEINS		Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.							Alexiadis V, 1998, EMBO J, V17, P3428, DOI 10.1093/emboj/17.12.3428; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Demeret C, 2001, ONCOGENE, V20, P3086, DOI 10.1038/sj.onc.1204333; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flanagan JF, 1999, NUCLEIC ACIDS RES, V27, P2022, DOI 10.1093/nar/27.9.2022; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004	19	123	128	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					523	525		10.1016/S0092-8674(01)00478-0	http://dx.doi.org/10.1016/S0092-8674(01)00478-0			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551498	Bronze			2022-12-28	WOS:000170973200001
J	Greco, V; Hannus, M; Eaton, S				Greco, V; Hannus, M; Eaton, S			Argosomes: A potential vehicle for the spread of morphogens through epithelia	CELL			English	Article							GRADIENT FORMATION; TRANSMEMBRANE LIGAND; LYMPHOCYTES-T; CELL-SURFACE; DROSOPHILA; HEDGEHOG; PROTEIN; NOTCH; GLYCOSAMINOGLYCANS; ENDOCYTOSIS	The formation of morphogen gradients is essential for tissue patterning. Morphogens are released from producing cells and spread through adjacent tissue; paradoxically, however, many morphogens, including Wingless, associate tightly with the cell membrane. Here, we describe a novel cell biological mechanism that disperses membrane fragments over large distances through the Drosophila imaginal disc epithelium. We call these membrane exovesicles argosomes. Argosomes are derived from basolateral membranes and are produced by many different regions of the disc. They travel through adjacent tissue where they are found predominantly in endosomes. Wingless protein colocalizes with argosomes derived from Wingless-producing cells. The properties of argosomes are consistent with their being a vehicle for the spread of Wingless protein.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Eaton, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr-108, D-01307 Dresden, Germany.		Eaton, Suzanne/D-7698-2017	Eaton, Suzanne/0000-0002-8319-284X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR063663] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baeg GH, 2001, DEVELOPMENT, V128, P87; BELLAICHE Y, 1998, IN PRESS NATURE; Binari RC, 1997, DEVELOPMENT, V124, P2623; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Klueg KM, 1999, J CELL SCI, V112, P3289; Klueg KM, 1998, MOL BIOL CELL, V9, P1709, DOI 10.1091/mbc.9.7.1709; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PETERS PJ, 1990, IMMUNOL TODAY, V11, P28; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	34	331	341	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					633	645		10.1016/S0092-8674(01)00484-6	http://dx.doi.org/10.1016/S0092-8674(01)00484-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551510	Bronze			2022-12-28	WOS:000170973200013
J	Wusthoff, CJ				Wusthoff, CJ			Medical mistakes and disclosure: The role of the medical student	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wusthoff, CJ (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.			Wusthoff, Courtney/0000-0002-1882-5567				*AMA COUNC ETH JUD, 1994, CODE MED ETH ANN CUR; American Medical Association, 2001, PRINC MED ETH; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Chiodo G, 1998, AM J ORTHOD DENTOFAC, V114, P721, DOI 10.1016/S0889-5406(98)70059-9; Kapp MB, 1997, J GEN INTERN MED, V12, P787, DOI 10.1046/j.1525-1497.1997.07167.x; Kohn KT, 2000, ERR IS HUMAN BUILDIN; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Lowes R L, 1997, Med Econ, V74, P101; Witman AB, 1996, ARCH INTERN MED, V156, P2565, DOI 10.1001/archinte.156.22.2565; Wolfe S, 1998, RN, V61, P28; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Wu AW, 1997, J GEN INTERN MED, V12, P770, DOI 10.1046/j.1525-1497.1997.07163.x	12	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1080	1081		10.1001/jama.286.9.1080	http://dx.doi.org/10.1001/jama.286.9.1080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559297				2022-12-28	WOS:000170802500025
J	Fevre, EM; Coleman, PG; Odiit, M; Magona, JW; Welburn, SC; Woolhouse, MEJ				Fevre, EM; Coleman, PG; Odiit, M; Magona, JW; Welburn, SC; Woolhouse, MEJ			The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda	LANCET			English	Article								Background Sleeping sickness, caused by two trypanosome subspecies, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, is a parasitic disease transmitted by the tsetse fly in sub-Saharan Africa. We report on a recent outbreak of T b rhodesiense sleeping sickness outside the established south-east Ugandan focus, in Soroti District where the disease had previously been absent. Soroti District has been the subject of large-scale livestock restocking activities and, because domestic cattle are important reservoirs of T b rhodesiense, we investigated the role of cattle in the origins of the outbreak. Methods We identified the origins of cattle entering the outbreak area in the 4 years preceding the outbreak. A matched case-control study was conducted to assess whether the distance of villages from the main market involved with restocking was a risk factor for sleeping sickness. We investigated the spatial clustering of sleeping sickness cases at the start of the outbreak. Findings Over 50% (1510 of 2796) of cattle traded at the market were reported to have originated from endemic sleeping sickness areas. The case-control study revealed that distance to the cattle market was a highly significant risk factor for sleeping sickness (p<0.001) and that there was a significant clustering of cases (27 of 28) close to the market at the start of the outbreak (p<0.001). As the outbreak progressed, the average distance of cases moved away from the cattle market (0.014 km per day, 95% CI 0.008-0.020 km per day, p<0.001). Interpretations The results are consistent with the disease being introduced by cattle infected with T b rhodesiense imported to the market from the endemic sleeping sickness focus. The subsequent spread of the disease away from the market suggests that sleeping sickness is becoming established in this new focus. Public health measures directed at controlling the infection in the animal reservoir should be considered to prevent the spread of sleeping sickness.	Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Livestock Hlth Res Inst, Tororo, Uganda	University of Edinburgh	Fevre, EM (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.			Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086				ABARU DE, 1985, TROP MED PARASITOL, V36, P72; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; Hide G, 1996, PARASITOL TODAY, V12, P50, DOI 10.1016/0169-4758(96)80654-5; HIDE G, 1991, EXP PARASITOL, V72, P430, DOI 10.1016/0014-4894(91)90089-F; KOERNER T, 1995, PARASITOL TODAY, V11, P303, DOI 10.1016/0169-4758(95)80046-8; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; LANCIEN J, 1991, ANN SOC BELG MED TR, V71, P35; MEHLITZ D, 1981, TROPENMED PARASITOL, V32, P129; Odiit M, 1997, E AFR MED J, V74, P792; ONYANGO RJ, 1966, T ROY SOC TROP MED H, V60, P175, DOI 10.1016/0035-9203(66)90024-1; ONYANGO RJ, 1967, HUMAN TRYPANOSOMIASI, P43; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0	13	146	149	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					625	628		10.1016/S0140-6736(01)05778-6	http://dx.doi.org/10.1016/S0140-6736(01)05778-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530149				2022-12-28	WOS:000170615500010
J	Sleigh, AC; Jackson, S				Sleigh, AC; Jackson, S			Dams, development, and health: a missed opportunity	LANCET			English	Editorial Material									Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; Univ Queensland, Sch Econ, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Sleigh, AC (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.		sleigh, adrian/J-4540-2019	sleigh, adrian/0000-0001-8443-7864				[Anonymous], 1993, PARASITIC DIS WATER; BRODY H, 2001, ADDRESSING PROJECT S; Jackson S, 2000, COMMUNIS POST-COMMUN, V33, P223, DOI 10.1016/S0967-067X(00)00005-2; MUSHKIN SJ, 1962, J POLIT ECON, V70, P129, DOI 10.1086/258730; Pearson Lestor B., 1969, PARTNERS DEV REPORT; Sleigh A, 1998, LANCET, V351, P1449, DOI 10.1016/S0140-6736(05)78866-8; Strauss J, 1998, J ECON LIT, V36, P766; *WORLD COMM DAMS, 2000, DAMS DEV NEW FRAM DE	8	15	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					570	571		10.1016/S0140-6736(00)04072-1	http://dx.doi.org/10.1016/S0140-6736(00)04072-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558476				2022-12-28	WOS:000167119100002
J	Watson, SA				Watson, SA			Oncogenic targets of beta-catenin-mediated transcription in molecular pathogenesis of intestinal polyposis	LANCET			English	Editorial Material							COLORECTAL-CANCER; COLON-CARCINOMA; ACTIVATION; PATHWAY; GASTRIN; COMPLEX; GENE		Univ Nottingham, Acad Unit Canc Studies, Nottingham NG7 2UH, England	University of Nottingham	Watson, SA (corresponding author), Univ Nottingham, Acad Unit Canc Studies, Nottingham NG7 2UH, England.	sue.watson@nottingham.ac.uk						Barker N, 2000, ADV CANCER RES, V77, P1; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Smith AM, 2000, GUT, V47, P820, DOI 10.1136/gut.47.6.820; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Watson SA, 1998, GASTROENTEROLOGY, V114, pA701; WATSON SA, 1999, DIGESTION, V60, P600; Yamada T, 2000, CANCER RES, V60, P4761	14	17	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					572	573		10.1016/S0140-6736(00)04074-5	http://dx.doi.org/10.1016/S0140-6736(00)04074-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558478				2022-12-28	WOS:000167119100004
J	MARAIS, DJD; STRAUSS, H; SUMMONS, RE; HAYES, JM				MARAIS, DJD; STRAUSS, H; SUMMONS, RE; HAYES, JM			CARBON ISOTOPE EVIDENCE FOR THE STEPWISE OXIDATION OF THE PROTEROZOIC ENVIRONMENT	NATURE			English	Article							CENTRAL AUSTRALIA; AMADEUS BASIN; RECORD; OCEANS; EVAPORITE; PALEOSOL; DEPOSITS; DIOXIDE; SULFATE; OXYGEN	The oxidation of the Earth's crust and the increase in atmospheric oxygen early in Earth history have been linked to the accumulation of reduced carbon in sedimentary rocks. Trends in the carbon isotope composition of sedimentary organic carbon and carbonate show that during the Proterozoic aeon (2.5-0.54 Gyr ago) the organic carbon reservoir grew in size, relative to the carbonate reservoir. This increase, and the concomitant release of oxidizing power in the environment, occurred mostly during episodes of global rifting and orogeny.	RUHR UNIV BOCHUM, INST GEOL, W-4630 BOCHUM 1, GERMANY; BUR MINERAL RESOURCES, CANBERRA, ACT 2605, AUSTRALIA; INDIANA UNIV, DEPT GEOL SCI, BIOGEOCHEM LABS, BLOOMINGTON, IN 47405 USA; INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA	Ruhr University Bochum; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	MARAIS, DJD (corresponding author), NASA, AMES RES CTR, MOFFETT FIELD, CA 94035 USA.		Summons, Roger Everett/AAL-3789-2020					[Anonymous], 1992, PROTEROZOIC BIOSPHER; Badger M.R., 1987, PROGR PHOTOSYNTHESIS; BAKER AJ, 1989, NATURE, V337, P352, DOI 10.1038/337352a0; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BETTS JN, 1991, GLOBAL PLANET CHANGE, V97, P5, DOI 10.1016/0031-0182(91)90178-T; BEUKES NJ, 1989, SEDIMENTOLOGY, V36, P383, DOI 10.1111/j.1365-3091.1989.tb00615.x; BROECKER WS, 1983, SCI AM, V249, P146, DOI 10.1038/scientificamerican0983-146; BROWN JS, 1965, GEOL SOC AM BULL, V67, P1590; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CANFIELD DE, IN PRESS NATO ARW IN; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; Des Marais D.J, 1991, PALAEOGEOGRAPHY PALA, V97, P93, DOI DOI 10.1016/0031-0182(91)90185-T; EASTOE CJ, 1990, PRECAMBRIAN RES, V46, P353, DOI 10.1016/0301-9268(90)90021-H; ERIKSSON PG, 1992, PRECAMBRIAN RES, V54, P257, DOI 10.1016/0301-9268(92)90073-W; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; GARRELS RM, 1974, SEA, V5, P303; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; HARLAND WB, 1983, GEOL SOC AM MEM, V161, P279; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; Holland H. D., 1978, CHEM ATMOSPHERE OCEA, P1; Holland H.D., 1984, CHEM EVOLUTION ATMOS, P1; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; HOLLAND HD, 1973, HYDROGEOCHEMISTRY BI, P68; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; LINDSAY JF, 1987, GEOL SOC AM BULL, V99, P852, DOI 10.1130/0016-7606(1987)99<852:UPEITA>2.0.CO;2; McKirdy D.M., 1974, GEOLOGY, V2, P591, DOI [591, DOI 10.1130/0091-7613(1974)2<591:MAOCIC>2.0.CO;2]; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; PIPER JDA, 1983, GEOL SOC AM MEM, V161, P11; PIPER JDA, 1982, EARTH PLANET SC LETT, V59, P61, DOI 10.1016/0012-821X(82)90118-2; REDDING CE, 1980, ADV ORG GEOCHEM, P711; Schidlowski, 1982, MINERAL DEPOSITS EVO, P103; SCHIDLOWSKI M, 1976, GEOCHIM COSMOCHIM AC, V40, P449, DOI 10.1016/0016-7037(76)90010-7; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P361; STEWART AJ, 1979, SEDIMENTOLOGY, V26, P33, DOI 10.1111/j.1365-3091.1979.tb00337.x; Strauss H., 1992, PROTEROZOIC BIOSPHER, P117; SUMMONS RE, 1990, AM J SCI, V290A, P212; VEIZER J, 1982, NATURWISSENSCHAFTEN, V69, P173, DOI 10.1007/BF00364890; VEIZER J, 1992, GEOCHIM COSMOCHIM AC, V56, P875, DOI 10.1016/0016-7037(92)90033-F; VEIZER J, 1988, ORIGINS LIFE EVOL B, V18, P13, DOI 10.1007/BF01808778; VEIZER J, 1976, GEOCHIM COSMOCHIM AC, V40, P905, DOI 10.1016/0016-7037(76)90139-3; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; WALKER RN, 1977, NATURE, V265, P526, DOI 10.1038/265526a0; Windley B. F., 1984, EVOLVING CONTINENTS, P1; Worsley TR, 1986, PALEOCEANOGRAPHY, V1, P233, DOI 10.1029/PA001i003p00233; ZBINDEN EA, 1988, PRECAMBRIAN RES, V42, P141, DOI 10.1016/0301-9268(88)90014-9; [No title captured]; [No title captured]	59	319	328	13	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					605	609		10.1038/359605a0	http://dx.doi.org/10.1038/359605a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	11536507				2022-12-28	WOS:A1992JT82400046
J	FOMENKOVA, MN; KERRIDGE, JF; MARTI, K; MCFADDEN, LA				FOMENKOVA, MN; KERRIDGE, JF; MARTI, K; MCFADDEN, LA			COMPOSITIONAL TRENDS IN ROCK-FORMING ELEMENTS OF COMET HALLEY DUST	SCIENCE			English	Article							AQUEOUS ACTIVITY; PARENT BODY; PARTICLES; SPECTRA; CHONDRITES; SURFACE; IMPACT; GRAINS	The VEGA 1 and 2 spacecraft flew by comet P/Halley in 1986 carrying, among other instruments, two mass spectrometers to measure the elemental composition of dust particles emitted from the comet. Most particles seem to be a mixture of silicates of variable magnesium-iron composition and organic matter. Comprehensive study of data and consideration of the mass of dust particles reveal cometary grains of "unusual" composition: magnesium-rich and iron-rich particles. Magnesium-rich particles are most likely magnesium carbonates, which could not have formed under conditions of equilibrium condensation but rather require formation by aqueous alteration. The composition of the iron-rich particles can also be related to secondary processes in the comet.	UNIV CALIF SAN DIEGO,CALIF SPACE INST,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego	FOMENKOVA, MN (corresponding author), ACAD SCI USSR,SPACE RES INST,MOSCOW,USSR.		McFadden, Lucy-Ann/I-4902-2013	McFadden, Lucy-Ann/0000-0002-0537-9975				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARPIGNY C, 1979, ELEMENTS ISOTOPES UN, P189; BALEBANOV VM, 1984, VENUS HALLEY MISSION, P88; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P617; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CLARK BC, 1987, ASTRON ASTROPHYS, V187, P779; DELSEMME AH, 1991, COMETS POSTHALLEY ER, P377; DIKOV YP, 1989, ADV SPACE RES, V9, P253; DYCHNE A, 1991, 260891 SPAC RES I TE; EVLANOV EN, 1991, CHEM SPACE, P383; FOMENKOVA M, 1991, LPSC, V22, P397; FREDRIKSSON K, 1988, METEORITICS, V23, P35, DOI 10.1111/j.1945-5100.1988.tb00894.x; HALLIDAY I, 1987, ASTRON ASTROPHYS, V187, P921; INOGAMOV NA, 1986, DOKL AKAD NAUK SSSR, V277, P1377; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KERRIDGE JF, 1979, SCIENCE, V205, P395, DOI 10.1126/science.205.4404.395; KERRIDGE JF, 1979, P LUNAR PLANET SCI C, V10, P989; KISSEL J, 1986, NATURE, V321, P280, DOI 10.1038/321280a0; KISSEL J, 1987, APPL PHYS A-MATER, V42, P69, DOI 10.1007/BF00618161; KORTH A, 1989, NATURE, V337, P53, DOI 10.1038/337053a0; Kracher A., 1984, J GEOPHYS RES S, V89, pB559; LANGEVIN Y, 1987, ASTRON ASTROPHYS, V187, P761; LAWLER ME, 1989, ICARUS, V80, P225, DOI 10.1016/0019-1035(89)90135-8; MUKHIN L, 1991, NATURE, V350, P480, DOI 10.1038/350480a0; MUMMA MJ, 1990, BAAS, V22, P1088; PRINN RG, 1988, ORIGIN EVOLUTION PLA, P78; RIETMEIJER FJM, 1991, EARTH PLANET SC LETT, V102, P148, DOI 10.1016/0012-821X(91)90004-2; RIETMEIJER FJM, 1989, LUNAR PLANET SCI, V20, P904; SANDFORD SA, 1985, ASTROPHYS J, V291, P838, DOI 10.1086/163120; Sears D.W.G., 1988, METEORITES EARLY SOL, P3; SHRAMM LS, 1989, METEORITICS, V24, P99; ZINNER EK, 1989, LUNAR PLANET SCI, V20, P1245; ZOLENSKY ME, 1992, P LUNAR PLANET SCI, V22, P161	33	83	83	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					266	269		10.1126/science.11538058	http://dx.doi.org/10.1126/science.11538058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	11538058				2022-12-28	WOS:A1992JR86000024
J	SLEEP, NH; ZAHNLE, KJ; KASTING, JF; MOROWITZ, HJ				SLEEP, NH; ZAHNLE, KJ; KASTING, JF; MOROWITZ, HJ			ANNIHILATION OF ECOSYSTEMS BY LARGE ASTEROID IMPACTS ON THE EARLY EARTH	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; PENN STATE UNIV,DEPT GEOSCI,UNIVERSITY PK,PA 16802; GEORGE MASON UNIV,DEPT BIOL,FAIRFAX,VA 22030	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Mason University	SLEEP, NH (corresponding author), STANFORD UNIV,DEPT BIOPHYS,STANFORD,CA 94305, USA.		Kasting, James/AAF-6851-2020					BALDWIN RB, 1987, ICARUS, V71, P1, DOI 10.1016/0019-1035(87)90158-8; BALDWIN RB, 1987, ICARUS, V71, P19, DOI 10.1016/0019-1035(87)90159-X; BALDWIN RB, 1981, P LUNAR PLANET SCI A, V12, P19; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P2415, DOI 10.1029/JB090iB14p12415; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; CARLSON RW, 1979, EARTH PLANET SC LETT, V45, P123, DOI 10.1016/0012-821X(79)90114-6; CLOUD P, 1983, SCI AM, V249, P176, DOI 10.1038/scientificamerican0983-176; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; DAVIS PA, 1987, J GEOPHYS RES-SOLID, V92, pE387, DOI 10.1029/JB092iB04p0E387; DONNISON JR, 1984, MON NOT R ASTRON SOC, V210, P673, DOI 10.1093/mnras/210.3.673; Hartmann W.K., 1980, LUNAR HIGHLANDS CRUS, P155; HARTMANN WK, 1987, ICARUS, V69, P33, DOI 10.1016/0019-1035(87)90005-4; HUGHES DW, 1982, MON NOT R ASTRON SOC, V199, P1149, DOI 10.1093/mnras/199.4.1149; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; JANNASCH HW, 1983, HYDROTHERMAL PROCESS, P677; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KOROTEV RL, 1987, J GEOPHYS RES-SOLID, V92, pE447, DOI 10.1029/JB092iB04p0E447; LINDSTROM MM, 1986, J GEOPHYS RES-SOLID, V91, pD263, DOI 10.1029/JB091iB04p0D263; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MARVIN UB, 1989, SCIENCE, V243, P925, DOI 10.1126/science.243.4893.925; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; NEWSOM HE, 1988, NATURE, V338, P29; PIETERS CM, 1986, REV GEOPHYS, V24, P557, DOI 10.1029/RG024i003p00557; RINGWOOD AE, 1986, ORIGIN MOON, P331; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P214; Spudis P.D., 1988, P LUN PLAN SCI C, P155; SPUDIS PD, 1986, J GEOPHYS RES-SOLID, V91, pE84, DOI 10.1029/JB091iB13p00E84; Swindle T.D., 1986, P C KON HI LUN PLAN, P331; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1987, NATURE, V329, P710, DOI 10.1038/329710a0; WARREN PH, 1989, EARTH PLANET SC LETT, V91, P245, DOI 10.1016/0012-821X(89)90001-0; WETHERILL GW, 1988, ICARUS, V75, P552	35	325	334	1	53	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 9	1989	342	6246					139	142		10.1038/342139a0	http://dx.doi.org/10.1038/342139a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY739	11536616				2022-12-28	WOS:A1989AY73900055
J	Reynolds, T				Reynolds, T			Prognostic models abound, but how useful are they?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					473	476		10.7326/0003-4819-135-6-200109180-00023	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560467				2022-12-28	WOS:000170972500012
J	Merlani, P; Garnerin, P; Diby, M; Ferring, M; Ricou, B				Merlani, P; Garnerin, P; Diby, M; Ferring, M; Ricou, B			Quality improvement report - Linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care	BRITISH MEDICAL JOURNAL			English	Article							COST; UNIT; ANEMIA	Problem Need to decrease the number of requests for arterial blood gas analysis and increase their appropriateness to reduce the amount of blood drawn from patients, the time wasted by nurses, and the related cost. Design Assessment of the impact of a multifaceted intervention aimed at changing requests for arterial blood gas analysis in a before and after study. Background and setting Twenty bed surgical intensive care unit of a tertiary university affiliated hospital, receiving 1500 patients per year. Key measures for improvement Number of tests per patient day, proportion of tests complying with current guideline, and safety indicators (mortality, incident rate, length of stay). Comparison of three 10 month periods corresponding to baseline, pilot (first version of the guideline), and consolidated (second version of the guideline) periods from March 1997 to August 1999. Strategies for change Multifaceted intervention combining a new guideline developed by a multidisciplinary group, educational sessions, and monthly feedback about adherence to the guideline and use of blood gas analysis. Effects of change Substantial decrease in the number of tests per patient day (from 8.2 to 4.8; P < 0.0001), associated with increased adherence to the guideline (from 53% to 80%, P < 0.0001). No significant variation of safety indicators. Lessons learnt A multifaceted intervention can substantially decrease the number of requests for arterial blood gas analysis and increase their appropriateness without affecting patient safety.	Univ Hosp Geneva, Dept Anaesthesiol Pharmacol & Surg Intens Care, Div Surg Intens Care, CH-1211 Geneva 4, Switzerland; Univ Hosp Geneva, Hosp Qual Care Unit, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Ricou, B (corresponding author), Univ Hosp Geneva, Dept Anaesthesiol Pharmacol & Surg Intens Care, Div Surg Intens Care, CH-1211 Geneva 4, Switzerland.							Barie PS, 1996, J TRAUMA, V41, P714, DOI 10.1097/00005373-199610000-00020; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; BROWNING J A, 1989, Respiratory Care, V34, P269; EYSTER E, 1973, JAMA-J AM MED ASSOC, V223, P73, DOI 10.1001/jama.223.1.73; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; HENRY ML, 1986, AM J SURG, V151, P362, DOI 10.1016/0002-9610(86)90468-X; Klepzig H, 1998, DEUT MED WOCHENSCHR, V123, P719, DOI 10.1055/s-2007-1024044; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; MARTIN AR, 1980, NEW ENGL J MED, V303, P1330, DOI 10.1056/NEJM198012043032304; MUAKKASSA FF, 1990, J TRAUMA, V30, P1087, DOI 10.1097/00005373-199009000-00004; NIEHOFF J, 1988, CRIT CARE MED, V16, P701, DOI 10.1097/00003246-198807000-00011; Noseworthy TW, 1996, CRIT CARE MED, V24, P1168, DOI 10.1097/00003246-199607000-00017; Pilon CS, 1997, CRIT CARE MED, V25, P1308, DOI 10.1097/00003246-199708000-00016; RAFFIN TA, 1986, ANN INTERN MED, V105, P390, DOI 10.7326/0003-4819-105-3-390; Reason J, 1995, Qual Health Care, V4, P80, DOI 10.1136/qshc.4.2.80; ROBERTS DE, 1993, CRIT CARE MED, V21, P1452, DOI 10.1097/00003246-199310000-00011; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; SINGER M, 1994, INTENS CARE MED, V20, P542, DOI 10.1007/BF01705718; STUDNICKI J, 1993, ARCH PATHOL LAB MED, V117, P35; Wilcock PM, 2000, QUAL HEALTH CARE, V9, P199, DOI 10.1136/qhc.9.4.199	22	82	85	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					620	624		10.1136/bmj.323.7313.620	http://dx.doi.org/10.1136/bmj.323.7313.620			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557715	Green Published			2022-12-28	WOS:000171087300025
J	Kim, SK; Lund, J; Kiraly, M; Duke, K; Jiang, M; Stuart, JM; Eizinger, A; Wylie, BN; Davidson, GS				Kim, SK; Lund, J; Kiraly, M; Duke, K; Jiang, M; Stuart, JM; Eizinger, A; Wylie, BN; Davidson, GS			A gene expression map for Caenorhabditis elegans	SCIENCE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; PROTEIN; ORGANIZATION; MICROARRAY; MUTATIONS; DISCOVERY; PATTERNS; RNAI	We have assembled data from Caenorhabditis elegans DNA microarray experiments involving many growth conditions, developmental stages, and varieties of mutants. Co-regulated genes were grouped together and visualized in a three-dimensional expression map that displays correlations of gene expression profiles as distances in two dimensions and gene density in the third dimension. The gene expression map can be used as a gene discovery toot to identify genes that are co-regulated with known sets of genes (such as heat shock, growth control genes, germ line genes, and so forth) or to uncover previously unknown genetic functions (such as genomic instability in mates and sperm caused by specific transposons).	Stanford Univ, Sch Med, Dept Dev Biol & Genet, Stanford, CA 94305 USA; Stanford Med Informat, Stanford, CA 94305 USA; Sandia Natl Labs, Computat Comp & Math Ctr, Albuquerque, NM 87185 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Sandia National Laboratories	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol & Genet, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu		Stuart, Joshua/0000-0002-2171-565X; Lund, Jim/0000-0002-1437-8448				Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Davidson GS, 1998, J INTELL INF SYST, V11, P259, DOI 10.1023/A:1008690008856; DAVIDSON GS, IN PRESS IEEE S INF; DeRisi J, 1996, NAT GENET, V14, P457; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EDGAR LG, 1986, DEV BIOL, V114, P109, DOI 10.1016/0012-1606(86)90387-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FERGUSON EL, 1989, GENETICS, V123, P109; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kim S.O., UNPUB; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LHernault SW, 1995, METHOD CELL BIOL, V48, P273; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; VILLENEUVE AM, COMMUNICATION; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	31	510	526	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2087	2092		10.1126/science.1061603	http://dx.doi.org/10.1126/science.1061603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557892				2022-12-28	WOS:000171028700074
J	Emsley, J				Emsley, J			Good news is no news - How can scientists use the media to give their side of the story to the public?	NATURE			English	Editorial Material									Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Emsley, J (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.								0	5	5	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					113	113		10.1038/35093175	http://dx.doi.org/10.1038/35093175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557958	Bronze			2022-12-28	WOS:000170918800026
J	Hu, FB; Manson, JE; Stampfer, MJ; Colditz, G; Liu, S; Solomon, CG; Willett, WC				Hu, FB; Manson, JE; Stampfer, MJ; Colditz, G; Liu, S; Solomon, CG; Willett, WC			Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CIGARETTE-SMOKING; GLYCEMIC LOAD; FAT INTAKE; WEIGHT; PREVENTION; FIBER; HEALTH; NIDDM	Background: Previous studies have examined individual dietary and lifestyle factors in relation to type 2 diabetes, but the combined effects of these factors are largely unknown. Methods: We followed 84,941 female nurses from 1980 to 1996; these women were free of diagnosed cardiovascular disease, diabetes, and cancer at base line. Information about their diet and lifestyle was updated periodically. A low-risk group was defined according to a combination of five variables: a body-mass index (the weight in kilograms divided by the square of the height in meters) of less than 25; a diet high in cereal fiber and polyunsaturated fat and low in trans fat and glycemic load (which reflects the effect of diet on the blood glucose level); engagement in moderate-to-vigorous physical activity for at least half an hour per day; no current smoking; and the consumption of an average of at least half a drink of an alcoholic beverage per day. Results: During 16 years of follow-up, we documented 3300 new cases of type 2 diabetes. Overweight or obesity was the single most important predictor of diabetes. Lack of exercise, a poor diet, current smoking, and abstinence from alcohol use were all associated with a significantly increased risk of diabetes, even after adjustment for the body-mass index. As compared with the rest of the cohort, women in the low-risk group (3.4 percent of the women) had a relative risk of diabetes of 0.09 (95 percent confidence interval, 0.05 to 0.17). A total of 91 percent of the cases of diabetes in this cohort (95 percent confidence interval, 83 to 95 percent) could be attributed to habits and forms of behavior that did not conform to the low-risk pattern. Conclusions: Our findings support the hypothesis that the majority of cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle. (N Engl J Med 2001;345:790-7.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Liu, Simin/GSN-4159-2022; Robles-Sardin, Alma E/M-7714-2015; Liu, Simin/I-3689-2014; Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009	Robles-Sardin, Alma E/0000-0003-2044-7793; Liu, Simin/0000-0003-2098-3844; Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036798] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK36798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; [Anonymous], 1996, JAMA, V276, P241; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Liu SM, 2001, AM J CLIN NUTR, V73, P560; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; MANNING A, 2001, US TODAY        0108, pD7; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vessby B, 2000, BRIT J NUTR, V83, pS91; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P668; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; World Health Organization,, 1998, WHO TECHN REP SER	39	1869	1935	7	342	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					790	797		10.1056/NEJMoa010492	http://dx.doi.org/10.1056/NEJMoa010492			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556298				2022-12-28	WOS:000170906800003
J	Kizer, KW				Kizer, KW			Establishing health care performance standards in an era of consumerism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	American-Board-of-Interanl-Medicine-Foundation Forum	AUG, 2000	MONT TREMBLANT, CANADA	Amer Board Internal Med Fdn			MEDICARE BENEFICIARIES; QUALITY; NEED; CHOICES; WANT	As the US health care system begins to reengineer itself to address the need for quality improvement, it also is being actively reshaped by the expectations of consumers. The confluence of these forces requires a new approach to setting health care performance standards. The National Quality Forum (NQF) has been established as a private, not-for-profit, open membership, public benefit corporation for the purposes of developing consensus about standardized health care performance measures, reporting mechanisms, and a national strategy for health care quality improvement. The NQF has broad representation from all segments of the health care industry and provides an equitable way of addressing the disparate priorities of health care's many stakeholders. Agreement and implementation of standardized health care performance measures and achievement of quality improvement in the emerging era of consumerism will be facilitated by (1) establishing national goals for health care quality; (2) embracing public policy that recognizes the complementary roles of quality improvement, cost control, and improved access; (3) giving greater priority to measuring and reporting the performance of those aspects of the health care system that directly affect consumers; (4) focusing on creating a health care culture of excellence; and (5) promoting the active collaboration of all stakeholders.	Natl Qual Forum, Washington, DC 20005 USA		Kizer, KW (corresponding author), Natl Qual Forum, 601 13th St NW,Suite 500 N, Washington, DC 20005 USA.							ANNISON MH, 1998, TRUST MATTERS NEW DI; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; BERWICK DM, 1998, GOOD SHOULD GET MAKI; Bodenheimer T, 1999, NEW ENGL J MED, V340, P488, DOI 10.1056/NEJM199902113400621; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chyna J T, 2000, Healthc Exec, V15, P6; Cleary PD, 1997, JAMA-J AM MED ASSOC, V278, P1608, DOI 10.1001/jama.278.19.1608; CODDINGTON DC, 2000, MANAGED CARE CONSUME; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; COILE RC, 2001, FUTURESCAN 2001 MILL; *FDN ACC, 2000, COMP YOUR CAR COMM T; Heffler S, 2001, HEALTH AFFAIR, V20, P193, DOI 10.1377/hlthaff.20.2.193; Hogan C, 2000, HEALTH AFFAIR, V19, P217, DOI 10.1377/hlthaff.19.6.217; HORNING B, 2001, STATES HLTH, V11, P1; *I MED, 2000, INF FUT CRIT ISS HLT, P41; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kimberly J. R., 2000, QUALITY IMPERATIVE M; KIZER KW, 2000, ADV FEDERAL SECTOR H, P79; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Levine S R, 2000, Physician Exec, V26, P10; Lubalin JS, 1999, MED CARE RES REV, V56, P67, DOI 10.1177/107755899773743873; LUDBERG GD, 2001, SEVERED TRUST WHY AM; MAXWELL J, 2001, CORPORATE HLTH CARE; Meyer JA, 1999, MED CARE RES REV, V56, P103, DOI 10.1177/107755899773743882; NASH DB, 2000, CONNECTING NEW HEALT; *NAT QUAL FOR, 2001, NAT GOALS HEALTHC EQ; Office of Management and Budget, 1998, A119 OFF MAN BUDG; Planning Institute of Australia, 2018, LENS TIPP POINT CANB; President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry, 1998, QUAL 1 BETT HLTH CAR; Robinson JC, 2001, JAMA-J AM MED ASSOC, V285, P2622, DOI 10.1001/jama.285.20.2622; Safran DG, 1998, J FAM PRACTICE, V47, P213; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Sherer J L, 2000, Healthc Exec, V15, P12; Spranca M, 2000, HEALTH SERV RES, V35, P933; *VHA INC, 2000, CONS DEM CLIN QUAL G	36	67	67	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1213	1217		10.1001/jama.286.10.1213	http://dx.doi.org/10.1001/jama.286.10.1213			5	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	471CR	11559267				2022-12-28	WOS:000170910400032
J	Schwetz, BA				Schwetz, BA			New FDA Web sites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-28	WOS:000170910400007
J	Wentworth, P; Jones, LH; Wentworth, AD; Zhu, XY; Larsen, NA; Wilson, IA; Xu, X; Goddard, WA; Janda, KD; Eschenmoser, A; Lerner, RA				Wentworth, P; Jones, LH; Wentworth, AD; Zhu, XY; Larsen, NA; Wilson, IA; Xu, X; Goddard, WA; Janda, KD; Eschenmoser, A; Lerner, RA			Antibody catalysis of the oxidation of water	SCIENCE			English	Article							HYDROGEN TRIOXIDE HOOOH; LOW-TEMPERATURE OZONATION; MOLECULAR-OXYGEN; SINGLET OXYGEN; PEROXIDE; PHOTOOXIDATION; DECOMPOSITION; TRYPTOPHAN; MECHANISM; SEQUENCE	Recently we reported that antibodies can generate hydrogen peroxide (H2O2) from singlet molecular oxygen (O-1(2)*), We now show that this process is catalytic, and we identify the electron source for a quasi-unlimited generation of H2O2. Antibodies produce up to 500 mote equivalents of H2O2 from O-1(2)*, without a reduction in rate, and we have excluded metals or Cl- as the electron source. On the basis of isotope incorporation experiments and kinetic data, we propose that antibodies use H2O as an electron source, facilitating its addition to O-1(2)* to form H2O3 as the first intermediate in a reaction cascade that eventually leads to H2O2. X-ray crystallographic studies with xenon point to putative conserved oxygen binding sites within the antibody fold where this chemistry could be initiated. Our findings suggest a protective function of immunoglobulins against O-1(2)* and raise the question of whether the need to detoxify O-1(2)* has played a decisive role in the evolution of the immunoglobulin fold.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; ETH Zurich, Organ Chem Lab, CH-8092 Zurich, Switzerland	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Zhu, Xueyong/ABE-3068-2021	Jones, Lyn/0000-0002-8388-5865; Xu, Xin/0000-0002-5247-2937	NCI NIH HHS [CA27489] Funding Source: Medline; NICHD NIH HHS [HD 36385] Funding Source: Medline; NIGMS NIH HHS [GM43858] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD036385] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043858, R01GM043858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cacace F, 1999, SCIENCE, V285, P81, DOI 10.1126/science.285.5424.81; Cannac-Caffrey V, 1998, BIOCHIMIE, V80, P1003, DOI 10.1016/S0300-9084(99)80005-4; CERKOVNIK J, 1993, J AM CHEM SOC, V115, P12169, DOI 10.1021/ja00078a067; COREY EJ, 1986, J AM CHEM SOC, V108, P2472, DOI 10.1021/ja00269a070; Datta D., UNPUB; DEBY C, 1991, RECHERCHE, V228, P378; DETTY MR, 1990, J AM CHEM SOC, V112, P4086, DOI 10.1021/ja00166a083; FOOTE CS, 1968, ACCOUNTS CHEM RES, V1, P104, DOI 10.1021/ar50004a002; FOWLER AV, 1978, J BIOL CHEM, V253, P5521; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Han J, 1996, ANAL BIOCHEM, V234, P107, DOI 10.1006/abio.1996.0059; KANOFSKY JR, 1989, CHEM-BIOL INTERACT, V70, P1, DOI 10.1016/0009-2797(89)90059-8; Koller J, 1996, J AM CHEM SOC, V118, P2470, DOI 10.1021/ja9503387; LI TY, 1995, J AM CHEM SOC, V117, P3308, DOI 10.1021/ja00116a050; LIDE DR, 1992, HDB CHEM PHYSICS, P73; MCCORMICK JP, 1978, J AM CHEM SOC, V100, P312, DOI 10.1021/ja00469a068; Plesnicar B, 2000, CHEM-EUR J, V6, P809; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Sawyer D. T, 1991, OXYGEN CHEM; SCHARF HD, 1979, CATAL CHEM BIOCH THE, V12, P355; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; TILSON RF, 1988, J MOL BIOL, V199, P195; VINCENT MA, 1995, J PHYS CHEM-US, V99, P3109, DOI 10.1021/j100010a021; WALRANT P, 1974, PHOTOCHEM PHOTOBIOL, V19, P411, DOI 10.1111/j.1751-1097.1974.tb06533.x; WELINDER KG, 1991, MOL IMMUNOL, V28, P177, DOI 10.1016/0161-5890(91)90102-P; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; WILKINSON F, 1993, J PHYS CHEM REF DATA, V22, P113, DOI 10.1063/1.555934; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	29	242	259	9	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1806	1811		10.1126/science.1062722	http://dx.doi.org/10.1126/science.1062722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546867				2022-12-28	WOS:000170894400040
J	Reynolds, JNJ; Hyland, BI; Wickens, JR				Reynolds, JNJ; Hyland, BI; Wickens, JR			A cellular mechanism of reward-related learning	NATURE			English	Article							MEMBRANE-POTENTIAL FLUCTUATIONS; NIGROSTRIATAL DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; SELF-STIMULATION; SPINY NEURONS; IN-VIVO; BRAIN-STIMULATION; RAT NEOSTRIATUM; NEURAL-NETWORK; BASAL GANGLIA	Positive reinforcement helps to control the acquisition of learned behaviours. Here we report a cellular mechanism in the brain that may underlie the behavioural effects of positive reinforcement. We used intracranial self-stimulation (ICSS) as a model of reinforcement learning(1), in which each rat learns to press a lever that applies reinforcing electrical stimulation to its own substantia nigra(2,3). The outputs from neurons of the substantia nigra terminate on neurons in the striatum in close proximity to inputs from the cerebral cortex on the same striatal neurons(4). We measured the effect of substantia nigra stimulation on these inputs from the cortex to striatal neurons and also on how quickly the rats learned to press the lever. We found that stimulation of the substantia nigra (with the optimal parameters for lever-pressing behaviour) induced potentiation of synapses between the cortex and the striatum, which required activation of dopamine receptors. The degree of potentiation within ten minutes of the ICSS trains was correlated with the time taken by the rats to learn ICSS behaviour.	Univ Otago, Sch Med Sci, Neurosci Res Ctr, Dunedin, New Zealand; Univ Otago, Sch Med Sci, Dept Anat & Struct Biol, Dunedin, New Zealand; Univ Otago, Sch Med Sci, Dept Physiol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Wickens, JR (corresponding author), Univ Otago, Sch Med Sci, Neurosci Res Ctr, Dunedin, New Zealand.		Reynolds, John/C-5636-2009; Wickens, Jeffery R/N-6055-2014; Hyland, Brian I/F-7840-2012	Wickens, Jeffery R/0000-0002-8795-1209; Hyland, Brian I/0000-0001-7593-4885				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], [No title captured]; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BENINGER RJ, 1977, SCIENCE, V196, P547, DOI 10.1126/science.850798; BIELAJEW C, 1986, J NEUROSCI, V6, P919; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CORBETT D, 1980, BRAIN RES, V185, P1, DOI 10.1016/0006-8993(80)90666-6; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; HODOS W, 1962, J COMP PHYSIOL PSYCH, V55, P80, DOI 10.1037/h0047681; HUNT GE, 1994, PHARMACOL BIOCHEM BE, V48, P853, DOI 10.1016/0091-3057(94)90192-9; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; MAJOR R, 1978, PHYSIOL BEHAV, V20, P723, DOI 10.1016/0031-9384(78)90298-6; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; MILLER RM, 1981, MEANING PURPOSE INTA, P62; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; REYNOLDS RW, 1958, J COMP PHYSIOL PSYCH, V51, P193, DOI 10.1037/h0048362; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	30	559	572	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					67	70		10.1038/35092560	http://dx.doi.org/10.1038/35092560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544526				2022-12-28	WOS:000170801200039
J	Benhamou, Y; Bochet, M; Thibault, V; Calvez, V; Fievet, MH; Vig, P; Gibbs, CS; Brosgart, C; Fry, J; Namini, H; Katiama, C; Poynard, T				Benhamou, Y; Bochet, M; Thibault, V; Calvez, V; Fievet, MH; Vig, P; Gibbs, CS; Brosgart, C; Fry, J; Namini, H; Katiama, C; Poynard, T			Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study	LANCET			English	Article							MUTATIONS; IDENTIFICATION; REINFECTION; FAMCICLOVIR; THERAPY; TRIAL	Background Lamivudine-resistant hepatitis B virus (HBV) is found in about 15-32% of infected patients with or without co-infection with HIV-1 after 1 year of lamivudine therapy. Adefovir dipivoxil is active in vivo and in vitro against wild-type and lamivudine-resistant HBV. We assessed the safety and efficacy of a once daily dose of adefovir dipivoxil in an open-label trial for the treatment of lamivudine-resistant HBV infection in HIV-1-infected patients. Methods 35 HIV-1/HBV co-infected patients receiving lamivudine therapy (150 mg twice daily) as part of their current HIV-1 antiretroviral regimen were enrolled. Patients received a 10 mg once-daily dose of adefovir dipivoxil for 48 weeks while maintaining their existing anti-HIV-1 therapy, including lamivudine. Patients were assessed every 4 weeks for safety and efficacy. Findings Four patients withdrew from the study (two because of adverse events), leaving 31 patients who received adefovir dipivoxil for a median of 48 weeks (range 44-48). Mean decreases in serum HBV DNA concentrations from baseline (log 8.64 copies/mL [SE log 0.08]) were -log 3.40 copies/mL [log 0.12] at week 24 (n=31) and -log 4.01 copies/mL [log 0.17] at week 48 (n=29; p<0.0001). Two patients underwent hepatitis B e antigen seroconversion-one at week 32 and one at week 36. Adefovir dipivoxil was generally well tolerated, but was associated with a transient increase in serum alanine aminotransferase concentrations in 15 patients. We found no significant changes in either HIV-1 RNA or CD4 cell count. Interpretation These results indicate that 48 weeks of 10 mg daily adefovir dipivoxil is well tolerated and active against lamivudine-resistant HBV in HIV-1/HBV co-infected patients.	Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Serv Malad Infect, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Virol Lab, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Serv Pharm, F-75651 Paris 13, France; Univ Paris 06, CNRS, UPRESA 8087, Paris, France; Gilead Sci Inc, Foster City, CA 94404 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Gilead Sciences	Benhamou, Y (corresponding author), Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, 27 Blvd Hop, F-75651 Paris 13, France.	ybenhamou@teaser.fr	THIBAULT, Vincent/AAB-5241-2020; Poynard, Thierry/C-1355-2010; THIBAULT, Vincent/J-7193-2015	THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-3726-7230; THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-2050-640X				Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Atkins M, 1998, HEPATOLOGY, V28, p319A; Bartholomew MM, 1997, LANCET, V349, P20, DOI 10.1016/S0140-6736(96)02266-0; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Benhamou Y, 1996, ANN INTERN MED, V125, P705, DOI 10.7326/0003-4819-125-9-199611010-00001; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; CHANG TT, 2000, ANTIVIR THER S, V5, P44; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; DIENSTAG JL, 1995, NEW ENGL J MED, V333, P1657, DOI 10.1056/NEJM199512213332501; Gilson RJC, 1999, J VIRAL HEPATITIS, V6, P387, DOI 10.1046/j.1365-2893.1999.00182.x; Hardy H, 2001, ANN PHARMACOTHER, V35, P343, DOI 10.1345/aph.10044; Heathcote EJ, 1998, HEPATOLOGY, V28, p317A; Kahn J, 1999, JAMA-J AM MED ASSOC, V282, P2305, DOI 10.1001/jama.282.24.2305; KANE MA, 1993, GUT, V34, pS10, DOI 10.1136/gut.34.2_Suppl.S10; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Leung N.W.Y., 1999, Journal of Hepatology, V30, P59; Liaw YF, 1998, GASTROENTEROLOGY, V114, pA1289, DOI 10.1016/S0016-5085(98)85233-5; Nicoll AJ, 1998, ANTIMICROB AGENTS CH, V42, P3130, DOI 10.1128/AAC.42.12.3130; Niesters HGM, 1998, J INFECT DIS, V177, P1382, DOI 10.1086/517819; Perrillo R, 2000, HEPATOLOGY, V32, P129, DOI 10.1053/jhep.2000.8626; Pillay D., 1998, International Antiviral News, V6, P167; RUSTGI VK, 1984, ANN INTERN MED, V101, P795, DOI 10.7326/0003-4819-101-6-795; SCHINAZI R, 2000, ANTIVIRAL NEWS, P8; Schuhbauer H, 1999, WIRTSCHAFTSINF, V41, P58, DOI 10.1007/BF03250636; Thibault V, 1999, J CLIN MICROBIOL, V37, P3013, DOI 10.1128/JCM.37.9.3013-3016.1999; Tillmann HL, 1999, HEPATOLOGY, V30, P244, DOI 10.1002/hep.510300141; Xiong XF, 1998, HEPATOLOGY, V28, P1669, DOI 10.1002/hep.510280629; Xiong XF, 2000, HEPATOLOGY, V31, P219, DOI 10.1002/hep.510310132; Xiong XF, 1997, ANTIVIR RES, V36, P131, DOI 10.1016/S0166-3542(97)00050-8; Yoshida EM, 1998, CAN J GASTROENTEROL, V12, P125, DOI 10.1155/1998/617039	30	241	261	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2001	358	9283					718	723		10.1016/S0140-6736(01)05840-8	http://dx.doi.org/10.1016/S0140-6736(01)05840-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551579				2022-12-28	WOS:000170729500012
J	Murray, E; Davis, H; Tai, SS; Coulter, A; Gray, A; Haines, A				Murray, E; Davis, H; Tai, SS; Coulter, A; Gray, A; Haines, A			Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether a decision aid on benign prostatic hypertrophy influences decision making, health outcomes, and resource use. Design Randomised controlled trial. Setting 33 general practices in the United Kingdom. Participants 112 men with benign prostatic hypertrophy. Intervention Patients' decision aid consisting of an interactive multimedia programme with booklet and printed summary. Outcome measures Patients' and general practitioners' perceptions of who made the decision, conflict over decisions, treatment choice and prostatectomy rate, American Urological Association symptom scale, costs, anxiety, utility, and general health status. Results Both patients and general practitioners found the decision aid acceptable. A higher proportion of patients (32% v 4%; mean difference 28%,95% confidence interval 14% to 40%) and their general practitioners (46% v 25%; 21%, 3% to 40%) perceived that treatment decisions had been made mainly or only by patients in the intervention group compared with the control group. Patients in the intervention group had significantly lower decisional conflict scores than those in the control group at 3 and 9 months (2.3 v 2.6; - 0.3, - 0.5 to - 0.1, P < 0.01 at 3 months). No differences were found between the groups for anxiety general health status, prostatic symptoms, utility, or costs (excluding costs associated with the video disc equipment). Conclusions The decision aid reduced decisional conflict in men with benign prostatic hypertrophy, and the patients played a more active part in decision making. Such programmes could be delivered cheaply over the internet, and there are good arguments for coordinated investment in them, particularly for conditions in which patient utilities are important.	UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London N19 3UA, England; Picker Inst Europe, Oxford OX1 1RX, England; Univ Oxford, Hlth Econ Res Ctr, Oxford OX3 7LF, England	University of London; University College London; University of Oxford	Murray, E (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London N19 3UA, England.	elizabeth.murray@pcps.ucl.ac.uk	Coulter, Angela/N-6998-2019; Davis, Hilary/J-9356-2015	Coulter, Angela/0000-0002-6308-8375; Murray, Elizabeth/0000-0002-8932-3695; Davis, Hilary/0000-0002-0271-9655; Haines, Andy/0000-0002-8053-4605				Barry M.J., 1997, DIS MANAG CLIN OUTCO, V1, P5, DOI DOI 10.1016/S1088-3371(96)00004-6; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, MED CARE, V33, P771, DOI 10.1097/00005650-199508000-00003; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Elwyn G, 1999, BRIT MED J, V319, P753, DOI 10.1136/bmj.319.7212.753; Kasper J F, 1992, QRB Qual Rev Bull, V18, P183; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; MCCONNELL J, 1994, CLIN PRACTICE GUIDEL, V8; Murray E, 2001, BMJ-BRIT MED J, V323, P490, DOI 10.1136/bmj.323.7311.490; O'Connor AM, 1998, MED DECIS MAKING, V18, P295, DOI 10.1177/0272989X9801800307; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	13	124	124	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					493	496A		10.1136/bmj.323.7311.493	http://dx.doi.org/10.1136/bmj.323.7311.493			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532845	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000170838500022
J	BECKER, L; BADA, JL; WINANS, RE; HUNT, JE; BUNCH, TE; FRENCH, BM				BECKER, L; BADA, JL; WINANS, RE; HUNT, JE; BUNCH, TE; FRENCH, BM			FULLERENES IN THE 1.85-BILLION-YEAR-OLD SUDBURY IMPACT STRUCTURE	SCIENCE			English	Article							EARTHS EARLY ATMOSPHERE; MASS-SPECTROMETRY; ALLENDE METEORITE; ION FORMATION; C-60; CARBON; C60	Fullerenes (C-60 and C-70) have been identified by laser desorption, laser desorption postionization, and high-resolution electron-impact mass spectrometry in shock-produced breccias (Onaping Formation) of the Sudbury impact structure in Ontario, Canada, The C-60 isotope is present at a level of a few parts per million. The fullerenes were likely synthesized within the impact plume from the carbon contained in the bolide. The oxidation of the fullerenes during the 1.85 billion years of exposure was apparently prevented by the presence of sulfur in the form of sulfide-silicate complexes associated with the fullerenes.	ARGONNE NATL LAB,DIV CHEM,ARGONNE,IL 60439; NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035; NASA HEADQUARTERS,WASHINGTON,DC 20546	United States Department of Energy (DOE); Argonne National Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA)	BECKER, L (corresponding author), UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,LA JOLLA,CA 92093, USA.			Winans, Randall/0000-0002-7080-7673				AVERMANN M, 1992, TECTONOPHYSICS, V216, P227, DOI 10.1016/0040-1951(92)90169-7; BECKER L, 1993, NATURE, V361, P595, DOI 10.1038/361595a0; BECKER L, UNPUB; BECKER L, 1993, THESIS U CALIFORNIA; BRINKMALM G, 1992, CHEM PHYS LETT, V191, P345, DOI 10.1016/0009-2614(92)85312-X; BURROWS AG, 1929, ONT DEP MINES B, V38, P1; BUSECK PR, 1992, SCIENCE, V257, P215, DOI 10.1126/science.257.5067.215; CHANG TM, 1992, J AM CHEM SOC, V114, P7603, DOI 10.1021/ja00045a066; CHIBANTE LPF, 1993, GEOCHIM COSMOCHIM AC, V57, P1879, DOI 10.1016/0016-7037(93)90119-H; CREASY WR, 1988, CHEM PHYS, V126, P453, DOI 10.1016/0301-0104(88)85053-5; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; DALY TK, 1993, SCIENCE, V259, P1599, DOI 10.1126/science.259.5101.1599; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; DIBIOZALO FR, 1994, NATURE, V369, P37; Dietz R.S., 1968, SHOCK METAMORPHISM N, P267; DIETZ RS, 1964, J GEOL, V72, P412, DOI 10.1086/626999; FAGGART BE, 1985, SCIENCE, V230, P436, DOI 10.1126/science.230.4724.436; French B.M., 1968, SHOCK METAMORPHISM N, P383; FRENCH BM, 1972, GEOL ASSOC CAN SPEC, V10, P19; GREENWOOD PF, 1990, ORG MASS SPECTROM, V25, P353, DOI 10.1002/oms.1210250703; GRIEVE RAF, 1991, J GEOPHYS RES-PLANET, V96, P22753, DOI 10.1029/91JE02513; HAHN JH, 1988, SCIENCE, V239, P1523, DOI 10.1126/science.239.4847.1523; HEYMANN D, 1992, LUNAR PLANET SCI, V23, P1053; HEYMANN D, 1991, LUNAR PLANET SCI, V22, P569; HEYMANN D, 1993, LUNAR PLANET, V24, P437; HEYMANN D, 1994, LUNAR PLANET SCI, V25, P545; HOWARD JB, 1990, NATURE, V352, P141; HUNT JE, 1991, NATO ASI SER, P309; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1990, NASA CONF P, V3061, P275; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KROUGH TE, 1984, ONT GEOL SURV SPEC, V1, P431; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MCKINNON JT, 1992, COMBUST FLAME, V88, P102, DOI 10.1016/0010-2180(92)90010-M; MUIR TL, 1984, ONT GEOL SURV REP, V1, P103; OBERBECK VR, 1989, LUNAR PLANET SCI, V20, P671; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; PILLINGER CT, 1993, PHILOS T R SOC A, V343, P73, DOI 10.1098/rsta.1993.0042; ROHLING EA, 1984, J CHEM PHYS, V81, P3332; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; TAYLOR R, 1993, NATURE, V366, P728, DOI 10.1038/366728a0; TAYLOR R, 1991, NATURE, V351, P277, DOI 10.1038/351277a0; UGARTE D, 1992, NATURE, V359, P707, DOI 10.1038/359707a0; WEBSTER A, 1991, NATURE, V352, P412, DOI 10.1038/352412a0; WEBSTER A, 1993, MONTHLY NOT R ASTRON, V255, P41; WURZ P, 1992, VACUUM, V43, P381, DOI 10.1016/0042-207X(92)90041-T; WURZ P, 1992, J PHYS CHEM-US, V96, P10129, DOI 10.1021/j100204a011; ZENOBI R, 1989, SCIENCE, V246, P1026, DOI 10.1126/science.246.4933.1026	51	115	119	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1994	265	5172					642	645		10.1126/science.11536660	http://dx.doi.org/10.1126/science.11536660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NZ538	11536660				2022-12-28	WOS:A1994NZ53800027
J	CRAIG, H; WHARTON, RA; MCKAY, CP				CRAIG, H; WHARTON, RA; MCKAY, CP			OXYGEN SUPERSATURATION IN ICE-COVERED ANTARCTIC LAKES - BIOLOGICAL VERSUS PHYSICAL CONTRIBUTIONS	SCIENCE			English	Article								Freezing in ice-covered lakes causes dissolved gases to become supersaturated while at the same time removing gases trapped in the ablating ice cover. Analysis of N2, O2, and Ar in bubbles from Lake Hoare ice shows that, white O2 is approximately 2.4 times supersaturated in the water below the ice, only 11% of the O2 input to this lake is due to biological activity: 89% of the O2 is derived from meltwater inflow. Trapped bubbles in a subliming ice cover provide a natural "fluxmeter" for gas exchange: in Lake Hoare as much as 70% of the total gas loss may occur by advection through the ice cover, including approximately 75% of the N2, approximately 59% of the O2, and approximately 57% of the Ar losses. The remaining gas fractions are removed by respiration at the lower boundary (O2) and by molecular exchange with the atmosphere in the peripheral summer moat around the ice.	UNIV NEVADA SYST,DESERT RES INST,RENO,NV 89506; NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	CRAIG, H (corresponding author), UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,ISOTOPE LAB,LA JOLLA,CA 92093, USA.				NCCDPHP CDC HHS [DP84-16340] Funding Source: Medline	NCCDPHP CDC HHS		BALL DG, 1960, GEOL SOC AM BULL, V71, P1703, DOI 10.1130/0016-7606(1960)71[1703:SLADBM]2.0.CO;2; CRAIG H, 1987, SCIENCE, V235, P199, DOI 10.1126/science.235.4785.199; GREEN W, IN PRESS ANTARCTIC R; MCKAY CP, 1985, NATURE, V313, P561, DOI 10.1038/313561a0; TOP Z, 1985, GEOPHYS RES LETT, V12, P821, DOI 10.1029/GL012i012p00821; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; WHARTON RA, 1987, NATURE, V325, P343, DOI 10.1038/325343a0; WHARTON RA, 1986, LIMNOL OCEANOGR, V31, P437, DOI 10.4319/lo.1986.31.2.0437	8	63	63	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 17	1992	255	5042					318	321		10.1126/science.11539819	http://dx.doi.org/10.1126/science.11539819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ695	11539819				2022-12-28	WOS:A1992GZ69500038
J	TOWE, KM				TOWE, KM			AEROBIC RESPIRATION IN THE ARCHEAN	NATURE			English	Article											TOWE, KM (corresponding author), SMITHSONIAN INST,DEPT PALEOBIOL,WASHINGTON,DC 20560, USA.							BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BRALOWER TJ, 1984, GEOLOGY, V12, P614, DOI 10.1130/0091-7613(1984)12<614:LPASDC>2.0.CO;2; Chapman D.J., 1983, P302; Claypool G.E., 1974, NATURAL GASES MARINE, P99, DOI DOI 10.1007/978-1-4684-2757-8_8; CLOUD P, 1973, ECON GEOL, V68, P1135, DOI 10.2113/gsecongeo.68.7.1135; DREVER JI, 1974, GEOL SOC AM BULL, V85, P1099, DOI 10.1130/0016-7606(1974)85<1099:GMFTOO>2.0.CO;2; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; GARRELS RM, 1974, SEA, V5, P303; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HENRICHS SM, 1987, GEOMICROBIOL J, V5, P191, DOI 10.1080/01490458709385971; Holland HD., 1984, CHEM EVOLUTION ATMOS; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KASTING JF, 1983, PRECAMBRIAN RES, V20, P121, DOI 10.1016/0301-9268(83)90069-4; KNOLL AH, 1979, ORIGINS LIFE EVOL B, V9, P313, DOI 10.1007/BF00926824; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MOFETT JW, 1990, NATURE, V345, P421; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; REIMER TO, 1979, PRECAMBRIAN RES, V9, P93, DOI 10.1016/0301-9268(79)90053-6; ROSENFELD WD, 1959, SCIENCE, V130, P1658, DOI 10.1126/science.130.3389.1658-a; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1988, MOL EVOLUTION FOSSIL, P89; SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030; TOWE KM, 1985, ORIGINS LIFE EVOL B, V15, P235, DOI 10.1007/BF01808171; Towe KM, 1988, MOL EVOLUTION FOSSIL, P114; VEIZER J, 1985, J GEOL, V93, P625, DOI 10.1086/628992; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1980, HDB ENV CHEM A, V1, P87; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; WINFREY MR, 1983, APPL ENVIRON MICROB, V45, P193, DOI 10.1128/AEM.45.1.193-199.1983; WOLIN MJ, 1987, GEOMICROBIOL J, V5, P239, DOI 10.1080/01490458709385972	32	56	58	2	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 1	1990	348	6296					54	56		10.1038/348054a0	http://dx.doi.org/10.1038/348054a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF994	11536471				2022-12-28	WOS:A1990EF99400059
J	Van Dover, CL; Humphris, SE; Fornari, D; Cavanaugh, CM; Collier, R; Goffredi, SK; Hashimoto, J; Lilley, MD; Reysenbach, AL; Shank, TM; Von Damm, KL; Banta, A; Gallant, RM; Gotz, D; Green, D; Hall, J; Harmer, TL; Hurtado, LA; Johnson, P; McKiness, ZP; Meredith, C; Olson, E; Pan, IL; Turnipseed, M; Won, Y; Young, CR; Vrijenhoek, RC				Van Dover, CL; Humphris, SE; Fornari, D; Cavanaugh, CM; Collier, R; Goffredi, SK; Hashimoto, J; Lilley, MD; Reysenbach, AL; Shank, TM; Von Damm, KL; Banta, A; Gallant, RM; Gotz, D; Green, D; Hall, J; Harmer, TL; Hurtado, LA; Johnson, P; McKiness, ZP; Meredith, C; Olson, E; Pan, IL; Turnipseed, M; Won, Y; Young, CR; Vrijenhoek, RC			Biogeography and ecological setting of Indian Ocean hydrothermal vents	SCIENCE			English	Article							MID-ATLANTIC RIDGE; SHRIMP; FLUIDS; BRESILIIDAE; DISPERSAL; PRIMERS; FAUNA	Within the endemic invertebrate faunas of hydrothermal vents, five biogeographic provinces are recognized. Invertebrates at two Indian Ocean vent fields (Kairei and Edmond) belong to a sixth province, despite ecological settings and invertebrate-bacterial symbioses similar to those of both western Pacific and Atlantic vents. Most organisms found at these Indian Ocean vent fields have evolutionary affinities with western Pacific vent faunas, but a shrimp that ecologically dominates Indian Ocean vents closely resembles its Mid-Atlantic counterpart. These findings contribute to a global assessment of the biogeography of chemosynthetic faunas and indicate that the Indian Ocean vent community follows asymmetric assembly rules biased toward Pacific evolutionary alliances.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Harvard Univ, Cambridge, MA 02138 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Japan Marine Sci & Technol Ctr, Kanagawa 2370061, Japan; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Portland State Univ, Dept Biol, Portland, OR 97201 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ Southampton, Southampton Oceanog Ctr, Southampton, Hants, England; Louisiana State Univ, Baton Rouge, LA 70803 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA	William & Mary; Woods Hole Oceanographic Institution; Harvard University; Oregon State University; Monterey Bay Aquarium Research Institute; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Washington; University of Washington Seattle; Portland State University; Woods Hole Oceanographic Institution; University System Of New Hampshire; University of New Hampshire; NERC National Oceanography Centre; University of Southampton; Louisiana State University System; Louisiana State University; University of Hawaii System; University of Hawaii Manoa	Van Dover, CL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	cindy_vandover@wm.edu	Harmer Luke, Tara/R-6816-2018; Luke, Tara Harmer/S-5923-2019; Hurtado, Luis A/B-5953-2008	Harmer Luke, Tara/0000-0003-2529-1708; Luke, Tara Harmer/0000-0003-2529-1708; Hurtado, Luis A/0000-0002-9773-4996; Banta, Amy/0000-0002-1843-5059; Van Dover, Cindy/0000-0001-9845-8391				AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Bielawski JP, 1996, MOL BIOL EVOL, V13, P889, DOI 10.1093/oxfordjournals.molbev.a025649; BRIAIS A, 1995, MAR GEOPHYS RES, V17, P431, DOI 10.1007/BF01371787; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Chevaldonne P, 1998, CAH BIOL MAR, V39, P347; Craig H., 1980, EOS, V61, P992; DEMETS C, 1988, J GEOPHYS RES-SOLID, V93, P11877, DOI 10.1029/JB093iB10p11877; Donval J.P., 1997, EOS T AM GEOPHYS UNI, V78, pF832; EVANS WC, 1988, J GEOPHYS RES-SOLID, V93, P15305, DOI 10.1029/JB093iB12p15305; Fisher C.R., 1995, GEOPHYS MONOGR SER, P297; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOUQUET Y, 1993, ECON GEOL BULL SOC, V88, P2018, DOI 10.2113/gsecongeo.88.8.2018; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; HERZIG PM, 1988, CAN MINERAL, V26, P721; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Kleinrock MC, 1996, NATURE, V382, P149, DOI 10.1038/382149a0; LILLEY M, UNPUB; LUTZ RA, 1979, AM ZOOL, V19, P927; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Mironov AN, 1998, CAH BIOL MAR, V39, P367; Palumbi Stephen R., 1996, P205; PLUGER WL, 1990, MAR MINING, V9, P73; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Pond DW, 2000, MAR ECOL PROG SER, V198, P171, DOI 10.3354/meps198171; Reysenbach AL, 2000, NATURE, V404, P835, DOI 10.1038/35009029; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Robinson JL, 1995, LIMNOL OCEANOGR, V40, P1496, DOI 10.4319/lo.1995.40.8.1496; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; TUNNICLIFFE V, 1988, PROC R SOC SER B-BIO, V233, P347, DOI 10.1098/rspb.1988.0025; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1998, GEOLOGICAL SOC SPEC, V118, P225; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover Cindy Lee, 1995, Geological Society Special Publication, V87, P257; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; VANDOVER CL, 1990, GORDA RIDGE, P253; VANDOVER CL, IN PRESS MAR ECOL PR; Von Damm KL, 1998, EARTH PLANET SC LETT, V160, P521, DOI 10.1016/S0012-821X(98)00108-3; Von Damm KL, 2000, J GEOPHYS RES-SOL EA, V105, P11203, DOI 10.1029/1999JB900414; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; VRIJENHOEK RC, 1997, JAMSTEC DEEP SEA RES, V111; White SN, 1998, MAR GEOPHYS RES, V20, P41, DOI 10.1023/A:1004376229719; AF393376 GENB; AF393378 GENB; AF393377 GENB; AF393379 GENB	52	261	262	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					818	823		10.1126/science.1064574	http://dx.doi.org/10.1126/science.1064574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11557843				2022-12-28	WOS:000171851800037
J	Derry, WB; Putzke, AP; Rothman, JH				Derry, WB; Putzke, AP; Rothman, JH			Caenorhabditis elegans p53: Role in apoptosis, meiosis, and stress resistance	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; TRANSCRIPTIONAL ACTIVATION; GENETIC-CONTROL; DROSOPHILA P53; TUMOR-ANTIGEN; C-ELEGANS; PROTEIN; EMBRYOGENESIS; ACCUMULATION; CHECKPOINT	We have identified a homolog of the mammalian p53 tumor suppressor protein in the nematode Caenorhabditis elegans that is expressed ubiquitously in embryos. The gene encoding this protein, cep-1, promotes DNA damage-induced apoptosis and is required for normal meiotic chromosome segregation in the germ line. Moreover, although somatic apoptosis is unaffected, cep-1 mutants show hypersensitivity to hypoxia-induced lethality and decreased longevity in response to starvation-induced stress. Overexpression of cep-1 promotes widespread caspase-independent cell death, demonstrating the critical importance of regulating p53 function at appropriate levels. These findings show that C. elegans p53 mediates multiple stress responses in the soma, and mediates apoptosis and meiotic chromosome segregation in the germ line.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Derry, WB (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	derry@lifesci.ucsb.edu	Derry, Brent/CAF-4503-2022	Derry, Brent/0000-0002-1977-8475	NATIONAL INSTITUTE ON AGING [R01AG013736] Funding Source: NIH RePORTER; NIA NIH HHS [AG13736] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Alarcon R, 1999, CANCER RES, V59, P6046; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DERRY WB, UNPUB; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HENIKOFF S, 1995, GENE, V163, P17; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Riddle D. L, 1997, C ELEGANS, P47; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHMID P, 1991, DEVELOPMENT, V113, P857; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2	32	372	399	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					591	595		10.1126/science.1065486	http://dx.doi.org/10.1126/science.1065486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11557844				2022-12-28	WOS:000171695600046
J	Xiong, JP; Stehle, T; Diefenbach, B; Zhang, RG; Dunker, R; Scott, DL; Joachimiak, A; Goodman, SL; Arnaout, MA				Xiong, JP; Stehle, T; Diefenbach, B; Zhang, RG; Dunker, R; Scott, DL; Joachimiak, A; Goodman, SL; Arnaout, MA			Crystal structure of the extracellular segment of integrin alpha V beta 3	SCIENCE			English	Article							IIB-IIIA COMPLEX; LIGAND-BINDING; A-DOMAIN; CELL-ADHESION; CONFORMATIONAL-CHANGES; PROTEIN; AFFINITY; SITES; FIBRINOGEN; INSIGHTS	Integrins are alpha beta heterodimeric receptors that mediate divalent cation-dependent cell-cell and cell-matrix adhesion through tightly regulated interactions with ligands. We have solved the crystal structure of the extracellular portion of integrin alphaV beta3 at 3.1 Angstrom resolution. Its 12 domains assemble into an ovoid "head" and two "tails." In the crystal, alphaV beta3 is severely bent at a defined region in its tails, reflecting an unusual flexibility that may be linked to integrin regulation. The main intersubunit interface ties within the head, between a seven-bladed beta -propeller from alphaV and an A domain from beta3, and bears a striking resemblance to the G alpha /G beta interface in G proteins. A metal ion-dependent adhesion site (MIDAS) in the betaA domain is positioned to participate in a ligand-binding interface formed of loops from the propeller and betaA domains. MIDAS ties adjacent to a calcium-binding site with a potential regulatory function.	Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Merck KGaA, Dept Biotechnol, D-64271 Darmstadt, Germany; Merck KGaA, Dept Biomed Res Immunol Oncol, D-64271 Darmstadt, Germany; Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck KGaA; Merck KGaA; United States Department of Energy (DOE); Argonne National Laboratory	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, 149 13th St, Charlestown, MA 02129 USA.	arnaout@receptor.mgh.harvard.edu		Goodman, Simon L./0000-0002-3480-1346	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549, P01DK050305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; DU XP, 1993, J BIOL CHEM, V268, P23087; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187; FITZGERALD LA, 1985, J BIOL CHEM, V260, P1366; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Mehta RJ, 1998, BIOCHEM J, V330, P861; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARISE LV, 1985, J BIOL CHEM, V260, P1750; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pujades C, 1997, MOL BIOL CELL, V8, P2647, DOI 10.1091/mbc.8.12.2647; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; [No title captured]	45	1043	1097	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					339	345		10.1126/science.1064535	http://dx.doi.org/10.1126/science.1064535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11546839	Green Accepted			2022-12-28	WOS:000171601400034
J	Majeed, A; Bindman, AB; Weiner, JP				Majeed, A; Bindman, AB; Weiner, JP			Use of risk adjustment in setting budgets and measuring performance in primary care II: advantages, disadvantages, and practicalities	BRITISH MEDICAL JOURNAL			English	Article							CAPITATION RATES		UCL, Sch Publ Policy, London WC1H 9EZ, England; Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94110 USA; Johns Hopkins Sch Publ Hlth, Hlth Serv Res & Dev Ctr, Baltimore, MD 21025 USA	University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Majeed, A (corresponding author), UCL, Sch Publ Policy, London WC1H 9EZ, England.	a.majeed@ucl.ac.uk		Majeed, Azeem/0000-0002-2357-9858				Andrews JS, 1997, ARCH PEDIAT ADOL MED, V151, P236, DOI 10.1001/archpedi.1997.02170400022005; Bodenheimer T, 2000, HEALTH AFFAIR, V19, P200, DOI 10.1377/hlthaff.19.4.200; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1064, DOI 10.1056/NEJM200004063421422; *DEP HLTH, 2000, NHS PLAN; Fowles JB, 1996, JAMA-J AM MED ASSOC, V276, P1316, DOI 10.1001/jama.276.16.1316; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; Maguire AM, 1998, AM J MANAG CARE, V4, P797; Majeed A, 2001, BRIT MED J, V323, P604, DOI 10.1136/bmj.323.7313.604; MCCORMICK A, 1995, MORBIDITY STAT GEN P; NEWHOUSE JP, 1994, HEALTH AFFAIR, V13, P132, DOI 10.1377/hlthaff.13.1.132; *NHS EX, 1999, QUAL PERF NHS HIGH L; Reid R., 1999, MEASURING MORBIDITY; SALEMSCHATZ S, 1994, JAMA-J AM MED ASSOC, V272, P871, DOI 10.1001/jama.272.11.871; [No title captured]	14	24	25	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					607	610		10.1136/bmj.323.7313.607	http://dx.doi.org/10.1136/bmj.323.7313.607			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557710	Green Published, Bronze			2022-12-28	WOS:000171087300021
J	Greene, JD; Sommerville, RB; Nystrom, LE; Darley, JM; Cohen, JD				Greene, JD; Sommerville, RB; Nystrom, LE; Darley, JM; Cohen, JD			An fMRI investigation of emotional engagement in moral judgment	SCIENCE			English	Article							WORKING-MEMORY; BRAIN	The long-standing rationalist tradition in moral psychology emphasizes the rote of reason in moral judgment. A more recent trend places increased emphasis on emotion. Although both reason and emotion are likely to play important roles in moral judgment, relatively tittle is known about their neural correlates, the nature of their interaction, and the factors that modulate their respective behavioral influences in the context of moral judgment. In two functional magnetic resonance imaging (fMRI) studies using moral dilemmas as probes, we apply the methods of cognitive neuroscience to the study of moral judgment. We argue that moral dilemmas vary systematically in the extent to which they engage emotional processing and that these variations in emotional engagement influence moral judgment. These results may shed light on some puzzling patterns in moral judgment observed by contemporary philosophers.	Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greene, JD (corresponding author), Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.							Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; DAMASIO AR, 1994, DESCARTES ERROR; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; HAIDT JD, IN PRESS PSYCH REV; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; STROOP JR, 1935, J EXP PSYCHOL, V72, P219; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomson J.J., 1986, RIGHTS RESTITUTION R, P94	15	2521	2591	45	665	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2105	2108		10.1126/science.1062872	http://dx.doi.org/10.1126/science.1062872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	473FB	11557895				2022-12-28	WOS:000171028700078
J	Bayley, H; Cremer, PS				Bayley, H; Cremer, PS			Stochastic sensors inspired by biology	NATURE			English	Article							SINGLE-MOLECULE; SUPPORTED MEMBRANES; ALPHA-HEMOLYSIN; GROWTH CONES; PROTEIN; TRANSPORT; DNA; DISCRIMINATION; SPECTROSCOPY; PORES	Sensory systems use a variety of membrane-bound receptors, including responsive ion channels, to discriminate between a multitude of stimuli. Here we describe how engineered membrane pores can be used to make rapid and sensitive biosensors with potential applications that range from the detection of biological warfare agents to pharmaceutical screening. Notably, use of the engineered pores in stochastic sensing, a single-molecule detection technology, reveals the identity of an analyte as well as its concentration.	Texas A&M Univ, Dept Med Biochem & Genet, Hlth Sci Ctr, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Texas A&M Univ, Ctr Integrated Microchem Syst, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bayley, H (corresponding author), Texas A&M Univ, Dept Med Biochem & Genet, Hlth Sci Ctr, College Stn, TX 77843 USA.	bayley@tamu.edu	Zdilla, Michael J/B-4145-2011; Wunder, Stephanie L/B-5066-2012	Bayley, Hagan/0000-0003-2499-6116				Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Ball P, 2001, NATURE, V409, P413, DOI 10.1038/35053198; Bayley H, 2000, CHEM REV, V100, P2575, DOI 10.1021/cr980099g; Bayley H, 2000, ADV MATER, V12, P139, DOI 10.1002/(SICI)1521-4095(200001)12:2<139::AID-ADMA139>3.3.CO;2-H; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; BORMAN S, 2000, C EN, P48; Boxer SG, 2000, CURR OPIN CHEM BIOL, V4, P704, DOI 10.1016/S1367-5931(00)00139-3; Braha O, 2000, NAT BIOTECHNOL, V18, P1005, DOI 10.1038/79275; Braha O, 1997, CHEM BIOL, V4, P497, DOI 10.1016/S1074-5521(97)90321-5; Cheley S, 1999, PROTEIN SCI, V8, P1257, DOI 10.1110/ps.8.6.1257; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Cremer PS, 1999, J AM CHEM SOC, V121, P8130, DOI 10.1021/ja991453a; Deamer DW, 2000, TRENDS BIOTECHNOL, V18, P147, DOI 10.1016/S0167-7799(00)01426-8; Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0; Figeys D, 2000, ANAL CHEM, V72, p330A, DOI 10.1021/ac002800y; Fisher TE, 2000, NEURON, V27, P435, DOI 10.1016/S0896-6273(00)00055-6; Glazier SA, 2000, LANGMUIR, V16, P10428, DOI 10.1021/la000690k; Gu LQ, 1999, NATURE, V398, P686, DOI 10.1038/19491; Gu LQ, 2001, SCIENCE, V291, P636, DOI 10.1126/science.291.5504.636; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Hirn R, 1998, FARADAY DISCUSS, V111, P17; HLADKY SB, 1970, NATURE, V225, P451, DOI 10.1038/225451a0; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Hulteen JC, 1998, J AM CHEM SOC, V120, P6603, DOI 10.1021/ja980045o; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; Ide T, 1999, BIOCHEM BIOPH RES CO, V265, P595, DOI 10.1006/bbrc.1999.1720; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kodadek T, 2001, CHEM BIOL, V8, P105, DOI 10.1016/S1074-5521(00)90067-X; KRAMER RH, 1990, NEURON, V4, P335, DOI 10.1016/0896-6273(90)90046-I; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Lucas SW, 2000, ANAL BIOCHEM, V282, P70, DOI 10.1006/abio.2000.4568; McGeoch JEM, 2000, MED BIOL ENG COMPUT, V38, P113, DOI 10.1007/BF02344699; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Sackmann E, 2000, TRENDS BIOTECHNOL, V18, P58, DOI 10.1016/S0167-7799(99)01412-2; Sanchez-Quesada J, 2000, J AM CHEM SOC, V122, P11757, DOI 10.1021/ja002436k; Schmidt C, 2000, ANGEW CHEM INT EDIT, V39, P3137, DOI 10.1002/1521-3773(20000901)39:17<3137::AID-ANIE3137>3.0.CO;2-D; Schuster B, 1998, BBA-BIOMEMBRANES, V1370, P280, DOI 10.1016/S0005-2736(97)00274-5; Schuster B, 2001, LANGMUIR, V17, P499, DOI 10.1021/la0008784; Stora T, 1999, ANGEW CHEM INT EDIT, V38, P389, DOI 10.1002/(SICI)1521-3773(19990201)38:3<389::AID-ANIE389>3.0.CO;2-U; Straub B, 2001, NAT BIOTECHNOL, V19, P121, DOI 10.1038/84369; Sun L, 2000, J AM CHEM SOC, V122, P12340, DOI 10.1021/ja002429w; TONUCCI RJ, 1992, SCIENCE, V258, P783, DOI 10.1126/science.258.5083.783; Trivedi B, 1998, NEURON, V21, P895, DOI 10.1016/S0896-6273(00)80604-2; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wiegand G, 2000, REV SCI INSTRUM, V71, P2309, DOI 10.1063/1.1150447; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Yang TL, 2000, ANAL CHEM, V72, P2587, DOI 10.1021/ac000131i; Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0	54	916	1003	7	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					226	230		10.1038/35093038	http://dx.doi.org/10.1038/35093038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557992				2022-12-28	WOS:000170918800058
J	Berriman, AC; Hinde, DJ; Dasgupta, M; Morton, CR; Butt, RD; Newton, JO				Berriman, AC; Hinde, DJ; Dasgupta, M; Morton, CR; Butt, RD; Newton, JO			Unexpected inhibition of fusion in nucleus-nucleus collisions	NATURE			English	Article							FISSION-FRAGMENT ANISOTROPIES; AVERAGE ANGULAR MOMENTA; HEAVY-ION REACTIONS; CROSS-SECTIONS; QUASI-FISSION; EMISSION	Unstable heavy atomic nuclei not found in nature can be created by fusing two stable nuclei, in a process analogous to colliding charged droplets of liquid. Recently, the formation of a handful of super-heavy nuclei with atomic numbers 114 (ref. 1) and 116 (ref. 2) has been achieved by fusion of heavy nuclei. The electrostatic energy of such systems is very large (which is the reason super-heavy nuclei are unstable), so although the two nuclei may initially be captured by the nuclear potential, rather than fusing, they almost always separate after transfer of mass to the lighter nucleus. This process, called quasi-fission(3,4), can inhibit fusion by many orders of magnitude. Understanding this inhibition may hold the key to forming more super-heavy elements. Theoretically, inhibition is predicted (ref. 5 and references therein) when the product Z(1)Z(2) of the charges of the projectile and target nuclei is larger than about 1,600. Here we report measurements of three fusion reactions with Z(1)Z(2) around half this value, each forming Ra-88(216). We find convincing model-independent evidence both of inhibition of fusion, and of the presence of quasi-fission. These results defy interpretation within the standard picture of nuclear fusion and fission.	Australian Natl Univ, Dept Nucl Phys, Res Sch Phys Sci & Engn, Canberra, ACT 0200, Australia	Australian National University	Hinde, DJ (corresponding author), Australian Natl Univ, Dept Nucl Phys, Res Sch Phys Sci & Engn, Canberra, ACT 0200, Australia.		Hinde, David J/D-5051-2013; Dasgupta, Mahananda/D-6951-2013	Hinde, David J/0000-0002-4595-0742; Dasgupta, Mahananda/0000-0002-1677-9421; Berriman, Annette/0000-0003-2580-4892				Abe Y, 1996, PHYS REP, V275, P49, DOI 10.1016/0370-1573(96)00003-8; BACK BB, 1985, PHYS REV C, V31, P2104, DOI 10.1103/PhysRevC.31.2104; Balantekin AB, 1996, PHYS REV C, V54, P1853, DOI 10.1103/PhysRevC.54.1853; BLOCKI JP, 1986, NUCL PHYS A, V459, P145, DOI 10.1016/0375-9474(86)90061-8; Bohr N., 1936, NATURE, V137, P344, DOI [10.1038/137344a0, DOI 10.1038/137344A0]; Dasgupta M, 1998, ANNU REV NUCL PART S, V48, P401, DOI 10.1146/annurev.nucl.48.1.401; DAVIES KTR, 1985, PHYS REV C, V31, P915, DOI 10.1103/PhysRevC.31.915; Hagino K, 1999, COMPUT PHYS COMMUN, V123, P143, DOI 10.1016/S0010-4655(99)00243-X; HAHN RL, 1987, PHYS REV C, V36, P2132, DOI 10.1103/PhysRevC.36.2132; HINDE DJ, 1982, NUCL PHYS A, V385, P109, DOI 10.1016/0375-9474(82)90492-4; Hinde DJ, 1996, PHYS REV C, V53, P1290, DOI 10.1103/PhysRevC.53.1290; LESTONE JP, 1993, NUCL PHYS A, V559, P277, DOI 10.1016/0375-9474(93)90192-Z; MOLLER P, 1977, NUCL PHYS A, V281, P354, DOI 10.1016/0375-9474(77)90031-8; MORTON CR, 1995, PHYS REV C, V52, P243, DOI 10.1103/PhysRevC.52.243; Oganessian YT, 1999, NATURE, V400, P242, DOI 10.1038/22281; Oganessian YT, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.011301; Prasad GVR, 1996, PHYS REV C, V54, P815, DOI 10.1103/PhysRevC.54.815; RAMAMURTHY VS, 1990, PHYS REV LETT, V65, P25, DOI 10.1103/PhysRevLett.65.25; ROWLEY N, 1993, PHYS LETT B, V314, P179, DOI 10.1016/0370-2693(93)90446-O; SAHM CC, 1985, NUCL PHYS A, V441, P316, DOI 10.1016/0375-9474(85)90036-3; TOKE J, 1985, NUCL PHYS A, V440, P327, DOI 10.1016/0375-9474(85)90344-6; VERGANI P, 1993, PHYS REV C, V48, P1815, DOI 10.1103/PhysRevC.48.1815	22	164	166	2	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					144	147		10.1038/35093069	http://dx.doi.org/10.1038/35093069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557975				2022-12-28	WOS:000170918800041
J	Hwang, UW; Friedrich, M; Tautz, D; Park, CJ; Kim, W				Hwang, UW; Friedrich, M; Tautz, D; Park, CJ; Kim, W			Mitochondrial protein phylogeny joins myriapods with chelicerates	NATURE			English	Article							ARTHROPOD PHYLOGENY; HOX GENES; SEQUENCE; EXPRESSION; EVOLUTION; POSITION; INSECTS; PATTERN; MODEL	The animal phylum Arthropoda is very useful for the study of body plan evolution given its abundance of morphologically diverse species and our profound understanding of Drosophila development(1). However, there is a lack of consistently resolved phylogenetic relationships between the four extant arthropod subphyla, Hexapoda, Myriapoda, Chelicerata and Crustacea. Recent molecular studies(2-4) have strongly supported a sister group relationship between Hexapoda and Crustacea, but have not resolved the phylogenetic position of Chelicerata and Myriapoda. Here we sequence the mitochondrial genome of the centipede species Lithobius forficatus and investigate its phylogenetic information content. Molecular phylogenetic analysis of conserved regions from the arthropod mitochondrial proteome yields highly resolved and congruent trees. We also rnd that a sister group relationship between Myriapoda and Chelicerata is strongly supported. We propose a model to explain the apparently parallel evolution of similar head morphologies in insects and myriapods.	Kyungpook Natl Univ, Dept Biol, Teachers Coll, Taegu 702701, South Korea; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; Univ Cologne, Abt Evolut Genet, Inst Genet, D-50931 Cologne, Germany	Kyungpook National University; Seoul National University (SNU); Wayne State University; University of Cologne	Friedrich, M (corresponding author), Kyungpook Natl Univ, Dept Biol, Teachers Coll, Taegu 702701, South Korea.	mf@biology.biosci.wayne.edu	Tautz, Diethard/D-4304-2011; Tautz, Diethard/H-8436-2014	Tautz, Diethard/0000-0002-0460-5344				Adachi J, 1996, J MOL EVOL, V42, P459; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Akam M, 2000, P NATL ACAD SCI USA, V97, P4438, DOI 10.1073/pnas.97.9.4438; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CISNE JL, 1974, SCIENCE, V186, P13, DOI 10.1126/science.186.4158.13; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; delle Cave L., 1991, P189; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Garcia-Machado E, 1999, J MOL EVOL, V49, P142, DOI 10.1007/PL00006527; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Hausdorf B, 2000, SYST BIOL, V49, P130, DOI 10.1080/10635150050207438; Kusche K, 2001, MOL BIOL EVOL, V18, P1566, DOI 10.1093/oxfordjournals.molbev.a003943; MUSE SV, 2000, HY PHY 0 7 BETA; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; SNODGRASS RE, 1938, SMITHSON MISC COLLEC, V138, P1; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366	30	212	220	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					154	157		10.1038/35093090	http://dx.doi.org/10.1038/35093090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557978				2022-12-28	WOS:000170918800044
J	Mirabel, IF; Dhawan, V; Mignani, RP; Rodrigues, I; Guglielmetti, F				Mirabel, IF; Dhawan, V; Mignani, RP; Rodrigues, I; Guglielmetti, F			A high-velocity black hole on a Galactic-halo orbit in the solar neighbourhood	NATURE			English	Article							X-RAY TRANSIENT; KINEMATICS	Only a few of the dozen or so known stellar-mass black holes have been observed away from the plane of the Galaxy(1). Those few could have been ejected from the plane as a result of a 'kick' received during a supernova explosion, or they could be remnants of the population of massive stars formed in the early stages of evolution of the Galaxy. Determining their orbital motion should help to distinguish between these options. Here we report the transverse motion (in the plane of the sky) for the black-hole X-ray nova XTE J1118+480 (refs 2-5), from which we derive a large space velocity. This X-ray binary system has an eccentric orbit around the Galactic Centre, like most objects in the halo of the Galaxy, such as ancient stars and globular clusters. The properties of the system suggest that its age is comparable to or greater than the age of the Galactic disk. Only an extraordinary 'kick' from a supernova could have launched the black hole into an orbit like this from a birthplace in the disk of the Galaxy.	CE Saclay, Serv Astrophys, CEA, F-91191 Gif Sur Yvette, France; Inst Astron & Fis Espacio, RA-1428 Buenos Aires, DF, Argentina; Natl Radio Astron Observ, Socorro, NM 87801 USA; European So Observ, DE-85740 Garching, Germany; Space Telescope Sci Inst, Baltimore, MD 21218 USA	CEA; UDICE-French Research Universities; Universite Paris Saclay; Instituto de Astronomia y Fisica del Espacio (IAFE); National Radio Astronomy Observatory (NRAO); European Southern Observatory; Space Telescope Science Institute	Mirabel, IF (corresponding author), CE Saclay, Serv Astrophys, CEA, F-91191 Gif Sur Yvette, France.	fmirabel@cea.fr	de Oliveira Filho, Irapuan Rodrigues/C-6834-2013	de Oliveira Filho, Irapuan Rodrigues/0000-0003-2141-9399; Mignani, Roberto/0000-0002-8685-583X				Chiba M, 2000, ASTRON J, V119, P2843, DOI 10.1086/301409; Dauphole B, 1996, ASTRON ASTROPHYS, V313, P119; DHAWAN V, 2000, 7395 IAU; Fender RP, 2001, MON NOT R ASTRON SOC, V322, pL23, DOI 10.1046/j.1365-8711.2001.04362.x; FRONTERA F, IN PRESS ASTROPHYS J; Fryer CL, 2001, ASTROPHYS J, V554, P548, DOI 10.1086/321359; Grenier IA, 2000, AIP CONF PROC, V515, P261; HASWELL CA, 2000, 7407 IAU; Hynes RI, 2000, ASTROPHYS J, V539, pL37, DOI 10.1086/312836; JOHNSON DRH, 1987, ASTRON J, V93, P864, DOI 10.1086/114370; Johnston KV, 1996, ASTROPHYS J, V465, P278, DOI 10.1086/177418; KULKARNI SR, 1993, NATURE, V364, P421, DOI 10.1038/364421a0; McClintock JE, 2001, ASTROPHYS J, V555, P477, DOI 10.1086/321449; McClintock JE, 2001, ASTROPHYS J, V551, pL147, DOI 10.1086/320030; MIHALAS D, 1981, GALACTIC ASTRONOMY, P382; Mirabel IF, 1998, NATURE, V392, P673, DOI 10.1038/33603; Nelemans G, 1999, ASTRON ASTROPHYS, V352, pL87; Oort J H, 1926, OBSERVATORY, V49, P302; POOLEY GG, 2000, 7390 IAU; REMILLARD R, 2000, 7389 IAU; Toscano M, 1999, MON NOT R ASTRON SOC, V307, P925, DOI 10.1046/j.1365-8711.1999.02685.x; Uemura M, 2000, PUBL ASTRON SOC JPN, V52, pL15, DOI 10.1093/pasj/52.4.L15; Wagner RM, 2001, ASTROPHYS J, V556, P42, DOI 10.1086/321572; White NE, 1996, ASTROPHYS J, V473, pL25, DOI 10.1086/310380; ZAHN JP, 1977, ASTRON ASTROPHYS, V57, P383	25	121	122	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					139	141		10.1038/35093060	http://dx.doi.org/10.1038/35093060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557973	Green Submitted			2022-12-28	WOS:000170918800039
J	Levinson, W; Cohen, MS; Brady, D; Duffy, FD				Levinson, W; Cohen, MS; Brady, D; Duffy, FD			To change or not to change: "Sounds like you have a dilemma"	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SMOKING-CESSATION		Univ Chicago, Med Ctr, Chicago, IL 60637 USA; Med Coll Georgia, Augusta, GA 30912 USA; Emory Univ, Sch Med, Atlanta, GA 30303 USA; Amer Board Internal Med, Philadelphia, PA 19106 USA	University of Chicago; University of Chicago Medical Center; University System of Georgia; Augusta University; Emory University; American Board of Internal Medicine	Levinson, W (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	wendy@medicine.bsd.uchicago.edu						Bandura A, 1986, SOCIAL FDN THOUGHTS; FIORE M, 1996, SMOKING CESSATION SM; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; Goldstein MG, 1997, ARCH INTERN MED, V157, P1313, DOI 10.1001/archinte.157.12.1313; GORDON GH, 1998, J CLIN OUTCOMES MANA, V5, P45; GUISE B, 2001, TXB PRIMARY CARE MED, P479; Hughes JR, 1999, JAMA-J AM MED ASSOC, V281, P72, DOI 10.1001/jama.281.1.72; Meichenbaum D., 1987, FACILITATION TREATME, DOI [10.1007/978-1-4684-5359-1, DOI 10.1007/978-1-4684-5359-1]; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; Mullen PD, 1997, PATIENT EDUC COUNS, V32, P157; OCKENE JK, 1987, PREV MED, V16, P723, DOI 10.1016/0091-7435(87)90054-5; OCONNELL D, 1997, BEHAV MED PRIMARY CA, P125; Prochaska J. O., 1986, TREATING ADDICTIVE B, P3, DOI DOI 10.1007/978-1-4613-2191-0_; Prochaska J. O., 1994, CHANGING GOOD; PROCHASKA JO, 1991, CLIN CHEST MED, V12, P727; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Smith RC, 1998, ANN INTERN MED, V128, P118, DOI 10.7326/0003-4819-128-2-199801150-00008; [No title captured]	18	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					386	391		10.7326/0003-4819-135-5-200109040-00027	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00027			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529714				2022-12-28	WOS:000170780600019
J	Murray, E; Davis, H; Tai, SS; Coulter, A; Gray, A; Haines, A				Murray, E; Davis, H; Tai, SS; Coulter, A; Gray, A; Haines, A			Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMATION; QUESTIONNAIRE	Objective To determine whether a decision aid on hormone replacement therapy influences decision making and health outcomes. Design Randomised controlled trial. Setting 26 general practices in the United Kingdom. Participants 205 women considering hormone replacement therapy. Intervention Patients' decision aid consisting of an interactive multimedia programme with booklet and printed summary. Outcome measures Patients' and general practitioners' perceptions of who made the decision, decisional conflict, treatment choice, menopausal symptoms, costs, anxiety, and general health status. Results Both patients and general practitioners found the decision aid acceptable. At three months, mean scores for decisional conflict were significantly lower in the intervention group than in the control group (2.5 v 2.8; mean difference - 0.3, 95% confidence interval - 0.5 to - 0.2); this difference was maintained during follow up. A higher proportion of general practitioners perceived that treatment decisions had been made "mainly or only" by the patient in the intervention group than mi the control group (55% v 31%; 24%, 8% to 40%). At three months a lower proportion of women in the intervention group than in the control group were undecided about treatment (14% v 26%; - 12%, - 23% to - 0.4%), and a higher proportion had decided against hormone replacement therapy (46% v 32%; 14%, 1% to 28%); these differences were no longer apparent by nine months. No differences were found between the groups for anxiety, use of health service resources, general health status, or utility. The higher costs of the intervention were largely due to the video disc technology used. Conclusions An interactive multimedia decision aid in the NHS would be popular with patients, reduce decisional conflict, and enable patients to play a more active part in decision making without increasing anxiety. The use of web based technology would reduce the cost of the intervention.	UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London N19 3UA, England; Picker Inst Europe, Oxford OX1 1RX, England; Univ Oxford, Hlth Econ Res Ctr, Oxford OX3 7LF, England	University of London; University College London; University of Oxford	Murray, E (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London N19 3UA, England.	elizabeth.murray@pcps.ucl.ac.uk	Coulter, Angela/N-6998-2019; Davis, Hilary/J-9356-2015	Coulter, Angela/0000-0002-6308-8375; Davis, Hilary/0000-0002-0271-9655; Murray, Elizabeth/0000-0002-8932-3695; Haines, Andy/0000-0002-8053-4605				BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Coulter A, 1999, BRIT MED J, V318, P318, DOI 10.1136/bmj.318.7179.318; Department of Health, 1999, SAV LIV OUR HLTH NAT; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; ENGLAND SL, 1992, SOC SCI MED, V34, P1217, DOI 10.1016/0277-9536(92)90314-G; Entwistle VA, 1998, INT J TECHNOL ASSESS, V14, P212, DOI 10.1017/S0266462300012204; *FDN INF MED DEC M, 1996, HORM REPL THER SHAR; Flood AB, 1996, J GEN INTERN MED, V11, P342, DOI 10.1007/BF02600045; FOX S, 1 PEW INT AM LIF; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; Hilditch JR, 1996, MATURITAS, V24, P161, DOI 10.1016/0378-5122(96)01038-9; Hilditch JR, 1996, MATURITAS, V25, P231; ISAACS AJ, 1995, BRIT MED J, V311, P1399, DOI 10.1136/bmj.311.7017.1399; Jones R, 1999, BRIT MED J, V319, P1241, DOI 10.1136/bmj.319.7219.1241; KAPLAN, 1989, MED CARE, V27, P679; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; LLEWELLYNTHOMAS HA, 1995, MED DECIS MAKING, V15, P101, DOI 10.1177/0272989X9501500201; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; Molenaar S, 2000, MED DECIS MAKING, V20, P112, DOI 10.1177/0272989X0002000114; Murray E, 2001, BMJ-BRIT MED J, V323, P493, DOI 10.1136/bmj.323.7311.493; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; OCONNOR AM, 1993, BRIT MED J, V319, P731; Townsend J, 1998, BRIT J GEN PRACT, V48, P955; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolf AMD, 1996, ARCH INTERN MED, V156, P1333, DOI 10.1001/archinte.156.12.1333	28	102	103	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					490	+		10.1136/bmj.323.7311.490	http://dx.doi.org/10.1136/bmj.323.7311.490			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469WF	11532844	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000170838500021
J	Sharara, AI; Rockey, DC				Sharara, AI; Rockey, DC			Medical progress - Gastroesophageal variceal hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTRAHEPATIC-PORTOSYSTEMIC SHUNT; BLEEDING ESOPHAGEAL-VARICES; PROSPECTIVE RANDOMIZED TRIAL; CONTROLLED CLINICAL-TRIAL; GASTROINTESTINAL-TRACT HEMORRHAGE; COST-EFFECTIVENESS ANALYSIS; DISTAL SPLENORENAL SHUNT; PORTAL-HYPERTENSION; ENDOSCOPIC SCLEROTHERAPY; CIRRHOTIC-PATIENTS		Duke Univ, Med Ctr, Duke Liver Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; Amer Univ Beirut, Med Ctr, Dept Med, Div Gastroenterol, Beirut, Lebanon	Duke University; Duke University; American University of Beirut	Rockey, DC (corresponding author), Duke Univ, Med Ctr, Duke Liver Ctr, Box 3083, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002124, R01DK057830] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK57830, DK 02124] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBILLOS A, 1995, GASTROENTEROLOGY, V109, P1257, DOI 10.1016/0016-5085(95)90586-3; Angelico M, 1997, GASTROENTEROLOGY, V113, P1632, DOI 10.1053/gast.1997.v113.pm9352866; AVGERINOS A, 1993, J HEPATOL, V19, P301, DOI 10.1016/S0168-8278(05)80586-0; BEPPU K, 1981, GASTROINTEST ENDOSC, V27, P213, DOI 10.1016/S0016-5107(81)73224-3; Bernard B, 1997, HEPATOLOGY, V25, P63, DOI 10.1053/jhep.1997.v25.pm0008985266; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; Bernard B, 1997, J HEPATOL, V26, P312, DOI 10.1016/S0168-8278(97)80047-5; BESSON I, 1995, NEW ENGL J MED, V333, P555, DOI 10.1056/NEJM199508313330904; BLAISE M, 1994, HEPATOLOGY, V20, P34, DOI 10.1016/0270-9139(94)90131-7; BLEI AT, 1986, HEPATOLOGY, V6, P107, DOI 10.1002/hep.1840060120; BOSCH J, 1989, HEPATOLOGY, V10, P962, DOI 10.1002/hep.1840100612; BOYER TD, 1977, GASTROENTEROLOGY, V72, P584; BURROUGHS AK, 1989, NEW ENGL J MED, V321, P857, DOI 10.1056/NEJM198909283211303; BURROUGHS AK, 1992, BAILLIERE CLIN GASTR, V6, P437, DOI 10.1016/0950-3528(92)90031-9; BURROUGHS AK, 1983, NEW ENGL J MED, V309, P1539, DOI 10.1056/NEJM198312223092502; CALES P, 1990, GASTROENTEROLOGY, V98, P156, DOI 10.1016/0016-5085(90)91305-P; Cales P, 2001, NEW ENGL J MED, V344, P23, DOI 10.1056/NEJM200101043440104; CELLO JP, 1987, NEW ENGL J MED, V316, P11, DOI 10.1056/NEJM198701013160103; Chalasani N, 1999, AM J GASTROENTEROL, V94, P3285; Chalasani N, 2000, GASTROENTEROLOGY, V118, P138, DOI 10.1016/S0016-5085(00)70422-7; CHUNG R, 1983, ARCH SURG-CHICAGO, V118, P482; Cipolletta L, 1998, GASTROINTEST ENDOSC, V47, P400, DOI 10.1016/S0016-5107(98)70227-5; CONN HO, 1975, GASTROENTEROLOGY, V68, P211; CONN HO, 1991, HEPATOLOGY, V13, P902, DOI 10.1002/hep.1840130517; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983; DEFRANCHIS R, 1992, GASTROENTEROL CLIN N, V21, P85; DELARBOL LR, 1991, J HEPATOL, V13, P179, DOI 10.1016/0168-8278(91)90812-P; Escorsell A, 2000, HEPATOLOGY, V32, P471, DOI 10.1053/jhep.2000.16601; Feu F, 1996, GASTROENTEROLOGY, V111, P1291, DOI 10.1053/gast.1996.v111.pm8898643; FEU F, 1995, LANCET, V346, P1056, DOI 10.1016/S0140-6736(95)91740-3; FORT E, 1990, HEPATOLOGY, V11, P678, DOI 10.1002/hep.1840110423; GARCIAPAGAN JC, 1994, HEPATOLOGY, V19, P1095, DOI 10.1002/hep.1840190506; GARCIAPAGAN JC, 1991, ANN INTERN MED, V114, P869, DOI 10.7326/0003-4819-114-10-869; GARCIATSAO G, 1986, HEPATOLOGY, V6, P101, DOI 10.1002/hep.1840060119; GARCIATSAO G, 1985, HEPATOLOGY, V5, P419, DOI 10.1002/hep.1840050313; GIMSON AES, 1986, HEPATOLOGY, V6, P410, DOI 10.1002/hep.1840060314; GORES GJ, 1989, GASTROENTEROLOGY, V96, P1552, DOI 10.1016/0016-5085(89)90526-X; Gournay J, 2000, HEPATOLOGY, V31, P1239, DOI 10.1053/jhep.2000.8106; GRAHAM DY, 1981, GASTROENTEROLOGY, V80, P800; Gralnek IM, 1999, HEPATOLOGY, V29, P44, DOI 10.1002/hep.510290141; GREGORY PB, 1991, NEW ENGL J MED, V324, P1779; GROSZMANN RJ, 1990, GASTROENTEROLOGY, V99, P1401, DOI 10.1016/0016-5085(90)91168-6; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; HASKAL ZJ, 1994, AM J ROENTGENOL, V163, P439, DOI 10.2214/ajr.163.2.8037046; HENDERSON JM, 1994, WORLD J SURG, V18, P205, DOI 10.1007/BF00294402; HILLON P, 1982, HEPATOLOGY, V2, P528; Huang YH, 2000, GASTROINTEST ENDOSC, V52, P160, DOI 10.1067/mge.2000.104976; Jabbour N, 1996, Liver Transpl Surg, V2, P139, DOI 10.1002/lt.500020210; JALAN R, 1995, AM J GASTROENTEROL, V90, P1932; Jalan R, 1997, HEPATOLOGY, V26, P1115; JALAN R, 1995, J HEPATOL, V23, P123, DOI 10.1016/0168-8278(95)80325-4; Jenkins SA, 1997, GUT, V41, P526, DOI 10.1136/gut.41.4.526; KORANSKY JR, 1978, AM J SURG, V136, P339, DOI 10.1016/0002-9610(78)90290-8; LABERGE JM, 1995, GASTROENTEROLOGY, V108, P1143, DOI 10.1016/0016-5085(95)90213-9; LAINE L, 1991, WESTERN J MED, V155, P274; LAINE L, 1993, ANN INTERN MED, V119, P1, DOI 10.7326/0003-4819-119-1-199307010-00001; Laine L, 1996, GASTROENTEROLOGY, V110, P529, DOI 10.1053/gast.1996.v110.pm8566601; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; LEBREC D, 1984, HEPATOLOGY, V4, P355, DOI 10.1002/hep.1840040301; LEBREC D, 1982, HEPATOLOGY, V2, P523; LEBREC D, 1988, J HEPATOL, V7, P118, DOI 10.1016/S0168-8278(88)80515-4; LEBREC D, 1980, GASTROENTEROLOGY, V79, P1139; LEVACHER S, 1995, LANCET, V346, P865, DOI 10.1016/S0140-6736(95)92708-5; Lo GH, 2000, HEPATOLOGY, V32, P461, DOI 10.1053/jhep.2000.16236; LO GH, 1995, HEPATOLOGY, V22, P466, DOI 10.1016/0270-9139(95)90567-7; LO GH, 1992, GASTROINTEST ENDOSC, V38, P421, DOI 10.1016/S0016-5107(92)70469-6; LO GH, 1997, HEPATOLOGY, V25, P1104; MCCORMICK PA, 1995, SCAND J GASTROENTERO, V30, P377, DOI 10.3109/00365529509093294; Meddi P, 1999, HEPATOLOGY, V29, P1074, DOI 10.1002/hep.510290411; Merkel C, 2000, HEPATOLOGY, V32, P930, DOI 10.1053/jhep.2000.19322; Merkel C, 2000, HEPATOLOGY, V31, P324, DOI 10.1002/hep.510310210; Moitinho E, 1999, GASTROENTEROLOGY, V117, P626, DOI 10.1016/S0016-5085(99)70455-5; Nevens F, 1999, DIGESTION, V60, P35, DOI 10.1159/000051487; ORLOFF MJ, 1994, HEPATOLOGY, V20, P863, DOI 10.1002/hep.1840200414; Owens CA, 1998, GASTROENTEROLOGY, V114, P975, DOI 10.1016/S0016-5085(98)70317-8; PAGLIARO L, 1992, ANN INTERN MED, V117, P59, DOI 10.7326/0003-4819-117-1-59; PASCAL JP, 1987, NEW ENGL J MED, V317, P856, DOI 10.1056/NEJM198710013171403; PASCAL JP, 1988, NEW ENGL J MED, V318, P994; POLIO J, 1986, SEMIN LIVER DIS, V6, P318, DOI 10.1055/s-2008-1040614; POYNARD T, 1991, NEW ENGL J MED, V324, P1532, DOI 10.1056/NEJM199105303242202; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rockey DC, 2000, GASTROENTEROLOGY, V118, P1261, DOI 10.1016/S0016-5085(00)70379-9; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Rockey DC, 1998, GASTROENTEROLOGY, V114, P344, DOI 10.1016/S0016-5085(98)70487-1; Rossle M, 1996, DIGEST DIS, V14, P12, DOI 10.1159/000171579; Rossle M, 1997, LANCET, V349, P1043, DOI 10.1016/S0140-6736(96)08189-5; Russo MW, 2000, HEPATOLOGY, V31, P358, DOI 10.1002/hep.510310215; Saeed ZA, 1997, HEPATOLOGY, V25, P71, DOI 10.1053/jhep.1997.v25.pm0008985267; SALMERON JM, 1993, HEPATOLOGY, V17, P800, DOI 10.1016/0270-9139(93)90155-G; SANYAL AJ, 1994, HEPATOLOGY, V20, P46, DOI 10.1002/hep.1840200109; Sanyal AJ, 1996, GASTROENTEROLOGY, V111, P138, DOI 10.1053/gast.1996.v111.pm8698192; Sanyal AJ, 1997, ANN INTERN MED, V126, P849, DOI 10.7326/0003-4819-126-11-199706010-00001; Sarin SK, 1999, NEW ENGL J MED, V340, P988, DOI 10.1056/NEJM199904013401302; Schepis F, 2001, HEPATOLOGY, V33, P333, DOI 10.1053/jhep.2001.21410; SMITH JL, 1982, GASTROENTEROLOGY, V82, P968; SORENSEN TIA, 1984, NEW ENGL J MED, V311, P1594; SPINA GP, 1992, J HEPATOL, V16, P338, DOI 10.1016/S0168-8278(05)80666-X; STIEGMANN GV, 1992, NEW ENGL J MED, V326, P1527, DOI 10.1056/NEJM199206043262304; Sung JJY, 1995, LANCET, V346, P1666, DOI 10.1016/S0140-6736(95)92840-5; SUNG JJY, 1993, LANCET, V342, P637, DOI 10.1016/0140-6736(93)91758-E; Teran JC, 1997, GASTROENTEROLOGY, V112, P473, DOI 10.1053/gast.1997.v112.pm9024301; TERES J, 1993, GASTROENTEROLOGY, V105, P1508, DOI 10.1016/0016-5085(93)90158-9; VIALLET A, 1975, GASTROENTEROLOGY, V69, P1297; Villanueva C, 1996, NEW ENGL J MED, V334, P1624, DOI 10.1056/NEJM199606203342502; Villanueva C, 2001, NEW ENGL J MED, V345, P647, DOI 10.1056/NEJMoa003223; VILLENEUVE JP, 1986, HEPATOLOGY, V6, P1239, DOI 10.1002/hep.1840060602; VINEL JP, 1986, HEPATOLOGY, V6, P116, DOI 10.1002/hep.1840060122; VINEL JP, 1992, GASTROENTEROLOGY, V102, P1760, DOI 10.1016/0016-5085(92)91740-U; VINEL JP, 1992, GASTROENTEROLOGY, V103, P359; Vorobioff J, 1996, GASTROENTEROLOGY, V111, P701, DOI 10.1053/gast.1996.v111.pm8780575; WESTABY D, 1989, HEPATOLOGY, V9, P274, DOI 10.1002/hep.1840090219	112	225	243	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					669	681		10.1056/NEJMra003007	http://dx.doi.org/10.1056/NEJMra003007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466XG	11547722				2022-12-28	WOS:000170671000007
J	CANFIELD, DE; THAMDRUP, B				CANFIELD, DE; THAMDRUP, B			THE PRODUCTION OF S-34-DEPLETED SULFIDE DURING BACTERIAL DISPROPORTIONATION OF ELEMENTAL SULFUR	SCIENCE			English	Article							SULFATE REDUCTION RATES; MARINE-SEDIMENTS; BLACK-SEA; MANGANESE REDUCTION; COASTAL SEDIMENTS; ORGANIC-MATTER; IRON; ISOTOPE; OXIDATION; KINETICS	Bacteria that disproportionate elemental sulfur fractionate sulfur isotopes such that sulfate is enriched in sulfur-34 by 12.6 to 15.3 per mil and sulfide is depleted in sulfur-34 by 7.3 to 8.6 per mil. Through a repeated cycle of sulfide oxidation to S-0 and subsequent disproportionation, these bacteria can deplete sedimentary sulfides in sulfur-34. A prediction, borne out by observation, is that more extensive sulfide oxidation will lead to sulfides that are more depleted in sulfur-34. Thus, the oxidative part of the sulfur cycle creates circumstances by which sulfides become more depleted in sulfur-34 than would be possible with sulfate-reducing bacteria alone.	GEORGIA INST TECHNOL,SCH EARTH & ATMOSPHER SCI,ATLANTA,GA 30332	University System of Georgia; Georgia Institute of Technology	CANFIELD, DE (corresponding author), MAX PLANCK INST MARINE MICROBIOL,FAHRENHEITSTR 1,D-28359 BREMEN,GERMANY.		Thamdrup, Bo/F-3889-2016; Canfield, Don/C-1735-2012	Thamdrup, Bo/0000-0002-1221-7077; Canfield, Don/0000-0001-7602-8366				BEMER RA, 1964, MAR GEOL, V1, P117; BEMER RA, 1985, AM J SCI, V285, P193; BURDIGE DJ, 1986, GEOMICROBIOL J, V4, P361, DOI 10.1080/01490458609385944; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; CANFIELD DE, 1992, AM J SCI, V292, P659, DOI 10.2475/ajs.292.9.659; CANFIELD DE, UNPUB; CHAMBERS LA, 1975, CAN J MICROBIOL, V21, P1602, DOI 10.1139/m75-234; CHAMBERS LA, 1982, GEOCHIM COSMOCHIM AC, V46, P721, DOI 10.1016/0016-7037(82)90023-0; CHANTON JP, 1985, THESIS U N CAROLINA; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; FRY B, 1991, DEEP-SEA RES, V38, pS1003, DOI 10.1016/S0198-0149(10)80021-4; GOLDHABER MB, 1975, SOIL SCI, V119, P42, DOI 10.1097/00010694-197501000-00008; GOLDHABER MB, 1974, SEA, P569; HARRISON A, 1958, T FARADAY SOC, V53, P84; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; LUTHER GW, 1991, DEEP-SEA RES, V38, pS1121, DOI 10.1016/S0198-0149(10)80027-5; MURAMOTO JA, 1991, DEEP-SEA RES, V38, pS1151, DOI 10.1016/S0198-0149(10)80029-9; Ohmoto H., 1992, STABLE ISOT STABLE I, V23, P70; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2; UYAMA F, 1985, GEOCHEM J, V19, P301, DOI 10.2343/geochemj.19.301; WESTRICH J, UNPUB; Westrich J.T., 1983, THESIS YALE U, pYale	31	461	488	5	103	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 23	1994	266	5193					1973	1975		10.1126/science.11540246	http://dx.doi.org/10.1126/science.11540246			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ267	11540246				2022-12-28	WOS:A1994PZ26700024
J	HARTGERS, WA; DAMSTE, JSS; REQUEJO, AG; ALLAN, J; HAYES, JM; DELEEUW, JW				HARTGERS, WA; DAMSTE, JSS; REQUEJO, AG; ALLAN, J; HAYES, JM; DELEEUW, JW			EVIDENCE FOR ONLY MINOR CONTRIBUTIONS FROM BACTERIA SEDIMENTARY ORGANIC-CARBON	NATURE			English	Article							BASIN; PHOTOSYNTHESIS; DISTRIBUTIONS; HYDROCARBONS; ORIGINS; SULFUR; SHALE	BECAUSE their molecular signatures are often prominent in extracts of sediments, bacteria are thought to be important contributors to petroleum source beds(1). It has been shown recently(2,3), however, that abundances of biomarkers do not always reflect relative contributions to sedimentary organic carbon (C-org). The contribution of photosynthetic green sulphur bacteria to sediments can be assessed effectively because the diagenetic products of distinctive carotenoids from these organisms occur widely(4-11) and their biomass is isotopically labelled, being enriched in C-13 (refs 11, 13). We show here that, although sediments and oils from the Western Canada and Williston basins contain prominent biomarkers of photosynthetic bacteria, the absence of C-13 enrichment in the total C-org requires that the bacterial contribution is in fact minimal. Although the importance of bacterial reworking of sedimentary debris cannot be doubted(14), we argue that our findings, when considered in conjunction with those from other settings, suggest that bacterial biomass may commonly represent only a minor component of total C-org in carbonaceous rocks.	TEXAS A&M UNIV,GEOCHEM & ENVIRONV RES GRP,COLLEGE STN,TX 77845; ESSO RESOURCES CANADA LTD,CALGARY T2P 0H6,AB,CANADA; INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405	Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	HARTGERS, WA (corresponding author), NETHERLANDS INST SEA RES,DIV MARINE BIOGEOCHEM,POB 59,1790 AB DEN BURG,NETHERLANDS.		de Leeuw, Jan W/F-6471-2011; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854				ALLAN J, 1991, B CAN PETROL GEOL, V39, P107; COLLISTER JW, 1992, ORG GEOCHEM, V19, P265, DOI 10.1016/0146-6380(92)90042-V; DAMSTE JSS, 1993, NATURE, V362, P827, DOI 10.1038/362827a0; DAMSTE JSS, 1993, GEOCHIM COSMOCHIM AC, V57, P389; DERENNE S, 1991, ORGANIC GEOCHEMISTRY, P408; DOUGLAS AG, 1991, GEOCHIM COSMOCHIM AC, V55, P275, DOI 10.1016/0016-7037(91)90417-4; EDLINGTON TI, IN PRESS ORG GEOCHEM; EGLINTON TI, 1991, ORGANIC GEOCHEMISTRY, P411; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; HARTGERS WA, 1991, ORGANIC GEOCHEMISTRY, P420; HARTGERS WA, 1993, J CHEM SOC CHEM COMM, V23, P1715; HAYES JM, 1987, NATURE, V329, P48, DOI 10.1038/329048a0; KOHNEN MEL, 1992, SCIENCE, V256, P358, DOI 10.1126/science.256.5055.358; KOHNEN MEL, 1991, NATURE, V349, P775, DOI 10.1038/349775a0; Liaaen-Jensen S., 1978, PHOTOSYNTHETIC BACTE, P233; Ostroukhov S. B., 1982, PETROL CHEM-USSR+, V22, P723; OURLSSON G, 1984, SCI AM, V251, P34; PARKES RJ, 1993, MAR GEOL, V113, P55, DOI 10.1016/0025-3227(93)90149-P; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; REPETA DJ, 1989, NATURE, V342, P69, DOI 10.1038/342069a0; REPETA DJ, 1993, GEOCHIM COSMOCHIM AC, V57, P4337, DOI 10.1016/0016-7037(93)90334-S; REQUEJO AG, 1992, ORG GEOCHEM, V19, P245, DOI 10.1016/0146-6380(92)90041-U; Schaefle J., 1977, TETRAHEDRON LETT, V18, P3673, DOI [DOI 10.1016/S0040-4039(01)83324-4, 10.1016/S0040-4039(01)83324-4]; SCHOELL M, 1994, SCIENCE, V263, P1122, DOI 10.1126/science.263.5150.1122; SCHWARK L, 1990, ORG GEOCHEM, V16, P749, DOI 10.1016/0146-6380(90)90114-F; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; XINKE Y, 1990, ORG GEOCHEM, V15, P433, DOI 10.1016/0146-6380(90)90170-5; [No title captured]	30	70	75	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					224	227		10.1038/369224a0	http://dx.doi.org/10.1038/369224a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	11539490				2022-12-28	WOS:A1994NM06700053
J	CANFIELD, DE; DESMARAIS, DJ				CANFIELD, DE; DESMARAIS, DJ			AEROBIC SULFATE REDUCTION IN MICROBIAL MATS	SCIENCE			English	Article							COASTAL MARINE-SEDIMENTS; CYANOBACTERIAL MATS; OXYGEN MICROPROFILE; REDUCING BACTERIA; ORGANIC-MATTER; SULFUR; PHOTOSYNTHESIS; SULFIDE	Measurements of bacterial sulfate reduction and dissolved oxygen (O2) in hypersaline bacterial mats from Baja California, Mexico, revealed that sulfate reduction occurred consistently within the well-oxygenated photosynthetic zone of the mats. This evidence that dissimilatory sulfate reduction can occur in the presence of O2 challenges the conventional view that sulfate reduction is a strictly anaerobic process. At constant temperature, the rates of sulfate reduction in oxygenated mats during daytime were similar to rates in anoxic mats at night: thus, during a 24-hour cycle, variations in light and O2 have little effect on rates of sulfate reduction in these mats.			CANFIELD, DE (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.		Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				BERNER RA, 1980, EARLY DIAGENESIS; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; CANFIELD DE, UNPUB; Cohen Y., 1984, EOS, V65, P905; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; CYPIONKA H, 1985, FEMS MICROBIOL ECOL, V31, P39, DOI 10.1016/0378-1097(85)90045-X; Dijk C. v., 1983, FEBS LETT, V156, P340; DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873; HARGRAVE B, COMMUNICATION; HASTINGS D, 1988, LIMNOL OCEANOGR, V33, P391, DOI 10.4319/lo.1988.33.3.0391; JORGENSEN BB, 1977, MAR BIOL, V41, P7, DOI 10.1007/BF00390576; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1987, APPL ENVIRON MICROB, V53, P879, DOI 10.1128/AEM.53.4.879-886.1987; JORGENSEN BB, 1986, FEMS MICROBIOL ECOL, V38, P179, DOI 10.1016/0378-1097(86)90049-2; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1989, OPHELIA, V31, P29, DOI 10.1080/00785326.1989.10430849; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P814; JORGENSEN BB, 1988, LIMNOL OCEANOGR, V33, P99, DOI 10.4319/lo.1988.33.1.0099; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Lovely D.R., 1987, APPL ENVIRON MICROB, V53, P2636; MARAIS DJD, 1990, TRENDS ECOL EVOL, V5, P140, DOI 10.1016/0169-5347(90)90219-4; MARAIS DJD, 1989, MICROBIAL MATS PHYSL, pCH17; OREMLAND RS, 1988, ADV MICROB ECOL, V10, P285; Peck H. D. Jr., 1988, The Nitrogen and Sulphur Cycles. Proceedings of the 42nd Symposium of the Society for General Microbiology. Southampton, UK, January 1988., P99; Postgate J.R, 1979, SULPHATE REDUCING BA; REVSBECH NP, 1981, LIMNOL OCEANOGR, V26, P717, DOI 10.4319/lo.1981.26.4.0717; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; REVSBECH NP, 1980, LIMNOL OCEANOGR, V25, P403, DOI 10.4319/lo.1980.25.3.0403; REVSBECH NP, 1989, MICROBIAL MATS PHYSL, pCH13; SKYRING GW, 1983, AUST J MAR FRESH RES, V34, P359; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; Zhabina N.N., 1978, ENV BIOGEOCHEMISTRY, P735	36	310	315	5	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 22	1991	251	5000					1471	1473		10.1126/science.11538266	http://dx.doi.org/10.1126/science.11538266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC853	11538266				2022-12-28	WOS:A1991FC85300043
J	MELOSH, HJ; VICKERY, AM				MELOSH, HJ; VICKERY, AM			IMPACT EROSION OF THE PRIMORDIAL ATMOSPHERE OF MARS	NATURE			English	Article											MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.							Ahrens T.J., 1987, INT J IMPACT ENG, V5, P13; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; CAMERON AGW, 1983, ICARUS, V56, P195, DOI 10.1016/0019-1035(83)90032-5; CESS RD, 1980, ICARUS, V41, P159, DOI 10.1016/0019-1035(80)90169-4; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; HARTMANN WK, 1977, ICARUS, V31, P260, DOI 10.1016/0019-1035(77)90037-9; Melosh H.L, 1989, IMPACT CRATERING GEO; MELOSH HJ, 1988, EOS, V69, P388; NEUKUM G, 1976, SCIENCE, V194, P1381, DOI 10.1126/science.194.4272.1381; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; STROM RG, 1984, NASA SP469; WALKER JGC, 1987, ICARUS, V68, P87; WATKINS GH, 1983, THESIS MIT; 1981, BASALTIC VOLCANISM T	14	312	312	0	30	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 6	1989	338	6215					487	489		10.1038/338487a0	http://dx.doi.org/10.1038/338487a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	U0084	11536608				2022-12-28	WOS:A1989U008400048
J	BUTTERFIELD, NJ; KNOLL, AH; SWETT, K				BUTTERFIELD, NJ; KNOLL, AH; SWETT, K			EXCEPTIONAL PRESERVATION OF FOSSILS IN AN UPPER PROTEROZOIC SHALE	NATURE			English	Article									UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242	University of Iowa	BUTTERFIELD, NJ (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.			Butterfield, Nicholas/0000-0002-3046-7520				AWRAMIK SM, NATURE, V315, P655; CHRISTIEBLICK N, 1988, GEOLOGY, V16, P100, DOI 10.1130/0091-7613(1988)016<0100:SSIPS>2.3.CO;2; HORODYSKI RJ, 1978, SCIENCE, V199, P682, DOI 10.1126/science.199.4329.682; Jankauskas T.V, 1982, STRATOTYPE RIPHEAN P, P84; KIRSCHVINK JL, 1978, GEOL MAG, V115, P139, DOI 10.1017/S0016756800041200; KNOLL AH, 1985, PHILOS T R SOC B, V311, P111, DOI 10.1098/rstb.1985.0143; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; LANIER WP, 1988, J SEDIMENT PETROL, V58, P89; MAGARITZ M, 1986, NATURE, V320, P258, DOI 10.1038/320258a0; RAABEN ME, 1972, T GEOL I AKAD NAUK S, V217, P1; Round F.E., 1981, ECOLOGY ALGAE; SOUTHGATE PN, 1986, GEOLOGY, V14, P683, DOI 10.1130/0091-7613(1986)14<683:DEAMOP>2.0.CO;2; VEIZER J, 1983, GEOCHIM COSMOCHIM AC, V47, P295, DOI 10.1016/0016-7037(83)90142-4; VIDAL G, 1983, GEOL SOC AM MEM, V161, P265; Wilson C.B., 1961, GEOL MAG, V98, P89; YIN L, 1984, PALAEONT CATHAYANA, V2, P229	16	71	72	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 4	1988	334	6181					424	427		10.1038/334424a0	http://dx.doi.org/10.1038/334424a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5292	11542151				2022-12-28	WOS:A1988P529200055
J	Koepp, DM; Schaefer, LK; Ye, X; Keyomarsi, K; Chu, C; Harper, JW; Elledge, SJ				Koepp, DM; Schaefer, LK; Ye, X; Keyomarsi, K; Chu, C; Harper, JW; Elledge, SJ			Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase	SCIENCE			English	Article							F-BOX PROTEINS; CELL-CYCLE; FAMILY; PROTEOLYSIS; DEGRADATION; REGULATORS; SKP2; G(1)	Cyclin E binds and activates the cyclin-dependent kinase Cdk2 and catalyzes the transition from the G(1) phase to the S phase of the cell cycle. The amount of cyclin E protein present in the cell is tightly controlled by ubiquitin-mediated proteolysis. Here we identify the ubiquitin ligase responsible for cyclin E ubiquitination as SCFFbw7 and demonstrate that it is functionally conserved in yeast, flies, and mammals. Fbw7 associates specifically with phosphorylated cyclin E, and SCF Fbw7 catalyzes cyclin E ubiquitination in vitro. Depletion of Fbw7 leads to accumulation and stabilization of cyclin E in vivo in human and Drosophila melanogaster cells. Multiple F-box proteins contribute to cyclin E stability in yeast, suggesting an overlap in SCF E3 ligase specificity that allows combinatorial control of cyclin E degradation.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Elledge, SJ (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.		Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849; Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; KOEPP D, UNPUB; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu GY, 1998, P NATL ACAD SCI USA, V95, P15787, DOI 10.1073/pnas.95.26.15787	26	641	657	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					173	177		10.1126/science.1065203	http://dx.doi.org/10.1126/science.1065203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11533444				2022-12-28	WOS:000171448800055
J	Ogata, H; Audic, S; Renesto-Audiffren, P; Fournier, PE; Barbe, V; Samson, D; Roux, V; Cossart, P; Weissenbach, J; Claverie, JM; Raoult, D				Ogata, H; Audic, S; Renesto-Audiffren, P; Fournier, PE; Barbe, V; Samson, D; Roux, V; Cossart, P; Weissenbach, J; Claverie, JM; Raoult, D			Mechanisms of evolution in Rickettsia conorii and R. prowazekii	SCIENCE			English	Article							SPOTTED-FEVER; SEQUENCE; DNA; DATABASE; IDENTIFICATION; GENES	Rickettsia conorii is an obligate intracellular bacterium that causes Mediterranean spotted fever in humans. We determined the 1,268,755-nucleotide complete genome sequence of R. conorii, containing 1374 open reading frames. This genome exhibits 804 of the 834 genes of the previously determined R. prowazekii genome plus 552 supplementary open reading frames and a 10-fold increase in the number of repetitive elements. Despite these differences, the two genomes exhibit a nearly perfect colinearity that allowed the clear identification of different stages of gene alterations with gene remnants and 37 genes split in 105 fragments, of which 59 are transcribed. A 38-kilobase sequence inversion was dated shortly after the divergence of the genus.	AVENTIS, CNRS, UMR 1889, F-13402 Marseille 20, France; Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UMR 6020, F-13385 Marseille 05, France; Inst Pasteur, Unite Interact Bacteries Cellules, F-75724 Paris 15, France; CNRS, UMR 8030, F-91000 Evry, France; Genoscope, F-91000 Evry, France	Centre National de la Recherche Scientifique (CNRS); Sanofi-Aventis; Sanofi France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Claverie, JM (corresponding author), AVENTIS, CNRS, UMR 1889, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	Jean-Michel.Claverie@igs.cnrs-mrs.fr; Didier.Raoult@medecine.univ-mrs.fr	Fournier, Pierre-Edouard/AAC-6155-2021; Renesto, patricia/M-6105-2014; renesto, patricia/T-6446-2019; RAOULT, Didier/A-8434-2008; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019	Fournier, Pierre-Edouard/0000-0001-8463-8885; renesto, patricia/0000-0002-6749-7862; RAOULT, Didier/0000-0002-0633-5974; Claverie, Jean-Michel/0000-0003-1424-0315; Audic, Stephane/0000-0001-6193-4374				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audic S, 1998, P NATL ACAD SCI USA, V95, P10026, DOI 10.1073/pnas.95.17.10026; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Chakraburtty R, 1997, J BACTERIOL, V179, P5854, DOI 10.1128/jb.179.18.5854-5861.1997; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; COSSART P, 1995, CURR OPIN CELL BIOL, V7, P94, DOI 10.1016/0955-0674(95)80050-6; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Harris BZ, 1998, GENE DEV, V12, P1022, DOI 10.1101/gad.12.7.1022; HAYES SF, 1982, INFECT IMMUN, V37, P779, DOI 10.1128/IAI.37.2.779-785.1982; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Leisinger T, 1996, ESCHERICHIA COLI SAL, P434441; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ogata H, 2000, NUCLEIC ACIDS RES, V28, P4021, DOI 10.1093/nar/28.20.4021; Ogata H, 2001, SCIENCE, V291, P252; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Raoult D, 2001, EMERG INFECT DIS, V7, P73, DOI 10.3201/eid0701.010112; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; ROUX V, 1993, J BACTERIOL, V175, P4895, DOI 10.1128/JB.175.15.4895-4904.1993; Roux V, 1999, RICKETTSIAE RICKETTS, P52; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Sharp PM, 1996, MOL MICROBIOL, V22, P1055, DOI 10.1046/j.1365-2958.1996.01546.x; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; YAGUPSKY P, 1993, CLIN INFECT DIS, V17, P850, DOI 10.1093/clinids/17.5.850	40	341	852	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2093	2098		10.1126/science.1061471	http://dx.doi.org/10.1126/science.1061471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557893				2022-12-28	WOS:000171028700075
J	Vaughan, DG; Marshall, GJ; Connolley, WM; King, JC; Mulvaney, R				Vaughan, DG; Marshall, GJ; Connolley, WM; King, JC; Mulvaney, R			Climate change - Devil in the detail	SCIENCE			English	Editorial Material							SEA-ICE-EXTENT; ANTARCTIC PENINSULA; TEMPERATURE; INCREASES; SHELF; OCEAN		British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Vaughan, DG (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	d.vaughan@bas.ac.uk	Mulvaney, Robert/K-3929-2012; Vaughan, David/C-8348-2011	Mulvaney, Robert/0000-0002-5372-8148; Vaughan, David/0000-0002-9065-0570				Cai WJ, 1999, J CLIMATE, V12, P132, DOI 10.1175/1520-0442(1999)012<3087:SMTHLV>2.0.CO;2; Connolley WM, 1998, ANN GLACIOL, V27, P565; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Domack E. A., 2001, EOS, V82, P13, DOI [DOI 10.1029/01EO00009, DOI 10.1029/01E000009]; DOMACK EW, 1995, ANTARCT SCI, V7, P159, DOI 10.1017/S0954102095000228; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Fox AJ, 1998, ANN GLACIOL, V27, P636; FRASER WR, 1992, POLAR BIOL, V11, P525; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hofmann E., 1996, FDN ECOLOGICAL RES W, V70, P61, DOI DOI 10.1029/AR070P0061; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jacka TH, 1998, ANN GLACIOL, V27, P553; KING JC, 1994, INT J CLIMATOL, V14, P357, DOI 10.1002/joc.3370140402; King JC, 1998, ANN GLACIOL, V27, P571; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; PARKINSON C, IN PRESS ANN GLACIOL; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; SHUMAN CA, 1993, GEOPHYS RES LETT, V20, P2643, DOI 10.1029/93GL02810; Smith AM, 1998, ANN GLACIOL, V27, P113; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; WEATHERLY JW, 1991, J GEOPHYS RES-OCEANS, V96, P15119, DOI 10.1029/91JC01432	22	224	232	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1777	1779		10.1126/science.1065116	http://dx.doi.org/10.1126/science.1065116			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546858				2022-12-28	WOS:000170894400031
J	Bessereau, JL; Wright, A; Williams, DC; Schuske, K; Davis, MW; Jorgensen, EM				Bessereau, JL; Wright, A; Williams, DC; Schuske, K; Davis, MW; Jorgensen, EM			Mobilization of a Drosophila transposon in the Caenorhabditis elegans germ line	NATURE			English	Article							C-ELEGANS; MARINER; EXPRESSION; ELEMENT; GENE; SEQUENCE; ENCODES; MOS1; TC3	Transposons have been enormously useful for genetic analysis in both Drosophila and bacteria. Mutagenic insertions constitute molecular tags that are used to rapidly clone the mutated gene. Such techniques would be especially advantageous in the nematode Caenorhabditis elegans, as the entire sequence of the genome has been determined. Several different types of endogenous transposons are present in C. elegans, and these can be mobilized in mutator strains (reviewed in ref. 1). Unfortunately, use of these native transposons for regulated transposition in C. elegans is limited. First, all strains contain multiple copies of these transposons and thus new insertions do not provide unique tags. Second, mutator strains tend to activate the transposition of several classes of transposons, so that the type of transposon associated with a particular mutation is not known. Here we demonstrate that the Drosophila mariner element Mos1 can be mobilized in C. elegans. First, efficient mobilization of Mos1 is possible in somatic cells. Second, heritable insertions of the transposon can be generated in the germ line. Third, genes that have been mutated by insertion can be rapidly identified using inverse polymerase chain reaction. Fourth, these insertions can subsequently be remobilized to generate deletion and frameshift mutations by imperfect excision.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu	Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621; Davis, Mikel/0000-0003-1867-1593				BRYAN G, 1990, GENETICS, V125, P103; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANDIDO EPM, 1989, GENOME, V31, P690, DOI 10.1139/g89-126; CLARK SG, 1994, GENETICS, V137, P987; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hart DL, 1997, ANNU REV GENET, V31, P337, DOI 10.1146/annurev.genet.31.1.337; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; Kelly WG, 1997, GENETICS, V146, P227; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lohe AR, 2000, GENETICS, V154, P647; MEDHORA M, 1991, GENETICS, V128, P311; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Plasterk Ronald H.A., 1997, Cold Spring Harbor Monograph Series, V33, P97; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; SEDENSKY MM, 1994, NUCLEIC ACIDS RES, V22, P1719, DOI 10.1093/nar/22.9.1719; SULSTON JE, 1974, GENETICS, V77, P95; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; VANLUENEN HGAM, 1994, CELL, V79, P293, DOI 10.1016/0092-8674(94)90198-8; VANLUENEN HGAM, 1993, EMBO J, V12, P2513, DOI 10.1002/j.1460-2075.1993.tb05906.x; Waterston Robert H., 1997, Cold Spring Harbor Monograph Series, V33, P23; WILLIAMS BD, 1992, GENETICS, V131, P609	24	106	114	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					70	74		10.1038/35092567	http://dx.doi.org/10.1038/35092567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544527				2022-12-28	WOS:000170801200040
J	Kazatchkine, MD; Kaveri, SV				Kazatchkine, MD; Kaveri, SV			Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GUILLAIN-BARRE-SYNDROME; POOLED HUMAN-IGG; IDIOPATHIC THROMBOCYTOPENIC PURPURA; GAMMA-GLOBULIN; MULTIPLE-SCLEROSIS; THERAPEUTIC USE; IMMUNOGLOBULIN TREATMENT; NATURAL AUTOANTIBODIES; SYSTEMIC VASCULITIS; PLASMA-EXCHANGE		Hop Broussais, INSERM, U430, F-75014 Paris, France; Hop Europeen Georges Pompidou, Dept Clin Immunol, Paris, France; Univ Paris 06, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Kazatchkine, MD (corresponding author), Hop Broussais, INSERM, U430, 96 Rue Didot, F-75014 Paris, France.	michel.kazatchkine@egp.ap-hop-paris.fr						Abedi MR, 1996, CLIN EXP IMMUNOL, V105, P266, DOI 10.1046/j.1365-2249.1996.d01-767.x; Achiron A, 1998, NEUROLOGY, V50, P398, DOI 10.1212/WNL.50.2.398; ADIB M, 1990, J IMMUNOL, V145, P3807; ANDERSSON U, 1994, IMMUNOL REV, V139, P21, DOI 10.1111/j.1600-065X.1994.tb00855.x; ANDERSSON UG, 1993, IMMUNOLOGY, V79, P211; AREND WP, 1991, J IMMUNOL, V147, P1530; ASHKENAZI S, 1988, J PEDIATR-US, V113, P1008, DOI 10.1016/S0022-3476(88)80572-9; AUKRUST P, 1994, BLOOD, V84, P2136; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; BASTA M, 1994, J CLIN INVEST, V94, P1729, DOI 10.1172/JCI117520; Baudet V, 1996, SCAND J IMMUNOL, V43, P277, DOI 10.1046/j.1365-3083.1996.d01-36.x; Bendtzen K, 1998, IMMUNOL TODAY, V19, P209, DOI 10.1016/S0167-5699(98)01252-3; BLASCZYK R, 1993, LANCET, V341, P789, DOI 10.1016/0140-6736(93)90563-V; Campos RD, 2000, J CLIN IMMUNOL, V20, P77; Chapel HM, 1999, CLIN EXP IMMUNOL, V118, P29, DOI 10.1046/j.1365-2249.1999.00000.x; CLARKSON SB, 1986, NEW ENGL J MED, V314, P1236, DOI 10.1056/NEJM198605083141907; Comi G, 1997, MULT SCLER, V3, P93, DOI 10.1177/135245859700300207; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; CUNNINGHAMRUNDLES C, 1993, J CLIN IMMUNOL, V13, P272, DOI 10.1007/BF00919386; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; Dalakas MC, 1997, ANN INTERN MED, V126, P721, DOI 10.7326/0003-4819-126-9-199705010-00008; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Decocq G, 1996, THERAPIE, V51, P516; DESOUZA VR, 1995, EUR J IMMUNOL, V25, P1267, DOI 10.1002/eji.1830250521; DIETRICH G, 1990, J CLIN INVEST, V85, P620, DOI 10.1172/JCI114483; Fazekas F, 1997, LANCET, V349, P589, DOI 10.1016/S0140-6736(96)09377-4; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; Gajdos P, 1997, ANN NEUROL, V41, P789, DOI 10.1002/ana.410410615; Hahn AF, 1996, BRAIN, V119, P1067, DOI 10.1093/brain/119.4.1067; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hughes RAC, 1996, BRIT MED J, V313, P376; HUREZ V, 1993, EUR J IMMUNOL, V23, P783, DOI 10.1002/eji.1830230402; Hurez V, 1994, Ther Immunol, V1, P269; IMBACH P, 1981, LANCET, V1, P1228; IMBACH P, 1991, VOX SANG, V61, P240, DOI 10.1111/j.1423-0410.1991.tb00953.x; JAYNE DRW, 1993, ADV EXP MED BIOL, V336, P469; Kaveri S, 1996, J CLIN INVEST, V97, P865, DOI 10.1172/JCI118488; KAVERI SV, 1990, J IMMUNOL, V145, P4207; KAZATCHKINE MD, 1994, IMMUNOL REV, V139, P79, DOI 10.1111/j.1600-065X.1994.tb00858.x; KAZATCHKINE MD, 1997, ANTIBODIES, V3, P141; KIMBERLY RP, 1984, J IMMUNOL, V132, P745; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; LAM L, 1993, LANCET, V342, P678, DOI 10.1016/0140-6736(93)91784-J; LeHoang P, 2000, OCUL IMMUNOL INFLAMM, V8, P49, DOI 10.1076/0927-3948(200003)8:1;1-S;FT049; Leung DYM, 1996, CLIN EXP IMMUNOL, V104, P49, DOI 10.1111/cei.1996.104.s1.49; LEUNG DYM, 1989, LANCET, V2, P1298; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; Lockwood CM, 1996, CLIN EXP IMMUNOL, V104, P77, DOI 10.1111/cei.1996.104.s1.77; Lutz HU, 1996, BLOOD, V88, P184; MARCHALONIS JJ, 1992, P NATL ACAD SCI USA, V89, P3325, DOI 10.1073/pnas.89.8.3325; MILLER DJ, 1995, J IMMUNOL, V154, P2460; MISBAH SA, 1993, DRUG SAFETY, V9, P254, DOI 10.2165/00002018-199309040-00003; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Pashov A, 1996, INTRAVENOUS IMMUNOGLOBULIN, P317; Prasad NKA, 1998, J IMMUNOL, V161, P3781; ROSSI F, 1988, CLIN EXP IMMUNOL, V74, P311; ROSSI F, 1989, J IMMUNOL, V143, P4104; ROSSI F, 1991, CLIN EXP IMMUNOL, V83, P298; ROSSI F, 1989, IMMUNOL REV, V110, P135, DOI 10.1111/j.1600-065X.1989.tb00031.x; ROUX KH, 1990, J IMMUNOL, V144, P1387; Ryan ME, 1996, CLIN PEDIATR, V35, P23, DOI 10.1177/000992289603500105; SAADEH C, 1995, SOUTH MED J, V88, P866, DOI 10.1097/00007611-199508000-00018; SALAMA A, 1983, LANCET, V2, P193; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; SANDLER SG, 1995, TRANSFUS MED REV, V9, P1, DOI 10.1016/S0887-7963(05)80026-4; SAOUDI A, 1993, INT IMMUNOL, V5, P1559, DOI 10.1093/intimm/5.12.1559; Sharief MK, 1999, NEUROLOGY, V52, P1833, DOI 10.1212/WNL.52.9.1833; SILVERMAN ED, 1990, ARTHRITIS RHEUM, V33, P1015, DOI 10.1002/art.1780330714; Sooryanarayana, 1999, BIOCHEM BIOPH RES CO, V264, P896, DOI 10.1006/bbrc.1999.1592; Sorensen PS, 1998, NEUROLOGY, V50, P1273, DOI 10.1212/WNL.50.5.1273; Stangel M, 1998, J NEUROL SCI, V153, P203, DOI 10.1016/S0022-510X(97)00292-X; Stangel M, 1997, CLIN NEUROPHARMACOL, V20, P385, DOI 10.1097/00002826-199710000-00002; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; SULTAN Y, 1984, LANCET, V2, P765; SUNDBLAD A, 1994, IMMUNOL REV, V139, P125, DOI 10.1111/j.1600-065X.1994.tb00860.x; Svenson M, 1998, BLOOD, V91, P2054, DOI 10.1182/blood.V91.6.2054.2054_2054_2061; TAKEI S, 1993, J CLIN INVEST, V91, P602, DOI 10.1172/JCI116240; TOMITA S, 1993, J RHEUMATOL, V20, P362; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; vanderMeche FGA, 1997, MUSCLE NERVE, V20, P136, DOI 10.1002/(SICI)1097-4598(199702)20:2<136::AID-MUS1>3.0.CO;2-D; VASSILEV T, 1993, CLIN EXP IMMUNOL, V92, P369; Vassilev T, 1999, EUR J IMMUNOL, V29, P2436, DOI 10.1002/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.3.CO;2-0; Vassilev TL, 1999, BLOOD, V93, P3624, DOI 10.1182/blood.V93.11.3624.411a28_3624_3631; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820; WELCH TR, 1995, ARTHRITIS RHEUM, V38, P1333, DOI 10.1002/art.1780380923; Xu C, 1998, AM J PATHOL, V153, P1257, DOI 10.1016/S0002-9440(10)65670-2	91	952	998	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					747	755		10.1056/NEJMra993360	http://dx.doi.org/10.1056/NEJMra993360			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547745				2022-12-28	WOS:000170772900008
J	Muthuswamy, P; Alausa, M; Reilly, B				Muthuswamy, P; Alausa, M; Reilly, B			The effusion that would not go away.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Reilly, B (corresponding author), Cook Cty Hosp, Dept Med, 1835 W Harrison St, Chicago, IL 60612 USA.							Heffner JE, 1997, CHEST, V111, P970, DOI 10.1378/chest.111.4.970; Kassirer JP., 2009, LEARNING CLIN REASON; Light R, 1995, PLEURAL DIS; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; WAHL GW, 1999, DIAGNOSTIC STRATEGIE, P349; WRIGHT RS, 1994, CHEST, V106, P950, DOI 10.1378/chest.106.3.950	6	14	14	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					756	759		10.1056/NEJMcps011343	http://dx.doi.org/10.1056/NEJMcps011343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547746				2022-12-28	WOS:000170772900009
J	Greig-Midlane, H				Greig-Midlane, H			The parents' perspective on withdrawing treatment	BRITISH MEDICAL JOURNAL			English	Article											Greig-Midlane, H (corresponding author), 32 Littleheath, London SE7 8HU, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					390	390						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11548687				2022-12-28	WOS:000170581400029
J	Durrington, PN				Durrington, PN			Rigorous detection and vigorous treatment of familial hypercholesterolaemia	LANCET			English	Editorial Material									Univ Manchester, Manchester Royal Infirm, Clin Res Div 2, Manchester M13 9WL, Lancs, England	University of Manchester	Durrington, PN (corresponding author), Univ Manchester, Manchester Royal Infirm, Clin Res Div 2, Manchester M13 9WL, Lancs, England.	pdurrington@hq.cmht.nwests.nhs.uk						Bhatnagar D, 2000, BRIT MED J, V321, P1497, DOI 10.1136/bmj.321.7275.1497; Burns FS, 1920, ARCH DERMATOL SYPH, V2, P415, DOI 10.1001/archderm.1920.02350100003001; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Durrington P.N., 1995, HYPERLIPIDAEMIA DIAG, V2nd, P108; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; KOSOGLOU T, 2000, ATHEROSCLEROSIS, V151, P135; Marks D, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4290, DOI 10.3310/HTA4290]; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; TALMUD P, 1991, ATHEROSCLEROSIS, V89, P137, DOI 10.1016/0021-9150(91)90053-6; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Wood D, 1998, HEART, V80, pS1	12	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					574	575		10.1016/S0140-6736(00)04075-7	http://dx.doi.org/10.1016/S0140-6736(00)04075-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558479				2022-12-28	WOS:000167119100005
J	Yung, YL; Lee, T; Wang, CH; Shieh, YT				Yung, YL; Lee, T; Wang, CH; Shieh, YT			Dust: A diagnostic of the hydrologic cycle during the last glacial maximum	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; DESERT DUST; ICE; ATMOSPHERE; AEROSOLS; CLIMATE; SIMULATIONS; TRANSPORT; IMPACT	Dust concentrations in ice of the last glacial maximum (LGM) are high in ice cores from Greenland and Antarctica. The magnitude of the enhancements can be explained if the strength of the hydrologic cycle during the LGM was about half of that at present. This notion is consistent with a large decrease (5 degrees C) in ocean temperature during the LGM, as recently deduced from measurements of strontium and calcium in corals.	ACAD SINICA, INST EARTH SCI, TAIPEI 115, TAIWAN	Academia Sinica - Taiwan	Yung, YL (corresponding author), CALTECH, DIV GEOL & PLANETARY SCI, PASADENA, CA 91125 USA.		Yung, Yuk/AAM-4850-2021; Lee, Typhoon/N-8347-2013	Yung, Yuk/0000-0002-4263-2562; Wang, Chung-Ho/0000-0003-2014-6747	NINDS NIH HHS [NSC 84-2111-M-001-027GP] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALKANSKI YJ, 1993, J GEOPHYS RES-ATMOS, V98, P20573, DOI 10.1029/93JD02456; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; CHAPPELLAZ JA, 1993, TELLUS B, V45, P228, DOI 10.1034/j.1600-0889.1993.t01-2-00002.x; Crowley T. J., 1991, PALEOCLIMATOLOGY; Fairbridge R.W., 1961, PHYS CHEM EARTH, V4, P99, DOI [10.1016/0079-1946(61)90004-0, DOI 10.1016/0079-1946(61)90004-0]; FRIEDLINGSTEIN P, 1995, J GEOPHYS RES-ATMOS, V100, P7203, DOI 10.1029/94JD02948; GENTHON C, 1992, TELLUS B, V44, P371, DOI 10.1034/j.1600-0889.1992.00014.x; GROUSSET FE, 1992, EARTH PLANET SC LETT, V111, P175, DOI 10.1016/0012-821X(92)90177-W; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Hammer C. U., 1985, GEOPHYS MONOGR SER, V33, P90, DOI DOI 10.1029/GM033P0090/SUMMARY); Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; HARVEY LDD, 1988, NATURE, V334, P333, DOI 10.1038/334333a0; Holloway R.G., 1985, POLLEN RECORDS LATE, P39; JOUSSAUME S, 1993, J GEOPHYS RES-ATMOS, V98, P2767, DOI 10.1029/92JD01921; JOUZEL J, 1989, QUATERNARY RES, V31, P135, DOI 10.1016/0033-5894(89)90003-3; KUKLA G, 1988, GEOLOGY, V16, P811, DOI 10.1130/0091-7613(1988)016<0811:PCICDB>2.3.CO;2; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P1465; MURPHY JR, 1993, J GEOPHYS RES-PLANET, V98, P3197, DOI 10.1029/92JE02945; PETIT JR, 1981, NATURE, V293, P391, DOI 10.1038/293391a0; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; SANTEE M, 1993, J GEOPHYS RES-PLANET, V98, P3261, DOI 10.1029/92JE01896; SENIOR CA, 1993, J CLIMATE, V6, P393, DOI 10.1175/1520-0442(1993)006<0393:CDACTI>2.0.CO;2; SHIA RL, 1989, J GEOPHYS RES-ATMOS, V94, P18467, DOI 10.1029/JD094iD15p18467; STUTE M, 1992, SCIENCE, V256, P1000, DOI 10.1126/science.256.5059.1000; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; WEARE BC, 1994, J CLIMATE, V7, P248, DOI 10.1175/1520-0442(1994)007<0248:IBCPAS>2.0.CO;2; YANG H, 1991, J ATMOS SCI, V48, P442, DOI 10.1175/1520-0469(1991)048<0442:SOTPDA>2.0.CO;2; 1992, CLIMATE CHANGE 199 S; 1990, CLIMATE CHANGE IPCC	33	103	114	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	1996	271	5251					962	963		10.1126/science.271.5251.962	http://dx.doi.org/10.1126/science.271.5251.962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TV704	11536732				2022-12-28	WOS:A1996TV70400040
J	KASTING, JF				KASTING, JF			EARTHS EARLY ATMOSPHERE	SCIENCE			English	Review							CARBON-DIOXIDE; PRIMITIVE ATMOSPHERE; SURFACE TEMPERATURES; IRON-FORMATIONS; EVOLUTION; OXYGEN; ORIGIN; IMPACTS; LUMINOSITY; GREENHOUSE	Ideas about atmospheric composition and climate on the early Earth have evolved considerably over the last 30 years, but many uncertainties still remain. It is generally agreed that the atmosphere contained little or no free oxygen initially and that oxygen concentrations increased markedly near 2.0 billion years ago, but the precise timing of and reasons for its rise remain unexplained. Likewise, it is usually conceded that the atmospheric greenhouse effect must have been higher in the past to offset reduced solar luminosity, but the levels of atmospheric carbon dioxide and other greenhouse gases required remain speculative. A better understanding of past atmospheric evolution is important to understanding the evolution of life and to predicting whether Earth-like planets might exist elsewhere in the galaxy.			KASTING, JF (corresponding author), PENN STATE UNIV, DEPT GEOSCI, UNIV PK, PA 16802 USA.		Kasting, James/AAF-6851-2020					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ASTON B, 1924, NATURE, V114, P786; BENLOW A, 1977, ASTROPHYS SPACE SCI, V46, P293, DOI 10.1007/BF00644376; BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BLAKE AJ, 1977, J ATMOS SCI, V34, P720, DOI 10.1175/1520-0469(1977)034<0720:TEROAO>2.0.CO;2; Brown H., 1952, ATMOSPHERES EARTH PL, P258; BUDYKO MI, 1990, HIST EARTHS ATMOSPHE, V249, P1382; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; CANUTO VM, 1982, NATURE, V296, P816, DOI 10.1038/296816a0; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; Chang S., 1983, EARTHS EARLIEST BIOS, P53; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CLOUD P, 1972, AM J SCI, V272, P537, DOI 10.2475/ajs.272.6.537; Corliss J. B., 1981, Oceanologica Acta, V4, P59; Crowel J.C., 1983, T GEOL SOC S AFR, V86, P237; CROWLEY TJ, 1983, REV GEOPHYS, V21, P828, DOI 10.1029/RG021i004p00828; DELANO J, COMMUNICATION; DERRYLA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317; Dreibus G., 1989, ORIGIN EVOLUTION PLA, P268; EGGLER DH, UNPUB; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; Frakes L.A., 1979, CLIMATES GEOLOGIC TI; GILLILAND RL, 1989, GLOBAL PLANET CHANGE, V75, P35; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; HARTMANN WK, 1986, ORIGIN MOON; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HENDERSON-SELLERS A, 1979, NATURE, V279, P786, DOI 10.1038/279786a0; Hesstvedt E., 1974, Geofysiske Publikasjoner, V31, P1; Holland H.D., 1962, PETROLOGIC STUDIES V, P447; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1986, NATURE, V320, P27, DOI 10.1038/320027a0; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; HOLLAND HD, IN PRESS NOBEL S, V84; Holland HD., 1984, CHEM EVOLUTION ATMOS; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; HUNTEN DM, 1973, J ATMOS SCI, V30, P1481, DOI 10.1175/1520-0469(1973)030<1481:TEOLGF>2.0.CO;2; JONES B, 1991, ALCHERINGA, V97, P39; Kasting J.F., 1991, SUN TIME, P447; Kasting J.F., 1992, PROTEROZOIC BIOSPHER, P1185; KASTING JF, 1991, GLOBAL PLANET CHANGE, V97, P125; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1985, J GEOPHYS RES-ATMOS, V90, P10497, DOI 10.1029/JD090iD06p10497; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KASTING JF, 1988, SCI AM, V258, P90, DOI 10.1038/scientificamerican0288-90; KASTING JF, 1992, PROTEROZOIC BIOSPHER, P165; KASTING JF, IN PRESS J GEOL; KASTING JF, IN PRESS ICARUS; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; Klein C., 1992, PROTEROZOIC BIOSPHER, P139, DOI DOI 10.1017/CB09780511601064; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; KNOLL AH, 1979, ORIGINS LIFE EVOL B, V9, P313, DOI 10.1007/BF00926824; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; LANGE MA, 1982, ICARUS, V51, P96, DOI 10.1016/0019-1035(82)90031-8; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; LEVINE JS, 1982, J MOL EVOL, V18, P161, DOI 10.1007/BF01733042; LEVINE JS, 1979, ICARUS, V39, P295, DOI 10.1016/0019-1035(79)90172-6; Lovelock J.E., 1988, AGES GAIA; LOVELOCK JE, 1982, NATURE, V296, P561, DOI 10.1038/296561a0; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MATSUI T, 1986, NATURE, V319, P303, DOI 10.1038/319303a0; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NEWSOM HE, 1991, SCIENCE, V252, P926, DOI 10.1126/science.252.5008.926; NURSALL JR, 1959, NATURE, V183, P1170, DOI 10.1038/1831170b0; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; OZIMA M, 1980, NATURE, V284, P313, DOI 10.1038/284313a0; OZIMA M, 1989, ORIGIN EVOLUTION PLA, P306; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; Ronov AB, 1967, GEOCHEMISTRY, V11, P1041; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; RUBEY WW, 1951, GEOL SOC AM BULL, V62, P1111, DOI 10.1130/0016-7606(1951)62[1111:GHOSW]2.0.CO;2; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; RUNNEGAR B, 1991, ALCHERINGA, V97, P97; SAFRONOV VS, 1972, NASA TTF677 REP; Schidlowski M., 1983, P149; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Schopf JW, 1983, EARTHS EARLIEST BIOS; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; SHOCK EL, 1990, ORIGINS LIFE EVOL B, V20, P331, DOI 10.1007/BF01808115; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; SOFRONOV VS, 1986, PROTOSTARS PROTOPLAN, V2, P959; Stevenson DJ., 1990, ORIGIN EARTH, P231; SUMMERS D, 1992, 203RD ACS M GEOC SAN, P149; TOWE KM, 1981, PRECAMBRIAN RES, V16, P1, DOI 10.1016/0301-9268(81)90002-4; TOWE KM, 1983, PRECAMBRIAN RES, V20, P161, DOI 10.1016/0301-9268(83)90071-2; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; VANVALEN L, 1971, SCIENCE, V171, P439, DOI 10.1126/science.171.3970.439; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1978, PURE APPL GEOPHYS, V117, P498, DOI 10.1007/BF00876630; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; Wetherill G. W, 1986, ORIGIN MOON, P519; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAHNLE K, 1990, ICARUS, V84, P502, DOI 10.1016/0019-1035(90)90050-J; ZAHNLE K, 1990, GEOCHIM COSMOCHIM AC, V54, P2577, DOI 10.1016/0016-7037(90)90243-E; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; ZAHNLE KJ, 1988, ICARUS, V74, P62, DOI 10.1016/0019-1035(88)90031-0	118	963	992	13	409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	1993	259	5097					920	926		10.1126/science.11536547	http://dx.doi.org/10.1126/science.11536547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KL800	11536547				2022-12-28	WOS:A1993KL80000030
J	HEATH, JR; SHEEKS, RA; COOKSY, AL; SAYKALLY, RJ				HEATH, JR; SHEEKS, RA; COOKSY, AL; SAYKALLY, RJ			THE C7 CLUSTER - STRUCTURE AND INFRARED FREQUENCIES	SCIENCE			English	Article											HEATH, JR (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.			SAYKALLY, RICHARD/0000-0001-8942-3656; Cooksy, Andrew/0000-0002-2794-4269				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; BUSAROW KL, 1988, J CHEM PHYS, V89, P1968; DROWART J, 1959, J CHEM PHYS, V31, P1131, DOI 10.1063/1.1730519; FREED KF, 1982, ASTROPHYS J, V263, P718, DOI 10.1086/160543; FUSINA L, 1980, J MOL SPECTROSC, V79, P101, DOI 10.1016/0022-2852(80)90296-9; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; GEUSIC ME, 1986, J CHEM PHYS, V84, P2421, DOI 10.1063/1.450354; HEATH JR, 1989, SCIENCE, V244, P564, DOI 10.1126/science.11539817; Herzberg G., 1945, INFRARED RAMAN SPECT, V2; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; KARU D, 1990, APPL OPTICS, V29, P119; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; MOAZZENAHMADI N, 1989, CHEM PHYS LETT, V157, P1, DOI 10.1016/0009-2614(89)87196-9; MOAZZENAHMADI N, 1989, J CHEM PHYS, V91, P2140, DOI 10.1063/1.457073; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; ROHLFING EA, 1988, J CHEM PHYS, V89, P6103, DOI 10.1063/1.455426; SCHMUTTENMAER CA, 1990, SCIENCE, V249, P897, DOI 10.1126/science.11538082; SUZUKI H, 1981, 13TH OK C TRANS IONS; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; YANG SH, 1987, CHEM PHYS LETT, V139, P233, DOI 10.1016/0009-2614(87)80548-1	22	67	67	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 24	1990	249	4971					895	897						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV751	11538081	Green Accepted			2022-12-28	WOS:A1990DV75100037
J	Gaines, S				Gaines, S			Sex, love and science - Serious treatments of science in fiction can be illuminating for both scientists and non-scientists.	NATURE			English	Article													Gaines, Steven/Y-3234-2019						0	1	1	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					255	255		10.1038/35095130	http://dx.doi.org/10.1038/35095130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565008	Bronze			2022-12-28	WOS:000171040500017
J	Berwick, D; Davidoff, F; Hiatt, H; Smith, R				Berwick, D; Davidoff, F; Hiatt, H; Smith, R			Refining and implementing the Tavistock principles for everybody in health care	BRITISH MEDICAL JOURNAL			English	Article							ETHICAL PRINCIPLES; WORKING DRAFT		BMA House, London WC1H 9JR, England; Brigham & Womens Hosp, Boston, MA 02115 USA; Inst Healthcare Improvement, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Institute for Healthcare Improvement	Smith, R (corresponding author), BMA House, London WC1H 9JR, England.							Berwick D, 1997, BRIT MED J, V315, P1633, DOI 10.1136/bmj.315.7123.1633; Davidoff F, 2000, ANN INTERN MED, V133, P386, DOI 10.7326/0003-4819-133-5-200009050-00016; GAYLIN W, 1993, HARPERS          OCT, P57; Smith R, 1999, ANN INTERN MED, V130, P143, DOI 10.7326/0003-4819-130-2-199901190-00009; Smith R, 1999, BRIT MED J, V318, P248; Smith R, 1999, Nurs Stand, V13, P32	6	16	17	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					616	619		10.1136/bmj.323.7313.616	http://dx.doi.org/10.1136/bmj.323.7313.616			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557714	Green Published			2022-12-28	WOS:000171087300023
J	Radman, M				Radman, M			Fidelity and infidelity	NATURE			English	Editorial Material									Univ Paris 05, Lab Evolut & Med Mol Genet, INSERM, E9916, F-75730 Paris 15, France; Univ Paris 05, Dept Cell Biol, F-75730 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), Univ Paris 05, Lab Evolut & Med Mol Genet, INSERM, E9916, F-75730 Paris 15, France.		; Radman, Miroslav/HDM-5955-2022	Radman, Miroslav/0000-0002-7034-4365; Radman, Miroslav/0000-0003-0216-3148				CAPORALE LH, 1999, MOL STRATEGIES BIOL; Freidberg E. C., 1997, CORRECTING BLUEPRINT; Keller Evelyn Fox, 2000, CENTURY GENE	3	24	26	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					115	115		10.1038/35093178	http://dx.doi.org/10.1038/35093178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557959	Bronze			2022-12-28	WOS:000170918800027
J	Whitmarsh, RB; Manatschal, G; Minshull, TA				Whitmarsh, RB; Manatschal, G; Minshull, TA			Evolution of magma-poor continental margins from rifting to seafloor spreading	NATURE			English	Article							IBERIA ABYSSAL-PLAIN; SEISMIC-REFRACTION PROFILES; NAPPES EASTERN SWITZERLAND; TECTONIC EVOLUTION; MANTLE EXHUMATION; DEEP-STRUCTURE; BREAK-UP; TRANSITION; OCEAN; CRUST	The rifting of continents involves faulting (tectonism) and magmatism, which reflect the strain-rate and temperature dependent processes of solid-state deformation and decompression melting within the Earth(1,2). Most models of this rifting have treated tectonism and magmatism separately, and few numerical simulations have attempted to include continental break-up and melting, let alone describe how continental rifting evolves into seafloor spreading. Models of this evolution conventionally juxtapose continental and oceanic crust. Here we present observations that support the existence of a zone of exhumed continental mantle, several tens of kilometres wide, between oceanic and continental crust on continental margins where magma-poor rifting has taken place. We present geophysical and geological observations from the west Iberia margin(3-7), and geological mapping of margins of the former Tethys ocean now exposed in the Alps(8-13). We use these complementary findings to propose a conceptual model that focuses on the final stage of continental extension and break-up, and the creation of a zone of exhumed continental mantle that evolves oceanward into seafloor spreading. We conclude that the evolving stress and thermal fields are constrained by a rising and narrowing ridge of asthenospheric mantle, and that magmatism and rates of extension systematically increase oceanward.	Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Strasbourg 1, CGS EOST, F-67084 Strasbourg, France	NERC National Oceanography Centre; University of Southampton; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Whitmarsh, RB (corresponding author), Southampton Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.		Minshull, Timothy A/D-1147-2010; Whitmarsh, Robert/HCI-7293-2022	Minshull, Timothy A/0000-0002-8202-1379; 				ABE N, IN PRESS NONVOLCANIC, P143; BERTOTTI G, 1993, SEDIMENT GEOL, V86, P53, DOI 10.1016/0037-0738(93)90133-P; BOILLOT G, 1989, NATURE, V341, P523, DOI 10.1038/341523a0; Chian DP, 1999, J GEOPHYS RES-SOL EA, V104, P7443, DOI 10.1029/1999JB900004; Dean SM, 2000, J GEOPHYS RES-SOL EA, V105, P5859, DOI 10.1029/1999JB900301; DESMURS L, IN PRESS NONVOLCANIC, P235; ENGLAND P, 1983, J GEOPHYS RES, V88, P1145, DOI 10.1029/JB088iB02p01145; Froitzheim N, 1996, GEOL SOC AM BULL, V108, P1120, DOI 10.1130/0016-7606(1996)108<1120:KOJRME>2.3.CO;2; HARRY DL, 1992, TECTONICS, V11, P420, DOI 10.1029/91TC03012; HEBERT R, IN PRESS NONVOLCANIC, P161; Hermann J, 1997, J GEOPHYS RES-SOL EA, V102, P20123, DOI 10.1029/97JB01510; Lagabrielle Y, 1997, CR ACAD SCI II A, V325, P909, DOI 10.1016/S1251-8050(97)82369-5; LOUDEN KE, 1999, RESPONSE EARTHS LITH, P767; Manatschal G, 1997, ECLOGAE GEOL HELV, V90, P3; Manatschal G, 1999, TECTONICS, V18, P1099, DOI 10.1029/1999TC900041; MANATSCHAL G, IN PRESS NONVOLCANIC, P405; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MINSHULL TA, IN PRESS NONVOLCANIC, P537; Muntener O, 2000, J PETROL, V41, P175, DOI 10.1093/petrology/41.2.175; MUNTENER O, IN PRESS NONVOLCANIC, P267; Pickup SLB, 1996, GEOLOGY, V24, P1079, DOI 10.1130/0091-7613(1996)024<1079:IITNOT>2.3.CO;2; RAMPONE E, 1995, J PETROL, V36, P81, DOI 10.1093/petrology/36.1.81; Reston TJ, 1996, J GEOPHYS RES-SOL EA, V101, P8075, DOI 10.1029/95JB03466; Scharer U, 2000, EARTH PLANET SC LETT, V181, P555, DOI 10.1016/S0012-821X(00)00220-X; Skelton ADL, 2000, EARTH PLANET SC LETT, V178, P327, DOI 10.1016/S0012-821X(00)00087-X; Taylor B, 1999, J GEOPHYS RES-SOL EA, V104, P7497, DOI 10.1029/1998JB900115; Whitmarsh RB, 2000, TECTONICS, V19, P919, DOI 10.1029/2000TC900016; WHITMARSH RB, 2001, P ODP SCI RESULTS, P1; WHITMARSH RB, 1996, P OCEAN DRILLING PRO, V149, P665; WHITMARSH RB, IN PRESS NONVOLCANIC, P107	30	476	493	1	84	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					150	154		10.1038/35093085	http://dx.doi.org/10.1038/35093085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557977				2022-12-28	WOS:000170918800043
J	Cunningham, J				Cunningham, J			Discussing cancer screening with elderly patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Glendale Adventist Med Ctr, Family Practice Residency Program, Glendale, CA 91206 USA		Cunningham, J (corresponding author), Glendale Adventist Med Ctr, Family Practice Residency Program, Glendale, CA 91206 USA.							Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1175	1176		10.1001/jama.286.10.1175	http://dx.doi.org/10.1001/jama.286.10.1175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559256				2022-12-28	WOS:000170910400021
J	McCune, SL; Gockerman, JP; Rizzieri, DA				McCune, SL; Gockerman, JP; Rizzieri, DA			Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							I-131 TOSITUMOMAB; LOW-GRADE; PHASE-II; INFLIXIMAB		Duke Univ, Med Ctr, Div Oncol & Bone Marrow Transplantat, Dept Med, Durham, NC 27710 USA	Duke University	Rizzieri, DA (corresponding author), Duke Univ, Med Ctr, Div Oncol & Bone Marrow Transplantat, Dept Med, 2400 Pratt St,Box 3961 N Pavil, Durham, NC 27710 USA.	rizzi003@mc.duke.edu						ANDREW SM, 1990, CANCER RES, V50, P5225; BYRD JC, 2000, BLOOD S, V96, pS3615; CABANILLAS F, 2000, BLOOD S, V96, pS1429; COIFFIER B, 2000, BLOOD S, V96, pS950; CZUCZMAN MS, 2000, BLOOD S, V96, pS3154; Davis TA, 1999, J CLIN ONCOL, V17, P1851, DOI 10.1200/JCO.1999.17.6.1851; DYER MJS, 2001, CLL, V6, P2; EMMANOUILIDES C, 2000, BLOOD S, V96, pS4754; FLAVELL DJ, 2000, BLOOD S, V96, pS1475; GIRALDO P, 2000, BLOOD S, V96, pS3157; GOCKERMAN J, 2001, P SOC AM CLIN ONCOL, V20, P1137; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Guerette B, 1996, TRANSPLANTATION, V62, P962; Kaminski MS, 2000, BLOOD, V96, P1259, DOI 10.1182/blood.V96.4.1259.h8001259_1259_1266; KENNEDY B, 2000, BLOOD S, V96, pS4991; KIMBY E, 2000, BLOOD S, V96, pS2479; KITADA S, 2000, BLOOD S, V96, pS2216; LEONARD JP, 2000, BLOOD S, V96, pS3148; Lincoff AM, 1999, CIRCULATION, V99, P1951, DOI 10.1161/01.CIR.99.15.1951; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maloney DG, 1997, BLOOD, V90, P2188; PAN D, 2000, BLOOD S, V96, pS1746; PEDERSEN IM, 2000, BLOOD S, V96, pS702; RAI K, 2000, BLOOD S, V96, pS703; Ricart E, 2001, AM J GASTROENTEROL, V96, P722, DOI 10.1111/j.1572-0241.2001.03612.x; Rizzieri DA, 1999, BLOOD, V94, p253B; Vacca A, 1996, LEUKEMIA LYMPHOMA, V22, P473, DOI 10.3109/10428199609054786; Vose JM, 2000, J CLIN ONCOL, V18, P1316, DOI 10.1200/JCO.2000.18.6.1316; VOSO MT, 2000, BLOOD S, V96, pS1462; WISEMAN GA, 1999, P AMSOC CLIN ONCOL, V18, P13; WITZIG TE, 2000, BLOOD S, V96, pS3149	31	15	16	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1149	1152		10.1001/jama.286.10.1149	http://dx.doi.org/10.1001/jama.286.10.1149			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559240				2022-12-28	WOS:000170910400002
J	Bharani, A; Kumar, H				Bharani, A; Kumar, H			Diabetes inspidus induced by ofloxacin	BRITISH MEDICAL JOURNAL			English	Letter									MGM Med Coll, Dept Med, Indore 452001, Madhya Pradesh, India; MY Hosp, Indore 452001, Madhya Pradesh, India	MGM Medical College Indore; MGM Medical College Indore	Bharani, A (corresponding author), MGM Med Coll, Dept Med, Indore 452001, Madhya Pradesh, India.		Kumar, Hrishikesh/J-8013-2019					FORREST JN, 1978, NEW ENGL J MED, V298, P173, DOI 10.1056/NEJM197801262980401; Moser AM, 1994, HARRISONS PRINCIPLES, P1921	2	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					547	547		10.1136/bmj.323.7312.547	http://dx.doi.org/10.1136/bmj.323.7312.547			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546701	Bronze, Green Published			2022-12-28	WOS:000170934600022
J	Gindler, J; Li, Z; Berry, RJ; Zheng, JC; Correa, A; Sun, XM; Wong, LY; Cheng, LC; Erickson, JD; Wang, Y; Tong, QL				Gindler, J; Li, Z; Berry, RJ; Zheng, JC; Correa, A; Sun, XM; Wong, LY; Cheng, LC; Erickson, JD; Wang, Y; Tong, QL		Jiaxing City Collaborative Project	Folic acid supplements during pregnancy and risk of miscarriage	LANCET			English	Article							NEURAL-TUBE DEFECTS; METHYLENETETRAHYDROFOLATE REDUCTASE; PREVENTION	Background Although taking supplements that contain 400 mug of folic acid before and during early pregnancy reduces a woman's risk for having a baby with a neural-tube defect (NTD), the effects of such supplements on other pregnancy outcomes remain unclear. We examined whether the use of such supplements affects the occurrence of miscarriage. Methods Participants were women in China who had taken part in a recent folic acid campaign to prevent NTDs and who had registered in this campaign before they became pregnant for the first time. We examined the risk for miscarriage among women who had confirmed pregnancies and who had or had not taken pills containing only 400 mug of folic acid before and during early pregnancy. Results The overall rate of miscarriage was 9.1% (2155/23 806). The rates of miscarriage among women who had and had not taken folic acid pills before and during the first trimester were 9.0% and 9.3%, respectively (risk ratio 0.97 [95% Cl 0.84-1.12]). The distributions of gestational age at pregnancy diagnosis and at miscarriage were similar for both groups of women. Interpretation In this population-based study of a cohort of women whose use of folic acid supplements while pregnant had been previously documented and who had been pregnant for the first time, we found no evidence that daily consumption of 400 pg of folic acid before and during early pregnancy influenced their risk for miscarriage.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Beijing Univ, Hlth Sci Ctr, Natl Ctr Maternal Hlth & Infant Hlth, Beijing 100871, Peoples R China; Jiaxing City Collaborat Project Neural Tube Defec, Jiaxing, Zhejiang Provin, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.	rjb1@cdc.gov		Berry, Robert/0000-0002-7162-5046				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BENDICH A, 1991, MICRONUTRIENTS HLTH, P251; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2000, NEW ENGL J MED, V342, P1136; Botto LD, 1998, CLIN GENET, V53, P456; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.3.CO;2-K; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; FRENCH FE, 1962, PUBLIC HEALTH REP, V77, P835, DOI 10.2307/4591645; Hook EB, 2000, NEW ENGL J MED, V342, P1136; Hook EB, 1997, LANCET, V350, P513, DOI 10.1016/S0140-6736(97)01342-1; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; THIERSCH JB, 1952, AM J OBSTET GYNECOL, V63, P1298; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wald N, 1997, LANCET, V350, P665, DOI 10.1016/S0140-6736(05)63358-2; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Windham GC, 2000, AM J MED GENET, V90, P261, DOI 10.1002/(SICI)1096-8628(20000131)90:3<261::AID-AJMG18>3.0.CO;2-L; Xu Z., 1992, CHUNG HUA HSUEH TSA, V72, P216	18	73	79	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					796	800		10.1016/S0140-6736(01)05969-4	http://dx.doi.org/10.1016/S0140-6736(01)05969-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564486				2022-12-28	WOS:000170989300012
J	Aleksander, I				Aleksander, I			The self 'out there'	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London SW7 2AZ, England	Imperial College London	Aleksander, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London SW7 2AZ, England.							Aleksander I, 2000, P ROY SOC B-BIOL SCI, V267, P197, DOI 10.1098/rspb.2000.0987; ALEKSANDER I, 2001, BUILD MIND; Bressloff PC, 2001, PHILOS T R SOC B, V356, P1; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Koch C, 2001, NATURE, V411, P893, DOI 10.1038/35082161; Velmans M., 2000, UNDERSTANDING CONSCI	6	5	5	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					23	23		10.1038/35092640	http://dx.doi.org/10.1038/35092640			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544505	Bronze			2022-12-28	WOS:000170801200020
J	Tepaske, R; Velthuis, HT; Oudemans-van Straaten, HM; Heisterkamp, SH; van Deventer, SJH; Ince, C; Eysman, L; Kesecioglu, J				Tepaske, R; Velthuis, HT; Oudemans-van Straaten, HM; Heisterkamp, SH; van Deventer, SJH; Ince, C; Eysman, L; Kesecioglu, J			Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial	LANCET			English	Article							NITRIC-OXIDE; L-ARGININE; REPERFUSION INJURY; ENTERAL NUTRITION; LIVER PERFUSION; CRITICALLY ILL; LOW-FLOW; IMMUNONUTRITION; BYPASS; MODEL	Background Elderly patients and those with poor ventricular function have increased morbidity and mortality rates when undergoing surgery, We aimed to ascertain whether an oral immune-enhancing nutritional supplement could improve preoperative host defence, and subsequently lower postoperative infections and organ dysfunction in patients undergoing elective cardiac surgery who are at high risk of infection. Methods In this prospective, randomised, double-blind, placebo-controlled study, we randomly assigned 50 patients who were scheduled to undergo coronary artery bypass to receive either an oral immune-enhancing nutritional supplement containing L-arginine, omega3 polyunsaturated fatty acids, and yeast RNA (n=25), or a control (n=25) for a minimum of 5 days. Patients were included if they were aged 70 years or older, or had an ejection fraction of less than 0.4, or were scheduled to undergo mitral valve replacement, The main outcome was preoperative host defence (delayed-type hypersensitivity response to recall antigens, expression of HLA-DR epitopes on monocytes, and concentration of interleukin 6 in plasma). Analysis was per protocol. Findings Five patients (two in the treatment group) were excluded because they did not take the minimum dose. Preoperative expression of HLA-DR epitopes on monocytes was significantly higher in patients given the study treatment (109% [95% CI 92-128]) than those given the control (69% [58-82]) compared with baseline (100%) (p=0.02, repeated measures ANOVA). However, concentration of interleukin 6 was significantly lower in the treatment group (0.90 pg/L [0.69-1.81]) than in the control group (1.94 pg/L [1.45-2.59]) (p=0.032, repeated measures ANOVA). Additionally, delayed-type hypersensitivity response to recall antigens improved preoperatively and remained better until hospital discharge. Interpretation Intake of an oral immune-enhancing nutritional supplement for a minimum of 5 days before surgery can improve outlook in high-risk patients who are undergoing elective cardiac surgery.	Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, CLB, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Expt & Clin Immunol Lab, NL-1100 DD Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Intens Care, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital	Tepaske, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Intens Care, C3-324,POB 22660, NL-1100 DD Amsterdam, Netherlands.	r.tepaske@amc.uva.nl						Atkinson S, 1998, CRIT CARE MED, V26, P1164, DOI 10.1097/00003246-199807000-00013; Beale RJ, 1999, CRIT CARE MED, V27, P2799, DOI 10.1097/00003246-199912000-00032; Braga M, 1996, EUR J SURG, V162, P105; BRAGA M, 1996, ARCH SURG-CHICAGO, V131, P157; CHEADLE WG, 1991, AM J SURG, V161, P639, DOI 10.1016/0002-9610(91)91247-G; DALY JM, 1995, ANN SURG, V221, P327, DOI 10.1097/00000658-199504000-00002; DeNicola L, 1997, MINER ELECTROL METAB, V23, P144; Efron D T, 1999, J Ren Nutr, V9, P142, DOI 10.1016/S1051-2276(99)90053-5; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harris WS, 1997, AM J CLIN NUTR, V65, P459, DOI 10.1093/ajcn/65.2.459; Hayashi N, 1998, JPEN-PARENTER ENTER, V22, P363, DOI 10.1177/0148607198022006363; HELLE M, 1991, J IMMUNOL METHODS, V138, P47, DOI 10.1016/0022-1759(91)90063-L; HIGGINS TL, 1992, JAMA-J AM MED ASSOC, V267, P2344, DOI 10.1001/jama.267.17.2344; Jones SM, 1996, HEPATOLOGY, V24, P163, DOI 10.1002/hep.510240127; Kelly RA, 1996, CIRC RES, V79, P363, DOI 10.1161/01.RES.79.3.363; Kress HG, 1999, CRIT CARE MED, V27, P1281, DOI 10.1097/00003246-199907000-00011; Kulka PJ, 1996, CRIT CARE MED, V24, P947, DOI 10.1097/00003246-199606000-00012; KULKARNI AD, 1994, J NUTR, V124, pS1442, DOI 10.1093/jn/124.suppl_8.1442S; LEMAIRE LC, 1988, SCAND J IMMUNOL, V47, P69; MAXWELL AP, 1986, CLIN ALLERGY, V16, P365, DOI 10.1111/j.1365-2222.1986.tb01969.x; MCBRIDE WT, 1995, BRIT J ANAESTH, V75, P724, DOI 10.1093/bja/75.6.724; Meydani S N, 1993, Nutr Clin Pract, V8, P65, DOI 10.1177/011542659300800265; MOORE S, 1958, ANAL CHEM, V30, P1185, DOI 10.1021/ac60139a005; Nonami Y, 1997, SURG TODAY, V27, P583, DOI 10.1007/BF02388212; OLeary MJ, 1996, BRIT J ANAESTH, V77, P118, DOI 10.1093/bja/77.1.118; Rinder CS, 1997, J LAB CLIN MED, V129, P592, DOI 10.1016/S0022-2143(97)90193-1; SATO H, 1995, J THORAC CARDIOV SUR, V110, P302, DOI 10.1016/S0022-5223(95)70226-1; Takala J, 1996, New Horiz, V4, P483; Yamauchi K, 1996, J NUTR, V126, P1571, DOI 10.1093/jn/126.6.1571; ZHONG Z, 1995, HEPATOLOGY, V22, P929, DOI 10.1016/0270-9139(95)90317-8	30	132	140	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2001	358	9283					696	701		10.1016/S0140-6736(01)05836-6	http://dx.doi.org/10.1016/S0140-6736(01)05836-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551575				2022-12-28	WOS:000170729500008
J	Winther, JF; Sankila, R; Boice, JD; Tulinius, H; Bautz, A; Barlow, L; Glattre, E; Langmark, F; Moller, TR; Mulvihill, JJ; Olafsdottir, GH; Ritvanen, A; Olsen, JH				Winther, JF; Sankila, R; Boice, JD; Tulinius, H; Bautz, A; Barlow, L; Glattre, E; Langmark, F; Moller, TR; Mulvihill, JJ; Olafsdottir, GH; Ritvanen, A; Olsen, JH			Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study	LANCET			English	Article							CHILDHOOD-CANCER; HEREDITARY RETINOBLASTOMA; RELATIVES; FAMILIES; RISK; TUMORS; SIBS; EPIDEMIOLOGY; SURVIVORS; NEOPLASMS	Background In some rare inherited disorders such as Li-Fraumeni syndrome, relatives of children with cancer are at increased risk of cancer. We aimed to assess relations between childhood cancer and sibling risk, and evaluate the influence of recessive conditions in cancer causation. Methods We did a population-based cohort study in the Nordic countries of 42 277 siblings of 25 605 children with cancer. Children with cancer were identified from records in the five Nordic cancer registries, and their siblings from nationwide population registries. Cancers in siblings were documented through record linkage with cancer registries and compared with national incidence rates. We also assessed cancer incidence in parents to identify familial cancer syndromes. Findings 284.2 cancers were expected in siblings, whereas 353 were diagnosed (standardised incidence ratio 1.24 95% CI 1.12-1.38). Risk ratios for siblings were highest in the first decade of life (2.59, 1.89-3.46). We excluded 56 families with genetic syndromes linked to cancer, which reduced this ratio from 1.7 to 1.0 (0.7-1.3) for siblings younger than 20 years, and from 1.3 to 1.0 (0.8-1.3) for those aged 20-29 years. We found no new patterns of familial cancer that indicated inherited susceptibility, or evidence that recessive conditions might contribute to cancers not explained by syndromes. 40% of cancers in siblings that occurred before age 20 years could be attributed to known genetic factors, whereas 60% remained unexplained. Interpretation Apart from rare cancer syndromes, paediatric cancer is not an indicator of increased cancer risk in siblings.	Finnish Canc Registry, FIN-00170 Helsinki, Finland; Natl Res & Dev Ctr Welf & Hlth, Finnish Register Congenital Malformat, Helsinki, Finland; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Dept Med, Nashville, TN USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA; Univ Oklahoma, Oklahoma City, OK USA; Iceland Canc Registry, Reykjavik, Iceland; Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; So Swedish Reg Registry, Lund, Sweden; Canc Registry Norway, Oslo, Norway	Finnish Cancer Registry; Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Board of Health & Welfare; University of Oslo	Winther, JF (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49,Box 839, DK-2100 Copenhagen, Denmark.		Winther, Jeanette Falck/AAS-2754-2020	Winther, Jeanette Falck/0000-0002-3440-5108; Olsen, Jorgen Helge/0000-0001-9633-5662				BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BIRCH JM, 1990, CANCER-AM CANCER SOC, V66, P2239, DOI 10.1002/1097-0142(19901115)66:10<2239::AID-CNCR2820661034>3.0.CO;2-Q; BONDY ML, 1991, GENET EPIDEMIOL, V8, P253, DOI 10.1002/gepi.1370080406; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BURKE E, 1991, CANCER-AM CANCER SOC, V67, P1467, DOI 10.1002/1097-0142(19910301)67:5<1467::AID-CNCR2820670535>3.0.CO;2-4; *DAN NAT BOARD HLT, 1999, CANC INC DENM 1996; DERKINDEREN DJ, 1988, INT J CANCER, V41, P499, DOI 10.1002/ijc.2910410405; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; Draper GJ, 1996, BRIT J CANCER, V74, P152, DOI 10.1038/bjc.1996.331; DRAPER GJ, 1977, J MED GENET, V14, P81, DOI 10.1136/jmg.14.2.81; FARWELL J, 1984, NEW ENGL J MED, V311, P749, DOI 10.1056/NEJM198409203111201; HARTLEY AL, 1991, J NATL CANCER I, V83, P955, DOI 10.1093/jnci/83.13.955; Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210; JONES SM, 1995, J MED GENET, V32, P627, DOI 10.1136/jmg.32.8.627; LI FP, 1995, CANCER EPIDEM BIOMAR, V4, P579; LI FP, 1976, J PEDIATR-US, V88, P419, DOI 10.1016/S0022-3476(76)80256-9; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindor NM, 1998, JNCI-J NATL CANCER I, V90, P1039, DOI 10.1093/jnci/90.14.1039; MILLER RW, 1971, J NATL CANCER I, V46, P203; MOUTOU C, 1994, J MED GENET, V31, P429, DOI 10.1136/jmg.31.6.429; MULVIHILL JJ, 1999, CATALOG HUMAN CANC G, P1; *NORD MED STAT COM, 1991, NOMESCO PUBL, V36; OLSEN JH, 1990, HUM GENET, V85, P283; OLSEN JH, 1995, NEW ENGL J MED, V333, P1594, DOI 10.1056/NEJM199512143332403; OLSEN JH, 1993, BRIT MED J, V307, P1030, DOI 10.1136/bmj.307.6911.1030; PASTORE G, 1985, FAM CANCER, P146; PERKKIO M, 1990, PEDIATR HEMAT ONCOL, V7, P159, DOI 10.3109/08880019009033386; Sankila R, 1998, NEW ENGL J MED, V338, P1339, DOI 10.1056/NEJM199805073381902; SCHULL WJ, 1977, GENETICS HUMAN CANC, P15; STEINBERG AG, 1960, CANCER, V13, P985, DOI 10.1002/1097-0142(196009/10)13:5<985::AID-CNCR2820130520>3.0.CO;2-J; STROM SS, 1991, AM J EPIDEMIOL, V134, P766; STRONG LC, 1984, J NATL CANCER I, V73, P303, DOI 10.1093/jnci/73.2.303; Tulinius H, 1992, APMIS Suppl, V31, P1	33	54	56	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					711	717		10.1016/S0140-6736(01)05838-X	http://dx.doi.org/10.1016/S0140-6736(01)05838-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551577				2022-12-28	WOS:000170729500010
J	Villanueva, C; Minana, J; Ortiz, J; Gallego, A; Soriano, G; Torras, X; Sainz, S; Boadas, J; Cusso, X; Guarner, C; Balanzo, J				Villanueva, C; Minana, J; Ortiz, J; Gallego, A; Soriano, G; Torras, X; Sainz, S; Boadas, J; Cusso, X; Guarner, C; Balanzo, J			Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPRANOLOL PLUS ISOSORBIDE-5-MONONITRATE; PORTAL-HYPERTENSION; RANDOMIZED-TRIAL; SCLEROTHERAPY; HEMORRHAGE; CIRRHOSIS; SURVIVAL; SHUNT	Background: After an episode of acute bleeding from esophageal varices, patients are at high risk for recurrent bleeding and death. We compared two treatments to prevent recurrent bleeding -- endoscopic ligation and combined medical therapy with nadolol and isosorbide mononitrate. Methods: We randomly assigned 144 patients with cirrhosis who were hospitalized with esophageal variceal bleeding to receive treatment with endoscopic ligation (72 patients) or the combined medical therapy (72 patients). Sessions of ligation were repeated every two to three weeks until the varices were eradicated. The mean (+/-SD) dose of nadolol was 96+/-56 mg per day, and the mean dose of isosorbide was 66+/-22 mg per day. The primary end points were recurrent bleeding, complications, and death. Results: The median follow-up period was 21 months. A total of 35 patients in the ligation group and 24 in the medication group had recurrent bleeding. The probability of recurrence was lower in the medication group, both for all episodes related to portal hypertension (P=0.04) and for recurrent variceal bleeding (P=0.04). There were major complications in nine patients treated with ligation (seven had bleeding esophageal ulcers and two had aspiration pneumonia) and two treated with medication (both had bradycardia and dyspnea) (P=0.05). Thirty patients in the ligation group died, as did 23 patients in the medication group (P=0.52). The probability of recurrent bleeding was lower for patients with a hemodynamic response to therapy, defined as a decrease in the hepatic venous pressure gradient of more than 20 percent from the base-line value or to less than 12 mm Hg (18 percent, vs. 54 percent in patients with no hemodynamic response at one year; P<0.001), and the probability of survival was higher (94 percent vs. 78 percent at one year, P=0.02). Conclusions: Combined therapy with nadolol and isosorbide mononitrate is more effective than endoscopic ligation for the prevention of recurrent bleeding and is associated with a lower rate of major complications. (N Engl J Med 2001;345:647-55.) Copyright (C) 2001 Massachusetts Medical Society.	Hosp Santa Creu & Sant Pau, Serv Patol Digest, Dept Gastroenterol, Barcelona 08025, Spain	Hospital of Santa Creu i Sant Pau	Villanueva, C (corresponding author), Hosp Santa Creu & Sant Pau, Serv Patol Digest, Dept Gastroenterol, Avgda St Antoni M Claret 167, Barcelona 08025, Spain.	cvillanueva@hsp.santpau.es		Guarner, Carlos/0000-0001-5957-9481; Gallego, Adolfo/0000-0002-8423-6787; Soriano, German/0000-0002-9267-6811				Altman D.G., 1991, PRACTICAL STAT MED R; Armitage P., 2001, STAT METHODS MED RES; BALANZO J, 1990, SURG GYNECOL OBSTET, V171, P489; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; BURROUGHS AK, 1989, HEPATOLOGY, V9, P801, DOI 10.1002/hep.1840090602; BURROUGHS AK, 1992, BAILLIERE CLIN GASTR, V6, P437, DOI 10.1016/0950-3528(92)90031-9; CHRISTENSEN E, 1987, HEPATOLOGY, V7, P1346, DOI 10.1002/hep.1840070628; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145; de la Pena J, 1999, GASTROINTEST ENDOSC, V49, P417, DOI 10.1016/S0016-5107(99)70036-2; DEFRANCHIS R, 1992, J HEPATOL, V15, P256, DOI 10.1016/0168-8278(92)90044-P; Escorsell A, 1998, HEPATOLOGY, V28, p770A; FEU F, 1995, LANCET, V346, P1056, DOI 10.1016/S0140-6736(95)91740-3; GARCIAPAGAN JC, 1991, ANN INTERN MED, V114, P869, DOI 10.7326/0003-4819-114-10-869; GIMSON AES, 1993, LANCET, V342, P391, DOI 10.1016/0140-6736(93)92812-8; Gournay J, 2000, HEPATOLOGY, V31, P1239, DOI 10.1053/jhep.2000.8106; GRAHAM DY, 1981, GASTROENTEROLOGY, V80, P800; Gralnek IM, 1999, HEPATOLOGY, V29, P44, DOI 10.1002/hep.510290141; GROSZMANN RJ, 1990, GASTROENTEROLOGY, V99, P1401, DOI 10.1016/0016-5085(90)91168-6; Jalan R, 1997, HEPATOLOGY, V26, P1115; LAINE L, 1993, ANN INTERN MED, V119, P1, DOI 10.7326/0003-4819-119-1-199307010-00001; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; Lo GH, 2000, HEPATOLOGY, V32, P461, DOI 10.1053/jhep.2000.16236; MCCORMICK PA, 1994, HEPATOLOGY, V20, pA106; MERKEL C, 1995, HEPATOLOGY, V22, P808, DOI 10.1016/0270-9139(95)90301-1; Merkel C, 1997, HEPATOLOGY, V26, P34; MORILLAS RM, 1994, HEPATOLOGY, V20, P1502, DOI 10.1002/hep.1840200620; Patch D, 2000, J HEPATOL, V32, P35, DOI 10.1016/S0168-8278(00)80464-X; POLIO J, 1986, SEMIN LIVER DIS, V6, P318, DOI 10.1055/s-2008-1040614; Preneta E, 1998, HEPATOLOGY, V28, p453A; STIEGMANN GV, 1992, NEW ENGL J MED, V326, P1527, DOI 10.1056/NEJM199206043262304; VANSTIEGMANN G, 1990, AM J SURG, V159, P21; VANSTIEGMANN G, 1986, GASTROINTEST ENDOSC, V32, P230, DOI 10.1016/S0016-5107(86)71815-4; Villanueva C, 1996, NEW ENGL J MED, V334, P1624, DOI 10.1056/NEJM199606203342502	34	226	235	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					647	655		10.1056/NEJMoa003223	http://dx.doi.org/10.1056/NEJMoa003223			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466XG	11547718				2022-12-28	WOS:000170671000003
J	Van de Werf, F; Armstrong, PW; Granger, C; Wallentin, L				Van de Werf, F; Armstrong, PW; Granger, C; Wallentin, L		Assessment Safety Efficacy New Thr	Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; THROMBOLYSIS	Background Current fibrinolytic therapies fail to achieve optimum reperfusion in many patients. Low-molecular-weight heparins and platelet glycoprotein IIb/IIIa inhibitors have shown the potential to improve pharmacological reperfusion therapy. We did a randomised, open-label trial to compare the efficacy and safety of tenecteplase plus enoxaparin or abciximab, with that of tenecteplase plus weight-adjusted unfractionated heparin in patients with acute myocardial infarction. Methods 6095 patients with acute myocardial infarction of less than 6 h were randomly assigned one of three regimens: full-dose tenecteplase and enoxaparin for a maximum of 7 days (enoxaparin group; n=2040), half-dose tenecteplase with weight-adjusted low-dose unfractionated heparin and a 12-h infusion of abciximab (abciximab group; n=2017), or full-dose tenecteplase with weight-adjusted unfractionated heparin for 48 h (unfractionated heparin group; n=2038). The primary endpoints were the composites of 30-day mortality, in-hospital reinfarction, or in-hospital refractory ischaemia (efficacy endpoint), and the above endpoint plus in-hospital intracranial haemorrhage or in-hospital major bleeding complications (efficacy plus safety endpoint). Analysis was by intention to treat. Findings There were significantly fewer efficacy endpoints in the enoxaparin and abciximab groups than in the unfractionated heparin group: 233/2037 (11.4%) versus 315/2038 (15.4%; relative risk 0.74 [95% CI 0.63-0.87], p=0.0002) for enoxaparin, and 223/2017 (11.1%) versus 315/2038 (15.4%; 0.72 [0.61-0.84], p<0.0001) for abciximab. The same was true for the efficacy plus safety endpoint: 280/2037 (13.7%) versus 347/2036 (17.0%; 0.81 [0.70-0.93], p=0.0037) for enoxaparin, and 287/2016 (14.2%) versus 347/2036 (17.0%; 0.84 [0.72-0.96], p=0.01416) for abciximab. Interpretation The tenecteplase plus enoxaparin or abciximab regimens studied here reduce the frequency of ischaemic complications of an acute myocardial infarction. In light of its ease of administration, tenecteplase plus enoxaparin seems to be an attractive alternative reperfusion regimen that warrants further study.	Univ Hosp Gasthuisberg, Dept Cardiol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Van de Werf, F (corresponding author), Univ Hosp Gasthuisberg, Dept Cardiol, Herestr 49, B-3000 Louvain, Belgium.	Frans.vandeWerf@uz.kuleuven.ac.be	Nicolau, Jose C/E-1487-2012; Manolis, Antonis/F-5003-2014; Badano, Luigi Paolo/H-9755-2019; Modena, Maria Grazia/N-2442-2015; Catarino, Cristina/K-5492-2013	Nicolau, Jose C/0000-0002-9680-3689; Manolis, Antonis/0000-0002-0336-4745; Badano, Luigi Paolo/0000-0002-0379-3283; Albuquerque, Denilson/0000-0003-1883-6546; Alexander, John/0000-0002-1444-2462; TRITTO, Isabella/0000-0003-0026-7154; Maggiorini, Marco/0000-0001-8180-2117; Brown, Alex/0000-0003-2112-3918; Modena, Maria Grazia/0000-0002-4704-4663; Arboleda-Sanchez, Jose Andres/0000-0002-0690-9245; Bogaerts, Kris/0000-0003-0188-8665; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Catarino, Cristina/0000-0002-3229-1434; Aylward, Philip/0000-0002-5358-8552				Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Armstrong PW, 2001, CIRCULATION, V103, P2862; Baird SH, 1998, J AM COLL CARDIOL, V31, p191A, DOI 10.1016/S0735-1097(97)84538-X; Brener SJ, 1999, CIRCULATION, V100, P649; Giugliano RP, 2001, AM HEART J, V141, P742, DOI 10.1067/mhj.2001.114975; Ross AM, 2001, CIRCULATION, V104, P648, DOI 10.1161/hc3101.093866; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SIMOONS ML, IN PRESS EUR HEART J; Topol EJ, 2000, CIRCULATION, V101, P2788; Topol EJ, 2001, LANCET, V357, P1905; Turpie AGG, 2001, ARCH INTERN MED, V161, P1484, DOI 10.1001/archinte.161.12.1484; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Wallentin L, 2001, CLIN CARDIOL, V24, pI12; White HD, 1998, CIRCULATION, V97, P1632, DOI 10.1161/01.CIR.97.16.1632	14	554	575	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					605	613						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530146				2022-12-28	WOS:000170615500007
J	Inwald, D; Vandyck, W				Inwald, D; Vandyck, W			Paralysing agents may be given up to but not at or beyond the point of extubation	BRITISH MEDICAL JOURNAL			English	Article							VENTILATION; LIFE		Inst Child Hlth, Portex Dept Anaesthesia Intens Therapy & Resp Med, London WC1N 1EH, England; Crown Off Chambers, London EC4Y 7EP, England	University of London; University College London	Inwald, D (corresponding author), Inst Child Hlth, Portex Dept Anaesthesia Intens Therapy & Resp Med, 30 Guilford St, London WC1N 1EH, England.			Inwald, David/0000-0001-9518-7821				Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; Hatherill M, 1998, BMJ-BRIT MED J, V317, P80, DOI 10.1136/bmj.317.7150.80a; *ROYAL COLL PAED C, 1997, WITHH WITHDR LIF SAV; Truog RD, 2000, NEW ENGL J MED, V342, P508, DOI 10.1056/NEJM200002173420712	4	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					389	390						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11548686				2022-12-28	WOS:000170581400028
J	KARLSSON, KR; CLAYTON, RN; GIBSON, EK; MAYEDA, TK				KARLSSON, KR; CLAYTON, RN; GIBSON, EK; MAYEDA, TK			WATER IN SNC METEORITES - EVIDENCE FOR A MARTIAN HYDROSPHERE	SCIENCE			English	Article							ANTARCTIC SHERGOTTITE; NOBLE-GASES; MARS; EETA-79001; AMPHIBOLE; OXYGEN	The Shergotty-Nakhla-Chassigny (SNC) meteorites, purportedly of martian origin, contain 0.04 to 0.4 percent water by weight. Oxygen isotopic analysis can bc used to determine whether this water is extraterrestrial or terrestrial. Such analysis reveals that a portion of the water is extraterrestrial and furthermore was not in oxygen isotopic equilibrium with the host rock. Lack of equilibrium between water and host rock implies that the lithosphere and hydrosphere of the SNC parent body formed two distinct oxygen isotopic reservoirs. If Mars was the parent body, the maintenance of two distinct reservoirs may result from the absence of plate tectonics on the planet.	NASA,LYNDON B JOHNSON SPACE CTR,PLANETARY SCI BRANCH,HOUSTON,TX 77058; UNIV CHICAGO,DEPT GEOPHYS SCI,CHICAGO,IL 60637; UNIV CHICAGO,ENRICO FERMI INST,DEPT CHEM,CHICAGO,IL 60637	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Chicago; University of Chicago								ASHWORTH JR, 1975, NATURE, V256, P714, DOI 10.1038/256714a0; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; CARR MH, 1987, NATURE, V326, P30, DOI 10.1038/326030a0; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; FALLICK AE, 1983, LUNAR PLANET SCI, V14, P183; FIREMAN EL, 1982, EARTH PLANET SC LETT, V60, P339, DOI 10.1016/0012-821X(82)90072-3; FLORAN RJ, 1978, GEOCHIM COSMOCHIM AC, V42, P1213, DOI 10.1016/0016-7037(78)90115-1; GOODING JL, 1990, METEORITICS, V25, P281, DOI 10.1111/j.1945-5100.1990.tb00712.x; GOODING JL, 1991, GEOCHIM COSMOCHIM AC, V26, P135; HARVEY HP, 1991, METEORITICS, V26, P343; JAKOSKY BM, 1991, ICARUS, V94, P14, DOI 10.1016/0019-1035(91)90138-J; JULL AJT, 1988, GEOCHIM COSMOCHIM AC, V52, P1309, DOI 10.1016/0016-7037(88)90285-2; KERRIDGE JF, 1988, LUNAR PLANET SCI, V19, P599; MUEHLENBACHS K, 1976, J GEOPHYS RES, V81, P4365, DOI 10.1029/JB081i023p04365; NORMAN DI, 1982, NATURE, V296, P551, DOI 10.1038/296551a0; ONEIL JR, 1966, J GEOPHYS RES, V71, P4956; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; SARAFIN R, 1985, EARTH PLANET SC LETT, V75, P72, DOI 10.1016/0012-821X(85)90051-2; SCHUELER B, 1990, GEOPHYS RES LETT, V17, P1295, DOI 10.1029/GL017i009p01295; Smykatz-Kloss W., 1974, DIFFERENTIAL THERMAL, DOI DOI 10.1007/978-3-642-65951-5; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; TREIMAN AH, 1985, METEORITICS, V20, P229, DOI 10.1111/j.1945-5100.1985.tb00862.x; TREIMAN AH, 1991, METEORITICS, V26, P402; WATSON LL, 1991, LUNAR PLANET SCI, V22, P1473; Wood C.A., 1981, P LUNAR PLANET SCI C, V12B, P1359; YANG J, 1985, LUNAR PLANET SCI, V16, P25	29	150	151	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 13	1992	255	5050					1409	1411		10.1126/science.11537889	http://dx.doi.org/10.1126/science.11537889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH744	11537889				2022-12-28	WOS:A1992HH74400046
J	MELOSH, HJ; SCHNEIDER, NM; ZAHNLE, KJ; LATHAM, D				MELOSH, HJ; SCHNEIDER, NM; ZAHNLE, KJ; LATHAM, D			IGNITION OF GLOBAL WILDFIRES AT THE CRETACEOUS TERTIARY BOUNDARY	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; US FOREST SERV,INTERMT FIRE SCI LAB,MISSOULA,MT 59807	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Agriculture (USDA); United States Forest Service	MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.		Baykaykom, supit/B-5173-2009					ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ W, 1986, EOS, V67, P653; ARGYLE E, 1986, SCIENCE, V234, P261, DOI 10.1126/science.234.4774.261-d; ARGYLE E, 1989, ICARUS, V77, P220, DOI 10.1016/0019-1035(89)90018-3; Bate R.R., 1971, FUNDAMENTALS ASTRODY; BOHOR BF, 1987, GEOLOGY, V15, P896, DOI 10.1130/0091-7613(1987)15<896:DSATML>2.0.CO;2; BOHOR BF, 1987, SCIENCE, V236, P705, DOI 10.1126/science.236.4802.705; BROWNLEE DE, 1985, ANNU REV EARTH PL SC, V13, P147, DOI 10.1146/annurev.ea.13.050185.001051; Chamberlain J. W., 1987, THEORY PLANETARY ATM, p[1, 89]; EMILIANI C, 1981, EARTH PLANET SC LETT, V55, P317, DOI 10.1016/0012-821X(81)90161-8; GLASSTONE S, 1977, EFFECTS NUCLEAR WEAP; HILDEBRAND AR, 1989, LUNAR PLANET SCI, V20, P414; HOLTON JR, 1979, INTRO DYNAMIC METEOR, P1; JONES EM, 1982, GEOL SOC AM SPEC PAP, V190, P175; KYTE FT, 1985, EARTH PLANET SC LETT, V73, P183, DOI 10.1016/0012-821X(85)90067-6; LAROCCA AJ, 1978, INFRARED HDB; Martin S., 1965, 10 S INT COMB, P877, DOI 10.1016/S0082-0784(65)80232-6; Melosh H.J, 1989, IMPACT CRATERING GEO, P1; Melosh H. J., 1982, GEOL SOC AM SPEC PAP, V190, P121; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MONTANARI A, 1983, GEOLOGY, V11, P668, DOI 10.1130/0091-7613(1983)11<668:SATCBA>2.0.CO;2; OKEEFE JD, 1988, GLOBAL CATASTROPHES, P133; SIMMS DL, 1967, COMBUST FLAME, V11, P377, DOI 10.1016/0010-2180(67)90058-2; SIMMS DL, 1963, COMBUST FLAME, V7, P253; SMIT J, 1981, NATURE, V292, P47, DOI 10.1038/292047a0; VICKERY AM, IN PRESS GEOL SOC AM; WHIPPLE FL, 1950, P NATL ACAD SCI USA, V36, P687, DOI 10.1073/pnas.36.12.687; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; WOLBACH WS, 1988, NATURE, V334, P665, DOI 10.1038/334665a0; ZAHNLE KJ, IN PRESS GEOL SOC AM; [No title captured], DOI DOI 10.1130/SPE190-P103	31	139	143	1	20	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 18	1990	343	6255					251	254		10.1038/343251a0	http://dx.doi.org/10.1038/343251a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	11536461				2022-12-28	WOS:A1990CJ68200067
J	Ramsey, JD; Butcher, MA; Murphy, MF; Lee, T; Johnston, A; Holt, DW				Ramsey, JD; Butcher, MA; Murphy, MF; Lee, T; Johnston, A; Holt, DW			A new method to monitor drugs at dance venues	BRITISH MEDICAL JOURNAL			English	Article							ECSTASY		Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London Kings Coll, London SE1 8WA, England; St Bartholomews & Royal London Sch Med & Dent, London EC1M 6BQ, England	St Georges University London; University of London; King's College London; University of London; Queen Mary University London	Holt, DW (corresponding author), Univ London St Georges Hosp, Sch Med, London SW17 0RE, England.			Johnston, Atholl/0000-0001-5787-2270				MOFFAT AC, 1986, CLARKES ISOLATION ID, P139; Ramsey JD, 1999, LANCET, V354, P2166, DOI 10.1016/S0140-6736(05)77071-9; RAMSEY JD, 1999, TICTAC VERSION 4 4; Sherlock K, 1999, J ACCID EMERG MED, V16, P194	4	30	30	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					603	603		10.1136/bmj.323.7313.603	http://dx.doi.org/10.1136/bmj.323.7313.603			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557708	Green Published, Bronze			2022-12-28	WOS:000171087300019
J	Anderson, DL				Anderson, DL			Geophysics - Top-down tectonics?	SCIENCE			English	Editorial Material							MANTLE; CONVECTION; SLABS		CALTECH, Seismol Lab, Pasadena, CA 91125 USA	California Institute of Technology	Anderson, DL (corresponding author), CALTECH, Seismol Lab, Pasadena, CA 91125 USA.	dla@gps.caltech.edu						BECKER T, IN PRESS GEOCHEM GEO; CHANDRASEKHAR S, 1961, HYDRODYNAMIC HYDROMA, P654; Cizkova H, 1999, GEOPHYS RES LETT, V26, P1501, DOI 10.1029/1999GL900261; Conrad CP, 1999, GEOPHYS RES LETT, V26, P3041, DOI 10.1029/1999GL005397; Dziewonski AM, 2000, PROBLEMS IN GEOPHYSICS FOR THE NEW MILLENNIUM, P289; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; Gu YJ, 2001, J GEOPHYS RES-SOL EA, V106, P11169, DOI 10.1029/2001JB000340; Karki BB, 2001, GEOPHYS RES LETT, V28, P2699, DOI 10.1029/2001GL012910; Montagner JP, 2000, PROBLEMS IN GEOPHYSICS FOR THE NEW MILLENNIUM, P217; Oganov AR, 2001, NATURE, V411, P934, DOI 10.1038/35082048; PEARSON JRA, 1958, J FLUID MECH, V4, P489, DOI 10.1017/S0022112058000616; TACKLEY P, 1998, CORE MANTLE BOUNDARY; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Wen LX, 1997, EARTH PLANET SC LETT, V146, P367, DOI 10.1016/S0012-821X(96)00238-5; WEN LX, 1995, EARTH PLANET SC LETT, V133, P185, DOI 10.1016/0012-821X(95)00064-J; ZHAO YS, 1994, PHYS EARTH PLANET IN, V85, P273, DOI 10.1016/0031-9201(94)90118-X	16	167	179	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2016	2018		10.1126/science.1065448	http://dx.doi.org/10.1126/science.1065448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557870				2022-12-28	WOS:000171028700051
J	Mokdad, AH; Bowman, BA; Ford, ES; Vinicor, F; Marks, JS; Koplan, JP				Mokdad, AH; Bowman, BA; Ford, ES; Vinicor, F; Marks, JS; Koplan, JP			The continuing epidemics of obesity and diabetes in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISK FACTOR SURVEILLANCE; WEIGHT-GAIN; HEALTH; MELLITUS; US; PREVENTION; PREVALENCE; OVERWEIGHT; EXERCISE	Context Recent reports show that obesity and diabetes have increased in the United States in the past decade. Objective To estimate the prevalence of obesity, diabetes, and use of weight control strategies among US adults in 2000. Design, Setting, and Participants The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in all states in 2000, with 184450 adults aged 18 years or older. Main Outcome Measures Body mass index (BMI), calculated from self-reported weight and height; self-reported diabetes; prevalence of weight loss or maintenance attempts; and weight control strategies used. Results In 2000, the prevalence of obesity (BMI greater than or equal to 30 kg/m(2)) was 19.8%, the prevalence of diabetes was 7.3% and the prevalence of both combined was 2.9%. Mississippi had the highest rates of obesity (24.3%) and of diabetes (8.8%); Colorado had the lowest rate of obesity (13.8%); and Alaska had the lowest rate of diabetes (4.4%). Twenty-seven percent of US adults did not engage in any physical activity, and another 28.2% were not regularly active. Only 24.4% of US adults consumed fruits and vegetables 5 or more times daily. Among obese participants who had had a routine checkup during the past year, 42.8% had been advised by a health care professional to lose weight. Among participants trying to lose or maintain weight, 17.5% were following recommendations to eat fewer calories and increase physical activity to more than 150 min/wk. Conclusions The prevalence of obesity and diabetes continues to increase among US adults. Interventions are needed to improve physical activity and diet in communities nationwide.	Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Nutr & Phys Activ, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mokdad, AH (corresponding author), Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, MS E62,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	ahm1@cdc.gov						ADAY LA, 1989, DESIGNING CONDUCTING, P79; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *AM DIAB ASS, 1997, DIAB FACTS FIG; CASPERSEN CJ, 1987, DHHS PUBLICATION PHS; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Fontaine K., 1998, DIS MANAG HLTH OUT, V3, P61; Fontanarosa PB, 1999, JAMA-J AM MED ASSOC, V282, P1581, DOI 10.1001/jama.282.16.1581; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; HANSEN RG, 1995, J IND ECON, V43, P261, DOI 10.2307/2950579; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HOLBROOK TL, 1989, INT J OBESITY, V13, P723; Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON DE, 1998, P SECT SURV METH AM; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Ray NF, 1998, DIABETES CARE, V21, P296; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *SAS I INC, 1998, SAS VERS 6; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; Shah BV, 1997, SUDAAN USERS MANUAL; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854	39	1884	1942	1	138	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1195	1200		10.1001/jama.286.10.1195	http://dx.doi.org/10.1001/jama.286.10.1195			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559264	Bronze			2022-12-28	WOS:000170910400029
J	Schwetz, BA				Schwetz, BA			Treatment for hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-28	WOS:000170910400006
J	Ishigaki, Y; Li, XJ; Serin, G; Maquat, LE				Ishigaki, Y; Li, XJ; Serin, G; Maquat, LE			Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20	CELL			English	Article							CAP-BINDING PROTEIN; GLUTATHIONE-PEROXIDASE 1; INITIATION-FACTOR 4E; POLY(A)-BINDING PROTEIN; RIBONUCLEOPROTEIN PARTICLE; UPF PROTEINS; FACTOR 4G; NUCLEAR; COMPLEX; YEAST	Nonsense-mediated decay (NMD) eliminates mRNAs that prematurely terminate translation. We used antibody to the nuclear cap binding protein CBP80 or its cytoplasmic counterpart eIF4E to immunopurify RNP containing nonsense-free or nonsense-containing transcripts. Data indicate that NMD takes place in association with CBP80. We defined other components of NMD-susceptible mRNP as CBP20, PABP2, eIF4G, and the NMD factors Upf2 and Upf3. Consistent with the dependence of NMD on translation, the NMD of CBP80-bound mRNA is blocked by cycloheximide or suppressor tRNA. These findings provide evidence that translation can take place in association with CBP80. They also indicate that CBP80-bound mRNA undergoes a "pioneer" round of translation, before CBP80-CBP20 are replaced by eIF4E, and Upf2 and Upf3 proteins dissociate from upstream of exon-exon junctions.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059614] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 33938] Funding Source: Medline; NIGMS NIH HHS [GM 59614] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Chu E, 1999, METH MOL B, V118, P265; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Das B, 2000, MOL CELL BIOL, V20, P2827, DOI 10.1128/MCB.20.8.2827-2838.2000; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; HARLOW E, 1999, USING ANTIBODIES LAB, P74; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MAQUAT LE, 1995, RNA, V1, P453; MAQUAT LE, 2001, IN PRESS COLD SPRING; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shen EC, 2000, J BIOL CHEM, V275, P23718, DOI 10.1074/jbc.M002312200; Sun XL, 2000, EMBO J, V19, P4734, DOI 10.1093/emboj/19.17.4734; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	55	445	457	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					607	617		10.1016/S0092-8674(01)00475-5	http://dx.doi.org/10.1016/S0092-8674(01)00475-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551508	Bronze			2022-12-28	WOS:000170973200011
J	Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK				Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK			A novel peptide recognition mode revealed by the X-ray structure of a core U2AF-(35)/U2AF(65) heterodimer	CELL			English	Article							SPLICING FACTOR U2AF(35); PRE-MESSENGER-RNA; RIBONUCLEOPROTEIN AUXILIARY FACTOR; PROLINE-RICH LIGANDS; BINDING PROTEINS; SMALL-SUBUNIT; SH3 DOMAINS; WW DOMAIN; U2 SNRNP; SITE AG	U2 auxiliary factor (U2AF) is an essential splicing factor that recognizes the 3' splice site and recruits the U2 snRNP to the branch point. The X-ray structure of the human core U2AF heterodimer, consisting of the U2AF(35) central domain and a proline-rich region of U2AF(65), has been determined at 2.2 Angstrom resolution. The structure reveals a novel protein-protein recognition strategy, in which an atypical RNA recognition motif (RRM) of U2AF(35) and the U2AF(65) polyproline segment interact via reciprocal "tongue-in-groove" tryptophan residues. Complementary biochemical experiments demonstrate that the core U2AF heterodimer binds RNA, and that the interacting tryptophan side chains are essential for U2AF dimerization. Atypical RRMs in other splicing factors may serve as protein-protein interaction motifs elsewhere during spliceosome assembly.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Programs Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu		Kielkopf, Clara/0000-0002-7648-8271; Burley, Stephen K./0000-0002-2487-9713				ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Creighton T. E., 1993, PROTEINS STRUCTURES; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KANAAR R, 1993, SCIENCE, V262, P569, DOI 10.1126/science.7692602; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 1998, METH MOL B, V84, P3; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; McKinney R, 1997, CURR GENET, V32, P323, DOI 10.1007/s002940050284; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; Rudner DZ, 1998, MOL CELL BIOL, V18, P1765, DOI 10.1128/MCB.18.4.1765; Rudner DZ, 1996, P NATL ACAD SCI USA, V93, P10333, DOI 10.1073/pnas.93.19.10333; Rudner DZ, 1998, MOL CELL BIOL, V18, P4004, DOI 10.1128/MCB.18.7.4004; Sanchez R, 2000, METH MOL B, V143, P97; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zorio DAR, 1999, RNA, V5, P487, DOI 10.1017/S1355838299982225; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	52	167	169	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					595	605		10.1016/S0092-8674(01)00480-9	http://dx.doi.org/10.1016/S0092-8674(01)00480-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551507	Bronze			2022-12-28	WOS:000170973200010
J	Kim, VN; Kataoka, N; Dreyfuss, G				Kim, VN; Kataoka, N; Dreyfuss, G			Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex	SCIENCE			English	Article							PRE-MESSENGER-RNA; TRANSLATIONAL TERMINATION CODON; OPEN READING FRAME; NUCLEAR EXPORT; BINDING-PROTEINS; HNRNP PROTEINS; K-PROTEIN; SURVEILLANCE; YEAST; IDENTIFICATION	Nonsense-mediated messenger RNA (mRNA) decay, or NMD, is a critical process of selective degradation of mRNAs that contain premature stop codons. NMD depends on both pre-mRNA splicing and translation, and it requires recognition of the position of stop codons relative to exon-exon junctions. A key factor in NMD is hUpf3, a mostly nuclear protein that shuttles between the nucleus and cytoplasm and interacts specifically with spliced mRNAs. We found that hUpf3 interacts with Y14, a component of post-splicing mRNA-protein (mRNP) complexes, and that hUpf3 is enriched in Y14-containing mRNP complexes. The mRNA export factors Aly/REF and TAP are also associated with nuclear hUpf3, indicating that hUpf3 is in mRNP complexes that are poised for nuclear export. Like Y14 and Aly/REF, hUpf3 binds to spliced mRNAs specifically (similar to 20 nucleotides) upstream of exon-exon junctions. The splicing-dependent binding of hUpf3 to mRNAs before export, as part of the complex that assembles near exon-exon junctions, allows it to serve as a link between splicing and NMD in the cytoplasm.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Kataoka, Naoyuki/H-6298-2019	Dreyfuss, Gideon/0000-0001-8129-8774; Kataoka, Naoyuki/0000-0002-4498-7420	NIGMS NIH HHS [5 R01 GM37125.14] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037125] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Brogna S, 1999, RNA, V5, P562, DOI 10.1017/S1355838299981359; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHOI YD, 1984, P NATL ACAD SCI-BIOL, V81, P7471, DOI 10.1073/pnas.81.23.7471; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; He F, 1996, RNA, V2, P153; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; MATUNIS EL, 1993, J CELL BIOL, V121, P219, DOI 10.1083/jcb.121.2.219; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHAEL WM, 1995, CELL, V83, P415; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Ohno M, 1996, GENE DEV, V10, P997, DOI 10.1101/gad.10.8.997; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	46	236	249	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1832	1836		10.1126/science.1062829	http://dx.doi.org/10.1126/science.1062829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546873				2022-12-28	WOS:000170894400048
J	Macdonald, JS; Smalley, SR; Benedetti, J; Hundahl, SA; Estes, NC; Stemmermann, GN; Haller, DG; Ajani, JA; Gunderson, LL; Jessup, JM; Martenson, JA				Macdonald, JS; Smalley, SR; Benedetti, J; Hundahl, SA; Estes, NC; Stemmermann, GN; Haller, DG; Ajani, JA; Gunderson, LL; Jessup, JM; Martenson, JA			Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC-CANCER; CURATIVE RESECTION; RADIATION-THERAPY; ADJUVANT; SURVIVAL; FLUOROURACIL; CHEMOTHERAPY; METAANALYSIS; DISSECTION; CARCINOMA	Background: Surgical resection of adenocarcinoma of the stomach is curative in less than 40 percent of cases. We investigated the effect of surgery plus postoperative (adjuvant) chemoradiotherapy on the survival of patients with resectable adenocarcinoma of the stomach or gastroesophageal junction. Methods: A total of 556 patients with resected adenocarcinoma of the stomach or gastroesophageal junction were randomly assigned to surgery plus postoperative chemoradiotherapy or surgery alone. The adjuvant treatment consisted of 425 mg of fluorouracil per square meter of body-surface area per day, plus 20 mg of leucovorin per square meter per day, for five days, followed by 4500 cGy of radiation at 180 cGy per day, given five days per week for five weeks, with modified doses of fluorouracil and leucovorin on the first four and the last three days of radiotherapy. One month after the completion of radiotherapy, two five-day cycles of fluorouracil (425 mg per square meter per day) plus leucovorin (20 mg per square meter per day) were given one month apart. Results: The median overall survival in the surgery-only group was 27 months, as compared with 36 months in the chemoradiotherapy group; the hazard ratio for death was 1.35 (95 percent confidence interval, 1.09 to 1.66; P=0.005). The hazard ratio for relapse was 1.52 (95 percent confidence interval, 1.23 to 1.86; P<0.001). Three patients (1 percent) died from toxic effects of the chemoradiotherapy; grade 3 toxic effects occurred in 41 percent of the patients in the chemoradiotherapy group, and grade 4 toxic effects occurred in 32 percent. Conclusions: Postoperative chemoradiotherapy should be considered for all patients at high risk for recurrence of adenocarcinoma of the stomach or gastroesophageal junction who have undergone curative resection.	St Vincents Comprehens Canc Ctr, New York, NY USA; Kansas City Community Clin Oncol Program, Kansas City, MO USA; SW Oncol Grp, Ctr Stat, Seattle, WA USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Illinois, Coll Med, Peoria, IL 61656 USA; Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Univ Texas San Antonio, MD Anderson Canc Ctr, Houston, TX 77030 USA; Mayo Clin, Rochester, MN USA; Univ Texas San Antonio, San Antonio, TX 78285 USA	Saint Vincents Hospital Manhattan; Southwest Oncology Group; University of Hawaii System; University of Illinois System; University of Illinois Peoria; University System of Ohio; University of Cincinnati; University of Pennsylvania; University of Texas System; University of Texas at San Antonio (UTSA); UTMD Anderson Cancer Center; Mayo Clinic; University of Texas System; University of Texas at San Antonio (UTSA)	Macdonald, JS (corresponding author), SW Oncol Grp 9008, Operat Off, Publicat Off, 14980 Omicron Dr, San Antonio, TX 78245 USA.		Hundahl, Scott/AAF-2596-2020		NATIONAL CANCER INSTITUTE [U10CA038926, U10CA032102, U10CA035176] Funding Source: NIH RePORTER; NCI NIH HHS [CA32102, CA38926, CA35176] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1987, Cancer, V59, P2006; Beahrs OH, 1988, MANUAL STAGING CANC; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; COX DR, 1972, J R STAT SOC B, V34, P187; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; DENT DM, 1988, BRIT J SURG, V75, P110, DOI 10.1002/bjs.1800750206; DUPONT JB, 1978, CANCER-AM CANCER SOC, V41, P941, DOI 10.1002/1097-0142(197803)41:3<941::AID-CNCR2820410323>3.0.CO;2-M; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; GUNDERSON LL, 1982, INT J RADIAT ONCOL, V8, P1, DOI 10.1016/0360-3016(82)90377-7; GUNDERSON LL, 1995, CLIN ONCOLOGY, P1209; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Hundahl S A, 1996, Surg Oncol Clin N Am, V5, P129; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; *JAP RES SOC GASTR, JAP CLASS GASTR CARC; LANDRY J, 1990, INT J RADIAT ONCOL, V19, P1357, DOI 10.1016/0360-3016(90)90344-J; MALLIARD JA, 1991, PROG P AM SOC CLIN O, V10, P151; MCNEER G, 1951, ANN SURG, V134, P2, DOI 10.1097/00000658-195107000-00002; MOERTEL CG, 1969, LANCET, V2, P865; MOERTEL CG, 1984, J CLIN ONCOL, V2, P1249, DOI 10.1200/JCO.1984.2.11.1249; POON MA, 1989, J CLIN ONCOL, V7, P1407, DOI 10.1200/JCO.1989.7.10.1407; SCHEIN PS, 1982, CANCER, V49, P1771, DOI 10.1002/1097-0142(19820501)49:9<1771::AID-CNCR2820490907>3.0.CO;2-M; TAKAHASHI M, 1986, EUR J SURG ONCOL, V12, P247; Tepper JE, 1997, J CLIN ONCOL, V15, P2030, DOI 10.1200/JCO.1997.15.5.2030; THOMSON FB, 1952, SURG GYNECOL OBSTET, V95, P341; van de Velde CJH, 1998, ANN CHIR GYNAECOL FE, V87, P89; WANEBO HJ, 1993, ANN SURG, V218, P583, DOI 10.1097/00000658-199321850-00002; Zhang ZX, 1998, INT J RADIAT ONCOL, V42, P929, DOI 10.1016/S0360-3016(98)00280-6	27	2586	2776	1	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					725	730		10.1056/NEJMoa010187	http://dx.doi.org/10.1056/NEJMoa010187			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547741	Bronze			2022-12-28	WOS:000170772900003
J	Rattner, SL; Louis, DZ; Rabinowitz, C; Gottlieb, JE; Nasca, TJ; Markham, FW; Gottlieb, RP; Caruso, JW; Lane, JL; Veloski, J; Hojat, M; Gonnella, JS				Rattner, SL; Louis, DZ; Rabinowitz, C; Gottlieb, JE; Nasca, TJ; Markham, FW; Gottlieb, RP; Caruso, JW; Lane, JL; Veloski, J; Hojat, M; Gonnella, JS			Documenting and medical students' comparing clinical experiences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMBULATORY CARE; INTERNAL-MEDICINE; FAMILY MEDICINE; CLERKSHIP; CONTINUITY; ENCOUNTERS; ROTATION; MODEL	Context The decentralization of clinical teaching networks over the past decade calls for a systematic way to record the case-mix of patients, the severity of diseases, and the diagnostic procedures that medical students encounter in clinical clerkships. Objective To demonstrate a system that documents medical students' clinical experiences across clerkships. Design and Settings Evaluation of a method for recording student-patient clinical encounters using a pocket-sized computer-read patient encounter card at a US university hospital and its 16 teaching affiliates during academic years 1997-1998 through 1999-2000. Participants A total of 647 third-year medical students who completed patient encounter cards in 3 clerkships: family medicine, pediatrics, and internal medicine. Main Outcome Measures Number of patient encounters, principal and secondary diagnoses, severity of diseases, and diagnostic procedures as recorded on patient encounter cards; concordance of patient encounter card data with medical records. Results Students completed 86011 patient encounter cards: 48367 cards by 582 students in family medicine, 22604 cards by 469 students in pediatrics, and 15040 cards by 531 students in internal medicine. Significant differences were found in students' case-mix of patients, the level of disease severity, and the number of diagnostic procedures performed across the 3 clerkships. Stability of the findings within each clerkship across 3 academic years and the 77% concordance of students' reports of principal diagnosis with faculty's confirmation of diagnosis support the reliability and validity of the findings. Conclusions An instrument that facilitates students' documentation of clinical experiences can provide data on important differences among students' clerkship experiences. Data from this instrument can be used to assess the nature of students' clinical education.	Thomas Jefferson Univ, Jefferson Med Coll, Off Dean, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Family Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Pediat, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Rattner, SL (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Off Dean, 1025 Walnut St,Room 100, Philadelphia, PA 19107 USA.							Anderson MB, 1999, ACAD MED, V74, P13; ANDERSON TS, 1999, MED EDUC, V33, P429; Baker C, 1976, J Fam Pract, V3, P189; BEASLEY JW, 1985, J MED EDUC, V60, P320; Brennan BG, 1997, ACAD MED, V72, pS43, DOI 10.1097/00001888-199710001-00015; BUTTERFIELD PS, 1993, J GEN INTERN MED, V8, P189, DOI 10.1007/BF02599265; Carney PA, 2000, TEACH LEARN MED, V12, P21, DOI 10.1207/S15328015TLM1201_4; *CDCP, 2001, FASTATS A Z; Chatenay M, 1996, AM J SURG, V172, P366, DOI 10.1016/S0002-9610(96)00184-5; DENT JA, 1995, MED EDUC, V29, P58, DOI 10.1111/j.1365-2923.1995.tb02802.x; FERRELL BG, 1991, ACAD MED, V66, pS49, DOI 10.1097/00001888-199109000-00038; Frank SH, 1997, JAMA-J AM MED ASSOC, V278, P712, DOI 10.1001/jama.278.9.712; GONNELLA JS, 1984, JAMA-J AM MED ASSOC, V251, P637; GONNELLA JS, 1994, CLIN CRITERIA DIS ST; Grum CM, 1996, ACAD MED, V71, pS99, DOI 10.1097/00001888-199601000-00056; GRUPPEN LD, 1993, ACAD MED, V68, P674, DOI 10.1097/00001888-199309000-00013; HART AC, 1997, PROFESSIONAL ICD 9 C; Hobbs J, 1987, Fam Med, V19, P287; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; Kowlowitz V, 1996, ACAD MED, V71, P387, DOI 10.1097/00001888-199604000-00018; LINKS PS, 1988, MED TEACH, V10, P33, DOI 10.3109/01421598809019323; Louis DZ, 1996, ACAD MED, V71, pS19, DOI 10.1097/00001888-199610000-00032; Masters PA, 2001, J GEN INTERN MED, V16, P9; MUNRO JGC, 1984, MED EDUC, V18, P75, DOI 10.1111/j.1365-2923.1984.tb00976.x; PARKERSON GR, 1984, J MED EDUC, V59, P124; PARKERSON GR, 1986, J FAM PRACTICE, V23, P361; Parle JV, 1997, MED EDUC, V31, P99, DOI 10.1111/j.1365-2923.1997.tb02466.x; ROSEVEAR GC, 1989, ACAD MED, V64, P253, DOI 10.1097/00001888-198905000-00011; RUANE TJ, 1990, ACAD MED, V65, P138; SCHROEDER S A, 1988, Journal of General Internal Medicine, V3, pS5, DOI 10.1007/BF02600247; Schwiebert L P, 1993, Fam Med, V25, P257; SCHWIEBERT LP, 1993, TEACH LEARN MED, V5, P238; SELINE NE, 1987, FINAL REPORT STUDY C; SMITH BWH, 1989, J FAM PRACTICE, V29, P416; STIMMEL B, 1992, JAMA-J AM MED ASSOC, V268, P2060, DOI 10.1001/jama.268.15.2060; Vanek EP, 1993, TEACH LEARN MED, V5, P164; WITZKE DB, 1990, ACAD MED, V65, P440, DOI 10.1097/00001888-199007000-00005; ZIBARK J, 1997, HARV MED ED NEWS, V2, P8	38	61	61	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1035	1040		10.1001/jama.286.9.1035	http://dx.doi.org/10.1001/jama.286.9.1035			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559287	Bronze			2022-12-28	WOS:000170802500016
J	McMahon, SM; Miller, KH; Drake, J				McMahon, SM; Miller, KH; Drake, J			Social science and ecology - Networking tips for social scientists and ecologists	SCIENCE			English	Editorial Material									Univ Tennessee, Dept Ecol & Evolutionary Biol, Complex Syst Grp, Knoxville, TN 37996 USA; E Carolina Univ, Coastal Resources Management Program, Greenville, NC 27858 USA; E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	McMahon, SM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Complex Syst Grp, Knoxville, TN 37996 USA.							JOHNSON JC, 2001, J SOC STRUCT, V2; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; WASSERMAN S, 1994, ADV SOCIAL NETWORK A; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449; NETWORK ANAL MARKS W; NETWORKING INVISIBLE	6	19	20	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1604	1605		10.1126/science.1062026	http://dx.doi.org/10.1126/science.1062026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533467				2022-12-28	WOS:000170802900037
J	Schmitz, B; PeuckerEhrenbrink, E; Lindstrom, M; Tassinari, M				Schmitz, B; PeuckerEhrenbrink, E; Lindstrom, M; Tassinari, M			Accretion rates of meteorites and cosmic dust in the Early Ordovician	SCIENCE			English	Article							CHONDRITE PARENT BODY; ISOTOPE SYSTEMATICS; CONTINENTAL-CRUST; OSMIUM; RECORD; LIFE	Abundant fossil meteorites in marine, condensed Lower Ordovician limestones from Kinnekulle, Sweden, indicate that accretion rates of meteorites were one to two orders of magnitude higher during an interval of the Early Ordovician than at0 present, Osmium isotope and iridium analyses of whole-rock limestone indicate a coeval enhancement of one order of magnitude in the influx rate of cosmic dust. Enhanced accretion of cosmic matter may be related to the disruption of the L chondrite parent body around 500 million years ago.	WOODS HOLE OCEANOG INST,DEPT MARINE CHEM & GEOCHEM,WOODS HOLE,MA 02543; UNIV STOCKHOLM,DEPT GEOL & GEOCHEM,S-10691 STOCKHOLM,SWEDEN; PALEO GEOL CTR,S-53130 LINKOPING,SWEDEN	Woods Hole Oceanographic Institution; Stockholm University	Schmitz, B (corresponding author), GOTHENBURG UNIV,CTR EARTH SCI,DEPT MARINE GEOL,S-41381 GOTHENBURG,SWEDEN.			Peucker-Ehrenbrink, Bernhard/0000-0002-3819-992X				BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bland PA, 1996, GEOCHIM COSMOCHIM AC, V60, P2053, DOI 10.1016/0016-7037(96)00125-1; BOGARD DD, 1995, GEOCHIM COSMOCHIM AC, V59, P1383, DOI 10.1016/0016-7037(95)00051-Z; BURKE WH, 1982, GEOLOGY, V10, P516, DOI 10.1130/0091-7613(1982)10<516:VOSSTP>2.0.CO;2; ESSER BK, 1993, GEOCHIM COSMOCHIM AC, V57, P3093, DOI 10.1016/0016-7037(93)90296-9; ESSER BK, 1988, GEOCHIM COSMOCHIM AC, V52, P1383, DOI 10.1016/0016-7037(88)90209-8; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1995, GSA TODAY, V5, P189; Haack H, 1996, ICARUS, V119, P182, DOI 10.1006/icar.1996.0010; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; JENNISKENS P, 1994, METEORITICS, V29, P246, DOI 10.1111/j.1945-5100.1994.tb00678.x; LINDNER M, 1989, GEOCHIM COSMOCHIM AC, V53, P1597, DOI 10.1016/0016-7037(89)90241-X; LINDSTROM M, 1971, GEOL RUNDSCH, V60, P419, DOI DOI 10.1007/BF02000464; NYSTROM JO, 1988, NATURE, V336, P572, DOI 10.1038/336572a0; PEDERSEN RB, 1992, TERRA NOVA, V4, P217, DOI 10.1111/j.1365-3121.1992.tb00475.x; PeuckerEhrenbrink B, 1996, GEOCHIM COSMOCHIM AC, V60, P3187, DOI 10.1016/0016-7037(96)00161-5; PEUCKEREHRENBRINK B, 1995, EARTH PLANET SC LETT, V130, P155, DOI 10.1016/0012-821X(95)00003-U; RAVIZZA G, 1993, GEOCHIM COSMOCHIM AC, V57, P4301, DOI 10.1016/0016-7037(93)90324-P; RAVIZZA G, 1989, GEOCHIM COSMOCHIM AC, V53, P3257, DOI 10.1016/0016-7037(89)90105-1; Schmitz B, 1996, EARTH PLANET SC LETT, V145, P31, DOI 10.1016/S0012-821X(96)00205-1; SCHMITZ B, IN PRESS CHEM GEOL I; THORSLUND P, 1984, LITHOS, V17, P87, DOI 10.1016/0024-4937(84)90008-2; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	23	62	62	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 3	1997	278	5335					88	90		10.1126/science.278.5335.88	http://dx.doi.org/10.1126/science.278.5335.88			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XZ124	11536823				2022-12-28	WOS:A1997XZ12400042
J	SLOAN, LC; WALKER, JCG; MOORE, TC; REA, DK; ZACHOS, JC				SLOAN, LC; WALKER, JCG; MOORE, TC; REA, DK; ZACHOS, JC			POSSIBLE METHANE-INDUCED POLAR WARMING IN THE EARLY EOCENE	NATURE			English	Article							STRATOSPHERIC CLOUDS; CLIMATE; RATES; CH4	RECONSTRUCTIONS of early Eocene climate depict a world in which the polar environments support mammals and reptiles, deciduous forests, warm oceans and rare frost conditions 1-5. At the same time, tropical sea surface temperatures are interpreted to have been the same as or slightly cooler than present values 6. The question of how to warm polar regions of Earth without noticeably warming the tropics remains unresolved; increased amounts of greenhouse gases would be expected to warm all latitudes equally 7. Oceanic heat transport has been postulated as a mechanism for heating high latitudes 8-10, but it is difficult to explain the dynamics that would achieve this 7,11. Here we consider estimates of Eocene wetland areas and suggest that the flux of methane, an important greenhouse gas, may have been substantially greater during the Eocene than at present. Elevated methane concentrations would have enhanced early Eocene global warming, and also might specifically have prevented severe winter cooling of polar regions because of the potential of atmospheric methane to promote the formation of optically thick, polar stratospheric ice clouds 12-14.			SLOAN, LC (corresponding author), UNIV MICHIGAN,DEPT GEOL SCI,ANN ARBOR,MI 48109, USA.		Zachos, James C/A-7674-2008; Moore, Theodore/N-8848-2014	Zachos, James C/0000-0001-8439-1886; Moore, Theodore/0000-0003-4121-1325				ARTHUR MA, 1992, GEOL SOC AM PROG, V23, P178; Askin R.A., 1988, Geological Society of America Memoir, V169, P131; BARRON EJ, 1982, PALAEOGEOGR PALAEOCL, V40, P103, DOI 10.1016/0031-0182(82)90086-4; Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; CASE JA, 1988, GEOLOGY PALEONTOLOGY, P523; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Crowley TJ, 1991, PALEOCEANOGRAPHY, V6, P387, DOI 10.1029/91PA00432; CROWLEY TJ, 1991, QUATERNARY SCI REV, V10, P275, DOI 10.1016/0277-3791(91)90025-P; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Houghton J.T., 1990, CLIMATE CHANGE IPCC; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KINNE S, 1990, GEOPHYS RES LETT, V17, P373, DOI 10.1029/GL017i004p00373; MCCORMICK MP, 1987, J GEOPHYS RES-ATMOS, V92, P4297, DOI 10.1029/JD092iD04p04297; MCCORMICK MP, 1989, J GEOPHYS RES-ATMOS, V94, P11241, DOI 10.1029/JD094iD09p11241; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P741, DOI 10.1029/PA002i006p00741; POLLACK JB, 1985, J ATMOS SCI, V42, P245, DOI 10.1175/1520-0469(1985)042<0245:TIOPSC>2.0.CO;2; RAMANATHAN V, 1987, REV GEOPHYS, V25, P1441, DOI 10.1029/RG025i007p01441; RASMUSSEN RA, 1981, J GEOPHYS RES-OCEANS, V86, P9826, DOI 10.1029/JC086iC10p09826; RIND D, 1991, J GEOPHYS RES-ATMOS, V96, P7437, DOI 10.1029/91JD00009; RINSLAND CP, 1984, J GEOPHYS RES-ATMOS, V89, P7259, DOI 10.1029/JD089iD05p07259; Ronov A.B., 1979, INT GEOL REV, V21, P415, DOI 10.1080/00206818209467074; SCHWEITZER HJ, 1980, PALAEOGEOGR PALAEOCL, V30, P297, DOI 10.1016/0031-0182(80)90062-0; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; SHEPPARD JC, 1982, J GEOPHYS RES-OCEANS, V87, P1305, DOI 10.1029/JC087iC02p01305; SLOAN LC, 1990, THESIS PENNSYLVANIA; SLOAN LC, UNPUB GEOPHYS RES LE; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X	31	106	108	1	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 28	1992	357	6376					320	322		10.1038/357320a0	http://dx.doi.org/10.1038/357320a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW132	11536496	Green Published			2022-12-28	WOS:A1992HW13200044
J	CHYBA, C; SAGAN, C				CHYBA, C; SAGAN, C			ENDOGENOUS PRODUCTION, EXOGENOUS DELIVERY AND IMPACT-SHOCK SYNTHESIS OF ORGANIC-MOLECULES - AN INVENTORY FOR THE ORIGINS OF LIFE	NATURE			English	Review							CRETACEOUS-TERTIARY BOUNDARY; EARTHS PRIMITIVE ATMOSPHERE; EXTRATERRESTRIAL AMINO-ACIDS; CHEMICAL EVOLUTION; PREBIOTIC SYNTHESIS; BOLIDE IMPACTS; SOLAR-SYSTEM; CARBON; UV; PHOTOCHEMISTRY	Sources of organic molecules on the early Earth divide into three categories: delivery by extraterrestrial objects; organic synthesis driven by impact shocks; and organic synthesis by other energy sources (such as ultraviolet light or electrical discharges). Estimates of these sources for plausible end-member oxidation states of the early terrestrial atmosphere suggest that the heavy bombardment before 3.5 Gyr ago either produced or delivered quantities of organics comparable to those produced by other energy sources.	CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853	Cornell University								ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; Anders E., 1973, Moon, V8, P3, DOI 10.1007/BF00562747; ARVESEN JC, 1969, APPL OPTICS, V8, P2215, DOI 10.1364/AO.8.002215; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARAK I, 1975, ORIGINS LIFE EVOL B, V6, P483, DOI 10.1007/BF00928897; BARKER JL, 1968, GEOCHIM COSMOCHIM AC, V32, P627, DOI 10.1016/0016-7037(68)90053-7; BARNUN A, 1975, ICARUS, V24, P197, DOI 10.1016/0019-1035(75)90099-8; BARNUN A, 1970, SCIENCE, V168, P470, DOI 10.1126/science.168.3930.470; BRONSHTEN VA, 1983, PHYSICS METEORIC PHE; BROWNLEE DE, 1985, ANN REV EARTH PLANET, V13, P189; CANUTO VM, 1982, NATURE, V296, P816, DOI 10.1038/296816a0; CEPLECHA Z, 1977, COMETS ASTEROIDS MET, P143; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1991, ICARUS, V92, P217, DOI 10.1016/0019-1035(91)90047-W; CHYBA CF, 1990, NATURE, V348, P113, DOI 10.1038/348113a0; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CHYBA CF, 1991, THESIS CORNELL U; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; DELSEMME AH, 1991, COMETS POSTHALLEY ER, P377; DOHNANYI JS, 1971, SCIENCE, V173, P558, DOI 10.1126/science.173.3996.558; Dreibus G., 1989, ORIGIN EVOLUTION PLA, P268; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; FERNANDEZ JA, 1983, ICARUS, V54, P377, DOI 10.1016/0019-1035(83)90235-X; FERRIS JP, 1975, J AM CHEM SOC, V97, P2962, DOI 10.1021/ja00844a007; Folinsbee R.E., 1967, GEOCHIM COSMOCHIM AC, V31, P1625; FREUND F, 1986, ORIGINS LIFE EVOL B, V16, P291, DOI 10.1007/BF02422032; GILVARRY JJ, 1963, NATURE, V197, P624, DOI 10.1038/197624c0; Greenfield J.C., 1981, COMETS ORIGIN LIFE, P111; GRIEVE RAF, 1982, GEOL SOC AM SPEC PAP, V190, P25; GRUN E, 1985, ICARUS, V62, P244, DOI 10.1016/0019-1035(85)90121-6; HEROUX L, 1978, J GEOPHYS RES-SPACE, V83, P5305, DOI 10.1029/JA083iA11p05305; HONG KY, 1974, SCIENCE, V184, P984, DOI 10.1126/science.184.4140.984; Hughes D. W., 1978, Cosmic dust, P123; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LEVIN BY, 1986, METEORITICS, V21, P199, DOI 10.1111/j.1945-5100.1986.tb01242.x; Lewis J. S., 1982, SPEC PAP GEOL SOC AM, V190, P215; LOVE SG, 1991, ICARUS, V89, P26, DOI 10.1016/0019-1035(91)90085-8; MACKAY CP, 1988, NATURE, V332, P520; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MCKAY CP, 1989, LUNAR PLANET SCI C, V20, P671; MCKINNON WB, IN PRESS URANUS; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MELOSH HJ, 1981, MULTIRING BASINS, P29; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1991, NATURE, V350, P388; MOUNT GH, 1977, ASTROPHYS J, V214, pL47, DOI 10.1086/182440; MUKHIN LM, 1989, NATURE, V340, P46, DOI 10.1038/340046a0; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OBERBECK VR, 1989, NATURE, V339, P434, DOI 10.1038/339434b0; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; POLLACK JB, 1986, ICARUS, V67, P409, DOI 10.1016/0019-1035(86)90123-5; PRINN RG, 1987, EARTH PLANET SC LETT, V83, P1, DOI 10.1016/0012-821X(87)90046-X; RAO VV, 1967, CAN J CHEM ENG, V45, P61, DOI 10.1002/cjce.5450450201; Ryder G., 1990, EOS, V71, P322; Ryder G., 1990, EOS T AM GEOPHYS UN, VAGU71, P313, DOI [10.1029/90EO00086, DOI 10.1029/90EO00086, 10.1029/ 90EO00086]; SAGAN C, 1971, SCIENCE, V173, P417, DOI 10.1126/science.173.3995.417; SANFORD SA, 1989, ICARUS, V82, P146; SCATTERGOOD TW, 1989, ICARUS, V81, P413, DOI 10.1016/0019-1035(89)90061-4; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHLESINGER G, 1983, J MOL EVOL, V19, P383, DOI 10.1007/BF02101643; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; Schopf J.W., 1983, P214; SCHRAMM LS, 1989, METEORITICS, V24, P99, DOI 10.1111/j.1945-5100.1989.tb00950.x; SHOCK EL, 1990, NATURE, V343, P728, DOI 10.1038/343728a0; SHOEMAKER EM, 1990, ESA SP247, P155; SHOEMAKER EM, 1984, LUNAR PLANET SCI, V15, P780; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; STROM RG, 1987, ICARUS, V70, P517, DOI 10.1016/0019-1035(87)90093-5; THOMAS PJ, 1990, EOS, V71, P1429; TUNCEL G, 1987, NATURE, V329, P703, DOI 10.1038/329703a0; TURCO RP, 1982, ICARUS, V50, P1, DOI 10.1016/0019-1035(82)90096-3; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WALTER MR, 1983, EARTHS EARLIEST BIOS, P240; Whipple F. L., 1976, Memoires de la Societe Royal des Sciences de Liege. Collection in-8, V9, P101; WILHELMS DE, 1984, NASA, P107; ZAHNLE K, 1990, NATURE, V348, P157, DOI 10.1038/348157a0; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; ZAHNLE KJ, 1990, GEOL S AM S, V247, P271; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; 1981, BASALTIC VOLCANISM T; [No title captured], DOI DOI 10.1130/SPE190-P103	90	917	936	11	383	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JAN 9	1992	355	6356					125	132		10.1038/355125a0	http://dx.doi.org/10.1038/355125a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY629	11538392				2022-12-28	WOS:A1992GY62900047
J	YAMAGATA, Y; WATANABE, H; SAITOH, M; NAMBA, T				YAMAGATA, Y; WATANABE, H; SAITOH, M; NAMBA, T			VOLCANIC PRODUCTION OF POLYPHOSPHATES AND ITS RELEVANCE TO PREBIOTIC EVOLUTION	NATURE			English	Article							AQUEOUS-SOLUTION; PHOSPHORYLATION; PHOSPHORUS; ADENOSINE; AGENTS	PHOSPHATES would probably have been essential compounds for prebiotic evolution on the primitive Earth. In this context, there have been several studies of condensation of water-soluble phosphates to polyphosphates and phosphorylation and condensation or polymerization of biomolecules with polyphosphates 1-20. But most of the phosphorus on the early Earth would have been in the form of water-insoluble apatite, and the origin of the water-soluble polyphosphates required for prebiotic evolution has therefore been a mystery 21-24. Here we show, both from experiments that simulate magmatic conditions and from analysis of volatile condensates in volcanic gas, that volcanic activity can produce water-soluble polyphosphates through partial hydrolysis of P4O10. This mechanism seems to be the only viable route identified so far for the production of these species on the primitive Earth.			YAMAGATA, Y (corresponding author), KANAZAWA UNIV, FAC SCI, DEPT PHYS, 1-1 MARUNOUCHI, KANAZAWA, ISHIKAWA 920, JAPAN.							Best A.G, 1982, IGNEOUS METAMORPHIC; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CHUNG NM, 1971, TETRAHEDRON, V27, P1205, DOI 10.1016/S0040-4020(01)90868-3; FERRIS JP, 1968, SCIENCE, V161, P53, DOI 10.1126/science.161.3836.53; GRIFFITH EJ, 1977, ORIGINS LIFE EVOL B, V8, P71, DOI 10.1007/BF00927976; GRIFFITH EJ, 1977, CHEM EVOLUTION EARLY, P61; GULICK A, 1957, ANN NY ACAD SCI, V69, P309, DOI 10.1111/j.1749-6632.1957.tb49666.x; HANDSCHUH GJ, 1973, J MOL EVOL, V2, P251, DOI 10.1007/BF01654094; HULSHOF J, 1976, ORIGINS LIFE EVOL B, V7, P197, DOI 10.1007/BF00926938; LOHRMANN R, 1968, SCIENCE, V161, P64, DOI 10.1126/science.161.3836.64; LOHRMANN R, 1975, J MOL EVOL, V6, P237, DOI 10.1007/BF01794633; LOHRMANN R, 1971, SCIENCE, V171, P490, DOI 10.1126/science.171.3970.490; MAMBO VS, 1991, J VOLCANOL GEOTH RES, V46, P37, DOI 10.1016/0377-0273(91)90074-A; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1964, NATURE, V204, P1248, DOI 10.1038/2041248a0; PONNAMPE.C, 1965, SCIENCE, V148, P1221, DOI 10.1126/science.148.3674.1221; PONNAMPERUMA C, 1963, NATURE, V199, P222, DOI 10.1038/199222a0; RABINOWI.J, 1969, NATURE, V224, P795, DOI 10.1038/224795a0; RABINOWITZ J, 1970, HELV CHIM ACTA, V53, P1350, DOI 10.1002/hlca.19700530614; RABINOWITZ J, 1968, NATURE, V218, P442, DOI 10.1038/218442a0; Ross WH, 1924, IND ENG CHEM, V16, P563; SATO H, 1981, SCI REP KANAZAWA U, V26, P51; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SCHWARTZ A, 1968, NATURE, V218, P443, DOI 10.1038/218443a0; SCHWARTZ A, 1964, BIOCHIM BIOPHYS ACTA, V87, P694, DOI 10.1016/0926-6550(64)90290-7; Schwartz A. W., 1972, MOL EVOLUTION PREBIO, P129; SCHWARTZ AW, 1967, BIOCHIM BIOPHYS ACTA, V134, P9, DOI 10.1016/0005-2787(67)90083-4; SCHWARTZ AW, 1971, CHEM EVOLUTION ORIGI, V1, P207; TATSUMI Y, 1983, J GEOPHYS RES, V88, P5815, DOI 10.1029/JB088iB07p05815; Van Wazer J.R., 1958, PHOSPHORUS ITS COMPO, V1; WAENHELDT TV, 1967, BIOCHIM BIOPHYS ACTA, V1234, P1; YAMAGATA Y, 1982, ORIGINS LIFE EVOL B, V12, P333, DOI 10.1007/BF00927064; YAMAGATA Y, 1979, NATURE, V282, P284, DOI 10.1038/282284a0; YAMANAKA J, 1988, ORIGINS LIFE EVOL B, V18, P165, DOI 10.1007/BF01804669	34	241	248	5	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	1991	352	6335					516	519		10.1038/352516a0	http://dx.doi.org/10.1038/352516a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA226	11536483				2022-12-28	WOS:A1991GA22600058
J	Poliakoff, M; Anastas, P				Poliakoff, M; Anastas, P			A principled stance	NATURE			English	Article									Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England	University of Nottingham	Poliakoff, M (corresponding author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.		Anastas, Paul/L-3258-2013	Anastas, Paul/0000-0003-4777-5172				Anastas P, 2001, CHEM BRIT, V37, P26; Anastas P. T., 1998, GREEN CHEM THEORY PR; HAMLEY PA, 2001, CHEM ENG, V72, P24; Ritter SK, 2001, CHEM ENG NEWS, V79, P24, DOI 10.1021/cen-v079n027.p024	4	135	136	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					257	257		10.1038/35095133	http://dx.doi.org/10.1038/35095133			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565009	Bronze			2022-12-28	WOS:000171040500018
J	Omi, K				Omi, K			Interview - Setting priorities puts new minister in the hot seat	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					1983	1983						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557860				2022-12-28	WOS:000171028700017
J	Petitto, LA; Holowka, S; Sergio, LE; Ostry, D				Petitto, LA; Holowka, S; Sergio, LE; Ostry, D			Language rhythms in baby hand movements	NATURE			English	Article									York Univ, Dept Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada; Haskins Labs Inc, New Haven, CT 06511 USA; McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	York University - Canada; Yale University; Haskins Laboratories; McGill University	Petitto, LA (corresponding author), Dartmouth Coll, Dept Psychol, 302 Silsby Hall, Hanover, NH 03755 USA.		Sergio, Lauren/AAK-3274-2020; Galantucci, Bruno/E-5770-2010					Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Lieberman Philip, 2000, HUMAN LANGUAGE OUR R; Locke J.L., 1993, CHILDS PATH SPOKEN L; Locke JL, 2000, SCIENCE, V288, P449, DOI 10.1126/science.288.5465.449; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; MEIER RP, 1995, LANGUAGE, GESTURE, AND SPACE, P391; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; PETITTO LA, 1991, SCIENCE, V251, P1493, DOI 10.1126/science.2006424; Pinker S, 1992, ADAPTED MIND EVOLUTI, P451; STUDDERTKENNEDY MG, 1991, COGNITION SYMBOLIC P, P38; van der Stelt J. M., 1986, WENNER GREN CTR IN B, P163; Vihman M. M., 1996, PHONOLOGICAL DEV ORI	12	69	71	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					35	36		10.1038/35092613	http://dx.doi.org/10.1038/35092613			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544514				2022-12-28	WOS:000170801200027
J	Barzansky, B; Etzel, SI				Barzansky, B; Etzel, SI			Educational programs in US medical schools, 2000-2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								We used data from the 2000-2001 Liaison Committee on Medical Education Annual Medical School Questionnaire, which had a 100% response rate, and other sources to describe the status of medical education programs in the United States. In 2000-2001, the number of full-time medical school faculty members was 103553, a 1.1% increase from 1999-2000. The 37092 applicants for the class entering in 2000 represented a 3.7% decrease from the number of applicants in 1999. The majority of medical schools (58%) were in the process of major curriculum review and change during 2000-2001. In 72 schools (58%), students were required to pass both Steps 1 and 2 of the United States Medical Licensing Examinations to advance or graduate. The availability of patients to participate in clinical teaching during 2000-2001 decreased in almost half of schools compared with 1999-2000. Many schools reported difficulty in recruiting or retaining volunteer faculty members to provide clinical education in the community. Forty medical schools provided monetary payment to some or all community volunteer faculty members.	Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, Chicago, IL 60610 USA	American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad & Grad Med Educ Policy & Stand, 515 N State St, Chicago, IL 60610 USA.							Barzansky B, 2000, JAMA-J AM MED ASSOC, V284, P1114, DOI 10.1001/jama.284.9.1114; Barzansky B, 1998, JAMA-J AM MED ASSOC, V280, P803, DOI 10.1001/jama.280.9.803; Boex JR, 2000, ACAD MED, V75, P419, DOI 10.1097/00001888-200005000-00007; BUSSIGEL M, 1988, INNOVATION PROCESSES, P130; Fields SA, 1998, ACAD MED, V73, P95, DOI 10.1097/00001888-199801000-00019; FLEXNER A, 1910, MED ED US CANADA, V4; Krakower JY, 2000, JAMA-J AM MED ASSOC, V284, P1127, DOI 10.1001/jama.284.9.1127	7	30	30	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1049	+		10.1001/jama.286.9.1049	http://dx.doi.org/10.1001/jama.286.9.1049			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559289				2022-12-28	WOS:000170802500018
J	Branch, WT; Kern, D; Haidet, P; Weissmann, P; Gracey, CF; Mitchell, G; Inui, T				Branch, WT; Kern, D; Haidet, P; Weissmann, P; Gracey, CF; Mitchell, G; Inui, T			Teaching the human dimensions of care in clinical settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEDSIDE CASE PRESENTATIONS; PROFESSIONAL-DEVELOPMENT; PERCEPTIONS; CURRICULUM; RESIDENTS; PHYSICIAN; EXPERIENCE; AWARENESS; MEDICINE; FACULTY	Despite repeated calls to emphasize the humanistic dimensions of care during medical education, these are few known techniques for effective teaching of humanism. We describe the barriers that inhibit humanistic teaching and suggest pragmatic teaching methods to overcome such barriers and teach humanistic care in clinical settings. We began by asking participants at a conference on patient-physician communications sponsored by the American Academy on Physician and Patient in June 1 1998, "What can we do in the patient's presence to improve and teach the human dimensions of care? Please provide one or more examples of approaches you found to be effective. " We augmented this information with suggestions from a number of colleagues in other settings. In a series of iterations, we analyzed all their suggestions to identify key teaching methods. We found that barriers to teaching humanism largely consist of elements of the informal and hidden curricula in medical schools. We then defined methods to help teachers overcome these barriers. Specific methods fall into the 3 categories of taking advantage of seminal events, role modeling, and using active learning skills. We believe that formal courses and other well-motivated endeavors that take place away from patients fall to foster humanistic care. In contrast, we present pragmatic teaching methods that can be used in the fast-paced setting of the clinical environment.	Emory Univ, Sch Med, Dept Med, Div Gen Med, Atlanta, GA 30322 USA; Johns Hopkins Univ Sch, Bayview Med Ctr, Baltimore, MD USA; Baylor Coll Med, Houston Vet Affairs Med Ctr, Houston, TX 77030 USA; Univ Minnesota, Sch Med, Fairview, MN USA; Univ Rochester, Sch Med, Dept Med, Rochester, NY USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Fetzer Inst, Kalamazoo, MI USA	Emory University; Johns Hopkins University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; University of Minnesota System; University of Rochester; Indiana University System; Indiana University-Purdue University Indianapolis	Branch, WT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Gen Med, 1525 Clifton Rd, Atlanta, GA 30322 USA.	william-branch@emory.org	Weissmann, Peter/L-1074-2019					*AM COLL PHYS ETH, 1992, ANN INTERN MED, V117, P94; Baldwin DC, 1998, ACAD MED, V73, P1195, DOI 10.1097/00001888-199811000-00019; BALDWIN DWC, 1991, WESTERN J MED, V155, P140; Beaudoin C, 1998, CAN MED ASSOC J, V159, P765; Bowen JL, 1999, AM J MED, V107, P193; BRANCH W, 1991, J GEN INTERN MED, V6, P573, DOI 10.1007/BF02598231; Branch WT, 1995, J GEN INTERN MED, V10, P691, DOI 10.1007/BF02602767; Branch WT, 2000, J GEN INTERN MED, V15, P503, DOI 10.1046/j.1525-1497.2000.06298.x; BRANCH WT, 1991, ANN INTERN MED, V114, P482, DOI 10.7326/0003-4819-114-6-482; Branch WT, 2000, ACAD MED, V75, P127, DOI 10.1097/00001888-200002000-00006; Burack JH, 1999, J GEN INTERN MED, V14, P49, DOI 10.1046/j.1525-1497.1999.00280.x; Cohen-Cole SA, 1995, MED INTERVIEW CLIN C, P405; Cross K.P., 1981, ADULTS LEARNERS; ENDE J, 1983, JAMA-J AM MED ASSOC, V250, P777, DOI 10.1001/jama.250.6.777; Ende J, 1997, J GEN INTERN MED, V12, pS41, DOI 10.1046/j.1525-1497.12.s2.6.x; Freudtner C., 1994, ACAD MED, V69, P670; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; Hundert EM, 1996, ACAD MED, V71, P624, DOI 10.1097/00001888-199606000-00014; KAY J, 1990, JAMA-J AM MED ASSOC, V263, P572, DOI 10.1001/jama.263.4.572; KERN DE, 1998, CURRICULUM DEV MED E, P38; Knowles M., 1980, MODERN PRACTICE ADUL; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Kroenke K, 1997, SOUTHERN MED J, V90, P1069, DOI 10.1097/00007611-199711000-00002; LaCombe MA, 1997, ANN INTERN MED, V126, P217, DOI 10.7326/0003-4819-126-3-199702010-00007; Lehmann LS, 1997, NEW ENGL J MED, V336, P1150, DOI 10.1056/NEJM199704173361606; LINFORS EW, 1980, NEW ENGL J MED, V303, P1230, DOI 10.1056/NEJM198011203032110; Lipkin M, 1985, MED INTERVIEW CLIN C, P422; LIPKIN M, 1994, OFFICE PRACTICE MED, P970; Maguire P, 1996, EUR J CANCER, V32A, P1486, DOI 10.1016/0959-8049(96)00059-7; Marcus ER, 1999, ACAD MED, V74, P1211, DOI 10.1097/00001888-199911000-00014; Mezirow J., 1991, TRANSFORMATIVE DIMEN, DOI DOI 10.15123/UEL.89W1Y; Miller SZ, 1999, ACAD MED, V74, P800, DOI 10.1097/00001888-199907000-00014; MOORE GT, 1994, ACAD MED, V69, P983, DOI 10.1097/00001888-199412000-00017; Mutha S, 1997, ACAD MED, V72, P635, DOI 10.1097/00001888-199707000-00017; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; Palmer P., 1998, COURAGE TEACH EXPLOR; REULER JB, 1994, WESTERN J MED, V160, P335; REYNOLDS PP, 1991, ANN INTERN MED, V114, P91, DOI 10.7326/0003-4819-114-1-91; Romano J., 1941, JAMA CHICAGO ILL, V117, P664; Schoen Donald, 1987, ED REFLECTIVE PRACTI; SIMONS RJ, 1989, NEW ENGL J MED, V321, P1273, DOI 10.1056/NEJM198911023211821; Smith CS, 1997, ACAD MED, V72, P32; SMITH RC, 1995, ACAD MED, V70, P729, DOI 10.1097/00001888-199508000-00019; Sprinthall NA, 1994, MORAL DEV PROFESSION, P55; Stobo J., 1995, PROJECT PROFESSIONAL; SUTHERLAND TE, 1996, USING ACTIVE LEARNIN; WANGCHENG RM, 1989, J GEN INTERN MED, V4, P284, DOI 10.1007/BF02597397; Wear D, 1998, ANN INTERN MED, V129, P734, DOI 10.7326/0003-4819-129-9-199811010-00010; Westberg J, 1994, Fam Med, V26, P278; Wilkerson L, 1998, ACAD MED, V73, P387, DOI 10.1097/00001888-199804000-00011; WISE TN, 1985, PSYCHOSOMATICS, V26, P669, DOI 10.1016/S0033-3182(85)72811-3; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1; Wright S, 1996, ACAD MED, V71, P290, DOI 10.1097/00001888-199603000-00024; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706	55	195	201	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1067	1074		10.1001/jama.286.9.1067	http://dx.doi.org/10.1001/jama.286.9.1067			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559292	Bronze			2022-12-28	WOS:000170802500021
J	Dhoot, GK; Gustafsson, MK; Ai, XB; Sun, WT; Standiford, DM; Emerson, CP				Dhoot, GK; Gustafsson, MK; Ai, XB; Sun, WT; Standiford, DM; Emerson, CP			Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase	SCIENCE			English	Article							SONIC HEDGEHOG; HEPARAN-SULFATE; ARYLSULFATASE-A; ACTIVATION; MYOD; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; DOWNSTREAM; INDUCTION; MUSCLE	The developmental signaling functions of cell surface heparan sulfate proteoglycans (HSPGs) are dependent on their sulfation states. Here, we report the identification of QSulf1, the avian ortholog of an evolutionarily conserved protein family related to heparan-specific N-acetyl glucosamine sulfatases. QSulf1 expression is induced by Sonic hedgehog in myogenic somite progenitors in quail embryos and is required for the activation of MyoD, a Wnt-induced regulator of muscle specification. QSulf1 is localized on the cell surface and regulates heparan-dependent Writ signaling in C2C12 myogenic progenitor cells through a mechanism that requires its catalytic activity, providing evidence that QSulf1 regulates Writ signaling through desulfation of cell surface HSPGs.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of Pennsylvania; University of London; University of London Royal Veterinary College	Emerson, CP (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1157 BRBII-III,421 Curie Blvd, Philadelphia, PA 19104 USA.							Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1997, DEV BIOL, V185, P185, DOI 10.1006/dbio.1997.8555; Borycki AG, 1998, DEVELOPMENT, V125, P777; Cumberledge S, 1997, TRENDS GENET, V13, P421, DOI 10.1016/S0168-9525(97)01275-4; DHOOT GK, UNPUB; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBERTSON DA, 1992, BIOCHEM J, V288, P539, DOI 10.1042/bj2880539; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Wei G, 2000, J BIOL CHEM, V275, P27733	25	361	366	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1663	1666		10.1126/science.293.5535.1663	http://dx.doi.org/10.1126/science.293.5535.1663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533491	Green Submitted			2022-12-28	WOS:000170802900064
J	Gaherty, JB				Gaherty, JB			Seismic evidence for hotspot-induced buoyant flow beneath the Reykjanes Ridge	SCIENCE			English	Article							UPPER-MANTLE; ANISOTROPY; ICELAND; VELOCITIES; OCEAN; SEGMENTATION; TOMOGRAPHY; INVERSION; RAYLEIGH; PLUME	Volcanic hotspots and mid-ocean ridge spreading centers are the surface expressions of upwelling in Earth's mantle convection system, and their interaction provides unique information on upwelling dynamics. I investigated the influence of the Iceland hotspot on the adjacent mid-Atlantic spreading center using phase-delay times of seismic surface waves, which show anomalous polarization anisotropy-a delay-time discrepancy between waves with different polarizations. This anisotropy implies that the hotspot induces buoyancy-driven upwelling in the mantle beneath the ridge.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Gaherty, JB (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.							BarnouinJha K, 1997, J GEOPHYS RES-SOL EA, V102, P11979, DOI 10.1029/96JB03807; BELL RE, 1992, NATURE, V357, P583, DOI 10.1038/357583a0; Blackman DK, 1996, GEOPHYS J INT, V127, P415, DOI 10.1111/j.1365-246X.1996.tb04730.x; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; Fitton JG, 1997, EARTH PLANET SC LETT, V153, P197, DOI 10.1016/S0012-821X(97)00170-2; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; GEE LS, 1992, GEOPHYS J INT, V111, P363, DOI 10.1111/j.1365-246X.1992.tb00584.x; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Ito G, 1999, EARTH PLANET SC LETT, V165, P81, DOI 10.1016/S0012-821X(98)00216-7; Ito G, 2001, NATURE, V411, P681, DOI 10.1038/35079561; JUNG H, 2000, EOS S, V81, pF1209; Leveque JJ, 1998, GEOPHYS J INT, V133, P529, DOI 10.1046/j.1365-246X.1998.00504.x; MAUPIN V, 1985, GEOPHYS J ROY ASTR S, V83, P379, DOI 10.1111/j.1365-246X.1985.tb06493.x; MONTAGNER JP, 1991, J GEOPHYS RES-SOL EA, V96, P20337, DOI 10.1029/91JB01890; NATAF HC, 1986, J GEOPHYS RES-SOLID, V91, P7261, DOI 10.1029/JB091iB07p07261; Nicolas A., 1987, FORMATION ANISOTROPY, DOI DOI 10.1029/GD016P0111; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; Pritchard MJ, 2000, GEOPHYS J INT, V143, P119, DOI 10.1046/j.1365-246x.2000.00221.x; RIBE NM, 1992, J GEOPHYS RES-SOL EA, V97, P8737, DOI 10.1029/92JB00551; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; SCHILLING JG, 1973, NATURE, V242, P565, DOI 10.1038/242565a0; SCHLUE JW, 1977, GEOPHYS J ROY ASTR S, V49, P145, DOI 10.1111/j.1365-246X.1977.tb03706.x; Searle RC, 1998, EARTH PLANET SC LETT, V160, P463, DOI 10.1016/S0012-821X(98)00104-6; Silveira G, 1998, PHYS EARTH PLANET IN, V106, P257, DOI 10.1016/S0031-9201(98)00079-X; Smallwood JR, 1998, J GEOPHYS RES-SOL EA, V103, P5185, DOI 10.1029/97JB03387; VOGT PR, 1971, EARTH PLANET SC LETT, V13, P153, DOI 10.1016/0012-821X(71)90118-X; Webb SC, 1998, SCIENCE, V280, P1227, DOI 10.1126/science.280.5367.1227; White RS, 1997, PHILOS T R SOC A, V355, P319, DOI 10.1098/rsta.1997.0011; Wolfe CJ, 1997, NATURE, V385, P245, DOI 10.1038/385245a0; Wolfe CJ, 1998, SCIENCE, V280, P1230, DOI 10.1126/science.280.5367.1230; Yale MM, 1998, EARTH PLANET SC LETT, V161, P45, DOI 10.1016/S0012-821X(98)00136-8; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	32	55	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1645	1647		10.1126/science.1061565	http://dx.doi.org/10.1126/science.1061565			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533487				2022-12-28	WOS:000170802900059
J	Yuan, MS; Konstantopoulos, N; Lee, JS; Hansen, L; Li, ZW; Karin, M; Shoelson, SE				Yuan, MS; Konstantopoulos, N; Lee, JS; Hansen, L; Li, ZW; Karin, M; Shoelson, SE			Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK beta	SCIENCE			English	Article							KAPPA-B KINASE; NECROSIS-FACTOR-ALPHA; INDUCED TYROSINE PHOSPHORYLATION; SKELETAL-MUSCLE; ACTIVATION; RECEPTOR; ASPIRIN; IMPAIRS; GLUCOSE; AGENTS	We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the I kappaB kinase beta (IKK beta) attenuated insulin signaling in cultured cells, whereas IKK beta inhibition reversed insulin resistance. Thus, IKK beta, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion (Ikk beta (+/-)) protected against the development of insulin resistance during high-fat feeding and in obese Lep(ob/ob) mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKK beta pathway as a target for insulin sensitization.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	Steven.Shoelson@joslin.Harvard.edu	Lee, Jongsoon/AAG-1674-2020		NIAID NIH HHS [AI43477] Funding Source: Medline; NIDDK NIH HHS [DK51729, DK45493] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045493, R01DK051729, R37DK051729] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARON SH, 1982, DIABETES CARE, V5, P64, DOI 10.2337/diacare.5.1.64; CARO JF, 1989, DIABETES METAB REV, V5, P665, DOI 10.1002/dmr.5610050804; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ebstein W, 1876, BERLINER KLIN WOCHEN, V13, P337; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; FURST DE, 1994, ARTHRITIS RHEUM-US, V37, P1, DOI 10.1002/art.1780370102; GILGORE SG, 1960, DIABETES, V9, P392, DOI 10.2337/diab.9.5.392; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Harhaj EW, 1997, J BIOL CHEM, V272, P5409, DOI 10.1074/jbc.272.9.5409; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; KONSTANTOPOULOS N, UNPUB; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee J.-S., UNPUB; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; ROBINSON KA, 1993, AM J PHYSIOL, V265, pE36, DOI 10.1152/ajpendo.1993.265.1.E36; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	29	1453	1597	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1673	1677		10.1126/science.1061620	http://dx.doi.org/10.1126/science.1061620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533494				2022-12-28	WOS:000170802900067
J	Moore, A; Herrera, G; Nyamongo, J; Lackritz, E; Granade, T; Nahlen, B; Oloo, A; Opondo, G; Muga, R; Janssen, R				Moore, A; Herrera, G; Nyamongo, J; Lackritz, E; Granade, T; Nahlen, B; Oloo, A; Opondo, G; Muga, R; Janssen, R			Estimated risk of HIV transmission by blood transfusion in Kenya	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POPULATION; CHILDREN; REGION	Background During the past decade, developing countries have received limited support for blood safety programmes. The Kenya Ministry of Health did a collaborative multicentre assessment to establish the risk of HIV transmission by transfusion in Kenya, to promote awareness of blood safety issues in this country with a mature HIV epidemic, and to identify methods to reduce the risk of HIV transmission by blood transfusion in Kenya. Methods For 12 weeks, from April to July 1994, we collected information and blood samples from all blood donors, and pretransfusion samples were collected from all recipients in six government hospitals in Kenya. Blood donations were collected and screened for HIV according to standard practice in the hospital laboratories. Test results at a reference laboratory were compared with those of the hospital laboratories and risk of transfusion-associated HIV transmission was calculated. Findings The prevalence of HIV among blood donors was 6.4% (120 of 1877) and varied by hospital (range 2-20%). HIV test results were available for 1290 donor-recipient pairs. Of these, 26 HIV-positive donations were given to HIV-negative patients. We estimate that 2.0% of transfusions transmitted HIV. Problems in the hospitals that contributed to transfusion risk included inconsistent refrigeration, data entry errors, equipment failure, and lack of a quality-assurance programme. Interpretation A high proportion of blood transfusions transmitted HIV in this high-prevalence area of Africa, primarily because of erroneous laboratory practices. On the basis of these results, the Kenya Ministry of Health introduced a number of practical and inexpensive interventions to improve national blood safety.	CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; CDCP, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Kenya Minist Hlth, Nairobi, Kenya; Kenya Minist Hlth, Kisumu, Kenya; Kenya Govt Med Res Ctr, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Janssen, R (corresponding author), CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.		Nahlen, Bernard/AAH-2051-2021; Oloo, James Aggrey/CAF-3948-2022	Oloo, James Aggrey/0000-0001-7495-1827; Lackritz, Eve/0000-0002-5397-7291				ADDOYOBO EOD, 1991, TROP DOCT, V21, P162, DOI 10.1177/004947559102100409; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; DORWARD JA, 1989, TROP DOCT, V19, P155, DOI 10.1177/004947558901900404; FOSTER S, 1995, LANCET, V346, P225, DOI 10.1016/S0140-6736(95)91272-X; Fransen L., 1992, SAFE BLOOD DEV COUNT, P11; GREENBERG AE, 1988, JAMA-J AM MED ASSOC, V259, P545, DOI 10.1001/jama.259.4.545; GUMODOKA B, 1993, AIDS, V7, P387, DOI 10.1097/00002030-199303000-00013; JACOBS B, 1994, E AFR MED J, V71, P720; LACKRITZ EM, 1993, AIDS, V7, P995, DOI 10.1097/00002030-199307000-00014; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; McFarland W, 1997, AIDS, V11, pS97; SAVARIT D, 1992, BRIT MED J, V305, P498, DOI 10.1136/bmj.305.6852.498; SCHREIBER GB, 1996, NEW ENGL J MED, V334, P1885; WATSONWILLIAMS EJ, 1994, 10 INT C AIDS AUG	15	80	85	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					657	660		10.1016/S0140-6736(01)05783-X	http://dx.doi.org/10.1016/S0140-6736(01)05783-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530174				2022-12-28	WOS:000170615500031
J	Collet, JP; Vanasse, M; Marois, P; Amar, M; Goldberg, J; Lambert, J; Lassonde, M; Hardy, P; Fortin, J; Tremblay, SD; Montgomery, D; Lacroix, J; Robinson, A; Majnemer, A				Collet, JP; Vanasse, M; Marois, P; Amar, M; Goldberg, J; Lambert, J; Lassonde, M; Hardy, P; Fortin, J; Tremblay, SD; Montgomery, D; Lacroix, J; Robinson, A; Majnemer, A		HBO-CP Res Grp	Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial	LANCET			English	Article							MOTOR FUNCTION MEASURE; THERAPY	Background The use of hyperbaric oxygen for children with cerebral palsy has spread worldwide, despite little scientific evidence of efficacy. We did a randomised trial to assess the efficacy and side-effects of this form of therapy in children with cerebral palsy. Methods 111 children with cerebral palsy aged 3-12 years were randomly assigned hyperbaric oxygen (n=57) or slightly pressurised room air (n=54). All children received 40 treatments over 2 months. Hyperbaric oxygen treatment was Ih in 100% oxygen at 1.75 atmospheres absolute (ATA); children on slightly pressurised air received air at 1.3 ATA (the lowest pressure at which pressure can be felt, thereby ensuring the maintenance of masking). The main outcome measure was gross motor function. Secondary outcomes included performance in activities of daily living, attention, working memory, and speech. Findings For all outcomes, both groups improved over the course of the study, but without any difference between the two treatments. The score on the global gross motor function measure increased by 3.0% in the children on slightly pressurised air and 2.9% in those on hyperbaric oxygen. The mean difference between treatments was -0.40 (95% CI -1.69 to 0.90, p=0.544). Other changes were seen in speech, attention, memory, and functional skills. Ear problems occurred in 27 children treated by hyperbaric oxygen and in 15 treated with hyperbaric air (p=0.004). Interpretation In this study, hyperbaric oxygen did not improve the condition of children with cerebral palsy compared with slightly pressurised air. The improvement seen in both groups for all dimensions tested deserves further consideration.	Sir Mortimer B Davis Jewish Gen Hosp, Randomised Clin Trial Unit, Montreal, PQ H3T 1E2, Canada; Hop St Justine, Pediat Neurol Dept, Montreal, PQ H3T 1C5, Canada; Hop St Justine, Speech Therapy Dept, Montreal, PQ H3T 1C5, Canada; Hop St Justine, Ctr Readaptat Marie Enfant, Montreal, PQ H3T 1C5, Canada; Hop St Justine, Pediat Intens Care Unit, Montreal, PQ H3T 1C5, Canada; Ctr Hosp Hotel Dieu Levis, Levis, PQ, Canada; McGill Univ, Dept Educ Phys, Montreal, PQ, Canada; Inst Maritime Quebec, Montreal, PQ, Canada; Ctr Hosp Reg Rimouski, Montreal, PQ, Canada; Univ Montreal, Fac Med, Dept Social & Prevent Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; McGill University; Universite de Montreal; Universite de Montreal; McGill University	Collet, JP (corresponding author), Sir Mortimer B Davis Jewish Gen Hosp, Randomised Clin Trial Unit, 3755 Cote Ste Catherine,Suite A132, Montreal, PQ H3T 1E2, Canada.							BIETHER JK, 1993, PEDIAT PERINATOL EPI, V6, P339; Blanshard J, 1996, CLIN OTOLARYNGOL, V21, P400, DOI 10.1046/j.1365-2273.1996.00813.x; BLEILE K, 1994, MANUAL ARTICULATION, P120; BOWER E, 1992, DEV MED CHILD NEUROL, V34, P25; DELATOLAS J, 1993, ETUDE EPIDEMIOLOGIQU; DUDLEY JG, 1980, BATTERIE TESTS LANGA; FELDMAN AB, 1990, PHYS THER, V70, P602, DOI 10.1093/ptj/70.10.602; Greenberg LM, 1996, TOVA TEST VARIABLES; HAMPSON NB, 1999, HYPERBARIC OXYGENTHE; Kent R, 1994, REFERENCE MANUAL COM; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; LEILE KJ, 1993, ARTICULATORY PHONOLO; MACHADO JJ, 1989, AM COLL HYP MED ORL; Molnar GE, 1985, PEDIAT REHABILITATIO, P481; Montgomery D, 1999, UNDERSEA HYPERBAR M, V26, P235; Neubauer R, 1985, MED SUBACQUEA IPERBA, V5, P75; Neubauer RA, 1998, NEUROL RES, V20, pS33; Nighoghossian N, 1997, J NEUROL SCI, V150, P27, DOI 10.1016/S0022-510X(97)05398-7; Nordmark E, 1997, SCAND J REHABIL MED, V29, P25; Pervin L. A, 1993, PERSONALITY THEORY R; Prefontaine R. R., 1968, VOCABULAIRE ORAL ENF; QIBIAO W, 1995, P 11 INT C HYP MED F, P79; ROTHSTEIN JM, 1991, PHYS THER, V71, P589, DOI 10.1093/ptj/71.8.589; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Trahan J, 1999, PEDIAT PHYS THER, V11, P12; *U MONTR, 1993, EX ENF DYSPR PROT EX	26	102	112	1	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					582	586		10.1016/S0140-6736(00)04054-X	http://dx.doi.org/10.1016/S0140-6736(00)04054-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558483				2022-12-28	WOS:000167119100009
J	Gersonde, R; Kyte, FT; Bleil, U; Diekmann, B; Flores, JA; Gohl, K; Grahl, G; Hagen, R; Kuhn, G; Sierro, FJ; Volker, D; Abelmann, A; Bostwick, JA				Gersonde, R; Kyte, FT; Bleil, U; Diekmann, B; Flores, JA; Gohl, K; Grahl, G; Hagen, R; Kuhn, G; Sierro, FJ; Volker, D; Abelmann, A; Bostwick, JA			Geological record and reconstruction of the late Pliocene impact of the Eltanin asteroid in the Southern Ocean	NATURE			English	Article							ANTARCTICA; HISTORY; ICE	In 1995, an expedition on board the research vessel FS Polarstern explored the impact site of the Eltanin asteroid in the Southern Ocean, the only known asteroid impact into a deep ocean basin. Analyses of the geological record of the impact region place the event in the late Pliocene (similar to 2.15 Myr) and constrain the sire of the asteroid to be >1 km, The explosive force inferred for this event places it at the threshold of impacts believed to have global consequences, and its study should therefore provide a baseline for the reconstruction and modelling of similar events, which are common on geological timescales.	UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90095; UNIV BREMEN,FACHBEREICH GEOWISSENSCH,D-28334 BREMEN,GERMANY; UNIV SALAMANCA,DEPT GEOL,S-37008 SALAMANCA,SPAIN; MACQUARIE UNIV,SCH EARTH SCI,SYDNEY,NSW 2109,AUSTRALIA; USN,RES LAB,WASHINGTON,DC 20375	University of California System; University of California Los Angeles; University of Bremen; University of Salamanca; Macquarie University; United States Department of Defense; United States Navy; Naval Research Laboratory	Gersonde, R (corresponding author), ALFRED WEGENER INST POLAR & MARINE RES,POSTBOX 120161,D-27515 BREMERHAVEN,GERMANY.		Sierro, Francisco/A-4714-2008; Flores, Jose-Abel/D-4218-2009	Sierro, Francisco/0000-0002-8647-456X; Gohl, Karsten/0000-0002-9558-2116; Flores, Jose-Abel/0000-0003-1909-293X; Diekmann, Bernhard/0000-0001-5129-3649; Abelmann, Andrea/0000-0001-9432-0002; Kuhn, Gerhard/0000-0001-6069-7485				BARRETT PJ, 1992, NATURE, V359, P816, DOI 10.1038/359816a0; BARRETT PJ, IN PRESS P TERRA ANT, V3; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Bruno LA, 1997, EARTH PLANET SC LETT, V147, P37, DOI 10.1016/S0012-821X(97)00003-4; Burckle LH, 1996, GEOLOGY, V24, P235, DOI 10.1130/0091-7613(1996)024<0235:PPDIPA>2.3.CO;2; CANDE SC, 1982, EARTH PLANET SC LETT, V57, P63, DOI 10.1016/0012-821X(82)90173-X; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; DEMUIZON C, 1981, I FRANCAIS ETUDES AN, V6; GERSONDE R, IN PRESS MICROPALEON; GORBUNOVA ZN, 1976, INIT REP DSDP, V35, P479; Grieve RAF, 1994, HAZARDS DUE COMETS A, P417; Hall BL, 1997, J GEOL, V105, P285, DOI 10.1086/515922; HARWOOD DM, 1983, ANTARCT J US, V18, P98; HILLS JG, 1994, HAZARDS DUE COMETS A, P779; KELLOGG DE, 1984, ANTARCT J US, V19, P44; KENNETT JP, 1993, GEOGR ANN, V75, P20; KYTE FT, 1988, SCIENCE, V241, P63, DOI 10.1126/science.241.4861.63; KYTE FT, 1986, GEOLOGY, V14, P485, DOI 10.1130/0091-7613(1986)14<485:RVISCA>2.0.CO;2; KYTE FT, 1981, NATURE, V292, P417, DOI 10.1038/292417a0; KYTE FT, 1985, GEOCHIM COSMOCHIM AC, V49, P1095, DOI 10.1016/0016-7037(85)90001-8; MARGOLIS SV, 1990, SCIENCE, V251, P1594; Melosh H.L, 1989, IMPACT CRATERING GEO; OKEEFE JD, 1981, J LUNAR PLANET SCI, V12, P785; Perch-Nielsen K., 1985, PLANKTON STRATIGRAPH, V1, P427; QUILTY PG, 1992, RECENT PROGR ANTARCT, P699; RAFFI I, 1993, PALEOCEANOGRAPHY, V8, P387, DOI 10.1029/93PA00755; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Stroeven AP, 1996, GEOLOGY, V24, P727, DOI 10.1130/0091-7613(1996)024<0727:OMMTAP>2.3.CO;2; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; Toon OB, 1997, REV GEOPHYS, V35, P41, DOI 10.1029/96RG03038; WEBB PN, 1991, QUATERNARY SCI REV, V10, P215, DOI 10.1016/0277-3791(91)90020-U; WEBB PN, 1984, GEOLOGY, V12, P287, DOI 10.1130/0091-7613(1984)12<287:CMSAIV>2.0.CO;2; WEI W, 1992, PALEOCEANOGRAPHY, V8, P85; 1965, MARINE GEOLOGY USNS	34	130	134	0	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 27	1997	390	6658					357	363		10.1038/37044	http://dx.doi.org/10.1038/37044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YH549	11536816	Green Submitted			2022-12-28	WOS:A1997YH54900051
J	LYONS, JR; YUNG, YL; ALLEN, M				LYONS, JR; YUNG, YL; ALLEN, M			SOLAR CONTROL OF THE UPPER-ATMOSPHERE OF TRITON	SCIENCE			English	Article							IONOSPHERE; PHOTOCHEMISTRY; CHEMISTRY; NEPTUNE; METHANE; CARBON; TITAN; MODEL	If the upper atmosphere and ionosphere of Triton are controlled by precipitation of electrons from Neptune's magnetosphere as previously proposed, Triton could have the only ionosphere in the solar system not controlled by solar radiation. However, a new model of Triton's atmosphere, in which only solar radiation is present, predicts a large column of carbon atoms. With an assumed, but reasonable, rate of charge transfer between N2+ and C, a peak C+ abundance results that is close to the peak electron densities measured by Voyager in Triton's ionosphere. These results suggest that Triton's upper atmospheric chemistry may thus be solar-controlled. Measurement of key reaction rate constants, currently unknown or highly uncertain at Triton's low temperatures, would help to clarify the chemical and physical processes occurring in Triton's atmosphere.	CALTECH,JET PROP LAB,DIV EARTH & SPACE SCI,PASADENA,CA 91109	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	LYONS, JR (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.		Yung, Yuk/AAM-4850-2021	Yung, Yuk/0000-0002-4263-2562				ANICICH VG, 1986, ASTROPHYS J SUPPL S, V62, P553, DOI 10.1086/191151; BRAUN W, 1969, PROC R SOC LON SER-A, V312, P417, DOI 10.1098/rspa.1969.0168; BROADFOOT AL, 1989, SCIENCE, V246, P1459, DOI 10.1126/science.246.4936.1459; CANTU AM, 1981, PHYS REV A, V23, P1223, DOI 10.1103/PhysRevA.23.1223; CRUIKSHANK DP, 1991, B AM ASTRON SOC, V23, P1208; DELITSKY ML, 1990, GEOPHYS RES LETT, V17, P1725, DOI 10.1029/GL017i010p01725; HERBERT F, 1991, J GEOPHYS RES-PLANET, V96, P19241, DOI 10.1029/91JA01821; HUSAIN D, 1971, T FARADAY SOC, V67, P2025, DOI 10.1039/tf9716702025; IP WH, 1990, GEOPHYS RES LETT, V17, P1713, DOI 10.1029/GL017i010p01713; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Lyons J. L., UNPUB; MAJEED T, 1990, GEOPHYS RES LETT, V17, P1721, DOI 10.1029/GL017i010p01721; Rebbert R. E., 1972, J PHOTOCHEM, V1, P171; REES MH, 1989, PHYSICS CHEM UPPER A; RICHARDSON JD, 1990, GEOPHYS RES LETT, V17, P1673, DOI 10.1029/GL017i010p01673; SCHRODER K, 1991, J PHYS B-AT MOL OPT, V24, P2487, DOI 10.1088/0953-4075/24/10/007; SMITH GR, 1982, J GEOPHYS RES-SPACE, V87, P1351, DOI 10.1029/JA087iA03p01351; SPENCER JR, 1990, GEOPHYS RES LETT, V17, P1769, DOI 10.1029/GL017i010p01769; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1661, DOI 10.1029/GL017i010p01661; SUMMERS ME, 1989, ASTROPHYS J, V346, P495, DOI 10.1086/168031; SUMMERS ME, 1991, GEOPHYS RES LETT, V18, P2309, DOI 10.1029/91GL01334; THOMPSON WR, 1990, SCIENCE, V250, P415, DOI 10.1126/science.11538073; TORR MR, 1985, J GEOPHYS RES-SPACE, V90, P6675, DOI 10.1029/JA090iA07p06675; TRAFTON L, 1984, ICARUS, V58, P312, DOI 10.1016/0019-1035(84)90048-4; TYLER GL, 1989, SCIENCE, V246, P1466, DOI 10.1126/science.246.4936.1466; VANDISHOECK E, IN PRESS PROTOSTARS, V3; WHYTE AR, 1983, CHEM PHYS LETT, V98, P590, DOI 10.1016/0009-2614(83)80248-6; YELLE RV, 1989, NATURE, V339, P288, DOI 10.1038/339288a0; YELLE RV, 1991, ICARUS, V89, P347, DOI 10.1016/0019-1035(91)90182-S; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; YUNG YL, 1990, GEOPHYS RES LETT, V17, P1717, DOI 10.1029/GL017i010p01717	32	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 10	1992	256	5054					204	206						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM896	11540928				2022-12-28	WOS:A1992HM89600023
J	MCKAY, CP; TOON, OB; KASTING, JF				MCKAY, CP; TOON, OB; KASTING, JF			MAKING MARS HABITABLE	NATURE			English	Review							ATMOSPHERIC CARBON-DIOXIDE; CLIMATIC-CHANGE; MARTIAN PALEOCLIMATE; TERRESTRIAL PLANETS; NOBLE-GASES; RICH PLANET; CO2; EARTH; WATER; ABUNDANCE	Mars is believed to be lifeless, but it may be possible to transform it into a planet suitable for habitation by plants, and conceivably humans. The success of such an enterprise would depend on the abundance, distribution and form of materials on the planet that could provide carbon dioxide, water and nitrogen.	NASA,AMES RES CTR,DIV EARTH SYST SCI,MOFFETT FIELD,CA 94035; PENN STATE UNIV,DEPT GEOSCI,UNIVERSITY PK,PA 16802	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	MCKAY, CP (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035, USA.		Kasting, James/AAF-6851-2020					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; [Anonymous], 1975, COMMUNITIES ECOSYSTE; AVERNER MM, 1976, NASA SP414; BAUER JA, 1981, Z PFLANZENPHYSIOL, V103, P445; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; BILLINGS CE, 1973, NASA SP3006, P1; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Burns J. A., 1973, Icarus, V19, P126, DOI 10.1016/0019-1035(73)90145-0; CARR MH, 1986, ICARUS, V68, P187, DOI 10.1016/0019-1035(86)90019-9; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; CESS RD, 1980, ICARUS, V41, P159, DOI 10.1016/0019-1035(80)90169-4; CLARK B, 1991, MARS; CLARK BC, 1979, GEOPHYS RES LETT, V6, P811, DOI 10.1029/GL006i010p00811; DOLE SH, 1970, HABITABLE PLANETS MA; DREIBUS G, 1987, ICARUS, V71, P225, DOI 10.1016/0019-1035(87)90148-5; DREIBUS G, 1985, METEORITICS, V20, P367; Drew M C., 1979, CURR ADV PLANT SCI, V36, P1; FANALE FP, 1982, ICARUS, V50, P381, DOI 10.1016/0019-1035(82)90131-2; FANALE FP, 1974, J GEOPHYS RES, V79, P3397, DOI 10.1029/JC079i024p03397; FANALE FP, 1979, J GEOPHYS RES, V84, P8404, DOI 10.1029/JB084iB14p08404; FOGG MJ, 1989, JBIS-J BRIT INTERPLA, V42, P577; FOX JL, 1983, J GEOPHYS RES-SPACE, V88, P9027, DOI 10.1029/JA088iA11p09027; GIERASCH PJ, 1973, J ATMOS SCI, V30, P1502, DOI 10.1175/1520-0469(1973)030<1502:APVATC>2.0.CO;2; GREELEY R, 1987, SCIENCE, V236, P1653, DOI 10.1126/science.236.4809.1653; HAMMITT JK, 1987, NATURE, V330, P711, DOI 10.1038/330711a0; HAYNES RH, 1990, MORAL EXPERTISE, P161; HICKLENTON PR, 1980, CAN J BOT, V58, P2181, DOI 10.1139/b80-250; HOFFERT MI, 1981, ICARUS, V47, P112, DOI 10.1016/0019-1035(81)90096-8; JOOS F, 1991, NATURE, V349, P772, DOI 10.1038/349772a0; KASTING JF, 1984, J ATMOS CHEM, V1, P403, DOI 10.1007/BF00053803; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; Klingler J M, 1989, Adv Space Res, V9, P173, DOI 10.1016/0273-1177(89)90225-1; KONG TY, 1977, ICARUS, V32, P168, DOI 10.1016/0019-1035(77)90058-6; LEWIS JS, 1972, EARTH PLANET SC LETT, V15, P286, DOI 10.1016/0012-821X(72)90174-4; LIU SC, 1976, ICARUS, V28, P231, DOI 10.1016/0019-1035(76)90035-X; LLOYD NDH, 1977, PLANT PHYSIOL, V59, P936, DOI 10.1104/pp.59.5.936; LOVELOCK J, 1979, GAIA; Lovelock J.E., 1984, GREENING MARS; LOVELOCK JE, 1982, NATURE, V296, P561, DOI 10.1038/296561a0; MACEWEN JD, 1973, NASA SP3006, P455; MADDOX J, 1990, NATURE, V346, P311, DOI 10.1038/346311a0; McElroy M. B., 1977, Journal of Geophysical Research, V82, P4379, DOI 10.1029/JS082i028p04379; McKay C P, 1986, Adv Space Res, V6, P269, DOI 10.1016/0273-1177(86)90096-7; MCKAY CP, 1989, REV GEOPHYS, V27, P189, DOI 10.1029/RG027i002p00189; McKay CP, 1982, J BRIT INTER SOC, V35, P427; McKay CP, 1990, MORAL EXPERTISE, P184; MCKAY CP, 1985, AM ASTRONAUT SOC SCI, V62; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Meyer T R, 1989, J Br Interplanet Soc, V42, P147; OBERG JE, 1981, NEW EARTHS; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Oyama V. I., 1977, Journal of Geophysical Research, V82, P4669, DOI 10.1029/JS082i028p04669; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; PEPIN RO, 1987, REV GEOPHYS, V25, P293, DOI 10.1029/RG025i002p00293; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; POLLACK JB, 1982, ICARUS, V51, P169, DOI 10.1016/0019-1035(82)90079-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POSTAWKO SE, 1986, J GEOPHYS RES-SOLID, V91, pD431, DOI 10.1029/JB091iB04p0D431; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; RAMANATHAN V, 1985, J GEOPHYS RES-ATMOS, V90, P5547, DOI 10.1029/JD090iD03p05547; RASOOL SI, 1977, NATURE, V266, P822, DOI 10.1038/266822a0; ROGERS HH, 1983, SCIENCE, V220, P428, DOI 10.1126/science.220.4595.428; ROTH EM, 1964, ATMOSPHERE SPACE CAB, P13; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SAGAN C, 1973, ICARUS, V20, P513, DOI 10.1016/0019-1035(73)90026-2; Salisbury F.B., 1985, PLANT PHYSIOL; SECKBACH J, 1970, NATURE, V227, P744, DOI 10.1038/227744a0; SQUYRES SW, 1986, SCIENCE, V231, P249, DOI 10.1126/science.231.4735.249; STOKER CR, 1985, AM ASTRONAUT SOC SCI, V75; STOKER CR, 1985, AM ASTRONAUT SOC SCI, V74; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; TOULMIN P, 1976, SCIENCE, V194, P81, DOI 10.1126/science.194.4260.81; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; TUREKIAN KK, 1975, J ATMOS SCI, V32, P1257, DOI 10.1175/1520-0469(1975)032<1257:TNHAMF>2.0.CO;2; Valenzuela D.P., 1989, ADSORPTION EQUILIBRI; WEAST RC, 1978, CRC HDB CHEM PHYSICS; WELCH BE, 1963, FED PROC, V22, P1053; YUNG YL, 1988, ICARUS, V76, P146, DOI 10.1016/0019-1035(88)90147-9; ZENT AP, 1986, J GEOPHYS RES-SOLID, V91, pD439, DOI 10.1029/JB091iB04p0D439; ZENT AP, 1987, ICARUS, V71, P241, DOI 10.1016/0019-1035(87)90149-7	85	103	104	3	69	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 8	1991	352	6335					489	496		10.1038/352489a0	http://dx.doi.org/10.1038/352489a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA226	11538095	Green Submitted			2022-12-28	WOS:A1991GA22600051
J	RAU, GH; TAKAHASHI, T; MARAIS, DJD				RAU, GH; TAKAHASHI, T; MARAIS, DJD			LATITUDINAL VARIATIONS IN PLANKTON DELTA-C-13 - IMPLICATIONS FOR CO2 AND PRODUCTIVITY IN PAST OCEANS	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; COLUMBIA UNIV,LAMONT DOHERTY GEOL OBSERV,PALISADES,NY 10964	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Columbia University	RAU, GH (corresponding author), UNIV CALIF SANTA CRUZ,INST FIS TEORICA,SANTA CRUZ,CA 95064, USA.							ARTHUR MA, 1985, NATURE, V315, P216, DOI 10.1038/315216a0; BARRON EJ, 1985, CARBON CYCLE ATMOSPH, P504; BIGGS DC, 1987, OCEAN DRILLING PROJE, V113, P77; BRALOWER TJ, 1984, GEOLOGY, V12, P614, DOI 10.1130/0091-7613(1984)12<614:LPASDC>2.0.CO;2; CALDER JA, 1973, GEOCHIM COSMOCHIM AC, V37, P133, DOI 10.1016/0016-7037(73)90251-2; CHIPMAN DW, 1985, CARBON CHEM S ATLANT; DEAN WE, 1986, MAR GEOL, V70, P119, DOI 10.1016/0025-3227(86)90092-7; Degens E.T., 1969, ORG GEOCHEM, P304, DOI DOI 10.1007/978-3-642-87734-6_14; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; DESCOLASGROS C, 1985, MAR BIOL, V87, P1, DOI 10.1007/BF00396999; DEUSER WG, 1970, NATURE, V225, P1069, DOI 10.1038/2251069a0; Eadie B.J., 1973, MAR CHEM, V1, P199, DOI [10.1016/0304-4203(73)90004-2, DOI 10.1016/0304-4203(73)90004-2]; ELSAYED SZ, 1984, MARINE PHYTOPLANKTON, P19; ESTEP MLF, 1984, GEOCHIM COSMOCHIM AC, V48, P591, DOI 10.1016/0016-7037(84)90287-4; FONTUGNE M, 1978, EARTH PLANET SC LETT, V41, P365, DOI 10.1016/0012-821X(78)90191-7; FONTUGNE MR, 1981, OCEANOL ACTA, V4, P85; Holm-Hansen O., 1977, ADAPTATIONS ANTARCTI, P11; KERBY NW, 1985, ADV BOT RES, V11, P71, DOI 10.1016/S0065-2296(08)60169-X; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; LEWAN MD, 1986, GEOCHIM COSMOCHIM AC, V50, P1583, DOI 10.1016/0016-7037(86)90121-3; MCCABE B, 1985, THESIS U WAIKATO; MIZUTANI H, 1982, ORIGINS LIFE EVOL B, V12, P377, DOI 10.1007/BF00927070; PARDUE JW, 1976, GEOCHIM COSMOCHIM AC, V40, P309, DOI 10.1016/0016-7037(76)90208-8; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; RAU GH, 1987, EARTH PLANET SC LETT, V82, P269, DOI 10.1016/0012-821X(87)90201-9; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Sackett W.M., 1974, ADV ORG GEOCHEM, P661; SACKETT WM, 1986, ORG GEOCHEM, V9, P63, DOI 10.1016/0146-6380(86)90087-2; SACKETT WM, 1965, SCIENCE, V148, P235, DOI 10.1126/science.148.3667.235; Sharkey T. D., 1985, INORGANIC CARBON UPT, P389; SMITH SV, 1981, NATURE, V294, P252, DOI 10.1038/294252a0; WADA E, 1987, DEEP-SEA RES, V34, P829, DOI 10.1016/0198-0149(87)90039-2; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WONG WW, 1978, GEOCHIM COSMOCHIM AC, V42, P1809, DOI 10.1016/0016-7037(78)90236-3	36	448	465	2	64	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 12	1989	341	6242					516	518		10.1038/341516a0	http://dx.doi.org/10.1038/341516a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU721	11536614				2022-12-28	WOS:A1989AU72100048
J	Heppner, FL; Musahl, C; Arrighi, I; Klein, MA; Rulicke, T; Oesch, B; Zinkernagel, RM; Kalinke, U; Aguzzi, A				Heppner, FL; Musahl, C; Arrighi, I; Klein, MA; Rulicke, T; Oesch, B; Zinkernagel, RM; Kalinke, U; Aguzzi, A			Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; PRP KNOCKOUT MICE; B-CELLS; VARIANT CJD; PURIFICATION; LYMPHOCYTES; REPLICATION; RESISTANT; LACKING; AGENT	Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy are initiated by extracerebral exposure to prions. Although prion transmission from extracerebral sites to the brain represents a potential target for prophylaxis, attempts at vaccination have been limited by the poor immunogenicity of prion proteins. To circumvent this, we expressed an anti-prion protein (anti-PrP) mu chain in Prnp(o/o) mice. Transgenic mice developed sustained anti-PrP titers, which were not suppressed by introduction of Prnp(+) alleles. Transgene expression prevented pathogenesis of prions introduced by intraperitoneal injection in the spleen and brain. Expression of endogenous PrP (PrPC) in the spleen and brain was unaffected, suggesting that immunity was responsible for protection. This indicates the feasibility of immunological inhibition of prion disease in vivo.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Prion AG, CH-8057 Zurich, Switzerland; European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Rome, Italy	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; European Molecular Biology Laboratory (EMBL)	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Heppner, Frank/ABH-8393-2020; Aguzzi, Adriano/A-3351-2008	Heppner, Frank/0000-0001-9816-8917; Aguzzi, Adriano/0000-0002-0344-6708; Kalinke, Ulrich/0000-0003-0503-9564				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; HEPPNER FL, UNPUB; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; KOSCO MH, 1992, J IMMUNOL, V148, P2331; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0	28	274	298	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					178	182		10.1126/science.1063093	http://dx.doi.org/10.1126/science.1063093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11546838				2022-12-28	WOS:000171448800056
J	Levinsky, NG; Yu, W; Ash, A; Moskowitz, M; Gazelle, G; Saynina, O; Emanuel, EJ				Levinsky, NG; Yu, W; Ash, A; Moskowitz, M; Gazelle, G; Saynina, O; Emanuel, EJ			Influence of age on medicare expenditures and medical care in the last year of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ILL HOSPITALIZED ADULTS; SERIOUSLY ILL; DEATH; MORBIDITY; DECISIONS	Context Expenditures for Medicare beneficiaries in the last year of life decrease with increasing age. The cause of this phenomenon is uncertain. Objectives To examine this pattern in detail and evaluate whether decreases in aggressiveness of medical care explain the phenomenon. Design, Setting, and Patients Analysis of sample Medicare data for beneficiaries aged 65 years or older from Massachusetts (n=34131) and California (n=19064) who died in 1996. Main Outcome Measure Medical expenditures during the last year of life, analyzed by age group, sex, race, place and cause of death, comorbidity, and use of hospital services. Results For Massachusetts and California, respectively, Medicare expenditures per beneficiary were $35300 and $27800 among those aged 65 through 74 years vs $22000 and $21600 for those aged 85 years or older. The pattern of decreasing Medicare expenditures with age is pervasive, persisting throughout the last year of life in both states for both sexes, for black and white beneficiaries, for persons with varying levels of comorbidity, and for those receiving hospice vs conventional care, regardless of cause and site of death. The aggressiveness of medical care in both Massachusetts and California also decreased with age, as judged by less frequent hospital and intensive care unit admissions and by markedly decreasing use of cardiac catheterization, dialysis, ventilators, and pulmonary artery monitors, regardless of cause of death. Decrease in the cost of hospital services accounts for approximately 80% of the decrease in Medicare expenditures with age in both states. Conclusions Medicare expenditures in the last year of life decrease with age, especially for those aged 85 years or older. This is in large part because the aggressiveness of medical care in the last year of life decreases with increasing age.	Boston Univ, Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Hlth Care Res Unit, Boston, MA 02118 USA; US Dept Vet Affairs, Hlth Econ Resource Ctr Hlth Sci, Res Serv, Menlo Pk, CA USA; US Dept Vet Affairs, Hlth Econ Resource Ctr Hlth Sci, Dev Serv, Menlo Pk, CA USA; US Dept Vet Affairs, Ctr Cooperat Studies Hlth Serv, Menlo Pk, CA USA; Harvard Vanguard Med Associates, Palliat & Support Med Program, Boston, MA USA; Natl Bur Econ Res, Palo Alto, CA USA; NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA	Boston University; US Department of Veterans Affairs; US Department of Veterans Affairs; US Department of Veterans Affairs; Harvard Vanguard Medical Associates; National Bureau of Economic Research; National Institutes of Health (NIH) - USA	Levinsky, NG (corresponding author), Boston Univ, Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Hlth Care Res Unit, 715 Albany St, Boston, MA 02118 USA.		Ash, Arlene/AAG-2914-2019	Ash, Arlene/0000-0002-8448-0253	CLINICAL CENTER [Z01CL010508] Funding Source: NIH RePORTER	CLINICAL CENTER		Callahan D, 2000, NEW ENGL J MED, V342, P654, DOI 10.1056/NEJM200003023420910; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Hamel MB, 1999, ANN INTERN MED, V131, P721, DOI 10.7326/0003-4819-131-10-199911160-00002; Hamel MB, 2000, J AM GERIATR SOC, V48, pS176, DOI 10.1111/j.1532-5415.2000.tb03129.x; Hamel MB, 1996, J AM GERIATR SOC, V44, P1043, DOI 10.1111/j.1532-5415.1996.tb02935.x; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; Johnson MF, 2000, J CLIN ETHIC, V11, P323; Levinsky NG, 1999, J AM GERIATR SOC, V47, P553, DOI 10.1111/j.1532-5415.1999.tb02569.x; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; PICKLE LW, 1996, ATLAS US MORTALITY, P4; RILEY G, 1987, INQUIRY-J HEALTH CAR, V24, P233; Yu W, 2000, J GEN INTERN MED, V15, P97, DOI 10.1046/j.1525-1497.2000.02349.x	14	148	148	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1349	1355		10.1001/jama.286.11.1349	http://dx.doi.org/10.1001/jama.286.11.1349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560540	Green Published, Bronze			2022-12-28	WOS:000171024500028
J	Wessely, S				Wessely, S			Chronic fatigue syndrome - Trials and tribulations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Guys King & St Thomas Sch med, Dept Psychol Med, London SE5 8AF, England; Inst Psychiat, London, England	University of London; King's College London; University of London; King's College London	Wessely, S (corresponding author), Guys King & St Thomas Sch med, Dept Psychol Med, 103 Denmark Hill, London SE5 8AF, England.		Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929				Deyo RA, 1997, NEW ENGL J MED, V336, P1176, DOI 10.1056/NEJM199704173361611; GRANN D, 2001, NY TIMES        0617, P52; Joyce J, 1998, JAMA-J AM MED ASSOC, V280, P264, DOI 10.1001/jama.280.3.264; Natelson BH, 2001, JAMA-J AM MED ASSOC, V285, P2557, DOI 10.1001/jama.285.20.2557; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360	5	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1378	1379		10.1001/jama.286.11.1378	http://dx.doi.org/10.1001/jama.286.11.1378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560545				2022-12-28	WOS:000171024500033
J	Leary, RH				Leary, RH			Energy landscapes - Flirting with catastrophe	SCIENCE			English	Editorial Material									San Diego Supercomp Ctr, La Jolla, CA 92037 USA		Leary, RH (corresponding author), San Diego Supercomp Ctr, La Jolla, CA 92037 USA.							FRANKEL T, 1997, GEOMETRY PHYSICS, P382; GILMORE R, 1996, CATASTROPHE THEORY S; Milnor J. W., 1963, ANN MATH STUD, V51; Morse M, 1931, T AM MATH SOC, V33, P72, DOI 10.2307/1989459; Poston T., 1978, CATASTROPHE THEORY I; Thom R., 2018, STRUCTURAL STABILITY; Wales DJ, 2001, SCIENCE, V293, P2067, DOI 10.1126/science.1062565; Woodcock A., 1978, CATASTROPHE THEORY	8	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2013	2014		10.1126/science.1065303	http://dx.doi.org/10.1126/science.1065303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557867				2022-12-28	WOS:000171028700048
J	Valbuzzi, A; Yanofsky, C				Valbuzzi, A; Yanofsky, C			Inhibition of the B-subtilis regulatory protein TRAP by the TRAP-inhibitory protein, AT	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; BACILLUS-SUBTILIS; LEADER RNA; EXPRESSION; OPERON; GENES; BIOSYNTHESIS; TRANSCRIPTS; REPEATS; DOMAIN	An anti-TRAP (AT) protein, a factor of previously unknown function, conveys the metabolic signal that the cellular transfer RNA for tryptophan (tRNA(Trp)) is predominantly uncharged. Expression of the operon encoding AT is induced by uncharged tRNA(Trp). AT associates with TRAP, the trp operon attenuation protein, and inhibits its binding to its target RNA sequences. This relieves TRAP-mediated transcription termination and translation inhibition, increasing the rate of tryptophan biosynthesis. AT binds to TRAP primarily when it is in the tryptophan-activated state. The 53-residue AT polypeptide is homologous to the zinc-binding domain of DnaJ. The mechanisms regulating tryptophan biosynthesis in Bacillus subtilis differ from those used by Escherichia coli.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1995, P NATL ACAD SCI USA, V92, P7916, DOI 10.1073/pnas.92.17.7916; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BABITZKE P, 1994, J BIOL CHEM, V269, P16597; Du HS, 1997, J BACTERIOL, V179, P2582, DOI 10.1128/jb.179.8.2582-2586.1997; GOLLNICK P, IN PRESS BACILLUS SU; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; HALL CV, 1982, J BACTERIOL, V151, P918, DOI 10.1128/JB.151.2.918-923.1982; Henner Dennis, 1993, P269; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Miller J. H, 1972, EXPT MOL GENETICS; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VALBUZZI A, UNPUB; YANOFSKY C, 1999, ENCY MOL BIOL, V4, P2676	22	61	64	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2057	2059		10.1126/science.1062187	http://dx.doi.org/10.1126/science.1062187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557884				2022-12-28	WOS:000171028700065
J	Hardie, RC; Raghu, P				Hardie, RC; Raghu, P			Visual transduction in Drosophila	NATURE			English	Review							LIGHT-SENSITIVE CHANNELS; PDZ-DOMAIN PROTEIN; INAD-SIGNALING COMPLEXES; SINGLE-PHOTON RESPONSES; CGMP-GATED CHANNEL; TRP CA2+ CHANNEL; PHOSPHOLIPASE-C; KINASE-C; PHOTORECEPTOR DEACTIVATION; DIACYLGLYCEROL KINASE	The brain's capacity to analyse and interpret information is limited ultimately by the input it receives. This sets a premium on information capacity of sensory receptors, which can be maximized by optimizing sensitivity, speed and reliability of response. Nowhere is selection pressure for information capacity stronger than in the visual system, where speed and sensitivity can mean the difference between life and death. Phototransduction in flies represents the fastest G-protein-signalling cascade known. Analysis in Drosophila has revealed many of the underlying molecular strategies, leading to the discovery and characterization of signalling molecules of widespread importance.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	rch14@hermes.cam.ac.uk	Sikandar, Usama/F-6586-2016; Padinjat, Raghu/Z-5578-2019	Hardie, Roger/0000-0001-5531-3264				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; AHO AC, 1988, NATURE, V334, P348, DOI 10.1038/334348a0; Bahner M, 2000, J BIOL CHEM, V275, P2901, DOI 10.1074/jbc.275.4.2901; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; FERREIRA PA, 1994, J BIOL CHEM, V269, P3129; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Fleig A, 2001, BIOPHYS J, V80, p609A; GRAY P, 1985, PROC R SOC SER B-BIO, V223, P379, DOI 10.1098/rspb.1985.0007; HARDIE RC, 1986, TRENDS NEUROSCI, V9, P419, DOI 10.1016/0166-2236(86)90136-0; Hardie RC, 1995, J NEUROPHYSIOL, V74, P2590, DOI 10.1152/jn.1995.74.6.2590; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOWARD J, 1987, PROC R SOC SER B-BIO, V231, P415, DOI 10.1098/rspb.1987.0053; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KAUPP UB, 1992, ANNU REV PHYSIOL, V54, P153; KAUPP UB, 1995, CURR OPIN NEUROBIOL, V5, P434, DOI 10.1016/0959-4388(95)80002-6; KIRSCHFELD K, 1980, NATURWISSENSCHAFTEN, V67, P516, DOI 10.1007/BF01047639; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Li CJ, 1999, P NATL ACAD SCI USA, V96, P13474, DOI 10.1073/pnas.96.23.13474; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Minke B, 2000, HDB BIOL PHYSICS, V3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NASI E, 2000, HDB BIOL PHYS, V0003, P00389; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Oberwinkler J, 2000, J NEUROSCI, V20, P1701; PAK WL, 1976, SCIENCE, V194, P956, DOI 10.1126/science.824732; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Putney JW, 1999, BIOESSAYS, V21, P38; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schwarzer A, 2000, J BIOL CHEM, V275, P13448, DOI 10.1074/jbc.275.18.13448; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Stavenga DG, 1995, PROG RETIN EYE RES, V15, P231, DOI 10.1016/1350-9462(95)00011-9; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; Womack KB, 2000, J NEUROSCI, V20, P2792; WU CF, 1978, J GEN PHYSIOL, V71, P249, DOI 10.1085/jgp.71.3.249; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; YEANDLE S, 1973, J GEN PHYSIOL, V61, P552, DOI 10.1085/jgp.61.5.552; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	95	376	386	0	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					186	193		10.1038/35093002	http://dx.doi.org/10.1038/35093002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557987				2022-12-28	WOS:000170918800053
J	Affolter, J; Webb, DJ				Affolter, J; Webb, DJ			Urotensin II: a new mediator in cardiopulmonary regulation?	LANCET			English	Editorial Material							ORPHAN-RECEPTOR; ENDOGENOUS LIGAND; VASOCONSTRICTOR; GPR14; IDENTIFICATION; RESPONSES; RAT		Univ Edinburgh, Western Gen Hosp, Ctr Cardiovasc Sci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Webb, DJ (corresponding author), Univ Edinburgh, Western Gen Hosp, Ctr Cardiovasc Sci, Edinburgh EH4 2XU, Midlothian, Scotland.							Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Douglas SA, 2000, BRIT J PHARMACOL, V131, P1262, DOI 10.1038/sj.bjp.0703690; Hay DWP, 2000, BRIT J PHARMACOL, V131, P10, DOI 10.1038/sj.bjp.0703533; Hillier C, 2001, CIRCULATION, V103, P1378, DOI 10.1161/01.CIR.103.10.1378; Kelsall CJ, 1998, GEN COMP ENDOCR, V112, P210, DOI 10.1006/gcen.1998.7166; Liu QY, 1999, BIOCHEM BIOPH RES CO, V266, P174, DOI 10.1006/bbrc.1999.1796; MacLean MR, 2000, BRIT J PHARMACOL, V130, P201, DOI 10.1038/sj.bjp.0703314; Maguire JJ, 2000, BRIT J PHARMACOL, V131, P441, DOI 10.1038/sj.bjp.0703601; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Opgaard OS, 2000, EUR J PHARMACOL, V406, P265, DOI 10.1016/S0014-2999(00)00672-5; Stirrat A, 2001, AM J PHYSIOL-HEART C, V280, pH925, DOI 10.1152/ajpheart.2001.280.2.H925; Watanabe T, 2001, CIRCULATION, V104, P16, DOI 10.1161/hc2601.092848	15	27	28	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					774	775		10.1016/S0140-6736(01)06005-6	http://dx.doi.org/10.1016/S0140-6736(01)06005-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564476				2022-12-28	WOS:000170989300002
J	Fang, JY; Piao, SL; Tang, ZY; Peng, CH; Wei, J				Fang, JY; Piao, SL; Tang, ZY; Peng, CH; Wei, J			Interannual variability in net primary production and precipitation	SCIENCE			English	Editorial Material							CLIMATE		Beijing Univ, Minist Educ, Dept Urban & Environm Sci, Beijing 100871, Peoples R China; Beijing Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; Minist Nat Resources, Ontario Forest Res Inst, Sault Ste Marie, ON P6A 2E5, Canada; Univ Missouri, Dept Geosci, Kansas City, MO 64110 USA	Peking University; Peking University; Ministry of Natural Resources & Forestry; Natural Resources Canada; University of Missouri System; University of Missouri Kansas City	Fang, JY (corresponding author), Beijing Univ, Minist Educ, Dept Urban & Environm Sci, Beijing 100871, Peoples R China.	jyfang@urban.pku.edu.cn	Fang, Jingyun/A-4282-2009; Tang, Zhiyao/B-8795-2008; Peng, Changhui/G-8248-2012					FANG JY, 2001, 0103 PEK U CTR EC RE; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004	8	210	271	9	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1723	1723		10.1126/science.293.5536.1723a	http://dx.doi.org/10.1126/science.293.5536.1723a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546840				2022-12-28	WOS:000170894400001
J	Ghavidel, A; Schultz, MC				Ghavidel, A; Schultz, MC			TATA binding protein-associated CK2 transduces DNA damage, signals to the RNA polymerase III transcriptional machinery	CELL			English	Article							CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BETA-SUBUNIT; GENE; YEAST; CHECKPOINT; PROMOTERS; CKII; TBP	Here we report that RNA polymerase (pol) III transcription is repressed in response to DNA damage by downregulation of TFIIIB, the core component of the pol III transcriptional machinery. Protein kinase CK2 transduces this stress signal to TFIIIB. CK2 associates with and normally activates the TATA binding protein (TBP) subunit of TFIIIB. The beta regulatory subunit of CK2 binds to TBP and is required for high TBP-associated CK2 activity and pol III transcription in unstressed cells. Transcriptional repression induced by DNA damage requires CK2 and coincides with downregulation of TBP-associated CK2 and dissociation of catalytic subunits from TBP-CK2 complexes. Therefore, CK2 is the terminal effector in a signaling pathway that represses pol III transcription when genome integrity is compromised.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Schultz, MC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.							Aboussekhra A, 1998, GENE DEV, V12, P411, DOI 10.1101/gad.12.3.411; Aboussekhra A, 1996, EMBO J, V15, P3912, DOI 10.1002/j.1460-2075.1996.tb00765.x; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; Dobrowolska G, 1999, MOL CELL BIOCHEM, V191, P3, DOI 10.1023/A:1006882910351; Fan HY, 1996, GENETICS, V142, P749; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Ghavidel A, 1999, MOL CELL BIOCHEM, V191, P143, DOI 10.1023/A:1006885522221; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; *IARC, 1999, IARC MON EV CARC R 3, V71, P1059; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; KOCH H, 1976, BIOCHIM BIOPHYS ACTA, V454, P436, DOI 10.1016/0005-2787(76)90270-7; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Maldonado E, 1999, FEBS LETT, V443, P256, DOI 10.1016/S0014-5793(98)01734-7; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCulloch V, 2000, EMBO J, V19, P4134, DOI 10.1093/emboj/19.15.4134; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Moore DD, 1995, GLOB MOB SURV; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; NIKOLOV DB, 1994, NAT STRUCT BIOL, V1, P621, DOI 10.1038/nsb0994-621; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Raman C, 1998, J IMMUNOL, V161, P5817; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SETHY I, 1995, J BIOL CHEM, V270, P28463; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; SMITH GJ, 1983, MUTAT RES, V111, P405, DOI 10.1016/0027-5107(83)90036-2; TEITZ T, 1990, MUTAT RES, V236, P85, DOI 10.1016/0921-8777(90)90036-5; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	52	112	118	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					575	584		10.1016/S0092-8674(01)00473-1	http://dx.doi.org/10.1016/S0092-8674(01)00473-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551505	Bronze			2022-12-28	WOS:000170973200008
J	Higgins, CF; Linton, KJ				Higgins, CF; Linton, KJ			Structural biology - The xyz of ABC transporters	SCIENCE			English	Editorial Material							MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN		Imperial Coll Sch Med, MRC, Ctr Clin Sci, London W12 0NN, England	Imperial College London	Higgins, CF (corresponding author), Imperial Coll Sch Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus,DuCane Rd, London W12 0NN, England.	christopher.higgins@csc.mrc.ac.uk						Blott EJ, 1999, EMBO J, V18, P6800, DOI 10.1093/emboj/18.23.6800; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; ROSENBERG M, IN PRESS EMBO J; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685	10	68	71	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1782	1784		10.1126/science.1065588	http://dx.doi.org/10.1126/science.1065588			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546861				2022-12-28	WOS:000170894400034
J	Maroun, F; Ozanam, F; Magnussen, OM; Behm, RJ				Maroun, F; Ozanam, F; Magnussen, OM; Behm, RJ			The role of atomic ensembles in the reactivity of bimetallic electrocatalysts	SCIENCE			English	Article							CARBON-MONOXIDE; UNDERPOTENTIAL DEPOSITION; INITIAL-STAGES; PD DEPOSITION; SURFACE; PALLADIUM; ELECTRODES; ADSORPTION; AU(111); PB	Bimetallic electrodes are used in a number of electrochemical processes, but the rote of particular arrangements of surface metal atoms (ensembles) has not been studied directly. We have evaluated the electrochemical/catalytic properties of defined atomic ensembles in atomically flat PdAu(111) electrodes with variable surface stoichiometry that were prepared by controlled electrodeposition on Au(111). These properties are derived from infrared spectroscopic and voltammetric data obtained for electrode surfaces for which the concentration and distribution of the respective metal atoms are determined in situ by atomic resolution scanning tunneling microscopy with chemical contrast. Palladium monomers are identified as the smallest ensemble ("critical ensemble") for carbon monoxide adsorption and oxidation, whereas hydrogen adsorption requires at least palladium dimers.	Univ Ulm, Abt Oberflachenchem & Katalyse, D-89069 Ulm, Germany; Ecole Polytech, CNRS, Phys Mat Condensee Lab, F-91128 Palaiseau, France	Ulm University; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Behm, RJ (corresponding author), Univ Ulm, Abt Oberflachenchem & Katalyse, D-89069 Ulm, Germany.	juergen.behm@chemie.uni-ulm.de	Behm, Rolf Jürgen/D-9276-2019	Behm, Rolf Jürgen/0000-0002-7565-0628				Alvarez B, 2001, J ELECTROANAL CHEM, V497, P125, DOI 10.1016/S0022-0728(00)00466-6; BALDAUF M, 1993, ELECTROCHIM ACTA, V38, P2145, DOI 10.1016/0013-4686(93)80091-D; CAMPBELL CT, 1997, HDB HETEROGENEOUS CA, V2, P814; CARNAL D, 1995, ELECTROCHIM ACTA, V40, P1223, DOI 10.1016/0013-4686(95)00066-N; de Boer F.R., 1988, COHESION METALS TRAN; Gasteiger HA, 1996, CATAL LETT, V36, P1, DOI 10.1007/BF00807197; Gleich B, 1997, SURF SCI, V386, P48, DOI 10.1016/S0039-6028(97)00302-6; GREEN MP, 1990, J ELECTROCHEM SOC, V137, P3493, DOI 10.1149/1.2086255; Hoshi N, 2000, J ELECTROANAL CHEM, V485, P55, DOI 10.1016/S0022-0728(00)00098-X; Kibler LA, 2000, SURF SCI, V461, P155, DOI 10.1016/S0039-6028(00)00569-0; Kibler LA, 1999, SURF SCI, V443, P19, DOI 10.1016/S0039-6028(99)00968-1; LAM YL, 1977, NOUV J CHIM, V1, P461; Lin WF, 1999, J PHYS CHEM B, V103, P6968, DOI 10.1021/jp9910901; Markovic NM, 2000, SURF SCI, V465, P103, DOI 10.1016/S0039-6028(00)00674-9; MAROUN F, UNPUB; NAGL C, 1994, SURF SCI, V321, P237, DOI 10.1016/0039-6028(94)90189-9; Naohara H, 1998, J PHYS CHEM B, V102, P4366, DOI 10.1021/jp980624f; NEWMAN RC, 1994, SCIENCE, V263, P1708, DOI 10.1126/science.263.5154.1708; Ross PN, 1998, FRONT ELECT, P43; Sadigh B, 1999, PHYS REV LETT, V83, P1379, DOI 10.1103/PhysRevLett.83.1379; Schmid AK, 1996, PHYS REV LETT, V77, P2977, DOI 10.1103/PhysRevLett.77.2977; SYKES MF, 1976, J PHYS A-MATH GEN, V9, P87, DOI 10.1088/0305-4470/9/1/014; Wan LJ, 2000, J ELECTROANAL CHEM, V484, P189, DOI 10.1016/S0022-0728(00)00082-6; WATANABE M, 1975, J ELECTROANAL CHEM, V60, P275, DOI 10.1016/S0022-0728(75)80262-2; Zou SZ, 1999, J ELECTROANAL CHEM, V474, P155, DOI 10.1016/S0022-0728(99)00329-0	25	415	417	10	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1811	1814		10.1126/science.1061696	http://dx.doi.org/10.1126/science.1061696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546868				2022-12-28	WOS:000170894400041
J	Spudis, PD				Spudis, PD			Planetary science - What is the moon made of?	SCIENCE			English	Editorial Material							LUNAR PROSPECTOR		Lunar & Planetary Inst, Houston, TX 77058 USA		Spudis, PD (corresponding author), Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA.	spudis@lpi.usra.edu						Binder AB, 1998, SCIENCE, V281, P1475, DOI 10.1126/science.281.5382.1475; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; HARTMANN WK, 1986, ORIGIN MOON; Heiken G., 1991, Lunar sourcebook. A user's guide to the Moon; Lawrence DJ, 2000, J GEOPHYS RES-PLANET, V105, P20307, DOI 10.1029/1999JE001177; Lucey PG, 2000, J GEOPHYS RES-PLANET, V105, P20297, DOI 10.1029/1999JE001117; Lucey PG, 1998, J GEOPHYS RES-PLANET, V103, P3679, DOI 10.1029/97JE03019; NOZETTE S, 1994, SCIENCE, V266, P1835, DOI 10.1126/science.266.5192.1835; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495	9	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1779	+		10.1126/science.1064469	http://dx.doi.org/10.1126/science.1064469			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546859				2022-12-28	WOS:000170894400032
J	Berlin, S; Ellegren, H				Berlin, S; Ellegren, H			Evolutionary genetics - Clonal inheritance of avian mitochondrial DNA	NATURE			English	Article							MODERN HUMANS; ORIGIN		Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden	Uppsala University	Berlin, S (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	hans.ellegren@ebc.uu.se						Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Ellegren H, 2000, TRENDS ECOL EVOL, V15, P188, DOI 10.1016/S0169-5347(00)01821-8; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Fridolfsson AK, 2000, GENETICS, V155, P1903; Garcia-Moreno J, 2000, MOL BIOL EVOL, V17, P1826, DOI 10.1093/oxfordjournals.molbev.a026283; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; MONTELL H, IN PRESS MOL BIOL EV; Nesje M, 2000, HEREDITAS, V132, P261, DOI 10.1111/j.1601-5223.2000.00261.x; Sharma A, 2000, SCIENCE, V288, P977	14	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					37	38		10.1038/35092623	http://dx.doi.org/10.1038/35092623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544517				2022-12-28	WOS:000170801200030
J	Mumby, PJ; Chisholm, JRM; Clark, CD; Hedley, JD; Jaubert, J				Mumby, PJ; Chisholm, JRM; Clark, CD; Hedley, JD; Jaubert, J			Spectrographic imaging - A bird's-eye view of the health of coral reefs	NATURE			English	Article							SPECTRAL DISCRIMINATION		Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Observ Oceanol Europeen, Ctr Sci Monaco, MC-98000 Monaco, Monaco; Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Ctr Earth Observat Sci, Sheffield S10 2TN, S Yorkshire, England; Khaled Bin Sultan Living Oceans Fdn, E Lansing, MI 48823 USA	Newcastle University - UK; University of Sheffield; University of Sheffield	Mumby, PJ (corresponding author), Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Ridley Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Mumby, Peter/F-9914-2010; Clark, Chris/C-3830-2009	Mumby, Peter/0000-0002-6297-9053; Clark, Chris/0000-0002-1021-6679				CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Clark CD, 2000, INT J REMOTE SENS, V21, P2321, DOI 10.1080/01431160050029602; English S., 1997, SURVEY MANUAL TROPIC; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Holden H, 1998, REMOTE SENS ENVIRON, V65, P217, DOI 10.1016/S0034-4257(98)00029-7; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Lubin D, 2001, REMOTE SENS ENVIRON, V75, P127, DOI 10.1016/S0034-4257(00)00161-9; Mumby PJ, 2001, MAR BIOL, V139, P183; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Pittock AB, 1999, AM ZOOL, V39, P10; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7	13	51	53	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					36	36		10.1038/35092617	http://dx.doi.org/10.1038/35092617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544515				2022-12-28	WOS:000170801200028
J	Darney, PD				Darney, PD			Misoprostol: a boon to safe motherhood ... or not?	LANCET			English	Editorial Material									Univ Calif San Francisco, San Francisco Gen Hosp, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Darney, PD (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94110 USA.							Bamigboye AA, 1998, AM J OBSTET GYNECOL, V179, P1043, DOI 10.1016/S0002-9378(98)70212-1; CARBONELL JL, 1997, CONTRACEPTION, V56, P165; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; Hale RW, 2001, NEW ENGL J MED, V344, P59, DOI 10.1056/NEJM200101043440112; Jain JA, 1999, AM J OBSTET GYNECOL, V181, P1386, DOI 10.1016/S0002-9378(99)70380-7; O'Brien P, 1998, OBSTET GYNECOL, V92, P212, DOI 10.1016/S0029-7844(98)00161-6; RUGALHO A, 1993, STUD FAM PLAN, V24, P319; Wagner M, 2001, LANCET, V357, P2142, DOI 10.1016/S0140-6736(00)05221-1	8	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					682	683		10.1016/S0140-6736(01)05846-9	http://dx.doi.org/10.1016/S0140-6736(01)05846-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551569				2022-12-28	WOS:000170729500002
J	Gulmezoglu, AM; Villar, J; Ngoc, NTN; Piaggio, G; Carroli, G; Adetoro, L; Abdel-Aleem, H; Cheng, LN; Hofmeyr, GJ; Lumbiganon, P; Unger, C; Prendiville, W; Pinol, A; Elbourne, D; El-Refaey, H; Schulz, KF				Gulmezoglu, AM; Villar, J; Ngoc, NTN; Piaggio, G; Carroli, G; Adetoro, L; Abdel-Aleem, H; Cheng, LN; Hofmeyr, GJ; Lumbiganon, P; Unger, C; Prendiville, W; Pinol, A; Elbourne, D; El-Refaey, H; Schulz, KF		WHO Collaborative Grp Evaluate Mis	WHO multicentre randomised trial of misoprostol in the management of the third stage of labour	LANCET			English	Article							ORAL MISOPROSTOL; POSTPARTUM HEMORRHAGE; OXYTOCIN; PREVENTION; ABORTION; SYNTOMETRINE; INDUCTION	Background Postpartum haemorrhage is a leading cause of maternal morbidity and mortality. Active management of the third stage of labour, including use of a uterotonic agent, has been shown to reduce blood loss. Misoprostol (a prostaglandin Ell. analogue) has been suggested for this purpose because it has strong uterotonic effects, can be given orally, is inexpensive, and does not need refrigeration for storage. We did a multicentre, double-blind, randomised controlled trial to determine whether oral misoprostol is as effective as oxytocin during the third stage of labour. Methods In hospitals in Argentina, China, Egypt, Ireland, Nigeria, South Africa, Switzerland, Thailand, and Vietnam, we randomly assigned women about to deliver vaginally to receive 600 mug misoprostol orally or 10 IU oxytocin intravenously or intramuscularly, according to routine practice, plus corresponding identical placebos. The medications were administered immediately after delivery as part of the active management of the third stage of labour. The primary outcomes were measured postpartum blood loss of 1000 mL or more, and the use of additional uterotonics without an unacceptable level of side-effects. We chose an upper limit of a 35% increase in the risk of blood loss of 1000 mL or more as the margin of clinical equivalence, which was assessed by the confidence interval of the relative risk. Analysis was by intention to treat. Findings 9264 women were assigned misoprostol and 9266 oxytocin. 37 women in the misoprostol group and 34 in the oxytocin group had emergency caesarean sections and were excluded. 366 (4%) of women on misoprostol, had a measured blood loss of 1000 mL or more, compared with 263 (3%) of those on oxytocin (relative risk 1.39 [95% CI 1.19-1.63], p<0.0001). 1398 (15%) women in the misoprostol group and 1002 (11%) in the oxytocin group required additional uterotonics (1.40 [1.29-1.51], p<0.0001). Misoprostol use was also associated with a significantly higher incidence of shivering (3.48 [3.15-3.84]) and raised body temperature (7.17 [5.67-9.07]) in the first hour after delivery. Interpretation 10 IU oxytocin (intravenous or intramuscular) is preferable to 600 mug oral misoprostol in the active management of the third stage of labour in hospital settings where active management is the norm.	WHO, Dept Reprod Hlth & Res, UNDP,UNFPA, World Bank Special Programme Res Dev & Res Traini, CH-1211 Geneva 27, Switzerland; Hung Vuong Obstet & Gynaecol Hosp, Ho Chi Minh City, Vietnam; Ctr Rosarino Estud Perinatales, Rosario, Santa Fe, Argentina; Ctr Res Reprod Hlth, Shagamu, Nigeria; Assiut Univ Hosp, Dept Obstet & Gynaecol, Assiut, Egypt; Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; Univ Witwatersrand, Effect Care Res Unit, Johannesburg, South Africa; Khon Kaen Univ, Dept Obstet & Gynaecol, Khon Kaen, Thailand; Univ Zurich, Dept Obstet & Gynaecol, Zurich, Switzerland; Limmattal Hosp, Zurich, Switzerland; Coombe Lying In Hosp, Dublin 8, Ireland; London Sch Hyg & Trop Med, London WC1, England; Chelsea & Westminster Hosp, Imperial Coll Sch Med, London, England; Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA	The World Bank; United Nations Population Fund; World Health Organization; Egyptian Knowledge Bank (EKB); Assiut University; University of Witwatersrand; Khon Kaen University; University of Zurich; Trinity College Dublin; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of North Carolina; University of North Carolina Chapel Hill	Villar, J (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP,UNFPA, World Bank Special Programme Res Dev & Res Traini, CH-1211 Geneva 27, Switzerland.	villarj@who.ch						Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Amant F, 1999, BRIT J OBSTET GYNAEC, V106, P1066, DOI 10.1111/j.1471-0528.1999.tb08115.x; Andolina K, 1999, AM J OBSTET GYNECOL, V180, pS69; Bamigboye AA, 1998, AM J OBSTET GYNECOL, V179, P1043, DOI 10.1016/S0002-9378(98)70212-1; CHUA S, 1993, BRIT J OBSTET GYNAEC, V100, P874, DOI 10.1111/j.1471-0528.1993.tb14325.x; Cook CM, 1999, AUST NZ J OBSTET GYN, V39, P414; Danielsson KG, 1999, OBSTET GYNECOL, V93, P275, DOI 10.1016/S0029-7844(98)00436-0; El-Refaey H, 2000, BRIT J OBSTET GYNAEC, V107, P1104, DOI 10.1111/j.1471-0528.2000.tb11108.x; ElRefaey H, 1996, LANCET, V347, P1257, DOI 10.1016/S0140-6736(96)90771-0; ElRefaey H, 1997, BRIT J OBSTET GYNAEC, V104, P336, DOI 10.1111/j.1471-0528.1997.tb11464.x; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; Etuk S J, 1997, West Afr J Med, V16, P165; Fawcus S, 1997, TROP DOCT, V27, P159, DOI 10.1177/004947559702700314; GIBBENS D, 1972, J OBSTET GYN BR COMM, V79, P644; GULMEZOGLU AM, 2001, COCHRANE LIB; Hofmeyr GJ, 1998, BRIT J OBSTET GYNAEC, V105, P971; Hofmeyr GJ, 2001, S AFR MED J, V91, P432; Hofmeyr GJ, 2000, COCHRANE LIB; Hofmeyr GJ, 1998, P 17 C PRIOR PER CAR, P53; Hogerzeil H.V., 1993, WHODAP936; JONES B, 1996, BMJ-BRIT MED J, V313, P3; Lieberman E, 1999, AM J PUBLIC HEALTH, V89, P506, DOI 10.2105/AJPH.89.4.506; Lumbiganon P, 1999, BRIT J OBSTET GYNAEC, V106, P304, DOI 10.1111/j.1471-0528.1999.tb08266.x; Ng PS, 2001, HUM REPROD, V16, P31, DOI 10.1093/humrep/16.1.31; Nordstrom L, 1997, BRIT J OBSTET GYNAEC, V104, P781, DOI 10.1111/j.1471-0528.1997.tb12020.x; NORMAN JE, 1991, LANCET, V338, P1233, DOI 10.1016/0140-6736(91)92102-8; PRENDIVILLE WJ, 2000, COCHRANE LIB; SENN S, 1999, STAT ISSUES DRUG DEV, P187; Singh K, 1999, BRIT J OBSTET GYNAEC, V106, P266, DOI 10.1111/j.1471-0528.1999.tb08241.x; Surbek DV, 1999, OBSTET GYNECOL, V94, P255, DOI 10.1016/S0029-7844(99)00271-9; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; Walley RL, 2000, BRIT J OBSTET GYNAEC, V107, P1111, DOI 10.1111/j.1471-0528.2000.tb11109.x	32	233	240	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2001	358	9283					689	695		10.1016/S0140-6736(01)05835-4	http://dx.doi.org/10.1016/S0140-6736(01)05835-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551574				2022-12-28	WOS:000170729500007
J	Harrington, C				Harrington, C			Regulating nursing homes - Residential nursing facilities in the United States	BRITISH MEDICAL JOURNAL			English	Article									Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Harrington, C (corresponding author), Univ Calif San Francisco, Dept Social & Behav Sci, 3333 Calif St, San Francisco, CA 94118 USA.							AARONSON WE, 1994, GERONTOLOGIST, V34, P775, DOI 10.1093/geront/34.6.775; *AM HLTH CAR ASS, 1999, FACTS TRENDS 1999 NU; ANDERSEN A, 1998, 1998 99 GUIDE NURSIN; Cohen JW, 1996, J HEALTH ECON, V15, P23, DOI 10.1016/0167-6296(95)00030-5; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2000, GERONTOLOGIST, V40, P5; HARRINGTON C, IN PRESS AM J PUBLIC; HARRINGTON C, 2000, NURSING FACILITIES S; HILZENRATH DS, 2000, WASHINGTON POST 0204, pG3; *I MED COMM AD NUR, 1986, NURS STAFF HOSP NURS; KERRISON SH, IN PRESS BMJ; NAKHNIKIAN E, 2001, LONG TERM CARE PROVI; PEAR R, 2000, NY TIMES        0929, pA26; Spector WD, 1998, HEALTH ECON, V7, P639, DOI 10.1002/(SICI)1099-1050(1998110)7:7<639::AID-HEC373>3.0.CO;2-0; *US DEP HHS, ASS QUAL NURS HOM CA; *US DEP HHS HLTH C, 1995, 2001 STAT OP AN PROV; *US GEN ACC OFF, 1987, MED MED STRONG ENF N; *US GEN ACC OFF, 1999, GAOHEHS0023; *US GEN ACC OFF, 1999, GAOHEHS9946; *US GEN ACC OFF, 1998, GAOHEHS98202; *US HLTH CAR FIN A, 2000, NAT HLTH EXP 1960 19; *US HLTH CAR FIN A, 2000, REP C APPR MIN NURS, V1; *US SEC EXCH COMM, 2001, 112040 SEC; *US SEN SPEC COMM, 1974, 11 US SEN SPEC COMM; Vladeck B.C., 1980, UNLOVING CARE NURSIN; Wunderlich G, 1996, NURSING STAFF HOSP N; Wunderlich G. S., 2001, IMPROVING QUALITY LO; 2000, MCKNIGHTS LONG TERM, V21, P6; 2000, MCKNIGHTS LONG TERM, V22, P14; 1998, FED REG, V63, P65561; 2001, BALTIMORE SUN   0113, pC10	31	39	39	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					507	510		10.1136/bmj.323.7311.507	http://dx.doi.org/10.1136/bmj.323.7311.507			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469WF	11532849	Green Published			2022-12-28	WOS:000170838500026
J	Chen, LF; Fischle, W; Verdin, E; Greene, WC				Chen, LF; Fischle, W; Verdin, E; Greene, WC			Duration of nuclear NF-kappa B action regulated by reversible acetylation	SCIENCE			English	Article							HISTONE DEACETYLASES; ALPHA; EXPRESSION; PHOSPHORYLATION; INHIBITOR; PROTEINS; BINDING	The nuclear expression and action of the nuclear factor kappa B (NF-kappaB) transcription factor requires signal-coupled phosphorylation and degradation of the I kappaB inhibitors, which normally bind and sequester this pleiotropically active factor in the cytoplasm. The subsequent molecular events that regulate the termination of nuclear NF-kappaB action remain poorly defined, although the activation of de novo I kappaB alpha gene expression by NF-kappaB likely plays a key rote. Our studies now demonstrate that the RelA subunit of NF-kappaB is subject to inducible acetylation and that acetylated forms of RelA interact weakly, if at all, with I kappaB alpha. Acetytated RelA is subsequently deacetylated through a specific interaction with histone deacetylase 3 (HDAC3). This deacetylation reaction promotes effective binding to I kappaB alpha and leads in turn to I kappaB alpha -dependent nuclear export of the complex through a chromosomal region maintenance-1 (CRM-1)-dependent pathway. Deacetylation of RelA by HDAC3 thus acts as an intranuclear molecular switch that both controls the duration of the NF-kappaB transcriptional response and contributes to the replenishment of the depleted cytoplasmic pool of latent NF-kappaB-I kappaB alpha complexes.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	wgreene@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; NIMH NIH HHS [P30MH59037] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOGERD H, 1993, J VIROL, V67, P2496, DOI 10.1128/JVI.67.5.2496-2502.1993; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Denoyelle S., SYNTHESIS SAR STUDY; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	24	994	1029	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1653	1657		10.1126/science.1062374	http://dx.doi.org/10.1126/science.1062374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533489	Green Submitted			2022-12-28	WOS:000170802900062
J	Griffin, CT; Srinivasan, Y; Zheng, YW; Huang, W; Coughlin, SR				Griffin, CT; Srinivasan, Y; Zheng, YW; Huang, W; Coughlin, SR			A role of thrombin receptor signaling in endothelial cells during embryonic development	SCIENCE			English	Article							TISSUE FACTOR; TRANSGENIC MICE; GROWTH-FACTOR; PROTHROMBIN DEFICIENCY; BLEEDING EVENTS; GENE-EXPRESSION; LETHALITY; COAGULATION; HEMORRHAGE	The coagulation protease thrombin triggers fibrin formation, platelet activation, and other cellular responses at sites of tissue injury. We report a rote for PAR1, a protease-activated G protein-coupled receptor for thrombin, in em,. bryonic development. Approximately half of Par1(-/-) mouse embryos died at midgestation with bleeding from multiple sites. PAR1 is expressed in endothelial cells, and a PAR1 transgene driven by an endothetial-specific promoter prevented death of Par1(-/-) embryos. our results suggest that the coagulation cascade and PAR1 modulate endothelial cell function in developing blood vessels and that thrombin's actions on endothelial cells-rather than on platelets, mesenchymal cells, or fibrinogen-contribute to vascular development and hemostasis in the mouse embryo.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL44907, HL65590] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590, R01HL044907] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; Esmon CT, 2000, BLOOD, V95, P1113, DOI 10.1182/blood.V95.4.1113.004k54_1113_1116; GOSPODAROWICZ D, 1978, J CELL BIOL, V77, P774, DOI 10.1083/jcb.77.3.774; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Papadimitriou E, 1997, AM J PHYSIOL-CELL PH, V272, pC1112, DOI 10.1152/ajpcell.1997.272.4.C1112; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rugh R, 1990, MOUSE ITS REPROD DEV; SAMBRANO GR, IN PRESS NATURE; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SOIFER SJ, 1994, AM J PATHOL, V144, P60; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Toomey JR, 1996, BLOOD, V88, P1583; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Xue JC, 1998, P NATL ACAD SCI USA, V95, P7603, DOI 10.1073/pnas.95.13.7603	27	221	236	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1666	1670		10.1126/science.1061259	http://dx.doi.org/10.1126/science.1061259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533492				2022-12-28	WOS:000170802900065
J	Sachs, C; Hildebrand, M; Volkening, S; Wintterlin, J; Ertl, G				Sachs, C; Hildebrand, M; Volkening, S; Wintterlin, J; Ertl, G			Spatiotemporal self-organization in a surface reaction: From the atomic to the mesoscopic scale	SCIENCE			English	Article							PT(111); ADSORBATES; OXIDATION; PLATINUM; OXYGEN	Scanning tunneling microscopy data revealed the atomic processes in propagating reaction fronts that occur in the catalytic oxidation of hydrogen on Pt(111). The fronts were also characterized on mesoscopic Length scales with respect to their velocity and width. Simulations on the basis of a reaction-diffusion model reproduce the experimental findings qualitatively welt. The quantitative comparison reveals the limitations of this traditional approach to modeling spatiotemporal pattern formation in nonlinear dynamics.	Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Wintterlin, J (corresponding author), Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany.							Bedurftig K, 1999, J CHEM PHYS, V111, P11147, DOI 10.1063/1.480472; CREIGHTON JR, 1982, SURF SCI, V122, pL648, DOI 10.1016/0039-6028(82)90089-9; CREIGHTON JR, 1984, SURF SCI, V136, P449, DOI 10.1016/0039-6028(84)90623-X; Eiswirth M., 1995, CHEM WAVES PATTERNS, P447; FISHER GB, 1980, PHYS REV LETT, V44, P683, DOI 10.1103/PhysRevLett.44.683; Hildebrand M, 1998, PHYS REV E, V58, P5483, DOI 10.1103/PhysRevE.58.5483; Hildebrand M, 1996, J PHYS CHEM-US, V100, P19089, DOI 10.1021/jp961668w; Hildebrand M, 1998, PHYS REV LETT, V81, P2602, DOI 10.1103/PhysRevLett.81.2602; IMBIHL R, 1995, CHEM REV, V95, P697, DOI 10.1021/cr00035a012; Michaelides A, 2001, J AM CHEM SOC, V123, P4235, DOI 10.1021/ja003576x; Michaelides A, 2001, J CHEM PHYS, V114, P513, DOI 10.1063/1.1328746; Mikhailov A. S., 1994, FDN SYNERGETICS, VI; MO YW, 1991, PHYS REV LETT, V66, P1998, DOI 10.1103/PhysRevLett.66.1998; Morgenstern M, 1997, Z PHYS CHEM, V198, P43, DOI 10.1524/zpch.1997.198.Part_1_2.043; ROTERMUND HH, 1990, NATURE, V343, P355, DOI 10.1038/343355a0; SACHS C, UNPUB; Shenoy VB, 2000, PHYS REV LETT, V84, P1491, DOI 10.1103/PhysRevLett.84.1491; SILVERBERG M, 1987, J CHEM PHYS, V87, P3178, DOI 10.1063/1.453005; TAMMARO M, 1995, J CHEM PHYS, V103, P10277, DOI 10.1063/1.469929; Volkening S, 1999, PHYS REV LETT, V83, P2672, DOI 10.1103/PhysRevLett.83.2672	20	137	140	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1635	1638		10.1126/science.1062883	http://dx.doi.org/10.1126/science.1062883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533484				2022-12-28	WOS:000170802900056
J	Bell, CM; Redelmeier, DA				Bell, CM; Redelmeier, DA			Mortality among patients admitted to hospitals on weekends as compared with weekdays	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ADMINISTRATIVE DATA; PERINATAL-MORTALITY; BIRTH-WEIGHT; CARE; OUTCOMES; QUALITY; SUPERVISION; GUIDELINES; MANAGEMENT	Background: The level of staffing in hospitals is often lower on weekends than on weekdays, despite a presumably consistent day-to-day burden of disease. It is uncertain whether in-hospital mortality rates among patients with serious conditions differ according to whether they are admitted on a weekend or on a weekday. Methods: We analyzed all acute care admissions from emergency departments in Ontario, Canada, between 1988 and 1997 (a total of 3,789,917 admissions). We compared in-hospital mortality among patients admitted on a weekend with that among patients admitted on a weekday for three prespecified diseases: ruptured abdominal aortic aneurysm (5454 admissions), acute epiglottitis (1139), and pulmonary embolism (11,686) and for three control diseases: myocardial infarction (160,220), intracerebral hemorrhage (10,987), and acute hip fracture (59,670), as well as for the 100 conditions that were the most common causes of death (accounting for 1,820,885 admissions). Results: Weekend admissions were associated with significantly higher in-hospital mortality rates than were weekday admissions among patients with ruptured abdominal aortic aneurysms (42 percent vs. 36 percent, P<0.001), acute epiglottitis (1.7 percent vs. 0.3 percent, P=0.04), and pulmonary embolism (13 percent vs. 11 percent, P=0.009). The differences in mortality persisted for all three diagnoses after adjustment for age, sex, and coexisting disorders. There were no significant differences in mortality between weekday and weekend admissions for the three control diagnoses. Weekend admissions were also associated with significantly higher mortality rates for 23 of the 100 leading causes of death and were not associated with significantly lower mortality rates for any of these conditions. Conclusions: Patients with some serious medical conditions are more likely to die in the hospital if they are admitted on a weekend than if they are admitted on a weekday. (N Engl J Med 2001;345:663-8.) Copyright (C) 2001 Massachusetts Medical Society.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto	Redelmeier, DA (corresponding author), Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol Unit, Rm G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dar@ices.on.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469				Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; BELL BM, 1993, JAMA-J AM MED ASSOC, V269, P403, DOI 10.1001/jama.269.3.403; Blegen MA, 1998, NURS ECON, V16, P196; BOYES AP, 1994, J ADV NURS, V20, P462, DOI 10.1111/j.1365-2648.1994.tb02382.x; BREDAHL C, 1992, INJURY, V23, P83, DOI 10.1016/0020-1383(92)90037-S; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRYK A, 1996, HIERARCHICAL LINEAR; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Czaplinski C, 1998, MED CARE, V36, P1626, DOI 10.1097/00005650-199812000-00002; DeCoster C, 1997, CAN MED ASSOC J, V157, P889; DELFINO RJ, 1993, ARCH ENVIRON HEALTH, V48, P140, DOI 10.1080/00039896.1993.9940812; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DOWDING VM, 1987, BRIT J OBSTET GYNAEC, V94, P413, DOI 10.1111/j.1471-0528.1987.tb03118.x; Evans C, 2000, BRIT MED J, V320, P218, DOI 10.1136/bmj.320.7229.218; Fogelholm R, 1996, STROKE, V27, P398, DOI 10.1161/01.STR.27.3.398; FRANTZ TD, 1993, OTOLARYNG HEAD NECK, V109, P457, DOI 10.1177/019459989310900311; GIROTTI MJ, 1994, J TRAUMA, V36, P101, DOI 10.1097/00005373-199401000-00016; Haupt MT, 1999, CRIT CARE MED, V27, P422; Hawker GA, 1997, J CLIN EPIDEMIOL, V50, P265, DOI 10.1016/S0895-4356(96)00368-X; HENDRY RA, 1981, BRIT J OBSTET GYNAEC, V88, P1200, DOI 10.1111/j.1471-0528.1981.tb01197.x; HOWARD G, 1991, NEUROEPIDEMIOLOGY, V10, P251, DOI 10.1159/000110281; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; JONES L, 1997, CTV NATL NEWS   1214; KATZ DJ, 1994, J VASC SURG, V19, P804, DOI 10.1016/S0741-5214(94)70005-2; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; Lamn H, 1973, N Engl J Med, V289, P923; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; MACFARLANE A, 1978, BRIT MED J, V2, P1670, DOI 10.1136/bmj.2.6153.1670; MALENKA DJ, 1994, J CLIN EPIDEMIOL, V47, P1027, DOI 10.1016/0895-4356(94)90118-X; MANGOLD WD, 1981, AM J PUBLIC HEALTH, V71, P601, DOI 10.2105/AJPH.71.6.601; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MATHERS CD, 1983, J EPIDEMIOL COMMUN H, V37, P57, DOI 10.1136/jech.37.1.57; McCloskey JM, 1998, NURS OUTLOOK, V46, P199, DOI 10.1016/S0029-6554(98)90047-1; MCKEE M, 1992, SOC SCI MED, V34, P549, DOI 10.1016/0277-9536(92)90210-H; Moore J D Jr, 1996, Mod Healthc, V26, P99; MOORE JD, 1996, MOD HEALTHCARE, V26, P84; MOORE JD, 1996, MOD HEALTHCARE, V26, P99; Moulton D, 2000, CAN MED ASSOC J, V162, P1602; *ONT NURS ASS, 2000, INT AN; Ottesen MM, 1996, EUR HEART J, V17, P429; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; RILEY G, 1993, MED CARE, V31, P921, DOI 10.1097/00005650-199310000-00005; ROGOT E, 1976, AM J EPIDEMIOL, V103, P198, DOI 10.1093/oxfordjournals.aje.a112218; Roos LL, 1996, MED CARE, V34, P570, DOI 10.1097/00005650-199606000-00007; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Siddique RM, 1996, ARCH INTERN MED, V156, P2343, DOI 10.1001/archinte.156.20.2343; Snijders T.A., 1999, INTRO BASIC ADV MULT; STANLEY FJ, 1978, DEV MED CHILD NEUROL, V20, P300; Strzalka A, 1996, J Nurs Care Qual, V10, P59; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; THORPE KE, 1990, JAMA-J AM MED ASSOC, V263, P3177, DOI 10.1001/jama.263.23.3177; TRUDEAU R, 1997, HLTH REP, V9, P43; WALLACE M, 1999, GUIDELINES MANAGING; Williams J. I., 1996, PATTERNS HLTH CARE O, P339; Williams JI, 1996, INVENTORY STUDIES AC; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551, DOI 10.2106/00004623-199510000-00010	61	819	830	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					663	668		10.1056/NEJMsa003376	http://dx.doi.org/10.1056/NEJMsa003376			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466XG	11547721				2022-12-28	WOS:000170671000006
J	Lam, RW				Lam, RW			Patients' preferences and counselling for depression in primary care	LANCET			English	Editorial Material							CONTROLLED TRIALS; MAJOR DEPRESSION		Univ British Columbia, Dept Psychiat, UBC Hosp, Vancouver, BC V6T 2A1, Canada	University of British Columbia	Lam, RW (corresponding author), Univ British Columbia, Dept Psychiat, UBC Hosp, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.		Lam, Raymond W/D-2529-2013	Lam, Raymond W/0000-0001-7142-4669				Bedi N, 2000, BRIT J PSYCHIAT, V175, P217; Bower P, 2000, BMJ-BRIT MED J, V321, P1389, DOI 10.1136/bmj.321.7273.1389; Churchill R, 1999, BRIT J GEN PRACT, V49, P738; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; Priest RG, 1996, BRIT MED J, V313, P858; Schulberg HC, 1997, ARCH FAM MED, V6, P334, DOI 10.1001/archfami.6.4.334; Scott C, 1997, BRIT J PSYCHIAT, V171, P131, DOI 10.1192/bjp.171.2.131; SIBBALD B, 1993, BMJ-BRIT MED J, V306, P29, DOI 10.1136/bmj.306.6869.29; Silverman WA, 1996, LANCET, V347, P171, DOI 10.1016/S0140-6736(96)90347-5; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383	14	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					575	576		10.1016/S0140-6736(00)04076-9	http://dx.doi.org/10.1016/S0140-6736(00)04076-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558480				2022-12-28	WOS:000167119100006
J	Whyte, AS; Garnett, PA; Whittington, AE				Whyte, AS; Garnett, PA; Whittington, AE			Bats in the belfry, bugs in the bed?	LANCET			English	Editorial Material									Victoria Hosp, Fife Area Lab, Dept Microbiol, Kirkcaldy KY2 5AG, Fife, Scotland; Natl Museums Scotland, Edinburgh EH1 1JF, Midlothian, Scotland		Whyte, AS (corresponding author), Victoria Hosp, Fife Area Lab, Dept Microbiol, Kirkcaldy KY2 5AG, Fife, Scotland.		Whittington, Andrew E/L-3179-2019	Whittington, Andrew E/0000-0002-0465-1172				KLOET GS, 1964, CHECK LIST BRIT INSE; Paul J, 2000, BRIT MED J, V320, P1141, DOI 10.1136/bmj.320.7242.1141; SOUTHWOOD T.R.E., 1959, LAND WATER BUGS BRIT	3	11	12	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					604	604		10.1016/S0140-6736(00)04057-5	http://dx.doi.org/10.1016/S0140-6736(00)04057-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558488				2022-12-28	WOS:000167119100014
J	Holland, HD				Holland, HD			Geochemistry - Evidence for life on Earth more than 3850 million years ago	SCIENCE			English	Editorial Material											Holland, HD (corresponding author), HARVARD UNIV,DEPT EARTH & PLANETARY SCI,20 OXFORD ST,CAMBRIDGE,MA 02138, USA.							Chang S., 1983, EARTHS EARLIEST BIOS, P53; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640	4	39	41	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 3	1997	275	5296					38	39		10.1126/science.275.5296.38	http://dx.doi.org/10.1126/science.275.5296.38			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WA903	11536783				2022-12-28	WOS:A1997WA90300035
J	HEATH, JR; COOKSY, AL; GRUEBELE, MHW; SCHMUTTENMAER, CA; SAYKALLY, RJ				HEATH, JR; COOKSY, AL; GRUEBELE, MHW; SCHMUTTENMAER, CA; SAYKALLY, RJ			DIODE-LASER ABSORPTION-SPECTROSCOPY OF SUPERSONIC CARBON CLUSTER BEAMS - THE V3 SPECTRUM OF C-5	SCIENCE			English	Article											HEATH, JR (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.			Cooksy, Andrew/0000-0002-2794-4269; SAYKALLY, RICHARD/0000-0001-8942-3656				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; DOUGLAS AE, 1951, ASTROPHYS J, V114, P466, DOI 10.1086/145486; DROWART J, 1959, J CHEM PHYS, V31, P1131, DOI 10.1063/1.1730519; EWING DW, 1987, CHEM PHYS LETT, V134, P413, DOI 10.1016/0009-2614(87)87164-6; FUSINA L, 1980, J MOL SPECTROSC, V79, P101, DOI 10.1016/0022-2852(80)90296-9; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; HEATH JR, UNPUB; HEATH JR, 1987, ASTROPHYS J, V314, P352; Herzberg G, 1942, ASTROPHYS J, V96, P314, DOI 10.1086/144464; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; HOFFMANN R, 1966, TETRAHEDRON, V22, P521, DOI 10.1016/0040-4020(66)80020-0; Huggins W., 1882, P R SOC LONDON, V33, P1; KRISHNAN R, 1986, J CHEM PHYS, V85, P6623; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; MAGERS DH, 1986, J CHEM PHYS, V84, P3284, DOI 10.1063/1.450259; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; MCKELLAR ARW, IN PRESS CHEM PHYS L; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; RITCHIE JP, 1986, J CHEM PHYS, V85, P5175, DOI 10.1063/1.451711; ROHLFING EA, 1984, J CHEM PHYS, V81, P3322, DOI 10.1063/1.447994; VALA M, 1989, J CHEM PHYS, V90, P595, DOI 10.1063/1.456458; VANZEE RJ, 1988, J CHEM PHYS, V88, P3465, DOI 10.1063/1.453895; WHITESIDE RA, 1981, CHEM PHYS LETT, V78, P538, DOI 10.1016/0009-2614(81)85253-0	25	89	89	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 5	1989	244	4904					564	566						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	U4450	11539817				2022-12-28	WOS:A1989U445000023
J	Stenni, B; Masson-Delmotte, V; Johnsen, S; Jouzel, J; Longinelli, A; Monnin, E; Rothlisberger, R; Selmo, E				Stenni, B; Masson-Delmotte, V; Johnsen, S; Jouzel, J; Longinelli, A; Monnin, E; Rothlisberger, R; Selmo, E			An oceanic cold reversal during the last deglaciation	SCIENCE			English	Article							ICE CORE; DEUTERIUM EXCESS; ANTARCTIC ICE; CLIMATE; PRECIPITATION; TRANSITION; SURFACE; RECORD	A detailed deuterium excess profile measured along the Dome C EPICA (European Project for ice Coring in Antarctica) core reveals the timing and strength of the sea surface temperature changes at the source regions for Dome C precipitation. We infer that an Oceanic Cold Reversal took place in the southern Indian Ocean, 800 years after the Antarctic Cold Reversal. The temperature gradient between the oceanic moisture source and Antarctica is similar to the Dome C sodium profile during the deglaciation, illustrating the strong link between this gradient and the strength of the atmospheric circulation.	Univ Trieste, Dept Geol Environm & Marine Sci, Trieste, Italy; Inst Pierre Simon Laplace, CEA, CNRS 1572, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Univ Copenhagen, Dept Geophys, Niels Bohr Inst, Copenhagen, Denmark; Univ Parma, Dept Earth Sci, Parma, Italy; Univ Bern, Inst Phys, Bern, Switzerland	University of Trieste; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen; Niels Bohr Institute; University of Parma; University of Bern	Stenni, B (corresponding author), Univ Trieste, Dept Geol Environm & Marine Sci, Trieste, Italy.		Masson-Delmotte, Valerie L/G-1995-2011	Masson-Delmotte, Valerie L/0000-0001-8296-381X; Stenni, Barbara/0000-0003-4950-3664				Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; ARISTARAIN AJ, 1986, CLIMATIC CHANGE, V8, P69, DOI 10.1007/BF00158970; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; CIAIS P, 1994, J GEOPHYS RES-ATMOS, V99, P16793, DOI 10.1029/94JD00412; *CLIMAP PROJ MEMB, 1981, MAP CHART SER, pCH36; DANSGAARD W, 1964, TELLUS, V16, P436; Delaygue G, 2000, TELLUS B, V52, P19, DOI 10.1034/j.1600-0889.2000.00951.x; DELMOTTE M, 1997, THESIS U J FOURIER G; EXTON HJ, 1986, OCEANIC WHITECAPS TH, P175; HOFFMANN G, IN PRESS J GEOPHYS R; HOFFMANN GW, COMMUNICATION; Johnsen SJ, 1989, TELLUS B, V41, P452, DOI 10.1111/j.1600-0889.1989.tb00321.x; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; JOUSSAUME S, 1995, WCRP REPORT, V92, P425; JOUZEL J, 1984, J GEOPHYS RES-ATMOS, V89, P1749, DOI 10.1029/JD089iD07p11749; JOUZEL J, 1995, CLIM DYNAM, V11, P151, DOI 10.1007/BF00223498; Jouzel J, 2001, GEOPHYS RES LETT, V28, P3199, DOI 10.1029/2000GL012243; JOUZEL J, 1982, NATURE, V299, P688, DOI 10.1038/299688a0; Labracherie M, 1989, PALEOCEANOGRAPHY, V4, P629, DOI 10.1029/PA004i006p00629; LORIUS C, 1979, NATURE, V280, P644, DOI 10.1038/280644a0; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Mulvaney R, 2000, GEOPHYS RES LETT, V27, P2673, DOI 10.1029/1999GL011254; PETIT JR, 1991, J GEOPHYS RES-ATMOS, V96, P5113, DOI 10.1029/90JD02232; Rothlisberger R, 2000, J GEOPHYS RES-ATMOS, V105, P20565, DOI 10.1029/2000JD900264; SCHWANDER J, IN PRESS GEOPHYS RES; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Stager JC, 1997, SCIENCE, V276, P1834, DOI 10.1126/science.276.5320.1834; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Vimeux F, 2001, CLIM DYNAM, V17, P503, DOI 10.1007/PL00007928; Vimeux F, 1999, NATURE, V398, P410, DOI 10.1038/18860; Werner M, 2001, TELLUS B, V53, P53, DOI 10.1034/j.1600-0889.2001.01154.x	34	172	177	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2074	2077		10.1126/science.1059702	http://dx.doi.org/10.1126/science.1059702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557889				2022-12-28	WOS:000171028700070
J	Wellman, B				Wellman, B			Computer networks as social networks	SCIENCE			English	Editorial Material							TECHNOLOGY	Computer networks are inherently social networks, linking people, organizations, and knowledge. They are social institutions that should not be studied in isolation but as integrated into everyday lives. The proliferation of computer networks has facilitated a deemphasis on group solidarities at work and in the community and afforded a turn to networked societies that are Loosely bounded and sparsely knit. The Internet increases people's social capital, increasing contact with friends and relatives who Live nearby and far away. New toots must be developed to help people navigate and find knowledge in complex, fragmented, networked societies.	Univ Toronto, Ctr Urban & Community Studies, Toronto, ON M5S 2G8, Canada	University of Toronto	Wellman, B (corresponding author), Univ Toronto, Ctr Urban & Community Studies, 455 Spadina Ave, Toronto, ON M5S 2G8, Canada.	wellman@chass.utoronto.ca						ACKERMAN M, 1996, C COMP SUPP COOP WOR; ANDERSON B, IN PRESS AM BEHAV SC; [Anonymous], COMMUNICATION; BARLOW JP, 1995, HARPERS          AUG, P40; Baym N. K., 1997, CULTURE INTERNET, P103; Boissevain J., 1974, FRIENDS FRIENDS NETW; Bradner Erin, 1998, EUR COMP SUPP COOP W; BUXTON B, 1992, P GRAPH INT 92 VANC; Castells M., 2000, RISE NETWORK SOC; CHEN W, IN PRESS INTERNET EV; CONTRACTOR N, 1998, LECT NOTES COMPUTER, P201; Contractor Noshir S., 1999, MANAGE COMMUNICATION, V13, P154; CROSS R, 2000, TIES SHARE RELATIONA; DiMaggio P, 2001, ANNU REV SOCIOL, V27, P307, DOI 10.1146/annurev.soc.27.1.307; DIMMICK J, 2001, INT COMM ASS ANN M W; DODGE M, 2001, MAPPING CYPBERSPACE; Fischer Claude, 1992, AM CALLING SOCIAL HI; FISH RS, 1993, COMMUN ACM, V36, P48, DOI 10.1145/151233.151237; Fong E., 2001, OFFICE LEARNING TECH; HAMPTON K, IN PRESS AM BEHAV SC; HAMPTON K, IN PRESS CITY COMMUN; Hampton K.H., 2001, THESIS U TORONTO; Hampton KN, 1999, AM BEHAV SCI, V43, P475, DOI 10.1177/00027649921955290; Haythornthwaite C, 1998, J AM SOC INFORM SCI, V49, P1101; HAYTHORNTHWAITE C, IN PRESS AM BEHAV SC; HOWARD P, IN PRESS AM BEHAV SC; JERGENS V, 1998, NY TIMES        0903; JONES Q, 2000, CSCW 2000 PHIL PA DE; KATZ J, IN PRESS AM BEHAV SC; Katz J, 1997, WIRED            DEC, P274; KATZ J, 1997, WIRED            DEC, P68; KATZ J, 1997, WIRED            DEC, P76; KEW M, IN PRESS CURR SOCIOL; Kochen Manfred, 1989, SMALL WORLD; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Kraut R, 2001, INTERNET PARADOX REV; LaRose R., 2001, J ONLINE BEHAV, V1, P1; LIECHTI O, 2000, SIGGROUP B, V21, P3; LING R, IN PRESS PERPETUAL C; LIU Y, 2001, ANN C INT COMM ASS W; Matei S, 2001, COMMUN RES, V28, P429, DOI 10.1177/009365001028004004; Moore G., 1997, VIDEO MEDIATED COMMU, P301; NARDI BA, 2000, 1 MONDAY, V5, P30; *NAT TEL INF ADM, 2000, FALL NET; NAZER N, 2000, THESIS U TORONTO; Nie N., 2000, STUDY OFFERS EARLY L; NIE N, IN PRESS AM BEHAV SC; Odlyzko Andrew, 2000, HIST COMMUNICATIONS; Reddick Andrew., 2000, DUAL DIGITAL DIVIDE; RESNICK P, 1999, CHI 99 C SEATTL WA M; Rheingold Howard, 2000, VIRTUAL COMMUNITY, V2; SACK W, 2000, COMP SUPP COOP WORK; Slouka M., 1995, WAR WORLDS CYBERSPAC; SMITH MA, 1999, COMMUNITIES CYBERSPA, P195; SOUTHWICK S, 1996, LISZT SEARCHABLE DIR; Stoll C., 1995, SILICON SNAKE OIL 2; WATTS D, 1999, SMALL WORLDS; Wellman B, 2001, INT J URBAN REGIONAL, V25, P227, DOI 10.1111/1468-2427.00309; WELLMAN B, IN PRESS AM BEHAV SC; WELLMAN B, IN PRESS INTERNET EV; WELLMAN B, 1999, NETWORKS GLOBAL VILL, P1; Wellman B., 1999, NETWORKS GLOBAL VILL, P167; Wellman B., 1997, CULTURE INTERNET, P179; Witte JC, 2000, SOC SCI COMPUT REV, V18, P179, DOI 10.1177/089443930001800207	64	350	366	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2031	2034		10.1126/science.1065547	http://dx.doi.org/10.1126/science.1065547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	473FB	11557877				2022-12-28	WOS:000171028700058
J	Sherr, CJ				Sherr, CJ			Parsing Ink4a/Arf: "Pure" p16-null mice	CELL			English	Review							TUMOR SUPPRESSION; P16(INK4A); SENESCENCE; P19(ARF); LOCUS; SUSCEPTIBILITY; GROWTH; P53		St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Howard Hughes Med Inst, Memphis, TN 38117 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital	Sherr, CJ (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Howard Hughes Med Inst, 332 N Lauderdale, Memphis, TN 38117 USA.	sherr@stjude.org	Sherr, Charles J/N-8074-2018	Sherr, Charles J/0000-0002-5516-6206				Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; QUELLE DE, 1995, CELL, V83, P993; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Reznikoff CA, 1996, CANCER RES, V56, P2886; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	19	50	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					531	534		10.1016/S0092-8674(01)00486-X	http://dx.doi.org/10.1016/S0092-8674(01)00486-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551500	Bronze			2022-12-28	WOS:000170973200003
J	Firschke, C; Schomig, A				Firschke, C; Schomig, A			Mitral-valve endocarditis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Deutsch Herzzentrum Munchen, D-80636 Munich, Germany	German Heart Centre Munich; Technical University of Munich	Firschke, C (corresponding author), Deutsch Herzzentrum Munchen, D-80636 Munich, Germany.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					739	739		10.1056/NEJMicm980894	http://dx.doi.org/10.1056/NEJMicm980894			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547743				2022-12-28	WOS:000170772900005
J	Feachem, RGA				Feachem, RGA			Globalisation is good for your health, mostly	BRITISH MEDICAL JOURNAL			English	Article									Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94105 USA; Univ Calif Berkeley, San Francisco, CA 94105 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Feachem, RGA (corresponding author), Univ Calif San Francisco, Inst Global Hlth, 74 New Montgomery St,Suite 508, San Francisco, CA 94105 USA.		Robles-Sardin, Alma E/M-7714-2015	Robles-Sardin, Alma E/0000-0003-2044-7793				DOLLAR D, 1992, ECON DEV CULT CHANGE, V40, P523, DOI 10.1086/451959; Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; SACHS JD, 1995, BROOKINGS PAP ECO AC, P1	4	59	59	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					504	506		10.1136/bmj.323.7311.504	http://dx.doi.org/10.1136/bmj.323.7311.504			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469WF	11532848	Green Published, Green Accepted			2022-12-28	WOS:000170838500025
J	Kapiteijn, E; Marijnen, CAM; Nagtegaal, ID; Putter, H; Steup, WH; Wiggers, T; Rutten, HJT; Pahlman, L; Glimelius, B; van Krieken, JHJM; Leer, JWH; van de Velde, CJH				Kapiteijn, E; Marijnen, CAM; Nagtegaal, ID; Putter, H; Steup, WH; Wiggers, T; Rutten, HJT; Pahlman, L; Glimelius, B; van Krieken, JHJM; Leer, JWH; van de Velde, CJH		Dutch Colorectal Canc Grp	Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE RANDOMIZED TRIAL; LOCAL RECURRENCE; CURATIVE SURGERY; CARCINOMA; ADENOCARCINOMA; LYMPHADENECTOMY; IRRADIATION; MULTICENTER; STOCKHOLM; RESECTION	Background: Short-term preoperative radiotherapy and total mesorectal excision have each been shown to improve local control of disease in patients with resectable rectal cancer. We conducted a multicenter, randomized trial to determine whether the addition of preoperative radiotherapy increases the benefit of total mesorectal excision. Methods: We randomly assigned 1861 patients with resectable rectal cancer either to preoperative radiotherapy (5 Gy on each of five days) followed by total mesorectal excision (924 patients) or to total mesorectal excision alone (937 patients). The trial was conducted with the use of standardization and quality-control measures to ensure the consistency of the radiotherapy, surgery, and pathological techniques. Results: Of the 1861 patients randomly assigned to one of the two treatment groups, 1805 were eligible to participate. The overall rate of survival at two years among the eligible patients was 82.0 percent in the group assigned to both radiotherapy and surgery and 81.8 percent in the group assigned to surgery alone (P=0.84). Among the 1748 patients who underwent a macroscopically complete local resection, the rate of local recurrence at two years was 5.3 percent. The rate of local recurrence at two years was 2.4 percent in the radiotherapy-plus-surgery group and 8.2 percent in the surgery-only group (P<0.001). Conclusions: Short-term preoperative radiotherapy reduces the risk of local recurrence in patients with rectal cancer who undergo a standardized total mesorectal excision. (N Engl J Med 2001;345:638-46.) Copyright (C) 2001 Massachusetts Medical Society.	Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; Univ Med Ctr St Radboud, Dept Pathol, Nijmegen, Netherlands; Univ Med Ctr St Radboud, Dept Radiotherapy, Nijmegen, Netherlands; Leyenburg Hosp, Dept Surg, The Hague, Netherlands; Univ Groningen Hosp, Dept Surg, Groningen, Netherlands; Catharina Hosp, Dept Surg, Eindhoven, Netherlands; Univ Uppsala, Akad Sjukhuset, Dept Surg, Uppsala, Sweden; Univ Uppsala, Akad Sjukhuset, Dept Oncol, Uppsala, Sweden	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Catharina Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	van de Velde, CJH (corresponding author), Leiden Univ, Med Ctr, Dept Surg K6R, POB 9600, NL-2300 RC Leiden, Netherlands.		Kapiteijn, Ellen/AAK-6065-2020; Rutten, H.J./B-5739-2011; Putter, Hein/C-2244-2018; Rutten, Harm/AAV-3638-2020; Rutten, Harm J/H-9595-2017; Leer, J.W.H./H-8067-2014; Nagtegaal, Iris D/A-2448-2014; Rutten, Harm J T/J-9820-2014; van Krieken, Joannes H J M/D-4138-2009	Kapiteijn, Ellen/0000-0002-4814-6426; Putter, Hein/0000-0001-5395-1422; Nagtegaal, Iris D/0000-0003-0887-4127; van Krieken, Joannes H J M/0000-0001-6544-1040; Marijnen, Corrie/0000-0003-0189-5953				Aitken RJ, 1996, BRIT J SURG, V83, P214, DOI 10.1046/j.1365-2168.1996.02057.x; Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; CARLSSON U, 1987, DIS COLON RECTUM, V30, P431, DOI 10.1007/BF02556491; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Dahlberg M, 1999, BRIT J SURG, V86, P379, DOI 10.1046/j.1365-2168.1999.01040.x; Dahlberg M, 1998, DIS COLON RECTUM, V41, P543, DOI 10.1007/BF02235256; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; FLETCHER GH, 1991, RADIOTHER ONCOL, V20, P10, DOI 10.1016/0167-8140(91)90106-Q; FRYKHOLM GJ, 1993, DIS COLON RECTUM, V36, P564, DOI 10.1007/BF02049863; GOLDBERG PA, 1994, EUR J CANCER, V30A, P1602, DOI 10.1016/0959-8049(94)00312-S; HARNSBERGER JR, 1994, DIS COLON RECTUM, V37, P73, DOI 10.1007/BF02047218; Havenga K, 1999, EUR J SURG ONCOL, V25, P368, DOI 10.1053/ejso.1999.0659; HERMANEK P, 1995, TUMORI, V81, P60; HOLM T, 1994, BRIT J SURG, V81, P452, DOI 10.1002/bjs.1800810344; Kapiteijn E, 1999, EUR J SURG, V165, P410, DOI 10.1080/110241599750006613; Kapiteijn E, 1998, EUR J SURG ONCOL, V24, P528, DOI 10.1016/S0748-7983(98)93500-4; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marijnen CAM, 2001, J CLIN ONCOL, V19, P1976, DOI 10.1200/JCO.2001.19.7.1976; Martling AL, 2000, LANCET, V356, P93, DOI 10.1016/S0140-6736(00)02469-7; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501; MYERSON RJ, 1995, INT J RADIAT ONCOL, V32, P41, DOI 10.1016/0360-3016(94)00493-5; Nagtegaal ID, 2000, J CLIN ONCOL, V18, P1771, DOI 10.1200/JCO.2000.18.8.1771; Pahlman L, 1997, NEW ENGL J MED, V336, P1539; Pahlman L, 1997, NEW ENGL J MED, V336, P980; PAHLMAN L, 1993, BRIT J SURG, V80, P1333, DOI 10.1002/bjs.1800801040; PHILLIPS RKS, 1984, BRIT J SURG, V71, P12, DOI 10.1002/bjs.1800710104; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; RAO AR, 1981, CANCER-AM CANCER SOC, V48, P1492, DOI 10.1002/1097-0142(19810915)48:6<1492::AID-CNCR2820480636>3.0.CO;2-K; Wiggers T, 1996, DIS COLON RECTUM, V39, P323, DOI 10.1007/BF02049476	29	3018	3173	3	90	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					638	646		10.1056/NEJMoa010580	http://dx.doi.org/10.1056/NEJMoa010580			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466XG	11547717	Green Published			2022-12-28	WOS:000170671000002
J	SQUYRES, SW; KASTING, JF				SQUYRES, SW; KASTING, JF			EARLY MARS - HOW WARM AND HOW WET	SCIENCE			English	Article							SMALL MARTIAN VALLEYS; TERRESTRIAL PLANETS; CHAOTIC OBLIQUITY; CLIMATIC CHANGE; MASS-LOSS; EVOLUTION; EARTH; ORIGIN; ATMOSPHERE; SURFACE	Early in its history, Mars underwent fluvial erosion that has been interpreted as evidence for a warmer, wetter climate. However, no atmosphere composed of only CO2 and H2O appears capable of producing mean planetary temperatures even close to 0 degrees C. Rather than by precipitation, aquifer recharge and ground water seepage may have been enabled by hydrothermal convection driven by geothermal heat and heat associated with impacts. Some climatic warming was probably necessary to allow water to flow for long distances across the surface. Modest warming could be provided by even a low-pressure CO2 atmosphere if it was supplemented with small amounts of CH4, NH3, or SO2. Episodic excursions to high obliquities may also have raised temperatures over some portions of the planet's surface.	PENN STATE UNIV,DEPT GEOSCI,STATE COLL,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	SQUYRES, SW (corresponding author), CORNELL UNIV,CTR RADIOPHYS & SPACE RES,ITHACA,NY 14853, USA.		Kasting, James/AAF-6851-2020					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; BRAKENRIDGE GR, 1985, GEOLOGY, V13, P859, DOI 10.1130/0091-7613(1985)13<859:AHSOMO>2.0.CO;2; Brown L.L., 1993, WORKSHOP EARLY MARS, P3; Brutsaert W., 2013, EVAPORATION ATMOSPHE; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; CLIFFORD SM, 1981, CONTRIBUTION LUNAR P, V441, P46; CLIFFORD SM, 1985, J GEOPHYS RES S, V90, pD144; CORADINI A, 1983, PHYS EARTH PLANET IN, V31, P145, DOI 10.1016/0031-9201(83)90106-1; CRADDOCK RA, 1990, J GEOPHYS RES-SOLID, V95, P14265, DOI 10.1029/JB095iB09p14265; GIERASCH PJ, 1973, J ATMOS SCI, V30, P1502, DOI 10.1175/1520-0469(1973)030<1502:APVATC>2.0.CO;2; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; GOLDSPIEL JM, 1993, ICARUS, V105, P479, DOI 10.1006/icar.1993.1143; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; GOLDSPIEL JM, 1993, ICARUS, V106, P346, DOI 10.1006/icar.1993.1177; GOLDSPIEL JM, 1994, THESIS CORNELL U ITH; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; GULICK VC, 1993, WORKSHOP EARLY MARS, P12; GULICK VC, 1992, LUNAR PLANET SCI, V22, P509; HARTMANN WK, 1970, ICARUS, V12, P131, DOI 10.1016/0019-1035(70)90039-4; HIGGINS CG, 1982, GEOLOGY, V10, P147, DOI 10.1130/0091-7613(1982)10<147:DSDBSO>2.0.CO;2; HUNTEN DM, 1987, ICARUS, V69, P532, DOI 10.1016/0019-1035(87)90022-4; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KOCHEL RC, 1985, J GEOPHYS RES S, V91, pE175; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; MATSUI T, 1986, NATURE, V319, P303, DOI 10.1038/319303a0; MCKAY CP, 1991, NATURE, V352, P489, DOI 10.1038/352489a0; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PIERI D, 1976, ICARUS, V27, P25, DOI 10.1016/0019-1035(76)90182-2; PIERI DC, 1980, SCIENCE, V210, P895, DOI 10.1126/science.210.4472.895; PLAUT JJ, 1988, ICARUS, V75, P357; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POSTAWKO SE, 1986, J GEOPHYS RES-SOLID, V91, pD431, DOI 10.1029/JB091iB04p0D431; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SAGAN C, 1991, B AM ASTRON SOC, V23, P1211; Schubert G., 1992, MARS, P147, DOI [10.2307/j.ctt207g59v.9, DOI 10.2307/J.CTT207G59V.9]; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; SLOAN CE, 1976, 979 US GEOL SURV PRO; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALLACE D, 1979, ICARUS, V39, P385, DOI 10.1016/0019-1035(79)90148-9; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; Wasson J.T., 1979, ASTEROIDS, P926; Wetherill G. W, 1986, ORIGIN MOON, P519; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; Wood C.A., 1981, P LUNAR PLANET SCI C, V12B, P1359	65	207	208	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					744	749		10.1126/science.265.5173.744	http://dx.doi.org/10.1126/science.265.5173.744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539185				2022-12-28	WOS:A1994PA37200022
J	OHMOTO, H; KAKEGAWA, T; LOWE, DR				OHMOTO, H; KAKEGAWA, T; LOWE, DR			3.4-BILLION-YEAR-OLD BIOGENIC PYRITES FROM BARBERTON, SOUTH-AFRICA - SULFUR ISOTOPE EVIDENCE	SCIENCE			English	Article							BEARING	Laser ablation mass spectroscopy analyses of sulfur isotopic compositions of microscopic-sized grains of pyrite that formed about 3.4 billion years ago in the Barberton Greenstone Belt, South Africa, show that the pyrite formed by bacterial reduction of seawater sulfate. These data imply that by about 3.4 billion years ago sulfate-reducing bacteria had become active, the oceans were rich in sulfate, and the atmosphere contained appreciable amounts (>>10(-13) of the present atmospheric level) of free oxygen.	STANFORD UNIV,DEPT GEOL,STANFORD,CA 94305; TOHOKU UNIV,INST MINERAL PETROL & ECON GEOL,SENDAI,MIYAGI 980,JAPAN	Stanford University; Tohoku University	OHMOTO, H (corresponding author), PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802, USA.				NCI NIH HHS [NCA2-332] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AULT WV, 1963, BIOGEOCHEMISTRY SULF, P16; CROWE DE, 1990, GEOCHIM COSMOCHIM AC, V54, P2075, DOI 10.1016/0016-7037(90)90272-M; Jones L. M., 1986, TERRA COGNITA, V6, P263; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; KELLEY SP, 1990, GEOCHIM COSMOCHIM AC, V54, P883, DOI 10.1016/0016-7037(90)90381-T; LOWE DR, 1977, J GEOL, V85, P699, DOI 10.1086/628358; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Ohmoto H, 1979, GEOCHEMISTRY HYDROTH, V10, P509; OHMOTO H, 1990, STABLE ISOTOPES FLUI, P70; Ohmoto H, 1992, EARLY ORGANIC EVOLUT, P378, DOI DOI 10.1007/978-3-642-76884-2_29; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	11	126	132	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					555	557		10.1126/science.11539502	http://dx.doi.org/10.1126/science.11539502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	11539502				2022-12-28	WOS:A1993MC93500036
J	GRUN, E; ZOOK, HA; BAGUHL, M; FECHTIG, H; HANNER, MS; KISSEL, J; LINDBLAD, BA; LINKERT, D; LINKERT, G; MANN, IB; MCDONNELL, JAM; MORFILL, GE; POLANSKEY, C; RIEMANN, R; SCHWEHM, G; SIDDIQUE, N				GRUN, E; ZOOK, HA; BAGUHL, M; FECHTIG, H; HANNER, MS; KISSEL, J; LINDBLAD, BA; LINKERT, D; LINKERT, G; MANN, IB; MCDONNELL, JAM; MORFILL, GE; POLANSKEY, C; RIEMANN, R; SCHWEHM, G; SIDDIQUE, N			ULYSSES DUST MEASUREMENTS NEAR JUPITER	SCIENCE			English	Article							GOSSAMER RING	Submicrometer- to micrometer-sized particles were recorded by the Ulysses dust detector within 40 days of the Jupiter flyby. Nine impacts were recorded within 50 Jupiter radii with most of them recorded after closest approach. Three of these impacts are consistent with particles on prograde orbits around Jupiter and the rest are believed to have resulted from gravitationally focused interplanetary dust. From the ratio of the impact rate before the Jupiter flyby to the impact rate after the Jupiter flyby it is concluded that interplanetary dust particles at the distance of Jupiter move on mostly retrograde orbits. On 10 March 1992, Ulysses passed through an intense dust stream. The dust detector recorded 126 impacts within 26 hours. The stream particles were moving on highly inclined and apparently hyperbolic orbits with perihelion distances of >5 astronomical units. Interplanetary dust is lost rather quickly from the solar system through collisions and other mechanisms and must be almost continuously replenished to maintain observed abundances. Dust flux measurements, therefore, give evidence of the recent rates of production from sources such as comets, asteroids, and moons, as well as the possible presence of interstellar grains.	NASA, LYNDON B JOHNSON SPACE CTR, HOUSTON, TX 77058 USA; JET PROP LAB, PASADENA, CA 91109 USA; MAX PLANCK INST AERON, W-3411 KATLENBURG DUHM, GERMANY; UNIV KENT, CANTERBURY CT2 7NR, ENGLAND; MAX PLANCK INST EXTRATERRESTR PHYS, W-8046 GARCHING, GERMANY; EUROPEAN SPACE AGCY, EUROPEAN SPACE TECHNOL CTR, 2200 AG NOORDWIJK, NETHERLANDS	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; University of Kent; Max Planck Society; European Space Agency	GRUN, E (corresponding author), MAX PLANCK INST NUCL PHYS, W-6900 HEIDELBERG 1, GERMANY.							BAGUHL M, IN PRESS P HYPERVELO; DIVINE N, 1992, 52179214 JET PROP LA; GOLLER JR, 1989, PLANET SPACE SCI, V37, P1197, DOI 10.1016/0032-0633(89)90014-7; GRUN E, 1992, ASTRON ASTROPHYS SUP, V92, P411; GRUN E, 1992, GEOPHYS RES LETT, V19, P1311, DOI 10.1029/92GL00629; Grun E., 1984, PLANETARY RINGS, P275; GURNETT DA, 1983, ICARUS, V53, P236, DOI 10.1016/0019-1035(83)90145-8; HOLZER TE, 1989, ANNU REV ASTRON ASTR, V27, P199; HUMES DH, 1974, J GEOPHYS RES, V79, P3677, DOI 10.1029/JA079i025p03677; HUMES DH, 1980, J GEOPHYS RES-SPACE, V85, P5841, DOI 10.1029/JA085iA11p05841; KAISER ML, COMMUNICATION; MARSDEN BG, 1989, CATALOGUE COMETARY O; NORTHROP TG, 1989, ICARUS, V79, P101, DOI 10.1016/0019-1035(89)90110-3; SHOWALTER MR, 1985, NATURE, V316, P526, DOI 10.1038/316526a0; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951; SMITH EJ, 1992, SCIENCE, V257, P1503, DOI 10.1126/science.257.5076.1503; STONE RG, 1992, ASTRON ASTROPHYS SUP, V92, P291	17	40	40	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	1992	257	5076					1550	1552		10.1126/science.11538054	http://dx.doi.org/10.1126/science.11538054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JM570	11538054				2022-12-28	WOS:A1992JM57000033
J	DEBERGH, C; BEZARD, B; OWEN, T; CRISP, D; MAILLARD, JP; LUTZ, BL				DEBERGH, C; BEZARD, B; OWEN, T; CRISP, D; MAILLARD, JP; LUTZ, BL			DEUTERIUM ON VENUS - OBSERVATIONS FROM EARTH	SCIENCE			English	Article							ATMOSPHERE; HYDROGEN; ABUNDANCE; ESCAPE; MODEL; MARS; WET	Absorption lines of HDO and H2O have been detected in a 0.23-wave number resolution spectrum of the dark side of Venus in the interval 2.34 to 2.43 micrometers, where the atmosphere is sounded in the altitude range from 32 to 42 kilometers (8 to 3 bars). The resulting value of the deuterium-to-hydrogen ratio (D/H) is 120 +/- 40 times the telluric ratio, providing unequivocal confirmation of in situ Pioneer Venus mass spectrometer measurements that were in apparent conflict with an upper limit set from International Ultraviolet Explorer spectra. The 100-fold enrichment of the D/H ratio on Venus compared to Earth is thus a fundamental constraint on models for its atmospheric evolution.	LOWELL OBSERV,FLAGSTAFF,AZ 86001; UNIV HAWAII,INST ASTRON,HONOLULU,HI 96822; CALTECH,JET PROP LAB,PASADENA,CA 91109; INST ASTROPHYS,F-75014 PARIS,FRANCE	University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; Sorbonne Universite	DEBERGH, C (corresponding author), OBSERV PARIS,DEPT RECH SPATIALE,SECT MEUDON,F-92195 MEUDON,FRANCE.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998; Bezard, Bruno/0000-0002-5433-5661				ALLEN D, 1990, 4962 INT ASTR UN CIR; ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; BERTAUX JL, 1989, NATURE, V338, P567, DOI 10.1038/338567a0; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; desBergh C., 1989, B AM ASTRON SOC, V21, P926; DONAHUE T, 1989, NATURE, V340, P514; DONAHUE TM, 1989, NATURE, V340, P513, DOI 10.1038/340513b0; DONAHUE TM, 1982, SCIENCE, V216, P630, DOI 10.1126/science.216.4546.630; Esposito L. W., 1983, Venus, P484; GRINSPOON DH, 1988, ICARUS, V74, P21, DOI 10.1016/0019-1035(88)90028-0; GRINSPOON DH, 1987, SCIENCE, V238, P1702, DOI 10.1126/science.238.4834.1702; HARTLE RE, 1983, J GEOPHYS RES LETT, V10, P1965; HUNTEN DM, 1989, ORIGIN EVOLUTION PLA, P00386; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; KAULA WM, 1990, SCIENCE, V247, P1191, DOI 10.1126/science.247.4947.1191; KUMAR S, 1985, ICARUS, V62, P494, DOI 10.1016/0019-1035(85)90189-7; Lewis J. S., 1970, Earth and Planetary Science Letters, V10, P73, DOI 10.1016/0012-821X(70)90066-X; MCELROY MB, 1982, SCIENCE, V215, P1614, DOI 10.1126/science.215.4540.1614; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; REVERCOMB HE, 1985, ICARUS, V61, P521, DOI 10.1016/0019-1035(85)90140-X; RODRIGUEZ JM, 1984, PLANET SPACE SCI, V32, P1235, DOI 10.1016/0032-0633(84)90067-9; Taylor HA, 1980, J GEOPHYS RES-SPACE, V85, P7765, DOI 10.1029/JA085iA13p07765; TUREKIAN KK, 1975, J ATMOS SCI, V32, P1257, DOI 10.1175/1520-0469(1975)032<1257:TNHAMF>2.0.CO;2; von Zahn U., 1983, Venus, P299; WALKER JCG, 1970, J GEOPHYS RES, V75, P3558, DOI 10.1029/JC075i018p03558	30	125	126	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					547	549		10.1126/science.251.4993.547	http://dx.doi.org/10.1126/science.251.4993.547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	11538265	Green Submitted			2022-12-28	WOS:A1991EV45900046
J	Kim, BN; Hiraga, K; Morita, K; Sakka, Y				Kim, BN; Hiraga, K; Morita, K; Sakka, Y			A high-strain-rate superplastic ceramic	NATURE			English	Article							TETRAGONAL ZIRCONIA; DEFORMATION; CAVITATION	High-strain-rate superplasticity describes the ability of a material to sustain large plastic deformation in tension at high strain rates of the order of 10(-2) to 10(-1) s(-1) and is of great technological interest for the shape-forming of engineering materials. High-strain-rate superplasticity has been observed in aluminium-based(1) and magnesium-based(2) alloys. But for ceramic materials, superplastic deformation has been restricted to low strain rates of the order of 10(-5) to 10(-4) s(-1) for most oxides(3,4) and nitrides(5) with the presence of intergranular cavities leading to premature failure. Here we show that a composite ceramic material consisting of tetragonal zirconium oxide, magnesium aluminate spinel and a-alumina phases exhibits superplasticity at strain rates up to 1 s(-1). The composite also exhibits a large tensile elongation, exceeding 1,050 per cent for a strain rate of 0.4 s(-1). The tensile flow behaviour and deformed microstructure of the material indicate that superplasticity is due to a combination of limited grain growth in the constitutive phases and the intervention of dislocation-induced plasticity in the zirconium oxide phase. We suggest that the present results hold promise for the application of shape-forming technologies to ceramic materials.	Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	National Institute for Materials Science	Kim, BN (corresponding author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.		Sakka, Yoshio/H-2536-2011	Sakka, Yoshio/0000-0001-8357-5843; MORITA, Koji/0000-0001-6040-7054; Hiraga, Keijiro/0000-0002-7651-5209				EVANS AG, 1980, J AM CERAM SOC, V63, P368, DOI 10.1111/j.1151-2916.1980.tb10194.x; KAJIHARA K, 1995, ACTA METALL MATER, V43, P1235, DOI 10.1016/0956-7151(94)00320-H; Kim BN, 1999, ACTA MATER, V47, P3433, DOI 10.1016/S1359-6454(99)00201-3; Kim BN, 2001, ACTA MATER, V49, P887, DOI 10.1016/S1359-6454(00)00376-1; Mabuchi M, 1996, PHILOS MAG A, V74, P887, DOI 10.1080/01418619608242166; McQueen HJ, 1975, TREATISE MATERIALS S, DOI 10.1016/b978-0-12-341806-7.50014-3; Morita K, 2001, PHIL MAG LETT, V81, P311, DOI 10.1080/09500830110041675; NIEH TG, 1985, SCRIPTA METALL MATER, V19, P1375, DOI 10.1016/0036-9748(85)90070-5; PILLING J, 1986, ACTA METALL MATER, V34, P669, DOI 10.1016/0001-6160(86)90182-3; SCHISSLER DJ, 1991, ACTA METALL MATER, V39, P3227, DOI 10.1016/0956-7151(91)90057-8; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15; Ting CJ, 1999, ACTA MATER, V47, P831, DOI 10.1016/S1359-6454(98)00401-7; WAKAI F, 1990, NATURE, V344, P421, DOI 10.1038/344421a0; Wakai F., 1986, ADV CERAM MATER, V1, P259, DOI DOI 10.1111/J.1551-2916.1986.TB00026.X; Wittenauer J, 1997, MATER SCI FORUM, V243-2, P653, DOI 10.4028/www.scientific.net/MSF.243-245.653	15	219	230	7	174	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					288	291		10.1038/35095025	http://dx.doi.org/10.1038/35095025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565026				2022-12-28	WOS:000171040500033
J	Feldstein, BD				Feldstein, BD			Toward meaning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		REMEN RN, 1996, KITCHEN TABLE WISDOM, P252	1	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1291	1292		10.1001/jama.286.11.1291	http://dx.doi.org/10.1001/jama.286.11.1291			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560517				2022-12-28	WOS:000171024500001
J	Losick, R; Sonenshein, AL				Losick, R; Sonenshein, AL			Molecular biology - Turning gene regulation on its head	SCIENCE			English	Editorial Material							BIOSYNTHESIS		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Harvard University; Tufts University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							ANSTON AA, 1999, NATURE, V401, P235; GOLLNICK P, IN PRESS BACILLUS SU; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; Valbuzzi A, 2001, SCIENCE, V293, P2057, DOI 10.1126/science.1062187; YANOFSKY C, 1987, ESCHERICHIA COLI SAL, V2, P1453	7	3	3	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2018	2019		10.1126/science.1064982	http://dx.doi.org/10.1126/science.1064982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557871				2022-12-28	WOS:000171028700052
J	Murphy, PM				Murphy, PM			Chemokines and the molecular basis of cancer metastasis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											Murphy, PM (corresponding author), NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000615, ZIAAI000615] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Stetler-Stevenson W.G., 2001, CANC PRINCIPLES PRAC, V6, P123	4	336	388	0	34	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					833	835		10.1056/NEJM200109133451113	http://dx.doi.org/10.1056/NEJM200109133451113			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556308				2022-12-28	WOS:000170906800013
J	Lawlor, DA; Ebrahim, S; Smith, GD				Lawlor, DA; Ebrahim, S; Smith, GD			Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality	BRITISH MEDICAL JOURNAL			English	Article							DIETARY-FAT; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CHOLESTEROL; CONSUMPTION; WOMEN; RATES; MEN	Objective To examine secular trends and geographical variations in sex differences in mortality from coronary heart disease and investigate how these relate to distributions in risk factors. Design National and international data were used to examine secular trends and geographical variations in sex differences in mortality from coronary heart disease and risk factors. Setting England and Wales, 1921-98; Australia, France,japan, Sweden, and the United States, 1947-97; 50 countries, 1992-6. Data sources Office for National Statistics, World Health Organization, and Food and Agriculture Organization of the United Nations. Results The 20th century epidemic of coronary heart disease affected only men in most industrialised countries and had a very rapid onset in England and Wales, which has been examined in detail. If this male only epidemic had not occurred there would have been 1.2 million fewer deaths from coronary heart disease in men in England and Wales over the past 50 years. Secular trends in mean per capita fat consumption show a similar pattern to secular trends in coronary heart disease mortality in mn. Fat consumption is positively correlated with coronary heart disease mortality in men (r,=0.79; 95% confidence interval 0.70 to 0.86) and inversely associated with coronary heart disease mortality in women (-0.30; -0.49 to -0.08) over this time. Although sex ratios for mortality from coronary heart disease show a clear period effect, those for lung cancer show a cohort effect. Sex ratios for stroke mortality were constant and close to unity for the entire period. Geographical variations in the sex ratio for coronary heart disease were associated with mean per capita fat consumption (0.64; 0.44 to 0.78) but were not associated with the sex ratio for smoking. Conclusion Sex differences are largely the result of environmental factors and hence not inevitable. Understanding the factors that determine sex differences has important implications for public health, particularly for countries and parts of countries where the death rates for coronary heart disease are currently increasing.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				*ADV PAN DIET REL, 1974, DIET COR HEART DIS; ANDERSON TW, 1973, JAMA-J AM MED ASSOC, V224, P336; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; CHARLES N, 1997, WOMEN FOOD FAMILIES; CHARLTON J, 1997, HLTH ADULT BRITAIN 1, P17; Charlton J, 1997, HLTH ADULT BRITAIN 1; CLIFTON PM, 1992, ARTERIOSCLER THROMB, V12, P955, DOI 10.1161/01.ATV.12.8.955; COOPER S, 1986, AGE AUSTERITY 1945 5, P34; Feinleib M, 1995, AM J MED SCI, V310, pS8, DOI 10.1097/00000441-199512000-00003; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; ISLES CG, 1992, LANCET, V339, P702, DOI 10.1016/0140-6736(92)90599-X; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; OREN L, 1974, CLIOS CONSCIOUSNESS, P226; PETERSEN S, 1999, CORONARY HEART DIS S; PLANT M, 1997, HLTH ADULT BRITAIN 1, P114; POSNER BM, 1995, J AM DIET ASSOC, V95, P171, DOI 10.1016/S0002-8223(95)00043-7; SASAKI S, 1992, AM J CLIN NUTR, V56, P716, DOI 10.1093/ajcn/56.4.716; STAMLER J, 1989, INT J EPIDEMIOL, V18, pS3; STEHBENS WE, 1987, LANCET, V1, P606; STEPHEN AM, 1994, BRIT J NUTR, V71, P775, DOI 10.1079/BJN19940183; STEPHEN AM, 1990, AM J CLIN NUTR, V52, P457, DOI 10.1093/ajcn/52.3.457; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; Walden CE, 1997, ARTERIOSCL THROM VAS, V17, P375, DOI 10.1161/01.ATV.17.2.375; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; ZHANG XH, 1995, INT J EPIDEMIOL, V24, P720, DOI 10.1093/ije/24.4.720	28	141	143	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					541	545		10.1136/bmj.323.7312.541	http://dx.doi.org/10.1136/bmj.323.7312.541			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546699	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000170934600020
J	Hatta, M; Gao, P; Halfmann, P; Kawaoka, Y				Hatta, M; Gao, P; Halfmann, P; Kawaoka, Y			Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses	SCIENCE			English	Article							A VIRUSES; HOST RANGE; HEMAGGLUTININ; HUMANS; GENE; PATHOGENICITY; PATHOGENESIS; ATTENUATION; MONKEYS; CELLS	In 1997, an H5N1 influenza A virus was transmitted from birds to humans in Hong Kong, killing 6 of the 18 people infected. When mice were infected with the human isolates, two virulence groups became apparent. Using reverse genetics, we showed that a mutation at position 627 in the PB2 protein influenced the outcome of infection in mice. Moreover, high cleavability of the hemagglutinin glycoprotein was an essential requirement for lethal infection.	Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019					ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CLEMENTS ML, 1992, J CLIN MICROBIOL, V30, P655, DOI 10.1128/JCM.30.3.655-662.1992; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kuechler E., 1982, NUCLEIC ACIDS RES, V10, P4803; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; MURPHY BR, 1982, SCIENCE, V218, P1330, DOI 10.1126/science.6183749; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; 1997, MORBID MORTAL WKLY R, V46, P1204	20	1065	1205	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1840	1842		10.1126/science.1062882	http://dx.doi.org/10.1126/science.1062882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546875				2022-12-28	WOS:000170894400050
J	Sumbre, G; Gutfreund, Y; Fiorito, G; Flash, T; Hochner, B				Sumbre, G; Gutfreund, Y; Fiorito, G; Flash, T; Hochner, B			Control of octopus arm extension by a peripheral motor program	SCIENCE			English	Article							SYSTEM; MOVEMENTS; BEHAVIOR	For goal-directed arm movements, the nervous system generates a sequence of motor commands that bring the arm toward the target. Control of the octopus arm is especially complex because the arm can be moved in any direction, with a virtually infinite number of degrees of freedom. Here we show that arm extensions can be evoked mechanically or electrically in arms whose connection with the brain has been severed. These extensions show kinematic features that are almost identical to normal behavior, suggesting that the basic motor program for voluntary movement is embedded within the neural circuitry of the arm itself. Such peripheral motor programs represent considerable simplification in the motor control of this highly redundant appendage.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol & Interdisciplinary, Ctr Neuronal Computat, IL-91904 Jerusalem, Israel; Staz Zool Anton Dohrn, Neurobiol Lab, I-80121 Naples, Italy; Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Stazione Zoologica Anton Dohrn di Napoli; Weizmann Institute of Science	Hochner, B (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol & Interdisciplinary, Ctr Neuronal Computat, IL-91904 Jerusalem, Israel.	bennyh@lobster.ls.huji.ac.il	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840				ALTMAN JS, 1971, NATURE, V229, P204, DOI 10.1038/229204a0; Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; BOYCOTT BB, 1950, SYM SOC EXP BIOL, V4, P432; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; Graziadei P., 1971, ANATOMY NERVOUS SYST, P45; Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOLLAND JJ, 1990, VIROLOGY, P151; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Kristan WB, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P206; Matzner H, 2000, J NEUROPHYSIOL, V83, P1315, DOI 10.1152/jn.2000.83.3.1315; Mussa-Ivaldi FA, 1999, CURR OPIN NEUROBIOL, V9, P713, DOI 10.1016/S0959-4388(99)00029-X; ROWELL CHF, 1963, J EXP BIOL, V40, P257; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; WELLS MJ, 1959, J EXP BIOL, V36, P590; YOUNG JZ, 1965, PROC R SOC SER B-BIO, V162, P47, DOI 10.1098/rspb.1965.0025	21	182	184	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1845	1848		10.1126/science.1060976	http://dx.doi.org/10.1126/science.1060976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546877				2022-12-28	WOS:000170894400052
J	Carmeliet, P				Carmeliet, P			Biomedicine - Clotting factors build blood vessels	SCIENCE			English	Editorial Material							ANGIOGENESIS; RECEPTORS; THROMBIN		Univ Leuven, B-3000 Louvain, Belgium	KU Leuven	Carmeliet, P (corresponding author), Univ Leuven, Herestr 49, B-3000 Louvain, Belgium.		Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821				Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; MELIS E, IN PRESS BIOCH BIOPH; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Preissner KT, 2000, J PATHOL, V190, P360; Rao LVM, 2001, TRENDS CARDIOVAS MED, V11, P14, DOI 10.1016/S1050-1738(01)00077-9; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Siegbahn A, 2000, HAEMOSTASIS, V30, P41	13	74	75	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1602	1604		10.1126/science.1064981	http://dx.doi.org/10.1126/science.1064981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533466				2022-12-28	WOS:000170802900036
J	Canfield, DE; Teske, A				Canfield, DE; Teske, A			Late Proterozoic rise in atmospheric oxygen concentration inferred from phylogenetic and sulphur-isotope studies	NATURE			English	Article							SULFATE REDUCTION; MARINE-SEDIMENTS; SULFUR CYCLE; EVOLUTION; OXIDATION; IRON; BACTERIA; RATES	The evolution of non-photosynthetic sulphide-oxidizing bacteria was contemporaneous with a large shift in the isotopic composition of biogenic sedimentary sulphides between 0.64 and 1.05 billion years ago. Both events were probably driven by a vise in atmospheric oxygen concentrations to greater than 5-18% of present levels-a change that may also have triggered the evolution of animals.			Canfield, DE (corresponding author), MAX PLANCK INST MARINE MICROBIOL, CELSIUSSTR 1, D-28359 BREMEN, GERMANY.		Teske, Andreas/AAQ-9577-2021; Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BLAND JA, 1978, ARCH MICROBIOL, V117, P79, DOI 10.1007/BF00689355; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; BRETSKY SS, 1976, PALAEONTOGR AM, V8, P217; BUMIE SW, 1972, ECON GEOL, V67, P895; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CAMPBELL KA, 1993, RES EXPLOR, V9, P326; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CAVANAUGH CM, 1994, AM ZOOL, V34, P79; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; COX DL, 1969, TREATISE INVERTEBRAT, pN225; DISTEL DL, 1994, J MOL EVOL, V38, P533, DOI 10.1007/BF00178852; FEDNKIN MA, 1992, PROTEROZOIC BIOSPHER, P389; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FRY B, 1991, DEEP-SEA RES, V38, pS655; GLAESSNER MF, 1971, GEOL SOC AM BULL, V82, P509, DOI 10.1130/0016-7606(1971)82[509:GDATRO]2.0.CO;2; GOEDERT JL, 1993, VELIGER, V36, P72; GOLDHABER MB, 1975, SOIL SCI, V119, P42, DOI 10.1097/00010694-197501000-00008; GUNDERSEN JK, 1990, NATURE, V345, P604, DOI 10.1038/345604a0; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1982, PHILOS T R SOC B, V298, P543, DOI 10.1098/rstb.1982.0096; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KUENEN JG, 1991, PROKARYOTES, P2638; LANE DJ, 1992, J BACTERIOL, V174, P269, DOI 10.1128/jb.174.1.269-278.1992; LINDH TB, 1983, THESIS U MIAMI; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; MAIDAK BL, 1994, NUCLEIC ACIDS RES, V22, P3485, DOI 10.1093/nar/22.17.3485; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MORAN NA, 1993, P R SOC LONDON B, V253, P157; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; NAKAI N, 1964, GEOCHIM COSMOCHIM AC, V28, P1893, DOI 10.1016/0016-7037(64)90136-X; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Overmann J, 1996, LIMNOL OCEANOGR, V41, P147, DOI 10.4319/lo.1996.41.1.0147; PFENNIG N, 1975, PLANT SOIL, V43, P1, DOI 10.1007/BF01928472; Pierson B.K., 1992, PROTEROZOIC BIOSPHER, P247; Pojeta J., 1988, NEW MEXICO BUREAU MI, V44, P201; Polz MF, 1996, INT J SYST BACTERIOL, V46, P94, DOI 10.1099/00207713-46-1-94; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; REID RGB, 1986, VELIGER, V29, P3; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; RUNNEGAR B, 1986, PALAEONTOLOGY, V29, P1; Runnegar B, 1991, PALAEOGEOGR PALAEOCL, V97, P97, DOI 10.1016/0031-0182(91)90186-U; Schidlowski M, 1993, ORGANIC GEOCHEMISTRY, P639; SERGEEV VN, 1995, J PALEONTOL, V69, P1; STRAUSS H, 1993, PRECAMBRIAN RES, V63, P225, DOI 10.1016/0301-9268(93)90035-Z; Teske A, 1996, SYST APPL MICROBIOL, V18, P517; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; TOWE KM, 1970, P NATL ACAD SCI USA, V65, P781, DOI 10.1073/pnas.65.4.781; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	61	619	669	6	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	1996	382	6587					127	132		10.1038/382127a0	http://dx.doi.org/10.1038/382127a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW672	11536736				2022-12-28	WOS:A1996UW67200038
J	Cruzan, JD; Braly, LB; Liu, K; Brown, MG; Loeser, JG; Saykally, RJ				Cruzan, JD; Braly, LB; Liu, K; Brown, MG; Loeser, JG; Saykally, RJ			Quantifying hydrogen bond cooperativity in water: VRT spectroscopy of the water tetramer	SCIENCE			English	Article							INFRARED-LASER SPECTROMETERS; (H2O)20 CLUSTERS; MODEL (H2O)8; TRIMER; DYNAMICS; DIMER	Measurement of the far-infrared vibration-rotation tunneling spectrum of the perdeuterated water tetramer is described, Precisely determined rotational constants and relative intensity measurements indicate a cyclic quasi-planar minimum energy structure, which is in agreement with recent ab initio calculations, The O-O separation deduced from the data indicates a rapid exponential convergence to the ordered bulk value with increasing cluster size. Observed quantum tunneling splittings are interpreted in terms of hydrogen bond rearrangements connecting two degenerate structures.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley				SAYKALLY, RICHARD/0000-0001-8942-3656				BELFORD D, 1987, J CHEM PHYS, V86, P7013, DOI 10.1063/1.452350; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1701, DOI 10.1063/1.1142410; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1693, DOI 10.1063/1.1142409; BRINK G, 1984, J PHYS CHEM-US, V88, P3412, DOI 10.1021/j150660a009; Bunker P.R., 2006, MOL SYMMETRY SPECTRO; DYKE TR, 1977, J CHEM PHYS, V66, P492, DOI 10.1063/1.433968; DYKE TR, 1977, J CHEM PHYS, V66, P498, DOI 10.1063/1.433969; DYKSTRA CE, 1989, J CHEM PHYS, V91, P6472, DOI 10.1063/1.457363; ELROD MJ, 1994, CHEM REV, V94, P1975, DOI 10.1021/cr00031a010; GREGORY JK, 1995, J CHEM PHYS, V102, P7817, DOI 10.1063/1.468982; Head-Gordon Martin, COMMUNICATION; KIM KS, 1986, CHEM PHYS LETT, V131, P451, DOI 10.1016/0009-2614(86)80564-4; KLOPPER W, 1995, CHEM PHYS LETT, V237, P536, DOI 10.1016/0009-2614(95)00342-2; LENTZ BR, 1973, J CHEM PHYS, V58, P5926; Liu K, 1996, SCIENCE, V271, P62, DOI 10.1126/science.271.5245.62; LIU K, 1994, FARADAY DISCUSS, V97, P35, DOI 10.1039/fd9949700035; LIU K, 1994, J AM CHEM SOC, V116, P3507, DOI 10.1021/ja00087a042; NARTEN AH, 1982, SCIENCE, V217, P1033, DOI 10.1126/science.217.4564.1033; OWICKI JC, 1975, J PHYS CHEM-US, V79, P1794, DOI 10.1021/j100584a010; PETERSON SW, 1957, ACTA CRYSTALLOGR, V10, P70, DOI 10.1107/S0365110X5700016X; PUGLIANO N, 1993, J CHEM PHYS, V98, P6600, DOI 10.1063/1.464803; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; SCHUTZ M, 1993, J CHEM PHYS, V99, P5228, DOI 10.1063/1.465991; SCHUTZ M, 1995, J CHEM PHYS, V103, P6114, DOI 10.1063/1.470439; SCHUTZ M, 1994, J CHEM PHYS, V100, P1780, DOI 10.1063/1.467292; STILLINGER FH, 1980, J CHEM PHYS, V73, P3384, DOI 10.1063/1.440534; SUZUKI S, 1994, CHEM PHYS LETT, V229, P499, DOI 10.1016/0009-2614(94)01056-0; WALES DJ, 1993, J CHEM PHYS, V98, P7257, DOI 10.1063/1.464717; WALES DJ, 1993, J AM CHEM SOC, V115, P11180, DOI 10.1021/ja00077a016; WALES DJ, 1993, J CHEM PHYS, V98, P7245, DOI 10.1063/1.464716; WALES DJ, 1993, J AM CHEM SOC, V115, P11191, DOI 10.1021/ja00077a017; WAWAK RJ, 1992, J PHYS CHEM-US, V96, P5138, DOI 10.1021/j100191a071; XANTHEAS SS, 1994, J CHEM PHYS, V100, P7523, DOI 10.1063/1.466846; XANTHEAS SS, 1993, J CHEM PHYS, V99, P8774, DOI 10.1063/1.465599; XANTHEAS SS, COMMUNICATION	35	385	392	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 5	1996	271	5245					59	62		10.1126/science.271.5245.59	http://dx.doi.org/10.1126/science.271.5245.59			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TP022	11536731				2022-12-28	WOS:A1996TP02200041
J	KOHNEN, MEL; SCHOUTEN, S; DAMSTE, JSS; DELEEUW, JW; MERRITT, DA; HAYES, JM				KOHNEN, MEL; SCHOUTEN, S; DAMSTE, JSS; DELEEUW, JW; MERRITT, DA; HAYES, JM			RECOGNITION OF PALEOBIOCHEMICALS BY A COMBINED MOLECULAR SULFUR AND ISOTOPE GEOCHEMICAL APPROACH	SCIENCE			English	Article							IMMATURE CRUDE OILS; BIOLOGICAL MARKERS; BOTRYOCOCCUS-BRAUNII; BLACK-SEA; SEDIMENTS; BACTERIA; LIPIDS; HYDROCARBONS; CARBON; IDENTIFICATION	Study of organic matter in immature sediments from a Messinian evaporitic basin shows that consideration of structures, modes of occurrence, and carbon isotopic compositions of free and sulfur-bound carbon skeletons allow identification of biochemical precursors. Detailed information concerning biotic communities present during deposition of sediments can be retrieved in this way. Moreover, unprecedented biochemicals were recognized; these extend the horizon of biomarker geochemistry.	DELFT UNIV TECHNOL,FAC CHEM TECHNOL & MAT SCI,ORGAN GEOCHEM UNIT,DE VRIES VAN HEYSTPLANTSOEN 2,2628 RZ DELFT,NETHERLANDS; INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LAB,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT GEOL,BIOGEOCHEM LAB,BLOOMINGTON,IN 47405	Delft University of Technology; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington			de Leeuw, Jan W/F-6471-2011; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854				BOON JJ, 1979, NATURE, V277, P125, DOI 10.1038/277125a0; BRASSELL SC, 1981, NATURE, V290, P693, DOI 10.1038/290693a0; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; DAMSTE JSS, 1989, ORG GEOCHEM, V14, P555; DAMSTE JSS, 1990, ORG GEOCHEM, V16, P1077; DAMSTE JSS, 1988, ORG GEOCHEM, V13, P593; DAMSTE JSS, 1989, GEOCHIM COSMOCHIM AC, V53, P1343; DAMSTE JSS, 1990, NATURE, V345, P609, DOI 10.1038/345609a0; DEEVEY ES, 1964, LIMNOL OCEANOGR, V9, P1, DOI 10.4319/lo.1964.9.1.0001; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DEROSA M, 1986, BIOCHIM BIOPHYS ACTA, V875, P487, DOI 10.1016/0005-2760(86)90068-8; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DEUSER WG, 1970, NATURE, V225, P1069, DOI 10.1038/2251069a0; Eglinton G., 1963, CHEM PLANT TAXONOMY, P87, DOI DOI 10.1016/B978-0-12-395540-1.50012-9; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; HOLZER G, 1979, J CHROMATOGR, V186, P795, DOI 10.1016/S0021-9673(00)95296-8; JOHNSON JE, 1948, J AM CHEM SOC, V70, P3664, DOI 10.1021/ja01191a035; KOHNEN MEL, 1990, GEOCHIM COSMOCHIM AC, V54, P3053, DOI 10.1016/0016-7037(90)90121-Z; KOHNEN MEL, 1991, GEOCHIM COSMOCHIM AC, V55, P1375, DOI 10.1016/0016-7037(91)90315-V; KOHNEN MEL, 1990, ACS SYM SER, V429, P444; Liaaen-Jensen S., 1978, PHOTOSYNTHETIC BACTE, P233; Liaaen-Jensen S., 1978, MARINE NATURAL PRODU, V2, P1; METZGER P, 1987, TETRAHEDRON LETT, V28, P3931, DOI 10.1016/S0040-4039(00)96423-2; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; NICHOLS PD, 1988, J PHYCOL, V24, P90; OREMLAND RS, 1982, NATURE, V296, P143, DOI 10.1038/296143a0; OURISSON G, 1979, PURE APPL CHEM, V51, P709, DOI 10.1351/pac197951040709; OURISSON G, 1982, TRENDS BIOCHEM SCI, V7, P236, DOI 10.1016/0968-0004(82)90028-7; PANGANAMALA RV, 1971, CHEM PHYS LIPIDS, V7, P336, DOI 10.1016/0009-3084(71)90011-9; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; Risatti J.B., 1984, ORG GEOCHEM, V6, P93, DOI DOI 10.1016/0146-6380(84)90030-5; ROWLAND SJ, 1985, ORG GEOCHEM, V8, P207, DOI 10.1016/0146-6380(85)90028-2; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P557, DOI 10.1016/0016-7037(87)90069-X; TORGERSEN T, 1981, LIMNOL OCEANOGR, V26, P110, DOI 10.4319/lo.1981.26.1.0110; VAI G B, 1977, Sedimentology, V24, P211, DOI 10.1111/j.1365-3091.1977.tb00255.x; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P2619, DOI 10.1016/S0031-9422(00)83930-8; WAKEHAM SG, 1990, GEOCHIM COSMOCHIM AC, V54, P1325, DOI 10.1016/0016-7037(90)90157-G; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	141	144	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 17	1992	256	5055					358	362		10.1126/science.256.5055.358	http://dx.doi.org/10.1126/science.256.5055.358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP032	11540057				2022-12-28	WOS:A1992HP03200030
J	HICKS, GR; RAYLE, DL; LOMAX, TL				HICKS, GR; RAYLE, DL; LOMAX, TL			THE DIAGEOTROPICA MUTANT OF TOMATO LACKS HIGH SPECIFIC ACTIVITY AUXIN BINDING-SITES	SCIENCE			English	Article									OREGON STATE UNIV, DEPT BOT & PLANT PATHOL, CORVALLIS, OR 97331 USA; OREGON STATE UNIV, CTR GENE RES & BIOTECHNOL, CORVALLIS, OR 97331 USA; SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA; SAN DIEGO STATE UNIV, INST MOLEC BIOL, SAN DIEGO, CA 92182 USA	Oregon State University; Oregon State University; California State University System; San Diego State University; California State University System; San Diego State University					NIDCD NIH HHS [DCB-8718731] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P327, DOI 10.1104/pp.65.2.327; CROSS JW, 1985, PLANT CELL ENVIRON, V8, P351, DOI 10.1111/j.1365-3040.1985.tb01410.x; DANIEL SG, IN PRESS PLANT PHYSL; FUJINO DW, 1988, PLANT PHYSIOL, V88, P780, DOI 10.1104/pp.88.3.780; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HICKS GR, IN PRESS P NATL ACAD; JACKSON MB, 1979, PHYSIOL PLANTARUM, V46, P347, DOI 10.1111/j.1399-3054.1979.tb02631.x; JONES AM, 1984, PLANT PHYSIOL, V74, P295, DOI 10.1104/pp.74.2.295; JONES AM, 1984, PLANT PHYSIOL, V75, P1111, DOI 10.1104/pp.75.4.1111; KELLY MO, 1986, PLANT PHYSIOL, V82, P713, DOI 10.1104/pp.82.3.713; Libbenga K. R., 1987, Plant hormones and their role in plant growth and development., P194; MELHADO LL, 1981, PLANT PHYSIOL, V68, P469, DOI 10.1104/pp.68.2.469; RUBERY PH, 1981, ANNU REV PLANT PHYS, V32, P569, DOI 10.1146/annurev.pp.32.060181.003033; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Venis M., 1985, HORMONE BINDING SITE; WIGHTMAN F, 1980, PHYSIOL PLANTARUM, V49, P304, DOI 10.1111/j.1399-3054.1980.tb02669.x; ZOBEL RW, 1972, J HERED, V63, P94, DOI 10.1093/oxfordjournals.jhered.a108241; ZOBEL RW, 1974, CAN J BOT, V52, P735, DOI 10.1139/b74-095; ZOBEL RW, 1973, PLANT PHYSIOL, V52, P385, DOI 10.1104/pp.52.4.385	19	71	71	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	1989	245	4913					52	54		10.1126/science.245.4913.52	http://dx.doi.org/10.1126/science.245.4913.52			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD786	11537490				2022-12-28	WOS:A1989AD78600029
J	Wirth, A; Krause, J				Wirth, A; Krause, J			Long-term weight loss with sibutramine - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; OVERWEIGHT; MAINTENANCE; PREVENTION; MANAGEMENT; ORLISTAT; DISEASE; HEALTH; MEN	Context Treatment of obesity requires long-term therapy, which can be hampered by difficulties in achieving patient compliance. The effectiveness of sibutramine hydrochloride in treating obesity has been shown in randomized controlled trials. Objective To compare the effectiveness of 2 distinct sibutramine regimens with each other and with placebo for weight reduction among obese persons. Design Randomized, double-blind, parallel-group placebo-controlled trial from April 1997 to September 1998. Setting One hundred eight private practices and 3 outpatient departments of university hospitals in Germany. Patients A total of 1102 obese adults (body mass index, 30-40 kg/m(2)) entered the 4-week open-label run-in period with 15 mg/d of sibutramine, 1001 of whom had weight loss of at least 2% or 2 kg were randomized into the 44-week randomized treatment period. Interventions Patients were randomly assigned to receive 15 mg/d of sibutramine continuously throughout weeks 1-48 (n=405); 15 mg/d of sibutramine intermittently during weeks 1-12, 19-30, and 37-48, with placebo during all other weeks (n=395); or placebo for weeks 5-48 (n=201). Main Outcome Measure Weight loss during the randomized treatment period, compared among all 3 groups. Results Mean weight loss in the intention-to-treat population during the 44-week randomized treatment period was 3.8 kg (4.0%) in patients receiving continuous therapy (95% confidence interval [CI], -4.42 to -3.20 kg) and was 3.3 kg (3.5%) in patients receiving intermittent therapy (95% CI, -3.96 to -2.66 kg), vs a mean weight gain of 0.2 kg (0.2%) (95% CI, -0.60 to 0.94 kg) in patients receiving placebo. Therapeutic equivalence of the 2 active treatments could be shown. Although there was a greater weight loss in the continuous than in the intermittent group, this difference was nonsignificant (P=:28) and the 95% Cis were within the predefined range of therapeutic equivalence-0 +/-1.5 kg (-1.37 to 0.28 for the intent-to-treat population). Overall weight loss during the 48-week period was 7.9 kg and 7.8 kg in the continuous and intermittent groups, respectively, but was 3.8 kg in the sibutramine run-in placebo group. Waist circumference reduction, triglyceride levels, and high-density lipoprotein cholesterol concentrations were also positively influenced by sibutramine treatment. Systolic and diastolic blood pressures were stable across all 3 groups. overall, adverse events occurred at similar frequencies across all treatment groups, but the proportion was lowest in the group receiving intermittent therapy. Conclusions Sibutramine, administered for 48 weeks to a typically obese population, results in clinically relevant weight loss compared with placebo. Regarding effectiveness, continuous and intermittent sibutramine therapies are equivalent and the safety profiles for both treatments are comparable.	Teutoburger Wald Klin, D-49214 Bad Rothenfelde, Germany; Knoll Deutschland GmbH, Klin Prufungen, Ludwigshafen, Germany		Wirth, A (corresponding author), Teutoburger Wald Klin, Teutoburger Wald Str 33, D-49214 Bad Rothenfelde, Germany.	wirthbr@t-online.de						Apfelbaum M, 1999, AM J MED, V106, P179, DOI 10.1016/S0002-9343(98)00411-2; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; ASTRUP A, 1998, INT J OBESITY, V22, P30; Bray G. A., 1994, International Journal of Obesity, V18, P60; Bray GA, 1999, OBES RES, V7, P189, DOI 10.1002/j.1550-8528.1999.tb00701.x; Bray GA, 1996, OBES RES, V4, P263, DOI 10.1002/j.1550-8528.1996.tb00544.x; Chalmers J, 1999, J HYPERTENS, V17, P151; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P503; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; Drouin P., 1994, International Journal of Obesity, V18, P60; *DTSCH AD GES, 1998, ADIPOSITAS, V8, P6; FRANK A, 1993, JAMA-J AM MED ASSOC, V269, P2132, DOI 10.1001/jama.269.16.2132; HAZENBERG BP, 1996, INT J OBESITY, V20, P156; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; JONES RN, 1994, DIAGN MICR INFEC DIS, V18, P61, DOI 10.1016/0732-8893(94)90135-X; Jones S.P., 1995, INT J OBES S2, V19, P41; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lean MEJ, 1997, INT J OBESITY, V21, pS30; Luque CA, 1999, ANN PHARMACOTHER, V33, P968, DOI 10.1345/aph.18319; McNeely W, 1998, DRUGS, V56, P1093, DOI 10.2165/00003495-199856060-00019; ROSSNER S, 1992, FACTORS DETERMINING; *ROYAL COLL PHYS, 1997, OV OB PAT PRINC MAN; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Ryan DH, 1995, OBES RES, V3, pS553, DOI 10.1002/j.1550-8528.1995.tb00227.x; *SCOTT INT GUID NE, 1996, OB SCOTL INT PREV WE; Sjostrom CD, 1997, OBES RES, V5, P519; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; SMITH I, 1997, INT J OBES RELAT MET, V53, P21; Van Gaal LF, 1998, INT J OBESITY, V22, pS38; VANGAAL LF, 1998, INT J OBES RELATE ME, V22, P272; WADDEN TA, 1993, OBESITY THEORY THERA, P163; WEINTRAUB M, 1991, CLIN PHARMACOL THER, V50, P330, DOI 10.1038/clpt.1991.144; *WHO, 1989, 125 WHO NUTR DU EUR; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801	35	180	181	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1331	1339		10.1001/jama.286.11.1331	http://dx.doi.org/10.1001/jama.286.11.1331			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560538	Bronze			2022-12-28	WOS:000171024500026
J	Hays, JT; Hurt, RD; Rigotti, NA; Niaura, R; Gonzales, D; Durcan, MJ; Sachs, DPL; Wolter, TD; Buist, AS; Johnston, JA; White, JD				Hays, JT; Hurt, RD; Rigotti, NA; Niaura, R; Gonzales, D; Durcan, MJ; Sachs, DPL; Wolter, TD; Buist, AS; Johnston, JA; White, JD			Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							NICOTINE PATCH; DEPENDENCE	Background: Smoking relapse is common after successful pharmacologic treatment for smoking cessation. No previous studies have examined long-term drug therapy used expressly for prevention of smoking relapse. Objective: To evaluate the efficacy of bupropion to prevent smoking relapse. Design: Randomized, placebo-controlled trial. Participants: 784 healthy community volunteers who were motivated to quit smoking and who smoked at least 15 cigarettes per day. Intervention: The participants received open-label, sustained-release bupropion, 300 mg/d, for 7 weeks. Participants who were abstinent throughout week 7 of open-label treatment were randomly assigned to receive bupropion, 300 mg/d, or placebo for 45 weeks and were subsequently followed for an additional year after the conclusion of the medication phase. Participants were briefly counseled at all follow-up visits. At the end of open-label bupropion treatment, 461 of 784 participants (58.8%) were abstinent from smoking. Measurement: Self-reported abstinence was confirmed by an expired air carbon monoxide concentration of 10 parts per million or less. Results: The point prevalence of smoking abstinence was significantly higher in the bupropion group than in the placebo group at the end (week 52) of drug therapy (55.1% vs. 42.3%, respectively; P = 0.008) and at week 78 (47.7% vs. 37.7%; P = 0.034) but did not differ at the final (week 104) follow-up visit (41.6% vs. 40.0%). The median time to relapse was significantly greater for bupropion recipients than for placebo recipients (156 days vs. 65 days; P = 0.021). The continuous abstinence rate was higher in the bupropion group than in the placebo group at study week 24 (17 weeks after randomization) (52.3% vs. 42.3%; P = 0.037) but did not differ between groups after week 24. Weight gain was significantly less in the bupropion group than in the placebo group at study weeks 52 (3.8 kg vs. 5.6 kg; P = 0.002) and 104 (4.1 kg vs. 5.4 kg; P = 0.016). Conclusions: in persons who stopped smoking with 7 weeks of bupropion treatment, sustained-release bupropion for 12 months delayed smoking relapse and resulted in less weight gain.	Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Brown Univ, Providence, RI 02912 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Palo Alto Ctr Pulm Dis Prevent, Palo Alto, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Mayo Clinic; Harvard University; Massachusetts General Hospital; Brown University; Oregon Health & Science University; GlaxoSmithKline; Stanford University	Hays, JT (corresponding author), Mayo Clin, Nicotine Res Ctr, 200 1st St SW, Rochester, MN 55905 USA.		Niaura, Raymond/AAE-7319-2019	Niaura, Raymond/0000-0002-0856-3540; Gonzales, David/0000-0002-4323-198X				Beck A.T, 1978, BECK DEPRESSION INVE; COX DR, 1972, J R STAT SOC B, V34, P187; Dale LC, 1998, J GEN INTERN MED, V13, P9, DOI 10.1046/j.1525-1497.1998.00002.x; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; FIORE MC, 1994, JAMA-J AM MED ASSOC, V271, P1940, DOI 10.1001/jama.271.24.1940; First M.B., 1990, USERS GUIDE STRUCTUR; GLYNN TJ, 1989, TO HELP YOUR PATIENT; HALL SM, 1984, J CONSULT CLIN PSYCH, V52, P372, DOI 10.1037/0022-006X.52.3.372; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Irvin JE, 1999, J CONSULT CLIN PSYCH, V67, P563, DOI 10.1037/0022-006X.67.4.563; JOHNSTON A, 1991, J CLIN PSYCHIAT, V52, P450; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Leischow S J, 1992, Arch Fam Med, V1, P233, DOI 10.1001/archfami.1.2.233; Meyers AW, 1997, J CONSULT CLIN PSYCH, V65, P448, DOI 10.1037/0022-006X.65.3.448; NIDES M, 1994, HEALTH PSYCHOL, V13, P354, DOI 10.1037/0278-6133.13.4.354; Perkins Kenneth A., 1994, Annals of Behavioral Medicine, V16, P46; RENNARD S, 1991, JAMA-J AM MED ASSOC, V266, P3133; Rigotti NA, 1999, ARCH INTERN MED, V159, P1169, DOI 10.1001/archinte.159.11.1169; SCHWARTZ JL, 1987, NIH PUBLICATION; Shiffman S, 1996, J CONSULT CLIN PSYCH, V64, P366, DOI 10.1037/0022-006X.64.2.366; SUTHERLAND G, 1992, LANCET, V340, P324, DOI 10.1016/0140-6736(92)91403-U; TONNESEN P, 1991, NEW ENGL J MED, V325, P311, DOI 10.1056/NEJM199108013250503	26	268	273	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					423	433		10.7326/0003-4819-135-6-200109180-00011	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472FH	11560455				2022-12-28	WOS:000170972500004
J	Karp, PD				Karp, PD			Pathway databases: A case study in computational symbolic theories	SCIENCE			English	Editorial Material							GENOME SEQUENCE	A pathway database (DB) is a DB that describes biochemical pathways, reactions, and enzymes. The EcoCyc pathway DB (see http://ecocyc.org) describes the metabolic, transport, and genetic-regulatory networks of Escherichia coli. EcoCyc is an example of a computational symbolic theory, which is a DB that structures a scientific theory within a formal ontology so that it is available for computational analysis. it is argued that by encoding scientific theories in symbolic form, we open new realms of analysis and understanding for theories that would otherwise be too large and complex for scientists to reason with effectively.	SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA	SRI International	Karp, PD (corresponding author), SRI Int, Bioinformat Res Grp, EK223,333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pkarp@ai.sri.com	Karp, Peter/C-3514-2012	Karp, Peter/0000-0002-5876-6418	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR007861] Funding Source: NIH RePORTER; NCRR NIH HHS [1-R01-RR07861-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Ellis LBM, 2000, NUCLEIC ACIDS RES, V28, P377, DOI 10.1093/nar/28.1.377; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARP P, 1996, P 4 INT C INT SYST M; KARP P, 1999, NUCL ACID PROTEIN DA, P269; Karp PD, 2000, BIOINFORMATICS, V16, P269, DOI 10.1093/bioinformatics/16.3.269; Karp PD, 1998, TRENDS BIOCHEM SCI, V23, P114, DOI 10.1016/S0968-0004(98)01184-0; Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56; Karp PP, 1999, TRENDS BIOTECHNOL, V17, P275, DOI 10.1016/S0167-7799(99)01316-5; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Romero P R, 2001, Pac Symp Biocomput, P471; SCHILLING C, 1988, P NATL ACAD SCI USA, V95, P4193; Stewart G., 1975, TOPICS NUMERICAL ANA, VII, P185, DOI [DOI 10.1016/B978-0-12-108550-6.50012-4, 10.1016/B978-0-12-496952-0.50023-4, DOI 10.1016/B978-0-12-496952-0.50023-4]	16	148	158	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2040	2044		10.1126/science.1064621	http://dx.doi.org/10.1126/science.1064621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557880				2022-12-28	WOS:000171028700061
J	Ackland, GJ; Butler, D				Ackland, GJ; Butler, D			Pack formation in cycling and orienteering - Avoiding conditions that draw competitors together may be a better way to test ability.	NATURE			English	Article									Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	University of Edinburgh	Ackland, GJ (corresponding author), Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland.		Ackland, Graeme J/H-2215-2015	Ackland, Graeme J/0000-0002-1205-7675				NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Olds T, 1998, EUR J APPL PHYSIOL, V77, P492, DOI 10.1007/s004210050365	2	3	3	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					127	127		10.1038/35093156	http://dx.doi.org/10.1038/35093156			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557967				2022-12-28	WOS:000170918800033
J	Kerrison, SH; Pollock, AM				Kerrison, SH; Pollock, AM			Regulating nursing homes - Caring for older people in the private sector in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England	University of London; University College London	Pollock, AM (corresponding author), UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England.	allyson.pollock@ucl.ac.uk		pollock, allyson/0000-0002-7388-3110				*AUD COMM, 1997, COMING AGE; AYRES L, 1992, RESPONSIVE REGULATIO; Braithwaite J, 1999, AUST J PUBL ADMIN, V58, P90, DOI 10.1111/1467-8500.00077; Braithwaite J, 2001, BRIT MED J, V323, P443, DOI 10.1136/bmj.323.7310.443; Carpenter GI, 2000, BRIT MED J, V320, P528, DOI 10.1136/bmj.320.7234.528; DAY P, 1987, MILBANK Q, V65, P303, DOI 10.2307/3349942; *DEP HLTH, 2000, COMM CAR STAT 2000 P; *DEP HLTH, 2001, NAT MIN STAND CAR HO; *DEP HLTH, 2000, COMM CAR STAT 2000 R; *FIN SERV AUTH, 2000, REG NEW MILL; Godden S, 2000, BRIT MED J, V320, P265, DOI 10.1136/bmj.320.7230.265; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2001, BRIT MED J, V323, P507, DOI 10.1136/bmj.323.7311.507; HILLER N, 2000, OFFICIAL HLTH STAT U, P247; *HLTH ADV SERV, 1998, NOT THEY AR OLD; Hood C, 2000, PUBLIC ADMIN, V78, P283, DOI 10.1111/1467-9299.00206; JANZON K, 2000, HLTH SERV J, V9, P26; KERRISON SH, IN PRESS PUBLIC LAW; KERRISON SH, IN PRESS HLTH SOCIAL; *NAT CAR STAND COM, 2001, NCSC UPD; ODEA G, 2000, J HLTH SOCIAL CARE C, V8, P159; *OFF FAIR TRAD, OLD PEOPL CONS CAR H; Player S., 2001, CRIT SOC POLICY, Vs21, P231; SCOT EX, 2001, REP CHIEF NURS OFF S; *SECR STAT HLTH, 2000, CM4815L; Sharman L., 2001, HOLDING ACCOUNT REV	26	26	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2001	323	7312					566	569		10.1136/bmj.323.7312.566	http://dx.doi.org/10.1136/bmj.323.7312.566			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546707	Green Published			2022-12-28	WOS:000170934600028
J	Luo, Y; Pfuetzner, RA; Mosimann, S; Paetzel, M; Frey, EA; Cherney, M; Kim, B; Little, JW; Strynadka, NCJ				Luo, Y; Pfuetzner, RA; Mosimann, S; Paetzel, M; Frey, EA; Cherney, M; Kim, B; Little, JW; Strynadka, NCJ			Crystal structure of LexA: A conformational switch for regulation of self-cleavage	CELL			English	Article							ESCHERICHIA-COLI; UMUD PROTEIN; INTERMOLECULAR CLEAVAGE; REPRESSOR; AUTODIGESTION; DNA; IDENTIFICATION; MECHANISM; PURIFICATION; PROGRAM	LexA repressor undergoes a self-cleavage reaction. In vivo, this reaction requires an activated form of RecA, but it occurs spontaneously in vitro at high pH. Accordingly, LexA must both allow self-cleavage and yet prevent this reaction in the absence of a stimulus. We have solved the crystal structures of several mutant forms of LexA. Strikingly, two distinct conformations are observed, one compatible with cleavage, and the other in which the cleavage site is similar to 20 Angstrom from the catalytic center. Our analysis provides insight into the structural and energetic features that modulate the interconversion between these two forms and hence the rate of the self-cleavage reaction. We suggest RecA activates the self-cleavage of LexA and related proteins through selective stabilization of the cleavable conformation.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of British Columbia; University of Alberta; University of Arizona; University of Arizona	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Paetzel, Mark/0000-0002-7408-5487	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024178] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24178] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; DEANDA J, 1983, J BIOL CHEM, V258, P536; Ferentz AE, 1997, NAT STRUCT BIOL, V4, P979, DOI 10.1038/nsb1297-979; FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GIMBLE FS, 1986, J MOL BIOL, V192, P39, DOI 10.1016/0022-2836(86)90462-6; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HURSTEL S, 1986, EMBO J, V5, P793, DOI 10.1002/j.1460-2075.1986.tb04283.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LIN LL, 1988, J BACTERIOL, V170, P2163, DOI 10.1128/jb.170.5.2163-2173.1988; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1994, METHOD ENZYMOL, V244, P266; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; McDonald JP, 1999, J MOL BIOL, V285, P2199, DOI 10.1006/jmbi.1998.2433; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P9804, DOI 10.1021/bi990637z; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Ptashne M, 1992, GENETIC SWITCH PHAGE; ROBERTS JW, 1978, P NATL ACAD SCI USA, V75, P4714, DOI 10.1073/pnas.75.10.4714; ROLAND KL, 1990, J BIOL CHEM, V265, P12828; ROLAND KL, 1992, J MOL BIOL, V228, P395, DOI 10.1016/0022-2836(92)90829-9; SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032; Shepley DP, 1996, P NATL ACAD SCI USA, V93, P11528, DOI 10.1073/pnas.93.21.11528; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SLILATY SN, 1991, PROTEIN ENG, V4, P919, DOI 10.1093/protein/4.8.919; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429	51	172	175	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					585	594		10.1016/S0092-8674(01)00479-2	http://dx.doi.org/10.1016/S0092-8674(01)00479-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551506	Bronze			2022-12-28	WOS:000170973200009
J	Brown, GD; Gordon, S				Brown, GD; Gordon, S			Immune recognition - A new receptor for beta-glucans	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PHAGOCYTOSIS; BINDING		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, GD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gbrown@molbiol.ox.ac.uk	brown, gordon/B-4249-2012	brown, gordon/0000-0002-0287-5383				Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; GIAIMIS J, 1993, J LEUKOCYTE BIOL, V54, P564, DOI 10.1002/jlb.54.6.564; JANUSZ MJ, 1988, IMMUNOLOGY, V65, P181; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Muller A, 1996, J IMMUNOL, V156, P3418; ROSS GD, 1985, J IMMUNOL, V134, P3307; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H	11	1166	1234	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					36	37		10.1038/35092620	http://dx.doi.org/10.1038/35092620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544516				2022-12-28	WOS:000170801200029
J	Pavlov, P; Svendsen, JI; Indrelid, S				Pavlov, P; Svendsen, JI; Indrelid, S			Human presence in the European Arctic nearly 40,000 years ago	NATURE			English	Article							ICE SHEETS; BARENTS; KARA; COLONIZATION; RUSSIA; EXTENT	The transition from the Middle to the Upper Palaeolithic, approximately 40,000-35,000 radiocarbon years ago, marks a turning point in the history of human evolution in Europe. Many changes in the archaeological and fossil record at this time have been associated with the appearance of anatomically modern humans(1,2). Before this transition, the Neanderthals roamed the continent, but their remains have not been found in the northernmost part of Eurasia. It is generally believed that this vast region was not colonized by humans until the final stage of the last Ice Age some 13,000-14,000 years ago(3,4). Here we report the discovery of traces of human occupation nearly 40,000 years old at Mamontovaya Kurya, a Palaeolithic site situated in the European part of the Russian Arctic. At this site we have uncovered stone artefacts, animal bones and a mammoth tusk with human-made marks from strata covered by thick Quaternary deposits. This is the oldest documented evidence for human presence at this high latitude; it implies that either the Neanderthals expanded much further north than previously thought or that modern humans were present in the Arctic only a few thousand years after their first appearance in Europe.	Univ Bergen, Ctr Studies Environm & Resources, N-5020 Bergen, Norway; Russian Acad Sci, Inst Language Literature & Hist, Komi Sci Ctr, Ural Div, Syktyvkar 167000, Russia; Univ Bergen, Bergen Museum, N-5020 Bergen, Norway	University of Bergen; Russian Academy of Sciences; Institute of Language, Literature & History, Komi Scientific Centre of the RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences; University of Bergen	Svendsen, JI (corresponding author), Univ Bergen, Ctr Studies Environm & Resources, N-5020 Bergen, Norway.	john.svendsen@smr.uib.no	Pavlov, Pavel Yu/S-3823-2016	Pavlov, Pavel Yu/0000-0001-8827-5719				ALLSWORTHJONES P, 1986, SZELETIAN, P83; ANIKOVICH MV, 1991, EARLY UPPER PALAEOLI; Astakhov VI, 1999, BOREAS, V28, P23, DOI 10.1111/j.1502-3885.1999.tb00205.x; Bader O.N., 1978, SUNGIR UPPER PALAEOL; Bar-Yosef O, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P39; Bocquet-Appel JP, 2000, ANTIQUITY, V74, P544, DOI 10.1017/S0003598X00059901; DERICCO F, 1998, CURR ANTHROPOL S, V39, P1; GAMBLE C, 1999, PALAEOLITHIC SOC EUR, P268; Halvorsen L. S., 2000, THESIS U BERGEN; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Kanivets V.I., 1976, PALEOLITHIC EXTREME; Kolosov YG, 1983, MOUSTERIAN SITES BEL; Mangerud J, 1999, BOREAS, V28, P46, DOI 10.1111/j.1502-3885.1999.tb00206.x; MOCHANOV YA, 1977, INITIAL SETTLING TER; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; PAVLOV PY, 1999, B I BIOL SYKTYVKAR, V2, P24; PAVLOV PY, 1986, PAMIATNIKI MAT KULTY, P7; PAVLOV PY, 1996, PALAEOLITHIC ARCHAEO, P44; Powers WR, 1996, INTERD CONT, P229; PRASLOV ND, 1982, PALEOLIT KOSTENKOVSK, P16; SINITSYN AA, 1997, RADIOUGLERODNAYA KHR, P21; Smith NP, 1999, COMPUT SCI ENG, V1, P96; Straus LG, 2000, ANTIQUITY, V74, P553; STRAUS LG, 1989, NATURE, V342, P476; STRINGER CB, 1996, AFRICAN EXODUS ORIGI, P84; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	27	104	109	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					64	67		10.1038/35092552	http://dx.doi.org/10.1038/35092552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544525				2022-12-28	WOS:000170801200038
J	Stevenson, PC				Stevenson, PC			The torturous road to democracy - domestic crisis in Nepal	LANCET			English	Article								Largely unnoticed by the outside world, an armed Maoist insurgence has wrested control of areas in 45 of Nepal's 75 administrative regions and has resulted in more than 1700 deaths since 1996.(1) State figures indicate that 1000 of these people were Maoist and about 400 were police-120 of whom died in attacks on police outposts in early April and July of 2001. alone. The remainder were "class enemies" of the "People's War"-ie, members of ruling parties. As public security collapses, the consequences for the Nepalese are random imprisonment, torture, and risk of extrajudiciary execution from both sides. Torture has increased greatly as a consequence of the insurgence, but was already deeply rooted in Nepalese authority and used as a primary approach to solving crime. More than 70% of Nepalese prisoners claim to have been tortured while in custody, and at least 50% claim they signed confessions as a result. INSEC (informal Sector Service Centre), a human rights organisation, documented 1035 cases of state perpetrated torture in the year 2000,(2) which has been suggested to be a gross underestimate of the true figure. The long-term physical, social, and psychosocial consequences for survivors are often severe. The Centre for Victims of Torture, Nepal, a non-government organisation based in Kathmandu, has been studying the effect of torture on survivors, and has implemented Nepal's only treatment programmes for those brave enough to seek help.			Stevenson, PC (corresponding author), 35 Mervan Rd, London SW2 1DR, England.		Stevenson, Philip C/E-8822-2013; stevenson, philip c/E-8741-2013	Stevenson, Philip C/0000-0002-0736-3619; stevenson, philip c/0000-0002-0736-3619				[Anonymous], 2001, AMNESTY INT REPORT; GURAGAIN G, 1994, INDELIBLE SCARS STUD; HARDING L, 2001, OBSERVER        0408, P18; *INF SECT SERV CTR, 2000, HUM RIGHTS YB 1999; *INF SECT SERV CTR, 2001, HUM RIGHTS YB 2000; Jaranson JM, 1995, TRANSCULT PSYCHIATRY, V32, P253; LAL CK, 2001, NEPAL TIMES, V39, P2; ORTMANN J, 1987, AM J SOCIAL PSYCHIAT, V7, P161; Sharma B., 1998, TRANSCULT PSYCHIATRY, V35, P85, DOI DOI 10.1177/136346159803500104; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Shrestha NM, 1995, TORTURE TORTURE VICT; Van Ommeren M, 2001, ARCH GEN PSYCHIAT, V58, P475, DOI 10.1001/archpsyc.58.5.475; VanOmmeren M, 1997, LANCET, V350, P595, DOI 10.1016/S0140-6736(05)63188-1; VANOMMEREN M, WAR VIOLENCE PUBLIC; 2000, AMNESTY INT REPORT; 1999, VOICE, V20, P18; 2001, NEPAL TIMES, V39, P1; 2000, ANN REPORT 1999	18	5	5	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					752	756		10.1016/S0140-6736(01)05844-5	http://dx.doi.org/10.1016/S0140-6736(01)05844-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551600				2022-12-28	WOS:000170729500032
J	White, A; Hayhoe, S; Hart, A; Ernst, E				White, A; Hayhoe, S; Hart, A; Ernst, E			Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists	BRITISH MEDICAL JOURNAL			English	Article									Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England; Colchester Dist Gen Hosp, Pain Clin, Colchester CO4 5JL, Essex, England; Univ Cent Lancashire, Fac Sci, Preston PR1 2HE, Lancs, England	University of Exeter; University of Central Lancashire	White, A (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England.							*BRIT MED ASS ETH, 1993, MED ETH TOD ITS PRAC; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ernst E, 1997, PAIN, V71, P123, DOI 10.1016/S0304-3959(97)03368-X; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; White A, 1997, ACUPUNCT MED, V15, P67	5	236	244	2	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					485	486		10.1136/bmj.323.7311.485	http://dx.doi.org/10.1136/bmj.323.7311.485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532840	Bronze, Green Published			2022-12-28	WOS:000170838500017
J	CRISP, D; ALLEN, DA; GRINSPOON, DH; POLLACK, JB				CRISP, D; ALLEN, DA; GRINSPOON, DH; POLLACK, JB			THE DARK SIDE OF VENUS - NEAR-INFRARED IMAGES AND SPECTRA FROM THE ANGLO-AUSTRALIAN-OBSERVATORY	SCIENCE			English	Article							HEATING RATES; NIGHT-SIDE; RADIATIVE-TRANSFER; LINE PARAMETERS; ENERGY-LEVELS; SOLAR FLUXES; ATMOSPHERE; INTENSITIES; GREENHOUSE; MESOSPHERE	Near-infrared images and spectra of the night side of Venus taken at the Anglo-Australian Telescope during February 1990 reveal four new thermal emission windows at 1.10, 1.18, 1.27, and 1.31 micrometers (mu-m), in addition to the previously discovered windows at 1.74 and 2.3-mu-m. Images of the Venus night side show similar bright and dark markings in all windows, but their contrast is much lower at short wavelengths. The 1.27-mu-m window includes a bright, high-altitude O2 airglow feature in addition to a thermal contribution from the deep atmosphere. Simulations of the 1.27- and 2.3-mu-m spectra indicate water vapor mixing ratios near 40 +/- 20 parts per million by volume between the surface and the cloud base. No large horizontal gradients in the water vapor mixing ratios were detected at these altitudes.	ANGLO AUSTRALIAN OBSERV,EPPING,NSW 2121,AUSTRALIA; NASA,AMES RES CTR,MOFFETT FIELD,CA 94035	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	CRISP, D (corresponding author), CALTECH,JET PROP LAB,MS 169-237,4800 OAK GROVE DR,PASADENA,CA 91109, USA.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998				ALLEN D, 1990, 4962 INT ASTR UN CIR; ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; ALLEN DA, 1986, ICARUS, V69, P221; BAILEY J, 1988, PUBL ASTRON SOC PAC, V100, P1178, DOI 10.1086/132286; BELL JF, 1991, SCIENCE, V252, P1293, DOI 10.1126/science.252.5010.1293; BELL JF, 1990, B AM ASTRON SOC, V22, P1052; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; BROWN LR, 1987, APPL OPTICS, V26, P5154, DOI 10.1364/AO.26.005154; CLOUGH SA, 1981, P SOC PHOTO-OPT INST, V277, P152; CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; CRISP D, 1989, SCIENCE, V246, P506, DOI 10.1126/science.246.4929.506; CRISP D, 1990, J GEOPHYS RES-SOLID, V95, P14577, DOI 10.1029/JB095iB09p14577; DEBERGH C, 1991, SCIENCE, V21, P547; GRINSPOON DH, 1987, SCIENCE, V238, P1702, DOI 10.1126/science.238.4834.1702; Hoffman JH, 1980, J GEOPHYS RES-SPACE, V85, P7882, DOI 10.1029/JA085iA13p07882; HUSSON N, 1986, ANN GEOPHYS A-UPPER, V4, P185; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; KAMP LW, 1988, NATURE, V336, P360, DOI 10.1038/336360a0; KAMP LW, 1990, ICARUS, V86, P510, DOI 10.1016/0019-1035(90)90231-W; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; Knollenberg RG, 1980, J GEOPHYS RES-SPACE, V85, P8039, DOI 10.1029/JA085iA13p08039; Moore JF, 1971, X6307248 NASA GODD S; Moroz V. I., 1983, Venus, P45; Oyama VI, 1980, J GEOPHYS RES-SPACE, V85, P7891, DOI 10.1029/JA085iA13p07891; PALMER KF, 1975, APPL OPTICS, V14, P208, DOI 10.1364/AO.14.000208; PARISOT JP, 1980, ICARUS, V42, P46, DOI 10.1016/0019-1035(80)90241-9; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8141, DOI 10.1029/JA085iA13p08141; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8223, DOI 10.1029/JA085iA13p08223; POLLACK JB, 1971, ICARUS, V14, P295, DOI 10.1016/0019-1035(71)90001-7; ROTHMAN LS, 1986, APPL OPTICS, V25, P1795, DOI 10.1364/AO.25.001795; ROTHMAN LS, 1987, APPL OPTICS, V26, P4085; Seiff A., 1983, Venus, P215; TOON OB, 1977, ICARUS, V30, P663, DOI 10.1016/0019-1035(77)90088-4; TOON OB, 1989, J GEOPHYS RES-ATMOS, V94, P16287, DOI 10.1029/JD094iD13p16287; WATTSON RB, 1986, J MOL SPECTROSC, V119, P83, DOI 10.1016/0022-2852(86)90203-1; YUNG YL, 1982, ICARUS, V51, P199, DOI 10.1016/0019-1035(82)90080-X	37	70	71	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 13	1991	253	5025					1263	1266		10.1126/science.11538493	http://dx.doi.org/10.1126/science.11538493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE689	11538493				2022-12-28	WOS:A1991GE68900035
J	ZHANG, YX; STOLPER, EM				ZHANG, YX; STOLPER, EM			WATER DIFFUSION IN A BASALTIC MELT	NATURE			English	Article							ION MICRO-PROBE; ELEVATED-TEMPERATURES; SUBMARINE BASALTS; SILICATE MELTS; GLASSES; CARBON; H2O; CO2; PRESSURES; ABUNDANCE	WATER is the most abundant volatile component in terrestrial basalts and is a significant constituent of the gases that escape from basaltic magmas. Knowledge of the diffusivity of water (and other volatiles) in basaltic melts is important for understanding the degassing of basaltic magma and for assessing the fractionation of volatiles during degassing. We report here measurements of water diffusivity in a basaltic liquid. The water concentration profiles through the samples, determined by Fourier-transform infrared spectroscopy, cannot be modelled adequately on the basis of a constant water diffusivity 1-7, but instead can be fitted by assuming that only molecular H2O is diffusing and that there is a local equilibrium between H2O molecules and OH groups 7-13. The concentration-dependent total water diffusivities in the basaltic melt at 1,300-1,500-degrees-C are 30-50 times as large as those in rhyolitic melts 4-7, and are greater than the total CO2 diffusivity in basaltic melts, contrary to previous expectations 14. These results suggest that diffusive fractionation would increase the ratio of water to carbon dioxide in growing bubbles relative to equilibrium partitioning, and decrease the ratio in interface melts near an advancing anhydrous phenocryst.			ZHANG, YX (corresponding author), CALTECH,DEPT GEOL & PLANETARY SCI,17025,PASADENA,CA 91125, USA.		Zhang, Youxue/D-2922-2011					BURN I, 1970, PHYS CHEM GLASSES, V11, P106; CABLE M, 1987, J MATER SCI, V22, P919, DOI 10.1007/BF01103530; CARROLL MR, 1990, EOS, V71, P1664; CHEKHMIR AS, 1988, GEOKHIMIYA+, V10, P303; Crank J., 1975, MATH DIFFUSION; DELANEY JR, 1978, GEOCHIM COSMOCHIM AC, V42, P581, DOI 10.1016/0016-7037(78)90003-0; DELANEY JR, 1981, EARTH PLANET SC LETT, V52, P191, DOI 10.1016/0012-821X(81)90220-X; DIXON JE, 1988, EARTH PLANET SC LETT, V90, P87, DOI 10.1016/0012-821X(88)90114-8; Doremus RH., 1969, REACT SOLIDS, P667; DUNN T, 1983, GEOCHIM COSMOCHIM AC, V47, P1923, DOI 10.1016/0016-7037(83)90209-0; ERNSBERGER FM, 1980, PHYS CHEM GLASSES, V21, P146; HARRIS DM, 1981, J GEOL, V89, P689, DOI 10.1086/628636; HARRIS DM, 1983, GEOCHIM COSMOCHIM AC, V47, P1139, DOI 10.1016/0016-7037(83)90244-2; JAMBON A, 1987, CHEM GEOL, V62, P177, DOI 10.1016/0009-2541(87)90084-2; KARSTEN JL, 1982, EARTH PLANET SC LETT, V59, P420, DOI 10.1016/0012-821X(82)90143-1; KYSER TK, 1984, GEOCHIM COSMOCHIM AC, V48, P2123, DOI 10.1016/0016-7037(84)90392-2; LAPHAM KE, 1984, J NON-CRYST SOLIDS, V67, P179, DOI 10.1016/0022-3093(84)90148-0; LUX G, 1987, GEOCHIM COSMOCHIM AC, V51, P1549, DOI 10.1016/0016-7037(87)90336-X; MOORE JG, 1977, J VOLCANOL GEOTH RES, V2, P309, DOI 10.1016/0377-0273(77)90018-X; MUENOW DW, 1979, EARTH PLANET SC LETT, V42, P71, DOI 10.1016/0012-821X(79)90191-2; PINEAU F, 1983, EARTH PLANET SC LETT, V62, P239, DOI 10.1016/0012-821X(83)90087-0; Roberts GJ, 1964, PHYS CHEM GLASSES-B, V5, P26; SMETS BM, 1983, PHYS CHEM GLASSES, V24, P635; STANTON TR, 1985, EOS, V66, P1131; STOLPER E, 1988, EARTH PLANET SC LETT, V87, P397, DOI 10.1016/0012-821X(88)90004-0; STOLPER E, 1982, CONTRIB MINERAL PETR, V81, P1, DOI 10.1007/BF00371154; WAKABAYASHI H, 1989, J AM CERAM SOC, V72, P1850, DOI 10.1111/j.1151-2916.1989.tb05990.x; WASSERBERG GJ, 1988, J GEOL, V65, P15; WATSON EB, 1982, EARTH PLANET SC LETT, V61, P346, DOI 10.1016/0012-821X(82)90065-6; ZHANG Y, 1990, GEOCHEM SOC GOLDSCHM, P94; ZHANG Y, IN PRESS EARTH PLANE; ZHANG YX, 1991, GEOCHIM COSMOCHIM AC, V55, P441, DOI 10.1016/0016-7037(91)90003-N; ZHANG YX, 1989, CONTRIB MINERAL PETR, V102, P492, DOI 10.1007/BF00371090	33	151	156	1	31	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 23	1991	351	6324					306	309		10.1038/351306a0	http://dx.doi.org/10.1038/351306a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM976	11538704				2022-12-28	WOS:A1991FM97600056
J	MILLER, SL; BADA, JL				MILLER, SL; BADA, JL			SUBMARINE HOT SPRINGS AND THE ORIGIN OF LIFE	NATURE			English	Article									UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,AMINO ACID DATING LAB A-012B,LA JOLLA,CA 92093	University of California System; University of California San Diego; Scripps Institution of Oceanography	MILLER, SL (corresponding author), UNIV CALIF SAN DIEGO,DEPT CHEM B-017,LA JOLLA,CA 92093, USA.							BADA JL, 1987, BIOSYSTEMS, V20, P21, DOI 10.1016/0303-2647(87)90016-5; BADA JL, 1978, EARTH PLANET SC LETT, V41, P67, DOI 10.1016/0012-821X(78)90042-0; BAROSS JA, 1983, NATURE, V303, P423, DOI 10.1038/303423a0; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; BERNHARDT G, 1984, NATURWISSENSCHAFTEN, V71, P583, DOI 10.1007/BF01189186; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; Corliss J. B., 1981, Oceanologica Acta, V4, P59; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; Feather M.S., 1973, ADV CARBOHYDR CHEM B, V28, P161, DOI 10.1016/S0065-2318(08)60383-2; Fox SW, 1972, MOL EVOLUTION ORIGIN; FULLER WD, 1972, J MOL EVOL, V1, P249, DOI 10.1007/BF01660244; GINOZA W, 1964, NATURE, V203, P606, DOI 10.1038/203606a0; HARADA K, 1964, NATURE, V201, P335, DOI 10.1038/201335a0; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; KNOLL AH, 1988, SCIENCE, V239, P199, DOI 10.1126/science.239.4836.199; LAWLESS JG, 1973, NATURE, V243, P405, DOI 10.1038/243405a0; MACDONALD KC, 1980, EARTH PLANET SC LETT, V48, P1, DOI 10.1016/0012-821X(80)90163-6; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MEGGY AB, 1956, J CHEM SOC, P1444, DOI 10.1039/jr9560001444; MILLER SL, 1976, J MOL EVOL, V9, P59, DOI 10.1007/BF01796123; MILLER SL, 1974, ORIGINS LIFE EARTH, P118; MOPPER K, 1980, MAR CHEM, V10, P55, DOI 10.1016/0304-4203(80)90058-4; NISBET EG, 1987, YOUNG EARTH; SIMONEIT BRT, 1985, CAN J EARTH SCI, V22, P1919, DOI 10.1139/e85-208; SLEEP NH, 1986, ORIGINS LIFE EVOL B, V16, P179, DOI 10.1007/BF02421968; Storch H.H., 1951, FISCHER TROPSCH RELA; STRIBLING R, 1988, ORIGINS LIFE, V17, P261; TRENT JD, 1984, NATURE, V307, P737, DOI 10.1038/307737a0; TUREKIAN KK, 1986, P NATL ACAD SCI USA, V83, P6241, DOI 10.1073/pnas.83.17.6241; VALLENTYNE JR, 1968, GEOCHIM COSMOCHIM AC, V32, P1853; WESTHEIMER FH, 1986, NATURE, V319, P534, DOI 10.1038/319534a0; WHITE RH, 1984, NATURE, V310, P430, DOI 10.1038/310430a0; YAYANOS AA, 1983, APPL ENVIRON MICROB, V46, P1357, DOI 10.1128/AEM.46.6.1357-1363.1983	35	254	258	3	105	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 18	1988	334	6183					609	611		10.1038/334609a0	http://dx.doi.org/10.1038/334609a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7090	11536607				2022-12-28	WOS:A1988P709000061
J	Giles, J				Giles, J			Relaxed restrictions blamed for rise in foot and mouth	NATURE			English	News Item																		Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					98	98		10.1038/35093234	http://dx.doi.org/10.1038/35093234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557938	Bronze			2022-12-28	WOS:000170918800009
J	Rigby, M; Forsstrom, J; Roberts, R; Wyatt, J				Rigby, M; Forsstrom, J; Roberts, R; Wyatt, J		TEAC Hlth Partners	Verifying quality and safety in health informatics services	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL SOFTWARE; INTERNET; ADVICE		Univ Keele, Ctr Hlth Planning & Management, Keele ST5 5BG, Staffs, England; Univ Turku, Med Informat Res Ctr Turku, FIN-20520 Turku, Finland; Univ Coll Swansea, Sch Postgrad Studies Med & Hlth Care, Swansea SA2 8PP, W Glam, Wales; UCL, Sch Publ Policy, Knowledge Management Unit, London WC1H 9QU, England	Keele University; University of Turku; Swansea University; University of London; University College London	Rigby, M (corresponding author), Univ Keele, Ctr Hlth Planning & Management, Keele ST5 5BG, Staffs, England.	m.j.rigby@keele.ac.uk	Wyatt, Jeremy/F-8160-2010; Rigby, Michael J/B-9310-2009	Wyatt, Jeremy/0000-0001-7008-1473; 				Anderson R, 1996, SECURITY CLIN INFORM; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Cavalli P, 1996, LANCET, V347, P965, DOI 10.1016/S0140-6736(96)91448-8; *COUNC EUR COMM, 1993, DEC 22 JUL 1993 MOD; Dick R.S., 1991, COMPUTER BASED PATIE; *EU COUNC, 1993, DIR 9342EEC MED DEV; Eysenbach G, 1998, JAMA-J AM MED ASSOC, V280, P1333, DOI 10.1001/jama.280.15.1333; Forsstrom J, 1997, INT J MED INFORM, V47, P143, DOI 10.1016/S1386-5056(97)00098-1; FORSSTROM J, 1999, EVALUATION CERTIFICA; Forsstrom JJ, 1999, INT J MED INFORM, V56, P169, DOI 10.1016/S1386-5056(99)00044-1; Hawking M, 1997, PERSONAL MEDICAL INFORMATION, P57; HAWKING M, 1995, J INF PRIMARY CA JUN, P3; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; *INST CHART ACC EN, 2001, INT CHART ACC BOD LA; *MULT, 2001, TOW EV CERT HLTHCAR; Rigby M, 1999, HEALTH POLICY, V46, P97, DOI 10.1016/S0168-8510(98)00055-4; Rigby M, 1998, ST HEAL T, V52, P1223; Rigby M, 1997, PERSONAL MEDICAL INFORMATION, P129; RIGBY M, 2000, TAKING HLTH TEL 21ST; Roberts R, 1997, PERSONAL MEDICAL INFORMATION, P67; Rogers R., 1999, BJHC&IM-British Journal of Healthcare Computing & Information Management, V16, P28; Sandvik H, 1999, BRIT MED J, V319, P29, DOI 10.1136/bmj.319.7201.29; Weisbord SD, 1997, NEW ENGL J MED, V337, P825, DOI 10.1056/NEJM199709183371205; WILKINSON P, 2000, TIMES           0531, P1; Wyatt J, 1997, INT J MED INFORM, V47, P165, DOI 10.1016/S1386-5056(97)00100-7; 1998, HLTH SERV J, V106, P6	26	66	68	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2001	323	7312					552	556		10.1136/bmj.323.7312.552	http://dx.doi.org/10.1136/bmj.323.7312.552			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546703	Bronze, Green Published			2022-12-28	WOS:000170934600024
J	Axtell, RL				Axtell, RL			Zipf distribution of US firm sizes	SCIENCE			English	Article							STABLE INTERMITTENT FLUCTUATIONS; POWER-LAW DISTRIBUTIONS; SCALING BEHAVIOR; GROWTH	Analyses of firm sizes have historically used data that included limited samples of small firms, data typically described by lognormal distributions. Using data on the entire population of tax-paying firms in the United States, I show here that the Zipf distribution characterizes firm sizes: the probability a firm is larger than size s is inversely proportional to s. These results hold for data from multiple years and for various definitions of firm size.	Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA	Brookings Institution	Axtell, RL (corresponding author), Brookings Inst, Ctr Social & Econ Dynam, 1775 Massachusetts Ave NW, Washington, DC 20036 USA.	raxtell@brookings.edu	Axtell, Robert/A-4376-2009	Axtell, Robert/0000-0002-7187-2960				Acs Z.J., 1999, ARE SMALL FIRMS IMPO; Acs Zoltan J., 1990, INNOVATION SMALL FIR; Amaral LAN, 1997, J PHYS I, V7, P621; AXTELL RL, UNPUB; Biham O, 1998, PHYS REV E, V58, P1352, DOI 10.1103/PhysRevE.58.1352; Breslau L, 1999, IEEE INFOCOM SER, P126, DOI 10.1109/INFCOM.1999.749260; BROWN C, 1989, J POLIT ECON, V97, P1027, DOI 10.1086/261642; Burgos JD, 1996, BIOSYSTEMS, V39, P227, DOI 10.1016/0303-2647(96)01618-8; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; GELLMANN M, 1994, QUARK JAGUAR, P92; Gibrat R., 1931, INEGALITIES EC APPL; Hart PE, 1996, ECON J, V106, P1242, DOI 10.2307/2235518; HART PE, 1956, J R STAT SOC SER A-G, V119, P150, DOI 10.2307/2342882; Ijiri Y, 1977, SKEW DISTRIBUTIONS S; Johnson N., 1994, CONTINUOUS UNIVARIAT, V2; KESTEN H, 1973, ACTA MATH-DJURSHOLM, V131, P207, DOI 10.1007/BF02392040; Malcai O, 1999, PHYS REV E, V60, P1299, DOI 10.1103/PhysRevE.60.1299; Marsili M, 1998, PHYS REV LETT, V80, P2741, DOI 10.1103/PhysRevLett.80.2741; Ramsden JJ, 2000, PHYSICA A, V277, P220, DOI 10.1016/S0378-4371(99)00572-5; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; STANLEY MHR, 1995, ECON LETT, V49, P453, DOI 10.1016/0165-1765(95)00696-D; Steindl Josef., 1965, RANDOM PROCESSES GRO; Sutton J, 1997, J ECON LIT, V35, P40; Takayasu H, 1998, FRACTALS, V6, P67, DOI 10.1142/S0218348X98000080; Watanabe MS, 1996, PHYS REV E, V53, P4187, DOI 10.1103/PhysRevE.53.4187; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	26	919	933	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1818	1820		10.1126/science.1062081	http://dx.doi.org/10.1126/science.1062081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	470WN	11546870				2022-12-28	WOS:000170894400043
J	Chalder, T; Hotopf, M; Unwin, C; Hull, L; Ismail, K; David, A; Wessely, S				Chalder, T; Hotopf, M; Unwin, C; Hull, L; Ismail, K; David, A; Wessely, S			Prevalence of Gulf war veterans who believe they have Gulf war syndrome: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH	Objectives To determine how many veterans in a random sample of British veterans who served in the Gulf war believe they have "Gulf war syndrome," to examine factors associated with the presence of this belief, and to compare the health status of those who believe they have Gulf war syndrome with those who do not. Design Questionnaire study asking British Gulf war veterans whether they believe they have Gulf war syndrome and about symptoms, fatigue, psychological distress, post-traumatic stress, physical functioning, and their perception of health, Participants 2961 respondents to questionnaires sent out to a random sample of 4250 Gulf war veterans (69.7%). Main outcome measure The proportion of veterans who believe they have Gulf war syndrome. Results Overall, 17.3% (95% confidence interval 15.9 to 18.7) of the respondents believed they had Gulf war syndrome. The belief was associated with the veteran having poor health, not serving in the army when responding to the questionnaire, and having received a high number of vaccinations before deployment to the Gulf. The strongest association was knowing another person who also thought they had Gulf war syndrome. Conclusions Substantial numbers of British Gulf war veterans believe they have Gulf war syndrome, which is associated with psychological distress, a high number of symptoms, and some reduction in activity levels. A combination of biological, psychological, and sociological factors are associated with the belief, and these factors should be addressed in clinical practice.	Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England; Kings Coll London, St Thomass Sch Med, London SE5 8AZ, England	University of London; King's College London; University of London; King's College London	Chalder, T (corresponding author), Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England.	sphatrc@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; David, Anthony S/C-1315-2011; Chalder, Trudie/A-5717-2011; David, Anthony/O-1750-2019; Hotopf, Matthew/E-4971-2010	David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929; Chalder, Trudie/0000-0003-0775-1045; Ismail, Khalida/0000-0001-6084-449X				CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; Hotopf M, 2000, BRIT MED J, V320, P1363, DOI 10.1136/bmj.320.7246.1363; Ismail K, 1999, LANCET, V353, P179, DOI 10.1016/S0140-6736(98)11339-9; O'Brien LS, 1998, TRAUMATIC EVENTS MEN; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7	13	29	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					473	476		10.1136/bmj.323.7311.473	http://dx.doi.org/10.1136/bmj.323.7311.473			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532836	Green Published, Bronze			2022-12-28	WOS:000170838500013
J	YUNG, YL; ALLEN, M; CRISP, D; ZUREK, RW; SANDER, SP				YUNG, YL; ALLEN, M; CRISP, D; ZUREK, RW; SANDER, SP			SPATIAL VARIATION OF OZONE DEPLETION RATES IN THE SPRINGTIME ANTARCTIC POLAR VORTEX	SCIENCE			English	Article									CALTECH,JET PROP LAB,PASADENA,CA 91109	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	YUNG, YL (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.		Crisp, David/F-6642-2017; Yung, Yuk/AAM-4850-2021	Crisp, David/0000-0002-4573-9998; Yung, Yuk/0000-0002-4263-2562				ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11480, DOI 10.1029/JD094iD09p11480; BARRETT JW, 1988, NATURE, V336, P455, DOI 10.1038/336455a0; BRUNE WH, 1989, EOS, V70, P1040; BUTCHART N, 1986, J ATMOS SCI, V43, P1319, DOI 10.1175/1520-0469(1986)043<1319:TAOTSP>2.0.CO;2; DEZAFRA RL, 1989, J GEOPHYS RES-ATMOS, V94, P11423, DOI 10.1029/JD094iD09p11423; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; FARMER CB, 1987, NATURE, V329, P126, DOI 10.1038/329126a0; KRUEGER A, 1988, NASA REF PUBL, V1201; MAHLMAN JD, 1986, GEOPHYS RES LETT, V13, P1316, DOI 10.1029/GL013i012p01316; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MCINTYRE ME, 1984, J ATMOS TERR PHYS, V46, P825, DOI 10.1016/0021-9169(84)90063-1; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; SANDER SP, 1989, SCIENCE, V245, P1095, DOI 10.1126/science.245.4922.1095; SANDERS RW, 1989, J GEOPHYS RES-ATMOS, V94, P11381, DOI 10.1029/JD094iD09p11381; SCHOEBERL MR, 1986, GEOPHYS RES LETT, V13, P1217, DOI 10.1029/GL013i012p01217; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; SOLOMON S, 1989, J GEOPHYS RES-ATMOS, V94, P11393, DOI 10.1029/JD094iD09p11393; STOLARSKI RS, 1986, GEOPHYS RES LETT, V13, P1210, DOI 10.1029/GL013i012p01210; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; TUNG KK, 1986, NATURE, V333, P811; WATSON B, 1989, J GEOPHYS RES-ATMOS, V94, P11179, DOI 10.1029/JD094iD09p11179; WATSON R, 1989, J GEOPHYS RES, V94, P16437	23	7	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 11	1990	248	4956					721	724		10.1126/science.11538181	http://dx.doi.org/10.1126/science.11538181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC926	11538181				2022-12-28	WOS:A1990DC92600030
J	BLAKE, DF; FREUND, F; KRISHNAN, KFM; ECHER, CJ; SHIPP, R; BUNCH, TE; TIELENS, AG; LIPARI, RJ; HETHERINGTON, CJD; CHANG, S				BLAKE, DF; FREUND, F; KRISHNAN, KFM; ECHER, CJ; SHIPP, R; BUNCH, TE; TIELENS, AG; LIPARI, RJ; HETHERINGTON, CJD; CHANG, S			THE NATURE AND ORIGIN OF INTERSTELLAR DIAMOND	NATURE			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,NATL CTR ELECTRON MICROSCOPY,BERKELEY,CA 94720; SURFACE SCI LABS,MT VIEW,CA 94043	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	BLAKE, DF (corresponding author), NASA,AMES RES CTR,MOFFETT FIELD,CA 94035, USA.							ASH RD, IN PRESS METEORITICS, V22; CAREY W, IN PRESS METEORITICS, V22; DECARLI PS, 1961, SCIENCE, V133, P1821, DOI 10.1126/science.133.3467.1821; HECHT JH, 1987, NATURE, V328, P765, DOI 10.1038/328765a0; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LEWIS RS, 1983, NATURE, V305, P767, DOI 10.1038/305767a0; LEWIS RS, 1983, SCI AM, V249, P66, DOI 10.1038/scientificamerican0883-66; MORAR JF, 1986, PHYS REV B, V33, P1346, DOI 10.1103/PhysRevB.33.1346; NUTH JA, 1987, NATURE, V329, P589, DOI 10.1038/329589b0; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; ROY R, 1987, NATURE, V325, P17, DOI 10.1038/325017a0; SWART PK, 1983, SCIENCE, V220, P406, DOI 10.1126/science.220.4595.406; TIELENS AGG, 1987, APJ, V319, pL103; VANDERBILT D, 1984, PHYS REV B, V30, P6118, DOI 10.1103/PhysRevB.30.6118	15	61	60	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 14	1988	332	6165					611	613		10.1038/332611a0	http://dx.doi.org/10.1038/332611a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M9218	11536600				2022-12-28	WOS:A1988M921800051
J	Mjolsness, E; DeCoste, D				Mjolsness, E; DeCoste, D			Machine learning for science: State of the art and future prospects	SCIENCE			English	Editorial Material							PREDICTION	Recent advances in machine learning methods, along with successful applications across a wide variety of fields such as planetary science and bioinformatics, promise powerful new tools for practicing scientists. This viewpoint highlights some useful characteristics of modern machine learning methods and their relevance to scientific applications. We conclude with some speculations on near-term progress and promising directions.	CALTECH, Jet Prop Lab, Machine Learning Syst Grp, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Mjolsness, E (corresponding author), CALTECH, Jet Prop Lab, Machine Learning Syst Grp, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	mjolsness@jpl.nasa.gov						BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BROWN M, 2000, P NATL ACAD SCI USA, V97, P1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burl MC, 1998, MACH LEARN, V30, P165, DOI 10.1023/A:1007400206189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Mitchell T.M, 2003, MACH LEARN; Mjolsness E, 2000, ADV NEUR IN, V12, P928; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Shiozawa M, 1999, NUCL INSTRUM METH A, V433, P240, DOI 10.1016/S0168-9002(99)00359-9; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799	15	203	224	11	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2051	+		10.1126/science.293.5537.2051	http://dx.doi.org/10.1126/science.293.5537.2051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557883				2022-12-28	WOS:000171028700064
J	Garfield, CF				Garfield, CF			Men's work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Garfield, Craig/AAE-2525-2020	Garfield, Craig/0000-0002-6512-6005					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1146	1146		10.1001/jama.286.10.1146	http://dx.doi.org/10.1001/jama.286.10.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559238				2022-12-28	WOS:000170910400001
J	Braun, R				Braun, R			Astronomy - Galaxy clusters reveal their secrets	SCIENCE			English	Editorial Material									Netherlands Fdn Res Astron, NL-7990 AA Dwingeloo, Netherlands		Braun, R (corresponding author), Netherlands Fdn Res Astron, NL-7990 AA Dwingeloo, Netherlands.	braun@nfra.nl						Balmer J.J., 1885, ANN PHYS CHEM, V261, P80, DOI [10.1002/andp.18852610506, DOI 10.1002/ANDP.18852610506]; EWEN HI, 1951, NATURE, V168, P356, DOI 10.1038/168356a0; FAN XW, UNPUB; LYMAN T, 1906, ASTROPHYS J, V23, P18; Rubin VC, 2000, PUBL ASTRON SOC PAC, V112, P747, DOI 10.1086/316573; TAYLOR AR, SCI SKA; van de Hulst H.C., 1945, NED TIJDSCHR NATUURK, V11, P210; Zwaan MA, 2001, SCIENCE, V293, P1800, DOI 10.1126/science.1063034	8	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1781	1782		10.1126/science.1064111	http://dx.doi.org/10.1126/science.1064111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546860				2022-12-28	WOS:000170894400033
J	Snyder, J; Slusky, JS; Cava, RJ; Schiffer, P				Snyder, J; Slusky, JS; Cava, RJ; Schiffer, P			How 'spin ice' freezes	NATURE			English	Article							MAGNETIC-PROPERTIES; FRUSTRATION; TEMPERATURE; HO2TI2O7; GLASS; SUSCEPTIBILITY; FERROMAGNET; ANISOTROPY; RELAXATION; BEHAVIOR	The large degeneracy of states resulting from the geometrical frustration of competing interactions is an essential ingredient of important problems in fields as diverse as magnetism(1), protein folding(2) and neural networks(3). As first explained by Pauling(4), geometrical frustration of proton positions is also responsible for the unusual low-temperature thermodynamics of ice and its measured 'ground state' entropy(5). Recent work has shown that the geometrical frustration of ice is mimicked by Dy2Ti2O7, a site-ordered magnetic material in which the spins reside on a lattice of corner-sharing tetrahedra where they form an unusual magnetic ground state known as 'spin ice'(6-13). Here we identify a cooperative spin-freezing transition leading to the spin-ice ground state in Dy2Ti2O7. This transition is associated with a very narrow range of relaxation times, and represents a new form of spin-freezing. The dynamics are analogous to those associated with the freezing of protons in ice, and they provide a means through which to study glass-like behaviour and the consequences of frustration in the limit of low disorder.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08540 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Princeton University; Princeton University	Schiffer, P (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.		Schiffer, Peter/F-3227-2011	Schiffer, Peter/0000-0002-6430-6549; Slusky, Joanna/0000-0003-0842-6340				Bramwell ST, 1998, J PHYS-CONDENS MAT, V10, pL215, DOI 10.1088/0953-8984/10/14/002; Bramwell ST, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047205; Casimir HBG, 1938, PHYSICA, V5, P507, DOI 10.1016/S0031-8914(38)80164-6; DEKKER C, 1989, PHYS REV B, V40, P243; DENHERTOG BC, 2000, CONDMAT0009225; DIRKMAAT AJ, 1987, PHYS REV B, V36, P352, DOI 10.1103/PhysRevB.36.352; FIORANI D, 1986, J PHYS C SOLID STATE, V19, P5495, DOI 10.1088/0022-3719/19/27/024; Gardner JS, 1999, PHYS REV LETT, V83, P211, DOI 10.1103/PhysRevLett.83.211; GIAQUE WF, 1936, J AM CHEM SOC, V58, P1144; GINGRAS MJP, 2000, CONDMAT0012275; HAIDA O, 1974, J CHEM THERMODYN, V6, P815, DOI 10.1016/0021-9614(74)90227-4; Harris M, 1999, NATURE, V399, P311, DOI 10.1038/20562; Harris MJ, 1998, PHYS REV LETT, V81, P4496, DOI 10.1103/PhysRevLett.81.4496; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HUSER D, 1983, PHYS REV B, V27, P3100, DOI 10.1103/PhysRevB.27.3100; KAWADA S, 1978, J PHYS SOC JPN, V44, P1881, DOI 10.1143/JPSJ.44.1881; Matsuhira K, 2000, J PHYS-CONDENS MAT, V12, pL649, DOI 10.1088/0953-8984/12/40/103; Matsuhira K, 2001, J PHYS-CONDENS MAT, V13, pL737, DOI 10.1088/0953-8984/13/31/101; MYDOSH JA, 1993, SPIN GLASES EXPT INT; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; PAULING L, 1945, NATURE CHEM BOND, P301; PETRENKO VF, 1999, PHYSICS ICE; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; RAMIREZ AP, 1990, PHYS REV LETT, V64, P2070, DOI 10.1103/PhysRevLett.64.2070; Ramirez AP., 2001, HDB MAGNETIC MAT, Vvol 13, P423, DOI DOI 10.1016/S1567-2719(01)13008-8; REICH DH, 1987, PHYS REV LETT, V59, P1969, DOI 10.1103/PhysRevLett.59.1969; Rosenkranz S, 2000, J APPL PHYS, V87, P5914, DOI 10.1063/1.372565; SCHIFFER P, 1995, PHYS REV LETT, V74, P2379, DOI 10.1103/PhysRevLett.74.2379; Siddharthan R, 1999, PHYS REV LETT, V83, P1854, DOI 10.1103/PhysRevLett.83.1854; Wills AS, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.064430	31	224	225	3	113	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					48	51		10.1038/35092516	http://dx.doi.org/10.1038/35092516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544520				2022-12-28	WOS:000170801200033
J	Lee, SK; Cowie, SE				Lee, SK; Cowie, SE			Medical students and remediation of error	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ British Columbia, Sch Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Lee, SK (corresponding author), Univ British Columbia, Sch Med, Vancouver, BC V5Z 1M9, Canada.							GREEN JA, 1988, ANN INTERN MED, V109, P234, DOI 10.7326/0003-4819-109-3-234; Hebert PC, 2001, CAN MED ASSOC J, V164, P509; HEBERT PC, 1996, DOING RIGHT PRACTICA, P74; KOHN LT, 2000, ERR IS HUMAN BUILDIN, P54; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; RITCHIE JH, 1995, BRIT MED J, V310, P888, DOI 10.1136/bmj.310.6984.888	6	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2001	286	9					1082	1083		10.1001/jama.286.9.1082	http://dx.doi.org/10.1001/jama.286.9.1082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469EW	11559298				2022-12-28	WOS:000170802500026
J	Meegan, ME; Conroy, RM; Lengeny, SO; Renhault, K; Nyangole, L				Meegan, ME; Conroy, RM; Lengeny, SO; Renhault, K; Nyangole, L			Effect on neonatal tetanus mortality after a culturally-based health promotion programme	LANCET			English	Article								The Maasai have high rates of death from neonatal tetanus, partly due to their custom of packing the umbilical stump with cow dung. We report on the effect of a simple health promotion programme, designed In consultation with the local community and carried out by local women. After introduction of the programme in 1981, neonatal (<6 weeks of age) tetanus rates fell sharply, and by 1988 annual death rates had dropped to 0.75 (range 0-3) per 1000 births in the intervention areas compared with 82 (74-93) per 1000 in control areas.	Royal Coll Surgeons Ireland, Dublin 2, Ireland; ICROSS Kenya, Ngong Hills, Kenya; McMaster Univ, Fac Med, Hamilton, ON L8S 4L8, Canada; Minist Hlth, Nairobi, Kenya	Royal College of Surgeons - Ireland; McMaster University	Conroy, RM (corresponding author), Royal Coll Surgeons Ireland, Mercer Bldg, Dublin 2, Ireland.		Conroy, Ronan/C-6416-2008	Conroy, Ronan/0000-0001-5983-8682				ANITAOBONG OE, 1993, ANN TROP PAEDIATR, V13, P7; Bennett J, 1996, INT J EPIDEMIOL, V25, P879, DOI 10.1093/ije/25.4.879; MULL DS, 1990, SOC SCI MED, V30, P675, DOI 10.1016/0277-9536(88)90253-5; Mustafa BEM, 1996, J TROP PEDIATRICS, V42, P110, DOI 10.1093/tropej/42.2.110; 1996, SOZ PRAVENTIVMED, V41, P262	5	43	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					640	641		10.1016/S0140-6736(01)05787-7	http://dx.doi.org/10.1016/S0140-6736(01)05787-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530155				2022-12-28	WOS:000170615500016
J	Edwards, SJL				Edwards, SJL			The doctrine of double effect is difficult but not impossible to apply	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Ctr Eth Med, Bristol BS2 8BH, Avon, England	University of Bristol	Edwards, SJL (corresponding author), Univ Bristol, Ctr Eth Med, Bristol BS2 8BH, Avon, England.							Zucker Marjorie B., 1997, MED FUTILITY EVALUAT; 1999, WITHHOLDING WITHDRAW	2	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					390	391						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11548688				2022-12-28	WOS:000170581400030
J	RYE, R; KUO, PH; HOLLAND, HD				RYE, R; KUO, PH; HOLLAND, HD			ATMOSPHERIC CARBON-DIOXIDE CONCENTRATIONS BEFORE 2.2-BILLION YEARS AGO	NATURE			English	Article							SURFACE TEMPERATURES; EARLY EARTH; DISSOLUTION; EVOLUTION; SEDIMENT; FEEDBACK	THE composition of the Earth's early atmosphere is a subject of continuing debate(1-4). In particular, it has been suggested that elevated concentrations of atmospheric carbon dioxide would have been necessary to maintain normal surface temperatures in the face of lower solar luminosity in early Earth history(5,6). Fossil weathering profiles, known as palaeosols, have provided semiquantitative constraints on atmospheric oxygen partial pressure (pO(2)) before 2.2 Gyr ago(36,37). Here we use the same well studied palaeosols to constrain atmospheric p(CO2) between 2.75 and 2.2 Gyr ago, The observation that iron lost from the tops of these profiles was reprecipitated lower down as iron silicate minerals(7-9), rather than as iron carbonate, indicates that atmospheric p(CO2) must have been less than 10(-1.4) atm-about 100 times today's level of 360 p.p.m., and at least five times lower than that required in one-dimensional climate models to compensate for lower solar luminosity at 2.75 Gyr. Our results suggest that either the Earth's early climate was much more sensitive to increases in p(CO2) than has been thought, or that one or more greenhouse gases other than CO2 contributed significantly to the atmosphere's radiative balance during the late Archaean and early Proterozoic eons.			RYE, R (corresponding author), HARVARD UNIV,DEPT EARTH & SPACE SCI,20 OXFORD ST,CAMBRIDGE,MA 02138, USA.							ARNDT NT, 1991, AUST J EARTH SCI, V38, P261, DOI 10.1080/08120099108727971; BAKER JA, 1955, USGS1257 WAT SUPPL P; BRUNO J, 1992, GEOCHIM COSMOCHIM AC, V56, P1149, DOI 10.1016/0016-7037(92)90052-K; BUICK R, 1995, NATURE, V375, P674; BUTTON A, 1981, EC GEOLOGY ANNIVERSA, V0075, P00686; BUTTON A, 1979, 133 U WITW EC GEOL R; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; COTTER RD, 1965, USGS1759BE WAT PAP; EUGSTER HP, 1973, ECON GEOL, V68, P1144, DOI 10.2113/gsecongeo.68.7.1144; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GREENBERG J, 1992, APPL GEOCHEM, V7, P185, DOI 10.1016/0883-2927(92)90036-3; Hayes JM, 1994, NOBEL S, P220; HOFFMAN PF, 1995, NATURE, V375, P537, DOI 10.1038/375537a0; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1994, CHEM EVOLUTION ATMOS; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; KLEIN C, 1983, IRON FORMATION FACTS, V6, P417; MACFARLANE AW, 1994, PRECAMBRIAN RES, V65, P297, DOI 10.1016/0301-9268(94)90110-4; MAY F, 1994, MINERAL MAG A, V58, P577; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Pinto J.P., 1988, GEOL SOC AM SPEC PAP, P21, DOI DOI 10.1130/SPE216-P21; POSTMA D, 1981, CHEM GEOL, V31, P225; POSTMA D, 1977, J SEDIMENT PETROL, V47, P1089; POTH CW, 1963, B PENNS GEOL SURVEY, V16; POTH CW, 1973, B WATER RESOURCES RE, V36; POWELL JD, 1985, USGS2274 WAT SUPP PA; PRASAD N, 1991, 91IC GEOL SURV CAN P, P43; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SAGAN C, 1994, 1ST INT C CIRC HAB Z, P2; SUTTON SJ, 1993, CAN J EARTH SCI, V30, P60, DOI 10.1139/e93-006; TOWE KM, 1994, NOBEL S, V84, P36; WALKER JCG, 1990, GLOBAL PLANET CHANGE, V82, P261; WILLIAMS DR, 1991, USGS90384 OP FIL REP; WUNSCH DR, 1993, THESIS 5	38	267	272	2	50	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 7	1995	378	6557					603	605		10.1038/378603a0	http://dx.doi.org/10.1038/378603a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TJ221	11536713				2022-12-28	WOS:A1995TJ22100072
J	JABLONSKI, D; RAUP, DM				JABLONSKI, D; RAUP, DM			SELECTIVITY OF END-CRETACEOUS MARINE BIVALVE EXTINCTIONS	SCIENCE			English	Article							TERTIARY BOUNDARY; DEEP-SEA; MASS EXTINCTIONS; OCEAN; EVOLUTION; PATTERNS; SIZE	Analyses of the end-Cretaceous or Cretaceous-Tertiary mass extinction show no selectivity of marine bivalve genera by life position (burrowing versus exposed), body size, bathymetric position on the continental shelf, or relative breadth of bathymetric range. Deposit-feeders as a group have significantly lower extinction intensities than suspension-feeders, but this pattern is due entirely to low extinction in two groups (Nuculoida and Lucinoidea), which suggests that survivorship was not simply linked to feeding mode. Geographically widespread genera have significantly lower extinction intensities than narrowly distributed genera. These results corroborate earlier work suggesting that some biotic factors that enhance survivorship during times of lesser extinction intensities are ineffectual during mass extinctions.			JABLONSKI, D (corresponding author), UNIV CHICAGO, DEPT GEOPHYS SCI, 5734 S ELLIS AVE, CHICAGO, IL 60637 USA.							BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Calder WA., 1984, SIZE FUNCTION LIFE H; CAMPOSCREASEY LS, 1994, DEEP-SEA RES PT I, V41, P369, DOI 10.1016/0967-0637(94)90009-4; DANDO PR, 1994, MAR ECOL PROG SER, V107, P169, DOI 10.3354/meps107169; ERWIN D H, 1989, Palaios, V4, P424, DOI 10.2307/3514587; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; HICKMAN CS, 1994, VELIGER, V37, P43; HUBER BT, 1994, MAR MICROPALEONTOL, V24, P91, DOI 10.1016/0377-8398(94)90017-5; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1986, B MAR SCI, V39, P565; Jablonski D., 1986, P183; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; JABLONSKI D, IN PRESS GEOL SOC AM; Jablonski David, 1995, P25; JOHNSON CC, 1990, EXTINCTION EVENTS EA, P305; JUMARS PA, 1990, PHILOS T R SOC A, V331, P85, DOI 10.1098/rsta.1990.0058; KAMERMANS P, 1994, MAR ECOL PROG SER, V104, P63, DOI 10.3354/meps104063; Kauffman E.G., 1973, P353; KAUFFMAN EG, 1978, PHILOS T ROY SOC B, V284, P277, DOI 10.1098/rstb.1978.0068; KAUFFMAN EG, 1986, GLOBAL BIOEVENTS, P279; KELLER G, 1993, MAR MICROPALEONTOL, V21, P1, DOI 10.1016/0377-8398(93)90010-U; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; LAMBSHEAD PJD, 1990, DEEP-SEA RES, V37, P1263, DOI 10.1016/0198-0149(90)90042-T; LEVINTON JS, 1991, MAR BIOL, V110, P375, DOI 10.1007/BF01344356; LIN JD, 1994, OIKOS, V69, P28, DOI 10.2307/3545280; MACLEOD KG, 1994, GEOLOGY, V22, P139, DOI 10.1130/0091-7613(1994)022<0139:BIEAMM>2.3.CO;2; MACLEOD KG, 1994, J PALEONTOL, V68, P1048, DOI 10.1017/S0022336000026652; MACLEOD KG, 1990, GEOLOGICAL SOC AM SP, V247, P509; MARINCOVICH L, 1993, J PALEONTOL, V67, P1; Martin R.A., 1992, Historical Biology, V6, P73; McGhee G.R. Jr, 1989, P133; McKinney M.L., 1990, P75; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; PAUL CRC, 1994, GEOLOGY, V22, P679, DOI 10.1130/0091-7613(1994)022<0679:IFACFI>2.3.CO;2; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POHLO R, 1969, Proceedings of the Malacological Society of London, V38, P361; RAUP D., 1991, ANAL PALEOBIOLOGY, V4, P207; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; REID RGB, 1986, VELIGER, V29, P3; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; RHODES MC, 1991, GEOLOGY, V19, P877, DOI 10.1130/0091-7613(1991)019<0877:MEESAP>2.3.CO;2; ROY K, 1994, PALEOBIOLOGY, V20, P274, DOI 10.1017/S0094837300012781; SEPKOSKI JJ, 1987, SCIENCE, V235, P64, DOI 10.1126/science.11539724; SHEEHAN PM, 1992, GEOLOGY, V20, P556, DOI 10.1130/0091-7613(1992)020<0556:MEOLDV>2.3.CO;2; SHEEHAN PM, 1986, GEOLOGY, V14, P868, DOI 10.1130/0091-7613(1986)14<868:DFAABT>2.0.CO;2; SORAUF JE, 1986, CAN J EARTH SCI, V23, P1265, DOI 10.1139/e86-123; STANLEY SM, 1986, PALEOBIOLOGY, V12, P89, DOI 10.1017/S0094837300003006; STANLEY SM, 1988, MOLLUSCA, V11, P105; TYLER PA, 1988, OCEANOGR MAR BIOL, V26, P227; VANVALEN LM, 1994, MASS-EXTINCTION DEBATES: HOW SCIENCE WORKS IN A CRISIS, P200; WARD PD, 1991, GEOLOGY, V19, P1181, DOI 10.1130/0091-7613(1991)019<1181:AAIBEP>2.3.CO;2; WESTROP SR, 1989, PALEOBIOLOGY, V15, P46, DOI 10.1017/S0094837300009179; WINGARD GL, 1990, US GEOL SURV B, V1881, pD1; WINGARD GL, 1994, US GEOL SURV PROF PA, V1535, P1	58	161	164	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	1995	268	5209					389	391		10.1126/science.11536722	http://dx.doi.org/10.1126/science.11536722			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU572	11536722				2022-12-28	WOS:A1995QU57200030
J	BUICK, R				BUICK, R			THE ANTIQUITY OF OXYGENIC PHOTOSYNTHESIS - EVIDENCE FROM STROMATOLITES IN SULFATE-DEFICIENT ARCHEAN LAKES	SCIENCE			English	Article							WESTERN-AUSTRALIA; LACUSTRINE STROMATOLITES; WARRAWOONA GROUP; NORTH-POLE; BIOSTRATIGRAPHY; MICROFOSSILS; ROCKS	The Tumbiana Formation, about 2700 million years old, was largely deposited in ephemeral saline lakes, as judged by the unusual evaporite paragenesis of carbonate and halite with no sulfate. Stromatolites of diverse morphology occur in the lacustrine sediments, some with palimpsest fabrics after erect filaments. These stromatolites were probably accreted by phototropic microbes that, from their habitat in shallow isolated basins with negligible sulfate concentrations, almost certainly metabolized by oxygenic photosynthesis.	HARVARD UNIV,MUSEUM BOT,CAMBRIDGE,MA 02138	Harvard University				Buick, Roger/0000-0003-0139-1659				ABELL PI, 1982, SEDIMENT GEOL, V32, P1, DOI 10.1016/0037-0738(82)90011-2; [Anonymous], EARTHS EARLIEST BIOS; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; BLAKE TS, 1987, GEOLOGY, V15, P229, DOI 10.1130/0091-7613(1987)15<229:CRATAT>2.0.CO;2; BLAKE TS, 1984, NATURE, V307, P721, DOI 10.1038/307721a0; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; GREY K, 1982, PRECAMBRIAN RES, V18, P347, DOI 10.1016/0301-9268(82)90008-0; Grotzinger J.P., 1989, SOC EC PALEONTOLOGIS, V44, P79, DOI DOI 10.2110/PEC; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HOLLAND HD, 1990, AM J SCI, V290A, P1; KRYLOV IN, 1982, SEDIMENT GEOL, V32, P27, DOI 10.1016/0037-0738(82)90012-4; KUMAR S, 1984, PRECAMBRIAN RES, V14, P96; LIANG YZ, 1985, PRECAMBRIAN RES, V29, P15, DOI 10.1016/0301-9268(85)90056-7; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P361; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SMITH RE, 1982, J PETROL, V23, P75, DOI 10.1093/petrology/23.1.75; SOUTHGATE PN, 1986, GEOLOGY, V14, P683, DOI 10.1130/0091-7613(1986)14<683:DEAMOP>2.0.CO;2; Thorne A.M., 1990, U W AUST PUBL, P14; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; TRENDALL AF, 1990, 3RD INT ARCH S PERTH, P81; VEIZER J, 1990, GEOCHIM COSMOCHIM AC, V54, P2717, DOI 10.1016/0016-7037(90)90007-8; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187; [No title captured]	27	265	275	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 3	1992	255	5040					74	77		10.1126/science.11536492	http://dx.doi.org/10.1126/science.11536492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX791	11536492				2022-12-28	WOS:A1992GX79100039
J	Hong, BH; Bae, SC; Lee, CW; Jeong, S; Kim, KS				Hong, BH; Bae, SC; Lee, CW; Jeong, S; Kim, KS			Ultrathin single-crystalline silver nanowire arrays formed in an ambient solution phase	SCIENCE			English	Article							CATION-PI INTERACTIONS; GOLD; CHEMISTRY; SURFACE	We report the synthesis of single-crystalline silver nanowires of atomic dimensions. The uttrathin silver wires with 0.4 nanometer width grow up to micrometer-scale length inside the pores of self-assembled calix[4]hydroquinone nanotubes by etectro-/photochemical redox reaction in an ambient aqueous phase. The present subnanowires are very stable under ambient air and aqueous environments, unlike previously reported metal wires of similar to1 nanometer diameter, which existed only transiently in ultrahigh vacuum. The wires exist as coherently oriented three-dimensional arrays of ultrahigh density and thus could be used as model systems for investigating one-dimensional phenomena and as nanoconnectors for designing nanoelectronic devices.	Pohang Univ Sci & Technol, Dept Chem, Div Mol & Life Sci, Natl Creat Res Initiat Ctr Superfunct Mat, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, KS (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Div Mol & Life Sci, Natl Creat Res Initiat Ctr Superfunct Mat, Pohang 790784, South Korea.	kim@postech.ac.kr	Bae, Sung C/A-3423-2008; Kim, Kwang Soo/C-7538-2012; Jeong, Sukmin/A-2048-2009; Hong, Byung Hee/J-4464-2013; Lee, Chi-Wan/AAW-1591-2021	Bae, Sung C/0000-0002-9765-6801; Kim, Kwang Soo/0000-0002-6929-5359; Hong, Byung Hee/0000-0001-8355-8875; Lee, Chi-Wan/0000-0002-9123-4464; Bae, Sang-Cheol/0000-0003-4658-1093				Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Choi HS, 1998, P NATL ACAD SCI USA, V95, P12094, DOI 10.1073/pnas.95.21.12094; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; GOMEZKAIFER M, 1994, J AM CHEM SOC, V116, P3580, DOI 10.1021/ja00087a051; Henrard L, 2000, EUR PHYS J B, V13, P661, DOI 10.1007/s100510050083; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; HONG BH, IN PRESS J AM CHEM S; Kim KS, 2000, CHEM REV, V100, P4145, DOI 10.1021/cr990051i; Kondo Y, 2000, SCIENCE, V289, P606, DOI 10.1126/science.289.5479.606; Kondo Y, 1997, PHYS REV LETT, V79, P3455, DOI 10.1103/PhysRevLett.79.3455; Meyer RR, 2000, SCIENCE, V289, P1324, DOI 10.1126/science.289.5483.1324; Remskar M, 2001, SCIENCE, V292, P479, DOI 10.1126/science.1059011; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Ugarte D, 1996, SCIENCE, V274, P1897, DOI 10.1126/science.274.5294.1897; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wang ZL, 2000, J PHYS CHEM B, V104, P5417, DOI 10.1021/jp000800w; Yanson AI, 1998, NATURE, V395, P783, DOI 10.1038/27405; Yoon J, 2000, J CHEM PHYS, V112, P9335, DOI 10.1063/1.481553; Zach MP, 2000, SCIENCE, V290, P2120, DOI 10.1126/science.290.5499.2120	20	643	671	6	401	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					348	351		10.1126/science.1062126	http://dx.doi.org/10.1126/science.1062126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11546837				2022-12-28	WOS:000171601400036
J	Morrow, DA; Antman, EM; Parsons, L; de Lemos, JA; Cannon, CP; Giugliano, RP; McCabe, CH; Barron, HV; Braunwald, E				Morrow, DA; Antman, EM; Parsons, L; de Lemos, JA; Cannon, CP; Giugliano, RP; McCabe, CH; Barron, HV; Braunwald, E			Application of the TIMI risk score for ST-Elevation MI in the National Registry of Myocardial Infarction 3	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE; MORTALITY; TRIAL	Context The Thrombolysis in Myocardial Infarction (TIMI) risk score for ST-elevation myocardial infarction (STEMI) is a simple integer score for bedside risk assessment of patients with STEMI Developed and validated in multiple clinical trials of fibrinolysis, the risk score has not been validated in a community-based population. Objective To validate the TIMI risk score in a population of STEMI patients reflective of contemporary practice. Design, Setting, and Participants The risk score was evaluated among 84029 patients with STEMI from the National Registry of Myocardial Infarction 3 (NRMI 3), which collected data on consecutive patients with myocardial infarction (MI) from 1529 US hospitals between April 1998 and June 2000. Main Outcome Measures Ability of the TIMI risk score to correctly predict risk of death in terms of model discrimination (c statistic) and calibration (agreement of predicted and observed death rates). Results Patients in NRMI 3 tended to be older, to be more often female, and to have a history of coronary disease more often than those in the derivation set. Forty-eight percent received reperfusion therapy. The TIMI risk score revealed a significant graded increase in mortality with rising score (range, 1.1%-30.0%; P<.001 for trend). The risk score showed strong prognostic capacity overall (c=0.74 vs 0.78 in derivation set) and among patients receiving acute reperfusion therapy (c=0.79). Predictive behavior of the risk score was similar between fibrinolytic-treated patients (n=23960, c=0.79) and primary percutaneous coronary intervention patients (n=15348; c=0.80). In contrast, among patients not receiving reperfusion therapy, the risk score underestimated death rates and offered lower discriminatory capacity (c=0.65). Conclusions Sufficiently simple to be practical at the bedside and effective for risk assessment across a spectrum of patients, the TIMI risk score may be useful in triage and treatment of patients with STEMI who are treated with reperfusion therapy.	Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA; Ovat Res Grp, Seattle, WA USA; Univ Texas SW, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Genentech Inc, Dept Med Affairs, San Francisco, CA 94080 USA	Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; Roche Holding; Genentech	Morrow, DA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Dept Med, 75 Francis St, Boston, MA 02115 USA.		de Lemos, James/ABD-6669-2021; Cannon, Christopher P/AAY-7644-2020; Giugliano, Robert/N-7233-2017	Cannon, Christopher P/0000-0003-4596-2791; Giugliano, Robert/0000-0003-4110-7675				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Becker RC, 1998, AM HEART J, V135, P786, DOI 10.1016/S0002-8703(98)70036-5; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Maseri A, 1997, CIRCULATION, V96, P4141; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3	11	180	192	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1356	1359		10.1001/jama.286.11.1356	http://dx.doi.org/10.1001/jama.286.11.1356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560541	Bronze			2022-12-28	WOS:000171024500029
J	McCracken, KG; Wilson, RE; McCracken, PJ; Johnson, KP				McCracken, KG; Wilson, RE; McCracken, PJ; Johnson, KP			Sexual selection - Are ducks impressed by Drakes' display?	NATURE			English	Article									Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; Univ Alaska Museum, Fairbanks, AK 99775 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Illinois Natural History Survey	McCracken, KG (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.							Birkhead TR, 1992, SPERM COMPETITION BI; Briskie JV, 1997, J AVIAN BIOL, V28, P73, DOI 10.2307/3677097; JOHNSGARD PA, 1996, RUDDY DUCKS OTHER ST; McCracken KG, 2000, AUK, V117, P820, DOI 10.1642/0004-8038(2000)117[0820:TCSPOT]2.0.CO;2; Mead C, 2000, NATURE, V407, P461, DOI 10.1038/35035183	5	10	11	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					128	128		10.1038/35093160	http://dx.doi.org/10.1038/35093160			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557968	Bronze			2022-12-28	WOS:000170918800034
J	Jouvenceau, A; Eunson, LH; Spauschus, A; Ramesh, V; Zuberi, SM; Kullmann, DM; Hanna, MG				Jouvenceau, A; Eunson, LH; Spauschus, A; Ramesh, V; Zuberi, SM; Kullmann, DM; Hanna, MG			Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel	LANCET			English	Article							HEREDITARY PAROXYSMAL ATAXIA; EPISODIC ATAXIA; CA2+ CHANNELS; SYNAPTIC-TRANSMISSION; GENERALIZED EPILEPSY; PROGRESSIVE ATAXIA; ALPHA(1A) SUBUNIT; GENE; MUTATION; ACETAZOLAMIDE	Background The genetic basis of most common forms of human paroxysmal disorders of the central nervous system, such as epilepsy, remains unidentified. Several animal models of absence epilepsy, commonly accompanied by ataxia, are caused by mutations in the brain P/Q-type voltage-gated calcium (Ca(2+)) channel. We aimed to determine whether the P/Q-type Ca(2+) channel is associated with both epilepsy and episodic ataxia type 2 in human beings. Methods We identified an 11-year-old boy with a complex phenotype comprising primary generalised epilepsy, episodic and progressive ataxia, and mild learning difficulties. We sequenced the entire coding region of the gene encoding the voltage-gated P/Q-type Ca(2+) channel (CACNA1A) on chromosome 19. We then introduced the newly identified heterozygous mutation into the full-length rabbit cDNA and did detailed electrophysiological expression studies of mutant and wild type Ca(2+) channels. Findings We identified a previously undescribed heterozygous point mutation (C5733T) in CACNA1A. This mutation introduces a premature stop codon (RI820stop) resulting in complete loss of the C terminal region of the pore-forming subunit of this Ca 2 channel. Expression studies provided direct evidence that this mutation impairs Ca(2+) channel function. Mutant/wild-type co-expression studies indicated a dominant negative effect. Interpretation Human absence epilepsy can be associated with dysfunction of the brain P/Q-type voltage-gated Ca 2 channel. The phenotype in this patient has striking parallels with the mouse absence epilepsy models.	UCL, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England; INSERM, U549, F-75014 Paris, France; Univ Bonn, Dept Neurol, D-5300 Bonn, Germany; Newcastle Gen Hosp, Dept Paediat Neurol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn; Newcastle General Hospital; University of Glasgow	Kullmann, DM (corresponding author), UCL, Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Jouvenceau, Anne/A-9694-2016; Hanna, Michael G/B-1995-2009	Kullmann, Dimitri M/0000-0001-6696-3545; Hanna, Michael/0000-0003-0825-4075				Ayata C, 2000, NEUROSCIENCE, V95, P639; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Campbell DB, 1999, MOL PHARMACOL, V55, P23, DOI 10.1124/mol.55.1.23; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Fletcher CF, 1999, HUM MOL GENET, V8, P1907, DOI 10.1093/hmg/8.10.1907; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GRIGGS RC, 1978, NEUROLOGY, V28, P1259, DOI 10.1212/WNL.28.12.1259; Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P427, DOI 10.1136/jnnp.65.4.427; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Scott VES, 1998, J NEUROSCI, V18, P641; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; VanBogaert P, 1996, NEUROPHYSIOL CLIN, V26, P335, DOI 10.1016/S0987-7053(97)85101-5; VIGHETTO A, 1988, ARCH NEUROL-CHICAGO, V45, P547, DOI 10.1001/archneur.1988.00520290083018; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WEI XY, 1994, J BIOL CHEM, V269, P1635; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Yue Q, 1998, AM J MED GENET, V77, P298, DOI 10.1002/(SICI)1096-8628(19980526)77:4<298::AID-AJMG9>3.0.CO;2-J; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613	29	270	282	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					801	807		10.1016/S0140-6736(01)05971-2	http://dx.doi.org/10.1016/S0140-6736(01)05971-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564488				2022-12-28	WOS:000170989300014
J	Laver, G; Garman, E				Laver, G; Garman, E			Virology - The origin and control of pandemic influenza	SCIENCE			English	Editorial Material									Australian Natl Univ, Canberra, ACT 2601, Australia; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Australian National University; University of Oxford	Laver, G (corresponding author), Australian Natl Univ, GPO Box 4, Canberra, ACT 2601, Australia.	elspeth@biop.ox.ac.uk		Garman, Elspeth/0000-0001-8329-5665				Dowdle Walter R., 1997, Journal of Infectious Diseases, V176, pS69, DOI 10.1086/514180; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; 2001, P ROYAL SOC M OR CON	4	45	52	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1776	1777		10.1126/science.1063817	http://dx.doi.org/10.1126/science.1063817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546857				2022-12-28	WOS:000170894400030
J	Raviv, U; Laurat, P; Klein, J				Raviv, U; Laurat, P; Klein, J			Fluidity of water confined to subnanometre films	NATURE			English	Article							THIN LIQUID-FILMS; SOLID-SURFACES; TRANSITION; VISCOSITY; DYNAMICS; FORCES	The fluidity of water in confined geometries is relevant to processes ranging from tribology to protein folding, and its molecular mobility in pores and slits has been extensively studied using a variety of approaches(1-6). Studies in which liquid flow is measured directly suggest that the viscosity of aqueous electrolytes confined to films of thickness greater than about 2-3 nm remains close to that in the bulk(7-9); this behaviour is similar to that of non-associative organic liquids confined to films thicker than about 7-8 molecular layers(8,10,11). Here we observe that the effective viscosity of water remains within a factor of three of its bulk value, even when it is confined to films in the thickness range 3.5 +/- 1 to 0.0 +/- 0.4 nm. This contrasts markedly with the behaviour of organic solvents, whose viscosity diverges when confined to films thinner than about 5-8 molecular layers(10-15). We attribute this to the fundamentally different mechanisms of solidification in the two cases. For non-associative liquids, confinement promotes solidification by suppressing translational freedom of the molecules(11,15-18); however, in the case of water, confinement seems primarily to suppress the formation of the highly directional hydrogen-bonded networks associated with freezing(1,3).	Weizmann Inst Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Klein, J (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		Raviv, Uri/C-3600-2019					BELLISSENTFUNEL MC, 1994, NATO ASI SERIES; Berman A, 1998, TRIBOL LETT, V4, P95, DOI 10.1023/A:1019103205079; CHAN DYC, 1985, J CHEM PHYS, V83, P5311, DOI 10.1063/1.449693; CHANDLER D, 1983, SCIENCE, V220, P787, DOI 10.1126/science.220.4599.787; CLIFFORD J, 1975, WATER DISPERSE SYSTE, P75; Cui ST, 2001, J CHEM PHYS, V114, P7189, DOI 10.1063/1.1359736; DRAKE JM, 1990, PHYS TODAY, V43, P43; Gallo P, 2000, J CHEM PHYS, V113, P11324, DOI 10.1063/1.1328073; Gao JP, 1997, PHYS REV LETT, V79, P705, DOI 10.1103/PhysRevLett.79.705; GRANICK S, 1991, SCIENCE, V253, P1374, DOI 10.1126/science.253.5026.1374; HAPPEL, 1965, LOW REYNOLDS NUMBER; HOMOLA AM, 1989, J TRIBOL-T ASME, V111, P675, DOI 10.1115/1.3261994; HORN RG, 1989, CHEM PHYS LETT, V162, P404, DOI 10.1016/0009-2614(89)87066-6; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1988, SCIENCE, V240, P189, DOI 10.1126/science.240.4849.189; ISRAELACHVILI JN, 1986, J COLLOID INTERF SCI, V110, P263, DOI 10.1016/0021-9797(86)90376-0; Klein J, 1998, J CHEM PHYS, V108, P6996, DOI 10.1063/1.476114; Meyer M, 1999, J PHYS CHEM B, V103, P9728, DOI 10.1021/jp98412f; PASHLEY RM, 1984, J COLLOID INTERF SCI, V101, P511, DOI 10.1016/0021-9797(84)90063-8; PASHLEY RM, 1981, J COLLOID INTERF SCI, V80, P153, DOI 10.1016/0021-9797(81)90171-5; RAVINA I, 1972, CLAY CLAY MINER, V20, P109, DOI 10.1346/CCMN.1972.0200302; RHYKERD CL, 1987, NATURE, V330, P461, DOI 10.1038/330461a0; ROBERTS AD, 1971, PROC R SOC LON SER-A, V325, P323, DOI 10.1098/rspa.1971.0172; TABOR D, 1969, PROC R SOC LON SER-A, V312, P435, DOI 10.1098/rspa.1969.0169; THOMPSON PA, 1995, ISR J CHEM, V35, P93; Tkachenko A, 1997, LANGMUIR, V13, P7146, DOI 10.1021/la970741m; Weinstein A, 1998, EUROPHYS LETT, V42, P61, DOI 10.1209/epl/i1998-00552-9; XIA XF, 1995, SURF SCI, V335, P401, DOI 10.1016/0039-6028(95)00449-1	28	551	560	3	219	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					51	54		10.1038/35092523	http://dx.doi.org/10.1038/35092523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544521				2022-12-28	WOS:000170801200034
J	MacPherson, H; Thomas, K; Walters, S; Fitter, M				MacPherson, H; Thomas, K; Walters, S; Fitter, M			The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Fdn Tradit Chinese Med, York YO24 4EY, N Yorkshire, England; Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Sheffield Hlth Econ Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	MacPherson, H (corresponding author), Fdn Tradit Chinese Med, York YO24 4EY, N Yorkshire, England.	hugh@ftcm.org.uk		Walters, Stephen/0000-0001-9000-8126; MacPherson, Hugh/0000-0003-4255-4768				*BRIT MED ASS BOAR, 2000, AC EFF SAF PRACT; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; *HOUS LORDS, 2000, COMPL ALT MED; MacPherson H, 1999, J ALTERN COMPLEM MED, V5, P223, DOI 10.1089/acm.1999.5.223; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5	5	246	255	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					486	487		10.1136/bmj.323.7311.486	http://dx.doi.org/10.1136/bmj.323.7311.486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532841	Bronze, Green Published			2022-12-28	WOS:000170838500018
J	Richardson, DK; Heffner, LJ				Richardson, DK; Heffner, LJ			Fetal-lung maturity: tests mature, interpretation not	LANCET			English	Editorial Material							AMNIOTIC-FLUID; PRETERM LABOR; INDEXES		Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Richardson, DK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA.			Heffner, Linda/0000-0001-9623-7210				ACOG educational bulletin, 1997, INT J GYNECOL OBSTET, V56, P191; ASHWOOD ER, 1993, OBSTET GYNECOL, V81, P619; DUBIN SB, 1990, CLIN CHEM, V36, P1867; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Field NT, 1997, CLIN OBSTET GYNECOL, V40, P366, DOI 10.1097/00003081-199706000-00012; Ghidini A, 1997, AM J PERINAT, V14, P75, DOI 10.1055/s-2007-994101; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; GLUCK L, 1971, AM J OBSTET GYNECOL, V109, P440, DOI 10.1016/0002-9378(71)90342-5; HALLMAN M, 1976, AM J OBSTET GYNECOL, V125, P613, DOI 10.1016/0002-9378(76)90782-1; HUNINK MGM, 1990, MED DECIS MAKING, V10, P201, DOI 10.1177/0272989X9001000307; Lauria MR, 1996, J REPROD MED, V41, P685; Macones GA, 1998, BRIT J OBSTET GYNAEC, V105, P541, DOI 10.1111/j.1471-0528.1998.tb10156.x; Myers ER, 1997, OBSTET GYNECOL, V90, P824, DOI 10.1016/S0029-7844(97)00412-2; Wijnberger LDE, 2001, BRIT J OBSTET GYNAEC, V108, P583, DOI 10.1111/j.1471-0528.2001.00142.x	14	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					684	686		10.1016/S0140-6736(01)05848-2	http://dx.doi.org/10.1016/S0140-6736(01)05848-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551571				2022-12-28	WOS:000170729500004
J	Huang, Y; Street-Perrott, FA; Metcalfe, SE; Brenner, M; Moreland, M; Freeman, KH				Huang, Y; Street-Perrott, FA; Metcalfe, SE; Brenner, M; Moreland, M; Freeman, KH			Climate change as the dominant control on glacial-interglacial variations in C-3 and C-4 plant abundance	SCIENCE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; LATE MIOCENE; EXPANSION; BOUNDARY; GRASSES; NEOGENE; RECORD; KENYA	Although C-4 plant expansions have been recognized in the late Miocene, identification of the underlying causes is complicated by the uncertainties associated with estimates of ancient precipitation, temperature, and partial pressure of atmospheric carbon dioxide (PCO2). Here we report the carbon isotopic compositions of leaf wax n-alkanes in take sediment cores from two sites in Mesoamerica that have experienced contrasting moisture variations since the last glacial maximum. Opposite isotopic trends obtained from these two sites indicate that regional climate exerts a strong control on the relative abundance of C-3 and C-4 plants and that in the absence of favorable moisture and temperature conditions, low PCO2 atone is insufficient to drive an expansion of C-4 plants.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Coll Swansea, Dept Geog, Swansea SA2 8PP, W Glam, Wales; Univ Edinburgh, Dept Geog, Edinburgh EH8 9XP, Midlothian, Scotland; Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Brown University; Swansea University; University of Edinburgh; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Huang, Y (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Metcalfe, Sarah/H-9484-2013; Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				Bernor R.L., 1996, P449; BOUTTON TW, 1994, NATURE, V372, P625, DOI 10.1038/372625a0; Bradbury JP, 1997, QUATERN INT, V43-4, P97, DOI 10.1016/S1040-6182(97)00025-6; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Connin SL, 1998, QUATERNARY RES, V50, P179, DOI 10.1006/qres.1998.1986; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fischer H.G., COMMUNICATION; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; HUANG CT, 1971, INSECT BIOCHEM, V1, P27; Huang YS, 1999, GEOCHIM COSMOCHIM AC, V63, P1383, DOI 10.1016/S0016-7037(99)00074-5; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; Latorre C, 1997, EARTH PLANET SC LETT, V146, P83, DOI 10.1016/S0012-821X(96)00231-2; LEYDEN BW, 1994, PALAEOGEOGR PALAEOCL, V109, P193, DOI 10.1016/0031-0182(94)90176-7; Metcalfe SE, 1997, J PALEOLIMNOL, V17, P155, DOI 10.1023/A:1007905824147; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; Muhs DR, 1999, GEOL SOC AM BULL, V111, P1861, DOI 10.1130/0016-7606(1999)111<1861:LQLINC>2.3.CO;2; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; RAMIREZ JO, 1995, GEOFISICA INT, V34, P107; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; RIELEY G, 1993, RAPID COMMUN MASS SP, V7, P488, DOI 10.1002/rcm.1290070617; Sage R.F., 1999, C4 PLANT BIOL, P3; Schulze ED, 1996, OECOLOGIA, V106, P352, DOI 10.1007/BF00334563; StreetPerrott FA, 1997, SCIENCE, V278, P1422, DOI 10.1126/science.278.5342.1422; SUKUMAR R, 1993, NATURE, V364, P703, DOI 10.1038/364703a0; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Williams DG, 1996, OECOLOGIA, V106, P455, DOI 10.1007/BF00329701	28	290	351	9	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1647	1651		10.1126/science.1060143	http://dx.doi.org/10.1126/science.1060143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533488				2022-12-28	WOS:000170802900060
J	Lunin, SD; Moll, S				Lunin, SD; Moll, S			Suppurative parotitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lunin, SD (corresponding author), Univ Texas, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.		Sheppard, Donald/B-4637-2008	Sheppard, Donald/0000-0001-8877-880X					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2001	345	9					662	662		10.1056/NEJMicm960417	http://dx.doi.org/10.1056/NEJMicm960417			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466XG	11547720				2022-12-28	WOS:000170671000005
J	Bihl, G; Meyers, A				Bihl, G; Meyers, A			Recurrent renal stone disease - advances in pathogenesis and clinical management	LANCET			English	Review							CALCIUM-OXALATE; CRYSTALLIZATION; PROTEIN; KIDNEY; UROLITHIASIS; INHIBITORS; GENE	Kidney stones are common in industrialised nations: up to 15% of white men and 6% of all women will develop one stone, with recurrence in about half these people. Risk factors for formation of stones include urinary promoters (calcium, urate, cystine, and sodium) and urinary inhibitors (magnesium, citrate, and nephrocalcin). Acute renal colic can be precipitated by dehydration and reduced urine output, increased protein intake, heavy physical exercise, and various medicines. Such colic manifests as severe loin pain and can be accompanied by frequent urination, dysuria, oliguria, and haematuria. Documentation of stone characteristics is extremely important: type, size, location, and underlying metabolic abnormalities. Such details can be obtained with a combination of biochemical investigations, microscopic examination of urine under polarised light, and an intravenous pyelogram. Ultrasonography and plain abdominal radiographs are also useful, especially for patients unable to tolerate an intravenous pyelogram. Acute therapy includes complete pain relief, rehydration, and encouragement of diuresis. Long-term management encompasses education of patients with regard to diet and fluid intake, control of calciuria, citrate replacement, and treatment of any underlying urinary-tract infection or metabolic abnormality. Stones smaller than 5 mm normally pass spontaneously, whereas larger stones, as big as 2 cm, are best treated with extracorporeal shock-wave lithotripsy. All physicians should have a clear understanding of the pathogenesis and clinical management (acute treatment and prevention of recurrence) of renal stone disease.	Addenbrookes Hosp, Addenbrookes Renal & Dialysis Ctr, Cambridge, England; Johannesburg Hosp, Stone Clin, Johannesburg, South Africa	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Witwatersrand	Bihl, G (corresponding author), Univ Stellenbosch, Tygerberg Hosp, Dept Internal Med, Renal Unit, POB 19161, Cape Town, South Africa.	gbihl@maties.sun.ac.za						ATMANI F, 1993, BIOCHEM BIOPH RES CO, V191, P1158, DOI 10.1006/bbrc.1993.1338; Baggio B, 2000, KIDNEY INT, V58, P1278, DOI 10.1046/j.1523-1755.2000.00283.x; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P977; BUSHINSKY DA, 1989, AM J PHYSIOL, V256, pF836, DOI 10.1152/ajprenal.1989.256.5.F836; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; COE FL, 1998, NEPHROLITHIASIS PATH, P1; CRELLIN J, 1982, APHORISMS HIPPOCRATE, P110; Dean C, 2000, CLIN SCI, V98, P471, DOI 10.1042/CS19990114; Glauser A, 2000, NEPHROL DIAL TRANSPL, V15, P1580, DOI 10.1093/ndt/15.10.1580; GROVER PK, 1990, CLIN SCI, V79, P9, DOI 10.1042/cs0790009; Grover PK, 2000, EUR J BIOCHEM, V267, P61, DOI 10.1046/j.1432-1327.2000.00954.x; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Hanson K A, 2001, Clin Excell Nurse Pract, V5, P21; HERRING LC, 1962, J UROLOGY, V88, P545, DOI 10.1016/S0022-5347(17)64842-0; HESS B, 1991, AM J PHYSIOL, V260, pF569, DOI 10.1152/ajprenal.1991.260.4.F569; HESS B, 1993, AM J PHYSIOL, V265, pF784, DOI 10.1152/ajprenal.1993.265.6.F784; HOSKING DH, 1983, J UROLOGY, V130, P1115, DOI 10.1016/S0022-5347(17)51711-5; Joly D, 1999, PEDIATR NEPHROL, V13, P945, DOI 10.1007/s004670050736; Kekec Z, 2000, BJU INT, V85, P783, DOI 10.1046/j.1464-410x.2000.00613.x; Koka RM, 2000, AM J PHYSIOL-RENAL, V278, pF989, DOI 10.1152/ajprenal.2000.278.6.F989; Konya E, 2000, INT J UROL, V7, P361, DOI 10.1046/j.1442-2042.2000.00211.x; LIESKE JC, 1993, AM J PHYSIOL, V264, pF800, DOI 10.1152/ajprenal.1993.264.5.F800; LIESKE JC, 1992, AM J PHYSIOL, V262, pF622, DOI 10.1152/ajprenal.1992.262.4.F622; Lingeman JE, 1996, SEMIN NEPHROL, V16, P487; Martini LA, 2000, NUTR REV, V58, P111, DOI 10.1111/j.1753-4887.2000.tb07541.x; Martins MC, 1996, BRIT J UROL, V78, P176, DOI 10.1046/j.1464-410X.1996.00633.x; Meyers A., 1998, AFR J NEPHROL, V2, P12; Monk RD, 1996, SEMIN NEPHROL, V16, P375; Monk RD, 1996, KIDNEY STONES MED SU, P759; Nakada SY, 2000, J UROLOGY, V163, P607, DOI 10.1016/S0022-5347(05)67944-X; PAK CYC, 1975, NEW ENGL J MED, V292, P497, DOI 10.1056/NEJM197503062921002; PANTANOWITZ D, 1973, S AFR MED J, V47, P128; PARKS JH, 1996, KIDNEY STONES MED SU, P905; Pearce SHS, 1998, J ROY COLL PHYS LOND, V32, P10; ROBERTSON WG, 1981, J CRYST GROWTH, V53, P182, DOI 10.1016/0022-0248(81)90064-6; Rumsby G, 2000, MOL UROL, V4, P349; SAKHAEE K, 1989, J UROLOGY, V141, P819, DOI 10.1016/S0022-5347(17)41019-6; Stapleton AMF, 1996, KIDNEY INT, V49, P880, DOI 10.1038/ki.1996.121; Takemura T, 2001, AM J KIDNEY DIS, V37, P138, DOI 10.1016/S0272-6386(01)80067-6; TISELIUS HG, 1995, J UROLOGY, V154, P940, DOI 10.1016/S0022-5347(01)66939-8; Whalley NA, 1999, BJU INT, V84, P243; WONG HY, 1996, KIDNEY STONES MED SU, P1007; Worcester EM, 1996, SEMIN NEPHROL, V16, P474	43	131	141	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					651	656		10.1016/S0140-6736(01)05782-8	http://dx.doi.org/10.1016/S0140-6736(01)05782-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530173				2022-12-28	WOS:000170615500030
J	Smith, HJ; Fischer, H; Wahlen, M; Mastroianni, D; Deck, B				Smith, HJ; Fischer, H; Wahlen, M; Mastroianni, D; Deck, B			Dual modes of the carbon cycle since the Last Glacial Maximum	NATURE			English	Article							ICE-CORE; ATMOSPHERIC CO2; GREENLAND ICE; RECORD	The most conspicuous feature of the record of past climate contained in polar ice is the rapid warming which occurs after long intervals of gradual cooling. During the last four transitions from glacial to interglacial conditions, over which such abrupt warmings occur, ice records indicate that the CO2 concentration of the atmosphere increased by roughly 80 to 100 parts per million by volume (refs 1-4). But the causes of the atmospheric CO2 concentration increases are unclear. Here we present the stable-carbon-isotope composition (delta(13)CO(2)) Of CO2 extracted from air trapped in ice at Taylor Dome, Antarctica, rom the Last Glacial Maximum to the onset of Holocene times. The global carbon cycle is shown to have operated in two distinct primary modes on the timescale of thousands of years, one when climate was changing relatively slowly and another when warming was rapid, each with a characteristic average stable-carbon-isotope composition of the net CO2 exchanged by the atmosphere with the land and oceans. delta(13)CO(2) increased betiveen 16.5 and 9 thousand years ago by slightly more than would be estimated to be caused by the physical effects of a 5 degrees C rise in global average sea surface temperature driving a CO2 efflux from the ocean, but our data do not allow specific causes to be constrained.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Smith, HJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	hjsmith@aaas.org	Fischer, Hubertus/A-1211-2014	Fischer, Hubertus/0000-0002-2787-4221				ANKLIN M, 1995, TELLUS B, V47, P461, DOI 10.1034/j.1600-0889.47.issue4.6.x; BARNOLA JM, 1995, TELLUS B, V47, P264, DOI 10.1034/j.1600-0889.47.issue1.22.x; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; *CLIMAP PROJ MEMB, 1981, MAP CHART SER; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; CRAIG H, 1988, SCIENCE, V242, P1675, DOI 10.1126/science.242.4886.1675; DELMAS RJ, 1993, TELLUS B, V45, P391, DOI 10.1034/j.1600-0889.1993.t01-3-00006.x; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fairbanks RG, 1990, PALEOCEANOGRAPHY, V5, P937, DOI 10.1029/PA005i006p00937; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; LEUENBERGER M, 1992, NATURE, V360, P449, DOI 10.1038/360449a0; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; MARINO BD, 1992, NATURE, V357, P461, DOI 10.1038/357461a0; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; NEFTEL A, 1988, NATURE, V331, P609, DOI 10.1038/331609a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SCHWANDER J, 1989, PHYS CH EAR, V8, P53; Smith HJ, 1997, GEOPHYS RES LETT, V24, P1, DOI 10.1029/96GL03700; SOWERS T, 1989, J GEOPHYS RES, V94, P3137; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; SUCHER C, 1997, TRAPPED GASES TAYLOR; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; TANS PP, 1993, GLOBAL BIOGEOCHEM CY, V7, P353, DOI 10.1029/93GB00053; WAHLEN M, 1991, GEOPHYS RES LETT, V18, P1457, DOI 10.1029/91GL01724; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	30	147	153	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	1999	400	6741					248	250		10.1038/22291	http://dx.doi.org/10.1038/22291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217MP	11536907	Green Published			2022-12-28	WOS:000081503800039
J	Foote, M; Sepkoski, JJ				Foote, M; Sepkoski, JJ			Absolute measures of the completeness of the fossil record	NATURE			English	Article							STRATIGRAPHIC RANGES; PRESERVATION; PROBABILITY; EXTINCTIONS; TAXA	Measuring the completeness of the fossil record is essential to understanding evolution over long timescales, particularly when comparing evolutionary patterns among biological groups with different preservational properties. Completeness measures have been presented for various groups based on gaps in the stratigraphic ranges of fossil taxa(1,2) and on hypothetical lineages implied by estimated evolutionary trees(3-5). Here we present and compare quantitative, widely applicable absolute measures of completeness at two taxonomic levels for a broader sample of higher taxa of marine animals than has previously been available. We provide an estimate of the probability of genus preservation per stratigraphic interval(6,7), and determine the proportion of living families with some fossil records(8-10). The two completeness measures use very different data and calculations. The probability of genus preservation depends almost entirely on the Palaeozoic and Mesozoic records, whereas the proportion of living: families with a fossil record is influenced largely by Cenozoic data. These measurements are nonetheless highly correlated, with outliers quite explicable, and we find that completeness is rather high for many animal groups.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Foote, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.							Benton Michael J., 1996, Historical Biology, V12, P111; BENTON MJ, 1995, GEOLOGY, V23, P601, DOI 10.1130/0091-7613(1995)023<0601:TTMACF>2.3.CO;2; BENTON MJ, 1994, GEOLOGY, V22, P111, DOI 10.1130/0091-7613(1994)022<0111:TTQOTF>2.3.CO;2; BENTON MJ, 1993, FOSSIL RECORD, V2; Cappetta H., 1987, Handbook of Paleoichthyology, V3B, P1; FISHER DC, 1994, INTERPRETING HIERARC, P133; Foote M, 1996, PALEOBIOLOGY, V22, P121, DOI 10.1017/S0094837300016134; Foote M, 1996, PALEOBIOLOGY, V22, P141, DOI 10.1017/S0094837300016146; Foote M, 1997, PALEOBIOLOGY, V23, P278, DOI 10.1017/S0094837300019692; HATLAND WB, 1990, GEOLOGIC TIME SCALE; Hitchin R, 1997, PALEOBIOLOGY, V23, P20, DOI 10.1017/S0094837300016626; Marshall CR, 1996, SCIENCE, V274, P1360, DOI 10.1126/science.274.5291.1360; NORELL MA, 1992, SCIENCE, V255, P1690, DOI 10.1126/science.255.5052.1690; Parker S.P., 1982, SYNOPSIS CLASSIFICAT; PATTERSON C, 1987, NATURE, V330, P248, DOI 10.1038/330248a0; Paul CRC, 1982, PROBLEMS PHYLOGENETI, P75; PAUL CRC, 1985, SPECIAL PAPERS PALAE, V33, P7; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; SCHOPF TJM, 1978, PALEOBIOLOGY, V4, P261, DOI 10.1017/S0094837300005996; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; SEPKOSKI JJ, 1992, MILWAUKEE PUBLIC MUS, V83, P156; Solow AR, 1997, PALEOBIOLOGY, V23, P271, DOI 10.1017/S0094837300019680; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295; WAGNER PJ, 1995, PALEOBIOLOGY, V21, P153, DOI 10.1017/S009483730001318X; Wills M.A., 1993, FOSS REC, P271; Zangerl R., 1981, Handbook of Paleoichthyology, V3, P1; [No title captured]	30	168	171	2	35	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	1999	398	6726					415	417		10.1038/18872	http://dx.doi.org/10.1038/18872			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182PW	11536900				2022-12-28	WOS:000079508200050
J	Sagan, C; Chyba, C				Sagan, C; Chyba, C			The early faint sun paradox: Organic shielding of ultraviolet-labile greenhouse gases	SCIENCE			English	Review							EARTHS EARLY ATMOSPHERE; CHARGED-PARTICLE IRRADIATION; OUTER SOLAR-SYSTEM; OPTICAL-PROPERTIES; AMORPHOUS-CARBON; EARLY MARS; VERTICAL-DISTRIBUTION; NORTHERN PLAINS; EARLY EVOLUTION; ENERGY YIELDS	Atmospheric mixing ratios of similar to 10(-5 +/- 1) for ammonia on the early Earth would have been sufficient, through the resulting greenhouse warming, to counteract the temperature effects of the faint early sun. One argument against such model atmospheres has been the short time scale for ammonia photodissociation by solar ultraviolet light. Here it is shown that ultraviotet absorption by steady-state amounts of high-attitude organic solids produced from methane photolysis may have shielded ammonia sufficiently that ammonia resupply rates were able to maintain surface temperatures above freezing.	CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853; UNIV ARIZONA,DEPT PLANETARY SCI,TUCSON,AZ 85721	Cornell University; University of Arizona								ABELSON PH, 1966, P NATL ACAD SCI USA, V55, P1365, DOI 10.1073/pnas.55.6.1365; ACKERMAN M, 1971, MESOSPHERIC MODELS R, P00149; ANDERSON DA, 1977, PHILOS MAG, V35, P17, DOI 10.1080/14786437708235968; ANDERSON DL, 1993, SCIENCE, V261, P170, DOI 10.1126/science.261.5118.170; ARAKAWA ET, 1985, PHYS REV B, V31, P8097, DOI 10.1103/PhysRevB.31.8097; ARCULUS RJ, 1985, ANNU REV EARTH PL SC, V13, P75, DOI 10.1146/annurev.ea.13.050185.000451; BADA JL, 1968, SCIENCE, V159, P423, DOI 10.1126/science.159.3813.423; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; BAULCH DL, 1982, J PHYS CHEM REF DATA, V11, P327, DOI 10.1063/1.555664; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; Burns R.C., 2012, MOL BIOL BIOCH BIOPH, DOI DOI 10.1007/978-3-642-80926-2; BUSSOLETTI E, 1987, ASTRON ASTROPHYS SUP, V70, P257; Carr M.H, 1996, WATER MARS; CHLEWICKI G, 1990, ASTROPHYS J, V365, P230, DOI 10.1086/169474; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; DAWSON GA, 1977, J GEOPHYS RES-OC ATM, V82, P3125, DOI 10.1029/JC082i021p03125; DULEY WW, 1984, ASTROPHYS J, V287, P694, DOI 10.1086/162727; Eiler JM, 1997, NATURE, V386, P665, DOI 10.1038/386665a0; ERIKSSON KA, 1982, TECTONOPHYSICS, V81, P179, DOI 10.1016/0040-1951(82)90128-7; FARQUHAR GD, 1980, PLANT PHYSIOL, V66, P710, DOI 10.1104/pp.66.4.710; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; GOLDSPIEL JM, 1994, THESIS CORNELL U; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; GREENBERG JM, 1990, ASTROPHYS J, V361, P260, DOI 10.1086/169191; GUZIK JA, 1987, ASTROPHYS J, V319, P957, DOI 10.1086/165512; HAGEMANN HJ, 1975, J OPT SOC AM, V65, P742, DOI 10.1364/JOSA.65.000742; HENDERSON-SELLERS A, 1980, NATURE, V287, P526, DOI 10.1038/287526a0; HENDERSONSELLER.A, 1973, NATURE, V279, P786; Holland HD., 1984, CHEM EVOLUTION ATMOS; HOLMAN MJ, 1993, ASTRON J, V105, P1987, DOI 10.1086/116574; HONG KY, 1974, SCIENCE, V184, P984, DOI 10.1126/science.184.4140.984; HUNTEN DM, 1976, ANNU REV EARTH PL SC, V4, P265, DOI 10.1146/annurev.ea.04.050176.001405; JENKINS GS, 1993, J GEOPHYS RES-ATMOS, V98, P8785, DOI 10.1029/93JD00033; JENNISKENS P, 1993, ASTRON ASTROPHYS, V272, P465; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KASTING JF, 1992, PROTEROZOIC BIOSPHER, P165; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; KHARE BN, 1978, SCIENCE, V199, P1199, DOI 10.1126/science.199.4334.1199; KHARE BN, 1981, ICARUS, V48, P290, DOI 10.1016/0019-1035(81)90110-X; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; KHARE BN, 1989, ICARUS, V79, P350, DOI 10.1016/0019-1035(89)90082-1; KNAUTH LP, 1976, GEOCHIM COSMOCHIM AC, V40, P1095, DOI 10.1016/0016-7037(76)90051-X; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; KUHN WR, 1983, NATURE, V301, P53, DOI 10.1038/301053a0; LANGFORD AO, 1992, SCIENCE, V255, P581, DOI 10.1126/science.255.5044.581; LASAGA AC, 1971, SCIENCE, V174, P53, DOI 10.1126/science.174.4004.53; LEE SC, 1981, 18TH S INT COMB PITT, P1159; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; LEVINE JS, 1980, GEOPHYS RES LETT, V7, P317, DOI 10.1029/GL007i005p00317; LOVELOCK J, 1988, AGES GAIA, pCH4; MCDONALD GD, 1994, ICARUS, V107, P137; MCGOVERN WE, 1969, J ATMOS SCI, V26, P623, DOI 10.1175/1520-0469(1969)26<623:TPETMO>2.0.CO;2; Miller S. L., 1981, ORIGINS LIFE, P135; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1984, ORIGINS LIFE EVOL B, V14, P83, DOI 10.1007/BF00933643; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NORTH GR, 1975, J ATMOS SCI, V32, P2033, DOI 10.1175/1520-0469(1975)032<2033:TOEBCM>2.0.CO;2; Noyes W.A., 1941, PHOTOCHEMISTRY GASES; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OBERBECK VR, 1993, J GEOL, V101, P1, DOI 10.1086/648193; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POLLACK JB, 1993, NEAR EARTH RESOURCES; QUINN PK, 1988, NATURE, V335, P336, DOI 10.1038/335336a0; RAGES K, 1980, ICARUS, V41, P119, DOI 10.1016/0019-1035(80)90164-5; RAVEN JA, 1992, NEW PHYTOL, V121, P5, DOI 10.1111/j.1469-8137.1992.tb01087.x; ROBINSON E, 1970, Journal of the Air Pollution Control Association, V20, P303; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; ROULEAU F, 1991, ASTROPHYS J, V377, P526, DOI 10.1086/170382; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SAGAN C, 1977, NATURE, V269, P224, DOI 10.1038/269224a0; SAGAN C, 1973, J THEOR BIOL, V39, P195, DOI 10.1016/0022-5193(73)90216-6; SAGAN C, 1973, J GEOPHYS RES, V78, P1250; SAGAN C, 1984, SATURN, P788; SCHAEFER MW, 1990, J GEOPHYS RES-SOLID, V95, P14291, DOI 10.1029/JB095iB09p14291; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; THOMAS PJ, 1997, COMETS ORIGIN EVOLUT, P147; THOMPSON WR, 1994, ICARUS, V112, P376, DOI 10.1006/icar.1994.1191; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; TJEPKEMA JD, 1981, NATURE, V294, P445, DOI 10.1038/294445a0; TOUPANCE G, 1977, ORIGINS LIFE EVOL B, V8, P259, DOI 10.1007/BF00930687; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1983, NATURE, V302, P518, DOI 10.1038/302518a0; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WANG WC, 1980, J ATMOS SCI, V37, P545, DOI 10.1175/1520-0469(1980)037<0545:EOIAFO>2.0.CO;2; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOFSY SC, 1973, J GEOPHYS RES, V78, P2619, DOI 10.1029/JC078i015p02619; YUNG YL, 1978, NATURE, V273, P730, DOI 10.1038/273730a0; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; [No title captured]	112	257	260	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 23	1997	276	5316					1217	1221		10.1126/science.276.5316.1217	http://dx.doi.org/10.1126/science.276.5316.1217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XA497	11536805				2022-12-28	WOS:A1997XA49700032
J	BOWRING, SA; GROTZINGER, JP; ISACHSEN, CE; KNOLL, AH; PELECHATY, SM; KOLOSOV, P				BOWRING, SA; GROTZINGER, JP; ISACHSEN, CE; KNOLL, AH; PELECHATY, SM; KOLOSOV, P			CALIBRATING RATES OF EARLY CAMBRIAN EVOLUTION	SCIENCE			English	Article							PHANEROZOIC TAXONOMIC DIVERSITY; SOUTHERN BRITAIN; IGNEOUS ROCKS; KINETIC-MODEL; TIME-SCALE; AGES; SURVIVORSHIP; ORDOVICIAN; BOUNDARY	An explosive episode of biological diversification occurred near the beginning of the Cambrian period. Evolutionary rates in the Cambrian have been difficult to quantify accurately because of a lack of high-precision ages. Currently, uranium-lead zircon geochronology is the most powerful method for dating rocks of Cambrian age. Uranium-lead zircon data from lower Cambrian rocks located in northeast Siberia indicate that the Cambrian period began at approximately 544 million years ago and that its oldest (Manykaian) stage lasted no less than 10 million years. Other data indicate that the Tommotian and Atdabanian stages together lasted only 5 to 10 million years. The resulting compression of Early Cambrian time accentuates the rapidity of both the faunal diversification and subsequent Cambrian turnover.	YAKUTIAN GEOSCI INST, YAKUTSK, RUSSIA; HARVARD UNIV, BOT MUSEUM, CAMBRIDGE, MA 02138 USA	Diamond & Precious Metal Geology Institute Siberian Branch of Russian Academy of Sciences; Harvard University	BOWRING, SA (corresponding author), MIT, DEPT EARTH ATMOSPHER & PLANETARY SCI, CAMBRIDGE, MA 02139 USA.		Koroleva, Olga/C-1306-2012; Kolosov, Petr/J-9338-2018					Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BOWRING SA, 1992, AM J SCI, V292, P1, DOI 10.2475/ajs.292.1.1; COMPSTON W, 1992, J GEOL SOC LONDON, V149, P171, DOI 10.1144/gsjgs.149.2.0171; Compston W., 1984, Journal of Geophysical Research, V89, P525, DOI 10.1029/JB089iS02p0B525; COOPER JA, 1992, J GEOL SOC LONDON, V149, P185, DOI 10.1144/gsjgs.149.2.0185; COWIE JW, 1989, PRECAMBRIAN CAMBRIAN, P186; Crimes T.P., 1989, Oxford Monographs on Geology and Geophysics, V12, P166; DROSER ML, 1988, GEOLOGY, V16, P233, DOI 10.1130/0091-7613(1988)016<0233:TIDAEO>2.3.CO;2; FOOTE M, 1988, PALEOBIOLOGY, V14, P258, DOI 10.1017/S0094837300011994; Gould, 1990, WONDERFUL LIFE; Harland W. B., 1989, GEOLOGIC TIME SCALE; ISACHSEN CE, UNPUB; KARLOVA GA, 1987, 1ST FINDINGS SKELETA, V292, P204; KHOMENTOVSKY VV, 1986, GEOL MAG, V123, P333, DOI 10.1017/S0016756800033422; KHOMENTOVSKY VV, 1966, GEOL MAG, V154; KNOLL AG, UNPUB; KOMAR VA, 1966, UPPER PRECAMBRIAN ST, V154; KRASILSHCHIKOV AA, 1970, GEOLOGIYA SSSR 1, V18, P91; KROGH TE, 1973, GEOCHIM COSMOCHIM AC, V37, P485, DOI 10.1016/0016-7037(73)90213-5; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Landing E., 1992, ORIGIN EARLY EVOLUTI, P283; LUDWIG KR, 1988, 88557 US GEOL SURV O; Meshkova N.P., 1973, PROBLEMY PALEONTOLOG; MISSARZHEVSKY VV, 1989, PROBLEMS UPPER PROTE, P59; MISSARZHEVSKY VV, 1989, OLDEST SKELETAL FOSS; MOCZYDLOWSKA M, 1991, ACRITARCH BIOSTRATIG, V29; ODIN GS, 1983, NATURE, V301, P21, DOI 10.1038/301021a0; OGURTSOVA RN, 1975, INT GEOL REV, V18, P921; PATCHETT PJ, 1980, J GEOL SOC LONDON, V137, P649, DOI 10.1144/gsjgs.137.5.0649; RAUP DM, 1978, PALEOBIOLOGY, V4, P1; Repina L. N., 1974, LOWER CAMBRIAN BIOST; Rozanov A., 1992, ORIGIN EARLY EVOLUTI, P205; SAMSON SD, 1992, GEOL SOC AM ABSTR, V24, P117; Sepkoski J.J. Jr, 1992, P553; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; SHPUNT BR, 1982, GEOLOGY USSR W PART; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; TUCKER RD, 1990, EARTH PLANET SC LETT, V100, P51, DOI 10.1016/0012-821X(90)90175-W; TUCKER RD, 1991, J GEOL SOC LONDON, V148, P435, DOI 10.1144/gsjgs.148.3.0435; VALENTINE JW, 1991, EVOLUTIONARY BIOL, V25, P279; WRIGHT AE, 1993, GEOL MAG, V130, P257, DOI 10.1017/S0016756800009900; [No title captured]	44	434	459	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	1993	261	5126					1293	1298		10.1126/science.11539488	http://dx.doi.org/10.1126/science.11539488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV656	11539488				2022-12-28	WOS:A1993LV65600019
J	LABANDEIRA, CC; SEPKOSKI, JJ				LABANDEIRA, CC; SEPKOSKI, JJ			INSECT DIVERSITY IN THE FOSSIL RECORD	SCIENCE			English	Article							PLANT DIVERSIFICATION; MASS EXTINCTIONS; EVOLUTION; ANGIOSPERMS; PATTERNS; MAMMALS; ORIGIN; RATES	Insects possess a surprisingly extensive fossil record. Compilation of the geochronologic ranges of insect families demonstrates that their diversity exceeds that of preserved vertebrate tetrapods through 91 percent of their evolutionary history. The great diversity of insects was achieved not by high origination rates but rather by low extinction rates comparable to the low rates of slowly evolving marine invertebrate groups. The great radiation of modern insects began 245 million years ago and was not accelerated by the expansion of angiosperms during the Cretaceous period. The basic trophic machinery of insects was in place nearly 100 million years before angiosperms appeared in the fossil record.	UNIV CHICAGO,DEPT GEOPHYS SCI,CHICAGO,IL 60637	University of Chicago	LABANDEIRA, CC (corresponding author), NATL MUSEUM NAT HIST,DEPT PALEOBIOL,WASHINGTON,DC 20560, USA.							[Anonymous], 1987, IMMATURE INSECTS; Arnol'di L.V., 1991, MESOZOIC COLEOPTERA; Bakkendort O., 1948, Entomologiske Meddelelser, V25, P213; Bambach RK, 1992, PALEONTOLOGICAL SOC, V6, P16, DOI [10.1017/S2475262200005761, DOI 10.1017/S2475262200005761]; Benton M.J., 1989, P218; Benton M. J., 1987, MEM SOC GEOL FR, V150, P21; BENTON MJ, 1985, SPEC PAP PALAEONTOL, V33, P185; Berenbaum M., 1992, P89; Boucot AJ., 1990, EVOLUTIONARY PALEOBI; BUJAK JP, 1979, MAR MICROPALEONTOL, V4, P1, DOI 10.1016/0377-8398(79)90002-1; Carpenter F. M., 1992, TREATISE INVERTEBR R, V4; COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION - CSIRO, 1991, INSECTS AUSTR TXB ST; COOPE GR, 1979, ANNU REV ECOL SYST, V10, P247, DOI 10.1146/annurev.es.10.110179.001335; COOPE GR, 1978, S ROYAL ENTOMOLOGICA, V9, P176; COOPE GR, 1991, ANTENNA, V15, P158; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; CROWSON RA, 1985, ENTOMOL GEN, V11, P99; Crowson RA, 1981, BIOL COLEOPTERA; Donner H., 1989, FAUNA N Z, V16, P1; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; DOYLE JA, 1993, PALEOBIOLOGY, V19, P141, DOI 10.1017/S0094837300015840; Eastop V. F., 1973, Symposia Royal Ent Soc Lond, V6, P157; EASTOP VF, 1983, EVOLUTION, V37, P163; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ERWIN DH, 1990, ANNU REV ECOL SYST, V21, P69, DOI 10.1146/annurev.ecolsys.21.1.69; FARRELL BD, 1991, AM NAT, V138, P881, DOI 10.1086/285258; FLESSA KW, 1985, NATURE, V313, P216, DOI 10.1038/313216a0; FREEMAN TN, 1965, CAN ENTOMOL, V97, P2069; Grimaldi D.A., 1990, B AM MUS NAT HIST, V195, P1; Harland W.B., 1990, GEOLOGIC TIME SCALE; Heie O.E., 1968, Beihefte Jber naturh Ges Hannover, V6, P25; HEIE O H, 1971, Entomologica Scandinavica, V2, P74; Hennig W., 1966, STUTTG BEITR NATURK, V150, P1; HICKEY LJ, 1975, SCIENCE, V189, P718, DOI 10.1126/science.189.4204.718; Hong Y.C., 1982, MESOZOIC FOSSIL INSE; House M. R., 1967, P41; HUGHES NF, 1987, REV PALAEOBOT PALYNO, V50, P255, DOI 10.1016/0034-6667(87)90003-0; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JANIS CM, 1989, PALAEONTOLOGY, V32, P463; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; JAREMBOWSKI EA, 1989, MESOZOIC RES, V2, P25; Kalugina N.S., 1985, DIPTEROUS INSECTS JU; KEILBACH R, 1982, DEUT ENTOMOL Z, V29, P129; KNOLL AH, 1987, REV PALAEOBOT PALYNO, V50, P127, DOI 10.1016/0034-6667(87)90043-1; Kozlov M.V., 1988, P16; Kukalova-Peck J., 1991, P141; Labandeira C. C., 1990, SHORT COURSES PALEON, V3, P214; LABANDEIRA CC, 1988, SCIENCE, V242, P913, DOI 10.1126/science.242.4880.913; LABANDEIRA CC, 1992, PALEONTOL SOC SPEC P, V6, P17; LABANDEIRA CC, 1990, THESIS U CHICAGO; Larsson S.G., 1978, Entomonograph, V1, P1; LIDGARD S, 1988, NATURE, V331, P344, DOI 10.1038/331344a0; LILLEGRAVEN J A, 1972, Taxon, V21, P261, DOI 10.2307/1218194; Martin P.S., 1984, P153; Martin PS, 1984, QUATERNARY EXTINCTIO; MARTINSNETO RG, 1991, SOC BRAS GEOL NORDES, V12, P59; MASNER L, 1969, P ENTOMOL SOC WASH, V71, P397; MATTHEWS JV, 1970, CAN J ZOOLOG, V48, P779, DOI 10.1139/z70-137; MATTHEWS JV, 1976, GEOL SURV CAN PAP B, V761, P217; Mayr W., 1969, PRINCIPLES SYSTEMATI; MCCAFFERTY WP, 1991, OVERVIEW SYSTEMATICS; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; MOCKFORD E L, 1972, Florida Entomologist, V55, P153, DOI 10.2307/3493140; NEWELL NORMAN D., 1952, JOUR PALEONTOL, V26, P371; NIKLAS K.J., 1985, Phanerozoic Diversity Patterns: Profiles in Macroevolution, P143, DOI DOI 10.1515/9781400855056.97; NIKLAS KJ, 1983, NATURE, V303, P614, DOI 10.1038/303614a0; NIKLAS KJ, 1978, BRITTONIA, V30, P373, DOI 10.2307/2806276; Niklas KJ, 1986, PATTERNS PROCESSES H, P383; OPLER P A, 1982, Journal of the Lepidopterists' Society, V36, P145; OPLER PA, 1973, SCIENCE, V179, P1321, DOI 10.1126/science.179.4080.1321; Padian K., 1985, P41; PELLMYR O, 1992, TRENDS ECOL EVOL, V7, P46, DOI 10.1016/0169-5347(92)90105-K; PIKE EM, 1992, PALEONTOL SOC SPEC P, V6, P234; Poinar GO., 1992, LIFE AMBER; PONOMARENKO AG, 1988, MESOZOIC BIOCENOTIC; PROCTOR M., 1972, POLLINATION FLOWERS; Rasnitsyn A.P., 1980, Trudy Paleontologicheskogo Instituta, V174, P1; RAUP D M, 1975, Paleobiology, V1, P82; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; RAYNER RJ, 1990, ZOOL J LINN SOC-LOND, V99, P309, DOI 10.1111/j.1096-3642.1990.tb00557.x; Rindal DSAE, 2007, FUNDAMENTALS PALEONT, V1535, P1; RODENDORF BB, 1974, PRIRODA, V5, P82; Rohdendorf B.B., 1980, T PALEONTOLOGICHESKO, V175, P1; Rohdendorf B. B., 1968, JURASSIC INSECTS KAR; ROZEFELDS A C, 1988, Proceedings of the Royal Society of Queensland, V99, P77; Rozen J. G., 1971, University of California Publications in Entomology, V63, P75; Schneider J., 1977, FREIBERGER FORSCH C, V326, P87; Schneider J.W., 1984, FREIBERGER FORSCH C, V391, P5; SCHOPF JW, 1991, S AFR J GEOL, V93, P33; SCHOPF JW, 1992, PROTEROZOIC BIOSPHER, P529; Sepkoski J.J. Jr, 1991, Short Courses in Paleontology, P136; Sepkoski J.J. Jr, 1985, P11; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P168, DOI 10.1017/S0094837300015852; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Sepkoski Jr J.J., 1992, MILWAUKEE PUBLIC MUS, V83, P1; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Stanley S.M., 1977, DEV PALAEONTOLOGY ST, V5, P209, DOI DOI 10.1016/S0920-5446(08)70327-3; Stanley S. M., 1979, MACROEVOLUTION PATTE; STANLEY SM, 1973, SYST ZOOL, V22, P486, DOI 10.2307/2412955; Stehli F. G, 1985, GREAT AM BIOTIC INTE; Stehr F. W., 1991, IMMATURE INSECTS, V2; STRONG DR, 1984, INSECTS PLANTS; TAPPAN H, 1988, J PALEONTOL, V62, P695; Valentine J.W., 1992, P17; Valentine J.W., 1990, P128; Valentine J. W., 1969, Palaeontology, V12, P684; VALENTINE J W, 1991, Palaios, V6, P81, DOI 10.2307/3514955; Valentine JW, 1985, PHANEROZOIC DIVERSIT; VIDAL G, 1982, NATURE, V297, P57, DOI 10.1038/297057a0; WHALLEY P, 1987, NATURE, V327, P562, DOI 10.1038/327562b0; WHALLEY PES, 1985, B BR MUS NAT HIS G, V83, P381; WILLEMSTEIN SC, 1987, LEIDEN BOT SER, V10, P1; Wilson, 1988, BIODIVERSITY, P170; Zwolfer H, 1978, SONDERB NATURWISS VE, V2, P7	118	424	441	2	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 16	1993	261	5119					310	315		10.1126/science.11536548	http://dx.doi.org/10.1126/science.11536548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM678	11536548				2022-12-28	WOS:A1993LM67800025
J	THOMPSON, WR; SAGAN, C				THOMPSON, WR; SAGAN, C			COLOR AND CHEMISTRY ON TRITON	SCIENCE			English	Article											THOMPSON, WR (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							Billmeyer F.W., 1981, PRINCIPLES COLOR TEC; BROADFOOT AL, 1989, SCIENCE, V246, P1459, DOI 10.1126/science.246.4936.1459; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CONRATH B, 1989, SCIENCE, V246, P1454, DOI 10.1126/science.246.4936.1454; CRUIKSHANK DP, 1984, ICARUS, V58, P306, DOI 10.1016/0019-1035(84)90047-2; CRUIKSHANK DP, 1988, ICARUS, V74, P413, DOI 10.1016/0019-1035(88)90112-1; CRUIKSHANK DP, 1984, ICARUS, V58, P293, DOI 10.1016/0019-1035(84)90046-0; DELITSKY ML, 1987, ICARUS, V70, P354, DOI 10.1016/0019-1035(87)90141-2; LARK NL, 1989, ICARUS, V79, P15, DOI 10.1016/0019-1035(89)90104-8; MCEWEN AS, GEOPHYS RES LETT, V17, P1733; MCKAY CP, 1989, GEOPHYS RES LETT, V16, P973, DOI 10.1029/GL016i008p00973; PISCITELLI JR, 1988, ICARUS, V76, P118, DOI 10.1016/0019-1035(88)90144-3; SAGAN C, 1990, NATURE, V346, P546, DOI 10.1038/346546a0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; SODERBLOM LA, 1990, SCIENCE, V250, P410, DOI 10.1126/science.250.4979.410; SPENCER JR, 1990, GEOPHYS RES LETT, V17, P1769, DOI 10.1029/GL017i010p01769; SPENCER JR, IN PRESS ICARUS; STANSBERRY JA, 1990, GEOPHYS RES LETT, V17, P1773, DOI 10.1029/GL017i010p01773; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; THOMPSON WR, 1989, GEOPHYS RES LETT, V16, P969, DOI 10.1029/GL016i008p00969; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; THOMPSON WR, 1989, GEOPHYS RES LETT, V16, P981, DOI 10.1029/GL016i008p00981; THOMPSON WR, 1990, INT J SUPERCOMPUT AP, V4, P48, DOI 10.1177/109434209000400205; THOMPSON WR, IN PRESS ICARUS; TYLER GL, 1989, SCIENCE, V246, P1466, DOI 10.1126/science.246.4936.1466	26	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 19	1990	250	4979					415	418		10.1126/science.11538073	http://dx.doi.org/10.1126/science.11538073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED616	11538073				2022-12-28	WOS:A1990ED61600032
J	CHYBA, CF; THOMAS, PJ; BROOKSHAW, L; SAGAN, C				CHYBA, CF; THOMAS, PJ; BROOKSHAW, L; SAGAN, C			COMETARY DELIVERY OF ORGANIC-MOLECULES TO THE EARLY EARTH	SCIENCE			English	Article									YALE UNIV,APPL PHYS SECT,NEW HAVEN,CT 06520	Yale University	CHYBA, CF (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							Abelson P.H., 1959, RES GEOCHEMISTRY, P79; ALLEN HJ, 1963, NASA TR R185 TECHN R; ALLEN M, 1987, ASTRON ASTROPHYS, V187, P502; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARAKAWA ET, 1989, BAAS, V21, P940; ARNOSTI C, 1987, ORG GEOCHEM, V11, P505, DOI 10.1016/0146-6380(87)90006-4; ATKINS PW, 1986, PHYSICAL CHEM; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARAK I, 1975, ORIGINS LIFE EVOL B, V6, P483, DOI 10.1007/BF00928897; BARNUN A, 1970, SCIENCE, V168, P470, DOI 10.1126/science.168.3930.470; BENSON SW, 1970, NSRDSDNBS21 PUBL; BENZ W, 1987, ICARUS, V71, P30, DOI 10.1016/0019-1035(87)90160-6; BRONSHTEN VA, 1983, PHYSICS METEORIC PHE; BROWN WT, 1981, AIP C, V78, P529; BURNHAM AK, 1987, ENERG FUEL, V1, P452, DOI 10.1021/ef00006a001; CEPLECHA Z, 1977, COMETS ASTEROIDS MET, pCH5; Chamberlin T C, 1908, Science, V28, P897, DOI 10.1126/science.28.730.897; CHANG S, 1978, NASA C PUBLICATION, V2089, P59; Chang S., 1983, EARTHS EARLIEST BIOS, P53; CHYBA C, 1988, NATURE, V332, P592, DOI 10.1038/332592a0; CHYBA C, 1989, NASA CONF P, V3036, P433; CHYBA C, 1987, NATURE, V330, P350, DOI 10.1038/330350a0; CHYBA C, 1987, NATURE, V329, P208, DOI 10.1038/329208a0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CLARK BC, 1988, ORIGINS LIFE EVOL B, V18, P209, DOI 10.1007/BF01804671; Cronin JR., 1988, ORGANIC MATTER CARBO, P819; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; DELSEMME AH, 1988, PHILOS T R SOC A, V325, P509, DOI 10.1098/rsta.1988.0064; DELSEMME AH, 1989, ADV SPACE RES, V9, P25; DURHAM R, 1989, ICARUS, V77, P59, DOI 10.1016/0019-1035(89)90006-7; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; FERNANDEZ JA, 1983, ICARUS, V54, P377, DOI 10.1016/0019-1035(83)90235-X; Folinsbee R.E., 1967, GEOCHIM COSMOCHIM AC, V31, P1625; GOBEL JH, 1980, ASTROPHYS J, V235, P104; GRADIE J, 1980, NATURE, V283, P840, DOI 10.1038/283840a0; Greenberg J., 1982, COMETS, P131; GREENBERG JM, 1986, GALAXY SOLAR SYSTEM, P103; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HOYLE F, 1988, NATURE, V331, P123, DOI 10.1038/331123c0; HOYLE F, 1987, NATURE, V328, P117, DOI 10.1038/328117a0; HOYLE F, 1988, NATURE, V331, P666, DOI 10.1038/331666c0; HUGHES DW, 1988, ICARUS, V73, P149, DOI 10.1016/0019-1035(88)90089-9; HUGHES DW, 1987, S DIVERSITY SIMILAAR, P43; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KASTING J F, 1989, Origins of Life and Evolution of the Biosphere, V19, P225, DOI 10.1007/BF02388821; KASTING JF, 1988, SCI AM, V258, P90, DOI 10.1038/scientificamerican0288-90; KASTING JF, UNPUB; Kasting JF, 1989, ORIGIN EVOLUTION PLA, P423; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; Khandelwal S., 1981, SHOCK WAVES CHEM, P1; KHARE BN, 1989, ICARUS, V79, P350, DOI 10.1016/0019-1035(89)90082-1; KRUEGER FR, 1987, NATURWISSENSCHAFTEN, V74, P312, DOI 10.1007/BF00367925; KSTING JF, 1986, SCIENCE, V234, P1383; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; LARSON HP, 1989, ASTROPHYS J, V338, P1106, DOI 10.1086/167260; LEVIN BY, 1986, METEORITICS, V21, P199, DOI 10.1111/j.1945-5100.1986.tb01242.x; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; LEWIS JS, 1984, SATUM, P788; LIU VC, 1978, GEOPHYS RES LETT, V5, P309, DOI 10.1029/GL005i004p00309; MCKAY CP, 1989, LUNAR PLANET SCI C, V20, P671; Melosh H.L, 1989, IMPACT CRATERING GEO; MONAGHAN JJ, 1985, COMPUT PHYS REP, V3, P71, DOI 10.1016/0167-7977(85)90010-3; MONAHAN JJ, 1988, COMMUNICATION; MUKHIN LM, 1989, NATURE, V340, P46, DOI 10.1038/340046a0; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; MUMMA MJ, 1989, ICARUS, V79, P362; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OKEEFE JD, 1982, SPECIAL PAPER GEOLOG, V190, P103, DOI DOI 10.1130/SPE190-P103; OPIK EJ, 1958, PHYSICS METEOR FLIGH; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; PONGRACIC H, 1988, THESIS MONASH U CLAY; PONNAMPERUMA C, 1981, COMETS ORIGIN LIFE; RATCLIFF MA, 1974, J ORG CHEM, V39, P1481, DOI 10.1021/jo00924a007; REUTER DC, 1989, B AM ASTRON SOC, V21, P937; ROTH P, 1976, BER BUNSEN PHYS CHEM, V80, P171, DOI 10.1002/bbpc.19760800216; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SAGDEEV RZ, 1988, NATURE, V331, P240, DOI 10.1038/331240a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHLESINGER G, 1983, J MOL EVOL, V19, P383, DOI 10.1007/BF02101643; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; SEKANINA Z, 1982, COMETS, P251; Shoemaker E. M., 1979, ASTEROIDS, P253; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, 1984, LUNAR PLANET SCI, V15, P780; SHURSHALOV IV, 1967, IZV AKAD NAUK SSSR M, V2, P184; SHURSHALOV IV, 1967, FLUID DYN, V2, P133; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; SMITH GG, 1964, J PHYS CHEM-US, V68, P1231, DOI 10.1021/j100787a506; SNYDER LE, 1983, ASTROPHYS J, V268, P123, DOI 10.1086/160937; STEVENSON DJ, 1983, EARTHS EARLIEST BIOS, P32; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; SZEKELY A, 1984, J PHYS CHEM-US, V88, P666, DOI 10.1021/j150648a009; THOMAS P, UNPUB; THOMAS PJ, 1989, LUNAR PLANET SCI C, V20, P117; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; TILLOTSON JH, 1962, GA3216 GEN AT CORP R; TSANG W, 1978, INT J CHEM KINET, V10, P41; TURCOTTE DL, 1986, J GEOPHYS RES-SOLID, V91, P1921, DOI 10.1029/JB091iB02p01921; VALLENTYNE JR, 1964, GEOCHIM COSMOCHIM AC, V28, P157, DOI 10.1016/0016-7037(64)90147-4; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1986, ORIGINS LIFE, V16, P117; Warnatz J., 1984, COMBUSTION CHEM; WEISSMAN PR, 1985, NATURE, V314, P517, DOI 10.1038/314517a0; WILKENING LL, 1978, NATURWISSENSCHAFTEN, V65, P73, DOI 10.1007/BF00440544; WOLFE RF, 1986, GALAXY SOLAR SYSTEM, P338; ZAHNLE K, UNPUB; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; 1983, LALP834 LOS AL NAT L	118	437	439	6	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 27	1990	249	4967					366	373		10.1126/science.11538074	http://dx.doi.org/10.1126/science.11538074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ702	11538074				2022-12-28	WOS:A1990DQ70200030
J	TURCO, RP; TOON, OB; ACKERMAN, TP; POLLACK, JB; SAGAN, C				TURCO, RP; TOON, OB; ACKERMAN, TP; POLLACK, JB; SAGAN, C			CLIMATE AND SMOKE - AN APPRAISAL OF NUCLEAR WINTER	SCIENCE			English	Review									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; PENN STATE UNIV,UNIVERSITY PK,PA 16802; CORNELL UNIV,ITHACA,NY 14853	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University	TURCO, RP (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024, USA.							ACKERMAN T, UNPUB; ACKERMAN TP, 1981, APPL OPTICS, V20, P3661, DOI 10.1364/AO.20.003661; ACKERMAN TP, 1988, AEROSOLS CLIMATE, P443; ALEKSANDROV VV, 1983, COMPUTING CTR ACADEM; ANDRONOVA AV, 1988, IZV AN SSSR FIZ ATM+, V24, P235; ANIKIN PP, 1988, IZVESTIA ATMOS OCEAN, V24, P247; APPLEBY L, REPORT RES ACTIVITIE; ARKIN WM, 1985, NUCLEAR BATTLEFIELDS; BARRIE LA, 1985, J GEOPHYS RES-ATMOS, V90, P5789, DOI 10.1029/JD090iD03p05789; BENNER WH, 1989, AEROSOL SCI TECH, V10, P84, DOI 10.1080/02786828908959223; BERGER A, 1986, EOS, V67, P617; BERRY MV, 1986, OPT ACTA, V33, P577, DOI 10.1080/713821987; BING G, 1985, UCRL93192 LAWR LIV N; BIRKS JW, 1986, IMPLICATIONS NUCLEAR, P155; BROYLES AA, 1985, AM J PHYS, V53, P323, DOI 10.1119/1.14159; BRUCE CW, 1983, APPL OPTICS, V22, P1051, DOI 10.1364/AO.22.001051; BUSH BW, 1985, DNATR85293A DEF NUCL; CESS RD, 1985, J GEOPHYS RES-ATMOS, V90, P2937, DOI 10.1029/JD090iD07p12937; Charlson RJ, 1982, PARTICULATE CARBON A, P3, DOI 10.1007/978-1-4684-4154-3_13; CHUNG YS, 1984, ATMOS ENVIRON, V18, P2143, DOI 10.1016/0004-6981(84)90201-4; CLARKE AD, 1982, APPL OPTICS, V21, P3011, DOI 10.1364/AO.21.003011; CLARKE AD, 1987, ATMOS ENVIRON, V21, P1455, DOI 10.1016/0004-6981(67)90093-5; CLARKE AD, 1982, APPL OPTICS, V21, P370; COCHRAN TB, 1984, NUCLEAR WEAPONS DATA, V1; COCHRAN TB, 1987, NUCLEAR WEAPONS DATA, V2; COLBECK I, 1986, ATMOS ENVIRON, V20, P1673, DOI 10.1016/0004-6981(86)90114-9; COTTON WR, 1985, AM SCI, V73, P275; COVEY C, 1985, BIOSCIENCE, V35, P563, DOI 10.2307/1309964; COVEY C, 1987, NATURE, V325, P701, DOI 10.1038/325701a0; COVEY C, 1985, J GEOPHYS RES-ATMOS, V90, P5615, DOI 10.1029/JD090iD03p05615; COVEY C, 1984, NATURE, V308, P21, DOI 10.1038/308021a0; CRUTZEN PJ, 1982, AMBIO, V11, P114; CRUTZEN PJ, 1984, CLIMATIC CHANGE, V6, P323, DOI 10.1007/BF00212627; DEITZ VR, 1983, CARBON, V11, P393; DLUGI R, 1989, AEROSOL SCI TECH, V10, P93, DOI 10.1080/02786828908959224; DOD RL, 1989, AEROSOL SCI TECH, V10, P20, DOI 10.1080/02786828908959217; EAGEN RC, 1974, J APPL METEOROL, V13, P553; EDWARDS LL, 1987, UCRL96242 LAWR LIV N; EINFELD W, 1987, SEP AM ASS AER RES A, P54; ELLIS WD, 1972, ATMOS ENVIRON, V6, P707, DOI 10.1016/0004-6981(72)90002-9; FRASER RS, 1984, ATMOS ENVIRON, V18, P2577, DOI 10.1016/0004-6981(84)90322-6; GHAN SJ, 1988, J GEOPHYS RES-ATMOS, V93, P8315, DOI 10.1029/JD093iD07p08315; GIORGI F, 1989, J GEOPHYS RES-ATMOS, V94, P1145, DOI 10.1029/JD094iD01p01145; GIORGI F, 1989, J GEOPHYS RES-ATMOS, V94, P1127, DOI 10.1029/JD094iD01p01127; GLASSTONE S, 1977, EFFECTS NUCLEAR WEAP; GLATZMAIER GA, 1988, MAR SCOPE ENUWAR MOS; GOLDING BW, 1986, NATURE, V319, P301, DOI 10.1038/319301a0; GOLIITSYN GS, 1988, IZV ATMOS OCEAN PHYS, V224, P227; GOLITSYN GS, 1985, TELLUS B, V37, P173, DOI 10.1111/j.1600-0889.1985.tb00065.x; GOLITSYN GS, 1987, DOKL AKAD NAUK SSSR+, V297, P1334; GOLITSYN GS, 1987, WCP142 WORLD MET ORG; GOLITSYN GS, 1986, WCP113 WORLD MET ORG; HABERLE RM, 1986, SCIENCE, V234, P459, DOI 10.1126/science.234.4775.459; HABERLE RM, 1985, GEOPHYS RES LETT, V12, P405, DOI 10.1029/GL012i006p00405; HALLETT J, 1989, AEROSOL SCI TECH, V10, P70, DOI 10.1080/02786828908959222; HARWELL MA, 1985, ENV CONSEQUENCES NUC, V2; HAYNES BS, 1981, PROG ENERG COMBUST, V7, P229, DOI 10.1016/0360-1285(81)90001-0; HEGG DA, 1987, J GEOPHYS RES-ATMOS, V92, P14701, DOI 10.1029/JD092iD12p14701; HEINTZENBERG J, 1982, ATMOS ENVIRON, V16, P2461, DOI 10.1016/0004-6981(82)90136-6; HUDSON JG, 1983, J ATMOS SCI, V40, P480, DOI 10.1175/1520-0469(1983)040<0480:EOCCOS>2.0.CO;2; JANZEN J, 1980, APPL OPTICS, V19, P2977, DOI 10.1364/AO.19.002977; KIRKWOOD J, 1984, 1300005 R D ASS REP; LEDLEY TS, 1986, CLIMATIC CHANGE, V8, P155, DOI 10.1007/BF00139752; LEE KT, 1983, THESIS U WASHINGTON; LEVI BG, 1985, PHYS TODAY, V38, P58, DOI 10.1063/1.880989; LUBIN D, 1989, J GEOPHYS RES-ATMOS, V94, P8491, DOI 10.1029/JD094iD06p08491; MACCRACKEN MC, 1984, UCRL91446 LAWR LIV N; MACCRACKEN MC, 1983, UCRL89770 LAWR LIV N; MALONE RC, 1985, SCIENCE, V230, P317, DOI 10.1126/science.230.4723.317; MALONE RC, 1986, J GEOPHYS RES-ATMOS, V91, P1039, DOI 10.1029/JD091iD01p01039; MALONE RC, 1988, MAR SCOPE ENUWAR MOS; MCINTOSH LA, 1987, 743 PAC SIERR RES CO; MEDALIA AI, 1972, J COLLOID INTERF SCI, V40, P233, DOI 10.1016/0021-9797(72)90013-6; METTLACH TR, 1987, J GEOPHYS RES-OCEANS, V92, P1967, DOI 10.1029/JC092iC02p01967; MITCHELL JFB, 1988, J GEOPHYS RES-ATMOS, V93, P7037, DOI 10.1029/JD093iD06p07037; MULCAHY MFR, 1975, CARBON, V13, P115, DOI 10.1016/0008-6223(75)90268-7; MULHOLLAND GW, 1988, SMOKE EMISSION OPTIC; MULHOLLAND GW, 1986, NBSIR863342 US DEP C; NELSON J, 1989, NATURE, V339, P611, DOI 10.1038/339611a0; OGREN JA, 1983, TELLUS B, V35, P241, DOI 10.1111/j.1600-0889.1983.tb00027.x; OGREN JA, 1982, PARTICULATE CARBON A, P379; OSULLIVAN EF, 1973, 1973 COMB I EUR S, P195; PATTERSON EM, 1986, GEOPHYS RES LETT, V13, P129, DOI 10.1029/GL013i002p00129; PENNER JE, 1986, NATURE, V324, P222, DOI 10.1038/324222a0; PENNER JE, 1989, AEROSOL SCI TECH, V10, P51, DOI 10.1080/02786828908959220; PENNER JE, 1986, J CLIM APPL METEOROL, V25, P1434, DOI 10.1175/1520-0450(1986)025<1434:SPDALS>2.0.CO;2; PENNER JE, 1989, AEROSOL SCI TECH, V10, P29; Pittock A B., 1986, ENV CONSEQUENCES NUC, V1; PITTOCK AB, 1989, CLIM DYN, V1, P191; PITTOCK AB, 1988, AEROSOLS CLIMATE, P395; PORCH W, 1987, ATMOS ENVIRON, V21, P2066, DOI 10.1016/0004-6981(87)90168-5; PORCH W, 1987, ATMOS ENVIRON, V21, P1250, DOI 10.1016/0004-6981(87)90255-1; PORCH WM, 1986, ATMOS ENVIRON, V20, P919, DOI 10.1016/0004-6981(86)90276-3; Pruppacher H.R., 2011, MICROPHYSICS CLOUDS; PUESCHEL RF, 1988, J GEOPHYS RES-ATMOS, V93, P8388, DOI 10.1029/JD093iD07p08388; PYNE SJ, 1986, DNATR85396 DEF NUCL; Radke L.F., 1988, AEROSOLS CLIMATE, P411; RADKE LF, 1980, 3RD P WORLD MET ORG; RAMASWAMY V, 1985, J GEOPHYS RES-ATMOS, V90, P5597, DOI 10.1029/JD090iD03p05597; ROBOCK A, 1988, SCIENCE, V242, P911, DOI 10.1126/science.242.4880.911; ROBOCK A, 1984, NATURE, V310, P667, DOI 10.1038/310667a0; ROBOCK A, 1988, AEROSOLS CLIMATE; ROESSLER DM, 1980, J OPT SOC AM, V70, P230, DOI 10.1364/JOSA.70.000230; ROGERS CF, 1989, JUN AIR POLL CONTR A; ROSEN H, 1978, APPL OPTICS, V17, P3859, DOI 10.1364/AO.17.003859; SASTRY MA, 1987, MIT17 PROGR SCI TECH; SCHNEIDER SH, 1988, NATURE, V333, P221, DOI 10.1038/333221a0; SIEGEL R, 1981, STRATEGIC TARGETING; SMALL RD, 1985, SCIENCE, V229, P465, DOI 10.1126/science.229.4712.465; SMALL RD, 1989, AEROSOL SCI TECH, V10, P37, DOI 10.1080/02786828908959219; SMALL RD, IN PRESS J APPL METE; SOKOLIK IN, 1988, IZV AN SSSR FIZ ATM+, V24, P274; Solomon F, 1986, MED IMPLICATIONS NUC; STENCHIKOV GL, 1985, CLIMATIC CONSEQUENCE; STEPHENS S, 1986, INT J CHEM KINET, V18, P1133, DOI 10.1002/kin.550181004; STEPHENS SL, 1985, BIOSCIENCE, V35, P557, DOI 10.2307/1309963; STEPHENS SL, 1989, AEROSOL SCI TECH, V10, P326, DOI 10.1080/02786828908959268; TEWARSON A, 1980, 18 INT S COMB COMB I, P563; THOMPSON S, 1988, APR DNA GLOB EFF M S; THOMPSON SL, 1985, NATURE, V317, P35, DOI 10.1038/317035a0; THOMPSON SL, 1987, J GEOPHYS RES-ATMOS, V92, P10942, DOI 10.1029/JD092iD09p10942; THOMPSON SL, 1986, FOREIGN AFF, V65, P981; TURCO R, 1989, AMBIO, V18, P391; TURCO R, 1987, 3RD INT C CARB PART; TURCO RP, 1987, ATMOS ENVIRON, V21, P2065, DOI 10.1016/0004-6981(87)90167-3; TURCO RP, 1987, ATMOS ENVIRON, V21, P1247, DOI 10.1016/0004-6981(87)90254-X; TURCO RP, 1983, SCIENCE, V222, P1283, DOI 10.1126/science.222.4630.1283; TURCO RP, 1988, ENVIRONMENT, V30, P8, DOI 10.1080/00139157.1988.9928918; TURCO RP, 1986, MED IMPLICATIONS NUC, P96; Twomey S., 1977, ATMOSPHERIC AEROSOLS; UTHE EE, 1982, APPL OPTICS, V21, P460, DOI 10.1364/AO.21.000460; VALERO FPJ, 1983, GEOPHYS RES LETT, V10, P1184, DOI 10.1029/GL010i012p01184; VELTISHCHEV NN, 1988, IZV AN SSSR FIZ ATM+, V24, P296; VOGELMANN AM, 1988, J GEOPHYS RES-ATMOS, V93, P5319, DOI 10.1029/JD093iD05p05319; VUPPUTURI RKR, 1986, ATMOS ENVIRON, V20, P665, DOI 10.1016/0004-6981(86)90181-2; WARNER F, 1988, ENVIRONMENT, V30, P2, DOI 10.1080/00139157.1988.9928916; WARNER F, 1987, ENVIRONMENT, V29, P4; WARREN SG, 1985, NATURE, V313, P467, DOI 10.1038/313467a0; WESTPHAL DL, 1988, J ATMOS SCI, V45, P2145, DOI 10.1175/1520-0469(1988)045<2145:ACSOMA>2.0.CO;2; WEXLER H, 1950, WEATHERWISE, V3, P129; 1988, A43351 UN REP; 1988, 5 US OFF SCI TECHN P; 1988, EFFECTS NUCLEAR WAR; 1979, EFFECTS NUCLEAR WAR; [No title captured]; 1981, 1979 80 STAT YB; 1983, U122878 R D ASS REP; 1986, INT PETROLEUM ENCY; 1985, EFFECTS ATMOSPHERE M; [No title captured]; 1982, EOS, V63, P1018	151	85	86	6	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 12	1990	247	4939					166	176		10.1126/science.11538069	http://dx.doi.org/10.1126/science.11538069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH520	11538069	Green Submitted			2022-12-28	WOS:A1990CH52000026
J	REPETA, DJ; SIMPSON, DJ; JORGENSEN, BB; JANNASCH, HW				REPETA, DJ; SIMPSON, DJ; JORGENSEN, BB; JANNASCH, HW			EVIDENCE FOR ANOXYGENIC PHOTOSYNTHESIS FROM THE DISTRIBUTION OF BACTERIOCHLOROPHYLLS IN THE BLACK-SEA	NATURE			English	Article									WOODS HOLE OCEANOG INST,DEPT BIOL,WOODS HOLE,MA 02543; AARHUS UNIV,DEPT ECOL & GENET,DK-8000 AARHUS C,DENMARK	Woods Hole Oceanographic Institution; Aarhus University	REPETA, DJ (corresponding author), WOODS HOLE OCEANOG INST,DEPT CHEM,WOODS HOLE,MA 02543, USA.		Jorgensen, Bo B/C-2214-2013	Jorgensen, Bo B/0000-0001-9398-8027				BERGSTEIN T, 1979, CAN J MICROBIOL, V25, P999, DOI 10.1139/m79-154; BROCKMANN H, 1976, PHILOS T ROY SOC B, V273, P277, DOI 10.1098/rstb.1976.0013; CAPLE MB, 1978, J BIOL CHEM, V253, P6730; DEUSER WG, 1971, DEEP-SEA RES, V18, P995, DOI 10.1016/0011-7471(71)90004-0; DICKMAN M, 1978, NATURE, V275, P191, DOI 10.1038/275191a0; HASHWA FA, 1978, HELGOLAND WISS MEER, V31, P249, DOI 10.1007/BF02297000; JANNASCH HW, 1974, AAPG BULL, V20, P419; KARL DM, 1988, EOS, V69, P1241; KRISS AE, 1953, DOKL AKAD NAUK SSSR+, V93, P1107; LIAAENJENSEN S, 1985, PURE APPL CHEM, V57, P649, DOI 10.1351/pac198557050649; LIAAENJENSEN S, 1978, MARINE NATURAL PRODU, V2, P2; LIAAENJENSEN S, 1965, ACTA CHEM SCAND, V19, P1025; MURRAY JW, 1989, NATURE, V338, P411, DOI 10.1038/338411a0; Pfenning N., 1978, PHOTOSYNTHETIC BACTE, P3; SIMPSON DJ, 1988, J AM CHEM SOC, V110, P1753, DOI 10.1021/ja00214a016; SMITH KM, 1983, J CHROMATOGR, V281, P209, DOI 10.1016/S0021-9673(01)87879-1; Sorokin Y. I., 1964, J CONS PERM INT EXPL, V29, P41, DOI [10.1093/icesjms/29.1.41, DOI 10.1093/ICESJMS/29.1.41]; TRUPER HG, 1968, LIMNOL OCEANOGR, V13, P225, DOI 10.4319/lo.1968.13.2.0225; WIRSEN CO, 1988, EOS, V69, P1241; WRIGHT SW, 1987, MAR ECOL PROG SER, V38, P259, DOI 10.3354/meps038259	20	179	185	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 2	1989	342	6245					69	72		10.1038/342069a0	http://dx.doi.org/10.1038/342069a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX868	11536615				2022-12-28	WOS:A1989AX86800056
J	MCCLURE, BA; GUILFOYLE, T				MCCLURE, BA; GUILFOYLE, T			RAPID REDISTRIBUTION OF AUXIN-REGULATED RNAS DURING GRAVITROPISM	SCIENCE			English	Article									UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65211	University of Missouri System; University of Missouri Columbia					NIDCD NIH HHS [DCB 8517676] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRIGGS WR, 1963, ANN REV PLANT PHYSL, V38, P311; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; MCCLURE BA, UNPUB; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TREWAVAS A, 1981, PLANT CELL ENVIRON, V4, P203, DOI 10.1111/j.1365-3040.1981.tb01048.x; VANDERHOEF LN, 1975, P NATL ACAD SCI USA, V72, P1822, DOI 10.1073/pnas.72.5.1822; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185	10	150	155	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 6	1989	243	4887					91	93		10.1126/science.11540631	http://dx.doi.org/10.1126/science.11540631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	R6469	11540631				2022-12-28	WOS:A1989R646900039
J	MCKAY, CP; SCATTERGOOD, TW; POLLACK, JB; BORUCKI, WJ; VANGHYSEGHEM, HT				MCKAY, CP; SCATTERGOOD, TW; POLLACK, JB; BORUCKI, WJ; VANGHYSEGHEM, HT			HIGH-TEMPERATURE SHOCK FORMATION OF N-2 AND ORGANICS ON PRIMORDIAL TITAN	NATURE			English	Article									SUNY STONY BROOK,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	MCKAY, CP (corresponding author), NASA,AMES RES CTR,SOLAR SYST EXPLORAT BRANCH,MOFFETT FIELD,CA 94035, USA.							ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; BORUCKI WJ, 1987, APPL OPTICS, V26, P4319, DOI 10.1364/AO.26.004319; BORUCKI WJ, 1984, REV GEOPHYS, V22, P363, DOI 10.1029/RG022i004p00363; BORUCKI WJ, 1985, ICARUS, V64, P221, DOI 10.1016/0019-1035(85)90087-9; BORUCKI WJ, 1987, NATURE, V328, P509, DOI 10.1038/328509a0; BORUCKI WJ, 1984, ICARUS, V60, P260, DOI 10.1016/0019-1035(84)90188-X; BORUCKI WJ, IN PRESS ICARUS; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHAMEIDES WL, 1979, NATURE, V277, P123, DOI 10.1038/277123a0; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; JONES TD, 1987, ICARUS, V72, P381, DOI 10.1016/0019-1035(87)90181-3; LEWIS JS, 1982, SP190 GEOL SOC AM, P215; LUNINE JI, IN PRESS ORIGIN EVOL; PARK C, 1978, J GEOPHYS RES-OCEANS, V83, P4029, DOI 10.1029/JC083iC08p04029; POLLACK JB, 1986, ICARUS, V67, P409, DOI 10.1016/0019-1035(86)90123-5; POLLACK JB, IN PRESS ORIGIN EVOL; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; PRINN RG, 1987, EARTH PLANET SC LETT, V83, P1, DOI 10.1016/0012-821X(87)90046-X; Stevenson DJ, 1986, SATELLITES, P687	19	67	67	1	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 7	1988	332	6164					520	522		10.1038/332520a0	http://dx.doi.org/10.1038/332520a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M8230	11536599				2022-12-28	WOS:A1988M823000051
J	Lorenz, KT; Chandler, DW; Barr, JW; Chen, WW; Barnes, GL; Cline, JI				Lorenz, KT; Chandler, DW; Barr, JW; Chen, WW; Barnes, GL; Cline, JI			Direct measurement of the preferred sense of NO rotation after collision with argon	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; INELASTIC-SCATTERING; ANGULAR-DISTRIBUTIONS; CHEMICAL-REACTIONS; STEREODYNAMICS; POLARIZATION; DYNAMICS; SYSTEM; BEAMS	The preferred sense of product molecule rotation (clockwise or counterclockwise) in a bimolecular collision system has been measured. Rotationally inelastic collisions of nitric oxide (NO) molecules with Ar atoms were studied by combining crossed molecular beams, circularly polarized resonant multiphoton ionization probing, and velocity-mapped ion imaging detection. The observed sense of NO product rotation varies with deflection angle and is a strong function of the NO final rotational state. The largest preferences for sense of rotation are observed at the highest kinematically allowed product rotational states; for tower rotational states, the variation with deflection angle becomes oscillatory. Quantum calculations on the most recently reported NO-Ar potential give good agreement with the observed oscillation patterns in the sense of rotation.	Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA; Univ Nevada, Dept Chem, Reno, NV 89557 USA; Univ Nevada, Chem Phys Program, Reno, NV 89557 USA	United States Department of Energy (DOE); Sandia National Laboratories; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Lorenz, KT (corresponding author), Sandia Natl Labs, Combust Res Facil, POB 969, Livermore, CA 94550 USA.		Barnes, George L/A-3552-2011; Barnes, George/D-6951-2012	Barnes, George L/0000-0001-9211-2736; 				Alexander AJ, 2000, PHYS CHEM CHEM PHYS, V2, P571, DOI 10.1039/a908928d; Alexander MH, 1999, J CHEM PHYS, V111, P7426, DOI 10.1063/1.480066; ALEXANDER MH, 1993, J CHEM PHYS, V99, P7725, DOI 10.1063/1.465702; ALEXANDER MH, 1987, J CHEM PHYS, V86, P2044, DOI 10.1063/1.452154; Aoiz FJ, 1997, CHEM PHYS LETT, V264, P487, DOI 10.1016/S0009-2614(96)01365-6; Aoiz FJ, 1996, J CHEM PHYS, V105, P4964, DOI 10.1063/1.472346; BOSANAC S, 1982, PHYS REV A, V26, P816, DOI 10.1103/PhysRevA.26.816; BROUARD M, 1995, CHEM DYNAMICS KINE 2, P936; Casavecchia P, 2000, REP PROG PHYS, V63, P355, DOI 10.1088/0034-4885/63/3/203; CASE DA, 1976, J CHEM PHYS, V64, P4212, DOI 10.1063/1.431992; CLINE JD, IN PRESS; de Miranda MP, 1999, J CHEM PHYS, V111, P5368, DOI 10.1063/1.479797; deMiranda MP, 1997, J CHEM PHYS, V106, P4509, DOI 10.1063/1.473483; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; HERTEL IV, 1977, ADV ATOM MOL PHYS, V13, P113; Kandel SA, 2000, J CHEM PHYS, V112, P670, DOI 10.1063/1.480602; Lorenz KT, 2000, PHYS CHEM CHEM PHYS, V2, P481; MANOLOPOULOS DE, 1986, J CHEM PHYS, V85, P6425, DOI 10.1063/1.451472; McCabe P, 1998, J CHEM PHYS, V108, P5695, DOI 10.1063/1.475979; MEYER H, 1995, J CHEM PHYS, V102, P3151, DOI 10.1063/1.468626; Rakitzis TP, 1999, J CHEM PHYS, V111, P10415, DOI 10.1063/1.480396; Simons JP, 1999, FARADAY DISCUSS, V113, P1, DOI 10.1039/a905761g; SUITS AG, 1992, J CHEM PHYS, V96, P8618, DOI 10.1063/1.462265; Uberna R, 1996, J CHEM PHYS, V105, P9847, DOI 10.1063/1.472935; UBERNA R, 1995, J CHEM PHYS, V103, P7934, DOI 10.1063/1.470211	25	107	112	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2063	2066		10.1126/science.1062754	http://dx.doi.org/10.1126/science.1062754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557886				2022-12-28	WOS:000171028700067
J	Waldschmidt, TJ; Noelle, RJ				Waldschmidt, TJ; Noelle, RJ			Immunology - Long live the mature B cell - a BAFFling mystery resolved	SCIENCE			English	Editorial Material							AUTOIMMUNE-DISEASE; MICE		Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Dartmouth Coll, Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	University of Iowa; Dartmouth College	Waldschmidt, TJ (corresponding author), Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA.			Waldschmidt, Thomas/0000-0001-6147-6991				Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Khare SD, 2001, TRENDS IMMUNOL, V22, P61, DOI 10.1016/S1471-4906(00)01843-3; Lentz VM, 1996, J IMMUNOL, V157, P598; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	15	25	42	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2012	2013		10.1126/science.1065591	http://dx.doi.org/10.1126/science.1065591			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557866				2022-12-28	WOS:000171028700047
J	Freimund, DL; Aflatooni, K; Batelaan, H				Freimund, DL; Aflatooni, K; Batelaan, H			Observation of the Kapitza-Dirac effect	NATURE			English	Article							STANDING LIGHT WAVES; ELECTRONS; SCATTERING; REFLECTION; LASER; PULSE; INTERFEROMETRY; DIFFRACTION; ATOMS	In their famous 1927 experiment, Davisson and Germer observed(1) the diffraction of electrons by a periodic material structure, so showing that electrons can behave like waves. Shortly afterwards, Kapitza(2) and Dirac(3) predicted that electrons should also be diffracted by a standing light wave(4). This Kapitza-Dirac effect is analogous to the diffraction of light by a grating, but with the roles of the wave and matter reversed. The electron and the light grating interact extremely weakly, via the 'ponderomotive potential'(5), so attempts to measure the Kapitza-Dirac effect had to wait for the development of the laser. The idea(6) that the underlying interaction with light is resonantly enhanced for electrons in an atom led to the observation(7) that atoms could be diffracted by a standing wave of light. Deflection of electrons by high-intensity laser light, which is also a consequence of the Kapitza-Dirac effect, has also been demonstrated(8). But the coherent interference that characterizes wave diffraction has not hitherto beenobserved(9),(10). Here we report the diffraction of free electrons from a standing light wave-a realization of the Kapitza-Dirac effect as originally proposed.	Univ Nebraska, Dept Phys & Astron, Brace Lab 116, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Batelaan, H (corresponding author), Univ Nebraska, Dept Phys & Astron, Brace Lab 116, POB 880111, Lincoln, NE 68588 USA.	hbatelaan2@unl.edu						ADAMS CS, 1994, PHYS REP, V240, P143, DOI 10.1016/0370-1573(94)90066-3; Aitchison I, 1998, NATURE, V392, P771; ALTSHULER S, 1966, PHYS REV LETT, V17, P231, DOI 10.1103/PhysRevLett.17.231; BARTELL LS, 1968, PHYS REV, V166, P1494, DOI 10.1103/PhysRev.166.1494; Batelaan H, 2000, CONTEMP PHYS, V41, P369, DOI 10.1080/00107510010001220; Batelaan H, 1997, PHYS REV LETT, V79, P4517, DOI 10.1103/PhysRevLett.79.4517; BOOT HAH, 1957, NATURE, V180, P1187, DOI 10.1038/1801187a0; BUCKSBAUM PH, 1988, PHYS REV LETT, V61, P1182, DOI 10.1103/PhysRevLett.61.1182; BUCKSBAUM PH, 1990, NATO ADV SCI I B-PHY, V212, P381; Davisson C, 1927, NATURE, V119, P558, DOI 10.1038/119558a0; FEDOROV MV, 1974, OPT COMMUN, V12, P205, DOI 10.1016/0030-4018(74)90392-7; FEDOROV MV, 1991, LASER SCI TECHNOLOGY, V13, P1; Forrey RC, 1999, PHYS REV A, V59, pR942, DOI 10.1103/PhysRevA.59.R942; GOULD PL, 1986, PHYS REV LETT, V56, P827, DOI 10.1103/PhysRevLett.56.827; Kapitza PL, 1933, P CAMB PHILOS SOC, V29, P297, DOI 10.1017/S0305004100011105; Larsen JJ, 1999, PHYS REV LETT, V83, P1123, DOI 10.1103/PhysRevLett.83.1123; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; MOTT N, 1991, NATURE, V350, P31, DOI 10.1038/350031a0; PFEIFFER HC, 1968, PHYS LETT A, VA 26, P362, DOI 10.1016/0375-9601(68)90374-5; RASEL EM, 1995, PHYS REV LETT, V75, P2633, DOI 10.1103/PhysRevLett.75.2633; Robinson JC, 1996, PHYS REV LETT, V76, P3304, DOI 10.1103/PhysRevLett.76.3304; SCHWARZ H, 1965, PHYS LETT, V19, P202, DOI 10.1016/0031-9163(65)90066-1; SCHWARZ H, 1973, PHYS LETT A, VA 43, P457, DOI 10.1016/0375-9601(73)90419-2; SLEATOR T, 1992, PHYS REV LETT, V68, P1996, DOI 10.1103/PhysRevLett.68.1996; Steck DA, 2000, PHYS REV E, V62, P3461, DOI 10.1103/PhysRevE.62.3461; TAKEDA Y, 1968, J PHYS SOC JPN, V25, P1202, DOI 10.1143/JPSJ.25.1202	26	171	177	4	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					142	143		10.1038/35093065	http://dx.doi.org/10.1038/35093065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557974	Green Published			2022-12-28	WOS:000170918800040
J	Mitton, S				Mitton, S			Fred Hoyle's biggest bang	LANCET			English	Editorial Material									Univ Cambridge, St Edmunds Coll, Cambridge CB2 2RU, England	University of Cambridge	Mitton, S (corresponding author), Univ Cambridge, St Edmunds Coll, Cambridge CB2 2RU, England.		Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806				BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Hoyle F., 2000, DIFFERENT APPROACH C	2	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					780	780		10.1016/S0140-6736(01)06010-X	http://dx.doi.org/10.1016/S0140-6736(01)06010-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564481				2022-12-28	WOS:000170989300007
J	Palumbi, SR				Palumbi, SR			Evolution - Humans as the world's greatest evolutionary force	SCIENCE			English	Review							BACILLUS-THURINGIENSIS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; DRUG-RESISTANCE; RAPID EVOLUTION; GENE; HIV-1; EXPRESSION; INFECTION; PLANTS	In addition to altering global ecology, technology and human population growth also affect evolutionary trajectories, dramatically accelerating evolutionary change in other species, especially in commercially important, pest, and disease organisms. Such changes are apparent in antibiotic and human immunodeficiency virus (HIV) resistance to drugs, plant and insect resistance to pesticides, rapid changes in invasive species, life-history change in commercial fisheries, and pest adaptation to biological engineering products. This accelerated evolution costs at least $33 billion to $50 billion a year in the United States. Slowing and controlling arms races in disease and,I pest management have been successful in diverse ecological and economic systems, illustrating how applied evolutionary principles can help reduce the impact of human-kind on evolution.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Palumbi, SR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	spalumbi@oeb.harvard.edu						Abbo S, 2000, SCIENCE, V287, P1927; Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; [Anonymous], 1986, PESTICIDE RESISTANCE; Arpaia S, 1997, THEOR APPL GENET, V95, P329, DOI 10.1007/s001220050567; Austin DJ, 1997, P ROY SOC B-BIOL SCI, V264, P1629, DOI 10.1098/rspb.1997.0227; BLACKSTONE NW, 1984, J EXP MAR BIOL ECOL, V80, P1, DOI 10.1016/0022-0981(84)90090-X; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; BYRD J, 2000, HERBICIDE RESISTANCE; CARRASCOTAUBER C, 1992, AM J AGR ECON, V74, P158, DOI 10.2307/1242999; *CDC, 1999, MORBID MORTAL WEEKLY, V48; Chaix-Couturier C, 2000, PHARMACOECONOMICS, V18, P425, DOI 10.2165/00019053-200018050-00002; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; Crandall KA, 1999, EVOLUTION OF HIV, P153; Desowitz R.S., 1991, MALARIA CAPERS MORE; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Endler J.A., 1986, Monographs in Population Biology, pviii; Ewald PW, 1994, EVOLUTION INFECT DIS; Flores PA, 1997, CLEV CLIN J MED, V64, P527, DOI 10.3949/ccjm.64.10.527; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Garrett L., 1994, COMING PLAGUE NEWLY; Georghiou G, 1991, OCCURRENCE RESISTANC; GOULD F, 1994, BIOCONTROL SCI TECHN, V4, P451, DOI 10.1080/09583159409355357; Gould F, 1995, WEED TECHNOL, V9, P830, DOI 10.1017/S0890037X00024301; GRAFTONCARDWELL EE, 1986, ENVIRON ENTOMOL, V15, P1130, DOI 10.1093/ee/15.6.1130; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; GULNIK SV, 1995, BIOCHEMISTRY-US, V34, P9282, DOI 10.1021/bi00029a002; HANDFORD P, 1977, J FISH RES BOARD CAN, V34, P954, DOI 10.1139/f77-148; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; HAUPTMANN RM, 1988, MOL GEN GENET, V211, P357, DOI 10.1007/BF00330616; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Heap IM, 1997, PESTIC SCI, V51, P235, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;235::AID-PS649&gt;3.0.CO;2-N; Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555; Hoy MA, 1998, PHILOS T ROY SOC B, V353, P1787, DOI 10.1098/rstb.1998.0331; HUGHES VM, 1983, NATURE, V302, P725, DOI 10.1038/302725a0; JOHNSTON RF, 1964, SCIENCE, V144, P548, DOI 10.1126/science.144.3618.548; Katzenstein D, 1997, LANCET, V350, P970, DOI 10.1016/S0140-6736(97)22040-4; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; Kuritzkes DR, 1996, AIDS, V10, P975, DOI 10.1097/00002030-199610090-00007; LAZARUS A, 2000, POSTGRAD MED, V108, P108; Levy S., 1994, ANTIBIOTIC PARADOX M; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; MALLET J, 1992, P ROY SOC B-BIOL SCI, V250, P165, DOI 10.1098/rspb.1992.0145; McKenzie J., 1996, ECOLOGICAL EVOLUTION; McKinnon PS, 2001, SUPPORT CARE CANCER, V9, P8, DOI 10.1007/s005200000177; National Research Council, 2000, FUT ROL PEST US AGR; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Palumbi Stephen R., 2001, EVOLUTION EXPLOSION; PFALLER MA, 2001, HOSP PRACT, V10; Pillay D, 2000, REV MED VIROL, V10, P231, DOI 10.1002/1099-1654(200007/08)10:4&lt;231::AID-RMV290&gt;3.0.CO;2-P; PIMENTEL D, 1991, PESTICIDE QUESTION E, P47; POTRYKUS I, 1995, EUPHYTICA, V85, P441, DOI 10.1007/BF00023978; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; RICKER WE, 1981, CAN J FISH AQUAT SCI, V38, P1636, DOI 10.1139/f81-213; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Singsit C, 1997, TRANSGENIC RES, V6, P169, DOI 10.1023/A:1018481805928; STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788; Tabashnik B.E., 1990, PESTICIDE RESISTANCE, P153; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; THOMPSON GA, 1987, WEED SCI, V35, P19; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; VANWORDRAGEN MF, 1993, TRANSGENIC RES, V2, P170, DOI 10.1007/BF01972611; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WEISMANN R, 1947, MITT SCHWEIZ ENTOMOL, V20, P484; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wong JK, 1997, P NATL ACAD SCI USA, V94, P12574, DOI 10.1073/pnas.94.23.12574; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264	76	812	849	10	530	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1786	1790		10.1126/science.293.5536.1786	http://dx.doi.org/10.1126/science.293.5536.1786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546863				2022-12-28	WOS:000170894400036
J	Hankey, GJ				Hankey, GJ			New drugs, or new trials of current drugs, for the treatment of acute ischaemic stroke?	LANCET			English	Editorial Material									Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Baron JC, 1999, CEREBROVASC DIS, V9, P193, DOI 10.1159/000015955; Collins R, 1997, NEW ENGL J MED, V336, P847, DOI 10.1056/NEJM199703203361207; Grotta JC, 2000, STROKE, V31, P278; GUBITZ G, 2001, COCHRANE LIB; HAND P, 2001, CEREBROVASC DIS, V11, P35; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; *STROK UN TRIAL CO, 2001, COCHR LIB; WARDLAW JM, 2001, COCHRANE LIB; Warlow CP, 2000, STROKE PRACTICAL GUI	10	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					683	684		10.1016/S0140-6736(01)05847-0	http://dx.doi.org/10.1016/S0140-6736(01)05847-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551570				2022-12-28	WOS:000170729500003
J	Barrett, MP				Barrett, MP			Veterinary link to drug resistance in human African trypanosomiasis?	LANCET			English	Editorial Material									Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Barrett, MP (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland.			Barrett, Mike/0000-0001-9447-3519				Barrett MP, 1999, PARASITOL TODAY, V15, P136, DOI 10.1016/S0169-4758(99)01414-3; GEERTS S, 1998, PAAT TECH SCI SER, P1; Hide G, 1999, CLIN MICROBIOL REV, V12, P112, DOI 10.1128/CMR.12.1.112; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8	5	22	22	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					603	604		10.1016/S0140-6736(01)05817-2	http://dx.doi.org/10.1016/S0140-6736(01)05817-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530144				2022-12-28	WOS:000170615500005
J	Beaglehole, R				Beaglehole, R			Global cardiovascular disease prevention: time to get serious	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; RISK-FACTORS; MORTALITY; TRENDS		Univ Auckland, Auckland 1, New Zealand	University of Auckland	Beaglehole, R (corresponding author), 206 Rue Chateau, F-01170 Vesancy, France.	beaglehole@compuserve.com						*ADV BOARD, 2001, 4 INT HEART HLTH C O; Beaglehole R, 1999, J CARDIOVASC RISK, V6, P63; BONITA R, IN PRESS GLOBAL BEHA; Bonita R, 2001, STROKE PREVENTION; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ebrahim S, 2001, INT J EPIDEMIOL, V30, P201, DOI 10.1093/ije/30.2.201; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Holtzman NA, 2001, INT J HEALTH SERV, V31, P445, DOI 10.2190/JPFC-A4NW-KWT6-Y2H7; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; MacGregor G., 1998, SALT DIET HLTH NEPTU; MAGNUS P, IN PRESS ARCH INTERN; McKinlay JB, 1999, AM J PUBLIC HEALTH, V89, P295, DOI 10.2105/AJPH.89.3.295; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; Nieto FJ, 1999, AM J PUBLIC HEALTH, V89, P292, DOI 10.2105/AJPH.89.3.292; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Rose G., 1992, STRATEGY PREVENTIVE; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; STARNLER J, 1999, JAMA-J AM MED ASSOC, V282, P2012; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organization, 2000, WORLD HLTH REP 2000; *WORLD HEART FED, 2001, BROCH WORLD HEART; Zhang X, 2000, J HYPERTENS, V18, pS25	27	67	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					661	663		10.1016/S0140-6736(01)05784-1	http://dx.doi.org/10.1016/S0140-6736(01)05784-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530175				2022-12-28	WOS:000170615500032
J	Henderson, MC; Jehangir, S				Henderson, MC; Jehangir, S			A swollen finger and abdominal pain	LANCET			English	Editorial Material							METASTATIC TUMORS; HAND		Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Henderson, MC (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA.							ABRAHAMS TG, 1995, SKELETAL RADIOL, V24, P135; BUCKLEY N, 1987, DIS COLON RECTUM, V30, P141, DOI 10.1007/BF02554955; HEALEY JH, 1986, J BONE JOINT SURG AM, V68A, P743, DOI 10.2106/00004623-198668050-00017; KERIN R, 1983, J BONE JOINT SURG AM, V65, P1331, DOI 10.2106/00004623-198365090-00016; MONSEES B, 1984, ARTHRITIS RHEUM, V27, P449, DOI 10.1002/art.1780270413	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					636	636		10.1016/S0140-6736(01)05781-6	http://dx.doi.org/10.1016/S0140-6736(01)05781-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530152				2022-12-28	WOS:000170615500013
J	Dayan, CM				Dayan, CM			Interpretation of thyroid function tests	LANCET			English	Review							THYROTROPIN-RELEASING-HORMONE; CONGENITAL HYPOTHYROIDISM; SERUM THYROTROPIN; RECEPTOR GENE; TSH RECEPTOR; MUTATION; THYROXINE; DISEASES; TRIIODOTHYRONINE; HYPERTHYROIDISM	The introduction of sensitive thyrotropin assays and free thyroid hormone measurements has simplified the interpretation of thyroid function tests. However, important pitfalls and difficult cases still exist. In this review, thyroid function test results are grouped into six different patterns. We propose that if assays for thyrotropin, free T3, and free T4 are all done, knowledge of these patterns coupled with clinical details and simple additional tests allow a diagnosis to be made in almost all cases.	Univ Bristol, Bristol Royal Infirm, Dept Med, Bristol BS2 8HW, Avon, England	Bristol Royal Infirmary; University of Bristol	Dayan, CM (corresponding author), Univ Bristol, Bristol Royal Infirm, Dept Med, Bristol BS2 8HW, Avon, England.		Dayan, Colin/AAH-6242-2019; Kapoor, Nitin/AAF-6805-2022; Kapoor, Nitin/ACB-7980-2022	Dayan, Colin/0000-0002-6557-3462; Kapoor, Nitin/0000-0002-9520-2072; Kapoor, Nitin/0000-0002-9520-2072				Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; AMINO N, 1976, CLIN ENDOCRINOL, V5, P115, DOI 10.1111/j.1365-2265.1976.tb02822.x; Arem R, 1997, TRENDS ENDOCRIN MET, V8, P282, DOI 10.1016/S1043-2760(97)00093-3; Bakiri F, 1999, ANN ENDOCRINOL-PARIS, V60, P422; BARTALENA L, 1992, THYROID, V2, P237, DOI 10.1089/thy.1992.2.237; BECKERS A, 1991, J CLIN ENDOCR METAB, V72, P477, DOI 10.1210/jcem-72-2-477; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; Biebermann H, 1999, PEDIATR RES, V46, P170, DOI 10.1203/00006450-199908000-00007; Bikker H, 1997, J CLIN ENDOCR METAB, V82, P649, DOI 10.1210/jc.82.2.649; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; CHATTERJEE VKK, 1994, BAILLIERE CLIN ENDOC, V8, P267; CHOE W, 1995, ENDOCRINOLOGIST, V5, P222, DOI 10.1097/00019616-199505000-00009; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Collu R, 1997, J CLIN ENDOCR METAB, V82, P1561, DOI 10.1210/jc.82.5.1561; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; DESAI RK, 1988, CLIN CHEM, V34, P944; DOCTER R, 1993, CLIN ENDOCRINOL, V39, P499, DOI 10.1111/j.1365-2265.1993.tb02401.x; Fuhrer D, 1999, THYROID, V9, P757, DOI 10.1089/thy.1999.9.757; Fujiwara H, 1997, NAT GENET, V16, P124, DOI 10.1038/ng0697-124; GAITAN E, 1990, ANNU REV NUTR, V10, P21, DOI [10.1146/annurev.nu.10.070190.000321, 10.1146/annurev.nutr.10.1.21]; GUTEKUNST R, 1989, J ENDOCRINOL INVEST, V12, P209, DOI 10.1007/BF03349967; Harjai KJ, 1997, ANN INTERN MED, V126, P63, DOI 10.7326/0003-4819-126-1-199701010-00009; HAY ID, 1991, CLIN CHEM, V37, P2002; Khan LK, 1998, LANCET, V352, P1519, DOI 10.1016/S0140-6736(98)00058-0; Kopp P, 1999, THYROID, V9, P65, DOI 10.1089/thy.1999.9.65; LaFranchi S, 1999, THYROID, V9, P735, DOI 10.1089/thy.1999.9.735; Lazarus JH, 1997, BRIT J GEN PRACT, V47, P305; Lazarus JH, 1998, THYROID, V8, P909, DOI 10.1089/thy.1998.8.909; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; MARIOTTI S, 1990, J CLIN ENDOCR METAB, V71, P661, DOI 10.1210/jcem-71-3-661; Miccoli P, 1996, SURGERY, V120, P1020, DOI 10.1016/S0039-6060(96)80049-3; Paschke R, 1997, NEW ENGL J MED, V337, P1675, DOI 10.1056/NEJM199712043372307; Rodien P, 1998, NEW ENGL J MED, V339, P1823, DOI 10.1056/NEJM199812173392505; Ross DS, 1998, ENDOCRIN METAB CLIN, V27, P169, DOI 10.1016/S0889-8529(05)70305-4; ROSS DS, 1994, THYROID, V4, P319, DOI 10.1089/thy.1994.4.319; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Schuppert F, 1997, THYROID, V7, P837, DOI 10.1089/thy.1997.7.837; SCHWAEGERLE SM, 1988, AM J CLIN PATHOL, V90, P715, DOI 10.1093/ajcp/90.6.715; Spencer CA, 1996, CLIN CHEM, V42, P140; Spencer CA, 1996, EUR J ENDOCRINOL, V135, P285, DOI 10.1530/eje.0.1350285; SQUIRE CR, IN PRESS LANCET; Stagnaro-Green A, 1993, THYROID TODAY, V16, P1; STEWART MF, 1986, ANN CLIN BIOCHEM, V23, P59, DOI 10.1177/000456328602300107; TAKESHITA A, 1994, THYROID, V4, P255, DOI 10.1089/thy.1994.4.255; Tiosano D, 1999, THYROID, V9, P887, DOI 10.1089/thy.1999.9.887; van de Graaf SAR, 1999, J CLIN ENDOCR METAB, V84, P2537, DOI 10.1210/jc.84.7.2537; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Ward G, 1997, AM J CLIN PATHOL, V108, P417; Xie J, 1997, J CLIN ENDOCR METAB, V82, P3933, DOI 10.1210/jc.82.12.3933	52	81	84	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					619	624		10.1016/S0140-6736(00)04060-5	http://dx.doi.org/10.1016/S0140-6736(00)04060-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558500				2022-12-28	WOS:000167119100034
J	Giles, J				Giles, J			Mad cow disease comes to Japan	NATURE			English	News Item																			0	9	10	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					240	240		10.1038/35095180	http://dx.doi.org/10.1038/35095180			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11564996	Bronze			2022-12-28	WOS:000171040500005
J	Johnson, S; Kent, SA; O'Leary, KJ; Merrigan, MM; Sambol, SP; Peterson, LR; Gerding, DN				Johnson, S; Kent, SA; O'Leary, KJ; Merrigan, MM; Sambol, SP; Peterson, LR; Gerding, DN			Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin a immunoassay	ANNALS OF INTERNAL MEDICINE			English	Article							B-POSITIVE STRAIN; SEROGROUPS; HAMSTERS; DISEASE; PCR	Background: Many clinical laboratories use toxin A immunoassays to test for Clostridium difficile. Objective: To describe the clinical course of a patient infected with a toxin variant strain of C difficile that was not detected by toxin A immunoassay; to genetically characterize this strain; and to estimate the number of laboratories that use only toxin A immunoassays. Design: Case report, molecular investigation, and laboratory survey. Setting: Tertiary care hospital in Chicago, Illinois. Patient: An 86-year-old man. Measurements: Restriction endonuclease analysis, polymerase chain reaction, and survey of regional clinical laboratories. Results: An elderly hospitalized man died of advanced pseudomembranous colitis. Four stool specimens submitted over a 2-month period had tested negative on toxin A immunoassay, but a strain of C difficile with a 1.8-kb deletion of the toxin A gene was recovered from each specimen. This strain, identified as restriction endonuclease analysis type CF4, is closely related to a widely disseminated variant, toxinotype VIII. Toxin A immunoassay was the only test being performed for detection of C difficile at 31 of 67 (46%) regional clinical laboratories. Conclusions: Toxin A variant strains of C difficile cause serious disease and are undetectable in clinical laboratories that use only toxin A immunoassays for C. difficile testing.	Vet Affairs Chicago Hlth Care Syst, Med Serv, Lakeside Div, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Chicago, IL USA	Northwestern University	Johnson, S (corresponding author), Vet Affairs Chicago Hlth Care Syst, Med Serv, Lakeside Div, Lakeside 333 E Huron St, Chicago, IL 60611 USA.	stu-johnson@northwestern.edu		Johnson, Stuart/0000-0001-9548-229X; O'Leary, Kevin/0000-0003-4715-5790				Alfa MJ, 2000, J CLIN MICROBIOL, V38, P2706, DOI 10.1128/JCM.38.7.2706-2714.2000; Altaie SS, 1996, LAB MED, V27, P468, DOI 10.1093/labmed/27.7.468; BOREK AP, 1998, 98 ANN M AM SOC MICR; BORRIELLO SP, 1992, INFECT IMMUN, V60, P4192, DOI 10.1128/IAI.60.10.4192-4199.1992; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; CLABOTS CR, 1993, 33 INT C ANT AG CHEM; DELMEE M, 1990, J MED MICROBIOL, V33, P85, DOI 10.1099/00222615-33-2-85; DEPITRE C, 1993, J MED MICROBIOL, V38, P434, DOI 10.1099/00222615-38-6-434; Gerding DN, 1996, AM J MED, V100, P485, DOI 10.1016/S0002-9343(95)00057-7; Johnson Stuart, 1999, P467; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Limaye AP, 2000, J CLIN MICROBIOL, V38, P1696, DOI 10.1128/JCM.38.4.1696-1697.2000; LYERLY DM, 1986, INFECT IMMUN, V54, P70, DOI 10.1128/IAI.54.1.70-76.1986; Moncrief JS, 2000, J CLIN MICROBIOL, V38, P3072, DOI 10.1128/JCM.38.8.3072-3075.2000; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sambol SP, 2000, INFECT IMMUN, V68, P5480, DOI 10.1128/IAI.68.10.5480-5487.2000; von Eichel-Streiber C, 1999, FEMS MICROBIOL LETT, V178, P163, DOI 10.1016/S0378-1097(99)00327-4; VONEICHELSTREIBER C, 1995, MOL MICROBIOL, V17, P313, DOI 10.1111/j.1365-2958.1995.mmi_17020313.x; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5	20	104	113	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					434	438		10.7326/0003-4819-135-6-200109180-00012	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560456				2022-12-28	WOS:000170972500005
J	Verrijzer, CP				Verrijzer, CP			Transcription - Transcription factor IID - Not so basal after all	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; TBP-LIKE FACTOR; C-ELEGANS; MULTIPLE		Leiden Univ, Med Ctr, Ctr Biomed Genet, MGC,Dept Mol & Cell Biol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verrijzer, CP (corresponding author), Leiden Univ, Med Ctr, Ctr Biomed Genet, MGC,Dept Mol & Cell Biol, Leiden, Netherlands.							Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Wassarman DA, 2000, P NATL ACAD SCI USA, V97, P1154, DOI 10.1073/pnas.97.3.1154; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	16	18	18	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2010	2011		10.1126/science.1064980	http://dx.doi.org/10.1126/science.1064980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557865				2022-12-28	WOS:000171028700046
J	Julius, D; Basbaum, AI				Julius, D; Basbaum, AI			Molecular mechanisms of nociception	NATURE			English	Review							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; ROOT GANGLION NEURONS; PDZ DOMAIN PROTEIN; CAPSAICIN-RECEPTOR; VANILLOID RECEPTOR-1; ION-CHANNEL; DIRECT ACTIVATION; SODIUM CURRENT; C-NOCICEPTORS	The sensation of pain alerts us to real or impending injury and triggers appropriate protective responses. Unfortunately, pain often outlives its usefulness as a warning system and instead becomes chronic and debilitating. This transition to a chronic phase involves changes within the spinal cord and brain, but there is also remarkable modulation where pain messages are initiated-at the level of the primary sensory neuron. Efforts to determine how these neurons detect pain-producing stimuli of a thermal, mechanical or chemical nature have revealed new signalling mechanisms and brought us closer to understanding the molecular events that facilitate transitions from acute to persistent pain.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@socrates.ucsf.edu						Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Baker MD, 2001, TRENDS PHARMACOL SCI, V22, P27, DOI 10.1016/S0165-6147(00)01585-6; Basbaum AI, 1999, CURR BIOL, V9, pR429, DOI 10.1016/S0960-9822(99)80273-5; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bevan S., 1999, TXB PAIN, P85; BURGESS GM, 1989, J NEUROSCI, V9, P3314; BURGESS PR, 1967, J PHYSIOL-LONDON, V190, P541, DOI 10.1113/jphysiol.1967.sp008227; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fields H. L., 1987, PAIN; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gebhart GF, 1996, PROG BRAIN RES, V113, P101, DOI 10.1016/S0079-6123(08)61083-3; Gold MR, 1998, J INTERV CARD ELECTR, V2, P345, DOI 10.1023/A:1009756520054; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kirschstein T, 1999, J NEUROPHYSIOL, V82, P2853, DOI 10.1152/jn.1999.82.6.2853; Kress M, 1996, P NATL ACAD SCI USA, V93, P14995, DOI 10.1073/pnas.93.26.14995; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; KRISHTAL OA, 1988, NEUROSCIENCE, V27, P995, DOI 10.1016/0306-4522(88)90203-5; LEMBECK F, 1982, CIBA F SYMP, V91, P35; Levine JD, 1999, TXB PAIN, P59; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; MCMAHON SB, 1999, TXB PAIN, P105; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Nakamura F, 1996, P NATL ACAD SCI USA, V93, P10465, DOI 10.1073/pnas.93.19.10465; PETERSEN M, 1993, PAIN, V54, P37, DOI 10.1016/0304-3959(93)90097-9; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; RAJA SN, 1999, TXB PAIN, P00011; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Sherrington C, 1906, INTEGRATIVE ACTION N; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9; Szolcsanyi J, 2000, TRENDS PHARMACOL SCI, V21, P203, DOI 10.1016/S0165-6147(00)01484-X; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Tognetto M, 2001, J NEUROSCI, V21, P1104; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Weidner C, 1999, J NEUROSCI, V19, P10184; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Womack KB, 2000, J NEUROSCI, V20, P2792; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	76	1681	1809	9	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					203	210		10.1038/35093019	http://dx.doi.org/10.1038/35093019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557989				2022-12-28	WOS:000170918800055
J	Scott, SH; Gribble, PL; Graham, KM; Cabel, DW				Scott, SH; Gribble, PL; Graham, KM; Cabel, DW			Dissociation between hand motion and population vectors from neural activity in motor cortex	NATURE			English	Article							ARM MOVEMENTS; REACHING MOVEMENTS; CORTICAL CONTROL; DIRECTION; REPRESENTATION; SHOULDER; MUSCLE; PATHS; SPACE	The population vector hypothesis was introduced almost twenty years ago to illustrate that a population vector constructed from neural activity in primary motor cortex (MI) of non-human primates could predict the direction of hand movement during reaching(1-6). Alternative explanations for this population signal have been suggested(7,8) but could not be tested experimentally owing to movement complexity in the standard reaching model. We re-examined this issue by recording the activity of neurons in contralateral MI of monkeys while they made reaching movements with their right arms oriented in the horizontal plane-where the mechanics of limb motion are measurable and anisotropic. Here we found systematic biases between the population vector and the direction of hand movement. These errors were attributed to a non-uniform distribution of preferred directions of neurons and the non-uniformity covaried with peak joint power at the shoulder and elbow. These observations contradict the population vector hypothesis and show that non-human primates are capable of generating reaching movements to spatial targets even though population vectors based on MI activity do not point in the direction of hand motion.	Queens Univ, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada.	steve@biomed.queensu.ca		Gribble, Paul/0000-0002-1368-032X				BATSCHELET E, 1981, MATH BIOL CIRCULAR S; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Cheng EJ, 2000, J MORPHOL, V245, P206, DOI 10.1002/1097-4687(200009)245:3<206::AID-JMOR3>3.3.CO;2-L; GABEL DW, IN PRESS J NEUROPHYS; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1996, J MUSCLE RES CELL M, V17, P207, DOI 10.1007/BF00124243; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; WINTER DA, 1984, CRIT REV BIOMED ENG, V9, P287; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	30	122	123	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					161	165		10.1038/35093102	http://dx.doi.org/10.1038/35093102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557980				2022-12-28	WOS:000170918800046
J	Mezey, G; Robbins, I				Mezey, G; Robbins, I			Usefulness and validity of post-traumatic stress disorder as a psychiatric category	BRITISH MEDICAL JOURNAL			English	Article							NATIONAL COMORBIDITY SURVEY; CORTISOL		Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London St Georges Hosp, SW London & St Georges Mental Hlth NHS Trust, Traumat Stress Serv, London SW17 0QT, England	St Georges University London; St Georges University London	Mezey, G (corresponding author), Univ London St Georges Hosp, Sch Med, Jenner Wing, London SW17 0RE, England.							American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; de Vries Martin, 1996, TRAUMATIC STRESS EFF, P400; DILLING H, 2000, NEW OXFORD TXB PSYCH, P108; Dolan Bridget, 1993, PSYCHOPATHIC ANTISOC; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; GREEN BL, 1992, J NERV MENT DIS, V180, P760, DOI 10.1097/00005053-199212000-00004; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Herman Judith, 2001, TRAUMA RECOVERY; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 1999, AM J PSYCHIAT, V156, P115, DOI 10.1176/ajp.156.1.115; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P645; SARTORIUS N, 1988, BRIT J PSYCHIAT, V152, P9, DOI 10.1192/S000712500029555X; Stein MB, 1997, BIOL PSYCHIAT, V42, P680, DOI 10.1016/S0006-3223(96)00489-1; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; WHO, 1992, ICD10 INT CLASS DIS; World Health Organization, 1995, BRIDG GAPS; YEHUDA R, 1993, BIOL PSYCHIAT, V34, P18, DOI 10.1016/0006-3223(93)90252-9	24	50	50	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					561	563		10.1136/bmj.323.7312.561	http://dx.doi.org/10.1136/bmj.323.7312.561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	471NC	11546705	Green Published			2022-12-28	WOS:000170934600026
J	Richards, C; Dingwall, R; Watson, A				Richards, C; Dingwall, R; Watson, A			Should NHS patients be allowed to contribute extra money to their care?	BRITISH MEDICAL JOURNAL			English	Article							RATIONING HEALTH-CARE; ALLOCATION; SYSTEM		Nottingham Hlth Author, Nottingham NG1 5DN, England; Univ Nottingham, Inst Study Genet Biorisk & Soc, Nottingham NG7 2RD, England; Nottingham City Hosp NHS Trust, Nottingham NG5 1PB, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Richards, C (corresponding author), Nottingham Hlth Author, Park Row, Nottingham NG1 5DN, England.		Dingwall, Robert WJ/A-9348-2008	Dingwall, Robert WJ/0000-0002-1588-3796				AARON H, 1990, SCIENCE, V247, P418, DOI 10.1126/science.2300804; ADAM S, 1999, 115 NHS EX; Beveridge W, 1942, CMND6404 HMSO; Doyle Y, 2000, BRIT MED J, V321, P563, DOI 10.1136/bmj.321.7260.563; FINNIS J, 1980, NATURAL TAX NATURAL; HADORN DC, 1991, JAMA-J AM MED ASSOC, V266, P3328, DOI 10.1001/jama.266.23.3328; Hohfeld Wesley., 1919, FUNDAMENTAL LEGAL CO; MacKenzie IZ, 1999, BRIT MED J, V318, P1070, DOI 10.1136/bmj.318.7190.1070; NELSON RM, 1992, J MED PHILOS, V17, P97, DOI 10.1093/jmp/17.1.97; Norheim OF, 1995, J MED PHILOS, V20, P639, DOI 10.1093/jmp/20.6.639; PAWLSON LG, 1992, J AM GERIATR SOC, V40, P628, DOI 10.1111/j.1532-5415.1992.tb02117.x; Sikora K, 1999, BMJ-BRIT MED J, V319, P461, DOI 10.1136/bmj.319.7208.461; SIKORA K, 2000, SUNDAY TIMES    0319, P7; STEVENS R, 1966, MED PRACTICE MODERN, P197; VANDEVEN WPMM, 1995, BRIT MED BULL, V51, P781, DOI 10.1093/oxfordjournals.bmb.a072993; WATSON AR, 1999, P R COLL PHYSICIANS, V29, P335; Weale A, 1998, BRIT MED J, V316, P410, DOI 10.1136/bmj.316.7129.410	17	8	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					563	565		10.1136/bmj.323.7312.563	http://dx.doi.org/10.1136/bmj.323.7312.563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	471NC	11546706	Green Published			2022-12-28	WOS:000170934600027
J	Lykke-Andersen, J; Shu, MD; Steitz, JA				Lykke-Andersen, J; Shu, MD; Steitz, JA			Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1	SCIENCE			English	Article							NONSENSE-MEDIATED DECAY; CAENORHABDITIS-ELEGANS; UPF PROTEINS; TRANSLATION; TERMINATION; INTERACTS; NUCLEUS; MESSAGE; COMPLEX; EXPORT	In mammalian cells, splice junctions play a dual rote in mRNA quality control: They mediate selective nuclear export of mature mRNA and they serve as a mark for mRNA surveillance, which subjects aberrant mRNAs with premature termination codons to nonsense-mediated decay (NMD). Here, we demonstrate that the protein RNPS1, a component of the postsplicing complex that is deposited 5' to exon-exon junctions, interacts with the evolutionarily conserved human Upf complex, a central component of NMD. Significantly, RNPS1 triggers NMD when tethered to the 3' untranslated region of beta -globin mRNA, demonstrating its role as a subunit of the postsplicing complex directly involved in mRNA surveillance.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	NCI NIH HHS [CA 16038] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Czaplinski K, 1999, BIOESSAYS, V21, P685, DOI 10.1002/(SICI)1521-1878(199908)21:8<685::AID-BIES8>3.0.CO;2-4; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; LYKKEANDERSEN J, UNPUB; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	32	301	314	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1836	1839		10.1126/science.1062786	http://dx.doi.org/10.1126/science.1062786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546874				2022-12-28	WOS:000170894400049
J	Pollitz, FF; Wicks, C; Thatcher, W				Pollitz, FF; Wicks, C; Thatcher, W			Mantle flow beneath a continental strike-slip fault: Postseismic deformation after the 1999 Hector Mine earthquake	SCIENCE			English	Article							MOJAVE DESERT; RADAR INTERFEROMETRY; CORE COMPLEX; CALIFORNIA; RHEOLOGY; LANDERS; LITHOSPHERE; ORIGIN; CRUST; FIELD	Two recent large earthquakes in the Mojave Desert, California-the magnitude 7.3 1992 Landers and magnitude 7.1 1999 Hector Mine earthquakes-have each been followed by elevated crustal strain rates over periods of months and years. Geodetic data collected after the Hector Mine earthquake exhibit a temporally decaying horizontal velocity field and a quadrant uplift pattern opposite to that expected for localized shear beneath the earthquake rupture. We interpret the origin of this accelerated crustal deformation to be vigorous flow in the upper mantle in response to the stress changes generated by the earthquake. Our results suggest that transient flow in the upper mantle is a fundamental component of the earthquake cycle and that the lower crust is a coherent stress guide coupling the upper crust with the upper mantle.	US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Pollitz, FF (corresponding author), US Geol Survey, 345 Middlefield Rd,MS 977, Menlo Pk, CA 94025 USA.	fpollitz@usgs.gov						Beard BL, 1997, J GEOPHYS RES-SOL EA, V102, P20149, DOI 10.1029/97JB01731; Behr J., 2000, SEISMOL RES LETT, V71, P11; BILLS BG, 1994, J GEOPHYS RES-SOL EA, V99, P22059, DOI 10.1029/94JB01192; BLOCK L, 1990, TECTONICS, V9, P557, DOI 10.1029/TC009i004p00557; BOUCHER C, 1999, 27 IIERS OBS PAR; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; Clark MK, 2000, GEOLOGY, V28, P703, DOI 10.1130/0091-7613(2000)28<703:TOBTEM>2.0.CO;2; Dreger D, 2000, GEOPHYS RES LETT, V27, P1941, DOI 10.1029/1999GL011245; FARMER GL, 1995, J GEOPHYS RES-SOL EA, V100, P8399, DOI 10.1029/95JB00070; Gans PB, 1998, SCIENCE, V279, P66, DOI 10.1126/science.279.5347.66; GLAZNER AF, 1991, J GEOPHYS RES-SOLID, V96, P13673, DOI 10.1029/91JB00175; GORDON D, 1993, GEODYNAMICS, V23, P131; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; James TS, 2000, QUATERNARY SCI REV, V19, P1527, DOI 10.1016/S0277-3791(00)00076-7; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Kaufmann G, 2000, J GEOPHYS RES-SOL EA, V105, P16341, DOI 10.1029/2000JB900079; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Massonnet D, 1996, NATURE, V382, P612, DOI 10.1038/382612a0; Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; MCCARTHY J, 1991, J GEOPHYS RES-SOLID, V96, P12259, DOI 10.1029/91JB01004; McKenzie D, 2000, J GEOPHYS RES-SOL EA, V105, P11029, DOI 10.1029/1999JB900446; NAKIBOGLU SM, 1983, J GEOPHYS RES, V88, P439, DOI 10.1029/JB088iB12p10439; Pollitz FF, 2000, J GEOPHYS RES-SOL EA, V105, P8035, DOI 10.1029/1999JB900380; Pollitz FF, 1997, J GEOPHYS RES-SOL EA, V102, P17921, DOI 10.1029/97JB01277; Pollitz FF, 1996, GEOPHYS J INT, V125, P1, DOI 10.1111/j.1365-246X.1996.tb06530.x; QU J, 1994, B SEISMOL SOC AM, V84, P596; Richards-Dinger KB, 2000, J GEOPHYS RES-SOL EA, V105, P10939, DOI 10.1029/2000JB900014; Royden LH, 1997, SCIENCE, V276, P788, DOI 10.1126/science.276.5313.788; SAUBER J, 1994, NATURE, V367, P264, DOI 10.1038/367264a0; Savage JC, 1997, J GEOPHYS RES-SOL EA, V102, P7565, DOI 10.1029/97JB00210; Scharroo R, 1998, J GEOPHYS RES-OCEANS, V103, P8113, DOI 10.1029/97JC03179; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668	34	231	245	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1814	1818		10.1126/science.1061361	http://dx.doi.org/10.1126/science.1061361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546869				2022-12-28	WOS:000170894400042
J	Chen, EY; Nguyen, TD				Chen, EY; Nguyen, TD			Gallbladder sludge	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Washington, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Chen, EY (corresponding author), Univ Washington, Seattle, WA 98195 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					E2	E2		10.1056/ENEJMicm010154	http://dx.doi.org/10.1056/ENEJMicm010154			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547762				2022-12-28	WOS:000170772900006
J	Westberg, K; Lynoe, N; Lalos, A; Lofgren, M; Sandlund, M				Westberg, K; Lynoe, N; Lalos, A; Lofgren, M; Sandlund, M			Getting informed consent from patients to take part in the clinical training of students: randomised trial of two strategies	BRITISH MEDICAL JOURNAL			English	Article									Umea Univ, S-90187 Umea, Sweden; Univ Hosp No Sweden, Dept Clin Sci, S-90185 Umea, Sweden	Umea University; Umea University	Lynoe, N (corresponding author), Umea Univ, S-90187 Umea, Sweden.							LYNOE N, 1995, SCAND J SOC MED, V23, P216, DOI 10.1177/140349489502300313; Lynoe N, 1998, MED EDUC, V32, P465; OFlynn N, 1997, BRIT MED J, V315, P1142	3	15	15	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					488	488		10.1136/bmj.323.7311.488	http://dx.doi.org/10.1136/bmj.323.7311.488			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	469WF	11532842	Bronze, Green Published			2022-12-28	WOS:000170838500019
J	Shimojo, S; Kamitani, Y; Nishida, S				Shimojo, S; Kamitani, Y; Nishida, S			Afterimage of perceptually filled-in surface	SCIENCE			English	Article							SUBJECTIVE CONTOURS; FILLING-IN; ILLUSION; DEPTH	An afterimage induced by prior adaptation to a visual stimulus is believed to be due to bleaching of photochemical pigments or neural adaptation in the retina. We report a type of afterimage that appears to require cortical adaptation. Fixating a neon-color spreading configuration led not only to negative afterimages corresponding to the inducers (local afterimages), but also to one corresponding to the perceptually fitted-in surface during adaptation (global afterimage). These afterimages were mutually exclusive, undergoing monocular rivalry. The strength of the global afterimage correlated to a greater extent with perceptual filling-in during adaptation than with the strength of the local afterimages. Thus, global afterimages are not merely by-products of local afterimages, but involve adaptation at a cortical representation of surface.	CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA; NTT Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Shimojo, S (corresponding author), CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA.							ANSTIS S, 1978, VISION RES, V18, P899, DOI 10.1016/0042-6989(78)90016-0; ATKINSON J, 1972, J EXP PSYCHOL, V98, P55; ATKINSON J, 1973, PERCEPT PSYCHOPHYS, V12, P257; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; CRASSINI B, 1982, VISION RES, V22, P203, DOI 10.1016/0042-6989(82)90184-5; DAVIES P, 1973, BRIT J PSYCHOL, V64, P325, DOI 10.1111/j.2044-8295.1973.tb01358.x; De Weerd P, 1998, VISION RES, V38, P2721, DOI 10.1016/S0042-6989(97)00432-X; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; KELLY DH, 1993, J OPT SOC AM A, V10, P29, DOI 10.1364/JOSAA.10.000029; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LOOMIS JM, 1978, J OPT SOC AM, V68, P411, DOI 10.1364/JOSA.68.000411; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; MEYER GE, 1987, J EXP PSYCHOL HUMAN, V13, P353; MOTHER G, 1998, MOTION AFTEREFFECT; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1998, VIS COGN, V2, P1; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pessoa L, 1998, TRENDS COGN SCI, V2, P422, DOI 10.1016/S1364-6613(98)01237-6; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; REDIES C, 1981, PERCEPTION, V10, P667, DOI 10.1068/p100667; REDIES C, 1984, VISION RES, V24, P1301, DOI 10.1016/0042-6989(84)90185-8; SHIRNOJO S, 1999, NEUR ABSTR, P1053; SHIVELY F, 1973, PERCEPT PSYCHOPHYS, V13, P525, DOI 10.3758/BF03205814; SINDERMANN F, 1972, VISION RES, V12, P763, DOI 10.1016/0042-6989(72)90002-8; TAKEICHI H, 1992, PERCEPTION, V21, P313, DOI 10.1068/p210313; VANTUIJL HFJM, 1975, ACTA PSYCHOL, V39, P441, DOI 10.1016/0001-6918(75)90042-6; Varin D., 1971, RIV PSICOL, V65, P101; VIRSU V, 1977, VISION RES, V17, P853, DOI 10.1016/0042-6989(77)90129-8; VIRSU V, 1962, MED BIOL, V56, P84; WARE C, 1980, PERCEPTION, V9, P103, DOI 10.1068/p090103	33	93	94	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1677	1680		10.1126/science.1060161	http://dx.doi.org/10.1126/science.1060161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	469FA	11533495				2022-12-28	WOS:000170802900068
J	SUMMERS, DP; CHANG, S				SUMMERS, DP; CHANG, S			PREBIOTIC AMMONIA FROM REDUCTION OF NITRITE BY IRON(II) ON THE EARLY EARTH	NATURE			English	Article							AQUEOUS-SOLUTION; CARBON-DIOXIDE; ATMOSPHERE; EVOLUTION; NITROGEN; FIXATION; SEAWATER; IMPACTS; OXYGEN; SULFUR	THEORIES for the origin of life require the availability of reduced (or 'fixed') nitrogen-containing compounds, in particular ammonia. In reducing atmospheres, such compounds are readily formed by electrical discharges1-2, but geochemical evidence suggests that the early Earth had a non-reducing atmosphere1,3-6, in which discharges would have instead produced NO (refs 7-10). This would have been converted into nitric and nitrous acids and delivered to the early oceans as acid rain11. It is known12-15, however, that Fe(II) was present in the early oceans at much higher concentrations than are found today, and thus the oxidation of Fe(II) to Fe(III) provides a possible means for reducing nitrites and nitrates to ammonia. Here we explore this possibility in a series of experiments which mimic a broad range of prebiotic seawater conditions (the actual conditions on the early Earth remain poorly constrained). We find that the reduction by Fe(II) of nitrites and nitrates to ammonia could have been a significant source of reduced nitrogen on the early Earth, provided that the ocean pH exceeded 7.3 and is favoured for temperatures greater than about 25-degrees-C.			SUMMERS, DP (corresponding author), NASA,AMES RES CTR,MOFFETT FIELD,CA 94035, USA.							BADA JL, 1968, SCIENCE, V159, P423, DOI 10.1126/science.159.3813.423; Broecker W.S., 1982, TRACERS SEA, P243; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Butler J. N., 1982, CARBON DIOXIDE EQUIL; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; DERRY LA, 1990, GEOCHIM COSMOCHIM AC, V54, P2965, DOI 10.1016/0016-7037(90)90114-Z; DOYLE MP, 1984, J AM CHEM SOC, V106, P3678, DOI 10.1021/ja00324a049; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; Freier R.K., 1976, AQUEOUS SOLUTIONS; GRATZEL M, 1970, BERICH BUNSEN GESELL, V74, P1003; GREGOR CB, 1988, CHEM CYCLES EVOLUTIO, P42; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HOLLAND HD, CHEM EVOLUTION ATMOS, P205; HOLLAND HD, 1989, CHEM EVOLUTION ATMOS, pCH4; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KUHN WR, 1983, NATURE, V301, P53, DOI 10.1038/301053a0; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; MATTIOLI GS, 1986, NATURE, V322, P626, DOI 10.1038/322626a0; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, P53; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; TURCOTTE DL, 1980, EARTH PLANET SC LETT, V48, P50; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAFIRIOU OC, 1979, MAR CHEM, V8, P9, DOI 10.1016/0304-4203(79)90029-X; [No title captured]	31	128	130	1	62	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 14	1993	365	6447					630	632		10.1038/365630a0	http://dx.doi.org/10.1038/365630a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB846	11540245				2022-12-28	WOS:A1993MB84600053
J	SCHMUTTENMAER, CA; COHEN, RC; PUGLIANO, N; HEATH, JR; COOKSY, AL; BUSAROW, KL; SAYKALLY, RJ				SCHMUTTENMAER, CA; COHEN, RC; PUGLIANO, N; HEATH, JR; COOKSY, AL; BUSAROW, KL; SAYKALLY, RJ			TUNABLE FAR-IR LASER SPECTROSCOPY OF JET-COOLED CARBON CLUSTERS - THE NU-2 BENDING VIBRATION OF C-3	SCIENCE			English	Article									UNIV CALIF BERKELEY,DIV CHEM SCI,BERKELEY,CA 94720; UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,BERKELEY,CA 94720	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	SCHMUTTENMAER, CA (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.		Cohen, Ronald C/A-8842-2011	Cohen, Ronald C/0000-0001-6617-7691; Cooksy, Andrew/0000-0002-2794-4269; SAYKALLY, RICHARD/0000-0001-8942-3656				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; COHEN RC, 1989, CHEM PHYS LETT, V164, P321, DOI 10.1016/0009-2614(89)85212-1; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; GAUSSET L, 1965, ASTROPHYS J, V142, P45, DOI 10.1086/148262; Herzberg G, 1942, ASTROPHYS J, V96, P314, DOI 10.1086/144464; KAUR D, 1990, APPL OPTICS, V29, P119, DOI 10.1364/AO.29.000119; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; RHEATH JR, 1989, SCIENCE, V244, P564; ROHLFING EA, 1988, J CHEM PHYS, V89, P6103, DOI 10.1063/1.455426; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; ZMUIDZINAS J, 1988, ASTROPHYS J, V335, P774, DOI 10.1086/166966	15	102	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 24	1990	249	4971					897	900		10.1126/science.11538082	http://dx.doi.org/10.1126/science.11538082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV751	11538082				2022-12-28	WOS:A1990DV75100038
J	Lukin, MD; Imamoglu, A				Lukin, MD; Imamoglu, A			Controlling photons using electromagnetically induced transparency	NATURE			English	Article							GROUP-VELOCITY; DISPERSIVE PROPERTIES; NONLINEAR OPTICS; ATOMIC COHERENCE; ENTANGLEMENT; LIGHT; GENERATION; STATES; MEDIA; GAS	It is well known that a dielectric medium can be used to manipulate properties of light pulses. However, optical absorption limits the extent of possible control: this is especially important for weak light pulses. Absorption in an opaque medium can be eliminated via quantum mechanical interference, an effect known as electromagnetically induced transparency. Theoretical and experimental work has demonstrated that this phenomenon can be used to slow down light pulses dramatically, or even bring them to a complete halt. Interactions between photons in such an atomic medium can be many orders of magnitude stronger than in conventional optical materials.	Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, ITAMP, Cambridge, MA 02138 USA; Sabanci Univ, Fac Engn & Nat Sci, TR-81474 Istanbul, Turkey	University of California System; University of California Santa Barbara; Harvard University; Harvard University; Sabanci University	Imamoglu, A (corresponding author), Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA.							Arimondo E., 1996, PROGR OPTICS, V35, P259; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Boyd R. W., 2003, NONLINEAR OPTICS; Budker D, 1999, PHYS REV LETT, V83, P1767, DOI 10.1103/PhysRevLett.83.1767; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; DUAN LM, UNPUB NATURE; DUAN LM, QUANTPH0105105; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Ham BS, 1997, OPT LETT, V22, P1138, DOI 10.1364/OL.22.001138; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; HARRIS SE, 1992, PHYS REV A, V46, pR29, DOI 10.1103/PhysRevA.46.R29; Harris SE, 1999, PHYS REV LETT, V82, P4611, DOI 10.1103/PhysRevLett.82.4611; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; HEMMER P, 1996, OPT LETT, V20, P982; Imamoglu A, 2000, OPT COMMUN, V179, P179, DOI 10.1016/S0030-4018(99)00667-7; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Jain M, 1996, PHYS REV LETT, V77, P4326, DOI 10.1103/PhysRevLett.77.4326; KASAPI A, 1995, PHYS REV LETT, V74, P2447, DOI 10.1103/PhysRevLett.74.2447; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Kocharovskaya O, 2001, PHYS REV LETT, V86, P628, DOI 10.1103/PhysRevLett.86.628; Liang JQ, 2000, PHYS REV LETT, V85, P2474, DOI 10.1103/PhysRevLett.85.2474; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lukin MD, 1999, PHYS REV LETT, V82, P1847, DOI 10.1103/PhysRevLett.82.1847; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Lukin MD, 1997, PHYS REV LETT, V79, P2959, DOI 10.1103/PhysRevLett.79.2959; Lukin MD, 2000, PHYS REV LETT, V84, P4232, DOI 10.1103/PhysRevLett.84.4232; Lukin MD, 2000, PHYS REV LETT, V84, P1419, DOI 10.1103/PhysRevLett.84.1419; MAIR A, UNPUB PHYS REV LETT; Matsko AB, 2001, PHYS REV LETT, V86, P2006, DOI 10.1103/PhysRevLett.86.2006; OREG J, 1984, PHYS REV A, V29, P690, DOI 10.1103/PhysRevA.29.690; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Schmidt H, 1996, OPT LETT, V21, P1936, DOI 10.1364/OL.21.001936; Schmidt O, 1996, PHYS REV A, V53, pR27, DOI 10.1103/PhysRevA.53.R27; Scully M.O., 1997, QUANTUM OPT; Shvydko YV, 1996, PHYS REV LETT, V77, P3232, DOI 10.1103/PhysRevLett.77.3232; Sokolov AV, 2000, PHYS REV LETT, V85, P562, DOI 10.1103/PhysRevLett.85.562; Vitali D, 2000, PHYS REV LETT, V85, P445, DOI 10.1103/PhysRevLett.85.445; XIAO M, 1995, PHYS REV LETT, V74, P666, DOI 10.1103/PhysRevLett.74.666; Zibrov AS, 1999, PHYS REV LETT, V83, P4049, DOI 10.1103/PhysRevLett.83.4049; [No title captured]	41	625	649	4	93	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					273	276		10.1038/35095000	http://dx.doi.org/10.1038/35095000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565022				2022-12-28	WOS:000171040500029
J	Reilly, BM				Reilly, BM			Pronouncing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Cook Cty Hosp, Dept Med, Room 2129,1835 W Harrison St, Chicago, IL 60612 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					467	470		10.7326/0003-4819-135-6-200109180-00017	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560461				2022-12-28	WOS:000170972500009
J	Vasbinder, GBC; Nelemans, PJ; Kessels, AGH; Kroon, AA; de Leeuw, PW; van Engelshoven, JMA				Vasbinder, GBC; Nelemans, PJ; Kessels, AGH; Kroon, AA; de Leeuw, PW; van Engelshoven, JMA			Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ENHANCED MR-ANGIOGRAPHY; TIME-OF-FLIGHT; MAGNETIC-RESONANCE ANGIOGRAPHY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; COLOR DOPPLER SONOGRAPHY; CODED DUPLEX SONOGRAPHY; SPIRAL CT ANGIOGRAPHY; CAPTOPRIL RENOGRAPHY; BREATH-HOLD	Purpose: To summarize and compare the validity of computed tomography angiography, magnetic resonance angiography, ultrasonography, captopril renal scintigraphy, and the captopril test for diagnosis of renal artery stenosis in patients suspected of having renovascular hypertension. Data Sources: For each diagnostic modality, published studies were identified by MEDLINE literature searches. Study Selection: Original studies were selected if they met the following criteria: 1) suspicion of renovascular hypertension was the indication for the test; 2) intra-arterial x-ray angiography was used as the gold standard; 3) a cutoff point for a positive test result was explicitly defined; and 4) absolute numbers of true-positive, false-negative, true-negative, and false-positive results were available or could be derived from the presented data. Data Extraction: A standard form was used to extract relevant data. Data Synthesis: Data on the accuracy of the different diagnostic methods were analyzed and compared by constructing summary receiver-operating characteristic (ROC) curves and by computing areas under the summary ROC curves. Results: Although accuracy varied greatly for all diagnostic modalities, summary ROC curves found that computed tomography angiography and gadolinium-enhanced, three-dimensional magnetic resonance angiography performed significantly better than the other diagnostic tests. Conclusions: Computed tomography angiography and gadolinium-enhanced three-dimensional magnetic resonance angiography seem to be preferred in patients referred for evaluation of renovascular hypertension. However, because few studies of these tests have been published, further research is recommended.	Univ Hosp Maastricht, Dept Radiol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Vasbinder, GBC (corresponding author), Univ Hosp Maastricht, Dept Radiol, Box 5800, NL-6202 AZ Maastricht, Netherlands.	bvas@rdia.azm.nl	de Leeuw, Peter W./J-4552-2016	de Leeuw, Peter W./0000-0002-4949-5812				[Anonymous], 1987, ARCH INTERN MED, V147, P820; ARLART IP, 1992, ROFO FORTSCHR RONTG, V157, P59, DOI 10.1055/s-2008-1032966; BARDELLI M, 1992, J HYPERTENS, V10, P985; Baxter GM, 1996, BRIT J RADIOL, V69, P810, DOI 10.1259/0007-1285-69-825-810; Bongers V, 2000, CLIN RADIOL, V55, P346, DOI 10.1053/crad.2000.0435; BORRELLO JA, 1995, RADIOLOGY, V197, P793, DOI 10.1148/radiology.197.3.7480758; BREITENSEHER M, 1992, ROFO FORTSCHR RONTG, V156, P228, DOI 10.1055/s-2008-1032873; Claudon M, 2000, RADIOLOGY, V214, P739, DOI 10.1148/radiology.214.3.r00fe02739; De Cobelli F, 2000, RADIOLOGY, V214, P373, DOI 10.1148/radiology.214.2.r00fe14373; DeCobelli F, 1996, RADIOLOGY, V201, P697, DOI 10.1148/radiology.201.3.8939218; deHaan MW, 1996, RADIOLOGY, V198, P449, DOI 10.1148/radiology.198.2.8596848; DERKX FHM, 1994, LANCET, V344, P237, DOI 10.1016/S0140-6736(94)93002-3; DONDI M, 1990, CONTRIB NEPHROL, V79, P181; Dondi M, 1992, J Nucl Biol Med, V36, P309; DUNNICK NR, 1991, RADIOL CLIN N AM, V29, P497; Eardley KS, 1999, J HUM HYPERTENS, V13, P217, DOI 10.1038/sj.jhh.1000785; Efron B, 1993, INTRO BOOTSTRAP, P313; Equine O, 1999, ARCH MAL COEUR VAISS, V92, P1043; FELLNER C, 1995, RADIOLOGY, V196, P681, DOI 10.1148/radiology.196.3.7644629; FOMMEI E, 1993, EUR J NUCL MED, V20, P617; GALANSKI M, 1994, ROFO FORTSCHR RONTG, V161, P519, DOI 10.1055/s-2008-1032579; Gezici A, 1999, UROL INT, V62, P1, DOI 10.1159/000030345; Halpern EJ, 1998, ACAD RADIOL, V5, P524, DOI 10.1016/S1076-6332(98)80203-1; HANDA N, 1988, J HYPERTENS, V6, pS458, DOI 10.1097/00004872-198812040-00144; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Kaatee R, 1997, RADIOLOGY, V205, P121, DOI 10.1148/radiology.205.1.9314973; KAHN D, 1994, NUCL MED COMMUN, V15, P515, DOI 10.1097/00006231-199407000-00005; Kaplan-Pavlovcic S, 1998, NEPHROL DIAL TRANSPL, V13, P313, DOI 10.1093/oxfordjournals.ndt.a027824; KARASCH T, 1993, DEUT MED WOCHENSCHR, V118, P1429, DOI 10.1055/s-2008-1059470; Kester ADM, 2000, MED DECIS MAKING, V20, P430, DOI 10.1177/0272989X0002000407; KLIEWER MA, 1993, RADIOLOGY, V189, P779, DOI 10.1148/radiology.189.3.8234704; Korst MBJM, 2000, AM J ROENTGENOL, V174, P629, DOI 10.2214/ajr.174.3.1740629; Laissy JP, 1996, MAGN RESON IMAGING, V14, P1033, DOI 10.1016/S0730-725X(96)00097-5; Leung DA, 1998, JMRI-J MAGN RESON IM, V8, P598, DOI 10.1002/jmri.1880080313; Loubeyre P, 1996, AM J ROENTGENOL, V167, P489, DOI 10.2214/ajr.167.2.8686634; Lucas P, 1996, Australas Radiol, V40, P276, DOI 10.1111/j.1440-1673.1996.tb00403.x; MANN SJ, 1992, ANN INTERN MED, V117, P845, DOI 10.7326/0003-4819-117-10-845; MANN SJ, 1991, AM J MED, V90, P30, DOI 10.1016/0002-9343(91)90503-P; MIRALLES M, 1993, EUR J VASCULAR SURG, V7, P188, DOI 10.1016/S0950-821X(05)80761-3; Miralles M, 1996, J VASC SURG, V23, P428, DOI 10.1016/S0741-5214(96)80007-3; Mittal BR, 1996, AM J KIDNEY DIS, V28, P209, DOI 10.1016/S0272-6386(96)90303-0; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; NITZSCHE E, 1991, RADIOLOGE, V31, P141; OLBRICT CJ, 1995, KIDNEY INT, V48, P1332, DOI 10.1038/ki.1995.418; OLIN JW, 1995, ANN INTERN MED, V122, P833, DOI 10.7326/0003-4819-122-11-199506010-00004; Oliva VL, 1998, AM J ROENTGENOL, V170, P169, DOI 10.2214/ajr.170.1.9423626; Pedersen E. B., 1996, Blood Pressure, V5, P342, DOI 10.3109/08037059609078072; POSTMA CT, 1990, ARCH INTERN MED, V150, P625, DOI 10.1001/archinte.150.3.625; POSTMA CT, 1992, BRIT J RADIOL, V65, P857, DOI 10.1259/0007-1285-65-778-857; Postma CT, 1997, AM J HYPERTENS, V10, P957, DOI 10.1016/S0895-7061(97)00157-X; Postma CT, 1996, J HUM HYPERTENS, V10, P181; Rieumont MJ, 1997, AM J ROENTGENOL, V169, P39, DOI 10.2214/ajr.169.1.9207498; SCHREIJ G, 1995, J HUM HYPERTENS, V9, P741; SETARO JF, 1991, AM J HYPERTENS, V4, pS698, DOI 10.1093/ajh/4.12.698S; SMITH HJ, 1993, ACTA RADIOL, V34, P150; Spies KP, 1995, AM J HYPERTENS, V8, P1222, DOI 10.1016/0895-7061(95)00250-2; STEPHAN D, 1993, ARCH MAL COEUR VAISS, V86, P1249; STROTZER M, 1995, ACTA RADIOL, V36, P243; STRUNK H, 1995, ROFO FORTSCHR RONTG, V162, P420, DOI 10.1055/s-2007-1015909; SVETKEY LP, 1991, AM J HYPERTENS, V4, pS711, DOI 10.1093/ajh/4.12.711S; Thornton J, 1999, EUR RADIOL, V9, P930, DOI 10.1007/s003300050769; Tremel F, 1996, ARCH MAL COEUR VAISS, V89, P1035; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Vigna C, 1998, AM J CARDIOL, V81, P365, DOI 10.1016/S0002-9149(97)00922-3; Wittenberg G, 1999, EUR RADIOL, V9, P546, DOI 10.1007/s003300050707; ZOLLER WG, 1990, KLIN WOCHENSCHR, V68, P830, DOI 10.1007/BF01796273	66	252	263	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					401	411		10.7326/0003-4819-135-6-200109180-00009	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560453				2022-12-28	WOS:000170972500002
J	Romanowicz, B; Giardini, D				Romanowicz, B; Giardini, D			Geophysics - The future of permanent seismic networks	SCIENCE			English	Editorial Material									Berkeley Seismol Lab, Berkeley, CA 94720 USA; ETH Zurich, Inst Geophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Romanowicz, B (corresponding author), Berkeley Seismol Lab, Berkeley, CA 94720 USA.		Romanowicz, barbara A/H-6726-2017; Giardini, Domenico/F-5406-2011	Romanowicz, barbara A/0000-0002-6208-6044; 				DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; Nolet G., 1986, ORFEUS SCI PLAN, P45; Romanowicz B.A., 1986, EOS T AM GEOPHYS UN, V67, P541	3	15	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2000	2001		10.1126/science.1061771	http://dx.doi.org/10.1126/science.1061771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557863				2022-12-28	WOS:000171028700036
J	Brass, EP				Brass, EP			Drug therapy: Changing the status of drugs from prescription to over-the-counter availability.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TO-OTC SWITCH; RECLASSIFICATION; PERSPECTIVES; GUIDELINES; VAGINITIS; SAFETY; RX		Harbor UCLA Med Ctr, Dept Med, Ctr Clin Pharmacol, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Brass, EP (corresponding author), Harbor UCLA Med Ctr, Dept Med, Ctr Clin Pharmacol, 1124 W Carson St, Torrance, CA 90502 USA.							Andrade SE, 1999, MED CARE, V37, P424, DOI 10.1097/00005650-199904000-00012; Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; *BRIST SQUIBB, 2000, FDA NONPR DRUGS ADV; Carlsten A, 1997, J CLIN PHARM THER, V22, P155; *CONS HEALTHC PROD, 2001, OTC SAL CAT; Consumer Healthcare Products Association, 2001, OTC FACTS FIG; Consumer Healthcare Products Association, 2001, CONS SURV SELF MED; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Frolkis JP, 1998, CIRCULATION, V98, P851, DOI 10.1161/01.CIR.98.9.851; GOSSEL TA, 1991, CLIN THER, V13, P200; Hollenbeak CS, 1999, PHARMACOECONOMICS, V16, P661, DOI 10.2165/00019053-199916060-00005; Juhl RP, 1998, CLIN THER, V20, pC111, DOI 10.1016/S0149-2918(98)80015-5; LESKO SM, 1995, JAMA-J AM MED ASSOC, V273, P929, DOI 10.1001/jama.273.12.929; Lipsky MS, 1999, ARCH FAM MED, V8, P297, DOI 10.1001/archfami.8.4.297; *MERCK, 2000, FDA NONPR DRUGS ADV; Rosenau P V, 1994, Med Care Rev, V51, P429, DOI 10.1177/107755879405100403; Sande MA, 1998, CLIN INFECT DIS, V26, P659, DOI 10.1086/514584; Schulke DG, 1998, CLIN THER, V20, pC124, DOI 10.1016/S0149-2918(98)80017-9; Shlaes DM, 1997, CLIN INFECT DIS, V25, P584, DOI 10.1086/513766; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; TAYLOR CA, 1994, J FAM PRACTICE, V38, P157; TEMIN P, 1983, J HEALTH ECON, V2, P187, DOI 10.1016/0167-6296(83)90016-4	22	100	100	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					810	816		10.1056/NEJMra011080	http://dx.doi.org/10.1056/NEJMra011080			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556302				2022-12-28	WOS:000170906800007
J	Harrison, SP; Yu, G; Takahara, H; Prentice, IC				Harrison, SP; Yu, G; Takahara, H; Prentice, IC			Palaeovegetation - Diversity of temperate plants in east Asia	NATURE			English	Article									Max Planck Inst Biogeochem, D-07701 Jena, Germany; Lund Univ, S-22300 Lund, Sweden; Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China; Kyoto Prefectural Univ, Univ Forest, Kyoto 606, Japan	Max Planck Society; Lund University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Kyoto Prefectural University	Harrison, SP (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.		Takahara, Hikaru/AAZ-6642-2020	Harrison, Sandy/0000-0001-5687-1903					0	314	340	1	108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					129	130		10.1038/35093166	http://dx.doi.org/10.1038/35093166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557970				2022-12-28	WOS:000170918800036
J	Sharp, D				Sharp, D			The psychology of employment	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), The Lancet, London WC1X 8RR, England.							COHEN D, 1999, SUCCEED PSYCHOMETRIC; LEATHAM S, DATA PROTECTION PSYC; Parkinson M., 2000, MASTER PSYCHOMETRIC; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; WINNETT R, 2001, SUNDAY TIMES LO 0701, P7	5	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					779	780		10.1016/S0140-6736(01)06009-3	http://dx.doi.org/10.1016/S0140-6736(01)06009-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564480				2022-12-28	WOS:000170989300006
J	Cederberg, A; Gronning, LM; Ahren, B; Tasken, K; Carlsson, P; Enerback, S				Cederberg, A; Gronning, LM; Ahren, B; Tasken, K; Carlsson, P; Enerback, S			FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance	CELL			English	Article							ENHANCER-BINDING-PROTEIN; PPAR-GAMMA ACTIVATORS; TARGETED DISRUPTION; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; UNCOUPLING PROTEIN; EXPRESSION; ALPHA; MICE	Obesity, hyperlipidemia, and insulin resistance are common forerunners of type 2 diabetes mellitus. We have identified the human winged helix/forkhead transcription factor gene FOXC2 as a key regulator of adipocyte metabolism. Increased FOXC2 expression, in adipocytes, has a pleiotropic effect on gene expression, which leads to a lean and insulin sensitive phenotype. FOXC2 affects adipocyte metabolism by increasing the sensitivity of the beta -adrenergic-cAMP-protein kinase A (PIKA) signaling pathway through alteration of adipocyte PKA holoenzyme composition. Increased FOXC2 levels, induced by high fat diet, seem to counteract most of the symptoms associated with obesity, including hypertriglyceridemia and diet-induced insulin resistance-a likely consequence hereof would bo protection against type 2 diabetes.	Univ Gothenburg, Dept Med Biochem, SE-40530 Gothenburg, Sweden; Univ Oslo, Inst Med Biochem, N-0317 Oslo, Norway; Lund Univ, Malmo Univ Hosp, Dept Med, SE-20520 Malmo, Sweden	University of Gothenburg; University of Oslo; Lund University; Skane University Hospital	Enerback, S (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.	sven.enerback@medgen.gu.se	Carlsson, Peter/B-5551-2008	Carlsson, Peter/0000-0001-6535-5927; Tasken, Kjetil/0000-0003-2841-4697				ABBOTT WGH, 1987, METABOLISM, V36, P576, DOI 10.1016/0026-0495(87)90170-3; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Coe NR, 1999, J LIPID RES, V40, P967; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; ENERBACK S, 1992, MOL CELL BIOL, V12, P4622, DOI 10.1128/MCB.12.10.4622; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fajas L, 1999, MOL CELL BIOL, V19, P5495; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iida K, 1997, DEVELOPMENT, V124, P4627; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Lowell BB, 1997, ANNU REV MED, V48, P307; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Murray I, 1999, J BIOL CHEM, V274, P36219, DOI 10.1074/jbc.274.51.36219; ORahilly S, 1997, NAT MED, V3, P1080, DOI 10.1038/nm1097-1080; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TASKEN K, 1993, J BIOL CHEM, V268, P23483; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095; Zimmet PZ, 1997, LANCET, V350, pSI1	43	414	439	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					563	573		10.1016/S0092-8674(01)00474-3	http://dx.doi.org/10.1016/S0092-8674(01)00474-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551504	Bronze			2022-12-28	WOS:000170973200007
J	Otto, CM				Otto, CM			Evaluation and management of chronic mitral regurgitation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR PERFORMANCE; NATURAL-HISTORY; VALVE PROLAPSE; FLAIL LEAFLET; SECONDARY; REPLACEMENT; DISEASE		Univ Washington, Div Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Otto, CM (corresponding author), Univ Washington, Div Cardiol, Seattle, WA 98195 USA.			Otto, Catherine/0000-0002-0527-9392				AKINS CW, 1994, ANN THORAC SURG, V58, P668, DOI 10.1016/0003-4975(94)90725-0; Bach DS, 1996, AM J CARDIOL, V78, P966, DOI 10.1016/S0002-9149(96)00481-X; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Carabello BA, 2000, J HEART VALVE DIS, V9, P600; CORIN WJ, 1995, J AM COLL CARDIOL, V25, P113, DOI 10.1016/0735-1097(94)00354-S; CRAWFORD MH, 1990, CIRCULATION, V81, P1173, DOI 10.1161/01.CIR.81.4.1173; DAVID TE, 1993, ANN THORAC SURG, V56, P7, DOI 10.1016/0003-4975(93)90396-Y; DELAHAYE JP, 1991, EUR HEART J, V12, P5, DOI 10.1093/eurheartj/12.suppl_B.5; Desjardins VA, 1996, AM J MED, V100, P149, DOI 10.1016/S0002-9343(97)89452-1; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; Flemming MA, 2000, AM HEART J, V140, P476, DOI 10.1067/mhj.2000.108242; Galloway A C, 1995, Semin Thorac Cardiovasc Surg, V7, P227; Grigioni F, 1999, J AM COLL CARDIOL, V34, P2078, DOI 10.1016/S0735-1097(99)00474-X; KONO T, 1992, J AM COLL CARDIOL, V20, P1594, DOI 10.1016/0735-1097(92)90455-V; Levine HJ, 1996, J AM COLL CARDIOL, V28, P1083, DOI 10.1016/S0735-1097(96)00288-4; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; MARCUS RH, 1994, ANN INTERN MED, V120, P177, DOI 10.7326/0003-4819-120-3-199402010-00001; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; Otto CM., 2000, TXB CLIN ECHOCARDIOG, V2nd, P265; OWINGS MF, 1999, VITAL HLTH STAT, V13; RANKIN JS, 1989, CIRCULATION, V79, P116; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; ROTHLISBERGER C, 1994, AM J CARDIOL, V73, P978, DOI 10.1016/0002-9149(94)90148-1; Tischler MD, 1998, AM J CARDIOL, V82, P242, DOI 10.1016/S0002-9149(98)00325-7	25	121	137	1	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					740	746		10.1056/NEJMcp003331	http://dx.doi.org/10.1056/NEJMcp003331			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547744				2022-12-28	WOS:000170772900007
J	He, XL; Chow, DC; Martick, MM; Garcia, KC				He, XL; Chow, DC; Martick, MM; Garcia, KC			Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone	SCIENCE			English	Article							STABLE ENTEROTOXIN RECEPTOR; A GUANYLYL CYCLASE; GLYCOSYLATION SITES; BINDING DOMAIN; ATRIAL; PROTEIN; LIGAND; HEAT; IDENTIFICATION; PHARMACOLOGY	Natriuretic peptides (NPs) are vasoactive cyclic-peptide hormones important in blood pressure regulation through interaction with natriuretic cell-surface receptors. We report the hormone-binding thermodynamics and crystal structures at 2.9 and 2.0 angstroms, respectively, of the extracellular domain of the unliganded human NP receptor (NPR-C) and its complex with CNP, a 22-amino acid NP. A single CNP molecule is bound in the interface of an NPR-C dimer, resulting in asymmetric interactions between the hormone and the symmetrically related receptors. Hormone binding induces a 20 angstrom closure between the membrane-proximal domains of the dimer. In each monomer, the opening of an interdomain cleft, which is tethered together by a linker peptide acting as a molecular spring, is likely a conserved allosteric trigger for intracellular signaling by the natriuretic receptor family.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 93405 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 93405 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 93405 USA.	kcgarcia@stanford.edu						Anand-Srivastava MB, 2000, BIOCHEMISTRY-US, V39, P6503, DOI 10.1021/bi992660q; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; DUDA T, 1995, BIOCHEM BIOPH RES CO, V212, P1046, DOI 10.1006/bbrc.1995.2075; ENGEL AM, 1994, J BIOL CHEM, V269, P17005; ENGEL AM, 1995, FEBS LETT, V360, P169, DOI 10.1016/0014-5793(95)00096-R; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FAIRBROTHER WJ, 1994, BIOCHEMISTRY-US, V33, P8897, DOI 10.1021/bi00196a006; Fenrick R, 1996, MOL CELL BIOCHEM, V165, P103, DOI 10.1007/BF00229471; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; Hasegawa M, 1999, EUR J BIOCHEM, V263, P338, DOI 10.1046/j.1432-1327.1999.00488.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itakura M, 1997, BIOCHEM J, V322, P585, DOI 10.1042/bj3220585; Janin J, 1997, STRUCTURE, V5, P473, DOI 10.1016/S0969-2126(97)00204-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1992, J BIOL CHEM, V267, P21691; Lucas KA, 2000, PHARMACOL REV, V52, P375; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Misono KS, 2000, CIRC RES, V86, P1135; Misono KS, 1999, BIOCHEMISTRY-US, V38, P516, DOI 10.1021/bi982127v; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Mowbray SL, 1999, J MOL BIOL, V294, P487, DOI 10.1006/jmbi.1999.3271; Pedro L, 1998, MOL CELL BIOCHEM, V178, P95, DOI 10.1023/A:1006808604321; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; RUDNER XL, 1995, P NATL ACAD SCI USA, V92, P5169, DOI 10.1073/pnas.92.11.5169; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; STULTS JT, 1994, BIOCHEMISTRY-US, V33, P11372, DOI 10.1021/bi00203a036; Takida S, 1999, HYPERTENSION, V33, P124, DOI 10.1161/01.HYP.33.1.124; Trachte GJ, 2000, J PHARMACOL EXP THER, V294, P210; TRACHTE GJ, 1995, AM J PHYSIOL-CELL PH, V268, pC978, DOI 10.1152/ajpcell.1995.268.4.C978; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; Wada A, 1996, INFECT IMMUN, V64, P5144, DOI 10.1128/IAI.64.12.5144-5150.1996	46	139	150	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1657	1662		10.1126/science.1062246	http://dx.doi.org/10.1126/science.1062246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533490				2022-12-28	WOS:000170802900063
J	Heyduk, AF; Nocera, DG				Heyduk, AF; Nocera, DG			Hydrogen produced from hydrohalic acid solutions by a two-electron mixed-valence photocatalyst	SCIENCE			English	Article							SOLAR-ENERGY STORAGE; METAL-COMPLEXES; RHODIUM; PHOTOCHEMISTRY; REDUCTION	Energy conversion cycles are aimed at driving unfavorable, small-molecule activation reactions with a photon harnessed by a transition metal complex. A challenge that has occupied researchers for several decades is to create molecular photocatalysts to promote the production of hydrogen from homogeneous solution. We now report the use of a two-electron mixed-valence dirhodium compound to photocatalyze the reduction of hydrohalic acid to hydrogen. In this cycle, photons break two R-II-X bonds of a LRhO-(RX2)-X-II core in the presence of a halogen trap to regenerate the active LRhO-Rh-O catalyst, which reacts with hydrohalic acid to produce hydrogen.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Nocera, DG (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.							Albright T. A., 1985, ORBITAL INTERACTIONS; BALCH AL, 1979, J AM CHEM SOC, V101, P3128, DOI 10.1021/ja00505a055; BROWN GM, 1979, J AM CHEM SOC, V101, P1298, DOI 10.1021/ja00499a051; Chanon M., 1988, PHOTOINDUCED ELECT T; CHERN SS, 1994, CHEM COMMUN, P1645; Ciamician G, 1912, Science, V36, P385, DOI 10.1126/science.36.926.385; COLLINSON E, 1959, T FARADAY SOC, V55, P2096, DOI 10.1039/tf9595502096; EVANS D, 1968, J CHEM SOC A, P2660, DOI 10.1039/j19680002660; GRATZEL M., 2001, ELECT TRANSFER CHEM, V5, P589; GRAY HB, 1981, SCIENCE, V214, P1201, DOI 10.1126/science.214.4526.1201; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; HEIDT LJ, 1962, J PHYS CHEM-US, V66, P336, DOI 10.1021/j100808a034; Heyduk AF, 1999, J AM CHEM SOC, V121, P5023, DOI 10.1021/ja9902017; MANN KR, 1977, J AM CHEM SOC, V99, P5525, DOI 10.1021/ja00458a071; MANN KR, 1980, J AM CHEM SOC, V102, P3965, DOI 10.1021/ja00531a056; Norris Jr J. R., 1989, PHOTOCHEMICAL ENERGY; Odom AL, 2000, INORG CHIM ACTA, V297, P330, DOI 10.1016/S0020-1693(99)00376-X; Sakata T., 1983, ENERGY RESOURCES PHO, P332; SIGAL IS, 1980, J AM CHEM SOC, V102, P7252, DOI 10.1021/ja00544a014; Sutin N, 1997, COMMENT INORG CHEM, V19, P67, DOI 10.1080/02603599708032729; WOODCOCK C, 1984, INORG CHEM, V23, P4207, DOI 10.1021/ic00193a022	22	284	288	5	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1639	1641		10.1126/science.1062965	http://dx.doi.org/10.1126/science.1062965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533485				2022-12-28	WOS:000170802900057
J	CALDEIRA, K; KASTING, JF				CALDEIRA, K; KASTING, JF			SUSCEPTIBILITY OF THE EARLY EARTH TO IRREVERSIBLE GLACIATION CAUSED BY CARBON-DIOXIDE CLOUDS	NATURE			English	Article							CLIMATE; CO2; LUMINOSITY; FEEDBACK; MARS	SIMPLE energy-balance climate models of the Budyko/Sellers type1,2 predict that a small (2-5%) decrease in solar output could result in runaway glaciation on the Earth. But solar fluxes 25-30% lower early in the Earth's history3,4 apparently did not lead to this result. One currently favoured explanation is that high partial pressures of carbon dioxide, caused by higher volcanic outgassing rates and/or slower rates of silicate weathering, created a large enough greenhouse effect to keep the planet warm5-7. This does not resolve the problem of climate stability, however, because as we argue here, the oceans can freeze much more quickly than CO2 can accumulate in the atmosphere. Had such a transient global glaciation occurred in the distant past when solar luminosity was low, it might have been irreversible because of the formation of highly reflective CO2 clouds, similar to those encountered in climate simulations of early Mars8. Our simulations of the early Earth, incorporating the possible formation of such clouds, suggest that the Earth might not be habitable today had it not been warm during the first part of its history.	PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CALDEIRA, K (corresponding author), PENN STATE UNIV,CTR EARTH SYST SCI,UNIV PK,PA 16802, USA.		Caldeira, Ken/E-7914-2011; Kasting, James/AAF-6851-2020	Caldeira, Ken/0000-0002-4591-643X; 				Allaart J. H., 1976, EARLY HIST EARTH, P177; BUDYKO MI, 1969, TELLUS, V21, P611, DOI 10.3402/tellusa.v21i5.10109; CAHALAN RF, 1979, J ATMOS SCI, V36, P1178, DOI 10.1175/1520-0469(1979)036<1178:ASTFEB>2.0.CO;2; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; HAMBREY MJ, 1985, PALAEOGEOGR PALAEOCL, V51, P255, DOI 10.1016/0031-0182(85)90088-4; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, IN PRESS ICARUS; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MARSHALL HG, 1988, J GEOPHYS RES-ATMOS, V93, P791, DOI 10.1029/JD093iD01p00791; MCWILLIAMS MO, 1980, J GEOL, V88, P1, DOI 10.1086/628470; NORTH GR, 1981, REV GEOPHYS, V19, P91, DOI 10.1029/RG019i001p00091; NORTH GR, 1979, J ATMOS SCI, V36, P1189, DOI 10.1175/1520-0469(1979)036<1189:DBSAMA>2.0.CO;2; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; Sellers W.D., 1969, J APPL METEOROL, V8, P392, DOI [DOI 10.1175/1520-0450(1969)008<0392:AGCMBO>2.0.CO;2, 10.1175/1520-0450(1969)0082.0.CO;2]; SUNDQUIST ET, 1991, QUATERNARY SCI REV, V10, P283, DOI 10.1016/0277-3791(91)90026-Q; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALTER M, 1979, AM SCI, V67, P142; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; WORSLEY TR, 1992, GEOLOGY, V19, P1161	23	159	168	2	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 17	1992	359	6392					226	228		10.1038/359226a0	http://dx.doi.org/10.1038/359226a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JN944	11540934				2022-12-28	WOS:A1992JN94400057
J	Schrope, M				Schrope, M			Listing resumes for species at risk	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					7	7		10.1038/35092677	http://dx.doi.org/10.1038/35092677			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544490	Bronze			2022-12-28	WOS:000170801200007
J	Schrope, M				Schrope, M			Environmental laws face military manoeuvres	NATURE			English	News Item																		2001, NATURE, V410, P505	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					7	7		10.1038/35092677	http://dx.doi.org/10.1038/35092677			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544490	Bronze			2022-12-28	WOS:000170801200006
